data_2lku_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lku _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.21 -49.73 26.37 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.159 0.89 . . . . 0.0 111.7 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.6 -34.15 76.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.472 -0.768 . . . . 0.0 112.04 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -61.52 -42.56 98.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.422 1.889 . . . . 0.0 111.934 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.756 1.223 . . . . 0.0 110.933 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.82 -45.6 85.92 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.712 0.805 . . . . 0.0 111.312 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.19 -43.73 95.64 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.239 0.927 . . . . 0.0 112.389 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -60.41 -42.93 97.0 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.352 -0.843 . . . . 0.0 111.892 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.12 -48.97 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 119.175 0.898 . . . . 0.0 111.148 173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.84 -38.25 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.051 1.34 . . . . 0.0 112.853 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -81.8 -28.83 32.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 0.0 112.834 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -78.1 -31.2 49.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -138.06 114.78 10.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.412 1.485 . . . . 0.0 109.737 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -66.56 -20.67 66.07 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.1 t -119.62 123.71 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.793 1.237 . . . . 0.0 109.119 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.64 139.09 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.344 1.058 . . . . 0.0 109.563 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.91 135.72 54.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.311 1.444 . . . . 0.0 110.02 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.57 116.64 29.11 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.353 1.061 . . . . 0.0 108.775 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ptm -162.16 176.05 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.492 1.517 . . . . 0.0 110.791 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.56 26.97 0.75 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.711 -1.243 . . . . 0.0 113.617 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.42 169.79 39.35 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.6 1.572 . . . . 0.0 113.266 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.2 p -97.75 176.37 5.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.072 1.349 . . . . 0.0 111.272 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -66.43 -26.32 67.17 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.804 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -86.29 -27.0 24.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.468 1.507 . . . . 0.0 112.401 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.93 78.51 59.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 0.0 110.678 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.11 178.99 1.64 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.322 3.348 . . . . 0.0 113.622 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -130.36 138.08 50.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.552 1.141 . . . . 0.0 109.688 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.18 160.99 28.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.651 1.18 . . . . 0.0 113.661 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.78 -126.56 8.22 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.633 1.111 . . . . 0.0 111.527 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -56.12 -49.55 73.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.933 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -52.2 66.11 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 111.323 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -57.83 -39.11 76.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.393 0.677 . . . . 0.0 111.337 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.5 m -63.27 -51.89 64.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.546 1.139 . . . . 0.0 110.935 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.24 -44.61 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.565 0.62 . . . . 0.0 111.088 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -61.28 -47.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.637 0.775 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -64.18 -40.5 96.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.224 1.01 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mt -59.71 -51.35 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.737 0.815 . . . . 0.0 111.291 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.17 -46.83 82.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.627 0.771 . . . . 0.0 111.286 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -52.6 -52.46 55.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.352 0.661 . . . . 0.0 110.727 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.5 m -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.527 1.931 . . . . 0.0 114.684 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.46 -39.46 76.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.711 0.804 . . . . 0.0 109.701 170.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 t30 123.74 68.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.979 3.712 . . . . 0.0 109.546 169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.93 152.56 28.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.28 178.49 7.56 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.675 2.916 . . . . 0.0 110.21 169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -163.48 141.2 7.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.856 1.263 . . . . 0.0 111.189 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.31 92.2 3.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.214 1.005 . . . . 0.0 109.663 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.9 m -75.37 111.57 10.78 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.98 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.6 t -92.73 126.77 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.604 1.962 . . . . 0.0 108.543 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -78.5 113.05 16.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.58 -25.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -4.28 58.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -173.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -74.45 -18.88 60.57 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -156.81 128.56 7.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.477 1.111 . . . . 0.0 110.657 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.8 -25.94 67.8 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.269 -0.894 . . . . 0.0 112.869 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.93 -30.7 69.22 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.202 -0.937 . . . . 0.0 112.393 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.51 -53.92 12.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.213 0.915 . . . . 0.0 108.993 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.86 66.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.71 -44.07 11.44 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.702 0.801 . . . . 0.0 112.41 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.16 -30.87 56.52 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-O 119.05 -0.861 . . . . 0.0 114.566 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.58 -20.63 66.05 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.141 1.471 . . . . 0.0 113.686 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -68.3 -38.65 81.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.12 0.968 . . . . 0.0 111.678 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.39 -29.31 30.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.399 1.08 . . . . 0.0 112.517 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.69 -34.33 72.73 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.98 1.312 . . . . 0.0 112.529 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -94.51 -58.58 2.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.663 1.585 . . . . 0.0 112.934 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t 107.8 -2.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 131.886 4.075 . . . . 0.0 110.406 -169.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -88.98 131.7 40.36 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.293 1.837 . . . . 0.0 111.602 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.19 142.64 12.24 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.636 2.891 . . . . 0.0 111.556 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 p 74.33 165.13 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 128.54 2.736 . . . . 0.0 114.09 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.61 159.21 59.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.03 1.732 . . . . 0.0 111.115 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.64 160.65 49.19 Favored 'Cis proline' 0 C--N 1.354 0.865 0 CA-C-N 120.159 1.093 . . . . 0.0 114.91 -2.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -140.19 130.36 25.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.935 1.294 . . . . 0.0 110.058 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.86 137.86 36.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.987 1.715 . . . . 0.0 109.641 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -140.53 136.8 33.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.158 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -144.82 128.62 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.159 1.384 . . . . 0.0 112.615 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 46.3 31.95 1.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.494 2.318 . . . . 0.0 115.883 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.54 10.58 37.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.227 -1.318 . . . . 0.0 115.686 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -147.06 149.07 32.34 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.694 1.747 . . . . 0.0 112.193 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -79.7 150.79 30.77 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.347 -0.845 . . . . 0.0 111.504 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -105.9 -33.73 7.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.929 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.0 -153.61 18.51 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.099 1.333 . . . . 0.0 113.382 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.66 -177.74 42.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.795 1.188 . . . . 0.0 114.135 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.7 t -63.15 -43.02 99.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 113.13 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.33 -46.38 88.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.978 0.808 . . . . 0.0 111.258 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.32 -45.46 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.834 0.853 . . . . 0.0 110.19 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.3 m -62.56 -47.62 83.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.056 1.342 . . . . 0.0 110.957 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.08 -46.15 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.857 1.263 . . . . 0.0 111.23 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.75 -38.55 80.2 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.898 0.772 . . . . 0.0 111.76 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.37 80.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.531 0.732 . . . . 0.0 112.666 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.9 -40.49 95.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.022 0.929 . . . . 0.0 112.268 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.533 1.133 . . . . 0.0 112.889 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.4 m -85.69 -11.91 52.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.043 0.937 . . . . 0.0 113.499 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.05 85.03 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.516 1.532 . . . . 0.0 114.059 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.43 -41.65 65.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 111.566 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.88 -42.01 97.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.506 -0.746 . . . . 0.0 110.033 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -59.7 -48.86 80.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.07 0.548 . . . . 0.0 109.691 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.16 -50.86 71.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.318 1.047 . . . . 0.0 111.918 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -72.14 -32.27 66.76 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.17 -39.6 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.393 0.997 . . . . 0.0 111.024 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.34 -43.21 99.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.842 1.201 . . . . 0.0 111.252 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.16 -39.6 86.96 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.382 -0.823 . . . . 0.0 112.366 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.33 -29.52 70.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.876 0.87 . . . . 0.0 113.186 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.3 mmt -76.8 -48.93 17.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.73 0.695 . . . . 0.0 112.138 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.3 p -80.05 -25.73 40.01 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 126.806 2.043 . . . . 0.0 112.344 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -54.8 -49.25 71.43 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 110.019 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -59.72 -41.21 90.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.653 1.115 . . . . 0.0 112.367 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -62.42 -41.62 98.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.146 1.778 . . . . 0.0 111.905 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -68.81 -46.85 67.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.033 1.333 . . . . 0.0 110.738 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.78 -53.55 53.73 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.194 1.797 . . . . 0.0 110.634 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.25 -47.53 78.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.222 1.009 . . . . 0.0 111.904 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -59.2 -42.25 90.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.237 0.615 . . . . 0.0 112.618 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.63 -43.56 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.52 -41.32 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.388 1.075 . . . . 0.0 112.63 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.3 p -78.93 -38.28 37.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.581 1.082 . . . . 0.0 112.587 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -73.91 -33.99 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -113.26 -7.35 13.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 61.05 -63.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 127.711 2.405 . . . . 0.0 114.47 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -91.57 121.1 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.008 1.323 . . . . 0.0 109.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.41 147.74 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.427 0.691 . . . . 0.0 110.847 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 125.63 47.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.707 1.603 . . . . 0.0 109.185 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -94.91 116.74 29.09 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptm -156.63 170.8 21.57 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 111.748 -169.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.47 -13.63 25.98 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.23 -163.89 25.59 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.753 1.644 . . . . 0.0 112.913 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.3 p -128.32 175.18 8.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.767 1.627 . . . . 0.0 111.439 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.66 -31.02 72.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.748 1.219 . . . . 0.0 111.958 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.3 -29.79 28.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.935 1.294 . . . . 0.0 112.915 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -138.06 84.29 21.2 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.4 1.48 . . . . 0.0 111.323 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.09 165.37 19.47 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.693 2.929 . . . . 0.0 112.396 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -80.06 124.86 29.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.4 m -58.04 138.52 55.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.762 0.825 . . . . 0.0 111.294 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.88 -119.53 5.79 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -52.47 -65.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.425 1.49 . . . . 0.0 114.16 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -64.4 -42.92 95.83 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.92 -45.72 82.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.24 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -61.48 -48.39 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.138 0.975 . . . . 0.0 110.431 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.72 -50.29 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.681 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.37 -31.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 119.24 0.927 . . . . 0.0 112.341 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.01 -45.71 84.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.694 0.679 . . . . 0.0 110.736 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.96 -50.58 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.853 0.861 . . . . 0.0 111.237 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.52 -50.3 74.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.813 0.733 . . . . 0.0 111.219 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -57.07 -52.91 63.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.029 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 t -66.34 -33.29 75.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 114.024 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -57.61 -34.22 69.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.446 1.098 . . . . 0.0 110.874 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 117.71 64.7 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.519 3.528 . . . . 0.0 109.887 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.81 154.61 31.54 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.93 172.44 16.18 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.549 2.833 . . . . 0.0 111.063 170.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.25 146.83 15.75 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.506 1.522 . . . . 0.0 110.459 170.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.3 118.29 35.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.205 0.602 . . . . 0.0 111.076 169.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -76.11 82.43 2.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.246 1.018 . . . . 0.0 110.413 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.22 104.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.02 119.93 20.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.017 0.527 . . . . 0.0 111.739 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -74.79 -34.81 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.79 -38.4 70.27 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.35 -21.63 59.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -99.02 -49.48 4.5 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.787 0.835 . . . . 0.0 113.115 -176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 69.0 -34.64 0.28 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.062 2.545 . . . . 0.0 115.772 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -42.86 99.35 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.919 -1.113 . . . . 0.0 109.693 170.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.09 -45.99 92.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.031 1.332 . . . . 0.0 111.652 169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -56.91 -39.76 75.04 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.431 1.092 . . . . 0.0 112.677 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -89.89 -33.91 16.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.1 -34.62 9.6 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 123.977 0.798 . . . . 0.0 114.727 -172.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -29.75 69.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.313 1.556 . . . . 0.0 110.984 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -63.5 -27.69 69.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.29 -1.506 . . . . 0.0 113.085 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -78.54 -37.55 42.59 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.007 0.821 . . . . 0.0 111.549 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -66.72 -35.22 79.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.426 1.09 . . . . 0.0 113.26 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.6 p -108.81 -14.1 14.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 114.937 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.1 m 66.53 6.17 4.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.527 1.931 . . . . 0.0 113.95 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -74.94 141.65 75.31 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.599 1.56 . . . . 0.0 113.155 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 -49.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.81 2.34 . . . . 0.0 114.105 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.4 p -149.74 125.86 10.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.138 0.975 . . . . 0.0 112.178 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.75 158.94 72.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.001 1.32 . . . . 0.0 112.396 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -64.43 163.26 59.28 Favored 'Cis proline' 0 C--N 1.357 0.982 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 2.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -149.16 134.47 18.37 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.999 0.92 . . . . 0.0 110.524 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.05 139.31 30.75 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.964 1.305 . . . . 0.0 109.475 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -143.35 137.75 28.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.414 1.086 . . . . 0.0 110.221 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 mt -139.25 121.84 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.588 -0.695 . . . . 0.0 110.785 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t70 64.44 -22.68 0.07 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.202 3.001 . . . . 0.0 116.893 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.03 10.72 0.06 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.845 1.688 . . . . 0.0 115.277 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.86 150.23 30.65 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.311 1.555 . . . . 0.0 111.074 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -73.53 141.75 46.72 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.889 -0.507 . . . . 0.0 111.026 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.94 -39.61 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.734 0.814 . . . . 0.0 111.836 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.53 -151.04 22.39 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.455 1.026 . . . . 0.0 113.942 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.25 -173.16 20.31 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.767 1.651 . . . . 0.0 113.387 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -60.98 -47.2 87.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.826 0.85 . . . . 0.0 112.842 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.05 -45.14 93.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.413 0.552 . . . . 0.0 111.587 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.45 -44.28 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.594 0.757 . . . . 0.0 109.998 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.1 m -62.89 -46.15 89.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.822 1.249 . . . . 0.0 111.198 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.97 -43.43 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.183 0.993 . . . . 0.0 111.252 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.97 -42.38 80.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.774 0.715 . . . . 0.0 111.973 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.36 79.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 112.771 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -66.39 -40.58 89.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.031 1.332 . . . . 0.0 112.304 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -70.98 -32.87 69.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.169 0.588 . . . . 0.0 112.436 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.69 -12.14 51.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.92 -0.1 87.62 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 125.404 1.478 . . . . 0.0 114.092 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.74 -36.58 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.468 1.107 . . . . 0.0 111.381 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.69 -46.44 85.5 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.884 -0.51 . . . . 0.0 110.176 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -56.75 -48.82 76.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.67 0.788 . . . . 0.0 110.986 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.07 -49.63 77.15 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.813 0.845 . . . . 0.0 111.668 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -71.43 -35.54 70.98 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.9 -42.08 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.679 1.127 . . . . 0.0 110.887 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.07 -43.05 99.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.048 0.84 . . . . 0.0 111.488 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -59.98 -42.48 94.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.343 -0.848 . . . . 0.0 111.866 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.05 72.79 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.235 0.925 . . . . 0.0 112.812 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.68 -54.36 7.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.743 0.817 . . . . 0.0 111.255 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.571 1.148 . . . . 0.0 113.058 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.916 2.486 . . . . 0.0 112.538 171.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.6 tp -67.33 -47.75 69.58 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.146 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -58.63 -37.26 75.53 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.303 0.956 . . . . 0.0 112.261 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.9 m -66.09 -41.65 90.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.508 1.923 . . . . 0.0 111.678 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.2 m -67.23 -45.89 75.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.625 1.17 . . . . 0.0 111.159 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 99.4 mt -56.92 -54.65 44.14 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.869 1.268 . . . . 0.0 110.343 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.71 -41.6 74.04 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.794 0.725 . . . . 0.0 112.153 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -61.7 -47.36 85.62 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.333 -0.855 . . . . 0.0 112.101 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.94 -36.76 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.414 1.461 . . . . 0.0 112.705 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.85 -40.77 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.712 1.205 . . . . 0.0 112.308 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -80.18 -45.39 18.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.571 0.748 . . . . 0.0 112.361 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 76.3 p -70.7 -38.86 73.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -100.77 -3.8 29.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.629 0.771 . . . . 0.0 112.921 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt 62.14 -59.53 0.12 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.344 2.658 . . . . 0.0 114.395 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.87 137.21 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.65 1.58 . . . . 0.0 108.977 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.04 142.25 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.453 0.701 . . . . 0.0 111.032 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.36 145.4 28.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.058 1.343 . . . . 0.0 110.768 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -123.8 116.18 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.928 1.691 . . . . 0.0 109.401 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -173.18 1.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.338 1.455 . . . . 0.0 112.311 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.19 -154.93 0.13 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.286 1.434 . . . . 0.0 113.31 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.79 -146.8 50.62 Favored Glycine 0 N--CA 1.481 1.689 0 O-C-N 120.574 -1.329 . . . . 0.0 113.605 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.5 p -128.62 175.61 8.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.537 1.535 . . . . 0.0 109.46 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.29 -14.56 63.08 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.718 -1.238 . . . . 0.0 112.903 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.34 -39.88 8.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.808 1.243 . . . . 0.0 113.53 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -90.04 119.37 69.32 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.961 0.904 . . . . 0.0 111.34 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 134.46 24.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.183 2.589 . . . . 0.0 112.334 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -80.35 -34.37 36.62 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.855 2.062 . . . . 0.0 112.982 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.55 153.58 2.35 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.331 2.252 . . . . 0.0 108.954 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.35 -35.77 89.3 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 123.731 0.682 . . . . 0.0 113.308 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.77 -51.66 61.11 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.25 1.025 . . . . 0.0 111.089 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -60.15 -43.17 95.97 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.368 -0.833 . . . . 0.0 111.939 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -59.95 -46.41 89.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.537 0.735 . . . . 0.0 110.792 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -59.85 -45.12 93.44 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.808 0.843 . . . . 0.0 110.729 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.07 -43.65 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.075 0.95 . . . . 0.0 112.413 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.81 -46.69 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 110.802 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -65.58 -38.49 89.69 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mt -59.09 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.645 1.578 . . . . 0.0 111.561 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.03 -48.28 79.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.338 0.972 . . . . 0.0 110.66 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -51.28 -56.53 12.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.19 70.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.432 2.293 . . . . 0.0 114.805 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.63 -29.89 66.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.926 1.291 . . . . 0.0 109.974 169.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.7 t30 109.58 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 130.309 3.444 . . . . 0.0 108.885 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.9 149.72 28.46 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 167.27 17.37 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.121 3.214 . . . . 0.0 110.101 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -169.16 158.67 8.52 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.619 1.568 . . . . 0.0 111.046 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 168.33 9.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.448 1.099 . . . . 0.0 110.327 175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -148.3 105.15 3.59 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 119.792 -1.817 . . . . 0.0 110.774 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -87.36 118.32 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.921 1.288 . . . . 0.0 108.378 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -86.01 101.27 12.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 109.126 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.47 -32.4 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.61 -24.89 66.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -168.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.15 -10.8 59.8 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -134.98 119.22 17.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.563 1.074 . . . . 0.0 113.354 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.1 -32.08 69.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.06 -41.56 81.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.902 0.881 . . . . 0.0 110.871 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.42 -49.16 74.82 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.204 0.602 . . . . 0.0 110.868 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -55.76 -43.68 76.92 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -82.34 -32.35 29.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.71 -38.33 12.14 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.373 0.987 . . . . 0.0 113.98 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.21 -26.42 65.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.552 1.176 . . . . 0.0 112.503 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.45 -37.63 81.59 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.658 0.783 . . . . 0.0 112.003 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.25 -44.3 38.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.89 0.876 . . . . 0.0 111.241 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -61.43 -41.56 97.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.208 1.003 . . . . 0.0 113.055 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.1 p -101.01 -18.87 16.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m 68.7 0.62 2.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.894 2.078 . . . . 0.0 114.561 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -74.08 140.54 77.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.58 -57.58 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.302 2.668 . . . . 0.0 115.259 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.8 p -149.01 122.49 9.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 112.386 -169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -64.52 157.59 71.89 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.015 1.326 . . . . 0.0 112.269 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.66 158.24 41.85 Favored 'Cis proline' 0 C--N 1.358 1.06 0 N-CA-C 116.07 1.527 . . . . 0.0 116.07 2.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.79 146.94 26.08 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.133 0.973 . . . . 0.0 111.299 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.0 141.5 47.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.627 1.571 . . . . 0.0 109.031 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -139.29 144.55 38.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 0.0 109.745 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.83 126.91 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.538 -0.726 . . . . 0.0 111.432 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.38 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 129.143 2.977 . . . . 0.0 117.86 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.44 4.91 0.12 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.657 1.598 . . . . 0.0 115.418 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -148.47 151.03 34.48 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.548 1.674 . . . . 0.0 111.596 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -73.09 147.56 44.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.353 0.596 . . . . 0.0 111.716 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -100.37 -40.14 7.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.402 1.081 . . . . 0.0 111.765 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.45 -155.63 22.64 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 125.571 1.558 . . . . 0.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.05 173.52 52.21 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.756 1.17 . . . . 0.0 113.752 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.44 -46.71 66.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.665 -0.903 . . . . 0.0 112.716 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.45 -40.27 90.58 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 111.641 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.6 -41.63 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.514 0.726 . . . . 0.0 110.242 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.2 m -63.85 -44.5 92.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.151 0.98 . . . . 0.0 111.956 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -57.85 -43.85 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.858 0.753 . . . . 0.0 111.108 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.11 -37.59 78.44 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.1 91.43 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 112.497 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -64.17 -42.04 96.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.259 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.13 -28.32 68.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.586 0.754 . . . . 0.0 112.497 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -87.48 -12.89 44.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.598 1.159 . . . . 0.0 113.581 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.66 0.34 84.13 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 125.616 1.579 . . . . 0.0 114.229 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.92 -37.66 64.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.79 1.236 . . . . 0.0 111.485 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.78 -45.48 89.55 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.624 -0.672 . . . . 0.0 110.812 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -56.72 -48.45 77.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 110.802 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.57 -48.53 81.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 0.0 111.797 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -70.21 -38.42 75.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.46 -40.59 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 119.564 1.074 . . . . 0.0 110.607 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.85 -46.11 90.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.534 0.607 . . . . 0.0 110.819 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -62.52 -35.95 81.05 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.092 -1.005 . . . . 0.0 112.661 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.3 -31.57 72.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.008 -1.058 . . . . 0.0 112.825 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.51 -46.8 9.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.319 1.047 . . . . 0.0 112.981 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.67 -18.92 21.62 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 130.568 3.547 . . . . 0.0 113.259 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.13 -56.51 20.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.999 0.919 . . . . 0.0 109.925 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -62.54 -38.5 90.26 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.4 m -64.7 -39.87 94.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 111.968 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.6 m -64.98 -51.52 61.28 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.572 0.749 . . . . 0.0 110.236 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.56 -42.79 93.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.942 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.89 -48.78 80.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.451 1.023 . . . . 0.0 112.395 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -62.24 -42.03 98.95 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.54 -0.725 . . . . 0.0 111.905 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.06 -56.33 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.093 0.957 . . . . 0.0 110.546 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -58.99 -45.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.622 1.169 . . . . 0.0 112.721 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -73.19 -41.72 63.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.565 0.746 . . . . 0.0 112.758 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -81.84 -32.31 31.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -15.7 30.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 59.56 -66.16 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.998 2.519 . . . . 0.0 114.057 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.32 122.31 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.388 1.875 . . . . 0.0 108.597 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.34 117.99 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.357 0.663 . . . . 0.0 110.391 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -96.42 128.01 42.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.065 0.946 . . . . 0.0 110.405 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.17 122.88 47.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.357 1.063 . . . . 0.0 109.991 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.58 -177.94 6.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.273 1.429 . . . . 0.0 111.434 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.72 37.97 0.31 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.593 -1.317 . . . . 0.0 112.76 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.59 -165.04 35.63 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 126.557 2.027 . . . . 0.0 112.016 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -156.93 -167.31 2.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.443 1.097 . . . . 0.0 110.892 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.42 -33.32 71.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.09 1.356 . . . . 0.0 113.012 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.82 -15.58 58.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.518 1.527 . . . . 0.0 113.778 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -148.3 70.8 10.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.642 1.577 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.76 146.31 48.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.032 2.488 . . . . 0.0 110.698 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -98.93 127.02 44.76 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.411 0.684 . . . . 0.0 110.218 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -65.94 155.07 37.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.565 1.146 . . . . 0.0 113.664 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.59 -118.38 4.79 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 124.237 0.922 . . . . 0.0 112.019 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -54.24 -58.6 6.76 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.748 1.219 . . . . 0.0 112.674 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -62.39 -46.51 88.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.606 -0.683 . . . . 0.0 111.746 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.38 -46.57 69.68 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.587 1.155 . . . . 0.0 111.092 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.0 m -65.59 -46.1 80.69 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.159 0.984 . . . . 0.0 110.843 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -44.16 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.201 0.91 . . . . 0.0 110.993 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.02 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.516 0.726 . . . . 0.0 111.032 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.62 -38.7 91.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.961 0.8 . . . . 0.0 112.453 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.49 -47.35 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.31 0.959 . . . . 0.0 110.889 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.36 -51.29 68.21 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.38 0.991 . . . . 0.0 111.218 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -49.14 -61.75 1.91 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.646 0.778 . . . . 0.0 110.522 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.9 p -68.5 -25.86 65.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.947 1.699 . . . . 0.0 115.049 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.92 -34.26 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.915 0.886 . . . . 0.0 109.318 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 115.58 55.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.218 3.407 . . . . 0.0 109.461 168.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.2 145.15 31.37 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.35 163.16 35.08 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.178 2.585 . . . . 0.0 110.742 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -160.84 162.39 32.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.541 1.536 . . . . 0.0 109.928 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.23 178.39 7.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.744 1.217 . . . . 0.0 108.739 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.0 m -150.92 159.6 44.45 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 119.727 -1.858 . . . . 0.0 112.963 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.89 133.94 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.305 1.042 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -79.12 118.02 20.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.382 0.673 . . . . 0.0 110.997 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.6 pt -69.35 -20.81 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.44 -3.99 49.1 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.07 -17.94 62.58 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.74 139.38 13.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.799 1.24 . . . . 0.0 111.211 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -64.65 -36.56 84.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.9 -43.81 97.78 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.644 -0.66 . . . . 0.0 111.022 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.35 -49.1 78.33 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.434 0.694 . . . . 0.0 111.036 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp85 -55.37 -38.85 69.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.108 0.963 . . . . 0.0 112.429 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -76.85 -50.22 13.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.664 1.186 . . . . 0.0 112.365 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.98 -26.8 54.93 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 115.591 0.997 . . . . 0.0 115.591 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.77 -33.87 74.86 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.634 1.217 . . . . 0.0 112.103 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.88 -43.69 98.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.841 0.856 . . . . 0.0 111.814 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.1 -44.63 75.75 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.636 0.774 . . . . 0.0 111.138 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.6 -41.18 89.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.75 0.82 . . . . 0.0 112.343 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.3 m -80.62 -21.89 41.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.4 p 69.24 -35.73 0.32 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.322 3.049 . . . . 0.0 113.716 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -70.66 137.23 85.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.754 1.622 . . . . 0.0 111.278 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.85 -27.57 0.69 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.875 2.383 . . . . 0.0 116.215 -169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 m -102.54 130.26 49.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.496 1.043 . . . . 0.0 112.915 -168.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -115.28 152.47 46.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.929 1.292 . . . . 0.0 110.504 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.53 157.64 55.37 Favored 'Cis proline' 0 C--N 1.355 0.92 0 N-CA-C 114.996 1.114 . . . . 0.0 114.996 -3.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.36 151.47 8.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.14 1.376 . . . . 0.0 111.298 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.0 tp -90.21 159.41 16.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.942 1.297 . . . . 0.0 110.735 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -150.31 139.76 21.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.433 1.093 . . . . 0.0 110.198 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 mt -142.68 126.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.719 -0.613 . . . . 0.0 111.139 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 63.37 -25.74 0.07 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.985 2.914 . . . . 0.0 117.407 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.01 10.26 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.914 1.721 . . . . 0.0 115.114 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.11 151.25 32.87 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.289 1.544 . . . . 0.0 111.243 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -71.64 161.02 31.65 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.42 1.105 . . . . 0.0 112.536 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -136.08 143.31 44.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.275 1.43 . . . . 0.0 109.31 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.93 -178.75 10.27 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.325 1.441 . . . . 0.0 115.54 -170.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.88 -173.8 20.19 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.971 1.272 . . . . 0.0 114.55 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.42 -45.09 94.88 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.678 -0.895 . . . . 0.0 113.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.72 -44.3 97.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.719 -0.613 . . . . 0.0 111.458 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.59 -44.07 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.756 0.822 . . . . 0.0 110.348 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.7 m -62.78 -44.89 94.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.067 1.347 . . . . 0.0 111.131 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.22 -45.55 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.597 1.159 . . . . 0.0 111.489 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.53 -42.06 87.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.095 0.861 . . . . 0.0 112.224 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.58 81.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.117 0.967 . . . . 0.0 112.457 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.98 -47.45 86.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.678 1.191 . . . . 0.0 111.605 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.19 -32.61 70.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.008 0.923 . . . . 0.0 113.2 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -83.38 -13.59 54.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.94 -6.34 76.51 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.023 1.296 . . . . 0.0 113.922 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.94 -37.16 72.84 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.765 1.226 . . . . 0.0 111.906 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.13 -43.23 78.79 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.665 -0.647 . . . . 0.0 110.38 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.79 -49.11 78.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.887 0.875 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.69 1.196 . . . . 0.0 112.054 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.06 -39.25 79.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.949 0.795 . . . . 0.0 112.844 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.52 -45.67 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.401 1.001 . . . . 0.0 110.414 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -62.77 -46.94 85.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.239 0.927 . . . . 0.0 111.647 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.91 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.458 -0.777 . . . . 0.0 112.126 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.03 81.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.952 0.796 . . . . 0.0 112.835 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.09 -40.58 82.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.802 0.728 . . . . 0.0 111.841 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.34 -47.52 83.85 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.139 0.575 . . . . 0.0 111.97 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.488 1.431 1 C-N-CA 132.153 4.181 . . . . 0.0 111.491 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.79 -65.6 0.65 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.983 1.265 . . . . 0.0 111.485 -171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -65.29 -29.0 69.72 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.448 -0.782 . . . . 0.0 112.136 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.1 m -63.56 -44.01 95.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.326 1.85 . . . . 0.0 112.117 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.9 m -64.65 -45.46 86.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.033 0.933 . . . . 0.0 110.375 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.2 mt -56.02 -50.22 71.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.059 0.544 . . . . 0.0 111.675 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.91 -48.48 78.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.478 0.711 . . . . 0.0 112.288 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.43 -38.65 87.91 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.506 -0.746 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.86 -47.58 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.178 -0.951 . . . . 0.0 110.727 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.22 -36.02 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.046 1.339 . . . . 0.0 113.008 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -84.28 -31.28 25.0 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.206 0.912 . . . . 0.0 113.054 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -70.77 -37.85 73.4 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.865 0.757 . . . . 0.0 112.757 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -137.39 114.17 10.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.249 1.42 . . . . 0.0 108.448 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.88 -33.81 76.53 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.12 137.25 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.53 1.059 . . . . 0.0 109.162 169.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.16 126.87 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.815 0.846 . . . . 0.0 109.454 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.08 125.71 47.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.511 1.125 . . . . 0.0 109.169 170.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -97.32 118.19 33.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.2 ptm -155.39 159.53 39.96 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -168.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.16 -20.53 48.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.217 1.007 . . . . 0.0 112.889 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.99 -170.38 43.1 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.186 1.375 . . . . 0.0 112.294 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 p -127.53 174.29 9.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 110.947 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -69.32 -21.43 63.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -83.31 -31.53 26.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.654 1.182 . . . . 0.0 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.37 100.24 3.59 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.321 1.448 . . . . 0.0 110.274 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.26 164.46 32.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.107 2.538 . . . . 0.0 111.458 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.6 139.36 30.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.289 0.636 . . . . 0.0 110.176 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.7 p -69.59 159.54 33.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.984 0.914 . . . . 0.0 113.196 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.11 -104.98 2.4 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 124.138 0.875 . . . . 0.0 111.283 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.76 -71.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.293 1.437 . . . . 0.0 112.728 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 m -60.98 -41.33 96.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.574 -0.704 . . . . 0.0 111.355 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -53.8 -46.43 71.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.3 1.44 . . . . 0.0 111.964 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.1 m -67.78 -51.38 49.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.554 1.142 . . . . 0.0 110.996 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.141 0.576 . . . . 0.0 111.742 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.98 -47.02 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.652 0.781 . . . . 0.0 111.031 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -64.73 -41.64 95.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.911 0.778 . . . . 0.0 112.126 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.91 -52.58 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.591 0.756 . . . . 0.0 111.187 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.33 -47.75 66.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.38 0.672 . . . . 0.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -50.2 -53.52 27.33 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.855 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -33.42 75.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.804 1.641 . . . . 0.0 114.277 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.41 -25.59 66.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.165 0.986 . . . . 0.0 111.61 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.5 t30 112.61 47.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.955 3.702 . . . . 0.0 110.862 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.44 132.89 21.3 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.32 122.4 6.09 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.424 2.749 . . . . 0.0 109.128 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -131.79 161.0 33.94 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -136.51 144.65 44.42 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.6 m -108.15 93.44 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 0.0 109.564 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.47 121.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.407 1.083 . . . . 0.0 109.341 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -74.32 122.92 23.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 111.278 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -119.15 -169.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.895 1.278 . . . . 0.0 111.27 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.9 -56.88 0.54 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.454 2.302 . . . . 0.0 112.208 169.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.39 -41.16 85.42 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.822 0.849 . . . . 0.0 110.532 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -73.77 109.4 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.993 0.917 . . . . 0.0 110.526 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -73.34 -27.63 61.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 113.488 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.99 -44.58 76.27 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.145 -0.972 . . . . 0.0 110.954 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.4 -40.5 89.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.711 0.804 . . . . 0.0 111.863 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -54.46 -37.99 65.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.025 0.93 . . . . 0.0 112.368 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -85.64 -46.06 11.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.44 1.096 . . . . 0.0 112.584 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.5 -30.91 57.61 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.54 -26.17 66.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.978 1.389 . . . . 0.0 113.033 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.22 -40.61 96.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.712 0.687 . . . . 0.0 111.682 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.64 -45.11 54.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.833 0.853 . . . . 0.0 111.468 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.43 -37.6 87.39 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.1 p -107.56 -20.85 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.0 m 69.41 -29.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.64 2.376 . . . . 0.0 114.702 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -75.27 128.48 84.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.579 1.552 . . . . 0.0 112.386 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.52 150.59 19.38 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.523 2.815 . . . . 0.0 111.422 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p 77.99 156.93 0.17 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.971 2.908 . . . . 0.0 113.419 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.54 157.8 64.69 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.165 1.786 . . . . 0.0 111.363 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.05 158.22 89.13 Favored 'Cis proline' 0 C--N 1.354 0.862 0 CA-C-N 119.999 1.035 . . . . 0.0 112.541 3.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.26 141.85 37.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.317 1.047 . . . . 0.0 110.36 -172.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.5 tp -95.08 144.91 25.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.955 1.302 . . . . 0.0 110.941 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -146.73 139.24 25.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 109.599 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mp -137.85 120.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.366 -0.834 . . . . 0.0 111.094 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 61.85 -24.92 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.968 3.307 . . . . 0.0 117.415 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.28 -1.89 0.04 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.09 1.805 . . . . 0.0 115.345 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.9 147.64 49.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.221 1.511 . . . . 0.0 111.708 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.31 158.76 30.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.423 1.106 . . . . 0.0 111.801 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -133.07 155.16 49.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.826 1.651 . . . . 0.0 108.968 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.79 -180.0 9.71 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.834 1.206 . . . . 0.0 114.568 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.2 -176.84 11.37 Favored Glycine 0 N--CA 1.474 1.223 0 C-N-CA 124.667 1.127 . . . . 0.0 113.996 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.25 -42.71 95.87 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.535 -0.979 . . . . 0.0 112.808 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.9 -47.16 86.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.432 0.56 . . . . 0.0 111.191 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.6 mt -60.67 -42.99 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.906 0.882 . . . . 0.0 110.304 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 m -62.81 -46.83 86.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.088 1.355 . . . . 0.0 111.327 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.51 -42.79 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.628 1.171 . . . . 0.0 111.656 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.95 -43.31 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.71 0.686 . . . . 0.0 111.564 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.74 95.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.888 . . . . 0.0 112.001 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.71 -37.77 88.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 112.782 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -69.37 -30.85 68.94 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.382 1.073 . . . . 0.0 112.254 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -87.99 -11.14 48.25 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.534 1.134 . . . . 0.0 113.949 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.36 84.07 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.176 1.37 . . . . 0.0 114.137 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.05 -34.43 50.46 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 112.104 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -64.45 -46.24 83.96 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.776 -0.578 . . . . 0.0 109.721 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -57.34 -48.39 79.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.547 1.139 . . . . 0.0 110.258 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.35 -52.96 62.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.839 0.856 . . . . 0.0 111.775 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -74.38 -33.61 63.1 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.578 -0.701 . . . . 0.0 112.869 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.56 -44.37 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.36 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -59.7 -43.27 94.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.199 1.363 . . . . 0.0 111.376 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -57.76 -47.82 81.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.374 0.67 . . . . 0.0 111.249 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.38 -31.28 71.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.132 0.973 . . . . 0.0 113.268 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.1 mmt -72.14 -36.5 69.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.301 -0.874 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.6 -40.42 76.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.681 0.792 . . . . 0.0 112.63 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.254 1.305 0 C-N-CA 129.643 3.177 . . . . 0.0 112.597 179.018 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.78 -51.28 67.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 109.755 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -58.92 -42.74 90.38 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.646 0.778 . . . . 0.0 112.566 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -64.68 -39.01 92.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.777 1.631 . . . . 0.0 112.081 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -62.54 -49.42 75.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.239 0.927 . . . . 0.0 110.39 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -56.98 -53.26 60.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.652 0.781 . . . . 0.0 110.943 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.27 -44.96 76.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.755 0.822 . . . . 0.0 112.314 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -59.91 -49.2 78.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.799 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.8 -34.92 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.293 1.406 . . . . 0.0 112.802 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.35 -36.28 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.936 1.295 . . . . 0.0 112.489 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.9 p -84.56 -39.03 19.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.71 0.804 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -74.44 -25.13 59.24 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -130.05 130.92 45.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.771 1.228 . . . . 0.0 109.605 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -68.85 -44.38 73.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -114.23 132.02 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.563 1.145 . . . . 0.0 109.243 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.87 121.04 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.207 0.603 . . . . 0.0 110.88 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.52 149.6 21.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.741 0.817 . . . . 0.0 110.528 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.5 114.09 18.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.367 1.467 . . . . 0.0 109.136 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -163.09 -178.57 6.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.257 1.823 . . . . 0.0 110.653 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.13 -39.9 65.35 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.774 -1.204 . . . . 0.0 111.709 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.84 161.9 46.34 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.926 1.727 . . . . 0.0 114.419 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -87.65 172.02 10.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.157 1.783 . . . . 0.0 111.774 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -71.96 -23.74 61.49 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.42 -13.42 32.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.518 1.527 . . . . 0.0 113.642 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -131.57 65.68 76.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.71 1.604 . . . . 0.0 110.276 169.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -71.7 143.12 41.17 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.486 2.79 . . . . 0.0 110.843 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.0 127.62 33.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.689 0.796 . . . . 0.0 112.12 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -54.89 145.25 20.46 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.443 . . . . 0.0 113.174 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.16 -143.35 16.56 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -51.71 -45.11 63.44 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.3 m -63.82 -47.07 82.27 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.32 1.418 . . . . 0.0 112.346 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.12 -40.72 90.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.785 0.834 . . . . 0.0 111.741 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -60.97 -48.06 83.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.452 0.701 . . . . 0.0 110.919 170.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.43 -42.85 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.629 1.172 . . . . 0.0 112.898 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -66.45 -34.85 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.205 1.366 . . . . 0.0 111.999 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.22 -41.54 89.97 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.777 0.717 . . . . 0.0 111.924 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mt -57.36 -51.53 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.85 1.26 . . . . 0.0 111.388 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.0 -47.57 77.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.272 1.029 . . . . 0.0 111.032 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -51.88 -55.74 18.3 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.252 0.621 . . . . 0.0 110.76 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -68.33 -33.12 73.73 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.983 1.713 . . . . 0.0 113.837 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.2 -29.99 69.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.374 1.07 . . . . 0.0 110.997 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 115.27 70.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 130.234 3.414 . . . . 0.0 111.038 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.97 139.48 12.7 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.97 119.46 5.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.089 2.526 . . . . 0.0 109.38 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -106.14 152.4 23.49 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.112 0.965 . . . . 0.0 112.011 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.15 171.72 7.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.272 1.429 . . . . 0.0 110.139 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 m -147.99 104.73 3.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.176 -1.577 . . . . 0.0 109.88 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.92 127.74 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.597 1.159 . . . . 0.0 109.022 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -73.42 93.8 2.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 110.865 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.99 -178.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.39 0.676 . . . . 0.0 110.507 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.05 -37.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.907 2.083 . . . . 0.0 113.104 172.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.1 -20.18 64.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.731 1.612 . . . . 0.0 113.38 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -125.06 134.9 52.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.068 1.347 . . . . 0.0 111.364 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.44 -28.66 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.38 1.072 . . . . 0.0 113.752 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.66 -44.05 71.33 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.308 -0.87 . . . . 0.0 111.739 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.19 -23.27 65.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.75 -26.08 68.48 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.86 0.755 . . . . 0.0 112.726 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -109.98 -53.02 2.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.74 1.216 . . . . 0.0 112.252 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.04 -34.09 53.26 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.355 -169.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -47.9 77.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.657 1.729 . . . . 0.0 111.939 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.08 -26.1 67.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -80.44 -34.78 35.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.054 0.942 . . . . 0.0 112.201 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -65.05 -37.96 89.27 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.916 1.286 . . . . 0.0 112.273 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -78.81 -68.31 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.99 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m 124.06 -17.2 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 1 C-N-CA 133.163 4.585 . . . . 0.0 110.966 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -67.59 121.69 80.2 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.445 1.498 . . . . 0.0 111.545 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.27 145.45 19.03 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.993 2.462 . . . . 0.0 110.411 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 80.3 165.49 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.025 2.13 . . . . 0.0 112.561 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.62 150.12 51.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.531 1.533 . . . . 0.0 110.53 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.78 -177.49 21.18 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 120.125 1.08 . . . . 0.0 113.157 4.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.1 140.78 23.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.749 1.22 . . . . 0.0 111.182 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 tp -103.32 141.22 36.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.627 1.571 . . . . 0.0 110.075 169.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -140.46 142.98 35.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.053 1.741 . . . . 0.0 110.157 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.2 mt -140.18 116.4 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.65 0.78 . . . . 0.0 110.852 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.63 -24.8 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 130.114 3.366 . . . . 0.0 118.069 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -16.2 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.631 1.586 . . . . 0.0 114.69 -170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.11 153.29 48.65 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.921 1.36 . . . . 0.0 112.87 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -81.09 149.23 29.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.906 -0.496 . . . . 0.0 111.515 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.07 -35.41 9.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.984 0.914 . . . . 0.0 112.311 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.26 -146.64 17.82 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 125.437 1.494 . . . . 0.0 111.937 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.02 165.72 47.66 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.293 0.949 . . . . 0.0 114.206 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.2 m -68.47 -41.56 80.01 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.736 -0.861 . . . . 0.0 112.244 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.13 -42.42 94.77 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.23 -0.919 . . . . 0.0 111.637 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.17 -40.34 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.247 0.619 . . . . 0.0 110.326 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.5 m -63.97 -43.21 96.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.085 0.954 . . . . 0.0 111.739 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.33 -46.13 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.914 0.779 . . . . 0.0 110.963 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -66.37 -37.17 84.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.743 0.701 . . . . 0.0 112.527 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.24 95.52 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.1 0.96 . . . . 0.0 111.971 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -67.54 -38.86 84.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.512 0.725 . . . . 0.0 112.771 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.1 -32.88 74.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 112.642 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 p -92.9 -10.03 38.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.52 -3.19 68.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.045 1.307 . . . . 0.0 114.485 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -72.37 -33.25 67.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.41 1.484 . . . . 0.0 112.493 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -47.2 70.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.716 0.689 . . . . 0.0 110.249 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -56.52 -48.79 76.49 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.684 1.194 . . . . 0.0 110.469 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.648 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.75 -33.13 72.02 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -39.93 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.3 0.954 . . . . 0.0 111.151 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.34 -44.73 96.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.12 0.873 . . . . 0.0 111.077 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.36 -36.36 79.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.409 -0.807 . . . . 0.0 112.701 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.88 74.52 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.038 1.29 . . . . 0.0 112.627 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.9 mtt -74.41 -41.99 59.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.836 0.854 . . . . 0.0 112.357 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 p -92.6 1.75 57.08 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 126.963 2.105 . . . . 0.0 114.272 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.65 -55.71 15.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.673 1.589 . . . . 0.0 109.798 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -61.37 -42.12 98.19 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.553 -0.717 . . . . 0.0 112.231 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -60.23 -39.45 86.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.335 1.854 . . . . 0.0 111.98 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 m -64.84 -49.16 71.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 110.141 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.09 -50.35 71.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.077 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.18 -48.65 75.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.527 1.131 . . . . 0.0 112.459 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.4 -42.72 99.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.558 -0.714 . . . . 0.0 111.821 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.9 -49.88 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.772 0.829 . . . . 0.0 111.787 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.14 -33.99 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.545 1.066 . . . . 0.0 112.772 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.2 p -74.93 -35.42 62.18 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.919 0.782 . . . . 0.0 112.781 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 m -79.37 -41.73 27.16 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.97 0.805 . . . . 0.0 112.976 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.03 -3.71 37.57 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 58.55 -74.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.536 2.334 . . . . 0.0 112.277 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.3 129.94 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.005 0.922 . . . . 0.0 109.642 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -137.79 131.27 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.423 0.689 . . . . 0.0 110.324 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.4 140.53 32.53 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.549 1.14 . . . . 0.0 111.314 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.18 108.41 16.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.714 1.606 . . . . 0.0 107.887 172.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.2 mtm -144.59 -176.72 5.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.273 1.429 . . . . 0.0 110.595 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -79.1 21.48 0.44 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.325 -1.485 . . . . 0.0 113.999 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.97 177.4 44.72 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.795 1.188 . . . . 0.0 114.733 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.4 p -97.46 -178.61 4.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.734 2.014 . . . . 0.0 111.244 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.06 -20.62 59.45 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.345 -0.847 . . . . 0.0 112.901 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.38 -31.82 37.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 111.853 172.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -134.17 74.61 67.32 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.892 1.277 . . . . 0.0 110.753 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 172.05 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.984 3.123 . . . . 0.0 111.281 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -99.3 152.43 19.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.053 0.941 . . . . 0.0 110.983 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.51 167.25 21.02 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.782 1.233 . . . . 0.0 113.507 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.73 -125.52 7.1 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.412 1.006 . . . . 0.0 112.362 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -60.31 -42.35 95.37 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.757 0.823 . . . . 0.0 112.591 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -59.2 -52.15 66.92 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.025 -1.047 . . . . 0.0 112.327 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -56.94 -44.56 82.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.783 1.233 . . . . 0.0 110.481 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.2 m -60.14 -47.69 84.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.461 1.104 . . . . 0.0 110.855 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.7 -42.57 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.249 1.02 . . . . 0.0 112.39 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.25 -34.66 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.476 1.489 . . . . 0.0 112.11 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.018 0.827 . . . . 0.0 111.69 170.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.84 -47.28 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.204 1.402 . . . . 0.0 111.258 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.92 -49.51 72.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.373 0.988 . . . . 0.0 111.409 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -49.42 -59.41 3.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.268 0.627 . . . . 0.0 109.845 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -67.97 -28.82 67.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.196 1.798 . . . . 0.0 114.91 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.78 -30.61 69.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 110.187 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.1 t30 111.15 55.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 130.721 3.608 . . . . 0.0 108.492 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.57 150.91 38.25 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.53 169.68 18.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.189 3.259 . . . . 0.0 110.696 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.8 164.8 26.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.254 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.24 167.06 19.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.37 1.468 . . . . 0.0 108.901 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -151.1 126.09 9.8 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 119.776 -1.827 . . . . 0.0 111.669 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.62 133.17 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.838 1.255 . . . . 0.0 109.591 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -74.17 125.59 28.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.94 0.496 . . . . 0.0 111.699 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 pt -72.93 -30.05 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.836 1.254 . . . . 0.0 113.038 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.66 167.6 13.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.194 0.998 . . . . 0.0 111.935 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 79.61 -107.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.919 2.488 . . . . 0.0 109.852 -170.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -55.71 124.22 16.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.722 1.209 . . . . 0.0 113.881 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.06 -39.64 90.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 113.653 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.83 -33.1 74.12 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.537 -0.727 . . . . 0.0 111.558 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.0 tp -72.45 -43.49 63.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.641 0.776 . . . . 0.0 111.157 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -56.09 -45.64 79.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.144 1.377 . . . . 0.0 112.345 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.18 -40.58 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.386 1.074 . . . . 0.0 111.575 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.92 -36.79 87.15 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 118.675 -1.07 . . . . 0.0 113.872 -172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.91 -44.58 95.71 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.416 1.608 . . . . 0.0 111.566 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.8 -48.23 75.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.47 -32.99 73.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.435 0.694 . . . . 0.0 112.823 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -69.26 -37.97 78.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 0.0 112.572 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 m -87.55 -24.37 24.05 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m 74.53 -41.53 0.48 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.321 2.648 . . . . 0.0 113.756 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -68.45 129.11 92.91 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.921 1.288 . . . . 0.0 110.73 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.53 158.81 16.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.784 2.989 . . . . 0.0 112.07 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p 75.13 162.62 0.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.558 2.743 . . . . 0.0 113.665 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -143.28 159.72 54.43 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.461 1.904 . . . . 0.0 110.68 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.28 149.81 53.97 Favored 'Cis proline' 0 C--N 1.354 0.832 0 CA-C-N 120.313 1.147 . . . . 0.0 114.007 -2.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.14 148.88 32.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 0.0 110.344 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -114.09 140.31 48.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.362 1.465 . . . . 0.0 110.609 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -132.71 145.52 51.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.99 2.116 . . . . 0.0 109.997 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mt -137.23 119.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.383 -0.823 . . . . 0.0 112.465 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 t70 63.67 -43.09 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.95 3.3 . . . . 0.0 117.179 168.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.96 9.34 0.03 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.562 2.506 . . . . 0.0 114.151 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.01 145.15 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.47 1.508 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.53 152.35 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.527 -0.733 . . . . 0.0 109.97 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -110.47 -36.65 5.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.119 0.968 . . . . 0.0 112.615 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.37 -159.15 23.28 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.109 1.338 . . . . 0.0 113.293 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.05 169.28 54.68 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.147 0.879 . . . . 0.0 114.028 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.0 p -68.7 -49.55 58.06 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.444 -1.033 . . . . 0.0 112.922 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.47 -39.11 86.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.891 -1.131 . . . . 0.0 111.657 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.3 -41.87 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.591 0.756 . . . . 0.0 110.381 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.8 m -62.76 -40.92 98.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 0.0 111.668 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.14 -46.91 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.132 0.878 . . . . 0.0 111.484 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -31.7 63.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.267 0.94 . . . . 0.0 113.504 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.23 83.11 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.072 -1.018 . . . . 0.0 112.594 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.68 -44.8 92.65 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.646 1.178 . . . . 0.0 112.035 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.68 -27.99 68.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.6 m -86.84 -14.69 41.37 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 113.666 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.81 75.71 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 125.354 1.455 . . . . 0.0 114.19 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.39 -34.64 63.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.552 1.141 . . . . 0.0 111.312 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.46 -45.56 86.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.524 -0.735 . . . . 0.0 110.719 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.03 -47.39 77.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.71 0.804 . . . . 0.0 111.002 175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.42 -50.33 73.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.867 0.867 . . . . 0.0 112.074 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -76.44 -32.97 58.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.17 -40.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.964 0.802 . . . . 0.0 110.618 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.39 -43.99 95.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.347 0.976 . . . . 0.0 111.591 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -55.87 -45.12 78.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.911 0.778 . . . . 0.0 111.051 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.68 94.89 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 113.071 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 57.8 mtt -64.79 -35.27 80.56 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.731 0.813 . . . . 0.0 112.343 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.3 -36.01 76.59 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.762 0.825 . . . . 0.0 112.768 170.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.892 2.477 . . . . 0.0 112.241 -179.435 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.98 -56.93 8.72 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.592 1.557 . . . . 0.0 110.622 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -59.67 -43.21 94.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.4 0.68 . . . . 0.0 111.784 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.11 -41.05 95.98 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.046 2.138 . . . . 0.0 112.163 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -67.78 -46.48 71.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.607 1.163 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -56.92 -53.82 53.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.404 0.681 . . . . 0.0 110.804 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.17 -43.85 78.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.259 0.623 . . . . 0.0 112.004 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.1 -51.08 71.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.771 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.92 -37.36 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.403 1.456 . . . . 0.0 112.214 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -63.64 -37.35 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.069 0.947 . . . . 0.0 112.648 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 p -86.37 -36.97 18.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.726 0.81 . . . . 0.0 113.169 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -75.92 -37.91 58.24 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.526 0.731 . . . . 0.0 112.804 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -110.11 114.66 28.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.01 0.924 . . . . 0.0 110.61 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -77.11 67.66 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.549 -1.344 . . . . 0.0 111.464 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.2 t 132.31 122.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 1 C-N-CA 133.913 4.885 . . . . 0.0 107.652 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.76 132.93 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.337 1.055 . . . . 0.0 109.337 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.59 137.9 38.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.49 1.516 . . . . 0.0 109.261 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -112.76 115.22 28.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.172 1.389 . . . . 0.0 107.732 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ptp -153.67 164.3 38.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.894 1.278 . . . . 0.0 112.933 -169.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -80.1 45.02 0.7 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.663 1.585 . . . . 0.0 111.261 174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.99 -161.93 27.02 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.151 1.358 . . . . 0.0 114.41 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.5 p -135.56 178.94 6.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.33 1.852 . . . . 0.0 111.18 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -66.36 -25.94 67.04 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.09 -26.44 19.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.853 1.261 . . . . 0.0 112.436 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -124.91 71.37 61.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.995 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.48 164.78 33.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.231 2.62 . . . . 0.0 110.902 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.48 129.62 34.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.925 0.49 . . . . 0.0 109.802 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.94 147.1 52.8 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.949 0.9 . . . . 0.0 112.673 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -116.06 4.71 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.057 0.837 . . . . 0.0 111.558 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -60.68 -54.98 38.75 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.874 0.87 . . . . 0.0 113.035 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -66.77 -39.44 87.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.642 -1.286 . . . . 0.0 112.22 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.57 -46.97 77.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.197 1.399 . . . . 0.0 111.151 170.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 m -61.24 -45.99 92.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.77 0.828 . . . . 0.0 110.247 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.81 -44.87 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.573 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.15 -34.97 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 120.78 1.627 . . . . 0.0 111.929 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -65.72 -35.43 80.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.791 0.723 . . . . 0.0 111.885 169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.35 -51.21 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.897 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 121.137 1.789 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -49.46 -55.86 11.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.047 0.539 . . . . 0.0 109.815 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -66.51 -29.19 69.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.323 2.249 . . . . 0.0 115.059 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tt -59.54 -30.75 68.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.944 1.698 . . . . 0.0 109.481 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 108.08 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 131.443 3.897 . . . . 0.0 107.347 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.2 152.98 32.15 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.53 179.19 5.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.31 3.34 . . . . 0.0 110.853 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.61 171.86 13.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.436 1.894 . . . . 0.0 110.38 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.91 147.95 50.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.847 0.859 . . . . 0.0 109.597 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 m -122.61 111.83 17.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.909 0.884 . . . . 0.0 110.576 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.09 124.43 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.354 1.062 . . . . 0.0 109.452 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -72.95 105.76 4.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 110.45 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.9 pt -89.2 -173.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.35 1.06 . . . . 0.0 112.039 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt 68.75 -14.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.462 2.305 . . . . 0.0 115.085 169.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -65.16 -19.73 66.12 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.052 1.741 . . . . 0.0 114.475 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -158.22 169.05 25.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.639 1.576 . . . . 0.0 112.01 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -64.88 -31.87 73.3 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.14 -36.25 83.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.104 0.866 . . . . 0.0 111.337 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.43 -23.11 56.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.396 1.078 . . . . 0.0 113.088 172.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -82.78 -51.51 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.609 1.095 . . . . 0.0 112.685 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -95.48 -43.87 7.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.826 1.25 . . . . 0.0 112.039 -169.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.51 61.06 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.684 0.659 . . . . 0.0 112.019 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 tp -59.64 -41.99 91.73 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.419 0.688 . . . . 0.0 111.882 172.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -63.74 -40.16 96.06 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.919 -0.488 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -72.04 -33.73 68.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.551 0.614 . . . . 0.0 112.416 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -65.3 -47.41 76.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.146 0.978 . . . . 0.0 112.95 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -92.01 -25.93 18.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 74.64 -8.02 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.917 2.087 . . . . 0.0 113.464 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -65.56 133.77 95.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.027 1.331 . . . . 0.0 111.436 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 -41.91 0.62 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.066 2.51 . . . . 0.0 115.199 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -143.9 107.44 4.61 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.175 0.898 . . . . 0.0 111.815 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.25 162.78 16.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.007 1.323 . . . . 0.0 112.465 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -64.53 169.1 37.5 Favored 'Cis proline' 0 C--N 1.355 0.911 0 CA-C-N 120.772 1.311 . . . . 0.0 115.275 0.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.12 166.66 31.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.72 150.23 27.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.48 1.912 . . . . 0.0 108.834 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.35 143.65 32.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.107 2.163 . . . . 0.0 109.81 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.42 172.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.687 1.595 . . . . 0.0 111.532 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.69 103.17 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.392 1.077 . . . . 0.0 112.676 -171.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.64 89.13 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 117.601 -1.666 . . . . 0.0 116.072 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.22 134.97 10.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.652 2.226 . . . . 0.0 113.054 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.09 148.4 36.1 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.918 -1.114 . . . . 0.0 110.651 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -99.41 -45.76 5.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.69 -161.83 13.55 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.928 1.251 . . . . 0.0 112.911 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.26 165.1 46.84 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 124.18 0.895 . . . . 0.0 115.126 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -66.81 -38.9 87.38 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.982 -0.716 . . . . 0.0 112.273 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.9 -45.89 91.08 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.608 -0.683 . . . . 0.0 111.434 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.24 -40.38 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.195 0.598 . . . . 0.0 110.346 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 80.1 m -62.92 -44.13 96.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.693 1.197 . . . . 0.0 111.641 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.71 -46.36 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.905 0.775 . . . . 0.0 111.141 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.84 -36.96 81.27 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.62 0.645 . . . . 0.0 112.26 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.89 91.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.277 1.031 . . . . 0.0 112.202 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.01 -38.88 92.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.63 0.772 . . . . 0.0 112.519 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.46 -31.37 72.41 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.976 0.911 . . . . 0.0 111.791 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.9 m -88.26 -12.33 43.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.81 -2.57 76.65 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.081 1.324 . . . . 0.0 114.239 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.84 -36.19 42.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.981 1.312 . . . . 0.0 111.693 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.68 -42.21 95.51 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.701 -0.625 . . . . 0.0 110.453 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -56.26 -49.17 74.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.307 1.043 . . . . 0.0 110.169 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.38 -46.72 87.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.335 0.654 . . . . 0.0 112.067 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -71.42 -36.67 71.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.01 -37.77 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.581 1.082 . . . . 0.0 110.861 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.08 -44.89 94.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 110.434 169.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.78 -39.75 85.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.372 -0.83 . . . . 0.0 112.21 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.87 -44.73 96.22 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.828 1.195 . . . . 0.0 112.045 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmt -63.25 -38.07 89.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.259 1.023 . . . . 0.0 112.357 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.7 m -67.36 -36.88 82.27 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.005 0.922 . . . . 0.0 112.709 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.8 m . . . . . 0 C--O 1.255 1.379 0 C-N-CA 128.048 2.539 . . . . 0.0 112.036 -177.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -67.68 -51.33 50.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.091 0.86 . . . . 0.0 111.792 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -64.61 -33.59 76.28 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.465 -0.772 . . . . 0.0 111.624 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -61.69 -43.19 99.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.433 2.293 . . . . 0.0 111.929 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -68.82 -43.41 75.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.868 1.267 . . . . 0.0 111.151 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.64 -41.12 89.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.868 0.867 . . . . 0.0 111.54 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.07 -42.96 99.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.525 1.057 . . . . 0.0 112.582 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.11 -40.9 98.99 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.275 -0.89 . . . . 0.0 111.816 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.04 -52.19 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.296 1.039 . . . . 0.0 110.853 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.09 -49.92 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.345 1.458 . . . . 0.0 112.101 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -74.85 -30.77 61.45 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.3 p -90.69 -36.56 14.27 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -38.81 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.223 -0.923 . . . . 0.0 112.21 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.77 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.088 2.955 . . . . 0.0 117.661 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.06 110.51 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.422 1.889 . . . . 0.0 107.66 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.26 158.29 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.85 117.17 15.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.177 1.391 . . . . 0.0 109.31 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -87.69 124.86 34.0 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.089 1.356 . . . . 0.0 109.924 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -163.45 172.97 13.74 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -69.81 -19.78 63.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.521 1.528 . . . . 0.0 114.083 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.1 -159.65 31.47 Favored Glycine 0 N--CA 1.477 1.417 0 C-N-CA 125.158 1.361 . . . . 0.0 113.547 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -136.47 -174.33 3.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.398 1.879 . . . . 0.0 110.348 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -80.38 -29.13 37.82 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.221 -0.924 . . . . 0.0 112.334 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.38 -34.36 65.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.638 1.175 . . . . 0.0 111.958 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -133.75 91.71 24.69 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.913 1.285 . . . . 0.0 110.413 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.64 157.52 48.34 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.739 2.293 . . . . 0.0 110.537 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -77.75 125.23 29.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.038 0.447 . . . . 0.0 110.275 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -59.49 143.54 49.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.297 1.439 . . . . 0.0 113.13 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.82 -100.4 2.08 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.085 0.85 . . . . 0.0 111.097 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -58.87 -64.3 0.99 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.454 1.501 . . . . 0.0 113.347 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -67.12 -37.41 83.83 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.706 -1.246 . . . . 0.0 111.447 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -54.42 -46.75 73.25 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.9 m -61.61 -48.0 82.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.263 1.025 . . . . 0.0 110.839 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.76 -49.03 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.918 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.93 -32.92 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.417 1.008 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -63.81 -41.55 97.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.911 0.885 . . . . 0.0 111.242 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 mt -59.6 -50.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 111.15 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.08 -52.22 65.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.424 0.69 . . . . 0.0 111.045 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -51.3 -55.59 17.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.983 0.513 . . . . 0.0 110.615 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -68.1 -31.02 70.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.094 1.758 . . . . 0.0 114.36 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.31 -33.9 71.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.7 t30 117.75 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.728 3.611 . . . . 0.0 109.645 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.13 137.79 23.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.83 89.81 1.27 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.723 2.948 . . . . 0.0 109.868 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -70.2 152.97 43.65 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.887 0.475 . . . . 0.0 110.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -129.23 121.33 27.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.399 0.619 . . . . 0.0 110.534 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -73.36 120.7 19.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.246 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.37 118.58 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.523 1.129 . . . . 0.0 108.092 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -75.07 120.03 20.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.033 0.933 . . . . 0.0 111.09 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -127.14 179.23 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.253 1.421 . . . . 0.0 112.082 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 77.71 -52.2 0.52 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 127.739 2.416 . . . . 0.0 112.406 169.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.25 -25.07 65.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.86 0.864 . . . . 0.0 112.983 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -104.13 113.94 27.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.717 2.407 . . . . 0.0 110.596 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.49 -28.63 69.33 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.36 -50.65 66.9 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 110.944 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.72 -39.91 91.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.39 0.676 . . . . 0.0 110.791 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -54.21 -44.53 71.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 0.0 112.082 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.093 0.957 . . . . 0.0 112.26 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.59 -42.68 46.82 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 113.776 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.81 -25.99 64.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.648 1.224 . . . . 0.0 113.341 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.07 -44.11 94.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.26 0.936 . . . . 0.0 111.376 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.41 -46.11 56.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.668 0.787 . . . . 0.0 111.19 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.94 -39.61 94.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 0.0 112.832 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.2 p -88.89 -35.68 16.38 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p 64.27 -23.24 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.222 2.609 . . . . 0.0 114.367 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -67.11 130.39 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.781 1.632 . . . . 0.0 111.27 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.25 136.97 13.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.83 2.354 . . . . 0.0 111.599 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.1 p 77.24 165.36 0.24 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 128.679 2.791 . . . . 0.0 114.65 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.65 161.89 49.62 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 127.208 2.203 . . . . 0.0 110.723 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -58.2 157.01 34.79 Favored 'Cis proline' 0 C--N 1.356 0.965 0 CA-C-N 120.777 1.313 . . . . 0.0 114.655 -2.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -152.7 132.43 13.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.021 0.528 . . . . 0.0 110.863 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 tt -93.9 142.35 27.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.027 1.331 . . . . 0.0 110.85 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -133.08 143.05 49.08 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.716 1.206 . . . . 0.0 111.519 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.52 138.64 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.07 1.348 . . . . 0.0 110.318 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -15.21 89.09 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.921 2.888 . . . . 0.0 115.809 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.3 55.65 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.167 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.8 130.49 21.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.189 1.994 . . . . 0.0 114.233 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -81.24 121.81 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.153 1.381 . . . . 0.0 108.841 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -92.59 -32.82 14.66 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.7 -154.1 16.6 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.819 1.2 . . . . 0.0 113.712 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.87 47.1 Favored Glycine 0 N--CA 1.473 1.1 0 C-N-CA 124.718 1.151 . . . . 0.0 115.498 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.5 t -58.58 -51.25 70.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.993 1.317 . . . . 0.0 112.782 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -60.64 -43.57 97.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.948 0.499 . . . . 0.0 111.77 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.13 -45.42 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.469 0.708 . . . . 0.0 110.24 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.1 -46.58 88.45 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.668 1.187 . . . . 0.0 110.882 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.23 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.87 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.17 -39.38 86.46 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.276 0.943 . . . . 0.0 111.916 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.44 79.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.649 -0.657 . . . . 0.0 112.226 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.86 -43.76 91.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.985 0.914 . . . . 0.0 112.047 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.24 -30.76 69.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.016 0.926 . . . . 0.0 112.79 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -84.79 -13.37 51.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.121 0.969 . . . . 0.0 113.374 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.26 83.89 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.418 1.485 . . . . 0.0 114.144 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -73.47 -38.82 65.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 111.571 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.15 -42.95 88.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.659 -0.65 . . . . 0.0 110.066 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -58.55 -48.08 82.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.583 0.753 . . . . 0.0 110.44 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.33 -50.17 72.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.861 0.865 . . . . 0.0 111.517 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -72.36 -35.37 68.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.252 -0.905 . . . . 0.0 113.435 -173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.43 -39.46 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.35 0.977 . . . . 0.0 110.722 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.95 -46.23 88.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.107 0.867 . . . . 0.0 111.296 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.73 -37.07 77.93 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.315 -0.865 . . . . 0.0 112.466 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.21 65.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 77.3 mtm -76.28 -38.24 56.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.606 0.639 . . . . 0.0 111.675 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.5 -41.34 69.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 127.668 2.387 . . . . 0.0 112.464 -172.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -54.36 47.45 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.03 1.332 . . . . 0.0 110.43 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.23 -35.2 76.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.856 -0.593 . . . . 0.0 112.218 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -62.94 -46.02 89.7 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.148 1.379 . . . . 0.0 111.439 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -62.27 -50.81 70.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.634 0.774 . . . . 0.0 111.137 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.04 -42.95 99.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.988 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.93 -48.99 77.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.639 1.109 . . . . 0.0 111.654 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.44 -41.7 90.21 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.355 0.662 . . . . 0.0 111.788 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.54 -53.34 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.916 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.2 -21.83 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.274 1.397 . . . . 0.0 113.681 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.3 p -80.14 -31.62 39.02 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.417 170.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.2 m -77.5 -38.5 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.662 0.665 . . . . 0.0 112.761 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.05 102.37 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.283 1.833 . . . . 0.0 108.999 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -60.84 -38.72 86.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.107 -0.995 . . . . 0.0 113.384 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -99.13 136.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.868 1.267 . . . . 0.0 109.096 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.15 136.82 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.05 142.24 30.78 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.28 1.032 . . . . 0.0 111.289 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -119.63 116.07 25.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.075 1.35 . . . . 0.0 108.623 169.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 48.2 mtm -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.819 1.247 . . . . 0.0 110.538 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -76.02 20.93 0.18 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.637 1.175 . . . . 0.0 113.78 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.19 168.12 41.15 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 126.797 2.141 . . . . 0.0 112.768 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -96.49 -175.48 3.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.961 1.304 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -11.1 33.97 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 170.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.17 -28.23 59.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 112.262 170.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -146.2 79.06 10.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.797 1.639 . . . . 0.0 111.075 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.47 135.99 64.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.027 2.485 . . . . 0.0 110.359 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -83.29 98.8 9.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.504 0.722 . . . . 0.0 112.413 -169.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.2 t 89.51 160.67 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.455 2.702 . . . . 0.0 112.325 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.08 -31.04 75.23 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 124.893 1.235 . . . . 0.0 113.408 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -62.0 -53.38 56.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.119 0.96 . . . . 0.0 110.671 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -61.73 -42.93 99.61 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.135 -0.978 . . . . 0.0 111.747 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.34 -44.26 92.67 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.038 0.935 . . . . 0.0 110.968 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.2 m -63.36 -45.13 92.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.862 0.865 . . . . 0.0 110.638 173.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.798 1.239 . . . . 0.0 112.514 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.02 -34.78 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 120.426 1.467 . . . . 0.0 111.8 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.91 -43.85 82.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 112.199 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.88 -51.49 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.559 1.544 . . . . 0.0 111.225 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.83 -49.09 69.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.309 1.043 . . . . 0.0 111.276 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -52.38 -49.89 63.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -68.24 -36.05 78.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.211 1.805 . . . . 0.0 114.176 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.87 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 120.78 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 131.051 3.74 . . . . 0.0 109.198 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.96 133.47 8.98 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -82.84 63.22 7.92 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.396 3.397 . . . . 0.0 108.422 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -70.01 168.68 14.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 113.891 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -134.38 172.54 12.75 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.377 1.084 . . . . 0.0 111.621 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -153.28 115.35 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.559 -1.338 . . . . 0.0 110.269 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.73 137.26 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.65 1.18 . . . . 0.0 110.324 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -81.05 123.24 28.21 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 112.106 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -27.95 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.839 1.256 . . . . 0.0 113.006 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.45 148.65 37.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.525 1.13 . . . . 0.0 109.731 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 66.0 6.56 4.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.468 1.907 . . . . 0.0 112.735 -169.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -135.3 57.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.673 1.989 . . . . 0.0 110.076 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -51.82 -37.27 51.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.239 1.416 . . . . 0.0 114.399 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.25 -42.63 91.59 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.343 1.057 . . . . 0.0 111.841 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.88 -41.98 64.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.356 1.062 . . . . 0.0 110.977 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -55.44 -47.12 76.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.909 1.284 . . . . 0.0 112.272 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -73.46 -49.03 28.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.184 0.594 . . . . 0.0 110.554 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.51 92.17 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.891 -0.949 . . . . 0.0 114.608 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.61 -57.76 11.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.372 1.086 . . . . 0.0 110.655 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -61.18 -37.97 84.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.588 0.755 . . . . 0.0 112.253 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.93 -36.84 80.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.858 1.263 . . . . 0.0 112.146 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -87.28 -38.7 16.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.795 1.638 . . . . 0.0 113.521 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.6 p -93.03 -28.25 16.5 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t 74.15 3.74 4.43 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 126.751 2.02 . . . . 0.0 113.318 -171.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -62.03 133.47 94.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.84 1.256 . . . . 0.0 112.041 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.45 -46.83 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.54 2.16 . . . . 0.0 114.662 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -147.46 124.92 11.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.318 0.963 . . . . 0.0 112.224 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.44 153.79 89.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.844 1.258 . . . . 0.0 112.0 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.22 158.7 94.91 Favored 'Cis proline' 0 C--N 1.354 0.855 0 CA-C-N 119.872 0.99 . . . . 0.0 113.662 7.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.59 128.6 27.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.488 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.19 129.21 40.88 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 109.177 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 141.83 47.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.409 1.884 . . . . 0.0 111.802 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.74 129.05 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 67.24 -19.34 0.12 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 128.218 2.607 . . . . 0.0 115.868 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.72 1.66 0.71 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.254 1.883 . . . . 0.0 115.153 -174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.34 158.88 43.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.141 1.47 . . . . 0.0 111.311 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -77.34 144.5 37.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.779 -0.576 . . . . 0.0 111.823 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -92.6 -40.06 10.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.71 1.204 . . . . 0.0 111.428 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.57 25.43 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.852 1.215 . . . . 0.0 113.49 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.47 169.73 33.23 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.04 1.305 . . . . 0.0 112.773 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 85.6 m -69.87 -44.55 69.59 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.591 -0.947 . . . . 0.0 113.099 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.01 -42.67 98.91 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.15 -0.969 . . . . 0.0 111.325 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.48 -40.2 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.9 0.88 . . . . 0.0 110.431 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.4 m -65.47 -42.71 91.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.621 1.169 . . . . 0.0 111.752 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -59.69 -43.8 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.022 0.828 . . . . 0.0 110.961 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -67.68 -37.04 81.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.845 0.748 . . . . 0.0 112.481 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.69 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.185 0.994 . . . . 0.0 112.19 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -63.78 -43.59 95.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.162 0.985 . . . . 0.0 112.113 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.18 -31.09 71.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 112.451 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.6 m -83.54 -14.2 52.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.442 1.097 . . . . 0.0 113.356 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.79 81.42 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.309 1.433 . . . . 0.0 114.31 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -71.25 -46.51 60.85 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.94 1.296 . . . . 0.0 111.031 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.58 -40.51 97.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.912 -0.493 . . . . 0.0 111.024 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.85 -47.92 83.17 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.355 0.662 . . . . 0.0 110.02 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.96 -49.42 74.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.309 0.644 . . . . 0.0 111.482 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -67.81 -39.08 84.0 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.78 -42.12 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.478 1.035 . . . . 0.0 110.536 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -45.52 91.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.872 0.76 . . . . 0.0 111.326 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -60.95 -40.59 93.92 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 112.292 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.82 82.98 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.809 0.843 . . . . 0.0 112.731 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.9 mmm -75.71 -45.91 34.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.145 0.978 . . . . 0.0 113.104 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.14 -45.67 7.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.774 1.23 . . . . 0.0 113.017 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.689 1.996 . . . . 0.0 113.178 -178.561 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.78 -53.36 58.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.447 1.099 . . . . 0.0 111.056 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -59.36 -42.89 92.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.494 0.718 . . . . 0.0 111.619 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.2 m -60.21 -45.35 93.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.398 1.479 . . . . 0.0 111.609 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.2 m -63.59 -54.83 29.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.463 1.105 . . . . 0.0 110.904 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.42 -43.57 98.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.858 0.863 . . . . 0.0 111.768 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.96 -50.36 74.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.563 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.145 0.884 . . . . 0.0 111.564 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 t -55.97 -58.99 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.901 0.881 . . . . 0.0 110.944 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -74.01 -19.52 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.3 p -89.54 -32.18 17.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.477 1.111 . . . . 0.0 112.716 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.7 t -66.01 -35.85 81.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.112 0.869 . . . . 0.0 111.71 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -156.48 130.04 8.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.675 1.19 . . . . 0.0 112.12 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.8 160.67 17.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.97 0.908 . . . . 0.0 112.468 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t 65.56 83.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.327 1.851 . . . . 0.0 109.728 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.72 130.96 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.784 0.834 . . . . 0.0 110.205 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.3 120.47 42.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.439 1.096 . . . . 0.0 110.018 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.02 120.5 35.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.307 1.043 . . . . 0.0 109.058 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -152.78 -176.14 5.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.641 1.576 . . . . 0.0 110.816 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -78.7 36.1 0.26 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.387 -1.445 . . . . 0.0 113.326 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.59 -173.5 45.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.95 1.262 . . . . 0.0 113.763 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -131.91 -174.05 3.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.749 1.619 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -63.96 -11.69 30.9 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.39 -30.29 69.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.324 1.049 . . . . 0.0 112.318 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -154.43 88.23 3.41 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.37 1.468 . . . . 0.0 110.147 170.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.04 134.55 62.91 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.445 2.764 . . . . 0.0 111.235 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -85.24 130.81 34.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.074 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.4 m -55.73 152.39 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.763 2.025 . . . . 0.0 115.184 -169.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.28 -117.69 4.52 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.53 1.062 . . . . 0.0 112.007 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -48.47 -60.88 2.33 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.526 2.33 . . . . 0.0 112.185 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -43.33 92.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.02 -1.05 . . . . 0.0 112.434 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -57.09 -46.92 82.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -60.48 -46.07 91.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.497 1.119 . . . . 0.0 111.013 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.07 -48.43 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.62 -35.04 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.925 1.239 . . . . 0.0 111.904 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.58 -43.38 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.071 1.348 . . . . 0.0 111.491 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.15 -51.4 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.561 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.01 -53.54 56.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.264 0.938 . . . . 0.0 111.115 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.52 -62.26 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.019 1.328 . . . . 0.0 110.608 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.9 p -68.8 -27.95 66.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.766 1.627 . . . . 0.0 115.271 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -32.53 70.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.311 1.044 . . . . 0.0 110.326 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 116.21 60.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 130.462 3.505 . . . . 0.0 109.989 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.3 150.88 32.65 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.02 162.91 36.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.142 2.561 . . . . 0.0 110.675 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.55 159.65 41.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.938 1.295 . . . . 0.0 110.727 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -133.23 169.39 16.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.48 1.512 . . . . 0.0 108.547 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 p -152.13 155.45 37.88 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.66 -1.275 . . . . 0.0 114.021 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.63 133.17 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.056 1.343 . . . . 0.0 110.027 -170.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -80.46 106.41 12.45 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.902 0.881 . . . . 0.0 111.892 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.38 -27.61 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.593 1.157 . . . . 0.0 113.411 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.37 -2.95 54.51 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.655 1.182 . . . . 0.0 113.532 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -88.63 -10.98 46.7 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -157.4 124.7 5.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.512 1.125 . . . . 0.0 111.946 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.16 -41.24 90.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.399 1.079 . . . . 0.0 113.157 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.53 -37.81 85.82 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.21 0.604 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.54 -52.01 65.14 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.691 0.796 . . . . 0.0 109.908 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.39 -47.27 82.13 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.136 0.974 . . . . 0.0 113.07 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -73.86 -41.46 62.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 0.0 111.398 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -40.48 33.38 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.663 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.68 -31.7 70.94 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.978 1.389 . . . . 0.0 112.064 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.54 -38.55 91.39 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.795 0.838 . . . . 0.0 112.069 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.04 -46.13 53.62 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.224 1.01 . . . . 0.0 111.152 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.1 -46.49 88.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 112.646 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -90.87 -20.21 22.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.0 m 62.92 6.12 2.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.89 1.676 . . . . 0.0 113.544 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -69.13 134.81 89.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.215 1.406 . . . . 0.0 111.911 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.1 -43.68 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 113.686 -169.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p -147.9 113.06 5.53 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.232 1.013 . . . . 0.0 110.945 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.43 158.49 20.55 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.695 1.198 . . . . 0.0 111.538 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.76 173.12 42.09 Favored 'Cis proline' 0 C--N 1.355 0.889 0 CA-C-N 120.839 1.335 . . . . 0.0 115.509 5.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -161.87 152.16 17.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.259 1.024 . . . . 0.0 112.495 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.97 148.15 25.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.554 1.942 . . . . 0.0 109.343 171.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -149.85 139.47 21.64 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.774 2.029 . . . . 0.0 111.217 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.3 pt -149.35 141.76 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.604 1.562 . . . . 0.0 112.174 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.78 -21.5 0.09 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 127.625 2.37 . . . . 0.0 115.926 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.89 5.17 2.23 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.134 2.302 . . . . 0.0 114.343 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.15 161.72 35.38 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.573 1.549 . . . . 0.0 111.19 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -75.21 150.92 38.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.211 -0.931 . . . . 0.0 111.688 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -101.91 -41.44 6.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.138 1.375 . . . . 0.0 111.009 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.53 -162.37 20.7 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 124.653 1.12 . . . . 0.0 114.468 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.9 -176.9 50.12 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.906 1.241 . . . . 0.0 115.615 -169.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.62 -41.13 98.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.306 1.042 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -57.87 -49.55 76.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.215 1.006 . . . . 0.0 111.773 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.4 -43.33 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.063 0.945 . . . . 0.0 110.312 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.0 m -62.75 -44.87 95.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.87 1.268 . . . . 0.0 111.351 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.99 -45.78 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.56 1.144 . . . . 0.0 111.313 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -70.16 -38.18 75.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.893 0.77 . . . . 0.0 112.273 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.42 -30.34 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 113.022 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -65.65 -37.6 86.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.725 1.21 . . . . 0.0 112.174 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.2 -40.34 82.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 0.0 112.77 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.6 p -85.56 -16.54 39.05 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.0 81.3 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.853 1.216 . . . . 0.0 113.217 -173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.69 -27.13 66.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.343 1.057 . . . . 0.0 111.89 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.87 -46.72 83.68 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.818 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.09 -48.66 79.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.401 0.546 . . . . 0.0 110.609 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -57.48 -48.48 79.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.565 0.746 . . . . 0.0 111.611 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -70.0 -38.86 76.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.61 -43.42 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 111.107 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.78 -44.66 95.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.163 0.892 . . . . 0.0 111.371 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.68 -40.26 87.25 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.745 -0.597 . . . . 0.0 111.823 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.74 83.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 113.087 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.06 -38.65 86.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.379 -0.826 . . . . 0.0 111.964 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.7 m -73.77 -37.09 65.1 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.635 2.374 . . . . 0.0 112.357 -172.668 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.51 -58.0 5.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 110.366 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.37 -31.11 72.18 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.242 -0.912 . . . . 0.0 112.429 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -60.66 -39.39 88.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.878 2.071 . . . . 0.0 112.24 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -70.22 -43.57 70.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.61 1.164 . . . . 0.0 111.004 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.3 -52.6 64.91 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.58 0.752 . . . . 0.0 110.485 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.17 -40.93 74.67 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 112.015 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.57 -50.11 73.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.341 -0.849 . . . . 0.0 111.774 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.35 -34.11 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.168 1.349 . . . . 0.0 112.672 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.43 -45.69 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.965 0.906 . . . . 0.0 112.207 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -76.92 -41.33 43.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.64 0.654 . . . . 0.0 112.641 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 m -78.27 -32.44 49.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -127.21 -7.74 5.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 66.44 -56.88 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.434 2.294 . . . . 0.0 114.972 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.08 124.38 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 109.177 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.32 138.64 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.122 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.4 126.05 52.9 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.125 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.81 100.59 12.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -145.29 151.01 37.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.389 1.075 . . . . 0.0 111.514 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.37 -19.67 59.43 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 178.57 34.32 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.999 1.761 . . . . 0.0 112.919 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 p -103.03 172.4 6.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.52 1.528 . . . . 0.0 111.128 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -64.12 -35.82 82.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.93 -15.93 52.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.016 1.326 . . . . 0.0 114.014 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -150.95 88.25 4.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.85 1.26 . . . . 0.0 111.022 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.52 168.97 20.59 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.314 2.676 . . . . 0.0 111.741 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -78.58 -3.23 42.77 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.6 m 72.99 -1.23 3.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.495 2.318 . . . . 0.0 115.236 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.47 -150.5 24.35 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 125.553 1.549 . . . . 0.0 112.754 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -60.37 -25.82 66.16 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.057 0.943 . . . . 0.0 113.174 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -59.01 -48.6 81.02 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.806 1.242 . . . . 0.0 111.554 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.63 -42.69 88.88 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.093 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 m -59.53 -46.69 88.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.366 0.985 . . . . 0.0 112.0 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 t -58.95 -46.06 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.955 0.902 . . . . 0.0 111.557 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -59.55 -45.23 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.143 0.577 . . . . 0.0 111.073 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -65.54 -38.7 90.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.722 1.209 . . . . 0.0 112.257 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mt -58.91 -49.38 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.915 1.286 . . . . 0.0 110.523 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 mt -63.74 -50.12 70.34 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.998 0.919 . . . . 0.0 111.176 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -53.98 -57.68 10.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 110.916 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.7 p -68.66 -27.63 66.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.869 1.668 . . . . 0.0 114.849 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.92 -34.86 72.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.266 0.939 . . . . 0.0 109.828 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.9 t30 118.71 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.504 3.522 . . . . 0.0 110.095 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.99 148.44 20.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.22 170.12 21.04 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.56 2.84 . . . . 0.0 110.605 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -155.08 143.66 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -106.93 89.96 3.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.809 0.843 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.3 p -72.66 81.37 1.12 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.138 -0.976 . . . . 0.0 109.868 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.08 116.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 108.41 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.66 94.67 3.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.702 1.201 . . . . 0.0 111.821 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -74.72 173.74 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.243 1.017 . . . . 0.0 111.313 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.95 -46.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.905 2.082 . . . . 0.0 112.425 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.36 -39.84 94.67 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.329 1.052 . . . . 0.0 112.284 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -95.5 124.23 39.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.64 1.176 . . . . 0.0 110.156 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.68 -26.79 67.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.134 0.974 . . . . 0.0 113.073 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.84 -38.98 93.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.851 0.75 . . . . 0.0 112.289 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.87 -32.98 71.63 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.607 0.763 . . . . 0.0 112.076 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -55.01 -43.78 73.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.208 1.003 . . . . 0.0 112.516 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -91.18 -45.37 8.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.393 1.077 . . . . 0.0 111.333 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.06 90.35 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.774 -1.014 . . . . 0.0 114.706 -169.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.91 -42.14 63.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 111.815 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.63 -40.84 96.29 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.869 -0.519 . . . . 0.0 111.445 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.91 -52.33 50.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.987 0.915 . . . . 0.0 111.447 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.15 -38.67 82.4 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.14 -28.81 25.29 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m 75.99 -4.84 2.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.813 2.445 . . . . 0.0 112.684 -169.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -76.79 137.3 66.46 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.975 -1.078 . . . . 0.0 111.437 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.71 -23.7 3.81 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.78 2.32 . . . . 0.0 111.532 169.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.6 m -96.19 131.17 42.94 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.564 1.546 . . . . 0.0 112.508 -169.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -138.8 151.74 69.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.859 2.063 . . . . 0.0 109.812 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.27 167.66 79.15 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 120.093 1.069 . . . . 0.0 113.317 5.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -160.69 161.07 32.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 113.18 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.75 141.78 30.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.26 2.224 . . . . 0.0 109.801 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.55 131.94 25.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.878 2.071 . . . . 0.0 110.352 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.9 mt -138.74 118.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.878 -1.139 . . . . 0.0 111.476 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.69 32.32 11.78 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.333 1.453 . . . . 0.0 114.249 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.68 65.87 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.601 1.096 . . . . 0.0 115.023 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -103.5 120.73 41.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.841 1.32 . . . . 0.0 111.022 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.01 106.72 8.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.184 0.993 . . . . 0.0 109.669 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -82.66 -31.43 28.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.634 1.173 . . . . 0.0 111.971 -170.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.66 -155.18 16.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.687 1.137 . . . . 0.0 114.892 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.87 177.19 54.25 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.647 1.118 . . . . 0.0 114.922 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 21.9 p -63.94 -44.94 91.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.193 0.997 . . . . 0.0 113.509 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.88 -44.38 97.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.467 0.707 . . . . 0.0 111.38 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.48 -45.31 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.631 0.773 . . . . 0.0 109.722 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -62.41 -47.56 83.59 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.44 -42.88 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 111.35 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -72.47 -34.8 67.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.852 0.751 . . . . 0.0 112.416 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.94 85.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.17 -40.86 86.68 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.768 1.227 . . . . 0.0 112.355 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -64.02 -39.04 93.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.94 0.896 . . . . 0.0 111.964 170.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -77.15 -16.57 59.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.928 0.891 . . . . 0.0 113.361 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.54 80.89 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.095 1.331 . . . . 0.0 113.82 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.11 -47.26 65.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.022 1.329 . . . . 0.0 110.883 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.7 tp -62.27 -42.91 99.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.717 -0.614 . . . . 0.0 110.534 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -59.43 -46.5 88.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.627 0.771 . . . . 0.0 110.537 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -63.98 -49.28 73.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.166 0.586 . . . . 0.0 111.613 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -68.72 -37.27 79.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.462 1.028 . . . . 0.0 112.886 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.14 -45.09 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.203 0.91 . . . . 0.0 110.495 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.63 -46.34 86.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.775 0.716 . . . . 0.0 111.083 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -60.76 -40.17 91.5 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.776 1.23 . . . . 0.0 112.074 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.58 89.47 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.815 0.846 . . . . 0.0 112.1 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -66.88 -33.17 75.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.288 0.635 . . . . 0.0 112.656 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.2 m -71.72 -43.05 66.56 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.453 2.301 . . . . 0.0 112.582 -173.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 tt -55.81 -50.92 69.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.443 1.097 . . . . 0.0 110.331 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -60.39 -43.46 96.63 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 0.0 111.68 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -37.77 80.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.426 1.89 . . . . 0.0 112.321 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.4 m -67.6 -49.37 63.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.392 1.077 . . . . 0.0 110.507 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.91 -46.36 85.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 110.976 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.36 -45.67 90.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.177 0.991 . . . . 0.0 112.236 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.328 -0.857 . . . . 0.0 111.781 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.02 -47.5 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.021 0.828 . . . . 0.0 111.15 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.74 -36.55 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.996 1.318 . . . . 0.0 113.123 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 p -84.33 -35.55 23.19 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.173 0.897 . . . . 0.0 112.906 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.3 t -75.58 -42.33 52.35 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -101.82 -6.44 23.59 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 63.47 -59.54 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.792 2.437 . . . . 0.0 114.566 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.3 125.1 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.437 1.495 . . . . 0.0 109.928 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.19 130.56 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.923 0.489 . . . . 0.0 111.369 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 139.42 34.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.56 1.144 . . . . 0.0 110.344 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.09 123.21 43.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 109.497 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -159.49 179.5 8.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.929 1.692 . . . . 0.0 109.855 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -77.91 35.16 0.2 Allowed 'General case' 0 CA--C 1.556 1.191 0 O-C-N 120.068 -1.645 . . . . 0.0 114.037 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.96 161.52 34.83 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.894 1.711 . . . . 0.0 113.77 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.6 p -94.76 -176.01 3.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.887 1.675 . . . . 0.0 111.588 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -67.22 -28.99 68.53 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.361 0.664 . . . . 0.0 111.95 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.12 -29.02 48.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.868 1.267 . . . . 0.0 112.561 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.69 73.95 75.03 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.273 1.429 . . . . 0.0 111.739 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.22 154.83 37.95 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.353 2.702 . . . . 0.0 111.954 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.06 146.19 32.93 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.885 0.874 . . . . 0.0 111.355 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -68.01 161.65 26.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.04 1.336 . . . . 0.0 113.684 -173.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.84 -146.71 21.51 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.696 1.141 . . . . 0.0 112.035 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -57.62 -32.23 67.03 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 m -59.3 -47.43 85.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.609 1.095 . . . . 0.0 112.056 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.67 -46.31 87.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.291 1.037 . . . . 0.0 110.743 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -44.99 91.61 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.871 0.868 . . . . 0.0 110.639 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.59 -43.0 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.645 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.66 -34.06 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.898 1.681 . . . . 0.0 112.158 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.97 -44.34 89.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.602 0.637 . . . . 0.0 111.405 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -59.19 -52.35 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.619 1.168 . . . . 0.0 111.466 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.0 mt -65.13 -47.88 75.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.57 0.748 . . . . 0.0 111.281 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -50.48 -55.94 13.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.903 0.881 . . . . 0.0 110.891 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 m -68.25 -36.08 78.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.823 1.649 . . . . 0.0 114.176 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.59 -32.83 71.92 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.301 1.44 . . . . 0.0 111.076 173.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.6 t30 122.69 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 131.261 3.825 . . . . 0.0 109.815 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.7 137.65 11.54 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.58 61.2 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.47 3.447 . . . . 0.0 109.268 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -62.18 156.53 21.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.452 1.101 . . . . 0.0 112.94 -171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -121.44 170.31 9.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.466 1.107 . . . . 0.0 110.902 171.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 m -149.89 121.59 8.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.293 -1.505 . . . . 0.0 111.46 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -106.92 129.67 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.597 1.559 . . . . 0.0 109.677 -173.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -80.42 107.97 13.66 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.249 0.62 . . . . 0.0 111.42 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.7 pt -64.28 -27.37 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.101 -0.999 . . . . 0.0 112.928 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -0.16 51.63 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.286 1.434 . . . . 0.0 113.385 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.04 -29.46 67.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.776 0.83 . . . . 0.0 112.638 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -159.41 139.64 12.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.82 1.248 . . . . 0.0 110.919 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.05 -40.37 63.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.014 1.726 . . . . 0.0 114.087 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 tp -66.08 -31.32 72.13 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.338 1.055 . . . . 0.0 112.168 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.72 -45.77 41.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.856 0.863 . . . . 0.0 110.016 171.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.09 -44.99 75.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.995 1.318 . . . . 0.0 112.591 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -84.44 -28.77 26.63 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.94 -31.75 64.19 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 124.403 1.002 . . . . 0.0 113.422 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.22 -31.77 70.48 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 1.284 . . . . 0.0 112.511 176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.07 -38.55 91.46 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.154 -0.966 . . . . 0.0 111.873 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -71.51 -40.3 70.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.512 0.725 . . . . 0.0 111.298 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -63.68 -38.03 89.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.937 1.295 . . . . 0.0 113.455 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.1 m -118.01 -19.79 8.98 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p 68.62 -12.09 0.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.611 2.364 . . . . 0.0 114.194 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -61.78 136.79 94.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 125.739 1.616 . . . . 0.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.53 -42.89 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.754 2.303 . . . . 0.0 115.371 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -140.22 108.72 5.87 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.113 0.869 . . . . 0.0 111.681 -169.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.34 162.71 71.22 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.511 1.524 . . . . 0.0 112.173 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.15 163.97 36.33 Favored 'Cis proline' 0 C--N 1.356 0.931 0 N-CA-C 116.027 1.51 . . . . 0.0 116.027 2.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.36 158.31 37.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.363 1.065 . . . . 0.0 111.512 170.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -105.94 138.97 41.21 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.358 1.863 . . . . 0.0 109.295 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.34 141.04 52.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.672 1.989 . . . . 0.0 111.162 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mt -139.03 123.07 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.93 -26.75 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.954 3.302 . . . . 0.0 117.014 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.51 1.39 0.04 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.447 1.975 . . . . 0.0 115.237 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -140.2 157.0 46.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.441 1.62 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -76.48 148.58 37.1 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.695 -0.628 . . . . 0.0 110.954 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -98.66 -43.66 6.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.931 1.292 . . . . 0.0 111.807 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.66 -165.73 24.98 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.276 1.417 . . . . 0.0 113.176 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.84 49.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.488 1.042 . . . . 0.0 112.994 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.8 m -61.48 -32.96 72.99 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.6 -39.15 87.07 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 112.049 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.55 -42.37 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.188 0.595 . . . . 0.0 109.586 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -62.61 -42.68 99.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.263 1.025 . . . . 0.0 111.924 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.46 -41.97 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.754 0.706 . . . . 0.0 111.417 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -67.9 -39.16 83.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.971 0.805 . . . . 0.0 112.281 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.89 81.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 112.617 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.67 -41.78 87.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.016 0.926 . . . . 0.0 112.025 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -68.46 -35.05 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.621 1.168 . . . . 0.0 112.624 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 p -90.02 -12.83 37.44 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.02 -0.17 72.22 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 125.463 1.506 . . . . 0.0 114.652 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.27 -37.26 85.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 111.846 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -66.4 -41.55 89.15 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.078 0.551 . . . . 0.0 111.191 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.82 -47.37 82.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.198 0.599 . . . . 0.0 110.568 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.67 -46.11 91.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.884 0.473 . . . . 0.0 111.947 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -68.56 -40.51 80.58 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.128 0.876 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.57 -39.41 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 118.993 0.815 . . . . 0.0 110.42 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.09 -43.67 91.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.236 0.925 . . . . 0.0 111.027 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -63.54 -38.92 92.97 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.902 -1.124 . . . . 0.0 112.777 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.51 83.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.94 0.791 . . . . 0.0 112.939 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.16 -47.95 10.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.394 1.078 . . . . 0.0 112.97 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.3 m -109.93 -28.3 8.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.283 1.433 . . . . 0.0 114.526 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 127.009 2.124 . . . . 0.0 114.293 177.146 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.72 -53.25 58.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 110.663 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -60.08 -37.46 80.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.1 0.56 . . . . 0.0 112.492 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 m -66.86 -40.84 87.99 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.174 1.79 . . . . 0.0 111.967 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -65.69 -47.25 76.08 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.29 1.036 . . . . 0.0 110.699 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.3 -54.21 48.07 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.748 1.219 . . . . 0.0 110.635 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.24 -43.0 78.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 111.954 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.06 -45.69 91.03 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.28 -0.887 . . . . 0.0 111.894 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.24 -37.82 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.563 1.529 . . . . 0.0 111.875 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.73 -33.74 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.04 0.936 . . . . 0.0 112.993 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 p -90.63 -43.47 10.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.1 p -73.27 -32.01 64.42 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -134.54 70.04 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 109.402 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.73 139.81 38.02 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t 83.52 88.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.958 2.503 . . . . 0.0 107.777 -169.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -108.08 133.03 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.06 0.544 . . . . 0.0 110.099 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.69 123.49 45.77 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.653 0.781 . . . . 0.0 108.965 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -104.98 116.12 31.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.311 1.045 . . . . 0.0 109.683 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.76 -167.99 1.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.042 1.737 . . . . 0.0 110.748 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.56 -1.11 53.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.98 171.64 15.3 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.065 1.793 . . . . 0.0 113.64 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.4 p -103.54 178.01 4.68 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.972 1.709 . . . . 0.0 110.684 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.6 -32.03 73.1 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.341 -0.849 . . . . 0.0 111.937 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.77 -32.92 58.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.936 1.294 . . . . 0.0 112.663 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -137.0 82.2 31.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.138 1.375 . . . . 0.0 110.634 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.63 171.77 16.91 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.786 2.99 . . . . 0.0 111.555 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -86.49 150.4 24.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.916 0.886 . . . . 0.0 111.224 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -72.37 171.31 12.45 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.425 1.49 . . . . 0.0 113.518 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 -136.89 22.02 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.353 0.977 . . . . 0.0 112.239 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -52.14 -40.87 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.747 0.819 . . . . 0.0 112.184 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 m -59.11 -43.61 91.91 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.317 -0.864 . . . . 0.0 112.576 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -62.65 -47.02 85.53 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.415 -0.803 . . . . 0.0 110.522 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.9 m -58.89 -44.47 91.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.017 0.927 . . . . 0.0 110.736 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.97 -44.18 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.006 1.322 . . . . 0.0 112.204 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.9 -43.71 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.901 0.773 . . . . 0.0 110.955 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.01 -40.0 94.27 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 mt -59.69 -53.46 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 112.195 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.17 -47.93 75.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.932 1.242 . . . . 0.0 110.834 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -49.1 -57.06 7.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.949 0.5 . . . . 0.0 110.331 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -67.02 -31.57 72.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.861 1.665 . . . . 0.0 114.266 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.39 -23.09 64.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.89 1.276 . . . . 0.0 111.222 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.8 t30 114.48 32.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 130.961 3.704 . . . . 0.0 112.282 168.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.76 138.42 29.63 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 121.261 -0.899 . . . . 0.0 113.089 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -82.17 49.89 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.457 3.438 . . . . 0.0 109.056 169.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -66.14 169.16 7.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.447 1.899 . . . . 0.0 115.133 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -150.96 130.04 12.62 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.588 0.755 . . . . 0.0 111.043 169.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.1 m -90.39 124.15 34.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.606 -0.684 . . . . 0.0 109.177 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.64 125.48 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 109.251 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -75.09 101.43 4.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.394 0.678 . . . . 0.0 111.026 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -72.36 -24.52 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.28 -1.72 34.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.969 1.308 . . . . 0.0 113.184 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.4 -24.85 66.54 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.574 1.149 . . . . 0.0 112.843 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -154.69 134.58 12.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 111.487 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.79 -41.78 87.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -25.14 67.83 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.701 1.137 . . . . 0.0 113.24 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.32 -46.98 21.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.083 0.953 . . . . 0.0 110.329 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -56.64 -47.86 78.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.874 0.87 . . . . 0.0 112.229 174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.08 -40.56 30.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.192 0.997 . . . . 0.0 112.449 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.01 -28.92 48.42 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.608 -170.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.3 tp -57.59 -36.71 72.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.756 1.278 . . . . 0.0 112.588 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -50.08 -43.8 51.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.362 1.065 . . . . 0.0 112.478 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -83.17 -30.19 28.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.789 0.836 . . . . 0.0 112.592 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -64.68 -39.66 94.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.8 p -88.68 -67.89 0.8 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.227 0.611 . . . . 0.0 111.894 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.2 m 130.05 -12.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 1 C-N-CA 133.598 4.759 . . . . 0.0 111.209 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -66.74 134.28 94.18 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.05 -43.37 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.888 2.392 . . . . 0.0 115.48 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.0 p -142.22 117.69 10.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.152 0.887 . . . . 0.0 112.176 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -60.6 159.19 26.19 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.298 1.439 . . . . 0.0 113.352 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -59.79 161.43 35.68 Favored 'Cis proline' 0 C--N 1.358 1.034 0 N-CA-C 115.672 1.374 . . . . 0.0 115.672 -2.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -154.82 161.91 41.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.38 1.072 . . . . 0.0 111.356 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.89 123.09 40.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.198 1.399 . . . . 0.0 109.418 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -111.31 138.3 47.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.508 1.123 . . . . 0.0 111.291 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 pt -149.89 110.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.727 1.611 . . . . 0.0 112.857 -169.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.24 41.49 32.14 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.994 1.317 . . . . 0.0 114.23 169.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.01 -8.5 69.94 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.265 0.935 . . . . 0.0 114.121 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -104.76 177.61 4.8 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.083 1.753 . . . . 0.0 110.516 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -150.77 161.71 42.11 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.892 1.33 . . . . 0.0 112.624 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -136.12 177.51 7.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.931 2.092 . . . . 0.0 109.898 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.78 -168.01 30.77 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.732 1.634 . . . . 0.0 115.624 -169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.62 -179.73 32.22 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.969 1.271 . . . . 0.0 113.99 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.1 m -67.5 -48.42 67.16 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.61 -42.39 88.06 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 111.811 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.73 -41.67 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.133 0.973 . . . . 0.0 110.593 172.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.2 m -64.16 -41.58 97.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.656 1.182 . . . . 0.0 111.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.12 -44.02 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.829 0.741 . . . . 0.0 111.281 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.92 -36.8 80.8 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.89 0.768 . . . . 0.0 112.476 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.0 83.89 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 112.522 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -65.59 -41.08 93.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.225 1.01 . . . . 0.0 112.322 172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -68.68 -29.59 68.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.661 0.785 . . . . 0.0 112.647 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -87.39 -13.53 43.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.48 1.112 . . . . 0.0 113.379 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.92 -0.61 84.45 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.49 1.519 . . . . 0.0 114.268 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.9 -39.13 64.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.825 1.25 . . . . 0.0 111.321 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.35 -45.07 92.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.775 0.43 . . . . 0.0 110.626 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.85 -47.9 76.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.084 0.953 . . . . 0.0 111.018 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.17 -47.93 83.89 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.124 0.57 . . . . 0.0 112.063 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -68.9 -42.59 76.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.587 -0.696 . . . . 0.0 112.585 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.99 -40.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.973 0.909 . . . . 0.0 111.153 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.26 -46.45 89.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.449 1.022 . . . . 0.0 110.696 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.52 -44.68 93.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.58 -0.7 . . . . 0.0 111.795 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.43 87.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.002 0.921 . . . . 0.0 113.151 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 85.0 mtp -70.19 -39.76 75.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.603 1.161 . . . . 0.0 112.579 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.22 -34.39 77.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.335 0.654 . . . . 0.0 111.973 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.211 2.605 . . . . 0.0 112.688 173.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.3 -52.07 39.69 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.494 1.517 . . . . 0.0 111.018 170.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.74 -42.39 98.91 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.345 -0.847 . . . . 0.0 112.345 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -60.12 -39.08 84.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.25 1.82 . . . . 0.0 111.866 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -68.0 -50.45 55.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.995 1.318 . . . . 0.0 110.379 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.29 -51.28 67.18 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.454 0.702 . . . . 0.0 111.334 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.75 -48.85 76.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.988 0.915 . . . . 0.0 112.112 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.32 -42.74 96.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.94 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.96 -43.75 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.325 -0.859 . . . . 0.0 111.074 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.73 -42.8 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.408 1.483 . . . . 0.0 112.934 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.9 p -76.4 -42.89 42.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.216 0.916 . . . . 0.0 112.329 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.7 p -76.35 -36.05 58.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -95.95 -13.76 23.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.41 -48.24 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.508 2.723 . . . . 0.0 115.032 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.26 120.74 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.493 1.917 . . . . 0.0 108.048 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.65 154.93 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.144 0.578 . . . . 0.0 111.154 -172.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.96 132.65 46.39 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.602 1.161 . . . . 0.0 110.452 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -108.24 114.94 29.2 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.3 ptm -160.73 174.23 14.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.777 1.231 . . . . 0.0 110.615 -169.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -85.3 29.78 0.65 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.014 -1.054 . . . . 0.0 113.274 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.83 172.43 42.59 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.517 1.532 . . . . 0.0 113.089 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.0 p -100.27 178.48 4.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.178 1.391 . . . . 0.0 110.742 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.56 -23.47 62.61 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -84.43 -30.2 25.51 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 112.394 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -132.14 76.0 73.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.614 1.566 . . . . 0.0 110.35 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.39 173.23 14.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.547 2.832 . . . . 0.0 111.001 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -112.27 136.23 51.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.8 0.84 . . . . 0.0 110.735 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.87 149.83 46.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 112.739 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.51 -113.19 3.94 Favored Glycine 0 N--CA 1.468 0.822 0 C-N-CA 124.1 0.857 . . . . 0.0 111.526 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -59.97 -57.12 14.23 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.646 1.178 . . . . 0.0 113.072 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.3 m -62.53 -46.36 88.76 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.387 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -52.23 -47.65 65.59 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.497 1.519 . . . . 0.0 111.341 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -61.57 -50.37 72.92 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.15 0.98 . . . . 0.0 110.54 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -59.13 -47.77 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.012 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.71 -35.44 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.479 1.036 . . . . 0.0 112.098 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -64.97 -38.48 91.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.003 0.819 . . . . 0.0 111.558 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mt -59.82 -51.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.823 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -59.3 -51.14 71.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.553 1.069 . . . . 0.0 111.723 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -51.38 -60.93 2.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.338 1.055 . . . . 0.0 110.654 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 94.1 p -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.046 1.738 . . . . 0.0 115.262 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -58.86 -32.65 69.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.31 1.044 . . . . 0.0 109.892 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 t30 114.63 56.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.717 3.607 . . . . 0.0 109.333 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.62 38.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.45 168.49 14.47 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.721 2.947 . . . . 0.0 112.281 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.46 141.1 15.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.427 1.491 . . . . 0.0 109.583 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -123.98 93.47 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.733 0.813 . . . . 0.0 109.746 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 m -78.93 115.81 18.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.732 -0.605 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.52 125.5 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.809 1.643 . . . . 0.0 108.518 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -78.15 107.46 10.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.714 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.67 -23.76 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.75 -11.38 60.15 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.928 -1.107 . . . . 0.0 112.848 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -70.0 -29.03 66.01 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.879 0.872 . . . . 0.0 113.05 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -154.4 135.44 13.86 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.883 0.765 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.98 -34.24 74.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.54 1.136 . . . . 0.0 111.668 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 -26.14 68.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.044 0.938 . . . . 0.0 112.738 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.65 -56.51 5.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.915 0.78 . . . . 0.0 109.47 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -55.24 -39.43 69.72 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -86.72 -36.87 18.42 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.81 -37.77 21.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.692 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -64.26 -39.43 93.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.533 1.167 . . . . 0.0 112.952 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -58.82 -37.35 76.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.004 0.522 . . . . 0.0 111.9 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.36 -40.63 50.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 111.781 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.56 -45.55 93.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.065 1.346 . . . . 0.0 113.503 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.5 p -95.81 -23.51 16.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 p 78.7 -12.05 1.13 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.944 2.898 . . . . 0.0 113.561 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -81.47 127.08 74.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 121.321 -0.862 . . . . 0.0 110.669 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -83.83 -12.34 8.6 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.419 2.746 . . . . 0.0 116.51 -169.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -123.34 171.13 9.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.98 1.264 . . . . 0.0 112.894 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.13 148.9 69.86 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.042 1.337 . . . . 0.0 110.526 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.42 156.9 69.3 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.894 0.998 . . . . 0.0 114.145 -3.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.37 139.04 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.408 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.59 149.1 21.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.526 1.53 . . . . 0.0 110.453 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -149.58 140.93 23.23 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -144.79 124.58 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.593 1.157 . . . . 0.0 112.405 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 61.7 -17.8 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.329 2.652 . . . . 0.0 117.504 169.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.04 6.17 1.11 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.379 1.942 . . . . 0.0 113.821 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -128.24 144.01 51.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.208 1.803 . . . . 0.0 110.433 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -91.63 163.49 14.09 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.974 1.369 . . . . 0.0 112.791 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -142.37 176.08 9.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.064 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.84 -169.99 39.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.369 -1.287 . . . . 0.0 114.523 -171.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.62 -163.65 35.37 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.878 1.228 . . . . 0.0 113.002 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.12 -50.51 72.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.654 0.782 . . . . 0.0 112.97 -172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -59.78 -43.98 94.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.916 0.78 . . . . 0.0 111.596 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.37 -43.05 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.33 0.652 . . . . 0.0 110.175 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -62.81 -44.2 96.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 111.066 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.68 -45.13 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.898 1.279 . . . . 0.0 111.235 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.31 -38.75 81.9 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.842 0.746 . . . . 0.0 112.237 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.26 80.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.096 0.958 . . . . 0.0 112.485 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -67.52 -38.94 85.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.859 1.264 . . . . 0.0 112.182 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -68.03 -36.52 80.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.061 0.944 . . . . 0.0 111.931 173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 m -84.28 -16.33 43.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.45 -0.39 80.64 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.107 1.337 . . . . 0.0 114.26 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -68.01 -42.83 80.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.764 1.226 . . . . 0.0 110.926 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.61 -43.78 92.67 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.028 -0.42 . . . . 0.0 110.531 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -55.44 -48.58 74.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.929 0.891 . . . . 0.0 111.182 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.06 -48.64 77.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.281 0.492 . . . . 0.0 111.776 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.85 -39.57 79.86 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.552 -0.718 . . . . 0.0 112.821 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -38.68 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.931 0.893 . . . . 0.0 111.035 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.3 -45.97 92.22 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.38 0.991 . . . . 0.0 111.368 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.95 -39.99 87.44 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.532 -0.73 . . . . 0.0 111.903 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.79 91.97 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.061 0.846 . . . . 0.0 112.899 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.5 mtm -68.28 -35.0 77.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.836 0.855 . . . . 0.0 112.674 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.5 t -65.97 -43.9 86.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.99 0.916 . . . . 0.0 111.891 170.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.255 1.353 0 C-N-CA 129.215 3.006 . . . . 0.0 112.408 174.07 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.51 -57.35 8.44 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.798 1.239 . . . . 0.0 110.947 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -59.88 -41.03 90.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.984 0.514 . . . . 0.0 111.193 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -60.84 -41.66 96.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.262 2.225 . . . . 0.0 112.881 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.5 m -66.91 -50.17 63.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.83 0.852 . . . . 0.0 110.317 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.33 -36.54 84.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.81 -48.72 80.53 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.261 1.024 . . . . 0.0 112.002 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -59.89 -41.67 92.1 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.093 -1.004 . . . . 0.0 111.782 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.66 -53.1 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.328 -0.858 . . . . 0.0 111.739 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.31 -30.24 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.924 1.238 . . . . 0.0 113.233 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.8 p -75.28 -30.14 60.33 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.204 0.911 . . . . 0.0 112.629 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.4 m -78.1 -40.75 37.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -107.07 -9.67 16.12 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 64.61 -47.96 0.32 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.733 2.813 . . . . 0.0 115.299 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -116.12 122.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.258 1.823 . . . . 0.0 109.369 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.36 135.54 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.873 0.869 . . . . 0.0 110.033 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.02 128.79 56.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.616 1.566 . . . . 0.0 108.941 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -108.83 120.14 41.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 109.764 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -156.45 167.34 30.75 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.92 1.688 . . . . 0.0 110.505 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -78.56 31.71 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.93 163.7 31.93 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.356 1.931 . . . . 0.0 113.018 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.1 p -82.06 178.43 8.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 111.199 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -64.31 -26.9 68.69 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.63 0.772 . . . . 0.0 112.449 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.8 -25.76 26.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 113.229 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -119.01 65.02 6.98 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.8 1.64 . . . . 0.0 111.169 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.93 150.05 85.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.059 2.506 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -94.77 115.03 27.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.042 0.537 . . . . 0.0 110.55 -170.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.14 146.44 33.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.838 1.255 . . . . 0.0 112.805 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.76 -149.0 19.19 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -53.44 -41.03 65.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -64.63 -46.51 82.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 112.541 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -57.43 -44.57 84.8 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.403 -0.811 . . . . 0.0 110.452 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -59.08 -43.76 91.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.788 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.1 -42.25 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.422 1.01 . . . . 0.0 111.821 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.67 -47.93 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.689 0.677 . . . . 0.0 110.967 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.43 -37.5 87.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.504 0.722 . . . . 0.0 111.811 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.6 -50.68 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.071 1.748 . . . . 0.0 112.278 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.12 -49.7 73.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.328 0.967 . . . . 0.0 110.82 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -53.12 -54.95 28.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.342 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -30.69 69.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.011 2.124 . . . . 0.0 115.007 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.9 tp -57.16 -31.66 65.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.43 1.092 . . . . 0.0 109.882 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 t30 112.53 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.495 3.518 . . . . 0.0 109.199 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.26 150.28 28.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.54 163.7 35.47 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.364 2.709 . . . . 0.0 110.542 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -161.72 164.95 28.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.595 1.558 . . . . 0.0 110.119 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.2 148.57 48.18 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.055 -0.403 . . . . 0.0 111.21 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.9 m -113.71 117.5 31.69 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 111.32 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.3 t -92.93 122.53 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.119 0.968 . . . . 0.0 109.463 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -81.96 93.16 6.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.404 1.482 . . . . 0.0 111.546 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -77.6 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.574 1.15 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.43 -54.09 0.64 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.653 1.981 . . . . 0.0 112.862 169.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -67.32 -44.36 79.31 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 111.89 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -87.81 128.52 35.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.632 1.173 . . . . 0.0 111.167 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.25 -40.55 86.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 113.341 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -61.79 -41.67 98.03 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.814 0.846 . . . . 0.0 111.22 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.88 -48.16 69.61 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.507 0.723 . . . . 0.0 110.745 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.35 -40.81 62.43 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.221 1.008 . . . . 0.0 112.305 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.22 -36.97 24.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.608 1.163 . . . . 0.0 113.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.62 -23.0 37.74 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.24 174.68 6.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.493 1.146 . . . . 0.0 111.478 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 73.6 -53.07 0.7 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.581 2.352 . . . . 0.0 110.085 -169.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -70.07 -38.71 75.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.63 1.572 . . . . 0.0 112.327 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -63.48 -49.53 73.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -97.01 -15.82 20.88 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p 80.52 -9.47 1.36 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 129.477 3.111 . . . . 0.0 114.227 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -68.7 132.03 91.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.211 -0.93 . . . . 0.0 111.382 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.21 -36.0 2.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.11 2.54 . . . . 0.0 115.007 -169.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -140.57 90.93 2.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.801 0.728 . . . . 0.0 111.454 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -60.77 158.74 30.34 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.303 1.441 . . . . 0.0 110.814 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.46 162.25 37.53 Favored 'Cis proline' 0 C--N 1.358 1.035 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 1.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 152.65 7.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.128 1.371 . . . . 0.0 112.53 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -93.77 146.78 23.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.046 1.339 . . . . 0.0 111.196 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -138.58 138.73 38.2 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.013 2.125 . . . . 0.0 110.675 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -143.29 127.18 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.307 1.443 . . . . 0.0 111.632 -172.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 51.87 23.15 1.98 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.28 41.96 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.809 1.195 . . . . 0.0 115.32 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.32 150.21 45.13 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.209 1.504 . . . . 0.0 111.215 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.83 150.04 29.31 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.989 -1.069 . . . . 0.0 111.967 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -97.72 -47.55 5.56 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.215 1.006 . . . . 0.0 111.638 173.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 145.95 -172.55 26.57 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.287 1.422 . . . . 0.0 112.81 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.26 164.18 41.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.413 1.006 . . . . 0.0 113.544 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.0 m -66.89 -41.75 86.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.625 -0.927 . . . . 0.0 112.874 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.02 -43.91 94.95 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.403 -0.811 . . . . 0.0 111.306 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.92 -42.1 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 109.978 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.2 m -63.0 -43.02 99.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.041 1.336 . . . . 0.0 111.581 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.8 t -60.02 -45.46 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.467 0.707 . . . . 0.0 111.346 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -71.32 -32.78 69.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.912 0.778 . . . . 0.0 112.82 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.73 80.09 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.011 -1.056 . . . . 0.0 112.783 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -63.3 -43.31 98.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.811 0.845 . . . . 0.0 112.071 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.19 -32.86 74.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.991 0.516 . . . . 0.0 112.222 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -86.92 -11.76 49.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.408 1.083 . . . . 0.0 113.614 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.81 -0.16 87.81 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.525 1.536 . . . . 0.0 114.582 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.83 -36.1 59.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 111.251 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.5 tp -64.42 -43.64 93.74 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.675 -0.641 . . . . 0.0 110.708 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -55.69 -48.39 75.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.454 0.702 . . . . 0.0 110.552 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.52 -47.89 82.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.358 0.663 . . . . 0.0 111.899 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -73.47 -35.03 65.65 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.28 -42.34 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.473 1.033 . . . . 0.0 110.793 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.01 -45.97 89.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.277 0.944 . . . . 0.0 111.03 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.83 -43.75 94.42 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.605 -0.685 . . . . 0.0 111.993 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.41 92.79 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.173 0.989 . . . . 0.0 112.868 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.02 -35.47 74.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.242 1.017 . . . . 0.0 112.549 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.19 -38.09 87.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.302 0.641 . . . . 0.0 112.059 170.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.732 2.413 . . . . 0.0 112.578 170.909 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.86 -47.04 79.34 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.97 0.804 . . . . 0.0 110.354 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.76 -43.83 90.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.023 0.529 . . . . 0.0 111.633 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.9 m -65.48 -43.89 88.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.042 1.737 . . . . 0.0 111.566 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -61.8 -53.4 56.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.941 0.897 . . . . 0.0 110.425 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.81 -50.16 75.01 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.625 0.77 . . . . 0.0 111.36 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -56.53 -49.19 75.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 112.359 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.88 -46.31 85.49 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.563 -0.711 . . . . 0.0 111.966 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.48 -48.28 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.86 0.755 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.37 -20.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 p -93.41 -37.31 12.05 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.976 0.807 . . . . 0.0 112.932 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 t -74.04 -43.02 59.37 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.87 0.759 . . . . 0.0 112.317 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -97.43 -10.54 25.24 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mttm 63.09 -40.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.072 2.549 . . . . 0.0 116.139 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -120.79 128.11 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.066 1.746 . . . . 0.0 108.731 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.09 139.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.49 0.586 . . . . 0.0 112.422 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.17 129.45 56.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.171 1.388 . . . . 0.0 110.643 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -107.53 128.92 54.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.967 0.907 . . . . 0.0 111.04 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -162.58 -175.56 4.54 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.858 1.663 . . . . 0.0 110.851 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -76.6 51.48 0.74 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.25 -1.531 . . . . 0.0 112.412 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.96 168.02 30.42 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.695 1.14 . . . . 0.0 114.305 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.7 p -113.15 -175.73 2.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.258 1.823 . . . . 0.0 111.401 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.88 -32.76 74.61 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.543 -0.723 . . . . 0.0 112.119 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.46 -32.72 42.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.834 1.253 . . . . 0.0 112.667 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -122.81 77.68 48.98 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.217 1.407 . . . . 0.0 110.636 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 164.85 33.07 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -107.34 138.35 43.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.999 0.919 . . . . 0.0 111.755 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.4 m -66.48 157.93 30.85 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.068 1.347 . . . . 0.0 113.849 -172.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 -118.92 4.73 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.392 0.996 . . . . 0.0 112.271 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -59.1 -46.17 88.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.295 1.038 . . . . 0.0 112.883 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.7 m -69.79 -44.21 70.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.906 -1.121 . . . . 0.0 112.146 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.19 -46.66 69.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.755 1.222 . . . . 0.0 110.832 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -59.9 -50.37 74.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.416 1.086 . . . . 0.0 110.539 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 t -61.56 -44.56 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.246 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.82 -34.89 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.424 1.465 . . . . 0.0 111.545 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -68.03 -37.43 81.35 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.242 0.928 . . . . 0.0 112.524 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.68 -51.41 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.774 1.23 . . . . 0.0 110.777 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.55 -51.27 70.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.804 0.729 . . . . 0.0 111.266 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -47.24 -59.2 3.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.087 0.555 . . . . 0.0 109.991 174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m -62.97 -33.97 76.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.602 1.961 . . . . 0.0 114.103 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.81 -21.4 66.41 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.295 1.438 . . . . 0.0 111.951 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 109.02 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 131.51 3.924 . . . . 0.0 110.697 169.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 136.53 24.31 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -169.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -83.58 48.18 2.55 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.549 3.5 . . . . 0.0 109.665 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.44 164.53 18.56 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -169.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -130.89 170.05 14.95 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.722 1.609 . . . . 0.0 110.038 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -147.99 137.64 22.43 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.088 -1.632 . . . . 0.0 110.761 170.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.4 140.49 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.106 0.962 . . . . 0.0 110.529 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.49 142.99 35.33 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.0 pt -89.01 -174.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.432 1.093 . . . . 0.0 109.718 168.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt 71.16 174.91 0.3 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.553 2.341 . . . . 0.0 113.869 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 78.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.527 2.731 . . . . 0.0 110.854 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.95 141.5 54.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.636 0.774 . . . . 0.0 111.007 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.65 -37.91 74.17 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.034 -1.041 . . . . 0.0 113.429 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.21 -26.41 66.6 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.072 -1.018 . . . . 0.0 111.75 176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.82 -15.96 40.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.418 1.087 . . . . 0.0 113.237 170.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -80.57 -51.96 8.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.094 1.316 . . . . 0.0 111.677 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.39 -20.78 8.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -170.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.08 -30.72 69.62 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 120.975 -1.078 . . . . 0.0 113.388 -170.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.85 -41.27 91.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.765 1.283 . . . . 0.0 111.52 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.47 -45.38 91.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.72 -0.612 . . . . 0.0 110.834 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -68.72 -38.53 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.311 0.644 . . . . 0.0 112.736 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -70.04 -44.96 68.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.988 0.813 . . . . 0.0 112.531 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.99 -17.96 33.89 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m 69.81 -5.42 1.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.297 2.239 . . . . 0.0 113.756 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -74.93 127.56 86.67 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.764 1.226 . . . . 0.0 111.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.6 143.33 21.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.154 2.569 . . . . 0.0 110.27 172.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p 64.53 -161.35 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.782 2.033 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -146.19 163.56 29.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.79 2.036 . . . . 0.0 110.675 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.16 172.64 17.17 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 120.229 1.117 . . . . 0.0 114.875 -6.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.78 121.89 21.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.815 1.246 . . . . 0.0 108.435 170.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.14 123.38 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.181 0.992 . . . . 0.0 109.541 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -106.48 134.74 49.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.615 1.566 . . . . 0.0 110.911 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.3 pt -129.96 112.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 111.306 172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.43 17.57 4.94 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.556 1.942 . . . . 0.0 114.469 172.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.07 -3.53 41.04 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.155 1.836 . . . . 0.0 114.62 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -100.99 149.14 24.23 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 111.402 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -103.16 132.2 49.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.253 1.421 . . . . 0.0 111.046 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -99.28 -28.86 13.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.128 0.971 . . . . 0.0 113.45 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.78 -156.8 18.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.468 1.508 . . . . 0.0 111.743 -169.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.44 169.19 41.05 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.704 1.145 . . . . 0.0 114.141 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.9 m -57.65 -34.31 69.22 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.15 -40.92 95.65 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.38 -0.825 . . . . 0.0 111.802 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.23 -40.92 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.678 0.791 . . . . 0.0 109.937 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 m -61.39 -44.64 96.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.046 0.938 . . . . 0.0 111.665 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.69 -43.62 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.324 0.65 . . . . 0.0 111.485 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.99 -41.73 95.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.259 0.936 . . . . 0.0 111.987 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.62 -31.26 71.15 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.76 0.824 . . . . 0.0 113.17 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -67.91 -35.74 78.98 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.985 -1.072 . . . . 0.0 111.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.29 -32.35 66.52 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.9 p -88.15 -15.75 35.25 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.734 1.152 . . . . 0.0 113.76 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.57 1.01 78.38 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 125.306 1.431 . . . . 0.0 113.955 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.89 -30.37 68.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.288 . . . . 0.0 111.999 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.62 -47.65 69.02 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.556 -0.715 . . . . 0.0 110.165 172.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -56.41 -47.46 78.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 110.923 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.79 -50.67 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.51 0.724 . . . . 0.0 111.852 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -73.1 -36.74 66.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.279 -0.888 . . . . 0.0 113.183 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.28 -38.32 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.367 0.985 . . . . 0.0 111.087 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.05 -46.35 91.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.273 0.942 . . . . 0.0 110.866 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.57 -36.26 80.13 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.402 -0.811 . . . . 0.0 112.738 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.69 -36.61 84.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.158 0.983 . . . . 0.0 112.683 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 72.9 mtm -73.18 -41.28 64.03 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.555 0.742 . . . . 0.0 112.254 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.87 -39.37 69.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 129.718 3.207 . . . . 0.0 115.76 -176.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.64 -62.61 1.62 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.516 1.127 . . . . 0.0 110.998 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -66.57 -30.72 71.08 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.62 -0.675 . . . . 0.0 112.172 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -63.32 -46.29 87.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.807 1.643 . . . . 0.0 111.668 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -65.29 -48.68 72.31 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.776 0.83 . . . . 0.0 110.651 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.11 -55.04 35.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.153 0.981 . . . . 0.0 110.735 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.85 -46.59 74.67 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 111.713 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.7 -51.59 69.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.796 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.78 -36.49 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.4 1.454 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.89 -13.9 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.924 1.238 . . . . 0.0 113.763 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -102.41 -38.15 7.72 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.22 0.918 . . . . 0.0 113.107 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 t -80.13 -50.57 10.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.988 0.813 . . . . 0.0 111.853 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -88.79 -15.09 35.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.34 -0.85 . . . . 0.0 112.731 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.04 -52.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.913 2.885 . . . . 0.0 115.241 172.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 t -102.08 116.83 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.43 1.492 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -135.64 133.34 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.148 0.431 . . . . 0.0 110.893 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.02 138.2 44.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.004 1.722 . . . . 0.0 109.2 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -125.18 117.61 24.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.53 1.132 . . . . 0.0 110.186 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -167.25 -170.5 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.99 2.116 . . . . 0.0 109.589 -176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -81.04 -32.37 34.12 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.218 1.372 . . . . 0.0 112.517 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 154.54 47.47 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.193 1.378 . . . . 0.0 113.387 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -96.8 -179.59 4.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.734 1.614 . . . . 0.0 110.789 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.47 -18.76 60.58 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.106 -0.996 . . . . 0.0 113.554 172.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.9 -27.64 23.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 112.355 171.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.38 72.77 80.64 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.733 1.613 . . . . 0.0 111.058 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.56 157.09 59.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.006 2.471 . . . . 0.0 110.994 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.03 126.91 33.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.204 0.602 . . . . 0.0 111.133 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.1 t -59.22 143.68 48.35 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.781 1.232 . . . . 0.0 112.178 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.07 -146.11 18.06 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.919 1.247 . . . . 0.0 111.61 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -55.45 -36.69 66.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -169.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 m -64.55 -47.07 80.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.898 1.226 . . . . 0.0 112.404 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -57.73 -43.76 85.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.307 0.958 . . . . 0.0 110.648 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 m -58.83 -46.95 86.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.114 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.4 -42.23 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.173 0.989 . . . . 0.0 112.13 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -59.91 -45.72 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.433 0.693 . . . . 0.0 110.872 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.68 -41.41 96.07 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.594 0.757 . . . . 0.0 111.912 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.49 -52.01 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 111.608 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.14 -50.29 68.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.801 0.728 . . . . 0.0 110.438 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -50.4 -56.36 11.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.798 0.839 . . . . 0.0 110.691 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.53 -31.56 70.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.35 1.86 . . . . 0.0 114.638 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.01 -29.18 68.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 0.0 110.659 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 112.88 63.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 130.163 3.385 . . . . 0.0 109.71 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.32 154.74 34.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.39 173.95 13.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.232 2.621 . . . . 0.0 110.336 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -161.15 145.87 13.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 109.773 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -123.33 95.2 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.919 0.888 . . . . 0.0 109.833 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.4 m -76.07 97.35 4.04 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.934 -1.104 . . . . 0.0 110.667 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.77 129.47 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.513 1.925 . . . . 0.0 110.137 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -74.41 107.59 6.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.83 0.852 . . . . 0.0 110.953 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.49 -28.75 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -20.4 49.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.331 1.052 . . . . 0.0 112.87 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.69 -42.83 93.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.207 1.403 . . . . 0.0 113.687 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -119.55 129.9 54.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.926 0.891 . . . . 0.0 111.551 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.4 -30.2 71.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.6 -52.47 17.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.992 0.814 . . . . 0.0 110.702 173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.46 -33.17 70.96 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.455 1.502 . . . . 0.0 112.417 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.07 -22.06 62.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.378 1.871 . . . . 0.0 113.523 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.47 -56.15 1.62 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.656 1.182 . . . . 0.0 113.427 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -19.03 79.82 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.42 -34.36 72.39 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.489 1.145 . . . . 0.0 112.584 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -59.04 -37.39 76.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.245 1.018 . . . . 0.0 112.523 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.96 -30.92 27.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.514 1.126 . . . . 0.0 112.179 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -62.6 -41.47 99.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.77 0.828 . . . . 0.0 112.447 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.5 p -82.12 -68.21 0.72 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.381 0.673 . . . . 0.0 111.953 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.2 m 123.31 -13.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 133.293 4.637 . . . . 0.0 111.099 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -70.45 128.32 91.3 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.059 1.344 . . . . 0.0 112.003 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.18 140.11 13.75 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.37 2.713 . . . . 0.0 110.625 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.6 p 64.9 -174.55 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.563 2.345 . . . . 0.0 113.108 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -138.32 159.96 65.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.139 1.776 . . . . 0.0 110.476 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.89 165.51 35.68 Favored 'Cis proline' 0 C--N 1.355 0.877 0 N-CA-C 115.739 1.399 . . . . 0.0 115.739 1.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -141.89 132.78 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.253 1.421 . . . . 0.0 109.559 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.59 138.19 40.61 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.026 1.331 . . . . 0.0 108.75 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -134.95 137.2 42.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.917 1.687 . . . . 0.0 110.773 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.2 124.53 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.973 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.34 49.78 5.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.917 2.087 . . . . 0.0 114.845 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.25 3.06 73.02 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.362 -1.243 . . . . 0.0 115.435 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.09 143.48 50.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.347 1.573 . . . . 0.0 111.835 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -82.97 142.4 31.41 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.754 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -94.44 -33.62 13.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.221 1.008 . . . . 0.0 112.101 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.31 -153.93 16.81 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.62 1.581 . . . . 0.0 112.008 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.98 162.36 37.04 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.398 0.999 . . . . 0.0 113.114 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.9 m -58.26 -33.72 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.16 -44.98 84.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 0.0 111.817 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.0 -42.47 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.934 0.893 . . . . 0.0 109.606 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.7 m -62.7 -46.42 88.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.369 1.068 . . . . 0.0 111.911 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.88 -41.89 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.388 0.54 . . . . 0.0 111.342 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.58 -34.23 65.01 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.977 0.808 . . . . 0.0 112.868 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.43 80.62 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.022 -1.049 . . . . 0.0 112.178 173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.11 -39.56 82.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.804 0.841 . . . . 0.0 112.437 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.74 -34.38 77.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.347 0.659 . . . . 0.0 111.971 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.07 -12.11 53.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.215 1.006 . . . . 0.0 113.571 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.49 -6.2 82.79 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 125.855 1.693 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -68.79 -37.41 79.27 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.01 1.324 . . . . 0.0 111.55 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.02 -40.73 96.69 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.933 -0.48 . . . . 0.0 111.17 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -60.74 -48.12 83.23 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.376 0.535 . . . . 0.0 109.8 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.2 -44.48 97.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.348 0.659 . . . . 0.0 112.01 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.28 -35.44 76.04 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.382 -0.824 . . . . 0.0 113.057 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.08 -41.39 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.528 1.058 . . . . 0.0 110.672 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -59.59 -45.78 90.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.352 0.978 . . . . 0.0 110.913 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -57.8 -43.05 85.39 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.472 -0.767 . . . . 0.0 111.674 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.19 66.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.85 -36.82 14.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.631 0.772 . . . . 0.0 113.021 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.92 -25.39 26.15 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.255 1.395 0 C-N-CA 128.163 2.585 . . . . 0.0 113.275 174.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.87 -48.15 77.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.519 0.727 . . . . 0.0 110.421 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.39 -42.9 88.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.769 -0.582 . . . . 0.0 112.081 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -66.96 -38.94 87.02 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.243 1.817 . . . . 0.0 111.884 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -63.82 -49.89 71.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.175 0.99 . . . . 0.0 110.475 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.91 -43.7 95.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.07 0.948 . . . . 0.0 111.394 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.63 -45.13 92.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.075 0.852 . . . . 0.0 112.618 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.4 -42.57 96.22 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -0.934 . . . . 0.0 111.356 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -60.82 -48.63 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.277 -0.89 . . . . 0.0 111.583 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.02 -38.03 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.553 1.141 . . . . 0.0 113.44 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -81.34 -33.36 32.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.938 0.895 . . . . 0.0 112.824 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -77.59 -32.26 53.5 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.23 112.42 11.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.145 1.378 . . . . 0.0 110.437 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -59.86 -38.16 81.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.95 134.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.192 1.797 . . . . 0.0 109.171 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.24 130.52 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.464 1.106 . . . . 0.0 109.903 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.19 127.21 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.084 0.954 . . . . 0.0 110.272 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.99 124.47 52.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -164.91 -177.82 4.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.846 1.658 . . . . 0.0 110.433 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.61 38.1 0.61 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.46 -1.4 . . . . 0.0 113.114 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.83 160.62 31.64 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 125.339 1.447 . . . . 0.0 113.368 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 p -96.93 -179.42 4.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.372 1.469 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.25 -29.75 68.63 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.608 -0.683 . . . . 0.0 112.337 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.55 -34.18 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.039 1.336 . . . . 0.0 112.502 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.01 76.2 67.13 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.612 1.565 . . . . 0.0 110.365 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.84 170.98 19.17 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.433 2.756 . . . . 0.0 111.569 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -114.02 136.51 52.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.98 0.912 . . . . 0.0 110.397 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.0 t -71.16 156.29 39.75 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.493 1.117 . . . . 0.0 112.313 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.49 -149.42 19.24 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 125.36 1.457 . . . . 0.0 111.803 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.03 -30.17 65.92 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -56.74 -53.37 58.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.314 1.446 . . . . 0.0 111.653 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.29 -40.29 89.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.373 -0.829 . . . . 0.0 110.653 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -58.59 -50.11 75.01 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.724 0.809 . . . . 0.0 111.321 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.21 -35.58 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.648 1.113 . . . . 0.0 112.517 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.27 -47.31 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.208 0.913 . . . . 0.0 111.054 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -65.04 -39.64 93.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.862 0.865 . . . . 0.0 112.312 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt -56.66 -49.49 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.59 1.156 . . . . 0.0 111.996 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.66 -51.33 67.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.078 0.854 . . . . 0.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -49.02 -57.06 7.16 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.458 0.703 . . . . 0.0 110.128 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 t -65.68 -33.58 76.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.832 2.053 . . . . 0.0 114.605 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.59 -28.31 67.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.819 0.736 . . . . 0.0 111.123 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 t30 110.96 57.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.96 3.304 . . . . 0.0 109.621 169.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 142.77 22.28 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.88 162.44 26.59 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.137 3.225 . . . . 0.0 110.499 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -163.65 165.94 22.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.255 1.022 . . . . 0.0 112.285 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.25 162.19 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 108.257 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.8 m -144.52 128.43 17.42 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 119.979 -1.701 . . . . 0.0 111.483 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.9 131.19 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.813 1.245 . . . . 0.0 110.289 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -75.7 110.02 9.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.136 0.574 . . . . 0.0 110.849 174.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -61.0 -29.74 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -87.57 8.13 26.52 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.671 1.188 . . . . 0.0 113.208 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.87 -31.07 71.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.955 0.902 . . . . 0.0 113.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.33 154.5 30.69 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.193 0.997 . . . . 0.0 111.693 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.716 1.207 . . . . 0.0 113.91 -169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.27 -31.85 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.39 -54.95 15.98 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.743 0.817 . . . . 0.0 110.963 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -57.87 -29.85 65.35 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.6 -37.99 11.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.98 -32.19 27.03 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 118.904 0.775 . . . . 0.0 113.428 -172.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.38 -36.94 74.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.881 0.872 . . . . 0.0 112.222 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.29 -53.34 45.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.151 1.38 . . . . 0.0 112.63 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -81.66 -23.88 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -67.08 -48.86 66.94 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.937 0.79 . . . . 0.0 112.471 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.0 p -77.84 -46.8 20.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.017 0.826 . . . . 0.0 112.081 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m 122.87 -26.11 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 1 C-N-CA 132.879 4.471 . . . . 0.0 112.693 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.08 142.14 68.3 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.514 -0.741 . . . . 0.0 112.034 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.12 -13.17 11.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.027 2.485 . . . . 0.0 116.162 -169.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -138.67 169.25 18.12 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.892 1.224 . . . . 0.0 112.521 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -137.06 155.85 75.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.737 1.615 . . . . 0.0 110.719 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.17 156.6 47.72 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.602 1.251 . . . . 0.0 115.281 -1.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.73 134.76 8.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.338 1.055 . . . . 0.0 110.968 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.48 140.99 38.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 111.197 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -131.97 132.6 43.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.252 1.821 . . . . 0.0 109.239 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.28 125.21 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.204 1.002 . . . . 0.0 109.348 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.3 22.83 5.09 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.34 48.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.308 0.956 . . . . 0.0 114.932 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.13 145.13 45.5 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.001 1.4 . . . . 0.0 110.993 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -76.87 143.9 39.36 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.265 -0.897 . . . . 0.0 111.97 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -103.76 -26.75 12.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.512 1.125 . . . . 0.0 112.055 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.36 -168.66 12.95 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 125.427 1.489 . . . . 0.0 113.55 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.36 172.67 55.12 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.789 1.185 . . . . 0.0 114.085 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 83.6 m -65.83 -41.99 91.11 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -63.45 -42.65 98.66 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.73 0.696 . . . . 0.0 111.376 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.63 -42.79 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 0.0 109.987 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -64.0 -42.78 97.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.935 1.294 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.39 -39.95 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.062 0.945 . . . . 0.0 111.519 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.22 -39.5 82.37 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.453 1.024 . . . . 0.0 112.435 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.68 91.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.72 0.808 . . . . 0.0 112.352 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -61.33 -45.2 95.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.243 1.417 . . . . 0.0 112.313 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -67.51 -29.17 68.52 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.966 0.906 . . . . 0.0 112.636 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -88.01 -12.85 43.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.459 1.104 . . . . 0.0 113.446 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.17 -1.44 87.62 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.65 1.595 . . . . 0.0 114.428 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.93 -35.29 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 111.822 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -49.06 76.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.423 0.689 . . . . 0.0 110.042 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -56.72 -49.03 76.4 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.122 0.969 . . . . 0.0 110.711 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.05 -46.91 88.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.405 0.682 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.94 -36.17 77.64 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.51 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.543 1.065 . . . . 0.0 110.751 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.58 -46.52 89.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.703 1.138 . . . . 0.0 111.36 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.11 -39.95 88.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.922 . . . . 0.0 112.555 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.05 78.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.572 -0.705 . . . . 0.0 111.966 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 mmt -67.27 -38.19 84.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.865 0.866 . . . . 0.0 112.805 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.5 -23.97 42.61 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.255 1.373 0 C-N-CA 127.265 2.226 . . . . 0.0 112.811 177.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.43 -54.43 43.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.819 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.26 -37.71 84.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -65.05 -40.99 95.54 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.883 1.673 . . . . 0.0 111.887 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.9 m -63.42 -48.18 78.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.861 0.864 . . . . 0.0 110.737 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.63 -49.32 77.95 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.247 0.619 . . . . 0.0 111.565 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.81 -45.16 86.53 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.668 0.787 . . . . 0.0 112.373 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -61.4 -44.66 96.76 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 111.787 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.9 -46.95 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.201 0.909 . . . . 0.0 111.484 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -60.19 -43.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 112.107 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -78.36 -29.05 47.26 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 m -79.96 -39.03 31.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.28 -10.97 12.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 60.97 -58.87 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.059 2.544 . . . . 0.0 114.813 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.46 125.77 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.414 1.486 . . . . 0.0 108.877 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.79 128.07 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.018 0.927 . . . . 0.0 110.761 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.42 142.13 34.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.038 1.335 . . . . 0.0 110.32 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.16 119.23 35.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.525 1.53 . . . . 0.0 109.624 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -174.19 -169.16 0.44 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.677 1.991 . . . . 0.0 110.038 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -91.59 -18.44 24.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.01 156.06 30.72 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.154 1.359 . . . . 0.0 113.143 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.7 p -86.85 177.31 7.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.073 1.349 . . . . 0.0 111.446 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.67 -28.78 69.84 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -87.68 -33.3 18.82 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.02 1.328 . . . . 0.0 112.475 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -120.56 84.7 36.85 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.13 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 139.35 52.03 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.523 2.149 . . . . 0.0 108.868 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -0.31 56.25 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.0 t -160.24 163.44 33.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.146 1.379 . . . . 0.0 111.613 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.61 -32.59 84.68 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.029 0.823 . . . . 0.0 113.058 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -73.3 -46.26 50.63 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.332 1.066 . . . . 0.0 112.364 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -62.31 -45.67 92.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.562 -0.712 . . . . 0.0 110.914 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.76 -46.72 74.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.094 0.958 . . . . 0.0 111.279 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.6 m -59.34 -51.61 69.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.092 0.957 . . . . 0.0 110.762 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.81 -37.89 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.846 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.16 -34.14 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 120.656 1.571 . . . . 0.0 111.92 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.02 -44.34 89.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.637 0.653 . . . . 0.0 111.223 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.04 -51.69 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 111.034 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.0 -50.61 71.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.401 1.08 . . . . 0.0 110.591 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.79 -51.43 68.97 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.184 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -68.23 -32.7 73.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.433 1.493 . . . . 0.0 114.05 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.45 -32.67 70.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.908 1.283 . . . . 0.0 110.609 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 118.7 72.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 129.989 3.316 . . . . 0.0 110.711 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.45 140.9 13.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.96 158.39 34.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.141 2.561 . . . . 0.0 108.248 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.88 172.6 17.76 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.51 155.3 42.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.911 1.284 . . . . 0.0 110.367 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -118.26 129.87 55.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.44 -0.787 . . . . 0.0 110.821 172.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -97.06 121.89 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.661 1.184 . . . . 0.0 108.485 173.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -74.23 90.47 2.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.593 1.157 . . . . 0.0 110.191 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pt -69.81 -17.51 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 -1.92 55.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.717 1.207 . . . . 0.0 113.116 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -64.25 -28.77 69.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.141 0.882 . . . . 0.0 112.975 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -159.27 162.27 36.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.242 1.417 . . . . 0.0 112.111 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.85 -31.58 70.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.533 -0.729 . . . . 0.0 112.781 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.63 -39.83 95.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.83 0.741 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.52 -51.49 56.08 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.89 -0.506 . . . . 0.0 110.914 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -56.01 -44.99 79.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.216 1.006 . . . . 0.0 112.858 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -83.34 -24.82 31.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.646 0.778 . . . . 0.0 112.658 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.57 -40.02 6.51 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.296 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.17 -33.55 74.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.493 1.647 . . . . 0.0 113.401 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -60.82 -31.38 70.79 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -83.45 -34.85 25.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.185 0.994 . . . . 0.0 112.158 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.23 -42.32 94.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.217 1.007 . . . . 0.0 112.337 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.9 p -83.47 -67.54 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.829 0.852 . . . . 0.0 112.695 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.6 m 135.05 -23.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 133.341 4.657 . . . . 0.0 111.218 -173.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -83.81 132.17 49.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.23 1.012 . . . . 0.0 111.775 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.02 -25.83 2.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.826 2.351 . . . . 0.0 114.72 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -95.93 151.55 19.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.563 1.145 . . . . 0.0 111.521 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -127.83 151.12 75.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.652 1.581 . . . . 0.0 110.605 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.79 155.95 52.55 Favored 'Cis proline' 0 C--N 1.355 0.869 0 CA-C-N 120.694 1.283 . . . . 0.0 114.422 -2.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -150.49 143.08 24.5 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.987 0.915 . . . . 0.0 110.728 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 tp -110.32 146.81 35.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.317 1.447 . . . . 0.0 111.458 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -148.76 137.81 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.825 2.05 . . . . 0.0 109.392 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -142.62 122.54 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.183 -0.948 . . . . 0.0 111.611 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.83 33.64 6.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.563 1.945 . . . . 0.0 115.284 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.95 -0.78 51.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.813 1.197 . . . . 0.0 115.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.51 141.0 48.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.033 1.417 . . . . 0.0 110.763 173.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -84.1 144.25 29.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.448 -0.783 . . . . 0.0 110.669 170.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.93 -31.69 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.969 0.908 . . . . 0.0 112.285 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.48 -151.2 17.06 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.055 1.312 . . . . 0.0 112.134 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.58 162.69 49.38 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 124.157 0.884 . . . . 0.0 112.934 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -56.23 -35.89 67.86 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.3 -39.97 84.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.633 0.773 . . . . 0.0 112.036 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.39 -42.22 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.406 0.682 . . . . 0.0 109.848 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 m -62.07 -47.27 85.45 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.469 1.108 . . . . 0.0 111.051 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.11 -44.72 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 0.0 111.338 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.35 -37.26 77.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.897 0.771 . . . . 0.0 112.444 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -29.91 70.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 113.048 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -70.85 -33.6 70.81 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.339 -0.851 . . . . 0.0 112.267 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.55 -40.38 76.85 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.9 p -81.05 -17.53 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.201 -0.937 . . . . 0.0 113.208 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.79 69.83 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.336 1.446 . . . . 0.0 113.57 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -36.93 84.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.95 1.3 . . . . 0.0 111.889 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.61 -40.68 97.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.321 0.648 . . . . 0.0 111.189 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.97 -44.34 94.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.965 0.506 . . . . 0.0 110.039 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -61.92 -44.17 97.33 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.326 173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -69.22 -38.84 78.76 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.796 1.18 . . . . 0.0 112.439 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.86 -39.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 118.859 0.754 . . . . 0.0 110.626 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.85 -45.88 92.78 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.132 0.878 . . . . 0.0 111.37 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -59.15 -44.85 92.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.97 0.908 . . . . 0.0 111.772 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.04 96.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.755 1.222 . . . . 0.0 112.807 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.9 mmt -73.57 -33.98 64.92 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.333 -0.854 . . . . 0.0 112.092 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.67 -47.0 70.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.037 0.935 . . . . 0.0 112.628 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.258 1.508 0 C-N-CA 128.755 2.822 . . . . 0.0 114.702 -175.249 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.453 0.168 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.42 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.18 -60.16 3.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.98 1.312 . . . . 0.0 113.225 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 -43.19 4.22 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-O 115.829 -2.034 . . . . 0.0 114.761 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.66 -29.82 2.12 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 122.927 2.081 . . . . 0.0 114.119 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.83 -46.29 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.21 -49.73 26.37 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.159 0.89 . . . . 0.0 111.7 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.6 -34.15 76.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.472 -0.768 . . . . 0.0 112.04 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -61.52 -42.56 98.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.422 1.889 . . . . 0.0 111.934 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.756 1.223 . . . . 0.0 110.933 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.82 -45.6 85.92 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.712 0.805 . . . . 0.0 111.312 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.19 -43.73 95.64 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.239 0.927 . . . . 0.0 112.389 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -60.41 -42.93 97.0 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.352 -0.843 . . . . 0.0 111.892 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.12 -48.97 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 119.175 0.898 . . . . 0.0 111.148 173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.84 -38.25 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.051 1.34 . . . . 0.0 112.853 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -81.8 -28.83 32.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 0.0 112.834 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -78.1 -31.2 49.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -138.06 114.78 10.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.412 1.485 . . . . 0.0 109.737 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -66.56 -20.67 66.07 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.1 t -119.62 123.71 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.793 1.237 . . . . 0.0 109.119 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.64 139.09 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.344 1.058 . . . . 0.0 109.563 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.91 135.72 54.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.311 1.444 . . . . 0.0 110.02 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.57 116.64 29.11 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.353 1.061 . . . . 0.0 108.775 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ptm -162.16 176.05 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.492 1.517 . . . . 0.0 110.791 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.56 26.97 0.75 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.711 -1.243 . . . . 0.0 113.617 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.42 169.79 39.35 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.6 1.572 . . . . 0.0 113.266 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.2 p -97.75 176.37 5.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.072 1.349 . . . . 0.0 111.272 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -66.43 -26.32 67.17 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.804 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -86.29 -27.0 24.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.468 1.507 . . . . 0.0 112.401 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.93 78.51 59.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 0.0 110.678 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.11 178.99 1.64 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.322 3.348 . . . . 0.0 113.622 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -130.36 138.08 50.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.552 1.141 . . . . 0.0 109.688 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.18 160.99 28.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.651 1.18 . . . . 0.0 113.661 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.78 -126.56 8.22 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.633 1.111 . . . . 0.0 111.527 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -56.12 -49.55 73.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.933 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -52.2 66.11 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 111.323 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -57.83 -39.11 76.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.393 0.677 . . . . 0.0 111.337 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.5 m -63.27 -51.89 64.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.546 1.139 . . . . 0.0 110.935 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.24 -44.61 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.565 0.62 . . . . 0.0 111.088 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -61.28 -47.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.637 0.775 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -64.18 -40.5 96.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.224 1.01 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mt -59.71 -51.35 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.737 0.815 . . . . 0.0 111.291 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.17 -46.83 82.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.627 0.771 . . . . 0.0 111.286 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -52.6 -52.46 55.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.352 0.661 . . . . 0.0 110.727 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.5 m -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.527 1.931 . . . . 0.0 114.684 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.46 -39.46 76.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.711 0.804 . . . . 0.0 109.701 170.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 t30 123.74 68.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.979 3.712 . . . . 0.0 109.546 169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.93 152.56 28.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.28 178.49 7.56 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.675 2.916 . . . . 0.0 110.21 169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -163.48 141.2 7.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.856 1.263 . . . . 0.0 111.189 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.31 92.2 3.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.214 1.005 . . . . 0.0 109.663 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.9 m -75.37 111.57 10.78 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.98 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.6 t -92.73 126.77 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.604 1.962 . . . . 0.0 108.543 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -78.5 113.05 16.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.58 -25.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -4.28 58.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -173.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -74.45 -18.88 60.57 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -156.81 128.56 7.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.477 1.111 . . . . 0.0 110.657 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.8 -25.94 67.8 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.269 -0.894 . . . . 0.0 112.869 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.93 -30.7 69.22 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.202 -0.937 . . . . 0.0 112.393 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.51 -53.92 12.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.213 0.915 . . . . 0.0 108.993 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.86 66.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.71 -44.07 11.44 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.702 0.801 . . . . 0.0 112.41 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.16 -30.87 56.52 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-O 119.05 -0.861 . . . . 0.0 114.566 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.58 -20.63 66.05 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.141 1.471 . . . . 0.0 113.686 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -68.3 -38.65 81.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.12 0.968 . . . . 0.0 111.678 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.39 -29.31 30.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.399 1.08 . . . . 0.0 112.517 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.69 -34.33 72.73 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.98 1.312 . . . . 0.0 112.529 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -94.51 -58.58 2.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.663 1.585 . . . . 0.0 112.934 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t 107.8 -2.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 131.886 4.075 . . . . 0.0 110.406 -169.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -88.98 131.7 40.36 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.293 1.837 . . . . 0.0 111.602 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.19 142.64 12.24 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.636 2.891 . . . . 0.0 111.556 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 p 74.33 165.13 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 128.54 2.736 . . . . 0.0 114.09 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.61 159.21 59.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.03 1.732 . . . . 0.0 111.115 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.64 160.65 49.19 Favored 'Cis proline' 0 C--N 1.354 0.865 0 CA-C-N 120.159 1.093 . . . . 0.0 114.91 -2.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -140.19 130.36 25.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.935 1.294 . . . . 0.0 110.058 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.86 137.86 36.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.987 1.715 . . . . 0.0 109.641 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -140.53 136.8 33.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.158 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -144.82 128.62 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.159 1.384 . . . . 0.0 112.615 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 46.3 31.95 1.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.494 2.318 . . . . 0.0 115.883 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.54 10.58 37.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.227 -1.318 . . . . 0.0 115.686 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -147.06 149.07 32.34 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.694 1.747 . . . . 0.0 112.193 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -79.7 150.79 30.77 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.347 -0.845 . . . . 0.0 111.504 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -105.9 -33.73 7.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.929 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.0 -153.61 18.51 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.099 1.333 . . . . 0.0 113.382 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.66 -177.74 42.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.795 1.188 . . . . 0.0 114.135 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.7 t -63.15 -43.02 99.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 113.13 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.33 -46.38 88.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.978 0.808 . . . . 0.0 111.258 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.32 -45.46 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.834 0.853 . . . . 0.0 110.19 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.3 m -62.56 -47.62 83.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.056 1.342 . . . . 0.0 110.957 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.08 -46.15 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.857 1.263 . . . . 0.0 111.23 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.75 -38.55 80.2 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.898 0.772 . . . . 0.0 111.76 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.37 80.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.531 0.732 . . . . 0.0 112.666 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.9 -40.49 95.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.022 0.929 . . . . 0.0 112.268 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.533 1.133 . . . . 0.0 112.889 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.4 m -85.69 -11.91 52.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.043 0.937 . . . . 0.0 113.499 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.05 85.03 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.516 1.532 . . . . 0.0 114.059 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.43 -41.65 65.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 111.566 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.88 -42.01 97.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.506 -0.746 . . . . 0.0 110.033 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -59.7 -48.86 80.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.07 0.548 . . . . 0.0 109.691 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.16 -50.86 71.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.318 1.047 . . . . 0.0 111.918 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -72.14 -32.27 66.76 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.17 -39.6 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.393 0.997 . . . . 0.0 111.024 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.34 -43.21 99.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.842 1.201 . . . . 0.0 111.252 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.16 -39.6 86.96 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.382 -0.823 . . . . 0.0 112.366 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.33 -29.52 70.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.876 0.87 . . . . 0.0 113.186 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.3 mmt -76.8 -48.93 17.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.73 0.695 . . . . 0.0 112.138 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.3 p -80.05 -25.73 40.01 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 126.806 2.043 . . . . 0.0 112.344 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.635 0.255 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.47 175.7 12.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.754 2.022 . . . . 0.0 110.386 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.1 -15.34 61.49 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.48 1.112 . . . . 0.0 113.514 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p -60.03 -23.11 1.09 Allowed Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 118.372 2.73 . . . . 0.0 118.372 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -62.26 178.9 0.72 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.639 2.893 . . . . 0.0 114.825 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.46 -8.15 5.71 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.588 1.555 . . . . 0.0 114.932 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -54.8 -49.25 71.43 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 110.019 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -59.72 -41.21 90.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.653 1.115 . . . . 0.0 112.367 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -62.42 -41.62 98.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.146 1.778 . . . . 0.0 111.905 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -68.81 -46.85 67.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.033 1.333 . . . . 0.0 110.738 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.78 -53.55 53.73 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.194 1.797 . . . . 0.0 110.634 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.25 -47.53 78.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.222 1.009 . . . . 0.0 111.904 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -59.2 -42.25 90.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.237 0.615 . . . . 0.0 112.618 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.63 -43.56 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.52 -41.32 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.388 1.075 . . . . 0.0 112.63 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.3 p -78.93 -38.28 37.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.581 1.082 . . . . 0.0 112.587 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -73.91 -33.99 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -113.26 -7.35 13.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 61.05 -63.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 127.711 2.405 . . . . 0.0 114.47 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -91.57 121.1 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.008 1.323 . . . . 0.0 109.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.41 147.74 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.427 0.691 . . . . 0.0 110.847 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 125.63 47.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.707 1.603 . . . . 0.0 109.185 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -94.91 116.74 29.09 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptm -156.63 170.8 21.57 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 111.748 -169.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.47 -13.63 25.98 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.23 -163.89 25.59 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.753 1.644 . . . . 0.0 112.913 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.3 p -128.32 175.18 8.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.767 1.627 . . . . 0.0 111.439 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.66 -31.02 72.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.748 1.219 . . . . 0.0 111.958 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.3 -29.79 28.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.935 1.294 . . . . 0.0 112.915 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -138.06 84.29 21.2 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.4 1.48 . . . . 0.0 111.323 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.09 165.37 19.47 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.693 2.929 . . . . 0.0 112.396 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -80.06 124.86 29.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.4 m -58.04 138.52 55.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.762 0.825 . . . . 0.0 111.294 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.88 -119.53 5.79 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -52.47 -65.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.425 1.49 . . . . 0.0 114.16 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -64.4 -42.92 95.83 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.92 -45.72 82.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.24 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -61.48 -48.39 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.138 0.975 . . . . 0.0 110.431 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.72 -50.29 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.681 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.37 -31.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 119.24 0.927 . . . . 0.0 112.341 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.01 -45.71 84.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.694 0.679 . . . . 0.0 110.736 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.96 -50.58 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.853 0.861 . . . . 0.0 111.237 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.52 -50.3 74.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.813 0.733 . . . . 0.0 111.219 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -57.07 -52.91 63.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.029 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 t -66.34 -33.29 75.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 114.024 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -57.61 -34.22 69.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.446 1.098 . . . . 0.0 110.874 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 117.71 64.7 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.519 3.528 . . . . 0.0 109.887 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.81 154.61 31.54 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.93 172.44 16.18 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.549 2.833 . . . . 0.0 111.063 170.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.25 146.83 15.75 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.506 1.522 . . . . 0.0 110.459 170.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.3 118.29 35.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.205 0.602 . . . . 0.0 111.076 169.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -76.11 82.43 2.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.246 1.018 . . . . 0.0 110.413 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.22 104.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.02 119.93 20.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.017 0.527 . . . . 0.0 111.739 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -74.79 -34.81 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.79 -38.4 70.27 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.35 -21.63 59.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -99.02 -49.48 4.5 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.787 0.835 . . . . 0.0 113.115 -176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 69.0 -34.64 0.28 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.062 2.545 . . . . 0.0 115.772 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -42.86 99.35 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.919 -1.113 . . . . 0.0 109.693 170.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.09 -45.99 92.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.031 1.332 . . . . 0.0 111.652 169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -56.91 -39.76 75.04 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.431 1.092 . . . . 0.0 112.677 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -89.89 -33.91 16.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.1 -34.62 9.6 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 123.977 0.798 . . . . 0.0 114.727 -172.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -29.75 69.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.313 1.556 . . . . 0.0 110.984 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -63.5 -27.69 69.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.29 -1.506 . . . . 0.0 113.085 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -78.54 -37.55 42.59 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.007 0.821 . . . . 0.0 111.549 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -66.72 -35.22 79.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.426 1.09 . . . . 0.0 113.26 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.6 p -108.81 -14.1 14.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 114.937 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.1 m 66.53 6.17 4.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.527 1.931 . . . . 0.0 113.95 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -74.94 141.65 75.31 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.599 1.56 . . . . 0.0 113.155 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 -49.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.81 2.34 . . . . 0.0 114.105 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.4 p -149.74 125.86 10.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.138 0.975 . . . . 0.0 112.178 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.75 158.94 72.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.001 1.32 . . . . 0.0 112.396 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -64.43 163.26 59.28 Favored 'Cis proline' 0 C--N 1.357 0.982 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 2.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -149.16 134.47 18.37 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.999 0.92 . . . . 0.0 110.524 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.05 139.31 30.75 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.964 1.305 . . . . 0.0 109.475 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -143.35 137.75 28.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.414 1.086 . . . . 0.0 110.221 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 mt -139.25 121.84 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.588 -0.695 . . . . 0.0 110.785 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t70 64.44 -22.68 0.07 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.202 3.001 . . . . 0.0 116.893 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.03 10.72 0.06 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.845 1.688 . . . . 0.0 115.277 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.86 150.23 30.65 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.311 1.555 . . . . 0.0 111.074 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -73.53 141.75 46.72 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.889 -0.507 . . . . 0.0 111.026 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.94 -39.61 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.734 0.814 . . . . 0.0 111.836 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.53 -151.04 22.39 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.455 1.026 . . . . 0.0 113.942 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.25 -173.16 20.31 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.767 1.651 . . . . 0.0 113.387 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -60.98 -47.2 87.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.826 0.85 . . . . 0.0 112.842 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.05 -45.14 93.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.413 0.552 . . . . 0.0 111.587 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.45 -44.28 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.594 0.757 . . . . 0.0 109.998 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.1 m -62.89 -46.15 89.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.822 1.249 . . . . 0.0 111.198 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.97 -43.43 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.183 0.993 . . . . 0.0 111.252 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.97 -42.38 80.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.774 0.715 . . . . 0.0 111.973 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.36 79.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 112.771 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -66.39 -40.58 89.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.031 1.332 . . . . 0.0 112.304 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -70.98 -32.87 69.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.169 0.588 . . . . 0.0 112.436 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.69 -12.14 51.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.92 -0.1 87.62 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 125.404 1.478 . . . . 0.0 114.092 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.74 -36.58 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.468 1.107 . . . . 0.0 111.381 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.69 -46.44 85.5 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.884 -0.51 . . . . 0.0 110.176 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -56.75 -48.82 76.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.67 0.788 . . . . 0.0 110.986 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.07 -49.63 77.15 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.813 0.845 . . . . 0.0 111.668 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -71.43 -35.54 70.98 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.9 -42.08 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.679 1.127 . . . . 0.0 110.887 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.07 -43.05 99.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.048 0.84 . . . . 0.0 111.488 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -59.98 -42.48 94.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.343 -0.848 . . . . 0.0 111.866 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.05 72.79 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.235 0.925 . . . . 0.0 112.812 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.68 -54.36 7.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.743 0.817 . . . . 0.0 111.255 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.571 1.148 . . . . 0.0 113.058 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.916 2.486 . . . . 0.0 112.538 171.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.479 0.18 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.57 59.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.3 tp -141.6 152.36 43.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.667 1.587 . . . . 0.0 110.426 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.8 p -61.51 123.06 74.92 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.724 1.61 . . . . 0.0 111.663 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.59 -34.14 81.71 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.109 3.206 . . . . 0.0 115.425 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.21 93.81 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.072 0.851 . . . . 0.0 112.192 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.6 tp -67.33 -47.75 69.58 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.146 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -58.63 -37.26 75.53 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.303 0.956 . . . . 0.0 112.261 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.9 m -66.09 -41.65 90.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.508 1.923 . . . . 0.0 111.678 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.2 m -67.23 -45.89 75.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.625 1.17 . . . . 0.0 111.159 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 99.4 mt -56.92 -54.65 44.14 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.869 1.268 . . . . 0.0 110.343 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.71 -41.6 74.04 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.794 0.725 . . . . 0.0 112.153 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -61.7 -47.36 85.62 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.333 -0.855 . . . . 0.0 112.101 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.94 -36.76 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.414 1.461 . . . . 0.0 112.705 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.85 -40.77 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.712 1.205 . . . . 0.0 112.308 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -80.18 -45.39 18.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.571 0.748 . . . . 0.0 112.361 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 76.3 p -70.7 -38.86 73.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -100.77 -3.8 29.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.629 0.771 . . . . 0.0 112.921 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt 62.14 -59.53 0.12 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.344 2.658 . . . . 0.0 114.395 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.87 137.21 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.65 1.58 . . . . 0.0 108.977 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.04 142.25 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.453 0.701 . . . . 0.0 111.032 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.36 145.4 28.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.058 1.343 . . . . 0.0 110.768 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -123.8 116.18 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.928 1.691 . . . . 0.0 109.401 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -173.18 1.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.338 1.455 . . . . 0.0 112.311 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.19 -154.93 0.13 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.286 1.434 . . . . 0.0 113.31 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.79 -146.8 50.62 Favored Glycine 0 N--CA 1.481 1.689 0 O-C-N 120.574 -1.329 . . . . 0.0 113.605 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.5 p -128.62 175.61 8.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.537 1.535 . . . . 0.0 109.46 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.29 -14.56 63.08 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.718 -1.238 . . . . 0.0 112.903 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.34 -39.88 8.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.808 1.243 . . . . 0.0 113.53 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -90.04 119.37 69.32 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.961 0.904 . . . . 0.0 111.34 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 134.46 24.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.183 2.589 . . . . 0.0 112.334 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -80.35 -34.37 36.62 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.855 2.062 . . . . 0.0 112.982 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.55 153.58 2.35 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.331 2.252 . . . . 0.0 108.954 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.35 -35.77 89.3 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 123.731 0.682 . . . . 0.0 113.308 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.77 -51.66 61.11 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.25 1.025 . . . . 0.0 111.089 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -60.15 -43.17 95.97 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.368 -0.833 . . . . 0.0 111.939 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -59.95 -46.41 89.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.537 0.735 . . . . 0.0 110.792 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -59.85 -45.12 93.44 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.808 0.843 . . . . 0.0 110.729 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.07 -43.65 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.075 0.95 . . . . 0.0 112.413 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.81 -46.69 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 110.802 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -65.58 -38.49 89.69 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mt -59.09 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.645 1.578 . . . . 0.0 111.561 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.03 -48.28 79.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.338 0.972 . . . . 0.0 110.66 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -51.28 -56.53 12.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.19 70.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.432 2.293 . . . . 0.0 114.805 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.63 -29.89 66.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.926 1.291 . . . . 0.0 109.974 169.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.7 t30 109.58 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 130.309 3.444 . . . . 0.0 108.885 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.9 149.72 28.46 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 167.27 17.37 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.121 3.214 . . . . 0.0 110.101 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -169.16 158.67 8.52 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.619 1.568 . . . . 0.0 111.046 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 168.33 9.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.448 1.099 . . . . 0.0 110.327 175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -148.3 105.15 3.59 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 119.792 -1.817 . . . . 0.0 110.774 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -87.36 118.32 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.921 1.288 . . . . 0.0 108.378 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -86.01 101.27 12.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 109.126 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.47 -32.4 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.61 -24.89 66.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -168.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.15 -10.8 59.8 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -134.98 119.22 17.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.563 1.074 . . . . 0.0 113.354 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.1 -32.08 69.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.06 -41.56 81.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.902 0.881 . . . . 0.0 110.871 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.42 -49.16 74.82 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.204 0.602 . . . . 0.0 110.868 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -55.76 -43.68 76.92 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -82.34 -32.35 29.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.71 -38.33 12.14 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.373 0.987 . . . . 0.0 113.98 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.21 -26.42 65.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.552 1.176 . . . . 0.0 112.503 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.45 -37.63 81.59 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.658 0.783 . . . . 0.0 112.003 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.25 -44.3 38.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.89 0.876 . . . . 0.0 111.241 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -61.43 -41.56 97.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.208 1.003 . . . . 0.0 113.055 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.1 p -101.01 -18.87 16.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m 68.7 0.62 2.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.894 2.078 . . . . 0.0 114.561 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -74.08 140.54 77.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.58 -57.58 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.302 2.668 . . . . 0.0 115.259 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.8 p -149.01 122.49 9.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 112.386 -169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -64.52 157.59 71.89 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.015 1.326 . . . . 0.0 112.269 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.66 158.24 41.85 Favored 'Cis proline' 0 C--N 1.358 1.06 0 N-CA-C 116.07 1.527 . . . . 0.0 116.07 2.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.79 146.94 26.08 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.133 0.973 . . . . 0.0 111.299 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.0 141.5 47.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.627 1.571 . . . . 0.0 109.031 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -139.29 144.55 38.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 0.0 109.745 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.83 126.91 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.538 -0.726 . . . . 0.0 111.432 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.38 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 129.143 2.977 . . . . 0.0 117.86 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.44 4.91 0.12 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.657 1.598 . . . . 0.0 115.418 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -148.47 151.03 34.48 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.548 1.674 . . . . 0.0 111.596 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -73.09 147.56 44.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.353 0.596 . . . . 0.0 111.716 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -100.37 -40.14 7.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.402 1.081 . . . . 0.0 111.765 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.45 -155.63 22.64 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 125.571 1.558 . . . . 0.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.05 173.52 52.21 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.756 1.17 . . . . 0.0 113.752 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.44 -46.71 66.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.665 -0.903 . . . . 0.0 112.716 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.45 -40.27 90.58 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 111.641 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.6 -41.63 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.514 0.726 . . . . 0.0 110.242 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.2 m -63.85 -44.5 92.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.151 0.98 . . . . 0.0 111.956 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -57.85 -43.85 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.858 0.753 . . . . 0.0 111.108 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.11 -37.59 78.44 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.1 91.43 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 112.497 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -64.17 -42.04 96.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.259 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.13 -28.32 68.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.586 0.754 . . . . 0.0 112.497 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -87.48 -12.89 44.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.598 1.159 . . . . 0.0 113.581 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.66 0.34 84.13 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 125.616 1.579 . . . . 0.0 114.229 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.92 -37.66 64.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.79 1.236 . . . . 0.0 111.485 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.78 -45.48 89.55 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.624 -0.672 . . . . 0.0 110.812 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -56.72 -48.45 77.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 110.802 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.57 -48.53 81.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 0.0 111.797 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -70.21 -38.42 75.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.46 -40.59 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 119.564 1.074 . . . . 0.0 110.607 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.85 -46.11 90.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.534 0.607 . . . . 0.0 110.819 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -62.52 -35.95 81.05 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.092 -1.005 . . . . 0.0 112.661 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.3 -31.57 72.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.008 -1.058 . . . . 0.0 112.825 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.51 -46.8 9.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.319 1.047 . . . . 0.0 112.981 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.67 -18.92 21.62 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 130.568 3.547 . . . . 0.0 113.259 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 110.751 -0.092 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.55 63.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.57 0.748 . . . . 0.0 112.586 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.3 mt -96.55 167.74 10.96 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.637 1.575 . . . . 0.0 110.13 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p -72.89 142.48 83.14 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 121.749 -0.595 . . . . 0.0 109.97 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.84 -34.44 96.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 0.0 112.739 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.23 -37.87 84.62 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.436 1.094 . . . . 0.0 113.366 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.13 -56.51 20.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.999 0.919 . . . . 0.0 109.925 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -62.54 -38.5 90.26 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.4 m -64.7 -39.87 94.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 111.968 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.6 m -64.98 -51.52 61.28 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.572 0.749 . . . . 0.0 110.236 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.56 -42.79 93.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.942 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.89 -48.78 80.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.451 1.023 . . . . 0.0 112.395 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -62.24 -42.03 98.95 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.54 -0.725 . . . . 0.0 111.905 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.06 -56.33 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.093 0.957 . . . . 0.0 110.546 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -58.99 -45.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.622 1.169 . . . . 0.0 112.721 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -73.19 -41.72 63.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.565 0.746 . . . . 0.0 112.758 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -81.84 -32.31 31.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -15.7 30.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 59.56 -66.16 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.998 2.519 . . . . 0.0 114.057 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.32 122.31 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.388 1.875 . . . . 0.0 108.597 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.34 117.99 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.357 0.663 . . . . 0.0 110.391 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -96.42 128.01 42.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.065 0.946 . . . . 0.0 110.405 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.17 122.88 47.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.357 1.063 . . . . 0.0 109.991 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.58 -177.94 6.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.273 1.429 . . . . 0.0 111.434 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.72 37.97 0.31 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.593 -1.317 . . . . 0.0 112.76 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.59 -165.04 35.63 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 126.557 2.027 . . . . 0.0 112.016 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -156.93 -167.31 2.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.443 1.097 . . . . 0.0 110.892 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.42 -33.32 71.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.09 1.356 . . . . 0.0 113.012 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.82 -15.58 58.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.518 1.527 . . . . 0.0 113.778 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -148.3 70.8 10.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.642 1.577 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.76 146.31 48.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.032 2.488 . . . . 0.0 110.698 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -98.93 127.02 44.76 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.411 0.684 . . . . 0.0 110.218 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -65.94 155.07 37.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.565 1.146 . . . . 0.0 113.664 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.59 -118.38 4.79 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 124.237 0.922 . . . . 0.0 112.019 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -54.24 -58.6 6.76 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.748 1.219 . . . . 0.0 112.674 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -62.39 -46.51 88.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.606 -0.683 . . . . 0.0 111.746 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.38 -46.57 69.68 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.587 1.155 . . . . 0.0 111.092 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.0 m -65.59 -46.1 80.69 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.159 0.984 . . . . 0.0 110.843 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -44.16 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.201 0.91 . . . . 0.0 110.993 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.02 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.516 0.726 . . . . 0.0 111.032 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.62 -38.7 91.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.961 0.8 . . . . 0.0 112.453 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.49 -47.35 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.31 0.959 . . . . 0.0 110.889 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.36 -51.29 68.21 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.38 0.991 . . . . 0.0 111.218 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -49.14 -61.75 1.91 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.646 0.778 . . . . 0.0 110.522 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.9 p -68.5 -25.86 65.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.947 1.699 . . . . 0.0 115.049 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.92 -34.26 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.915 0.886 . . . . 0.0 109.318 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 115.58 55.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.218 3.407 . . . . 0.0 109.461 168.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.2 145.15 31.37 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.35 163.16 35.08 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.178 2.585 . . . . 0.0 110.742 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -160.84 162.39 32.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.541 1.536 . . . . 0.0 109.928 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.23 178.39 7.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.744 1.217 . . . . 0.0 108.739 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.0 m -150.92 159.6 44.45 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 119.727 -1.858 . . . . 0.0 112.963 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.89 133.94 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.305 1.042 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -79.12 118.02 20.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.382 0.673 . . . . 0.0 110.997 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.6 pt -69.35 -20.81 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.44 -3.99 49.1 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.07 -17.94 62.58 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.74 139.38 13.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.799 1.24 . . . . 0.0 111.211 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -64.65 -36.56 84.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.9 -43.81 97.78 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.644 -0.66 . . . . 0.0 111.022 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.35 -49.1 78.33 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.434 0.694 . . . . 0.0 111.036 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp85 -55.37 -38.85 69.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.108 0.963 . . . . 0.0 112.429 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -76.85 -50.22 13.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.664 1.186 . . . . 0.0 112.365 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.98 -26.8 54.93 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 115.591 0.997 . . . . 0.0 115.591 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.77 -33.87 74.86 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.634 1.217 . . . . 0.0 112.103 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.88 -43.69 98.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.841 0.856 . . . . 0.0 111.814 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.1 -44.63 75.75 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.636 0.774 . . . . 0.0 111.138 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.6 -41.18 89.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.75 0.82 . . . . 0.0 112.343 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.3 m -80.62 -21.89 41.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.4 p 69.24 -35.73 0.32 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.322 3.049 . . . . 0.0 113.716 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -70.66 137.23 85.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.754 1.622 . . . . 0.0 111.278 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.85 -27.57 0.69 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.875 2.383 . . . . 0.0 116.215 -169.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 m -102.54 130.26 49.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.496 1.043 . . . . 0.0 112.915 -168.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -115.28 152.47 46.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.929 1.292 . . . . 0.0 110.504 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.53 157.64 55.37 Favored 'Cis proline' 0 C--N 1.355 0.92 0 N-CA-C 114.996 1.114 . . . . 0.0 114.996 -3.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.36 151.47 8.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.14 1.376 . . . . 0.0 111.298 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.0 tp -90.21 159.41 16.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.942 1.297 . . . . 0.0 110.735 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -150.31 139.76 21.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.433 1.093 . . . . 0.0 110.198 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 mt -142.68 126.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.719 -0.613 . . . . 0.0 111.139 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 63.37 -25.74 0.07 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.985 2.914 . . . . 0.0 117.407 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.01 10.26 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.914 1.721 . . . . 0.0 115.114 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.11 151.25 32.87 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.289 1.544 . . . . 0.0 111.243 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -71.64 161.02 31.65 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.42 1.105 . . . . 0.0 112.536 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -136.08 143.31 44.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.275 1.43 . . . . 0.0 109.31 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.93 -178.75 10.27 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.325 1.441 . . . . 0.0 115.54 -170.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.88 -173.8 20.19 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.971 1.272 . . . . 0.0 114.55 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.42 -45.09 94.88 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.678 -0.895 . . . . 0.0 113.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.72 -44.3 97.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.719 -0.613 . . . . 0.0 111.458 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.59 -44.07 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.756 0.822 . . . . 0.0 110.348 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.7 m -62.78 -44.89 94.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.067 1.347 . . . . 0.0 111.131 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.22 -45.55 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.597 1.159 . . . . 0.0 111.489 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.53 -42.06 87.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.095 0.861 . . . . 0.0 112.224 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.58 81.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.117 0.967 . . . . 0.0 112.457 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.98 -47.45 86.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.678 1.191 . . . . 0.0 111.605 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.19 -32.61 70.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.008 0.923 . . . . 0.0 113.2 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -83.38 -13.59 54.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.94 -6.34 76.51 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.023 1.296 . . . . 0.0 113.922 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.94 -37.16 72.84 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.765 1.226 . . . . 0.0 111.906 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.13 -43.23 78.79 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.665 -0.647 . . . . 0.0 110.38 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.79 -49.11 78.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.887 0.875 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.69 1.196 . . . . 0.0 112.054 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.06 -39.25 79.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.949 0.795 . . . . 0.0 112.844 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.52 -45.67 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.401 1.001 . . . . 0.0 110.414 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -62.77 -46.94 85.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.239 0.927 . . . . 0.0 111.647 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.91 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.458 -0.777 . . . . 0.0 112.126 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.03 81.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.952 0.796 . . . . 0.0 112.835 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.09 -40.58 82.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.802 0.728 . . . . 0.0 111.841 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.34 -47.52 83.85 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.139 0.575 . . . . 0.0 111.97 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.488 1.431 1 C-N-CA 132.153 4.181 . . . . 0.0 111.491 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.93 86.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.571 1.078 . . . . 0.0 112.007 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.4 mt -91.61 154.23 19.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.097 1.359 . . . . 0.0 109.44 169.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.6 p -78.23 153.21 79.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.104 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.5 -28.56 81.31 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.99 2.46 . . . . 0.0 113.213 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.49 61.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.79 -65.6 0.65 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.983 1.265 . . . . 0.0 111.485 -171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -65.29 -29.0 69.72 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.448 -0.782 . . . . 0.0 112.136 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.1 m -63.56 -44.01 95.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.326 1.85 . . . . 0.0 112.117 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.9 m -64.65 -45.46 86.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.033 0.933 . . . . 0.0 110.375 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.2 mt -56.02 -50.22 71.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.059 0.544 . . . . 0.0 111.675 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.91 -48.48 78.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.478 0.711 . . . . 0.0 112.288 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.43 -38.65 87.91 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.506 -0.746 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.86 -47.58 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.178 -0.951 . . . . 0.0 110.727 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.22 -36.02 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.046 1.339 . . . . 0.0 113.008 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -84.28 -31.28 25.0 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.206 0.912 . . . . 0.0 113.054 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -70.77 -37.85 73.4 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.865 0.757 . . . . 0.0 112.757 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -137.39 114.17 10.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.249 1.42 . . . . 0.0 108.448 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.88 -33.81 76.53 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.12 137.25 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.53 1.059 . . . . 0.0 109.162 169.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.16 126.87 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.815 0.846 . . . . 0.0 109.454 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.08 125.71 47.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.511 1.125 . . . . 0.0 109.169 170.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -97.32 118.19 33.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.2 ptm -155.39 159.53 39.96 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -168.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.16 -20.53 48.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.217 1.007 . . . . 0.0 112.889 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.99 -170.38 43.1 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.186 1.375 . . . . 0.0 112.294 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 p -127.53 174.29 9.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 110.947 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -69.32 -21.43 63.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -83.31 -31.53 26.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.654 1.182 . . . . 0.0 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.37 100.24 3.59 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.321 1.448 . . . . 0.0 110.274 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.26 164.46 32.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.107 2.538 . . . . 0.0 111.458 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.6 139.36 30.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.289 0.636 . . . . 0.0 110.176 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.7 p -69.59 159.54 33.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.984 0.914 . . . . 0.0 113.196 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.11 -104.98 2.4 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 124.138 0.875 . . . . 0.0 111.283 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.76 -71.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.293 1.437 . . . . 0.0 112.728 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 m -60.98 -41.33 96.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.574 -0.704 . . . . 0.0 111.355 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -53.8 -46.43 71.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.3 1.44 . . . . 0.0 111.964 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.1 m -67.78 -51.38 49.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.554 1.142 . . . . 0.0 110.996 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.141 0.576 . . . . 0.0 111.742 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.98 -47.02 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.652 0.781 . . . . 0.0 111.031 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -64.73 -41.64 95.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.911 0.778 . . . . 0.0 112.126 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.91 -52.58 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.591 0.756 . . . . 0.0 111.187 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.33 -47.75 66.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.38 0.672 . . . . 0.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -50.2 -53.52 27.33 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.855 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -33.42 75.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.804 1.641 . . . . 0.0 114.277 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.41 -25.59 66.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.165 0.986 . . . . 0.0 111.61 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.5 t30 112.61 47.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.955 3.702 . . . . 0.0 110.862 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.44 132.89 21.3 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.32 122.4 6.09 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.424 2.749 . . . . 0.0 109.128 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -131.79 161.0 33.94 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -136.51 144.65 44.42 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.6 m -108.15 93.44 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 0.0 109.564 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.47 121.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.407 1.083 . . . . 0.0 109.341 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -74.32 122.92 23.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 111.278 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -119.15 -169.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.895 1.278 . . . . 0.0 111.27 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.9 -56.88 0.54 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.454 2.302 . . . . 0.0 112.208 169.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.39 -41.16 85.42 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.822 0.849 . . . . 0.0 110.532 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -73.77 109.4 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.993 0.917 . . . . 0.0 110.526 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -73.34 -27.63 61.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 113.488 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.99 -44.58 76.27 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.145 -0.972 . . . . 0.0 110.954 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.4 -40.5 89.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.711 0.804 . . . . 0.0 111.863 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -54.46 -37.99 65.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.025 0.93 . . . . 0.0 112.368 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -85.64 -46.06 11.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.44 1.096 . . . . 0.0 112.584 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.5 -30.91 57.61 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.54 -26.17 66.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.978 1.389 . . . . 0.0 113.033 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.22 -40.61 96.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.712 0.687 . . . . 0.0 111.682 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.64 -45.11 54.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.833 0.853 . . . . 0.0 111.468 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.43 -37.6 87.39 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.1 p -107.56 -20.85 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.0 m 69.41 -29.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.64 2.376 . . . . 0.0 114.702 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -75.27 128.48 84.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.579 1.552 . . . . 0.0 112.386 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.52 150.59 19.38 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.523 2.815 . . . . 0.0 111.422 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p 77.99 156.93 0.17 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.971 2.908 . . . . 0.0 113.419 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.54 157.8 64.69 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.165 1.786 . . . . 0.0 111.363 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.05 158.22 89.13 Favored 'Cis proline' 0 C--N 1.354 0.862 0 CA-C-N 119.999 1.035 . . . . 0.0 112.541 3.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.26 141.85 37.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.317 1.047 . . . . 0.0 110.36 -172.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.5 tp -95.08 144.91 25.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.955 1.302 . . . . 0.0 110.941 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -146.73 139.24 25.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 109.599 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mp -137.85 120.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.366 -0.834 . . . . 0.0 111.094 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 61.85 -24.92 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.968 3.307 . . . . 0.0 117.415 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.28 -1.89 0.04 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.09 1.805 . . . . 0.0 115.345 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.9 147.64 49.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.221 1.511 . . . . 0.0 111.708 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.31 158.76 30.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.423 1.106 . . . . 0.0 111.801 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -133.07 155.16 49.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.826 1.651 . . . . 0.0 108.968 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.79 -180.0 9.71 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.834 1.206 . . . . 0.0 114.568 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.2 -176.84 11.37 Favored Glycine 0 N--CA 1.474 1.223 0 C-N-CA 124.667 1.127 . . . . 0.0 113.996 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.25 -42.71 95.87 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.535 -0.979 . . . . 0.0 112.808 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.9 -47.16 86.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.432 0.56 . . . . 0.0 111.191 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.6 mt -60.67 -42.99 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.906 0.882 . . . . 0.0 110.304 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 m -62.81 -46.83 86.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.088 1.355 . . . . 0.0 111.327 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.51 -42.79 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.628 1.171 . . . . 0.0 111.656 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.95 -43.31 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.71 0.686 . . . . 0.0 111.564 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.74 95.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.888 . . . . 0.0 112.001 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.71 -37.77 88.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 112.782 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -69.37 -30.85 68.94 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.382 1.073 . . . . 0.0 112.254 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -87.99 -11.14 48.25 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.534 1.134 . . . . 0.0 113.949 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.36 84.07 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.176 1.37 . . . . 0.0 114.137 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.05 -34.43 50.46 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 112.104 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -64.45 -46.24 83.96 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.776 -0.578 . . . . 0.0 109.721 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -57.34 -48.39 79.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.547 1.139 . . . . 0.0 110.258 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.35 -52.96 62.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.839 0.856 . . . . 0.0 111.775 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -74.38 -33.61 63.1 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.578 -0.701 . . . . 0.0 112.869 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.56 -44.37 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.36 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -59.7 -43.27 94.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.199 1.363 . . . . 0.0 111.376 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -57.76 -47.82 81.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.374 0.67 . . . . 0.0 111.249 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.38 -31.28 71.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.132 0.973 . . . . 0.0 113.268 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.1 mmt -72.14 -36.5 69.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.301 -0.874 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.6 -40.42 76.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.681 0.792 . . . . 0.0 112.63 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.254 1.305 0 C-N-CA 129.643 3.177 . . . . 0.0 112.597 179.018 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 119.742 -0.171 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.6 173.42 16.89 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.016 1.326 . . . . 0.0 113.195 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.55 154.93 43.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.086 1.754 . . . . 0.0 111.063 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 p -93.89 161.43 30.02 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.855 1.262 . . . . 0.0 110.661 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.46 -30.13 62.16 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.136 1.891 . . . . 0.0 111.455 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.96 87.93 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.103 0.865 . . . . 0.0 112.485 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.78 -51.28 67.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 109.755 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -58.92 -42.74 90.38 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.646 0.778 . . . . 0.0 112.566 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -64.68 -39.01 92.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.777 1.631 . . . . 0.0 112.081 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -62.54 -49.42 75.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.239 0.927 . . . . 0.0 110.39 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -56.98 -53.26 60.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.652 0.781 . . . . 0.0 110.943 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.27 -44.96 76.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.755 0.822 . . . . 0.0 112.314 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -59.91 -49.2 78.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.799 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.8 -34.92 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.293 1.406 . . . . 0.0 112.802 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.35 -36.28 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.936 1.295 . . . . 0.0 112.489 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.9 p -84.56 -39.03 19.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.71 0.804 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -74.44 -25.13 59.24 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -130.05 130.92 45.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.771 1.228 . . . . 0.0 109.605 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -68.85 -44.38 73.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -114.23 132.02 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.563 1.145 . . . . 0.0 109.243 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.87 121.04 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.207 0.603 . . . . 0.0 110.88 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.52 149.6 21.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.741 0.817 . . . . 0.0 110.528 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.5 114.09 18.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.367 1.467 . . . . 0.0 109.136 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -163.09 -178.57 6.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.257 1.823 . . . . 0.0 110.653 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.13 -39.9 65.35 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.774 -1.204 . . . . 0.0 111.709 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.84 161.9 46.34 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.926 1.727 . . . . 0.0 114.419 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -87.65 172.02 10.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.157 1.783 . . . . 0.0 111.774 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -71.96 -23.74 61.49 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.42 -13.42 32.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.518 1.527 . . . . 0.0 113.642 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -131.57 65.68 76.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.71 1.604 . . . . 0.0 110.276 169.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -71.7 143.12 41.17 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.486 2.79 . . . . 0.0 110.843 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.0 127.62 33.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.689 0.796 . . . . 0.0 112.12 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -54.89 145.25 20.46 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.443 . . . . 0.0 113.174 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.16 -143.35 16.56 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -51.71 -45.11 63.44 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.3 m -63.82 -47.07 82.27 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.32 1.418 . . . . 0.0 112.346 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.12 -40.72 90.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.785 0.834 . . . . 0.0 111.741 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -60.97 -48.06 83.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.452 0.701 . . . . 0.0 110.919 170.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.43 -42.85 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.629 1.172 . . . . 0.0 112.898 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -66.45 -34.85 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.205 1.366 . . . . 0.0 111.999 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.22 -41.54 89.97 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.777 0.717 . . . . 0.0 111.924 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mt -57.36 -51.53 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.85 1.26 . . . . 0.0 111.388 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.0 -47.57 77.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.272 1.029 . . . . 0.0 111.032 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -51.88 -55.74 18.3 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.252 0.621 . . . . 0.0 110.76 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -68.33 -33.12 73.73 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.983 1.713 . . . . 0.0 113.837 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.2 -29.99 69.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.374 1.07 . . . . 0.0 110.997 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 115.27 70.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 130.234 3.414 . . . . 0.0 111.038 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.97 139.48 12.7 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.97 119.46 5.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.089 2.526 . . . . 0.0 109.38 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -106.14 152.4 23.49 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.112 0.965 . . . . 0.0 112.011 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.15 171.72 7.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.272 1.429 . . . . 0.0 110.139 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 m -147.99 104.73 3.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.176 -1.577 . . . . 0.0 109.88 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.92 127.74 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.597 1.159 . . . . 0.0 109.022 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -73.42 93.8 2.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 110.865 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.99 -178.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.39 0.676 . . . . 0.0 110.507 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.05 -37.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.907 2.083 . . . . 0.0 113.104 172.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.1 -20.18 64.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.731 1.612 . . . . 0.0 113.38 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -125.06 134.9 52.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.068 1.347 . . . . 0.0 111.364 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.44 -28.66 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.38 1.072 . . . . 0.0 113.752 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.66 -44.05 71.33 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.308 -0.87 . . . . 0.0 111.739 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.19 -23.27 65.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.75 -26.08 68.48 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.86 0.755 . . . . 0.0 112.726 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -109.98 -53.02 2.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.74 1.216 . . . . 0.0 112.252 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.04 -34.09 53.26 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.355 -169.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -47.9 77.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.657 1.729 . . . . 0.0 111.939 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.08 -26.1 67.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -80.44 -34.78 35.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.054 0.942 . . . . 0.0 112.201 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -65.05 -37.96 89.27 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.916 1.286 . . . . 0.0 112.273 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -78.81 -68.31 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.99 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m 124.06 -17.2 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 1 C-N-CA 133.163 4.585 . . . . 0.0 110.966 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -67.59 121.69 80.2 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.445 1.498 . . . . 0.0 111.545 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.27 145.45 19.03 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.993 2.462 . . . . 0.0 110.411 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 80.3 165.49 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.025 2.13 . . . . 0.0 112.561 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.62 150.12 51.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.531 1.533 . . . . 0.0 110.53 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.78 -177.49 21.18 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 120.125 1.08 . . . . 0.0 113.157 4.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.1 140.78 23.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.749 1.22 . . . . 0.0 111.182 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 tp -103.32 141.22 36.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.627 1.571 . . . . 0.0 110.075 169.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -140.46 142.98 35.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.053 1.741 . . . . 0.0 110.157 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.2 mt -140.18 116.4 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.65 0.78 . . . . 0.0 110.852 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.63 -24.8 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 130.114 3.366 . . . . 0.0 118.069 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -16.2 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.631 1.586 . . . . 0.0 114.69 -170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.11 153.29 48.65 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.921 1.36 . . . . 0.0 112.87 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -81.09 149.23 29.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.906 -0.496 . . . . 0.0 111.515 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.07 -35.41 9.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.984 0.914 . . . . 0.0 112.311 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.26 -146.64 17.82 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 125.437 1.494 . . . . 0.0 111.937 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.02 165.72 47.66 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.293 0.949 . . . . 0.0 114.206 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.2 m -68.47 -41.56 80.01 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.736 -0.861 . . . . 0.0 112.244 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.13 -42.42 94.77 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.23 -0.919 . . . . 0.0 111.637 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.17 -40.34 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.247 0.619 . . . . 0.0 110.326 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.5 m -63.97 -43.21 96.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.085 0.954 . . . . 0.0 111.739 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.33 -46.13 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.914 0.779 . . . . 0.0 110.963 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -66.37 -37.17 84.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.743 0.701 . . . . 0.0 112.527 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.24 95.52 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.1 0.96 . . . . 0.0 111.971 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -67.54 -38.86 84.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.512 0.725 . . . . 0.0 112.771 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.1 -32.88 74.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 112.642 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 p -92.9 -10.03 38.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.52 -3.19 68.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.045 1.307 . . . . 0.0 114.485 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -72.37 -33.25 67.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.41 1.484 . . . . 0.0 112.493 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -47.2 70.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.716 0.689 . . . . 0.0 110.249 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -56.52 -48.79 76.49 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.684 1.194 . . . . 0.0 110.469 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.648 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.75 -33.13 72.02 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -39.93 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.3 0.954 . . . . 0.0 111.151 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.34 -44.73 96.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.12 0.873 . . . . 0.0 111.077 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.36 -36.36 79.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.409 -0.807 . . . . 0.0 112.701 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.88 74.52 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.038 1.29 . . . . 0.0 112.627 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.9 mtt -74.41 -41.99 59.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.836 0.854 . . . . 0.0 112.357 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 p -92.6 1.75 57.08 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 126.963 2.105 . . . . 0.0 114.272 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.62 -155.66 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.49 1.516 . . . . 0.0 111.346 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.86 36.87 0.14 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.33 1.852 . . . . 0.0 112.793 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -91.31 -27.46 0.3 Allowed Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 115.675 -2.107 . . . . 0.0 116.484 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -84.84 -168.8 0.56 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 CA-C-N 123.314 2.219 . . . . 0.0 112.036 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.27 -7.83 3.21 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.66 1.584 . . . . 0.0 115.065 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.65 -55.71 15.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.673 1.589 . . . . 0.0 109.798 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -61.37 -42.12 98.19 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.553 -0.717 . . . . 0.0 112.231 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -60.23 -39.45 86.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.335 1.854 . . . . 0.0 111.98 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 m -64.84 -49.16 71.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 110.141 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.09 -50.35 71.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.077 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.18 -48.65 75.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.527 1.131 . . . . 0.0 112.459 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.4 -42.72 99.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.558 -0.714 . . . . 0.0 111.821 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.9 -49.88 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.772 0.829 . . . . 0.0 111.787 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.14 -33.99 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.545 1.066 . . . . 0.0 112.772 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.2 p -74.93 -35.42 62.18 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.919 0.782 . . . . 0.0 112.781 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 m -79.37 -41.73 27.16 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.97 0.805 . . . . 0.0 112.976 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.03 -3.71 37.57 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 58.55 -74.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.536 2.334 . . . . 0.0 112.277 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.3 129.94 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.005 0.922 . . . . 0.0 109.642 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -137.79 131.27 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.423 0.689 . . . . 0.0 110.324 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.4 140.53 32.53 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.549 1.14 . . . . 0.0 111.314 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.18 108.41 16.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.714 1.606 . . . . 0.0 107.887 172.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.2 mtm -144.59 -176.72 5.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.273 1.429 . . . . 0.0 110.595 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -79.1 21.48 0.44 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.325 -1.485 . . . . 0.0 113.999 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.97 177.4 44.72 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.795 1.188 . . . . 0.0 114.733 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.4 p -97.46 -178.61 4.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.734 2.014 . . . . 0.0 111.244 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.06 -20.62 59.45 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.345 -0.847 . . . . 0.0 112.901 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.38 -31.82 37.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 111.853 172.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -134.17 74.61 67.32 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.892 1.277 . . . . 0.0 110.753 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 172.05 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.984 3.123 . . . . 0.0 111.281 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -99.3 152.43 19.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.053 0.941 . . . . 0.0 110.983 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.51 167.25 21.02 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.782 1.233 . . . . 0.0 113.507 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.73 -125.52 7.1 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.412 1.006 . . . . 0.0 112.362 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -60.31 -42.35 95.37 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.757 0.823 . . . . 0.0 112.591 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -59.2 -52.15 66.92 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.025 -1.047 . . . . 0.0 112.327 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -56.94 -44.56 82.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.783 1.233 . . . . 0.0 110.481 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.2 m -60.14 -47.69 84.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.461 1.104 . . . . 0.0 110.855 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.7 -42.57 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.249 1.02 . . . . 0.0 112.39 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.25 -34.66 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.476 1.489 . . . . 0.0 112.11 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.018 0.827 . . . . 0.0 111.69 170.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.84 -47.28 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.204 1.402 . . . . 0.0 111.258 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.92 -49.51 72.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.373 0.988 . . . . 0.0 111.409 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -49.42 -59.41 3.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.268 0.627 . . . . 0.0 109.845 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -67.97 -28.82 67.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.196 1.798 . . . . 0.0 114.91 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.78 -30.61 69.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 110.187 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.1 t30 111.15 55.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 130.721 3.608 . . . . 0.0 108.492 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.57 150.91 38.25 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.53 169.68 18.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.189 3.259 . . . . 0.0 110.696 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.8 164.8 26.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.254 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.24 167.06 19.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.37 1.468 . . . . 0.0 108.901 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -151.1 126.09 9.8 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 119.776 -1.827 . . . . 0.0 111.669 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.62 133.17 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.838 1.255 . . . . 0.0 109.591 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -74.17 125.59 28.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.94 0.496 . . . . 0.0 111.699 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 pt -72.93 -30.05 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.836 1.254 . . . . 0.0 113.038 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.66 167.6 13.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.194 0.998 . . . . 0.0 111.935 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 79.61 -107.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.919 2.488 . . . . 0.0 109.852 -170.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -55.71 124.22 16.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.722 1.209 . . . . 0.0 113.881 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.06 -39.64 90.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 113.653 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.83 -33.1 74.12 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.537 -0.727 . . . . 0.0 111.558 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.0 tp -72.45 -43.49 63.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.641 0.776 . . . . 0.0 111.157 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -56.09 -45.64 79.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.144 1.377 . . . . 0.0 112.345 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.18 -40.58 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.386 1.074 . . . . 0.0 111.575 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.92 -36.79 87.15 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 118.675 -1.07 . . . . 0.0 113.872 -172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.91 -44.58 95.71 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.416 1.608 . . . . 0.0 111.566 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.8 -48.23 75.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.47 -32.99 73.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.435 0.694 . . . . 0.0 112.823 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -69.26 -37.97 78.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 0.0 112.572 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 m -87.55 -24.37 24.05 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m 74.53 -41.53 0.48 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.321 2.648 . . . . 0.0 113.756 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -68.45 129.11 92.91 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.921 1.288 . . . . 0.0 110.73 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.53 158.81 16.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.784 2.989 . . . . 0.0 112.07 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p 75.13 162.62 0.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.558 2.743 . . . . 0.0 113.665 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -143.28 159.72 54.43 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.461 1.904 . . . . 0.0 110.68 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.28 149.81 53.97 Favored 'Cis proline' 0 C--N 1.354 0.832 0 CA-C-N 120.313 1.147 . . . . 0.0 114.007 -2.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.14 148.88 32.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 0.0 110.344 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -114.09 140.31 48.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.362 1.465 . . . . 0.0 110.609 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -132.71 145.52 51.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.99 2.116 . . . . 0.0 109.997 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mt -137.23 119.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.383 -0.823 . . . . 0.0 112.465 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 t70 63.67 -43.09 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.95 3.3 . . . . 0.0 117.179 168.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.96 9.34 0.03 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.562 2.506 . . . . 0.0 114.151 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.01 145.15 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.47 1.508 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.53 152.35 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.527 -0.733 . . . . 0.0 109.97 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -110.47 -36.65 5.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.119 0.968 . . . . 0.0 112.615 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.37 -159.15 23.28 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.109 1.338 . . . . 0.0 113.293 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.05 169.28 54.68 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.147 0.879 . . . . 0.0 114.028 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.0 p -68.7 -49.55 58.06 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.444 -1.033 . . . . 0.0 112.922 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.47 -39.11 86.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.891 -1.131 . . . . 0.0 111.657 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.3 -41.87 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.591 0.756 . . . . 0.0 110.381 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.8 m -62.76 -40.92 98.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 0.0 111.668 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.14 -46.91 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.132 0.878 . . . . 0.0 111.484 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -31.7 63.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.267 0.94 . . . . 0.0 113.504 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.23 83.11 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.072 -1.018 . . . . 0.0 112.594 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.68 -44.8 92.65 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.646 1.178 . . . . 0.0 112.035 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.68 -27.99 68.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.6 m -86.84 -14.69 41.37 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 113.666 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.81 75.71 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 125.354 1.455 . . . . 0.0 114.19 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.39 -34.64 63.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.552 1.141 . . . . 0.0 111.312 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.46 -45.56 86.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.524 -0.735 . . . . 0.0 110.719 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.03 -47.39 77.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.71 0.804 . . . . 0.0 111.002 175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.42 -50.33 73.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.867 0.867 . . . . 0.0 112.074 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -76.44 -32.97 58.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.17 -40.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.964 0.802 . . . . 0.0 110.618 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.39 -43.99 95.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.347 0.976 . . . . 0.0 111.591 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -55.87 -45.12 78.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.911 0.778 . . . . 0.0 111.051 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.68 94.89 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 113.071 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 57.8 mtt -64.79 -35.27 80.56 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.731 0.813 . . . . 0.0 112.343 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.3 -36.01 76.59 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.762 0.825 . . . . 0.0 112.768 170.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.892 2.477 . . . . 0.0 112.241 -179.435 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.81 65.05 3.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.684 1.194 . . . . 0.0 110.999 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.33 49.14 1.5 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.549 1.54 . . . . 0.0 112.804 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.5 p -77.34 -22.12 0.39 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 115.605 -2.14 . . . . 0.0 115.658 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -60.11 168.61 5.84 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.126 2.551 . . . . 0.0 114.372 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.29 -6.67 7.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.98 -56.93 8.72 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.592 1.557 . . . . 0.0 110.622 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -59.67 -43.21 94.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.4 0.68 . . . . 0.0 111.784 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.11 -41.05 95.98 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.046 2.138 . . . . 0.0 112.163 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -67.78 -46.48 71.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.607 1.163 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -56.92 -53.82 53.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.404 0.681 . . . . 0.0 110.804 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.17 -43.85 78.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.259 0.623 . . . . 0.0 112.004 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.1 -51.08 71.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.771 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.92 -37.36 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.403 1.456 . . . . 0.0 112.214 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -63.64 -37.35 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.069 0.947 . . . . 0.0 112.648 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 p -86.37 -36.97 18.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.726 0.81 . . . . 0.0 113.169 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -75.92 -37.91 58.24 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.526 0.731 . . . . 0.0 112.804 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -110.11 114.66 28.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.01 0.924 . . . . 0.0 110.61 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -77.11 67.66 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.549 -1.344 . . . . 0.0 111.464 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.2 t 132.31 122.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 1 C-N-CA 133.913 4.885 . . . . 0.0 107.652 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.76 132.93 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.337 1.055 . . . . 0.0 109.337 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.59 137.9 38.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.49 1.516 . . . . 0.0 109.261 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -112.76 115.22 28.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.172 1.389 . . . . 0.0 107.732 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ptp -153.67 164.3 38.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.894 1.278 . . . . 0.0 112.933 -169.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -80.1 45.02 0.7 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.663 1.585 . . . . 0.0 111.261 174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.99 -161.93 27.02 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.151 1.358 . . . . 0.0 114.41 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.5 p -135.56 178.94 6.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.33 1.852 . . . . 0.0 111.18 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -66.36 -25.94 67.04 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.09 -26.44 19.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.853 1.261 . . . . 0.0 112.436 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -124.91 71.37 61.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.995 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.48 164.78 33.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.231 2.62 . . . . 0.0 110.902 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.48 129.62 34.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.925 0.49 . . . . 0.0 109.802 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.94 147.1 52.8 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.949 0.9 . . . . 0.0 112.673 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -116.06 4.71 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.057 0.837 . . . . 0.0 111.558 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -60.68 -54.98 38.75 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.874 0.87 . . . . 0.0 113.035 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -66.77 -39.44 87.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.642 -1.286 . . . . 0.0 112.22 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.57 -46.97 77.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.197 1.399 . . . . 0.0 111.151 170.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 m -61.24 -45.99 92.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.77 0.828 . . . . 0.0 110.247 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.81 -44.87 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.573 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.15 -34.97 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 120.78 1.627 . . . . 0.0 111.929 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -65.72 -35.43 80.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.791 0.723 . . . . 0.0 111.885 169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.35 -51.21 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.897 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 121.137 1.789 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -49.46 -55.86 11.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.047 0.539 . . . . 0.0 109.815 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -66.51 -29.19 69.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.323 2.249 . . . . 0.0 115.059 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tt -59.54 -30.75 68.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.944 1.698 . . . . 0.0 109.481 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 108.08 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 131.443 3.897 . . . . 0.0 107.347 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.2 152.98 32.15 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.53 179.19 5.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.31 3.34 . . . . 0.0 110.853 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.61 171.86 13.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.436 1.894 . . . . 0.0 110.38 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.91 147.95 50.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.847 0.859 . . . . 0.0 109.597 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 m -122.61 111.83 17.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.909 0.884 . . . . 0.0 110.576 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.09 124.43 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.354 1.062 . . . . 0.0 109.452 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -72.95 105.76 4.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 110.45 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.9 pt -89.2 -173.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.35 1.06 . . . . 0.0 112.039 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt 68.75 -14.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.462 2.305 . . . . 0.0 115.085 169.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -65.16 -19.73 66.12 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.052 1.741 . . . . 0.0 114.475 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -158.22 169.05 25.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.639 1.576 . . . . 0.0 112.01 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -64.88 -31.87 73.3 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.14 -36.25 83.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.104 0.866 . . . . 0.0 111.337 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.43 -23.11 56.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.396 1.078 . . . . 0.0 113.088 172.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -82.78 -51.51 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.609 1.095 . . . . 0.0 112.685 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -95.48 -43.87 7.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.826 1.25 . . . . 0.0 112.039 -169.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.51 61.06 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.684 0.659 . . . . 0.0 112.019 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 tp -59.64 -41.99 91.73 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.419 0.688 . . . . 0.0 111.882 172.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -63.74 -40.16 96.06 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.919 -0.488 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -72.04 -33.73 68.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.551 0.614 . . . . 0.0 112.416 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -65.3 -47.41 76.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.146 0.978 . . . . 0.0 112.95 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -92.01 -25.93 18.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 74.64 -8.02 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.917 2.087 . . . . 0.0 113.464 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -65.56 133.77 95.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.027 1.331 . . . . 0.0 111.436 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 -41.91 0.62 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.066 2.51 . . . . 0.0 115.199 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -143.9 107.44 4.61 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.175 0.898 . . . . 0.0 111.815 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.25 162.78 16.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.007 1.323 . . . . 0.0 112.465 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -64.53 169.1 37.5 Favored 'Cis proline' 0 C--N 1.355 0.911 0 CA-C-N 120.772 1.311 . . . . 0.0 115.275 0.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.12 166.66 31.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.72 150.23 27.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.48 1.912 . . . . 0.0 108.834 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.35 143.65 32.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.107 2.163 . . . . 0.0 109.81 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.42 172.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.687 1.595 . . . . 0.0 111.532 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.69 103.17 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.392 1.077 . . . . 0.0 112.676 -171.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.64 89.13 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 117.601 -1.666 . . . . 0.0 116.072 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.22 134.97 10.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.652 2.226 . . . . 0.0 113.054 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.09 148.4 36.1 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.918 -1.114 . . . . 0.0 110.651 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -99.41 -45.76 5.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.69 -161.83 13.55 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.928 1.251 . . . . 0.0 112.911 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.26 165.1 46.84 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 124.18 0.895 . . . . 0.0 115.126 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -66.81 -38.9 87.38 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.982 -0.716 . . . . 0.0 112.273 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.9 -45.89 91.08 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.608 -0.683 . . . . 0.0 111.434 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.24 -40.38 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.195 0.598 . . . . 0.0 110.346 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 80.1 m -62.92 -44.13 96.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.693 1.197 . . . . 0.0 111.641 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.71 -46.36 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.905 0.775 . . . . 0.0 111.141 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.84 -36.96 81.27 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.62 0.645 . . . . 0.0 112.26 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.89 91.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.277 1.031 . . . . 0.0 112.202 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.01 -38.88 92.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.63 0.772 . . . . 0.0 112.519 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.46 -31.37 72.41 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.976 0.911 . . . . 0.0 111.791 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.9 m -88.26 -12.33 43.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.81 -2.57 76.65 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.081 1.324 . . . . 0.0 114.239 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.84 -36.19 42.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.981 1.312 . . . . 0.0 111.693 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.68 -42.21 95.51 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.701 -0.625 . . . . 0.0 110.453 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -56.26 -49.17 74.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.307 1.043 . . . . 0.0 110.169 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.38 -46.72 87.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.335 0.654 . . . . 0.0 112.067 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -71.42 -36.67 71.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.01 -37.77 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.581 1.082 . . . . 0.0 110.861 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.08 -44.89 94.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 110.434 169.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.78 -39.75 85.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.372 -0.83 . . . . 0.0 112.21 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.87 -44.73 96.22 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.828 1.195 . . . . 0.0 112.045 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmt -63.25 -38.07 89.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.259 1.023 . . . . 0.0 112.357 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.7 m -67.36 -36.88 82.27 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.005 0.922 . . . . 0.0 112.709 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.8 m . . . . . 0 C--O 1.255 1.379 0 C-N-CA 128.048 2.539 . . . . 0.0 112.036 -177.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.002 -0.047 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.22 62.54 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.3 93.46 0.64 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.236 1.414 . . . . 0.0 110.36 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.331 24.5 p 132.99 -50.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.648 1 C-N-CA 134.322 5.049 . . . . 0.0 112.765 172.128 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.87 -34.6 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 CA-C-N 122.305 1.859 . . . . 0.0 113.822 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.27 -46.63 2.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -67.68 -51.33 50.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.091 0.86 . . . . 0.0 111.792 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -64.61 -33.59 76.28 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.465 -0.772 . . . . 0.0 111.624 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -61.69 -43.19 99.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.433 2.293 . . . . 0.0 111.929 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -68.82 -43.41 75.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.868 1.267 . . . . 0.0 111.151 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.64 -41.12 89.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.868 0.867 . . . . 0.0 111.54 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.07 -42.96 99.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.525 1.057 . . . . 0.0 112.582 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.11 -40.9 98.99 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.275 -0.89 . . . . 0.0 111.816 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.04 -52.19 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.296 1.039 . . . . 0.0 110.853 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.09 -49.92 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.345 1.458 . . . . 0.0 112.101 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -74.85 -30.77 61.45 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.3 p -90.69 -36.56 14.27 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -38.81 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.223 -0.923 . . . . 0.0 112.21 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.77 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.088 2.955 . . . . 0.0 117.661 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.06 110.51 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.422 1.889 . . . . 0.0 107.66 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.26 158.29 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.85 117.17 15.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.177 1.391 . . . . 0.0 109.31 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -87.69 124.86 34.0 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.089 1.356 . . . . 0.0 109.924 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -163.45 172.97 13.74 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -69.81 -19.78 63.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.521 1.528 . . . . 0.0 114.083 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.1 -159.65 31.47 Favored Glycine 0 N--CA 1.477 1.417 0 C-N-CA 125.158 1.361 . . . . 0.0 113.547 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -136.47 -174.33 3.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.398 1.879 . . . . 0.0 110.348 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -80.38 -29.13 37.82 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.221 -0.924 . . . . 0.0 112.334 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.38 -34.36 65.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.638 1.175 . . . . 0.0 111.958 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -133.75 91.71 24.69 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.913 1.285 . . . . 0.0 110.413 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.64 157.52 48.34 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.739 2.293 . . . . 0.0 110.537 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -77.75 125.23 29.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.038 0.447 . . . . 0.0 110.275 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -59.49 143.54 49.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.297 1.439 . . . . 0.0 113.13 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.82 -100.4 2.08 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.085 0.85 . . . . 0.0 111.097 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -58.87 -64.3 0.99 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.454 1.501 . . . . 0.0 113.347 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -67.12 -37.41 83.83 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.706 -1.246 . . . . 0.0 111.447 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -54.42 -46.75 73.25 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.9 m -61.61 -48.0 82.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.263 1.025 . . . . 0.0 110.839 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.76 -49.03 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.918 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.93 -32.92 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.417 1.008 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -63.81 -41.55 97.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.911 0.885 . . . . 0.0 111.242 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 mt -59.6 -50.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 111.15 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.08 -52.22 65.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.424 0.69 . . . . 0.0 111.045 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -51.3 -55.59 17.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.983 0.513 . . . . 0.0 110.615 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -68.1 -31.02 70.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.094 1.758 . . . . 0.0 114.36 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.31 -33.9 71.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.7 t30 117.75 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.728 3.611 . . . . 0.0 109.645 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.13 137.79 23.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.83 89.81 1.27 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.723 2.948 . . . . 0.0 109.868 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -70.2 152.97 43.65 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.887 0.475 . . . . 0.0 110.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -129.23 121.33 27.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.399 0.619 . . . . 0.0 110.534 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -73.36 120.7 19.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.246 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.37 118.58 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.523 1.129 . . . . 0.0 108.092 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -75.07 120.03 20.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.033 0.933 . . . . 0.0 111.09 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -127.14 179.23 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.253 1.421 . . . . 0.0 112.082 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 77.71 -52.2 0.52 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 127.739 2.416 . . . . 0.0 112.406 169.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.25 -25.07 65.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.86 0.864 . . . . 0.0 112.983 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -104.13 113.94 27.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.717 2.407 . . . . 0.0 110.596 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.49 -28.63 69.33 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.36 -50.65 66.9 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 110.944 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.72 -39.91 91.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.39 0.676 . . . . 0.0 110.791 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -54.21 -44.53 71.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 0.0 112.082 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.093 0.957 . . . . 0.0 112.26 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.59 -42.68 46.82 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 113.776 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.81 -25.99 64.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.648 1.224 . . . . 0.0 113.341 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.07 -44.11 94.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.26 0.936 . . . . 0.0 111.376 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.41 -46.11 56.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.668 0.787 . . . . 0.0 111.19 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.94 -39.61 94.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 0.0 112.832 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.2 p -88.89 -35.68 16.38 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p 64.27 -23.24 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.222 2.609 . . . . 0.0 114.367 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -67.11 130.39 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.781 1.632 . . . . 0.0 111.27 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.25 136.97 13.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.83 2.354 . . . . 0.0 111.599 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.1 p 77.24 165.36 0.24 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 128.679 2.791 . . . . 0.0 114.65 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.65 161.89 49.62 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 127.208 2.203 . . . . 0.0 110.723 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -58.2 157.01 34.79 Favored 'Cis proline' 0 C--N 1.356 0.965 0 CA-C-N 120.777 1.313 . . . . 0.0 114.655 -2.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -152.7 132.43 13.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.021 0.528 . . . . 0.0 110.863 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 tt -93.9 142.35 27.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.027 1.331 . . . . 0.0 110.85 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -133.08 143.05 49.08 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.716 1.206 . . . . 0.0 111.519 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.52 138.64 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.07 1.348 . . . . 0.0 110.318 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -15.21 89.09 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.921 2.888 . . . . 0.0 115.809 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.3 55.65 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.167 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.8 130.49 21.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.189 1.994 . . . . 0.0 114.233 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -81.24 121.81 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.153 1.381 . . . . 0.0 108.841 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -92.59 -32.82 14.66 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.7 -154.1 16.6 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.819 1.2 . . . . 0.0 113.712 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.87 47.1 Favored Glycine 0 N--CA 1.473 1.1 0 C-N-CA 124.718 1.151 . . . . 0.0 115.498 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.5 t -58.58 -51.25 70.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.993 1.317 . . . . 0.0 112.782 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -60.64 -43.57 97.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.948 0.499 . . . . 0.0 111.77 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.13 -45.42 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.469 0.708 . . . . 0.0 110.24 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.1 -46.58 88.45 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.668 1.187 . . . . 0.0 110.882 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.23 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.87 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.17 -39.38 86.46 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.276 0.943 . . . . 0.0 111.916 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.44 79.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.649 -0.657 . . . . 0.0 112.226 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.86 -43.76 91.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.985 0.914 . . . . 0.0 112.047 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.24 -30.76 69.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.016 0.926 . . . . 0.0 112.79 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -84.79 -13.37 51.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.121 0.969 . . . . 0.0 113.374 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.26 83.89 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.418 1.485 . . . . 0.0 114.144 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -73.47 -38.82 65.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 111.571 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.15 -42.95 88.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.659 -0.65 . . . . 0.0 110.066 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -58.55 -48.08 82.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.583 0.753 . . . . 0.0 110.44 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.33 -50.17 72.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.861 0.865 . . . . 0.0 111.517 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -72.36 -35.37 68.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.252 -0.905 . . . . 0.0 113.435 -173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.43 -39.46 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.35 0.977 . . . . 0.0 110.722 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.95 -46.23 88.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.107 0.867 . . . . 0.0 111.296 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.73 -37.07 77.93 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.315 -0.865 . . . . 0.0 112.466 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.21 65.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 77.3 mtm -76.28 -38.24 56.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.606 0.639 . . . . 0.0 111.675 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.5 -41.34 69.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 127.668 2.387 . . . . 0.0 112.464 -172.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.2 173.57 11.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.321 1.049 . . . . 0.0 112.512 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -12.08 60.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -54.86 -46.94 99.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-O 115.555 -2.164 . . . . 0.0 116.28 -169.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.59 -40.49 5.52 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 123.47 2.275 . . . . 0.0 112.381 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.572 0.749 . . . . 0.0 111.504 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -54.36 47.45 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.03 1.332 . . . . 0.0 110.43 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.23 -35.2 76.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.856 -0.593 . . . . 0.0 112.218 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -62.94 -46.02 89.7 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.148 1.379 . . . . 0.0 111.439 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -62.27 -50.81 70.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.634 0.774 . . . . 0.0 111.137 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.04 -42.95 99.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.988 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.93 -48.99 77.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.639 1.109 . . . . 0.0 111.654 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.44 -41.7 90.21 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.355 0.662 . . . . 0.0 111.788 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.54 -53.34 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.916 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.2 -21.83 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.274 1.397 . . . . 0.0 113.681 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.3 p -80.14 -31.62 39.02 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.417 170.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.2 m -77.5 -38.5 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.662 0.665 . . . . 0.0 112.761 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.05 102.37 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.283 1.833 . . . . 0.0 108.999 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -60.84 -38.72 86.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.107 -0.995 . . . . 0.0 113.384 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -99.13 136.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.868 1.267 . . . . 0.0 109.096 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.15 136.82 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.05 142.24 30.78 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.28 1.032 . . . . 0.0 111.289 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -119.63 116.07 25.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.075 1.35 . . . . 0.0 108.623 169.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 48.2 mtm -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.819 1.247 . . . . 0.0 110.538 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -76.02 20.93 0.18 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.637 1.175 . . . . 0.0 113.78 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.19 168.12 41.15 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 126.797 2.141 . . . . 0.0 112.768 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -96.49 -175.48 3.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.961 1.304 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -11.1 33.97 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 170.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.17 -28.23 59.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 112.262 170.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -146.2 79.06 10.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.797 1.639 . . . . 0.0 111.075 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.47 135.99 64.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.027 2.485 . . . . 0.0 110.359 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -83.29 98.8 9.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.504 0.722 . . . . 0.0 112.413 -169.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.2 t 89.51 160.67 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.455 2.702 . . . . 0.0 112.325 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.08 -31.04 75.23 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 124.893 1.235 . . . . 0.0 113.408 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -62.0 -53.38 56.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.119 0.96 . . . . 0.0 110.671 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -61.73 -42.93 99.61 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.135 -0.978 . . . . 0.0 111.747 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.34 -44.26 92.67 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.038 0.935 . . . . 0.0 110.968 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.2 m -63.36 -45.13 92.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.862 0.865 . . . . 0.0 110.638 173.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.798 1.239 . . . . 0.0 112.514 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.02 -34.78 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 120.426 1.467 . . . . 0.0 111.8 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.91 -43.85 82.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 112.199 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.88 -51.49 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.559 1.544 . . . . 0.0 111.225 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.83 -49.09 69.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.309 1.043 . . . . 0.0 111.276 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -52.38 -49.89 63.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -68.24 -36.05 78.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.211 1.805 . . . . 0.0 114.176 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.87 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 120.78 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 131.051 3.74 . . . . 0.0 109.198 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.96 133.47 8.98 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -82.84 63.22 7.92 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.396 3.397 . . . . 0.0 108.422 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -70.01 168.68 14.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 113.891 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -134.38 172.54 12.75 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.377 1.084 . . . . 0.0 111.621 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -153.28 115.35 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.559 -1.338 . . . . 0.0 110.269 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.73 137.26 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.65 1.18 . . . . 0.0 110.324 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -81.05 123.24 28.21 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 112.106 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -27.95 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.839 1.256 . . . . 0.0 113.006 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.45 148.65 37.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.525 1.13 . . . . 0.0 109.731 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 66.0 6.56 4.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.468 1.907 . . . . 0.0 112.735 -169.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -135.3 57.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.673 1.989 . . . . 0.0 110.076 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -51.82 -37.27 51.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.239 1.416 . . . . 0.0 114.399 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.25 -42.63 91.59 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.343 1.057 . . . . 0.0 111.841 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.88 -41.98 64.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.356 1.062 . . . . 0.0 110.977 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -55.44 -47.12 76.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.909 1.284 . . . . 0.0 112.272 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -73.46 -49.03 28.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.184 0.594 . . . . 0.0 110.554 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.51 92.17 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.891 -0.949 . . . . 0.0 114.608 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.61 -57.76 11.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.372 1.086 . . . . 0.0 110.655 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -61.18 -37.97 84.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.588 0.755 . . . . 0.0 112.253 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.93 -36.84 80.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.858 1.263 . . . . 0.0 112.146 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -87.28 -38.7 16.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.795 1.638 . . . . 0.0 113.521 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.6 p -93.03 -28.25 16.5 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t 74.15 3.74 4.43 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 126.751 2.02 . . . . 0.0 113.318 -171.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -62.03 133.47 94.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.84 1.256 . . . . 0.0 112.041 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.45 -46.83 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.54 2.16 . . . . 0.0 114.662 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -147.46 124.92 11.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.318 0.963 . . . . 0.0 112.224 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.44 153.79 89.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.844 1.258 . . . . 0.0 112.0 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.22 158.7 94.91 Favored 'Cis proline' 0 C--N 1.354 0.855 0 CA-C-N 119.872 0.99 . . . . 0.0 113.662 7.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.59 128.6 27.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.488 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.19 129.21 40.88 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 109.177 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 141.83 47.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.409 1.884 . . . . 0.0 111.802 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.74 129.05 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 67.24 -19.34 0.12 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 128.218 2.607 . . . . 0.0 115.868 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.72 1.66 0.71 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.254 1.883 . . . . 0.0 115.153 -174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.34 158.88 43.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.141 1.47 . . . . 0.0 111.311 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -77.34 144.5 37.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.779 -0.576 . . . . 0.0 111.823 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -92.6 -40.06 10.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.71 1.204 . . . . 0.0 111.428 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.57 25.43 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.852 1.215 . . . . 0.0 113.49 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.47 169.73 33.23 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.04 1.305 . . . . 0.0 112.773 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 85.6 m -69.87 -44.55 69.59 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.591 -0.947 . . . . 0.0 113.099 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.01 -42.67 98.91 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.15 -0.969 . . . . 0.0 111.325 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.48 -40.2 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.9 0.88 . . . . 0.0 110.431 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.4 m -65.47 -42.71 91.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.621 1.169 . . . . 0.0 111.752 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -59.69 -43.8 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.022 0.828 . . . . 0.0 110.961 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -67.68 -37.04 81.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.845 0.748 . . . . 0.0 112.481 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.69 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.185 0.994 . . . . 0.0 112.19 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -63.78 -43.59 95.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.162 0.985 . . . . 0.0 112.113 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.18 -31.09 71.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 112.451 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.6 m -83.54 -14.2 52.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.442 1.097 . . . . 0.0 113.356 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.79 81.42 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.309 1.433 . . . . 0.0 114.31 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -71.25 -46.51 60.85 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.94 1.296 . . . . 0.0 111.031 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.58 -40.51 97.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.912 -0.493 . . . . 0.0 111.024 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.85 -47.92 83.17 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.355 0.662 . . . . 0.0 110.02 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.96 -49.42 74.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.309 0.644 . . . . 0.0 111.482 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -67.81 -39.08 84.0 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.78 -42.12 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.478 1.035 . . . . 0.0 110.536 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -45.52 91.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.872 0.76 . . . . 0.0 111.326 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -60.95 -40.59 93.92 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 112.292 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.82 82.98 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.809 0.843 . . . . 0.0 112.731 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.9 mmm -75.71 -45.91 34.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.145 0.978 . . . . 0.0 113.104 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.14 -45.67 7.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.774 1.23 . . . . 0.0 113.017 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.689 1.996 . . . . 0.0 113.178 -178.561 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.897 -0.038 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.75 172.24 13.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 111.363 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.01 -12.9 61.45 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -175.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.275 7.7 t -58.44 -37.68 57.33 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 116.243 -1.837 . . . . 0.0 115.753 -169.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -66.0 -44.27 7.79 Favored 'Trans proline' 0 C--N 1.355 0.916 0 CA-C-N 122.936 2.084 . . . . 0.0 112.191 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.26 -40.08 82.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.096 0.958 . . . . 0.0 111.843 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.78 -53.36 58.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.447 1.099 . . . . 0.0 111.056 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -59.36 -42.89 92.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.494 0.718 . . . . 0.0 111.619 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.2 m -60.21 -45.35 93.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.398 1.479 . . . . 0.0 111.609 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.2 m -63.59 -54.83 29.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.463 1.105 . . . . 0.0 110.904 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.42 -43.57 98.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.858 0.863 . . . . 0.0 111.768 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.96 -50.36 74.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.563 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.145 0.884 . . . . 0.0 111.564 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 t -55.97 -58.99 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.901 0.881 . . . . 0.0 110.944 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -74.01 -19.52 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.3 p -89.54 -32.18 17.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.477 1.111 . . . . 0.0 112.716 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.7 t -66.01 -35.85 81.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.112 0.869 . . . . 0.0 111.71 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -156.48 130.04 8.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.675 1.19 . . . . 0.0 112.12 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.8 160.67 17.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.97 0.908 . . . . 0.0 112.468 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t 65.56 83.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.327 1.851 . . . . 0.0 109.728 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.72 130.96 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.784 0.834 . . . . 0.0 110.205 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.3 120.47 42.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.439 1.096 . . . . 0.0 110.018 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.02 120.5 35.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.307 1.043 . . . . 0.0 109.058 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -152.78 -176.14 5.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.641 1.576 . . . . 0.0 110.816 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -78.7 36.1 0.26 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.387 -1.445 . . . . 0.0 113.326 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.59 -173.5 45.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.95 1.262 . . . . 0.0 113.763 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -131.91 -174.05 3.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.749 1.619 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -63.96 -11.69 30.9 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.39 -30.29 69.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.324 1.049 . . . . 0.0 112.318 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -154.43 88.23 3.41 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.37 1.468 . . . . 0.0 110.147 170.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.04 134.55 62.91 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.445 2.764 . . . . 0.0 111.235 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -85.24 130.81 34.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.074 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.4 m -55.73 152.39 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.763 2.025 . . . . 0.0 115.184 -169.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.28 -117.69 4.52 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.53 1.062 . . . . 0.0 112.007 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -48.47 -60.88 2.33 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.526 2.33 . . . . 0.0 112.185 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -43.33 92.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.02 -1.05 . . . . 0.0 112.434 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -57.09 -46.92 82.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -60.48 -46.07 91.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.497 1.119 . . . . 0.0 111.013 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.07 -48.43 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.62 -35.04 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.925 1.239 . . . . 0.0 111.904 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.58 -43.38 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.071 1.348 . . . . 0.0 111.491 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.15 -51.4 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.561 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.01 -53.54 56.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.264 0.938 . . . . 0.0 111.115 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.52 -62.26 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.019 1.328 . . . . 0.0 110.608 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.9 p -68.8 -27.95 66.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.766 1.627 . . . . 0.0 115.271 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -32.53 70.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.311 1.044 . . . . 0.0 110.326 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 116.21 60.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 130.462 3.505 . . . . 0.0 109.989 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.3 150.88 32.65 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.02 162.91 36.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.142 2.561 . . . . 0.0 110.675 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.55 159.65 41.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.938 1.295 . . . . 0.0 110.727 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -133.23 169.39 16.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.48 1.512 . . . . 0.0 108.547 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 p -152.13 155.45 37.88 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.66 -1.275 . . . . 0.0 114.021 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.63 133.17 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.056 1.343 . . . . 0.0 110.027 -170.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -80.46 106.41 12.45 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.902 0.881 . . . . 0.0 111.892 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.38 -27.61 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.593 1.157 . . . . 0.0 113.411 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.37 -2.95 54.51 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.655 1.182 . . . . 0.0 113.532 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -88.63 -10.98 46.7 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -157.4 124.7 5.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.512 1.125 . . . . 0.0 111.946 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.16 -41.24 90.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.399 1.079 . . . . 0.0 113.157 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.53 -37.81 85.82 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.21 0.604 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.54 -52.01 65.14 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.691 0.796 . . . . 0.0 109.908 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.39 -47.27 82.13 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.136 0.974 . . . . 0.0 113.07 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -73.86 -41.46 62.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 0.0 111.398 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -40.48 33.38 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.663 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.68 -31.7 70.94 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.978 1.389 . . . . 0.0 112.064 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.54 -38.55 91.39 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.795 0.838 . . . . 0.0 112.069 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.04 -46.13 53.62 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.224 1.01 . . . . 0.0 111.152 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.1 -46.49 88.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 112.646 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -90.87 -20.21 22.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.0 m 62.92 6.12 2.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.89 1.676 . . . . 0.0 113.544 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -69.13 134.81 89.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.215 1.406 . . . . 0.0 111.911 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.1 -43.68 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 113.686 -169.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p -147.9 113.06 5.53 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.232 1.013 . . . . 0.0 110.945 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.43 158.49 20.55 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.695 1.198 . . . . 0.0 111.538 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.76 173.12 42.09 Favored 'Cis proline' 0 C--N 1.355 0.889 0 CA-C-N 120.839 1.335 . . . . 0.0 115.509 5.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -161.87 152.16 17.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.259 1.024 . . . . 0.0 112.495 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.97 148.15 25.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.554 1.942 . . . . 0.0 109.343 171.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -149.85 139.47 21.64 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.774 2.029 . . . . 0.0 111.217 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.3 pt -149.35 141.76 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.604 1.562 . . . . 0.0 112.174 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.78 -21.5 0.09 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 127.625 2.37 . . . . 0.0 115.926 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.89 5.17 2.23 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.134 2.302 . . . . 0.0 114.343 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.15 161.72 35.38 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.573 1.549 . . . . 0.0 111.19 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -75.21 150.92 38.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.211 -0.931 . . . . 0.0 111.688 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -101.91 -41.44 6.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.138 1.375 . . . . 0.0 111.009 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.53 -162.37 20.7 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 124.653 1.12 . . . . 0.0 114.468 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.9 -176.9 50.12 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.906 1.241 . . . . 0.0 115.615 -169.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.62 -41.13 98.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.306 1.042 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -57.87 -49.55 76.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.215 1.006 . . . . 0.0 111.773 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.4 -43.33 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.063 0.945 . . . . 0.0 110.312 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.0 m -62.75 -44.87 95.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.87 1.268 . . . . 0.0 111.351 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.99 -45.78 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.56 1.144 . . . . 0.0 111.313 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -70.16 -38.18 75.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.893 0.77 . . . . 0.0 112.273 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.42 -30.34 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 113.022 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -65.65 -37.6 86.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.725 1.21 . . . . 0.0 112.174 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.2 -40.34 82.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 0.0 112.77 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.6 p -85.56 -16.54 39.05 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.0 81.3 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.853 1.216 . . . . 0.0 113.217 -173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.69 -27.13 66.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.343 1.057 . . . . 0.0 111.89 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.87 -46.72 83.68 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.818 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.09 -48.66 79.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.401 0.546 . . . . 0.0 110.609 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -57.48 -48.48 79.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.565 0.746 . . . . 0.0 111.611 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -70.0 -38.86 76.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.61 -43.42 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 111.107 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.78 -44.66 95.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.163 0.892 . . . . 0.0 111.371 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.68 -40.26 87.25 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.745 -0.597 . . . . 0.0 111.823 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.74 83.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 113.087 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.06 -38.65 86.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.379 -0.826 . . . . 0.0 111.964 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.7 m -73.77 -37.09 65.1 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.635 2.374 . . . . 0.0 112.357 -172.668 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.42 33.17 3.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.563 1.545 . . . . 0.0 113.294 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.78 -65.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.244 1.418 . . . . 0.0 113.208 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 p -74.5 -33.99 1.75 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 115.792 -2.051 . . . . 0.0 114.46 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -74.97 -40.44 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 122.84 2.05 . . . . 0.0 114.614 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.38 -46.93 2.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.51 -58.0 5.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 110.366 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.37 -31.11 72.18 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.242 -0.912 . . . . 0.0 112.429 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -60.66 -39.39 88.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.878 2.071 . . . . 0.0 112.24 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -70.22 -43.57 70.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.61 1.164 . . . . 0.0 111.004 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.3 -52.6 64.91 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.58 0.752 . . . . 0.0 110.485 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.17 -40.93 74.67 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 112.015 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.57 -50.11 73.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.341 -0.849 . . . . 0.0 111.774 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.35 -34.11 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.168 1.349 . . . . 0.0 112.672 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.43 -45.69 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.965 0.906 . . . . 0.0 112.207 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -76.92 -41.33 43.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.64 0.654 . . . . 0.0 112.641 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 m -78.27 -32.44 49.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -127.21 -7.74 5.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 66.44 -56.88 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.434 2.294 . . . . 0.0 114.972 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.08 124.38 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 109.177 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.32 138.64 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.122 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.4 126.05 52.9 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.125 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.81 100.59 12.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -145.29 151.01 37.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.389 1.075 . . . . 0.0 111.514 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.37 -19.67 59.43 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 178.57 34.32 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.999 1.761 . . . . 0.0 112.919 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 p -103.03 172.4 6.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.52 1.528 . . . . 0.0 111.128 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -64.12 -35.82 82.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.93 -15.93 52.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.016 1.326 . . . . 0.0 114.014 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -150.95 88.25 4.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.85 1.26 . . . . 0.0 111.022 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.52 168.97 20.59 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.314 2.676 . . . . 0.0 111.741 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -78.58 -3.23 42.77 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.6 m 72.99 -1.23 3.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.495 2.318 . . . . 0.0 115.236 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.47 -150.5 24.35 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 125.553 1.549 . . . . 0.0 112.754 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -60.37 -25.82 66.16 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.057 0.943 . . . . 0.0 113.174 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -59.01 -48.6 81.02 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.806 1.242 . . . . 0.0 111.554 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.63 -42.69 88.88 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.093 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 m -59.53 -46.69 88.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.366 0.985 . . . . 0.0 112.0 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 t -58.95 -46.06 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.955 0.902 . . . . 0.0 111.557 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -59.55 -45.23 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.143 0.577 . . . . 0.0 111.073 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -65.54 -38.7 90.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.722 1.209 . . . . 0.0 112.257 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mt -58.91 -49.38 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.915 1.286 . . . . 0.0 110.523 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 mt -63.74 -50.12 70.34 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.998 0.919 . . . . 0.0 111.176 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -53.98 -57.68 10.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 110.916 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.7 p -68.66 -27.63 66.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.869 1.668 . . . . 0.0 114.849 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.92 -34.86 72.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.266 0.939 . . . . 0.0 109.828 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.9 t30 118.71 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.504 3.522 . . . . 0.0 110.095 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.99 148.44 20.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.22 170.12 21.04 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.56 2.84 . . . . 0.0 110.605 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -155.08 143.66 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -106.93 89.96 3.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.809 0.843 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.3 p -72.66 81.37 1.12 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.138 -0.976 . . . . 0.0 109.868 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.08 116.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 108.41 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.66 94.67 3.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.702 1.201 . . . . 0.0 111.821 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -74.72 173.74 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.243 1.017 . . . . 0.0 111.313 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.95 -46.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.905 2.082 . . . . 0.0 112.425 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.36 -39.84 94.67 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.329 1.052 . . . . 0.0 112.284 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -95.5 124.23 39.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.64 1.176 . . . . 0.0 110.156 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.68 -26.79 67.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.134 0.974 . . . . 0.0 113.073 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.84 -38.98 93.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.851 0.75 . . . . 0.0 112.289 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.87 -32.98 71.63 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.607 0.763 . . . . 0.0 112.076 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -55.01 -43.78 73.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.208 1.003 . . . . 0.0 112.516 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -91.18 -45.37 8.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.393 1.077 . . . . 0.0 111.333 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.06 90.35 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.774 -1.014 . . . . 0.0 114.706 -169.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.91 -42.14 63.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 111.815 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.63 -40.84 96.29 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.869 -0.519 . . . . 0.0 111.445 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.91 -52.33 50.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.987 0.915 . . . . 0.0 111.447 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.15 -38.67 82.4 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.14 -28.81 25.29 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m 75.99 -4.84 2.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.813 2.445 . . . . 0.0 112.684 -169.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -76.79 137.3 66.46 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.975 -1.078 . . . . 0.0 111.437 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.71 -23.7 3.81 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.78 2.32 . . . . 0.0 111.532 169.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.6 m -96.19 131.17 42.94 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.564 1.546 . . . . 0.0 112.508 -169.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -138.8 151.74 69.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.859 2.063 . . . . 0.0 109.812 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.27 167.66 79.15 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 120.093 1.069 . . . . 0.0 113.317 5.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -160.69 161.07 32.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 113.18 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.75 141.78 30.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.26 2.224 . . . . 0.0 109.801 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.55 131.94 25.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.878 2.071 . . . . 0.0 110.352 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.9 mt -138.74 118.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.878 -1.139 . . . . 0.0 111.476 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.69 32.32 11.78 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.333 1.453 . . . . 0.0 114.249 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.68 65.87 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.601 1.096 . . . . 0.0 115.023 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -103.5 120.73 41.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.841 1.32 . . . . 0.0 111.022 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.01 106.72 8.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.184 0.993 . . . . 0.0 109.669 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -82.66 -31.43 28.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.634 1.173 . . . . 0.0 111.971 -170.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.66 -155.18 16.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.687 1.137 . . . . 0.0 114.892 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.87 177.19 54.25 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.647 1.118 . . . . 0.0 114.922 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 21.9 p -63.94 -44.94 91.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.193 0.997 . . . . 0.0 113.509 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.88 -44.38 97.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.467 0.707 . . . . 0.0 111.38 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.48 -45.31 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.631 0.773 . . . . 0.0 109.722 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -62.41 -47.56 83.59 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.44 -42.88 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 111.35 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -72.47 -34.8 67.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.852 0.751 . . . . 0.0 112.416 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.94 85.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.17 -40.86 86.68 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.768 1.227 . . . . 0.0 112.355 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -64.02 -39.04 93.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.94 0.896 . . . . 0.0 111.964 170.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -77.15 -16.57 59.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.928 0.891 . . . . 0.0 113.361 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.54 80.89 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.095 1.331 . . . . 0.0 113.82 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.11 -47.26 65.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.022 1.329 . . . . 0.0 110.883 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.7 tp -62.27 -42.91 99.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.717 -0.614 . . . . 0.0 110.534 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -59.43 -46.5 88.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.627 0.771 . . . . 0.0 110.537 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -63.98 -49.28 73.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.166 0.586 . . . . 0.0 111.613 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -68.72 -37.27 79.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.462 1.028 . . . . 0.0 112.886 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.14 -45.09 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.203 0.91 . . . . 0.0 110.495 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.63 -46.34 86.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.775 0.716 . . . . 0.0 111.083 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -60.76 -40.17 91.5 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.776 1.23 . . . . 0.0 112.074 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.58 89.47 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.815 0.846 . . . . 0.0 112.1 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -66.88 -33.17 75.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.288 0.635 . . . . 0.0 112.656 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.2 m -71.72 -43.05 66.56 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.453 2.301 . . . . 0.0 112.582 -173.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 173.68 15.27 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.068 1.347 . . . . 0.0 112.042 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.91 165.55 23.07 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.831 0.853 . . . . 0.0 113.155 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 t 179.55 -32.53 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 128.067 2.547 . . . . 0.0 114.615 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -68.93 -169.25 0.28 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 123.007 2.472 . . . . 0.0 113.069 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.43 -4.1 1.18 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 tt -55.81 -50.92 69.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.443 1.097 . . . . 0.0 110.331 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -60.39 -43.46 96.63 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 0.0 111.68 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -37.77 80.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.426 1.89 . . . . 0.0 112.321 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.4 m -67.6 -49.37 63.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.392 1.077 . . . . 0.0 110.507 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.91 -46.36 85.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 110.976 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.36 -45.67 90.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.177 0.991 . . . . 0.0 112.236 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.328 -0.857 . . . . 0.0 111.781 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.02 -47.5 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.021 0.828 . . . . 0.0 111.15 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.74 -36.55 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.996 1.318 . . . . 0.0 113.123 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 p -84.33 -35.55 23.19 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.173 0.897 . . . . 0.0 112.906 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.3 t -75.58 -42.33 52.35 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -101.82 -6.44 23.59 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 63.47 -59.54 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.792 2.437 . . . . 0.0 114.566 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.3 125.1 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.437 1.495 . . . . 0.0 109.928 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.19 130.56 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.923 0.489 . . . . 0.0 111.369 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 139.42 34.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.56 1.144 . . . . 0.0 110.344 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.09 123.21 43.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 109.497 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -159.49 179.5 8.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.929 1.692 . . . . 0.0 109.855 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -77.91 35.16 0.2 Allowed 'General case' 0 CA--C 1.556 1.191 0 O-C-N 120.068 -1.645 . . . . 0.0 114.037 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.96 161.52 34.83 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.894 1.711 . . . . 0.0 113.77 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.6 p -94.76 -176.01 3.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.887 1.675 . . . . 0.0 111.588 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -67.22 -28.99 68.53 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.361 0.664 . . . . 0.0 111.95 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.12 -29.02 48.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.868 1.267 . . . . 0.0 112.561 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.69 73.95 75.03 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.273 1.429 . . . . 0.0 111.739 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.22 154.83 37.95 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.353 2.702 . . . . 0.0 111.954 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.06 146.19 32.93 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.885 0.874 . . . . 0.0 111.355 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -68.01 161.65 26.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.04 1.336 . . . . 0.0 113.684 -173.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.84 -146.71 21.51 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.696 1.141 . . . . 0.0 112.035 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -57.62 -32.23 67.03 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 m -59.3 -47.43 85.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.609 1.095 . . . . 0.0 112.056 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.67 -46.31 87.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.291 1.037 . . . . 0.0 110.743 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -44.99 91.61 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.871 0.868 . . . . 0.0 110.639 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.59 -43.0 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.645 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.66 -34.06 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.898 1.681 . . . . 0.0 112.158 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.97 -44.34 89.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.602 0.637 . . . . 0.0 111.405 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -59.19 -52.35 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.619 1.168 . . . . 0.0 111.466 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.0 mt -65.13 -47.88 75.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.57 0.748 . . . . 0.0 111.281 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -50.48 -55.94 13.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.903 0.881 . . . . 0.0 110.891 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 m -68.25 -36.08 78.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.823 1.649 . . . . 0.0 114.176 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.59 -32.83 71.92 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.301 1.44 . . . . 0.0 111.076 173.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.6 t30 122.69 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 131.261 3.825 . . . . 0.0 109.815 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.7 137.65 11.54 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.58 61.2 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.47 3.447 . . . . 0.0 109.268 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -62.18 156.53 21.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.452 1.101 . . . . 0.0 112.94 -171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -121.44 170.31 9.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.466 1.107 . . . . 0.0 110.902 171.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 m -149.89 121.59 8.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.293 -1.505 . . . . 0.0 111.46 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -106.92 129.67 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.597 1.559 . . . . 0.0 109.677 -173.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -80.42 107.97 13.66 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.249 0.62 . . . . 0.0 111.42 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.7 pt -64.28 -27.37 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.101 -0.999 . . . . 0.0 112.928 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -0.16 51.63 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.286 1.434 . . . . 0.0 113.385 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.04 -29.46 67.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.776 0.83 . . . . 0.0 112.638 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -159.41 139.64 12.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.82 1.248 . . . . 0.0 110.919 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.05 -40.37 63.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.014 1.726 . . . . 0.0 114.087 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 tp -66.08 -31.32 72.13 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.338 1.055 . . . . 0.0 112.168 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.72 -45.77 41.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.856 0.863 . . . . 0.0 110.016 171.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.09 -44.99 75.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.995 1.318 . . . . 0.0 112.591 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -84.44 -28.77 26.63 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.94 -31.75 64.19 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 124.403 1.002 . . . . 0.0 113.422 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.22 -31.77 70.48 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 1.284 . . . . 0.0 112.511 176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.07 -38.55 91.46 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.154 -0.966 . . . . 0.0 111.873 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -71.51 -40.3 70.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.512 0.725 . . . . 0.0 111.298 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -63.68 -38.03 89.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.937 1.295 . . . . 0.0 113.455 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.1 m -118.01 -19.79 8.98 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p 68.62 -12.09 0.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.611 2.364 . . . . 0.0 114.194 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -61.78 136.79 94.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 125.739 1.616 . . . . 0.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.53 -42.89 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.754 2.303 . . . . 0.0 115.371 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -140.22 108.72 5.87 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.113 0.869 . . . . 0.0 111.681 -169.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.34 162.71 71.22 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.511 1.524 . . . . 0.0 112.173 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.15 163.97 36.33 Favored 'Cis proline' 0 C--N 1.356 0.931 0 N-CA-C 116.027 1.51 . . . . 0.0 116.027 2.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.36 158.31 37.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.363 1.065 . . . . 0.0 111.512 170.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -105.94 138.97 41.21 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.358 1.863 . . . . 0.0 109.295 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.34 141.04 52.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.672 1.989 . . . . 0.0 111.162 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mt -139.03 123.07 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.93 -26.75 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.954 3.302 . . . . 0.0 117.014 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.51 1.39 0.04 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.447 1.975 . . . . 0.0 115.237 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -140.2 157.0 46.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.441 1.62 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -76.48 148.58 37.1 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.695 -0.628 . . . . 0.0 110.954 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -98.66 -43.66 6.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.931 1.292 . . . . 0.0 111.807 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.66 -165.73 24.98 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.276 1.417 . . . . 0.0 113.176 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.84 49.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.488 1.042 . . . . 0.0 112.994 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.8 m -61.48 -32.96 72.99 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.6 -39.15 87.07 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 112.049 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.55 -42.37 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.188 0.595 . . . . 0.0 109.586 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -62.61 -42.68 99.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.263 1.025 . . . . 0.0 111.924 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.46 -41.97 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.754 0.706 . . . . 0.0 111.417 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -67.9 -39.16 83.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.971 0.805 . . . . 0.0 112.281 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.89 81.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 112.617 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.67 -41.78 87.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.016 0.926 . . . . 0.0 112.025 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -68.46 -35.05 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.621 1.168 . . . . 0.0 112.624 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 p -90.02 -12.83 37.44 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.02 -0.17 72.22 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 125.463 1.506 . . . . 0.0 114.652 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.27 -37.26 85.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 111.846 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -66.4 -41.55 89.15 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.078 0.551 . . . . 0.0 111.191 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.82 -47.37 82.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.198 0.599 . . . . 0.0 110.568 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.67 -46.11 91.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.884 0.473 . . . . 0.0 111.947 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -68.56 -40.51 80.58 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.128 0.876 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.57 -39.41 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 118.993 0.815 . . . . 0.0 110.42 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.09 -43.67 91.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.236 0.925 . . . . 0.0 111.027 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -63.54 -38.92 92.97 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.902 -1.124 . . . . 0.0 112.777 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.51 83.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.94 0.791 . . . . 0.0 112.939 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.16 -47.95 10.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.394 1.078 . . . . 0.0 112.97 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.3 m -109.93 -28.3 8.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.283 1.433 . . . . 0.0 114.526 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 127.009 2.124 . . . . 0.0 114.293 177.146 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.24 172.07 13.47 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.456 1.102 . . . . 0.0 113.201 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.65 134.26 53.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.677 1.191 . . . . 0.0 110.332 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 p -83.4 156.26 65.89 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.794 0.838 . . . . 0.0 110.356 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.54 -33.12 57.64 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.136 1.89 . . . . 0.0 111.38 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.44 98.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.801 0.84 . . . . 0.0 112.732 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.72 -53.25 58.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 110.663 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -60.08 -37.46 80.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.1 0.56 . . . . 0.0 112.492 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 m -66.86 -40.84 87.99 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.174 1.79 . . . . 0.0 111.967 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -65.69 -47.25 76.08 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.29 1.036 . . . . 0.0 110.699 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.3 -54.21 48.07 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.748 1.219 . . . . 0.0 110.635 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.24 -43.0 78.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 111.954 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.06 -45.69 91.03 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.28 -0.887 . . . . 0.0 111.894 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.24 -37.82 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.563 1.529 . . . . 0.0 111.875 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.73 -33.74 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.04 0.936 . . . . 0.0 112.993 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 p -90.63 -43.47 10.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.1 p -73.27 -32.01 64.42 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -134.54 70.04 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 109.402 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.73 139.81 38.02 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t 83.52 88.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.958 2.503 . . . . 0.0 107.777 -169.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -108.08 133.03 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.06 0.544 . . . . 0.0 110.099 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.69 123.49 45.77 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.653 0.781 . . . . 0.0 108.965 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -104.98 116.12 31.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.311 1.045 . . . . 0.0 109.683 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.76 -167.99 1.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.042 1.737 . . . . 0.0 110.748 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.56 -1.11 53.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.98 171.64 15.3 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.065 1.793 . . . . 0.0 113.64 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.4 p -103.54 178.01 4.68 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.972 1.709 . . . . 0.0 110.684 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.6 -32.03 73.1 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.341 -0.849 . . . . 0.0 111.937 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.77 -32.92 58.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.936 1.294 . . . . 0.0 112.663 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -137.0 82.2 31.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.138 1.375 . . . . 0.0 110.634 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.63 171.77 16.91 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.786 2.99 . . . . 0.0 111.555 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -86.49 150.4 24.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.916 0.886 . . . . 0.0 111.224 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -72.37 171.31 12.45 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.425 1.49 . . . . 0.0 113.518 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 -136.89 22.02 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.353 0.977 . . . . 0.0 112.239 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -52.14 -40.87 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.747 0.819 . . . . 0.0 112.184 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 m -59.11 -43.61 91.91 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.317 -0.864 . . . . 0.0 112.576 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -62.65 -47.02 85.53 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.415 -0.803 . . . . 0.0 110.522 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.9 m -58.89 -44.47 91.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.017 0.927 . . . . 0.0 110.736 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.97 -44.18 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.006 1.322 . . . . 0.0 112.204 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.9 -43.71 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.901 0.773 . . . . 0.0 110.955 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.01 -40.0 94.27 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 mt -59.69 -53.46 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 112.195 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.17 -47.93 75.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.932 1.242 . . . . 0.0 110.834 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -49.1 -57.06 7.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.949 0.5 . . . . 0.0 110.331 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -67.02 -31.57 72.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.861 1.665 . . . . 0.0 114.266 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.39 -23.09 64.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.89 1.276 . . . . 0.0 111.222 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.8 t30 114.48 32.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 130.961 3.704 . . . . 0.0 112.282 168.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.76 138.42 29.63 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 121.261 -0.899 . . . . 0.0 113.089 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -82.17 49.89 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.457 3.438 . . . . 0.0 109.056 169.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -66.14 169.16 7.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.447 1.899 . . . . 0.0 115.133 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -150.96 130.04 12.62 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.588 0.755 . . . . 0.0 111.043 169.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.1 m -90.39 124.15 34.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.606 -0.684 . . . . 0.0 109.177 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.64 125.48 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 109.251 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -75.09 101.43 4.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.394 0.678 . . . . 0.0 111.026 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -72.36 -24.52 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.28 -1.72 34.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.969 1.308 . . . . 0.0 113.184 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.4 -24.85 66.54 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.574 1.149 . . . . 0.0 112.843 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -154.69 134.58 12.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 111.487 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.79 -41.78 87.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -25.14 67.83 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.701 1.137 . . . . 0.0 113.24 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.32 -46.98 21.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.083 0.953 . . . . 0.0 110.329 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -56.64 -47.86 78.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.874 0.87 . . . . 0.0 112.229 174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.08 -40.56 30.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.192 0.997 . . . . 0.0 112.449 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.01 -28.92 48.42 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.608 -170.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.3 tp -57.59 -36.71 72.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.756 1.278 . . . . 0.0 112.588 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -50.08 -43.8 51.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.362 1.065 . . . . 0.0 112.478 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -83.17 -30.19 28.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.789 0.836 . . . . 0.0 112.592 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -64.68 -39.66 94.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.8 p -88.68 -67.89 0.8 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.227 0.611 . . . . 0.0 111.894 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.2 m 130.05 -12.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 1 C-N-CA 133.598 4.759 . . . . 0.0 111.209 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -66.74 134.28 94.18 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.05 -43.37 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.888 2.392 . . . . 0.0 115.48 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.0 p -142.22 117.69 10.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.152 0.887 . . . . 0.0 112.176 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -60.6 159.19 26.19 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.298 1.439 . . . . 0.0 113.352 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -59.79 161.43 35.68 Favored 'Cis proline' 0 C--N 1.358 1.034 0 N-CA-C 115.672 1.374 . . . . 0.0 115.672 -2.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -154.82 161.91 41.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.38 1.072 . . . . 0.0 111.356 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.89 123.09 40.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.198 1.399 . . . . 0.0 109.418 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -111.31 138.3 47.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.508 1.123 . . . . 0.0 111.291 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 pt -149.89 110.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.727 1.611 . . . . 0.0 112.857 -169.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.24 41.49 32.14 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.994 1.317 . . . . 0.0 114.23 169.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.01 -8.5 69.94 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.265 0.935 . . . . 0.0 114.121 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -104.76 177.61 4.8 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.083 1.753 . . . . 0.0 110.516 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -150.77 161.71 42.11 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.892 1.33 . . . . 0.0 112.624 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -136.12 177.51 7.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.931 2.092 . . . . 0.0 109.898 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.78 -168.01 30.77 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.732 1.634 . . . . 0.0 115.624 -169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.62 -179.73 32.22 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.969 1.271 . . . . 0.0 113.99 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.1 m -67.5 -48.42 67.16 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.61 -42.39 88.06 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 111.811 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.73 -41.67 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.133 0.973 . . . . 0.0 110.593 172.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.2 m -64.16 -41.58 97.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.656 1.182 . . . . 0.0 111.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.12 -44.02 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.829 0.741 . . . . 0.0 111.281 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.92 -36.8 80.8 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.89 0.768 . . . . 0.0 112.476 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.0 83.89 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 112.522 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -65.59 -41.08 93.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.225 1.01 . . . . 0.0 112.322 172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -68.68 -29.59 68.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.661 0.785 . . . . 0.0 112.647 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -87.39 -13.53 43.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.48 1.112 . . . . 0.0 113.379 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.92 -0.61 84.45 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.49 1.519 . . . . 0.0 114.268 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.9 -39.13 64.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.825 1.25 . . . . 0.0 111.321 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.35 -45.07 92.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.775 0.43 . . . . 0.0 110.626 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.85 -47.9 76.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.084 0.953 . . . . 0.0 111.018 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.17 -47.93 83.89 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.124 0.57 . . . . 0.0 112.063 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -68.9 -42.59 76.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.587 -0.696 . . . . 0.0 112.585 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.99 -40.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.973 0.909 . . . . 0.0 111.153 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.26 -46.45 89.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.449 1.022 . . . . 0.0 110.696 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.52 -44.68 93.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.58 -0.7 . . . . 0.0 111.795 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.43 87.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.002 0.921 . . . . 0.0 113.151 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 85.0 mtp -70.19 -39.76 75.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.603 1.161 . . . . 0.0 112.579 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.22 -34.39 77.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.335 0.654 . . . . 0.0 111.973 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.211 2.605 . . . . 0.0 112.688 173.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.36 164.48 35.71 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.581 1.552 . . . . 0.0 111.548 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.9 tp 70.65 -22.34 0.18 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.98 2.512 . . . . 0.0 114.43 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 p -63.37 -32.14 7.87 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-O 115.682 -2.104 . . . . 0.0 116.302 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.86 -167.13 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 CA-C-N 123.379 2.243 . . . . 0.0 111.615 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.07 -2.68 1.36 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.3 -52.07 39.69 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.494 1.517 . . . . 0.0 111.018 170.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.74 -42.39 98.91 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.345 -0.847 . . . . 0.0 112.345 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -60.12 -39.08 84.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.25 1.82 . . . . 0.0 111.866 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -68.0 -50.45 55.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.995 1.318 . . . . 0.0 110.379 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.29 -51.28 67.18 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.454 0.702 . . . . 0.0 111.334 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.75 -48.85 76.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.988 0.915 . . . . 0.0 112.112 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.32 -42.74 96.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.94 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.96 -43.75 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.325 -0.859 . . . . 0.0 111.074 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.73 -42.8 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.408 1.483 . . . . 0.0 112.934 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.9 p -76.4 -42.89 42.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.216 0.916 . . . . 0.0 112.329 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.7 p -76.35 -36.05 58.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -95.95 -13.76 23.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.41 -48.24 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.508 2.723 . . . . 0.0 115.032 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.26 120.74 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.493 1.917 . . . . 0.0 108.048 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.65 154.93 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.144 0.578 . . . . 0.0 111.154 -172.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.96 132.65 46.39 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.602 1.161 . . . . 0.0 110.452 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -108.24 114.94 29.2 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.3 ptm -160.73 174.23 14.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.777 1.231 . . . . 0.0 110.615 -169.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -85.3 29.78 0.65 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.014 -1.054 . . . . 0.0 113.274 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.83 172.43 42.59 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.517 1.532 . . . . 0.0 113.089 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.0 p -100.27 178.48 4.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.178 1.391 . . . . 0.0 110.742 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.56 -23.47 62.61 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -84.43 -30.2 25.51 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 112.394 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -132.14 76.0 73.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.614 1.566 . . . . 0.0 110.35 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.39 173.23 14.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.547 2.832 . . . . 0.0 111.001 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -112.27 136.23 51.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.8 0.84 . . . . 0.0 110.735 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.87 149.83 46.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 112.739 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.51 -113.19 3.94 Favored Glycine 0 N--CA 1.468 0.822 0 C-N-CA 124.1 0.857 . . . . 0.0 111.526 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -59.97 -57.12 14.23 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.646 1.178 . . . . 0.0 113.072 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.3 m -62.53 -46.36 88.76 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.387 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -52.23 -47.65 65.59 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.497 1.519 . . . . 0.0 111.341 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -61.57 -50.37 72.92 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.15 0.98 . . . . 0.0 110.54 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -59.13 -47.77 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.012 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.71 -35.44 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.479 1.036 . . . . 0.0 112.098 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -64.97 -38.48 91.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.003 0.819 . . . . 0.0 111.558 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mt -59.82 -51.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.823 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -59.3 -51.14 71.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.553 1.069 . . . . 0.0 111.723 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -51.38 -60.93 2.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.338 1.055 . . . . 0.0 110.654 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 94.1 p -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.046 1.738 . . . . 0.0 115.262 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -58.86 -32.65 69.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.31 1.044 . . . . 0.0 109.892 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 t30 114.63 56.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.717 3.607 . . . . 0.0 109.333 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.62 38.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.45 168.49 14.47 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.721 2.947 . . . . 0.0 112.281 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.46 141.1 15.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.427 1.491 . . . . 0.0 109.583 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -123.98 93.47 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.733 0.813 . . . . 0.0 109.746 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 m -78.93 115.81 18.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.732 -0.605 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.52 125.5 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.809 1.643 . . . . 0.0 108.518 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -78.15 107.46 10.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.714 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.67 -23.76 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.75 -11.38 60.15 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.928 -1.107 . . . . 0.0 112.848 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -70.0 -29.03 66.01 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.879 0.872 . . . . 0.0 113.05 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -154.4 135.44 13.86 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.883 0.765 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.98 -34.24 74.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.54 1.136 . . . . 0.0 111.668 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 -26.14 68.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.044 0.938 . . . . 0.0 112.738 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.65 -56.51 5.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.915 0.78 . . . . 0.0 109.47 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -55.24 -39.43 69.72 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -86.72 -36.87 18.42 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.81 -37.77 21.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.692 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -64.26 -39.43 93.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.533 1.167 . . . . 0.0 112.952 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -58.82 -37.35 76.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.004 0.522 . . . . 0.0 111.9 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.36 -40.63 50.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 111.781 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.56 -45.55 93.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.065 1.346 . . . . 0.0 113.503 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.5 p -95.81 -23.51 16.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 p 78.7 -12.05 1.13 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.944 2.898 . . . . 0.0 113.561 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -81.47 127.08 74.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 121.321 -0.862 . . . . 0.0 110.669 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -83.83 -12.34 8.6 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.419 2.746 . . . . 0.0 116.51 -169.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -123.34 171.13 9.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.98 1.264 . . . . 0.0 112.894 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.13 148.9 69.86 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.042 1.337 . . . . 0.0 110.526 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.42 156.9 69.3 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.894 0.998 . . . . 0.0 114.145 -3.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.37 139.04 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.408 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.59 149.1 21.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.526 1.53 . . . . 0.0 110.453 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -149.58 140.93 23.23 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -144.79 124.58 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.593 1.157 . . . . 0.0 112.405 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 61.7 -17.8 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.329 2.652 . . . . 0.0 117.504 169.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.04 6.17 1.11 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.379 1.942 . . . . 0.0 113.821 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -128.24 144.01 51.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.208 1.803 . . . . 0.0 110.433 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -91.63 163.49 14.09 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.974 1.369 . . . . 0.0 112.791 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -142.37 176.08 9.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.064 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.84 -169.99 39.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.369 -1.287 . . . . 0.0 114.523 -171.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.62 -163.65 35.37 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.878 1.228 . . . . 0.0 113.002 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.12 -50.51 72.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.654 0.782 . . . . 0.0 112.97 -172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -59.78 -43.98 94.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.916 0.78 . . . . 0.0 111.596 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.37 -43.05 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.33 0.652 . . . . 0.0 110.175 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -62.81 -44.2 96.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 111.066 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.68 -45.13 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.898 1.279 . . . . 0.0 111.235 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.31 -38.75 81.9 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.842 0.746 . . . . 0.0 112.237 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.26 80.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.096 0.958 . . . . 0.0 112.485 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -67.52 -38.94 85.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.859 1.264 . . . . 0.0 112.182 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -68.03 -36.52 80.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.061 0.944 . . . . 0.0 111.931 173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 m -84.28 -16.33 43.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.45 -0.39 80.64 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.107 1.337 . . . . 0.0 114.26 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -68.01 -42.83 80.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.764 1.226 . . . . 0.0 110.926 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.61 -43.78 92.67 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.028 -0.42 . . . . 0.0 110.531 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -55.44 -48.58 74.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.929 0.891 . . . . 0.0 111.182 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.06 -48.64 77.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.281 0.492 . . . . 0.0 111.776 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.85 -39.57 79.86 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.552 -0.718 . . . . 0.0 112.821 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -38.68 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.931 0.893 . . . . 0.0 111.035 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.3 -45.97 92.22 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.38 0.991 . . . . 0.0 111.368 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.95 -39.99 87.44 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.532 -0.73 . . . . 0.0 111.903 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.79 91.97 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.061 0.846 . . . . 0.0 112.899 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.5 mtm -68.28 -35.0 77.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.836 0.855 . . . . 0.0 112.674 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.5 t -65.97 -43.9 86.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.99 0.916 . . . . 0.0 111.891 170.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.255 1.353 0 C-N-CA 129.215 3.006 . . . . 0.0 112.408 174.07 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 119.806 -0.14 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.79 165.36 12.15 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.663 1.185 . . . . 0.0 112.813 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -25.59 51.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.301 1.041 . . . . 0.0 113.726 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.3 p -56.61 -39.58 78.8 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 115.861 -2.019 . . . . 0.0 116.333 -169.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.97 -12.21 16.26 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.961 2.093 . . . . 0.0 113.723 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.21 -58.15 2.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.246 1.018 . . . . 0.0 112.822 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.51 -57.35 8.44 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.798 1.239 . . . . 0.0 110.947 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -59.88 -41.03 90.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.984 0.514 . . . . 0.0 111.193 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -60.84 -41.66 96.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.262 2.225 . . . . 0.0 112.881 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.5 m -66.91 -50.17 63.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.83 0.852 . . . . 0.0 110.317 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.33 -36.54 84.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.81 -48.72 80.53 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.261 1.024 . . . . 0.0 112.002 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -59.89 -41.67 92.1 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.093 -1.004 . . . . 0.0 111.782 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.66 -53.1 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.328 -0.858 . . . . 0.0 111.739 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.31 -30.24 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.924 1.238 . . . . 0.0 113.233 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.8 p -75.28 -30.14 60.33 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.204 0.911 . . . . 0.0 112.629 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.4 m -78.1 -40.75 37.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -107.07 -9.67 16.12 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 64.61 -47.96 0.32 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.733 2.813 . . . . 0.0 115.299 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -116.12 122.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.258 1.823 . . . . 0.0 109.369 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.36 135.54 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.873 0.869 . . . . 0.0 110.033 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.02 128.79 56.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.616 1.566 . . . . 0.0 108.941 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -108.83 120.14 41.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 109.764 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -156.45 167.34 30.75 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.92 1.688 . . . . 0.0 110.505 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -78.56 31.71 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.93 163.7 31.93 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.356 1.931 . . . . 0.0 113.018 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.1 p -82.06 178.43 8.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 111.199 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -64.31 -26.9 68.69 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.63 0.772 . . . . 0.0 112.449 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.8 -25.76 26.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 113.229 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -119.01 65.02 6.98 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.8 1.64 . . . . 0.0 111.169 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.93 150.05 85.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.059 2.506 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -94.77 115.03 27.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.042 0.537 . . . . 0.0 110.55 -170.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.14 146.44 33.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.838 1.255 . . . . 0.0 112.805 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.76 -149.0 19.19 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -53.44 -41.03 65.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -64.63 -46.51 82.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 112.541 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -57.43 -44.57 84.8 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.403 -0.811 . . . . 0.0 110.452 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -59.08 -43.76 91.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.788 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.1 -42.25 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.422 1.01 . . . . 0.0 111.821 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.67 -47.93 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.689 0.677 . . . . 0.0 110.967 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.43 -37.5 87.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.504 0.722 . . . . 0.0 111.811 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.6 -50.68 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.071 1.748 . . . . 0.0 112.278 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.12 -49.7 73.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.328 0.967 . . . . 0.0 110.82 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -53.12 -54.95 28.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.342 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -30.69 69.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.011 2.124 . . . . 0.0 115.007 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.9 tp -57.16 -31.66 65.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.43 1.092 . . . . 0.0 109.882 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 t30 112.53 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.495 3.518 . . . . 0.0 109.199 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.26 150.28 28.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.54 163.7 35.47 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.364 2.709 . . . . 0.0 110.542 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -161.72 164.95 28.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.595 1.558 . . . . 0.0 110.119 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.2 148.57 48.18 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.055 -0.403 . . . . 0.0 111.21 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.9 m -113.71 117.5 31.69 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 111.32 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.3 t -92.93 122.53 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.119 0.968 . . . . 0.0 109.463 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -81.96 93.16 6.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.404 1.482 . . . . 0.0 111.546 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -77.6 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.574 1.15 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.43 -54.09 0.64 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.653 1.981 . . . . 0.0 112.862 169.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -67.32 -44.36 79.31 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 111.89 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -87.81 128.52 35.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.632 1.173 . . . . 0.0 111.167 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.25 -40.55 86.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 113.341 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -61.79 -41.67 98.03 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.814 0.846 . . . . 0.0 111.22 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.88 -48.16 69.61 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.507 0.723 . . . . 0.0 110.745 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.35 -40.81 62.43 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.221 1.008 . . . . 0.0 112.305 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.22 -36.97 24.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.608 1.163 . . . . 0.0 113.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.62 -23.0 37.74 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.24 174.68 6.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.493 1.146 . . . . 0.0 111.478 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 73.6 -53.07 0.7 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.581 2.352 . . . . 0.0 110.085 -169.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -70.07 -38.71 75.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.63 1.572 . . . . 0.0 112.327 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -63.48 -49.53 73.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -97.01 -15.82 20.88 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p 80.52 -9.47 1.36 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 129.477 3.111 . . . . 0.0 114.227 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -68.7 132.03 91.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.211 -0.93 . . . . 0.0 111.382 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.21 -36.0 2.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.11 2.54 . . . . 0.0 115.007 -169.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -140.57 90.93 2.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.801 0.728 . . . . 0.0 111.454 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -60.77 158.74 30.34 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.303 1.441 . . . . 0.0 110.814 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.46 162.25 37.53 Favored 'Cis proline' 0 C--N 1.358 1.035 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 1.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 152.65 7.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.128 1.371 . . . . 0.0 112.53 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -93.77 146.78 23.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.046 1.339 . . . . 0.0 111.196 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -138.58 138.73 38.2 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.013 2.125 . . . . 0.0 110.675 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -143.29 127.18 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.307 1.443 . . . . 0.0 111.632 -172.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 51.87 23.15 1.98 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.28 41.96 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.809 1.195 . . . . 0.0 115.32 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.32 150.21 45.13 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.209 1.504 . . . . 0.0 111.215 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.83 150.04 29.31 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.989 -1.069 . . . . 0.0 111.967 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -97.72 -47.55 5.56 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.215 1.006 . . . . 0.0 111.638 173.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 145.95 -172.55 26.57 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.287 1.422 . . . . 0.0 112.81 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.26 164.18 41.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.413 1.006 . . . . 0.0 113.544 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.0 m -66.89 -41.75 86.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.625 -0.927 . . . . 0.0 112.874 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.02 -43.91 94.95 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.403 -0.811 . . . . 0.0 111.306 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.92 -42.1 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 109.978 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.2 m -63.0 -43.02 99.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.041 1.336 . . . . 0.0 111.581 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.8 t -60.02 -45.46 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.467 0.707 . . . . 0.0 111.346 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -71.32 -32.78 69.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.912 0.778 . . . . 0.0 112.82 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.73 80.09 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.011 -1.056 . . . . 0.0 112.783 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -63.3 -43.31 98.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.811 0.845 . . . . 0.0 112.071 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.19 -32.86 74.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.991 0.516 . . . . 0.0 112.222 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -86.92 -11.76 49.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.408 1.083 . . . . 0.0 113.614 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.81 -0.16 87.81 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.525 1.536 . . . . 0.0 114.582 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.83 -36.1 59.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 111.251 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.5 tp -64.42 -43.64 93.74 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.675 -0.641 . . . . 0.0 110.708 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -55.69 -48.39 75.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.454 0.702 . . . . 0.0 110.552 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.52 -47.89 82.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.358 0.663 . . . . 0.0 111.899 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -73.47 -35.03 65.65 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.28 -42.34 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.473 1.033 . . . . 0.0 110.793 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.01 -45.97 89.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.277 0.944 . . . . 0.0 111.03 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.83 -43.75 94.42 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.605 -0.685 . . . . 0.0 111.993 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.41 92.79 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.173 0.989 . . . . 0.0 112.868 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.02 -35.47 74.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.242 1.017 . . . . 0.0 112.549 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.19 -38.09 87.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.302 0.641 . . . . 0.0 112.059 170.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.732 2.413 . . . . 0.0 112.578 170.909 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.6 -101.38 0.11 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.54 1.136 . . . . 0.0 109.1 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.88 157.06 36.99 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.55 0.74 . . . . 0.0 109.724 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -69.12 145.27 96.18 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.95 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.41 -34.86 73.22 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.993 2.462 . . . . 0.0 112.43 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.03 -47.7 85.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.35 1.06 . . . . 0.0 113.065 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.86 -47.04 79.34 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.97 0.804 . . . . 0.0 110.354 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.76 -43.83 90.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.023 0.529 . . . . 0.0 111.633 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.9 m -65.48 -43.89 88.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.042 1.737 . . . . 0.0 111.566 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -61.8 -53.4 56.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.941 0.897 . . . . 0.0 110.425 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.81 -50.16 75.01 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.625 0.77 . . . . 0.0 111.36 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -56.53 -49.19 75.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 112.359 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.88 -46.31 85.49 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.563 -0.711 . . . . 0.0 111.966 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.48 -48.28 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.86 0.755 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.37 -20.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 p -93.41 -37.31 12.05 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.976 0.807 . . . . 0.0 112.932 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 t -74.04 -43.02 59.37 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.87 0.759 . . . . 0.0 112.317 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -97.43 -10.54 25.24 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mttm 63.09 -40.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.072 2.549 . . . . 0.0 116.139 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -120.79 128.11 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.066 1.746 . . . . 0.0 108.731 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.09 139.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.49 0.586 . . . . 0.0 112.422 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.17 129.45 56.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.171 1.388 . . . . 0.0 110.643 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -107.53 128.92 54.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.967 0.907 . . . . 0.0 111.04 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -162.58 -175.56 4.54 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.858 1.663 . . . . 0.0 110.851 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -76.6 51.48 0.74 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.25 -1.531 . . . . 0.0 112.412 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.96 168.02 30.42 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.695 1.14 . . . . 0.0 114.305 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.7 p -113.15 -175.73 2.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.258 1.823 . . . . 0.0 111.401 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.88 -32.76 74.61 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.543 -0.723 . . . . 0.0 112.119 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.46 -32.72 42.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.834 1.253 . . . . 0.0 112.667 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -122.81 77.68 48.98 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.217 1.407 . . . . 0.0 110.636 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 164.85 33.07 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -107.34 138.35 43.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.999 0.919 . . . . 0.0 111.755 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.4 m -66.48 157.93 30.85 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.068 1.347 . . . . 0.0 113.849 -172.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 -118.92 4.73 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.392 0.996 . . . . 0.0 112.271 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -59.1 -46.17 88.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.295 1.038 . . . . 0.0 112.883 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.7 m -69.79 -44.21 70.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.906 -1.121 . . . . 0.0 112.146 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.19 -46.66 69.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.755 1.222 . . . . 0.0 110.832 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -59.9 -50.37 74.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.416 1.086 . . . . 0.0 110.539 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 t -61.56 -44.56 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.246 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.82 -34.89 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.424 1.465 . . . . 0.0 111.545 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -68.03 -37.43 81.35 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.242 0.928 . . . . 0.0 112.524 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.68 -51.41 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.774 1.23 . . . . 0.0 110.777 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.55 -51.27 70.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.804 0.729 . . . . 0.0 111.266 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -47.24 -59.2 3.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.087 0.555 . . . . 0.0 109.991 174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m -62.97 -33.97 76.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.602 1.961 . . . . 0.0 114.103 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.81 -21.4 66.41 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.295 1.438 . . . . 0.0 111.951 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 109.02 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 131.51 3.924 . . . . 0.0 110.697 169.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 136.53 24.31 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -169.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -83.58 48.18 2.55 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.549 3.5 . . . . 0.0 109.665 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.44 164.53 18.56 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -169.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -130.89 170.05 14.95 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.722 1.609 . . . . 0.0 110.038 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -147.99 137.64 22.43 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.088 -1.632 . . . . 0.0 110.761 170.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.4 140.49 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.106 0.962 . . . . 0.0 110.529 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.49 142.99 35.33 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.0 pt -89.01 -174.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.432 1.093 . . . . 0.0 109.718 168.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt 71.16 174.91 0.3 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.553 2.341 . . . . 0.0 113.869 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 78.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.527 2.731 . . . . 0.0 110.854 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.95 141.5 54.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.636 0.774 . . . . 0.0 111.007 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.65 -37.91 74.17 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.034 -1.041 . . . . 0.0 113.429 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.21 -26.41 66.6 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.072 -1.018 . . . . 0.0 111.75 176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.82 -15.96 40.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.418 1.087 . . . . 0.0 113.237 170.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -80.57 -51.96 8.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.094 1.316 . . . . 0.0 111.677 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.39 -20.78 8.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -170.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.08 -30.72 69.62 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 120.975 -1.078 . . . . 0.0 113.388 -170.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.85 -41.27 91.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.765 1.283 . . . . 0.0 111.52 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.47 -45.38 91.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.72 -0.612 . . . . 0.0 110.834 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -68.72 -38.53 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.311 0.644 . . . . 0.0 112.736 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -70.04 -44.96 68.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.988 0.813 . . . . 0.0 112.531 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.99 -17.96 33.89 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m 69.81 -5.42 1.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.297 2.239 . . . . 0.0 113.756 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -74.93 127.56 86.67 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.764 1.226 . . . . 0.0 111.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.6 143.33 21.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.154 2.569 . . . . 0.0 110.27 172.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p 64.53 -161.35 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.782 2.033 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -146.19 163.56 29.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.79 2.036 . . . . 0.0 110.675 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.16 172.64 17.17 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 120.229 1.117 . . . . 0.0 114.875 -6.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.78 121.89 21.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.815 1.246 . . . . 0.0 108.435 170.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.14 123.38 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.181 0.992 . . . . 0.0 109.541 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -106.48 134.74 49.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.615 1.566 . . . . 0.0 110.911 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.3 pt -129.96 112.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 111.306 172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.43 17.57 4.94 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.556 1.942 . . . . 0.0 114.469 172.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.07 -3.53 41.04 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.155 1.836 . . . . 0.0 114.62 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -100.99 149.14 24.23 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 111.402 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -103.16 132.2 49.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.253 1.421 . . . . 0.0 111.046 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -99.28 -28.86 13.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.128 0.971 . . . . 0.0 113.45 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.78 -156.8 18.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.468 1.508 . . . . 0.0 111.743 -169.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.44 169.19 41.05 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.704 1.145 . . . . 0.0 114.141 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.9 m -57.65 -34.31 69.22 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.15 -40.92 95.65 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.38 -0.825 . . . . 0.0 111.802 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.23 -40.92 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.678 0.791 . . . . 0.0 109.937 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 m -61.39 -44.64 96.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.046 0.938 . . . . 0.0 111.665 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.69 -43.62 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.324 0.65 . . . . 0.0 111.485 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.99 -41.73 95.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.259 0.936 . . . . 0.0 111.987 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.62 -31.26 71.15 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.76 0.824 . . . . 0.0 113.17 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -67.91 -35.74 78.98 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.985 -1.072 . . . . 0.0 111.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.29 -32.35 66.52 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.9 p -88.15 -15.75 35.25 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.734 1.152 . . . . 0.0 113.76 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.57 1.01 78.38 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 125.306 1.431 . . . . 0.0 113.955 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.89 -30.37 68.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.288 . . . . 0.0 111.999 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.62 -47.65 69.02 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.556 -0.715 . . . . 0.0 110.165 172.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -56.41 -47.46 78.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 110.923 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.79 -50.67 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.51 0.724 . . . . 0.0 111.852 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -73.1 -36.74 66.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.279 -0.888 . . . . 0.0 113.183 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.28 -38.32 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.367 0.985 . . . . 0.0 111.087 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.05 -46.35 91.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.273 0.942 . . . . 0.0 110.866 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.57 -36.26 80.13 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.402 -0.811 . . . . 0.0 112.738 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.69 -36.61 84.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.158 0.983 . . . . 0.0 112.683 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 72.9 mtm -73.18 -41.28 64.03 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.555 0.742 . . . . 0.0 112.254 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.87 -39.37 69.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 129.718 3.207 . . . . 0.0 115.76 -176.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 120.176 0.036 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.64 152.47 39.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.068 0.947 . . . . 0.0 112.58 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 mt 73.37 -51.33 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.579 2.751 . . . . 0.0 113.843 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.9 m -45.14 -53.99 15.27 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.682 2.393 . . . . 0.0 114.845 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.3 -12.47 19.02 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.372 2.048 . . . . 0.0 114.332 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.12 -72.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.375 0.988 . . . . 0.0 111.616 -174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.64 -62.61 1.62 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.516 1.127 . . . . 0.0 110.998 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -66.57 -30.72 71.08 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.62 -0.675 . . . . 0.0 112.172 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -63.32 -46.29 87.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.807 1.643 . . . . 0.0 111.668 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -65.29 -48.68 72.31 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.776 0.83 . . . . 0.0 110.651 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.11 -55.04 35.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.153 0.981 . . . . 0.0 110.735 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.85 -46.59 74.67 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 111.713 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.7 -51.59 69.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.796 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.78 -36.49 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.4 1.454 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.89 -13.9 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.924 1.238 . . . . 0.0 113.763 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -102.41 -38.15 7.72 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.22 0.918 . . . . 0.0 113.107 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 t -80.13 -50.57 10.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.988 0.813 . . . . 0.0 111.853 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -88.79 -15.09 35.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.34 -0.85 . . . . 0.0 112.731 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.04 -52.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.913 2.885 . . . . 0.0 115.241 172.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 t -102.08 116.83 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.43 1.492 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -135.64 133.34 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.148 0.431 . . . . 0.0 110.893 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.02 138.2 44.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.004 1.722 . . . . 0.0 109.2 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -125.18 117.61 24.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.53 1.132 . . . . 0.0 110.186 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -167.25 -170.5 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.99 2.116 . . . . 0.0 109.589 -176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -81.04 -32.37 34.12 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.218 1.372 . . . . 0.0 112.517 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 154.54 47.47 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.193 1.378 . . . . 0.0 113.387 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -96.8 -179.59 4.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.734 1.614 . . . . 0.0 110.789 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.47 -18.76 60.58 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.106 -0.996 . . . . 0.0 113.554 172.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.9 -27.64 23.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 112.355 171.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.38 72.77 80.64 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.733 1.613 . . . . 0.0 111.058 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.56 157.09 59.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.006 2.471 . . . . 0.0 110.994 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.03 126.91 33.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.204 0.602 . . . . 0.0 111.133 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.1 t -59.22 143.68 48.35 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.781 1.232 . . . . 0.0 112.178 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.07 -146.11 18.06 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.919 1.247 . . . . 0.0 111.61 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -55.45 -36.69 66.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -169.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 m -64.55 -47.07 80.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.898 1.226 . . . . 0.0 112.404 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -57.73 -43.76 85.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.307 0.958 . . . . 0.0 110.648 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 m -58.83 -46.95 86.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.114 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.4 -42.23 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.173 0.989 . . . . 0.0 112.13 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -59.91 -45.72 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.433 0.693 . . . . 0.0 110.872 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.68 -41.41 96.07 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.594 0.757 . . . . 0.0 111.912 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.49 -52.01 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 111.608 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.14 -50.29 68.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.801 0.728 . . . . 0.0 110.438 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -50.4 -56.36 11.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.798 0.839 . . . . 0.0 110.691 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.53 -31.56 70.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.35 1.86 . . . . 0.0 114.638 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.01 -29.18 68.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 0.0 110.659 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 112.88 63.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 130.163 3.385 . . . . 0.0 109.71 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.32 154.74 34.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.39 173.95 13.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.232 2.621 . . . . 0.0 110.336 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -161.15 145.87 13.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 109.773 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -123.33 95.2 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.919 0.888 . . . . 0.0 109.833 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.4 m -76.07 97.35 4.04 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.934 -1.104 . . . . 0.0 110.667 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.77 129.47 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.513 1.925 . . . . 0.0 110.137 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -74.41 107.59 6.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.83 0.852 . . . . 0.0 110.953 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.49 -28.75 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -20.4 49.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.331 1.052 . . . . 0.0 112.87 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.69 -42.83 93.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.207 1.403 . . . . 0.0 113.687 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -119.55 129.9 54.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.926 0.891 . . . . 0.0 111.551 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.4 -30.2 71.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.6 -52.47 17.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.992 0.814 . . . . 0.0 110.702 173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.46 -33.17 70.96 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.455 1.502 . . . . 0.0 112.417 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.07 -22.06 62.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.378 1.871 . . . . 0.0 113.523 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.47 -56.15 1.62 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.656 1.182 . . . . 0.0 113.427 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -19.03 79.82 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.42 -34.36 72.39 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.489 1.145 . . . . 0.0 112.584 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -59.04 -37.39 76.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.245 1.018 . . . . 0.0 112.523 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.96 -30.92 27.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.514 1.126 . . . . 0.0 112.179 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -62.6 -41.47 99.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.77 0.828 . . . . 0.0 112.447 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.5 p -82.12 -68.21 0.72 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.381 0.673 . . . . 0.0 111.953 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.2 m 123.31 -13.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 133.293 4.637 . . . . 0.0 111.099 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -70.45 128.32 91.3 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.059 1.344 . . . . 0.0 112.003 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.18 140.11 13.75 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.37 2.713 . . . . 0.0 110.625 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.6 p 64.9 -174.55 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.563 2.345 . . . . 0.0 113.108 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -138.32 159.96 65.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.139 1.776 . . . . 0.0 110.476 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.89 165.51 35.68 Favored 'Cis proline' 0 C--N 1.355 0.877 0 N-CA-C 115.739 1.399 . . . . 0.0 115.739 1.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -141.89 132.78 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.253 1.421 . . . . 0.0 109.559 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.59 138.19 40.61 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.026 1.331 . . . . 0.0 108.75 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -134.95 137.2 42.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.917 1.687 . . . . 0.0 110.773 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.2 124.53 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.973 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.34 49.78 5.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.917 2.087 . . . . 0.0 114.845 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.25 3.06 73.02 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.362 -1.243 . . . . 0.0 115.435 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.09 143.48 50.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.347 1.573 . . . . 0.0 111.835 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -82.97 142.4 31.41 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.754 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -94.44 -33.62 13.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.221 1.008 . . . . 0.0 112.101 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.31 -153.93 16.81 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.62 1.581 . . . . 0.0 112.008 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.98 162.36 37.04 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.398 0.999 . . . . 0.0 113.114 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.9 m -58.26 -33.72 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.16 -44.98 84.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 0.0 111.817 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.0 -42.47 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.934 0.893 . . . . 0.0 109.606 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.7 m -62.7 -46.42 88.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.369 1.068 . . . . 0.0 111.911 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.88 -41.89 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.388 0.54 . . . . 0.0 111.342 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.58 -34.23 65.01 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.977 0.808 . . . . 0.0 112.868 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.43 80.62 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.022 -1.049 . . . . 0.0 112.178 173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.11 -39.56 82.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.804 0.841 . . . . 0.0 112.437 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.74 -34.38 77.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.347 0.659 . . . . 0.0 111.971 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.07 -12.11 53.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.215 1.006 . . . . 0.0 113.571 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.49 -6.2 82.79 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 125.855 1.693 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -68.79 -37.41 79.27 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.01 1.324 . . . . 0.0 111.55 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.02 -40.73 96.69 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.933 -0.48 . . . . 0.0 111.17 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -60.74 -48.12 83.23 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.376 0.535 . . . . 0.0 109.8 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.2 -44.48 97.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.348 0.659 . . . . 0.0 112.01 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.28 -35.44 76.04 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.382 -0.824 . . . . 0.0 113.057 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.08 -41.39 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.528 1.058 . . . . 0.0 110.672 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -59.59 -45.78 90.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.352 0.978 . . . . 0.0 110.913 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -57.8 -43.05 85.39 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.472 -0.767 . . . . 0.0 111.674 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.19 66.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.85 -36.82 14.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.631 0.772 . . . . 0.0 113.021 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.92 -25.39 26.15 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.255 1.395 0 C-N-CA 128.163 2.585 . . . . 0.0 113.275 174.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 119.893 -0.098 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.99 48.03 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.7 tp -159.25 101.38 1.56 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.604 1.561 . . . . 0.0 108.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.5 p -92.62 159.96 35.44 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.751 1.22 . . . . 0.0 112.023 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.73 -36.37 94.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 112.705 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.65 91.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.87 -48.15 77.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.519 0.727 . . . . 0.0 110.421 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.39 -42.9 88.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.769 -0.582 . . . . 0.0 112.081 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -66.96 -38.94 87.02 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.243 1.817 . . . . 0.0 111.884 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -63.82 -49.89 71.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.175 0.99 . . . . 0.0 110.475 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.91 -43.7 95.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.07 0.948 . . . . 0.0 111.394 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.63 -45.13 92.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.075 0.852 . . . . 0.0 112.618 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.4 -42.57 96.22 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -0.934 . . . . 0.0 111.356 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -60.82 -48.63 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.277 -0.89 . . . . 0.0 111.583 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.02 -38.03 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.553 1.141 . . . . 0.0 113.44 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -81.34 -33.36 32.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.938 0.895 . . . . 0.0 112.824 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -77.59 -32.26 53.5 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.23 112.42 11.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.145 1.378 . . . . 0.0 110.437 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -59.86 -38.16 81.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.95 134.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.192 1.797 . . . . 0.0 109.171 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.24 130.52 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.464 1.106 . . . . 0.0 109.903 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.19 127.21 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.084 0.954 . . . . 0.0 110.272 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.99 124.47 52.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -164.91 -177.82 4.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.846 1.658 . . . . 0.0 110.433 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.61 38.1 0.61 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.46 -1.4 . . . . 0.0 113.114 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.83 160.62 31.64 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 125.339 1.447 . . . . 0.0 113.368 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 p -96.93 -179.42 4.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.372 1.469 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.25 -29.75 68.63 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.608 -0.683 . . . . 0.0 112.337 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.55 -34.18 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.039 1.336 . . . . 0.0 112.502 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.01 76.2 67.13 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.612 1.565 . . . . 0.0 110.365 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.84 170.98 19.17 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.433 2.756 . . . . 0.0 111.569 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -114.02 136.51 52.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.98 0.912 . . . . 0.0 110.397 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.0 t -71.16 156.29 39.75 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.493 1.117 . . . . 0.0 112.313 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.49 -149.42 19.24 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 125.36 1.457 . . . . 0.0 111.803 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.03 -30.17 65.92 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -56.74 -53.37 58.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.314 1.446 . . . . 0.0 111.653 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.29 -40.29 89.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.373 -0.829 . . . . 0.0 110.653 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -58.59 -50.11 75.01 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.724 0.809 . . . . 0.0 111.321 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.21 -35.58 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.648 1.113 . . . . 0.0 112.517 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.27 -47.31 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.208 0.913 . . . . 0.0 111.054 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -65.04 -39.64 93.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.862 0.865 . . . . 0.0 112.312 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt -56.66 -49.49 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.59 1.156 . . . . 0.0 111.996 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.66 -51.33 67.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.078 0.854 . . . . 0.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -49.02 -57.06 7.16 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.458 0.703 . . . . 0.0 110.128 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 t -65.68 -33.58 76.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.832 2.053 . . . . 0.0 114.605 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.59 -28.31 67.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.819 0.736 . . . . 0.0 111.123 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 t30 110.96 57.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.96 3.304 . . . . 0.0 109.621 169.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 142.77 22.28 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.88 162.44 26.59 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.137 3.225 . . . . 0.0 110.499 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -163.65 165.94 22.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.255 1.022 . . . . 0.0 112.285 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.25 162.19 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 108.257 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.8 m -144.52 128.43 17.42 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 119.979 -1.701 . . . . 0.0 111.483 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.9 131.19 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.813 1.245 . . . . 0.0 110.289 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -75.7 110.02 9.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.136 0.574 . . . . 0.0 110.849 174.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -61.0 -29.74 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -87.57 8.13 26.52 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.671 1.188 . . . . 0.0 113.208 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.87 -31.07 71.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.955 0.902 . . . . 0.0 113.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.33 154.5 30.69 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.193 0.997 . . . . 0.0 111.693 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.716 1.207 . . . . 0.0 113.91 -169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.27 -31.85 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.39 -54.95 15.98 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.743 0.817 . . . . 0.0 110.963 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -57.87 -29.85 65.35 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.6 -37.99 11.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.98 -32.19 27.03 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 118.904 0.775 . . . . 0.0 113.428 -172.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.38 -36.94 74.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.881 0.872 . . . . 0.0 112.222 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.29 -53.34 45.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.151 1.38 . . . . 0.0 112.63 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -81.66 -23.88 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -67.08 -48.86 66.94 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.937 0.79 . . . . 0.0 112.471 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.0 p -77.84 -46.8 20.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.017 0.826 . . . . 0.0 112.081 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m 122.87 -26.11 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 1 C-N-CA 132.879 4.471 . . . . 0.0 112.693 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.08 142.14 68.3 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.514 -0.741 . . . . 0.0 112.034 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.12 -13.17 11.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.027 2.485 . . . . 0.0 116.162 -169.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -138.67 169.25 18.12 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.892 1.224 . . . . 0.0 112.521 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -137.06 155.85 75.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.737 1.615 . . . . 0.0 110.719 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.17 156.6 47.72 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.602 1.251 . . . . 0.0 115.281 -1.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.73 134.76 8.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.338 1.055 . . . . 0.0 110.968 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.48 140.99 38.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 111.197 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -131.97 132.6 43.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.252 1.821 . . . . 0.0 109.239 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.28 125.21 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.204 1.002 . . . . 0.0 109.348 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.3 22.83 5.09 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.34 48.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.308 0.956 . . . . 0.0 114.932 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.13 145.13 45.5 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.001 1.4 . . . . 0.0 110.993 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -76.87 143.9 39.36 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.265 -0.897 . . . . 0.0 111.97 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -103.76 -26.75 12.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.512 1.125 . . . . 0.0 112.055 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.36 -168.66 12.95 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 125.427 1.489 . . . . 0.0 113.55 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.36 172.67 55.12 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.789 1.185 . . . . 0.0 114.085 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 83.6 m -65.83 -41.99 91.11 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -63.45 -42.65 98.66 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.73 0.696 . . . . 0.0 111.376 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.63 -42.79 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 0.0 109.987 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -64.0 -42.78 97.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.935 1.294 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.39 -39.95 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.062 0.945 . . . . 0.0 111.519 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.22 -39.5 82.37 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.453 1.024 . . . . 0.0 112.435 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.68 91.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.72 0.808 . . . . 0.0 112.352 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -61.33 -45.2 95.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.243 1.417 . . . . 0.0 112.313 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -67.51 -29.17 68.52 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.966 0.906 . . . . 0.0 112.636 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -88.01 -12.85 43.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.459 1.104 . . . . 0.0 113.446 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.17 -1.44 87.62 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.65 1.595 . . . . 0.0 114.428 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.93 -35.29 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 111.822 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -49.06 76.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.423 0.689 . . . . 0.0 110.042 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -56.72 -49.03 76.4 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.122 0.969 . . . . 0.0 110.711 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.05 -46.91 88.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.405 0.682 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.94 -36.17 77.64 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.51 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.543 1.065 . . . . 0.0 110.751 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.58 -46.52 89.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.703 1.138 . . . . 0.0 111.36 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.11 -39.95 88.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.922 . . . . 0.0 112.555 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.05 78.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.572 -0.705 . . . . 0.0 111.966 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 mmt -67.27 -38.19 84.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.865 0.866 . . . . 0.0 112.805 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.5 -23.97 42.61 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.255 1.373 0 C-N-CA 127.265 2.226 . . . . 0.0 112.811 177.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.751 -0.643 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.91 79.95 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.17 156.7 16.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.138 1.375 . . . . 0.0 109.858 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -81.53 154.78 71.43 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.655 0.782 . . . . 0.0 111.243 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.31 -37.43 95.2 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.122 2.548 . . . . 0.0 112.151 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.29 96.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.442 1.097 . . . . 0.0 112.902 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.43 -54.43 43.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.819 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.26 -37.71 84.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -65.05 -40.99 95.54 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.883 1.673 . . . . 0.0 111.887 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.9 m -63.42 -48.18 78.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.861 0.864 . . . . 0.0 110.737 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.63 -49.32 77.95 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.247 0.619 . . . . 0.0 111.565 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.81 -45.16 86.53 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.668 0.787 . . . . 0.0 112.373 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -61.4 -44.66 96.76 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 111.787 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.9 -46.95 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.201 0.909 . . . . 0.0 111.484 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -60.19 -43.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 112.107 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -78.36 -29.05 47.26 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 m -79.96 -39.03 31.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.28 -10.97 12.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 60.97 -58.87 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.059 2.544 . . . . 0.0 114.813 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.46 125.77 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.414 1.486 . . . . 0.0 108.877 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.79 128.07 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.018 0.927 . . . . 0.0 110.761 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.42 142.13 34.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.038 1.335 . . . . 0.0 110.32 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.16 119.23 35.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.525 1.53 . . . . 0.0 109.624 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -174.19 -169.16 0.44 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.677 1.991 . . . . 0.0 110.038 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -91.59 -18.44 24.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.01 156.06 30.72 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.154 1.359 . . . . 0.0 113.143 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.7 p -86.85 177.31 7.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.073 1.349 . . . . 0.0 111.446 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.67 -28.78 69.84 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -87.68 -33.3 18.82 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.02 1.328 . . . . 0.0 112.475 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -120.56 84.7 36.85 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.13 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 139.35 52.03 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.523 2.149 . . . . 0.0 108.868 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -0.31 56.25 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.0 t -160.24 163.44 33.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.146 1.379 . . . . 0.0 111.613 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.61 -32.59 84.68 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.029 0.823 . . . . 0.0 113.058 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -73.3 -46.26 50.63 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.332 1.066 . . . . 0.0 112.364 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -62.31 -45.67 92.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.562 -0.712 . . . . 0.0 110.914 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.76 -46.72 74.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.094 0.958 . . . . 0.0 111.279 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.6 m -59.34 -51.61 69.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.092 0.957 . . . . 0.0 110.762 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.81 -37.89 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.846 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.16 -34.14 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 120.656 1.571 . . . . 0.0 111.92 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.02 -44.34 89.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.637 0.653 . . . . 0.0 111.223 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.04 -51.69 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 111.034 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.0 -50.61 71.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.401 1.08 . . . . 0.0 110.591 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.79 -51.43 68.97 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.184 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -68.23 -32.7 73.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.433 1.493 . . . . 0.0 114.05 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.45 -32.67 70.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.908 1.283 . . . . 0.0 110.609 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 118.7 72.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 129.989 3.316 . . . . 0.0 110.711 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.45 140.9 13.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.96 158.39 34.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.141 2.561 . . . . 0.0 108.248 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.88 172.6 17.76 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.51 155.3 42.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.911 1.284 . . . . 0.0 110.367 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -118.26 129.87 55.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.44 -0.787 . . . . 0.0 110.821 172.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -97.06 121.89 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.661 1.184 . . . . 0.0 108.485 173.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -74.23 90.47 2.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.593 1.157 . . . . 0.0 110.191 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pt -69.81 -17.51 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 -1.92 55.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.717 1.207 . . . . 0.0 113.116 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -64.25 -28.77 69.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.141 0.882 . . . . 0.0 112.975 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -159.27 162.27 36.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.242 1.417 . . . . 0.0 112.111 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.85 -31.58 70.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.533 -0.729 . . . . 0.0 112.781 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.63 -39.83 95.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.83 0.741 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.52 -51.49 56.08 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.89 -0.506 . . . . 0.0 110.914 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -56.01 -44.99 79.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.216 1.006 . . . . 0.0 112.858 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -83.34 -24.82 31.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.646 0.778 . . . . 0.0 112.658 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.57 -40.02 6.51 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.296 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.17 -33.55 74.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.493 1.647 . . . . 0.0 113.401 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -60.82 -31.38 70.79 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -83.45 -34.85 25.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.185 0.994 . . . . 0.0 112.158 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.23 -42.32 94.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.217 1.007 . . . . 0.0 112.337 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.9 p -83.47 -67.54 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.829 0.852 . . . . 0.0 112.695 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.6 m 135.05 -23.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 133.341 4.657 . . . . 0.0 111.218 -173.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -83.81 132.17 49.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.23 1.012 . . . . 0.0 111.775 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.02 -25.83 2.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.826 2.351 . . . . 0.0 114.72 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -95.93 151.55 19.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.563 1.145 . . . . 0.0 111.521 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -127.83 151.12 75.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.652 1.581 . . . . 0.0 110.605 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.79 155.95 52.55 Favored 'Cis proline' 0 C--N 1.355 0.869 0 CA-C-N 120.694 1.283 . . . . 0.0 114.422 -2.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -150.49 143.08 24.5 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.987 0.915 . . . . 0.0 110.728 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 tp -110.32 146.81 35.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.317 1.447 . . . . 0.0 111.458 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -148.76 137.81 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.825 2.05 . . . . 0.0 109.392 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -142.62 122.54 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.183 -0.948 . . . . 0.0 111.611 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.83 33.64 6.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.563 1.945 . . . . 0.0 115.284 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.95 -0.78 51.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.813 1.197 . . . . 0.0 115.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.51 141.0 48.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.033 1.417 . . . . 0.0 110.763 173.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -84.1 144.25 29.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.448 -0.783 . . . . 0.0 110.669 170.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.93 -31.69 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.969 0.908 . . . . 0.0 112.285 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.48 -151.2 17.06 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.055 1.312 . . . . 0.0 112.134 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.58 162.69 49.38 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 124.157 0.884 . . . . 0.0 112.934 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -56.23 -35.89 67.86 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.3 -39.97 84.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.633 0.773 . . . . 0.0 112.036 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.39 -42.22 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.406 0.682 . . . . 0.0 109.848 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 m -62.07 -47.27 85.45 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.469 1.108 . . . . 0.0 111.051 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.11 -44.72 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 0.0 111.338 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.35 -37.26 77.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.897 0.771 . . . . 0.0 112.444 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -29.91 70.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 113.048 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -70.85 -33.6 70.81 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.339 -0.851 . . . . 0.0 112.267 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.55 -40.38 76.85 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.9 p -81.05 -17.53 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.201 -0.937 . . . . 0.0 113.208 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.79 69.83 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.336 1.446 . . . . 0.0 113.57 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -36.93 84.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.95 1.3 . . . . 0.0 111.889 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.61 -40.68 97.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.321 0.648 . . . . 0.0 111.189 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.97 -44.34 94.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.965 0.506 . . . . 0.0 110.039 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -61.92 -44.17 97.33 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.326 173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -69.22 -38.84 78.76 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.796 1.18 . . . . 0.0 112.439 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.86 -39.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 118.859 0.754 . . . . 0.0 110.626 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.85 -45.88 92.78 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.132 0.878 . . . . 0.0 111.37 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -59.15 -44.85 92.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.97 0.908 . . . . 0.0 111.772 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.04 96.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.755 1.222 . . . . 0.0 112.807 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.9 mmt -73.57 -33.98 64.92 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.333 -0.854 . . . . 0.0 112.092 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.67 -47.0 70.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.037 0.935 . . . . 0.0 112.628 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.258 1.508 0 C-N-CA 128.755 2.822 . . . . 0.0 114.702 -175.249 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.21 -49.73 26.37 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.159 0.89 . . . . 0.0 111.7 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.6 -34.15 76.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.472 -0.768 . . . . 0.0 112.04 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -61.52 -42.56 98.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.422 1.889 . . . . 0.0 111.934 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.756 1.223 . . . . 0.0 110.933 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.82 -45.6 85.92 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.712 0.805 . . . . 0.0 111.312 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.19 -43.73 95.64 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.239 0.927 . . . . 0.0 112.389 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -60.41 -42.93 97.0 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.352 -0.843 . . . . 0.0 111.892 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.12 -48.97 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 119.175 0.898 . . . . 0.0 111.148 173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.84 -38.25 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.051 1.34 . . . . 0.0 112.853 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -81.8 -28.83 32.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 0.0 112.834 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -78.1 -31.2 49.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -138.06 114.78 10.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.412 1.485 . . . . 0.0 109.737 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -66.56 -20.67 66.07 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.1 t -119.62 123.71 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.793 1.237 . . . . 0.0 109.119 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.64 139.09 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.344 1.058 . . . . 0.0 109.563 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.91 135.72 54.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.311 1.444 . . . . 0.0 110.02 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.57 116.64 29.11 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.353 1.061 . . . . 0.0 108.775 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ptm -162.16 176.05 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.492 1.517 . . . . 0.0 110.791 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.56 26.97 0.75 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.711 -1.243 . . . . 0.0 113.617 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.42 169.79 39.35 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.6 1.572 . . . . 0.0 113.266 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.2 p -97.75 176.37 5.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.072 1.349 . . . . 0.0 111.272 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -66.43 -26.32 67.17 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.804 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -86.29 -27.0 24.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.468 1.507 . . . . 0.0 112.401 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.93 78.51 59.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 0.0 110.678 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.11 178.99 1.64 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.322 3.348 . . . . 0.0 113.622 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -130.36 138.08 50.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.552 1.141 . . . . 0.0 109.688 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.18 160.99 28.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.651 1.18 . . . . 0.0 113.661 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.78 -126.56 8.22 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.633 1.111 . . . . 0.0 111.527 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -56.12 -49.55 73.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.933 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -52.2 66.11 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 111.323 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -57.83 -39.11 76.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.393 0.677 . . . . 0.0 111.337 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.5 m -63.27 -51.89 64.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.546 1.139 . . . . 0.0 110.935 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.24 -44.61 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.565 0.62 . . . . 0.0 111.088 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -61.28 -47.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.637 0.775 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -64.18 -40.5 96.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.224 1.01 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mt -59.71 -51.35 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.737 0.815 . . . . 0.0 111.291 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.17 -46.83 82.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.627 0.771 . . . . 0.0 111.286 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -52.6 -52.46 55.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.352 0.661 . . . . 0.0 110.727 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.5 m -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.527 1.931 . . . . 0.0 114.684 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.46 -39.46 76.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.711 0.804 . . . . 0.0 109.701 170.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 t30 123.74 68.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.979 3.712 . . . . 0.0 109.546 169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.93 152.56 28.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.28 178.49 7.56 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.675 2.916 . . . . 0.0 110.21 169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -163.48 141.2 7.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.856 1.263 . . . . 0.0 111.189 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.31 92.2 3.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.214 1.005 . . . . 0.0 109.663 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.9 m -75.37 111.57 10.78 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.98 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.6 t -92.73 126.77 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.604 1.962 . . . . 0.0 108.543 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -78.5 113.05 16.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.58 -25.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -4.28 58.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -173.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -74.45 -18.88 60.57 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -156.81 128.56 7.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.477 1.111 . . . . 0.0 110.657 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.8 -25.94 67.8 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.269 -0.894 . . . . 0.0 112.869 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.93 -30.7 69.22 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.202 -0.937 . . . . 0.0 112.393 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.51 -53.92 12.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.213 0.915 . . . . 0.0 108.993 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.86 66.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.71 -44.07 11.44 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.702 0.801 . . . . 0.0 112.41 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.16 -30.87 56.52 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-O 119.05 -0.861 . . . . 0.0 114.566 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.58 -20.63 66.05 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.141 1.471 . . . . 0.0 113.686 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -68.3 -38.65 81.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.12 0.968 . . . . 0.0 111.678 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.39 -29.31 30.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.399 1.08 . . . . 0.0 112.517 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.69 -34.33 72.73 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.98 1.312 . . . . 0.0 112.529 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -94.51 -58.58 2.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.663 1.585 . . . . 0.0 112.934 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t 107.8 -2.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 131.886 4.075 . . . . 0.0 110.406 -169.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -88.98 131.7 40.36 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.293 1.837 . . . . 0.0 111.602 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.19 142.64 12.24 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.636 2.891 . . . . 0.0 111.556 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 p 74.33 165.13 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 128.54 2.736 . . . . 0.0 114.09 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.61 159.21 59.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.03 1.732 . . . . 0.0 111.115 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.64 160.65 49.19 Favored 'Cis proline' 0 C--N 1.354 0.865 0 CA-C-N 120.159 1.093 . . . . 0.0 114.91 -2.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -140.19 130.36 25.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.935 1.294 . . . . 0.0 110.058 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.86 137.86 36.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.987 1.715 . . . . 0.0 109.641 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -140.53 136.8 33.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.158 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -144.82 128.62 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.159 1.384 . . . . 0.0 112.615 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 46.3 31.95 1.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.494 2.318 . . . . 0.0 115.883 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.54 10.58 37.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.227 -1.318 . . . . 0.0 115.686 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -147.06 149.07 32.34 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.694 1.747 . . . . 0.0 112.193 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -79.7 150.79 30.77 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.347 -0.845 . . . . 0.0 111.504 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -105.9 -33.73 7.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.929 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.0 -153.61 18.51 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.099 1.333 . . . . 0.0 113.382 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.66 -177.74 42.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.795 1.188 . . . . 0.0 114.135 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.7 t -63.15 -43.02 99.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 113.13 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.33 -46.38 88.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.978 0.808 . . . . 0.0 111.258 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.32 -45.46 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.834 0.853 . . . . 0.0 110.19 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.3 m -62.56 -47.62 83.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.056 1.342 . . . . 0.0 110.957 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.08 -46.15 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.857 1.263 . . . . 0.0 111.23 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.75 -38.55 80.2 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.898 0.772 . . . . 0.0 111.76 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.37 80.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.531 0.732 . . . . 0.0 112.666 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.9 -40.49 95.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.022 0.929 . . . . 0.0 112.268 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.533 1.133 . . . . 0.0 112.889 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.4 m -85.69 -11.91 52.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.043 0.937 . . . . 0.0 113.499 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.05 85.03 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.516 1.532 . . . . 0.0 114.059 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.43 -41.65 65.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 111.566 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.88 -42.01 97.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.506 -0.746 . . . . 0.0 110.033 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -59.7 -48.86 80.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.07 0.548 . . . . 0.0 109.691 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.16 -50.86 71.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.318 1.047 . . . . 0.0 111.918 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -72.14 -32.27 66.76 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.17 -39.6 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.393 0.997 . . . . 0.0 111.024 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.34 -43.21 99.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.842 1.201 . . . . 0.0 111.252 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.16 -39.6 86.96 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.382 -0.823 . . . . 0.0 112.366 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.33 -29.52 70.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.876 0.87 . . . . 0.0 113.186 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.3 mmt -76.8 -48.93 17.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.73 0.695 . . . . 0.0 112.138 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.3 p -80.05 -25.73 40.01 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 126.806 2.043 . . . . 0.0 112.344 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -54.8 -49.25 71.43 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 110.019 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -59.72 -41.21 90.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.653 1.115 . . . . 0.0 112.367 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -62.42 -41.62 98.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.146 1.778 . . . . 0.0 111.905 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -68.81 -46.85 67.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.033 1.333 . . . . 0.0 110.738 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.78 -53.55 53.73 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.194 1.797 . . . . 0.0 110.634 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.25 -47.53 78.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.222 1.009 . . . . 0.0 111.904 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -59.2 -42.25 90.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.237 0.615 . . . . 0.0 112.618 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.63 -43.56 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.52 -41.32 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.388 1.075 . . . . 0.0 112.63 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.3 p -78.93 -38.28 37.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.581 1.082 . . . . 0.0 112.587 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -73.91 -33.99 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -113.26 -7.35 13.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 61.05 -63.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 127.711 2.405 . . . . 0.0 114.47 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -91.57 121.1 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.008 1.323 . . . . 0.0 109.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.41 147.74 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.427 0.691 . . . . 0.0 110.847 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 125.63 47.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.707 1.603 . . . . 0.0 109.185 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -94.91 116.74 29.09 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptm -156.63 170.8 21.57 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 111.748 -169.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.47 -13.63 25.98 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.23 -163.89 25.59 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.753 1.644 . . . . 0.0 112.913 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.3 p -128.32 175.18 8.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.767 1.627 . . . . 0.0 111.439 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.66 -31.02 72.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.748 1.219 . . . . 0.0 111.958 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.3 -29.79 28.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.935 1.294 . . . . 0.0 112.915 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -138.06 84.29 21.2 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.4 1.48 . . . . 0.0 111.323 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.09 165.37 19.47 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.693 2.929 . . . . 0.0 112.396 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -80.06 124.86 29.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.4 m -58.04 138.52 55.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.762 0.825 . . . . 0.0 111.294 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.88 -119.53 5.79 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -52.47 -65.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.425 1.49 . . . . 0.0 114.16 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -64.4 -42.92 95.83 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.92 -45.72 82.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.24 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -61.48 -48.39 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.138 0.975 . . . . 0.0 110.431 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.72 -50.29 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.681 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.37 -31.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 119.24 0.927 . . . . 0.0 112.341 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.01 -45.71 84.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.694 0.679 . . . . 0.0 110.736 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.96 -50.58 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.853 0.861 . . . . 0.0 111.237 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.52 -50.3 74.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.813 0.733 . . . . 0.0 111.219 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -57.07 -52.91 63.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.029 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 t -66.34 -33.29 75.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 114.024 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -57.61 -34.22 69.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.446 1.098 . . . . 0.0 110.874 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 117.71 64.7 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.519 3.528 . . . . 0.0 109.887 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.81 154.61 31.54 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.93 172.44 16.18 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.549 2.833 . . . . 0.0 111.063 170.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.25 146.83 15.75 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.506 1.522 . . . . 0.0 110.459 170.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.3 118.29 35.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.205 0.602 . . . . 0.0 111.076 169.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -76.11 82.43 2.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.246 1.018 . . . . 0.0 110.413 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.22 104.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.02 119.93 20.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.017 0.527 . . . . 0.0 111.739 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -74.79 -34.81 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.79 -38.4 70.27 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.35 -21.63 59.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -99.02 -49.48 4.5 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.787 0.835 . . . . 0.0 113.115 -176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 69.0 -34.64 0.28 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.062 2.545 . . . . 0.0 115.772 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -42.86 99.35 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.919 -1.113 . . . . 0.0 109.693 170.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.09 -45.99 92.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.031 1.332 . . . . 0.0 111.652 169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -56.91 -39.76 75.04 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.431 1.092 . . . . 0.0 112.677 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -89.89 -33.91 16.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.1 -34.62 9.6 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 123.977 0.798 . . . . 0.0 114.727 -172.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -29.75 69.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.313 1.556 . . . . 0.0 110.984 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -63.5 -27.69 69.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.29 -1.506 . . . . 0.0 113.085 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -78.54 -37.55 42.59 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.007 0.821 . . . . 0.0 111.549 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -66.72 -35.22 79.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.426 1.09 . . . . 0.0 113.26 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.6 p -108.81 -14.1 14.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 114.937 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.1 m 66.53 6.17 4.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.527 1.931 . . . . 0.0 113.95 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -74.94 141.65 75.31 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.599 1.56 . . . . 0.0 113.155 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 -49.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.81 2.34 . . . . 0.0 114.105 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.4 p -149.74 125.86 10.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.138 0.975 . . . . 0.0 112.178 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.75 158.94 72.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.001 1.32 . . . . 0.0 112.396 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -64.43 163.26 59.28 Favored 'Cis proline' 0 C--N 1.357 0.982 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 2.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -149.16 134.47 18.37 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.999 0.92 . . . . 0.0 110.524 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.05 139.31 30.75 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.964 1.305 . . . . 0.0 109.475 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -143.35 137.75 28.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.414 1.086 . . . . 0.0 110.221 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 mt -139.25 121.84 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.588 -0.695 . . . . 0.0 110.785 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t70 64.44 -22.68 0.07 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.202 3.001 . . . . 0.0 116.893 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.03 10.72 0.06 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.845 1.688 . . . . 0.0 115.277 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.86 150.23 30.65 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.311 1.555 . . . . 0.0 111.074 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -73.53 141.75 46.72 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.889 -0.507 . . . . 0.0 111.026 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.94 -39.61 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.734 0.814 . . . . 0.0 111.836 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.53 -151.04 22.39 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.455 1.026 . . . . 0.0 113.942 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.25 -173.16 20.31 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.767 1.651 . . . . 0.0 113.387 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -60.98 -47.2 87.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.826 0.85 . . . . 0.0 112.842 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.05 -45.14 93.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.413 0.552 . . . . 0.0 111.587 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.45 -44.28 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.594 0.757 . . . . 0.0 109.998 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.1 m -62.89 -46.15 89.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.822 1.249 . . . . 0.0 111.198 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.97 -43.43 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.183 0.993 . . . . 0.0 111.252 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.97 -42.38 80.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.774 0.715 . . . . 0.0 111.973 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.36 79.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 112.771 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -66.39 -40.58 89.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.031 1.332 . . . . 0.0 112.304 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -70.98 -32.87 69.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.169 0.588 . . . . 0.0 112.436 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.69 -12.14 51.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.92 -0.1 87.62 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 125.404 1.478 . . . . 0.0 114.092 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.74 -36.58 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.468 1.107 . . . . 0.0 111.381 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.69 -46.44 85.5 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.884 -0.51 . . . . 0.0 110.176 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -56.75 -48.82 76.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.67 0.788 . . . . 0.0 110.986 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.07 -49.63 77.15 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.813 0.845 . . . . 0.0 111.668 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -71.43 -35.54 70.98 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.9 -42.08 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.679 1.127 . . . . 0.0 110.887 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.07 -43.05 99.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.048 0.84 . . . . 0.0 111.488 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -59.98 -42.48 94.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.343 -0.848 . . . . 0.0 111.866 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.05 72.79 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.235 0.925 . . . . 0.0 112.812 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.68 -54.36 7.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.743 0.817 . . . . 0.0 111.255 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.571 1.148 . . . . 0.0 113.058 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.916 2.486 . . . . 0.0 112.538 171.353 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.6 tp -67.33 -47.75 69.58 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.146 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -58.63 -37.26 75.53 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.303 0.956 . . . . 0.0 112.261 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.9 m -66.09 -41.65 90.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.508 1.923 . . . . 0.0 111.678 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.2 m -67.23 -45.89 75.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.625 1.17 . . . . 0.0 111.159 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 99.4 mt -56.92 -54.65 44.14 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.869 1.268 . . . . 0.0 110.343 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.71 -41.6 74.04 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.794 0.725 . . . . 0.0 112.153 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -61.7 -47.36 85.62 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.333 -0.855 . . . . 0.0 112.101 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.94 -36.76 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.414 1.461 . . . . 0.0 112.705 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.85 -40.77 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.712 1.205 . . . . 0.0 112.308 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -80.18 -45.39 18.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.571 0.748 . . . . 0.0 112.361 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 76.3 p -70.7 -38.86 73.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -100.77 -3.8 29.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.629 0.771 . . . . 0.0 112.921 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt 62.14 -59.53 0.12 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.344 2.658 . . . . 0.0 114.395 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.87 137.21 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.65 1.58 . . . . 0.0 108.977 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.04 142.25 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.453 0.701 . . . . 0.0 111.032 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.36 145.4 28.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.058 1.343 . . . . 0.0 110.768 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -123.8 116.18 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.928 1.691 . . . . 0.0 109.401 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -173.18 1.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.338 1.455 . . . . 0.0 112.311 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.19 -154.93 0.13 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.286 1.434 . . . . 0.0 113.31 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.79 -146.8 50.62 Favored Glycine 0 N--CA 1.481 1.689 0 O-C-N 120.574 -1.329 . . . . 0.0 113.605 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.5 p -128.62 175.61 8.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.537 1.535 . . . . 0.0 109.46 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.29 -14.56 63.08 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.718 -1.238 . . . . 0.0 112.903 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.34 -39.88 8.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.808 1.243 . . . . 0.0 113.53 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -90.04 119.37 69.32 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.961 0.904 . . . . 0.0 111.34 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 134.46 24.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.183 2.589 . . . . 0.0 112.334 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -80.35 -34.37 36.62 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.855 2.062 . . . . 0.0 112.982 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.55 153.58 2.35 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.331 2.252 . . . . 0.0 108.954 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.35 -35.77 89.3 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 123.731 0.682 . . . . 0.0 113.308 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.77 -51.66 61.11 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.25 1.025 . . . . 0.0 111.089 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -60.15 -43.17 95.97 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.368 -0.833 . . . . 0.0 111.939 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -59.95 -46.41 89.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.537 0.735 . . . . 0.0 110.792 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -59.85 -45.12 93.44 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.808 0.843 . . . . 0.0 110.729 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.07 -43.65 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.075 0.95 . . . . 0.0 112.413 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.81 -46.69 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 110.802 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -65.58 -38.49 89.69 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mt -59.09 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.645 1.578 . . . . 0.0 111.561 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.03 -48.28 79.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.338 0.972 . . . . 0.0 110.66 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -51.28 -56.53 12.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.19 70.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.432 2.293 . . . . 0.0 114.805 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.63 -29.89 66.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.926 1.291 . . . . 0.0 109.974 169.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.7 t30 109.58 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 130.309 3.444 . . . . 0.0 108.885 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.9 149.72 28.46 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 167.27 17.37 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.121 3.214 . . . . 0.0 110.101 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -169.16 158.67 8.52 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.619 1.568 . . . . 0.0 111.046 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 168.33 9.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.448 1.099 . . . . 0.0 110.327 175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -148.3 105.15 3.59 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 119.792 -1.817 . . . . 0.0 110.774 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -87.36 118.32 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.921 1.288 . . . . 0.0 108.378 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -86.01 101.27 12.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 109.126 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.47 -32.4 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.61 -24.89 66.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -168.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.15 -10.8 59.8 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -134.98 119.22 17.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.563 1.074 . . . . 0.0 113.354 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.1 -32.08 69.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.06 -41.56 81.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.902 0.881 . . . . 0.0 110.871 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.42 -49.16 74.82 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.204 0.602 . . . . 0.0 110.868 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -55.76 -43.68 76.92 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -82.34 -32.35 29.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.71 -38.33 12.14 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.373 0.987 . . . . 0.0 113.98 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.21 -26.42 65.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.552 1.176 . . . . 0.0 112.503 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.45 -37.63 81.59 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.658 0.783 . . . . 0.0 112.003 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.25 -44.3 38.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.89 0.876 . . . . 0.0 111.241 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -61.43 -41.56 97.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.208 1.003 . . . . 0.0 113.055 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.1 p -101.01 -18.87 16.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m 68.7 0.62 2.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.894 2.078 . . . . 0.0 114.561 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 74.2 t-105 -74.08 140.54 77.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 51.2 Cg_exo -63.58 -57.58 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.302 2.668 . . . . 0.0 115.259 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.8 p -149.01 122.49 9.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 112.386 -169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -64.52 157.59 71.89 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.015 1.326 . . . . 0.0 112.269 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.66 158.24 41.85 Favored 'Cis proline' 0 C--N 1.358 1.06 0 N-CA-C 116.07 1.527 . . . . 0.0 116.07 2.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.79 146.94 26.08 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.133 0.973 . . . . 0.0 111.299 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.0 141.5 47.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.627 1.571 . . . . 0.0 109.031 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -139.29 144.55 38.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 0.0 109.745 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.83 126.91 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.538 -0.726 . . . . 0.0 111.432 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.38 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 129.143 2.977 . . . . 0.0 117.86 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.44 4.91 0.12 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.657 1.598 . . . . 0.0 115.418 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -148.47 151.03 34.48 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.548 1.674 . . . . 0.0 111.596 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -73.09 147.56 44.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.353 0.596 . . . . 0.0 111.716 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -100.37 -40.14 7.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.402 1.081 . . . . 0.0 111.765 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.45 -155.63 22.64 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 125.571 1.558 . . . . 0.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.05 173.52 52.21 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.756 1.17 . . . . 0.0 113.752 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.44 -46.71 66.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.665 -0.903 . . . . 0.0 112.716 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.45 -40.27 90.58 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 111.641 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.6 -41.63 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.514 0.726 . . . . 0.0 110.242 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.2 m -63.85 -44.5 92.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.151 0.98 . . . . 0.0 111.956 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -57.85 -43.85 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.858 0.753 . . . . 0.0 111.108 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.11 -37.59 78.44 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.1 91.43 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 112.497 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -64.17 -42.04 96.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.259 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.13 -28.32 68.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.586 0.754 . . . . 0.0 112.497 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -87.48 -12.89 44.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.598 1.159 . . . . 0.0 113.581 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.66 0.34 84.13 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 125.616 1.579 . . . . 0.0 114.229 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.92 -37.66 64.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.79 1.236 . . . . 0.0 111.485 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.78 -45.48 89.55 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.624 -0.672 . . . . 0.0 110.812 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -56.72 -48.45 77.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 110.802 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.57 -48.53 81.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 0.0 111.797 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -70.21 -38.42 75.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.46 -40.59 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 119.564 1.074 . . . . 0.0 110.607 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.85 -46.11 90.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.534 0.607 . . . . 0.0 110.819 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -62.52 -35.95 81.05 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.092 -1.005 . . . . 0.0 112.661 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.3 -31.57 72.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.008 -1.058 . . . . 0.0 112.825 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.51 -46.8 9.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.319 1.047 . . . . 0.0 112.981 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.67 -18.92 21.62 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -172.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 130.568 3.547 . . . . 0.0 113.259 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.13 -56.51 20.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.999 0.919 . . . . 0.0 109.925 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -62.54 -38.5 90.26 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.4 m -64.7 -39.87 94.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 111.968 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.6 m -64.98 -51.52 61.28 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.572 0.749 . . . . 0.0 110.236 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.56 -42.79 93.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.942 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.89 -48.78 80.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.451 1.023 . . . . 0.0 112.395 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -62.24 -42.03 98.95 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.54 -0.725 . . . . 0.0 111.905 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.06 -56.33 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.093 0.957 . . . . 0.0 110.546 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -58.99 -45.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.622 1.169 . . . . 0.0 112.721 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -73.19 -41.72 63.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.565 0.746 . . . . 0.0 112.758 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -81.84 -32.31 31.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -15.7 30.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 59.56 -66.16 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.998 2.519 . . . . 0.0 114.057 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.32 122.31 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.388 1.875 . . . . 0.0 108.597 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.34 117.99 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.357 0.663 . . . . 0.0 110.391 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -96.42 128.01 42.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.065 0.946 . . . . 0.0 110.405 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.17 122.88 47.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.357 1.063 . . . . 0.0 109.991 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.58 -177.94 6.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.273 1.429 . . . . 0.0 111.434 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.72 37.97 0.31 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.593 -1.317 . . . . 0.0 112.76 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.59 -165.04 35.63 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 126.557 2.027 . . . . 0.0 112.016 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -156.93 -167.31 2.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.443 1.097 . . . . 0.0 110.892 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.42 -33.32 71.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.09 1.356 . . . . 0.0 113.012 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.82 -15.58 58.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.518 1.527 . . . . 0.0 113.778 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -148.3 70.8 10.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.642 1.577 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.76 146.31 48.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.032 2.488 . . . . 0.0 110.698 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -98.93 127.02 44.76 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.411 0.684 . . . . 0.0 110.218 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -65.94 155.07 37.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.565 1.146 . . . . 0.0 113.664 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.59 -118.38 4.79 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 124.237 0.922 . . . . 0.0 112.019 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -54.24 -58.6 6.76 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.748 1.219 . . . . 0.0 112.674 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -62.39 -46.51 88.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.606 -0.683 . . . . 0.0 111.746 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.38 -46.57 69.68 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.587 1.155 . . . . 0.0 111.092 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.0 m -65.59 -46.1 80.69 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.159 0.984 . . . . 0.0 110.843 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -44.16 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.201 0.91 . . . . 0.0 110.993 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.02 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.516 0.726 . . . . 0.0 111.032 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.62 -38.7 91.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.961 0.8 . . . . 0.0 112.453 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.49 -47.35 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.31 0.959 . . . . 0.0 110.889 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.36 -51.29 68.21 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.38 0.991 . . . . 0.0 111.218 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -49.14 -61.75 1.91 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.646 0.778 . . . . 0.0 110.522 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.9 p -68.5 -25.86 65.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.947 1.699 . . . . 0.0 115.049 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.92 -34.26 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.915 0.886 . . . . 0.0 109.318 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 115.58 55.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.218 3.407 . . . . 0.0 109.461 168.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.2 145.15 31.37 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.35 163.16 35.08 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.178 2.585 . . . . 0.0 110.742 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -160.84 162.39 32.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.541 1.536 . . . . 0.0 109.928 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.23 178.39 7.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.744 1.217 . . . . 0.0 108.739 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.0 m -150.92 159.6 44.45 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 119.727 -1.858 . . . . 0.0 112.963 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.89 133.94 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.305 1.042 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -79.12 118.02 20.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.382 0.673 . . . . 0.0 110.997 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.6 pt -69.35 -20.81 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.44 -3.99 49.1 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.07 -17.94 62.58 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.74 139.38 13.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.799 1.24 . . . . 0.0 111.211 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -64.65 -36.56 84.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.9 -43.81 97.78 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.644 -0.66 . . . . 0.0 111.022 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.35 -49.1 78.33 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.434 0.694 . . . . 0.0 111.036 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp85 -55.37 -38.85 69.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.108 0.963 . . . . 0.0 112.429 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -76.85 -50.22 13.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.664 1.186 . . . . 0.0 112.365 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.98 -26.8 54.93 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 115.591 0.997 . . . . 0.0 115.591 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.77 -33.87 74.86 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.634 1.217 . . . . 0.0 112.103 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.88 -43.69 98.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.841 0.856 . . . . 0.0 111.814 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.1 -44.63 75.75 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.636 0.774 . . . . 0.0 111.138 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.6 -41.18 89.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.75 0.82 . . . . 0.0 112.343 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.3 m -80.62 -21.89 41.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.4 p 69.24 -35.73 0.32 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.322 3.049 . . . . 0.0 113.716 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -70.66 137.23 85.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.754 1.622 . . . . 0.0 111.278 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.85 -27.57 0.69 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.875 2.383 . . . . 0.0 116.215 -169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 m -102.54 130.26 49.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.496 1.043 . . . . 0.0 112.915 -168.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -115.28 152.47 46.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.929 1.292 . . . . 0.0 110.504 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.53 157.64 55.37 Favored 'Cis proline' 0 C--N 1.355 0.92 0 N-CA-C 114.996 1.114 . . . . 0.0 114.996 -3.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.36 151.47 8.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.14 1.376 . . . . 0.0 111.298 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.0 tp -90.21 159.41 16.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.942 1.297 . . . . 0.0 110.735 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -150.31 139.76 21.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.433 1.093 . . . . 0.0 110.198 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 mt -142.68 126.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.719 -0.613 . . . . 0.0 111.139 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 63.37 -25.74 0.07 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.985 2.914 . . . . 0.0 117.407 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.01 10.26 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.914 1.721 . . . . 0.0 115.114 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.11 151.25 32.87 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.289 1.544 . . . . 0.0 111.243 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -71.64 161.02 31.65 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.42 1.105 . . . . 0.0 112.536 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -136.08 143.31 44.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.275 1.43 . . . . 0.0 109.31 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.93 -178.75 10.27 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.325 1.441 . . . . 0.0 115.54 -170.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.88 -173.8 20.19 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.971 1.272 . . . . 0.0 114.55 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.42 -45.09 94.88 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.678 -0.895 . . . . 0.0 113.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.72 -44.3 97.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.719 -0.613 . . . . 0.0 111.458 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.59 -44.07 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.756 0.822 . . . . 0.0 110.348 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.7 m -62.78 -44.89 94.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.067 1.347 . . . . 0.0 111.131 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.22 -45.55 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.597 1.159 . . . . 0.0 111.489 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.53 -42.06 87.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.095 0.861 . . . . 0.0 112.224 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.58 81.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.117 0.967 . . . . 0.0 112.457 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.98 -47.45 86.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.678 1.191 . . . . 0.0 111.605 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.19 -32.61 70.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.008 0.923 . . . . 0.0 113.2 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -83.38 -13.59 54.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.94 -6.34 76.51 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.023 1.296 . . . . 0.0 113.922 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.94 -37.16 72.84 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.765 1.226 . . . . 0.0 111.906 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.13 -43.23 78.79 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.665 -0.647 . . . . 0.0 110.38 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.79 -49.11 78.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.887 0.875 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.69 1.196 . . . . 0.0 112.054 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.06 -39.25 79.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.949 0.795 . . . . 0.0 112.844 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.52 -45.67 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.401 1.001 . . . . 0.0 110.414 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -62.77 -46.94 85.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.239 0.927 . . . . 0.0 111.647 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.91 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.458 -0.777 . . . . 0.0 112.126 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.03 81.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.952 0.796 . . . . 0.0 112.835 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.09 -40.58 82.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.802 0.728 . . . . 0.0 111.841 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.34 -47.52 83.85 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.139 0.575 . . . . 0.0 111.97 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.488 1.431 1 C-N-CA 132.153 4.181 . . . . 0.0 111.491 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.79 -65.6 0.65 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.983 1.265 . . . . 0.0 111.485 -171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -65.29 -29.0 69.72 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.448 -0.782 . . . . 0.0 112.136 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.1 m -63.56 -44.01 95.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.326 1.85 . . . . 0.0 112.117 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.9 m -64.65 -45.46 86.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.033 0.933 . . . . 0.0 110.375 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.2 mt -56.02 -50.22 71.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.059 0.544 . . . . 0.0 111.675 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.91 -48.48 78.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.478 0.711 . . . . 0.0 112.288 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.43 -38.65 87.91 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.506 -0.746 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.86 -47.58 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.178 -0.951 . . . . 0.0 110.727 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.22 -36.02 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.046 1.339 . . . . 0.0 113.008 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -84.28 -31.28 25.0 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.206 0.912 . . . . 0.0 113.054 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -70.77 -37.85 73.4 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.865 0.757 . . . . 0.0 112.757 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -137.39 114.17 10.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.249 1.42 . . . . 0.0 108.448 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.88 -33.81 76.53 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.12 137.25 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.53 1.059 . . . . 0.0 109.162 169.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.16 126.87 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.815 0.846 . . . . 0.0 109.454 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.08 125.71 47.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.511 1.125 . . . . 0.0 109.169 170.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -97.32 118.19 33.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.2 ptm -155.39 159.53 39.96 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -168.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.16 -20.53 48.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.217 1.007 . . . . 0.0 112.889 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.99 -170.38 43.1 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.186 1.375 . . . . 0.0 112.294 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 p -127.53 174.29 9.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 110.947 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -69.32 -21.43 63.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -83.31 -31.53 26.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.654 1.182 . . . . 0.0 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.37 100.24 3.59 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.321 1.448 . . . . 0.0 110.274 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.26 164.46 32.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.107 2.538 . . . . 0.0 111.458 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.6 139.36 30.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.289 0.636 . . . . 0.0 110.176 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.7 p -69.59 159.54 33.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.984 0.914 . . . . 0.0 113.196 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.11 -104.98 2.4 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 124.138 0.875 . . . . 0.0 111.283 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.76 -71.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.293 1.437 . . . . 0.0 112.728 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 m -60.98 -41.33 96.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.574 -0.704 . . . . 0.0 111.355 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -53.8 -46.43 71.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.3 1.44 . . . . 0.0 111.964 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.1 m -67.78 -51.38 49.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.554 1.142 . . . . 0.0 110.996 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.141 0.576 . . . . 0.0 111.742 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.98 -47.02 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.652 0.781 . . . . 0.0 111.031 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -64.73 -41.64 95.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.911 0.778 . . . . 0.0 112.126 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.91 -52.58 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.591 0.756 . . . . 0.0 111.187 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.33 -47.75 66.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.38 0.672 . . . . 0.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -50.2 -53.52 27.33 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.855 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -33.42 75.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.804 1.641 . . . . 0.0 114.277 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.41 -25.59 66.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.165 0.986 . . . . 0.0 111.61 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.5 t30 112.61 47.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.955 3.702 . . . . 0.0 110.862 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.44 132.89 21.3 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.32 122.4 6.09 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.424 2.749 . . . . 0.0 109.128 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -131.79 161.0 33.94 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -136.51 144.65 44.42 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.6 m -108.15 93.44 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 0.0 109.564 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.47 121.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.407 1.083 . . . . 0.0 109.341 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -74.32 122.92 23.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 111.278 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -119.15 -169.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.895 1.278 . . . . 0.0 111.27 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.9 -56.88 0.54 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.454 2.302 . . . . 0.0 112.208 169.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.39 -41.16 85.42 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.822 0.849 . . . . 0.0 110.532 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -73.77 109.4 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.993 0.917 . . . . 0.0 110.526 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -73.34 -27.63 61.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 113.488 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.99 -44.58 76.27 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.145 -0.972 . . . . 0.0 110.954 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.4 -40.5 89.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.711 0.804 . . . . 0.0 111.863 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -54.46 -37.99 65.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.025 0.93 . . . . 0.0 112.368 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -85.64 -46.06 11.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.44 1.096 . . . . 0.0 112.584 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.5 -30.91 57.61 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.54 -26.17 66.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.978 1.389 . . . . 0.0 113.033 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.22 -40.61 96.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.712 0.687 . . . . 0.0 111.682 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.64 -45.11 54.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.833 0.853 . . . . 0.0 111.468 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.43 -37.6 87.39 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.1 p -107.56 -20.85 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.0 m 69.41 -29.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.64 2.376 . . . . 0.0 114.702 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -75.27 128.48 84.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.579 1.552 . . . . 0.0 112.386 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.52 150.59 19.38 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.523 2.815 . . . . 0.0 111.422 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p 77.99 156.93 0.17 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.971 2.908 . . . . 0.0 113.419 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.54 157.8 64.69 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.165 1.786 . . . . 0.0 111.363 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.05 158.22 89.13 Favored 'Cis proline' 0 C--N 1.354 0.862 0 CA-C-N 119.999 1.035 . . . . 0.0 112.541 3.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.26 141.85 37.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.317 1.047 . . . . 0.0 110.36 -172.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.5 tp -95.08 144.91 25.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.955 1.302 . . . . 0.0 110.941 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -146.73 139.24 25.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 109.599 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mp -137.85 120.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.366 -0.834 . . . . 0.0 111.094 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 61.85 -24.92 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.968 3.307 . . . . 0.0 117.415 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.28 -1.89 0.04 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.09 1.805 . . . . 0.0 115.345 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.9 147.64 49.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.221 1.511 . . . . 0.0 111.708 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.31 158.76 30.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.423 1.106 . . . . 0.0 111.801 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -133.07 155.16 49.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.826 1.651 . . . . 0.0 108.968 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.79 -180.0 9.71 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.834 1.206 . . . . 0.0 114.568 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.2 -176.84 11.37 Favored Glycine 0 N--CA 1.474 1.223 0 C-N-CA 124.667 1.127 . . . . 0.0 113.996 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.25 -42.71 95.87 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.535 -0.979 . . . . 0.0 112.808 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.9 -47.16 86.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.432 0.56 . . . . 0.0 111.191 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.6 mt -60.67 -42.99 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.906 0.882 . . . . 0.0 110.304 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 m -62.81 -46.83 86.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.088 1.355 . . . . 0.0 111.327 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.51 -42.79 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.628 1.171 . . . . 0.0 111.656 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.95 -43.31 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.71 0.686 . . . . 0.0 111.564 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.74 95.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.888 . . . . 0.0 112.001 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.71 -37.77 88.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 112.782 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -69.37 -30.85 68.94 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.382 1.073 . . . . 0.0 112.254 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -87.99 -11.14 48.25 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.534 1.134 . . . . 0.0 113.949 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.36 84.07 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.176 1.37 . . . . 0.0 114.137 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.05 -34.43 50.46 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 112.104 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -64.45 -46.24 83.96 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.776 -0.578 . . . . 0.0 109.721 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -57.34 -48.39 79.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.547 1.139 . . . . 0.0 110.258 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.35 -52.96 62.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.839 0.856 . . . . 0.0 111.775 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -74.38 -33.61 63.1 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.578 -0.701 . . . . 0.0 112.869 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.56 -44.37 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.36 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -59.7 -43.27 94.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.199 1.363 . . . . 0.0 111.376 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -57.76 -47.82 81.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.374 0.67 . . . . 0.0 111.249 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.38 -31.28 71.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.132 0.973 . . . . 0.0 113.268 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.1 mmt -72.14 -36.5 69.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.301 -0.874 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.6 -40.42 76.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.681 0.792 . . . . 0.0 112.63 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.254 1.305 0 C-N-CA 129.643 3.177 . . . . 0.0 112.597 179.018 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.78 -51.28 67.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 109.755 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -58.92 -42.74 90.38 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.646 0.778 . . . . 0.0 112.566 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -64.68 -39.01 92.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.777 1.631 . . . . 0.0 112.081 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -62.54 -49.42 75.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.239 0.927 . . . . 0.0 110.39 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -56.98 -53.26 60.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.652 0.781 . . . . 0.0 110.943 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.27 -44.96 76.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.755 0.822 . . . . 0.0 112.314 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -59.91 -49.2 78.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.799 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.8 -34.92 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.293 1.406 . . . . 0.0 112.802 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.35 -36.28 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.936 1.295 . . . . 0.0 112.489 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.9 p -84.56 -39.03 19.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.71 0.804 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -74.44 -25.13 59.24 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -130.05 130.92 45.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.771 1.228 . . . . 0.0 109.605 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -68.85 -44.38 73.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -114.23 132.02 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.563 1.145 . . . . 0.0 109.243 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.87 121.04 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.207 0.603 . . . . 0.0 110.88 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.52 149.6 21.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.741 0.817 . . . . 0.0 110.528 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.5 114.09 18.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.367 1.467 . . . . 0.0 109.136 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -163.09 -178.57 6.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.257 1.823 . . . . 0.0 110.653 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.13 -39.9 65.35 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.774 -1.204 . . . . 0.0 111.709 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.84 161.9 46.34 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.926 1.727 . . . . 0.0 114.419 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -87.65 172.02 10.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.157 1.783 . . . . 0.0 111.774 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -71.96 -23.74 61.49 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.42 -13.42 32.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.518 1.527 . . . . 0.0 113.642 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -131.57 65.68 76.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.71 1.604 . . . . 0.0 110.276 169.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -71.7 143.12 41.17 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.486 2.79 . . . . 0.0 110.843 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.0 127.62 33.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.689 0.796 . . . . 0.0 112.12 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -54.89 145.25 20.46 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.443 . . . . 0.0 113.174 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.16 -143.35 16.56 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -51.71 -45.11 63.44 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.3 m -63.82 -47.07 82.27 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.32 1.418 . . . . 0.0 112.346 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.12 -40.72 90.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.785 0.834 . . . . 0.0 111.741 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -60.97 -48.06 83.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.452 0.701 . . . . 0.0 110.919 170.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.43 -42.85 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.629 1.172 . . . . 0.0 112.898 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -66.45 -34.85 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.205 1.366 . . . . 0.0 111.999 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.22 -41.54 89.97 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.777 0.717 . . . . 0.0 111.924 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mt -57.36 -51.53 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.85 1.26 . . . . 0.0 111.388 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.0 -47.57 77.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.272 1.029 . . . . 0.0 111.032 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -51.88 -55.74 18.3 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.252 0.621 . . . . 0.0 110.76 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -68.33 -33.12 73.73 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.983 1.713 . . . . 0.0 113.837 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.2 -29.99 69.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.374 1.07 . . . . 0.0 110.997 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 115.27 70.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 130.234 3.414 . . . . 0.0 111.038 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.97 139.48 12.7 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.97 119.46 5.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.089 2.526 . . . . 0.0 109.38 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -106.14 152.4 23.49 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.112 0.965 . . . . 0.0 112.011 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.15 171.72 7.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.272 1.429 . . . . 0.0 110.139 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 m -147.99 104.73 3.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.176 -1.577 . . . . 0.0 109.88 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.92 127.74 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.597 1.159 . . . . 0.0 109.022 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -73.42 93.8 2.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 110.865 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.99 -178.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.39 0.676 . . . . 0.0 110.507 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.05 -37.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.907 2.083 . . . . 0.0 113.104 172.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.1 -20.18 64.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.731 1.612 . . . . 0.0 113.38 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -125.06 134.9 52.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.068 1.347 . . . . 0.0 111.364 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.44 -28.66 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.38 1.072 . . . . 0.0 113.752 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.66 -44.05 71.33 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.308 -0.87 . . . . 0.0 111.739 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.19 -23.27 65.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.75 -26.08 68.48 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.86 0.755 . . . . 0.0 112.726 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -109.98 -53.02 2.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.74 1.216 . . . . 0.0 112.252 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.04 -34.09 53.26 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.355 -169.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -47.9 77.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.657 1.729 . . . . 0.0 111.939 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.08 -26.1 67.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -80.44 -34.78 35.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.054 0.942 . . . . 0.0 112.201 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -65.05 -37.96 89.27 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.916 1.286 . . . . 0.0 112.273 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -78.81 -68.31 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.99 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m 124.06 -17.2 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 1 C-N-CA 133.163 4.585 . . . . 0.0 110.966 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -67.59 121.69 80.2 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.445 1.498 . . . . 0.0 111.545 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.27 145.45 19.03 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.993 2.462 . . . . 0.0 110.411 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 80.3 165.49 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.025 2.13 . . . . 0.0 112.561 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.62 150.12 51.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.531 1.533 . . . . 0.0 110.53 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.78 -177.49 21.18 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 120.125 1.08 . . . . 0.0 113.157 4.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.1 140.78 23.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.749 1.22 . . . . 0.0 111.182 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 tp -103.32 141.22 36.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.627 1.571 . . . . 0.0 110.075 169.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -140.46 142.98 35.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.053 1.741 . . . . 0.0 110.157 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.2 mt -140.18 116.4 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.65 0.78 . . . . 0.0 110.852 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.63 -24.8 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 130.114 3.366 . . . . 0.0 118.069 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -16.2 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.631 1.586 . . . . 0.0 114.69 -170.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.11 153.29 48.65 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.921 1.36 . . . . 0.0 112.87 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -81.09 149.23 29.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.906 -0.496 . . . . 0.0 111.515 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.07 -35.41 9.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.984 0.914 . . . . 0.0 112.311 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.26 -146.64 17.82 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 125.437 1.494 . . . . 0.0 111.937 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.02 165.72 47.66 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.293 0.949 . . . . 0.0 114.206 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.2 m -68.47 -41.56 80.01 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.736 -0.861 . . . . 0.0 112.244 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.13 -42.42 94.77 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.23 -0.919 . . . . 0.0 111.637 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.17 -40.34 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.247 0.619 . . . . 0.0 110.326 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.5 m -63.97 -43.21 96.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.085 0.954 . . . . 0.0 111.739 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.33 -46.13 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.914 0.779 . . . . 0.0 110.963 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -66.37 -37.17 84.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.743 0.701 . . . . 0.0 112.527 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.24 95.52 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.1 0.96 . . . . 0.0 111.971 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -67.54 -38.86 84.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.512 0.725 . . . . 0.0 112.771 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.1 -32.88 74.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 112.642 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 p -92.9 -10.03 38.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.52 -3.19 68.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.045 1.307 . . . . 0.0 114.485 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -72.37 -33.25 67.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.41 1.484 . . . . 0.0 112.493 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -47.2 70.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.716 0.689 . . . . 0.0 110.249 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -56.52 -48.79 76.49 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.684 1.194 . . . . 0.0 110.469 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.648 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.75 -33.13 72.02 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -39.93 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.3 0.954 . . . . 0.0 111.151 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.34 -44.73 96.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.12 0.873 . . . . 0.0 111.077 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.36 -36.36 79.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.409 -0.807 . . . . 0.0 112.701 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.88 74.52 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.038 1.29 . . . . 0.0 112.627 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.9 mtt -74.41 -41.99 59.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.836 0.854 . . . . 0.0 112.357 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 p -92.6 1.75 57.08 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 126.963 2.105 . . . . 0.0 114.272 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.65 -55.71 15.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.673 1.589 . . . . 0.0 109.798 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -61.37 -42.12 98.19 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.553 -0.717 . . . . 0.0 112.231 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -60.23 -39.45 86.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.335 1.854 . . . . 0.0 111.98 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 m -64.84 -49.16 71.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 110.141 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.09 -50.35 71.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.077 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.18 -48.65 75.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.527 1.131 . . . . 0.0 112.459 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.4 -42.72 99.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.558 -0.714 . . . . 0.0 111.821 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.9 -49.88 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.772 0.829 . . . . 0.0 111.787 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.14 -33.99 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.545 1.066 . . . . 0.0 112.772 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.2 p -74.93 -35.42 62.18 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.919 0.782 . . . . 0.0 112.781 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 m -79.37 -41.73 27.16 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.97 0.805 . . . . 0.0 112.976 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.03 -3.71 37.57 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 58.55 -74.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.536 2.334 . . . . 0.0 112.277 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.3 129.94 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.005 0.922 . . . . 0.0 109.642 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -137.79 131.27 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.423 0.689 . . . . 0.0 110.324 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.4 140.53 32.53 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.549 1.14 . . . . 0.0 111.314 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.18 108.41 16.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.714 1.606 . . . . 0.0 107.887 172.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.2 mtm -144.59 -176.72 5.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.273 1.429 . . . . 0.0 110.595 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -79.1 21.48 0.44 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.325 -1.485 . . . . 0.0 113.999 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.97 177.4 44.72 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.795 1.188 . . . . 0.0 114.733 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.4 p -97.46 -178.61 4.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.734 2.014 . . . . 0.0 111.244 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.06 -20.62 59.45 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.345 -0.847 . . . . 0.0 112.901 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.38 -31.82 37.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 111.853 172.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -134.17 74.61 67.32 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.892 1.277 . . . . 0.0 110.753 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 172.05 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.984 3.123 . . . . 0.0 111.281 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -99.3 152.43 19.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.053 0.941 . . . . 0.0 110.983 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.51 167.25 21.02 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.782 1.233 . . . . 0.0 113.507 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.73 -125.52 7.1 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.412 1.006 . . . . 0.0 112.362 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -60.31 -42.35 95.37 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.757 0.823 . . . . 0.0 112.591 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -59.2 -52.15 66.92 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.025 -1.047 . . . . 0.0 112.327 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -56.94 -44.56 82.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.783 1.233 . . . . 0.0 110.481 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.2 m -60.14 -47.69 84.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.461 1.104 . . . . 0.0 110.855 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.7 -42.57 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.249 1.02 . . . . 0.0 112.39 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.25 -34.66 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.476 1.489 . . . . 0.0 112.11 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.018 0.827 . . . . 0.0 111.69 170.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.84 -47.28 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.204 1.402 . . . . 0.0 111.258 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.92 -49.51 72.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.373 0.988 . . . . 0.0 111.409 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -49.42 -59.41 3.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.268 0.627 . . . . 0.0 109.845 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -67.97 -28.82 67.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.196 1.798 . . . . 0.0 114.91 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.78 -30.61 69.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 110.187 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.1 t30 111.15 55.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 130.721 3.608 . . . . 0.0 108.492 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.57 150.91 38.25 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.53 169.68 18.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.189 3.259 . . . . 0.0 110.696 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.8 164.8 26.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.254 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.24 167.06 19.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.37 1.468 . . . . 0.0 108.901 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -151.1 126.09 9.8 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 119.776 -1.827 . . . . 0.0 111.669 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.62 133.17 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.838 1.255 . . . . 0.0 109.591 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -74.17 125.59 28.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.94 0.496 . . . . 0.0 111.699 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 pt -72.93 -30.05 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.836 1.254 . . . . 0.0 113.038 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.66 167.6 13.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.194 0.998 . . . . 0.0 111.935 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 79.61 -107.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.919 2.488 . . . . 0.0 109.852 -170.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -55.71 124.22 16.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.722 1.209 . . . . 0.0 113.881 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.06 -39.64 90.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 113.653 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.83 -33.1 74.12 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.537 -0.727 . . . . 0.0 111.558 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.0 tp -72.45 -43.49 63.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.641 0.776 . . . . 0.0 111.157 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -56.09 -45.64 79.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.144 1.377 . . . . 0.0 112.345 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.18 -40.58 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.386 1.074 . . . . 0.0 111.575 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.92 -36.79 87.15 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 118.675 -1.07 . . . . 0.0 113.872 -172.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.91 -44.58 95.71 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.416 1.608 . . . . 0.0 111.566 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.8 -48.23 75.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.47 -32.99 73.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.435 0.694 . . . . 0.0 112.823 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -69.26 -37.97 78.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 0.0 112.572 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 m -87.55 -24.37 24.05 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m 74.53 -41.53 0.48 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.321 2.648 . . . . 0.0 113.756 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -68.45 129.11 92.91 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.921 1.288 . . . . 0.0 110.73 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.53 158.81 16.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.784 2.989 . . . . 0.0 112.07 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p 75.13 162.62 0.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.558 2.743 . . . . 0.0 113.665 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -143.28 159.72 54.43 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.461 1.904 . . . . 0.0 110.68 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.28 149.81 53.97 Favored 'Cis proline' 0 C--N 1.354 0.832 0 CA-C-N 120.313 1.147 . . . . 0.0 114.007 -2.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.14 148.88 32.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 0.0 110.344 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -114.09 140.31 48.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.362 1.465 . . . . 0.0 110.609 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -132.71 145.52 51.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.99 2.116 . . . . 0.0 109.997 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mt -137.23 119.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.383 -0.823 . . . . 0.0 112.465 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 t70 63.67 -43.09 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.95 3.3 . . . . 0.0 117.179 168.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.96 9.34 0.03 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.562 2.506 . . . . 0.0 114.151 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.01 145.15 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.47 1.508 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.53 152.35 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.527 -0.733 . . . . 0.0 109.97 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -110.47 -36.65 5.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.119 0.968 . . . . 0.0 112.615 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.37 -159.15 23.28 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.109 1.338 . . . . 0.0 113.293 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.05 169.28 54.68 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.147 0.879 . . . . 0.0 114.028 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.0 p -68.7 -49.55 58.06 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.444 -1.033 . . . . 0.0 112.922 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.47 -39.11 86.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.891 -1.131 . . . . 0.0 111.657 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.3 -41.87 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.591 0.756 . . . . 0.0 110.381 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.8 m -62.76 -40.92 98.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 0.0 111.668 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.14 -46.91 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.132 0.878 . . . . 0.0 111.484 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -31.7 63.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.267 0.94 . . . . 0.0 113.504 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.23 83.11 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.072 -1.018 . . . . 0.0 112.594 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.68 -44.8 92.65 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.646 1.178 . . . . 0.0 112.035 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.68 -27.99 68.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.6 m -86.84 -14.69 41.37 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 113.666 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.81 75.71 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 125.354 1.455 . . . . 0.0 114.19 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.39 -34.64 63.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.552 1.141 . . . . 0.0 111.312 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.46 -45.56 86.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.524 -0.735 . . . . 0.0 110.719 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.03 -47.39 77.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.71 0.804 . . . . 0.0 111.002 175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.42 -50.33 73.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.867 0.867 . . . . 0.0 112.074 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -76.44 -32.97 58.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.17 -40.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.964 0.802 . . . . 0.0 110.618 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.39 -43.99 95.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.347 0.976 . . . . 0.0 111.591 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -55.87 -45.12 78.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.911 0.778 . . . . 0.0 111.051 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.68 94.89 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 113.071 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 57.8 mtt -64.79 -35.27 80.56 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.731 0.813 . . . . 0.0 112.343 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.3 -36.01 76.59 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.762 0.825 . . . . 0.0 112.768 170.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.892 2.477 . . . . 0.0 112.241 -179.435 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.98 -56.93 8.72 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.592 1.557 . . . . 0.0 110.622 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -59.67 -43.21 94.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.4 0.68 . . . . 0.0 111.784 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.11 -41.05 95.98 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.046 2.138 . . . . 0.0 112.163 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -67.78 -46.48 71.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.607 1.163 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -56.92 -53.82 53.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.404 0.681 . . . . 0.0 110.804 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.17 -43.85 78.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.259 0.623 . . . . 0.0 112.004 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.1 -51.08 71.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.771 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.92 -37.36 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.403 1.456 . . . . 0.0 112.214 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -63.64 -37.35 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.069 0.947 . . . . 0.0 112.648 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 p -86.37 -36.97 18.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.726 0.81 . . . . 0.0 113.169 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -75.92 -37.91 58.24 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.526 0.731 . . . . 0.0 112.804 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -110.11 114.66 28.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.01 0.924 . . . . 0.0 110.61 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -77.11 67.66 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.549 -1.344 . . . . 0.0 111.464 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.2 t 132.31 122.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 1 C-N-CA 133.913 4.885 . . . . 0.0 107.652 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.76 132.93 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.337 1.055 . . . . 0.0 109.337 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.59 137.9 38.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.49 1.516 . . . . 0.0 109.261 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -112.76 115.22 28.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.172 1.389 . . . . 0.0 107.732 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ptp -153.67 164.3 38.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.894 1.278 . . . . 0.0 112.933 -169.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -80.1 45.02 0.7 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.663 1.585 . . . . 0.0 111.261 174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.99 -161.93 27.02 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.151 1.358 . . . . 0.0 114.41 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.5 p -135.56 178.94 6.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.33 1.852 . . . . 0.0 111.18 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -66.36 -25.94 67.04 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.09 -26.44 19.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.853 1.261 . . . . 0.0 112.436 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -124.91 71.37 61.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.995 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.48 164.78 33.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.231 2.62 . . . . 0.0 110.902 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.48 129.62 34.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.925 0.49 . . . . 0.0 109.802 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.94 147.1 52.8 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.949 0.9 . . . . 0.0 112.673 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -116.06 4.71 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.057 0.837 . . . . 0.0 111.558 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -60.68 -54.98 38.75 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.874 0.87 . . . . 0.0 113.035 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -66.77 -39.44 87.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.642 -1.286 . . . . 0.0 112.22 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.57 -46.97 77.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.197 1.399 . . . . 0.0 111.151 170.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 m -61.24 -45.99 92.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.77 0.828 . . . . 0.0 110.247 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.81 -44.87 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.573 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.15 -34.97 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 120.78 1.627 . . . . 0.0 111.929 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -65.72 -35.43 80.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.791 0.723 . . . . 0.0 111.885 169.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.35 -51.21 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.897 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 121.137 1.789 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -49.46 -55.86 11.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.047 0.539 . . . . 0.0 109.815 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -66.51 -29.19 69.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.323 2.249 . . . . 0.0 115.059 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tt -59.54 -30.75 68.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.944 1.698 . . . . 0.0 109.481 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 108.08 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 131.443 3.897 . . . . 0.0 107.347 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.2 152.98 32.15 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.53 179.19 5.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.31 3.34 . . . . 0.0 110.853 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.61 171.86 13.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.436 1.894 . . . . 0.0 110.38 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.91 147.95 50.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.847 0.859 . . . . 0.0 109.597 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 m -122.61 111.83 17.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.909 0.884 . . . . 0.0 110.576 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.09 124.43 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.354 1.062 . . . . 0.0 109.452 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -72.95 105.76 4.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 110.45 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.9 pt -89.2 -173.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.35 1.06 . . . . 0.0 112.039 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt 68.75 -14.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.462 2.305 . . . . 0.0 115.085 169.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -65.16 -19.73 66.12 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.052 1.741 . . . . 0.0 114.475 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -158.22 169.05 25.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.639 1.576 . . . . 0.0 112.01 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -64.88 -31.87 73.3 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.14 -36.25 83.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.104 0.866 . . . . 0.0 111.337 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.43 -23.11 56.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.396 1.078 . . . . 0.0 113.088 172.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -82.78 -51.51 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.609 1.095 . . . . 0.0 112.685 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -95.48 -43.87 7.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.826 1.25 . . . . 0.0 112.039 -169.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.51 61.06 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.684 0.659 . . . . 0.0 112.019 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 tp -59.64 -41.99 91.73 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.419 0.688 . . . . 0.0 111.882 172.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -63.74 -40.16 96.06 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.919 -0.488 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -72.04 -33.73 68.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.551 0.614 . . . . 0.0 112.416 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -65.3 -47.41 76.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.146 0.978 . . . . 0.0 112.95 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -92.01 -25.93 18.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 74.64 -8.02 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.917 2.087 . . . . 0.0 113.464 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -65.56 133.77 95.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.027 1.331 . . . . 0.0 111.436 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 -41.91 0.62 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.066 2.51 . . . . 0.0 115.199 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -143.9 107.44 4.61 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.175 0.898 . . . . 0.0 111.815 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.25 162.78 16.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.007 1.323 . . . . 0.0 112.465 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -64.53 169.1 37.5 Favored 'Cis proline' 0 C--N 1.355 0.911 0 CA-C-N 120.772 1.311 . . . . 0.0 115.275 0.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.12 166.66 31.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.72 150.23 27.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.48 1.912 . . . . 0.0 108.834 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.35 143.65 32.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.107 2.163 . . . . 0.0 109.81 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.42 172.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.687 1.595 . . . . 0.0 111.532 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.69 103.17 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.392 1.077 . . . . 0.0 112.676 -171.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.64 89.13 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 117.601 -1.666 . . . . 0.0 116.072 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.22 134.97 10.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.652 2.226 . . . . 0.0 113.054 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.09 148.4 36.1 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.918 -1.114 . . . . 0.0 110.651 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -99.41 -45.76 5.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.69 -161.83 13.55 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.928 1.251 . . . . 0.0 112.911 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.26 165.1 46.84 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 124.18 0.895 . . . . 0.0 115.126 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -66.81 -38.9 87.38 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.982 -0.716 . . . . 0.0 112.273 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.9 -45.89 91.08 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.608 -0.683 . . . . 0.0 111.434 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.24 -40.38 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.195 0.598 . . . . 0.0 110.346 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 80.1 m -62.92 -44.13 96.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.693 1.197 . . . . 0.0 111.641 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.71 -46.36 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.905 0.775 . . . . 0.0 111.141 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.84 -36.96 81.27 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.62 0.645 . . . . 0.0 112.26 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.89 91.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.277 1.031 . . . . 0.0 112.202 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.01 -38.88 92.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.63 0.772 . . . . 0.0 112.519 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.46 -31.37 72.41 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.976 0.911 . . . . 0.0 111.791 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.9 m -88.26 -12.33 43.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.81 -2.57 76.65 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.081 1.324 . . . . 0.0 114.239 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.84 -36.19 42.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.981 1.312 . . . . 0.0 111.693 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.68 -42.21 95.51 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.701 -0.625 . . . . 0.0 110.453 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -56.26 -49.17 74.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.307 1.043 . . . . 0.0 110.169 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.38 -46.72 87.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.335 0.654 . . . . 0.0 112.067 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -71.42 -36.67 71.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.01 -37.77 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.581 1.082 . . . . 0.0 110.861 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.08 -44.89 94.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 110.434 169.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.78 -39.75 85.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.372 -0.83 . . . . 0.0 112.21 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.87 -44.73 96.22 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.828 1.195 . . . . 0.0 112.045 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmt -63.25 -38.07 89.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.259 1.023 . . . . 0.0 112.357 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.7 m -67.36 -36.88 82.27 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.005 0.922 . . . . 0.0 112.709 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.8 m . . . . . 0 C--O 1.255 1.379 0 C-N-CA 128.048 2.539 . . . . 0.0 112.036 -177.716 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -67.68 -51.33 50.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.091 0.86 . . . . 0.0 111.792 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -64.61 -33.59 76.28 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.465 -0.772 . . . . 0.0 111.624 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -61.69 -43.19 99.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.433 2.293 . . . . 0.0 111.929 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -68.82 -43.41 75.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.868 1.267 . . . . 0.0 111.151 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.64 -41.12 89.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.868 0.867 . . . . 0.0 111.54 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.07 -42.96 99.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.525 1.057 . . . . 0.0 112.582 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.11 -40.9 98.99 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.275 -0.89 . . . . 0.0 111.816 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.04 -52.19 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.296 1.039 . . . . 0.0 110.853 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.09 -49.92 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.345 1.458 . . . . 0.0 112.101 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -74.85 -30.77 61.45 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.3 p -90.69 -36.56 14.27 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -38.81 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.223 -0.923 . . . . 0.0 112.21 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.77 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.088 2.955 . . . . 0.0 117.661 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.06 110.51 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.422 1.889 . . . . 0.0 107.66 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.26 158.29 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.85 117.17 15.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.177 1.391 . . . . 0.0 109.31 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -87.69 124.86 34.0 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.089 1.356 . . . . 0.0 109.924 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -163.45 172.97 13.74 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -69.81 -19.78 63.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.521 1.528 . . . . 0.0 114.083 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.1 -159.65 31.47 Favored Glycine 0 N--CA 1.477 1.417 0 C-N-CA 125.158 1.361 . . . . 0.0 113.547 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -136.47 -174.33 3.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.398 1.879 . . . . 0.0 110.348 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -80.38 -29.13 37.82 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.221 -0.924 . . . . 0.0 112.334 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.38 -34.36 65.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.638 1.175 . . . . 0.0 111.958 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -133.75 91.71 24.69 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.913 1.285 . . . . 0.0 110.413 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.64 157.52 48.34 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.739 2.293 . . . . 0.0 110.537 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -77.75 125.23 29.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.038 0.447 . . . . 0.0 110.275 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -59.49 143.54 49.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.297 1.439 . . . . 0.0 113.13 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.82 -100.4 2.08 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.085 0.85 . . . . 0.0 111.097 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -58.87 -64.3 0.99 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.454 1.501 . . . . 0.0 113.347 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -67.12 -37.41 83.83 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.706 -1.246 . . . . 0.0 111.447 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -54.42 -46.75 73.25 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.9 m -61.61 -48.0 82.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.263 1.025 . . . . 0.0 110.839 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.76 -49.03 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.918 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.93 -32.92 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.417 1.008 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -63.81 -41.55 97.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.911 0.885 . . . . 0.0 111.242 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 mt -59.6 -50.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 111.15 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.08 -52.22 65.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.424 0.69 . . . . 0.0 111.045 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -51.3 -55.59 17.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.983 0.513 . . . . 0.0 110.615 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -68.1 -31.02 70.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.094 1.758 . . . . 0.0 114.36 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.31 -33.9 71.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.7 t30 117.75 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.728 3.611 . . . . 0.0 109.645 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.13 137.79 23.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.83 89.81 1.27 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.723 2.948 . . . . 0.0 109.868 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -70.2 152.97 43.65 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.887 0.475 . . . . 0.0 110.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -129.23 121.33 27.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.399 0.619 . . . . 0.0 110.534 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -73.36 120.7 19.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.246 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.37 118.58 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.523 1.129 . . . . 0.0 108.092 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -75.07 120.03 20.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.033 0.933 . . . . 0.0 111.09 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -127.14 179.23 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.253 1.421 . . . . 0.0 112.082 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 77.71 -52.2 0.52 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 127.739 2.416 . . . . 0.0 112.406 169.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.25 -25.07 65.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.86 0.864 . . . . 0.0 112.983 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -104.13 113.94 27.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.717 2.407 . . . . 0.0 110.596 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.49 -28.63 69.33 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.36 -50.65 66.9 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 110.944 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.72 -39.91 91.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.39 0.676 . . . . 0.0 110.791 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -54.21 -44.53 71.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 0.0 112.082 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.093 0.957 . . . . 0.0 112.26 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.59 -42.68 46.82 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 113.776 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.81 -25.99 64.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.648 1.224 . . . . 0.0 113.341 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.07 -44.11 94.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.26 0.936 . . . . 0.0 111.376 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.41 -46.11 56.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.668 0.787 . . . . 0.0 111.19 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.94 -39.61 94.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 0.0 112.832 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.2 p -88.89 -35.68 16.38 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p 64.27 -23.24 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.222 2.609 . . . . 0.0 114.367 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -67.11 130.39 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.781 1.632 . . . . 0.0 111.27 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.25 136.97 13.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.83 2.354 . . . . 0.0 111.599 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.1 p 77.24 165.36 0.24 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 128.679 2.791 . . . . 0.0 114.65 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.65 161.89 49.62 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 127.208 2.203 . . . . 0.0 110.723 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -58.2 157.01 34.79 Favored 'Cis proline' 0 C--N 1.356 0.965 0 CA-C-N 120.777 1.313 . . . . 0.0 114.655 -2.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -152.7 132.43 13.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.021 0.528 . . . . 0.0 110.863 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 tt -93.9 142.35 27.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.027 1.331 . . . . 0.0 110.85 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -133.08 143.05 49.08 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.716 1.206 . . . . 0.0 111.519 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.52 138.64 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.07 1.348 . . . . 0.0 110.318 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -15.21 89.09 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.921 2.888 . . . . 0.0 115.809 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.3 55.65 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.167 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.8 130.49 21.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.189 1.994 . . . . 0.0 114.233 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -81.24 121.81 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.153 1.381 . . . . 0.0 108.841 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -92.59 -32.82 14.66 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.7 -154.1 16.6 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.819 1.2 . . . . 0.0 113.712 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.87 47.1 Favored Glycine 0 N--CA 1.473 1.1 0 C-N-CA 124.718 1.151 . . . . 0.0 115.498 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.5 t -58.58 -51.25 70.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.993 1.317 . . . . 0.0 112.782 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -60.64 -43.57 97.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.948 0.499 . . . . 0.0 111.77 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.13 -45.42 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.469 0.708 . . . . 0.0 110.24 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.1 -46.58 88.45 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.668 1.187 . . . . 0.0 110.882 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.23 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.87 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.17 -39.38 86.46 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.276 0.943 . . . . 0.0 111.916 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.44 79.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.649 -0.657 . . . . 0.0 112.226 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.86 -43.76 91.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.985 0.914 . . . . 0.0 112.047 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.24 -30.76 69.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.016 0.926 . . . . 0.0 112.79 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -84.79 -13.37 51.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.121 0.969 . . . . 0.0 113.374 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.26 83.89 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.418 1.485 . . . . 0.0 114.144 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -73.47 -38.82 65.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 111.571 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.15 -42.95 88.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.659 -0.65 . . . . 0.0 110.066 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -58.55 -48.08 82.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.583 0.753 . . . . 0.0 110.44 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.33 -50.17 72.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.861 0.865 . . . . 0.0 111.517 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -72.36 -35.37 68.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.252 -0.905 . . . . 0.0 113.435 -173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.43 -39.46 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.35 0.977 . . . . 0.0 110.722 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.95 -46.23 88.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.107 0.867 . . . . 0.0 111.296 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.73 -37.07 77.93 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.315 -0.865 . . . . 0.0 112.466 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.21 65.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 77.3 mtm -76.28 -38.24 56.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.606 0.639 . . . . 0.0 111.675 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.5 -41.34 69.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 127.668 2.387 . . . . 0.0 112.464 -172.9 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -54.36 47.45 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.03 1.332 . . . . 0.0 110.43 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.23 -35.2 76.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.856 -0.593 . . . . 0.0 112.218 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -62.94 -46.02 89.7 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.148 1.379 . . . . 0.0 111.439 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -62.27 -50.81 70.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.634 0.774 . . . . 0.0 111.137 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.04 -42.95 99.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.988 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.93 -48.99 77.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.639 1.109 . . . . 0.0 111.654 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.44 -41.7 90.21 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.355 0.662 . . . . 0.0 111.788 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.54 -53.34 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.916 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.2 -21.83 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.274 1.397 . . . . 0.0 113.681 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.3 p -80.14 -31.62 39.02 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.417 170.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.2 m -77.5 -38.5 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.662 0.665 . . . . 0.0 112.761 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.05 102.37 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.283 1.833 . . . . 0.0 108.999 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -60.84 -38.72 86.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.107 -0.995 . . . . 0.0 113.384 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -99.13 136.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.868 1.267 . . . . 0.0 109.096 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.15 136.82 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.05 142.24 30.78 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.28 1.032 . . . . 0.0 111.289 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -119.63 116.07 25.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.075 1.35 . . . . 0.0 108.623 169.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 48.2 mtm -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.819 1.247 . . . . 0.0 110.538 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -76.02 20.93 0.18 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.637 1.175 . . . . 0.0 113.78 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.19 168.12 41.15 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 126.797 2.141 . . . . 0.0 112.768 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -96.49 -175.48 3.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.961 1.304 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -11.1 33.97 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 170.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.17 -28.23 59.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 112.262 170.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -146.2 79.06 10.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.797 1.639 . . . . 0.0 111.075 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.47 135.99 64.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.027 2.485 . . . . 0.0 110.359 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -83.29 98.8 9.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.504 0.722 . . . . 0.0 112.413 -169.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.2 t 89.51 160.67 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.455 2.702 . . . . 0.0 112.325 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.08 -31.04 75.23 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 124.893 1.235 . . . . 0.0 113.408 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -62.0 -53.38 56.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.119 0.96 . . . . 0.0 110.671 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -61.73 -42.93 99.61 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.135 -0.978 . . . . 0.0 111.747 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.34 -44.26 92.67 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.038 0.935 . . . . 0.0 110.968 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.2 m -63.36 -45.13 92.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.862 0.865 . . . . 0.0 110.638 173.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.798 1.239 . . . . 0.0 112.514 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.02 -34.78 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 120.426 1.467 . . . . 0.0 111.8 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.91 -43.85 82.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 112.199 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.88 -51.49 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.559 1.544 . . . . 0.0 111.225 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.83 -49.09 69.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.309 1.043 . . . . 0.0 111.276 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -52.38 -49.89 63.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -68.24 -36.05 78.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.211 1.805 . . . . 0.0 114.176 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.87 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 120.78 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 131.051 3.74 . . . . 0.0 109.198 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.96 133.47 8.98 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -82.84 63.22 7.92 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.396 3.397 . . . . 0.0 108.422 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -70.01 168.68 14.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 113.891 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -134.38 172.54 12.75 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.377 1.084 . . . . 0.0 111.621 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -153.28 115.35 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.559 -1.338 . . . . 0.0 110.269 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.73 137.26 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.65 1.18 . . . . 0.0 110.324 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -81.05 123.24 28.21 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 112.106 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -27.95 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.839 1.256 . . . . 0.0 113.006 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.45 148.65 37.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.525 1.13 . . . . 0.0 109.731 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 66.0 6.56 4.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.468 1.907 . . . . 0.0 112.735 -169.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -135.3 57.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.673 1.989 . . . . 0.0 110.076 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -51.82 -37.27 51.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.239 1.416 . . . . 0.0 114.399 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.25 -42.63 91.59 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.343 1.057 . . . . 0.0 111.841 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.88 -41.98 64.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.356 1.062 . . . . 0.0 110.977 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -55.44 -47.12 76.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.909 1.284 . . . . 0.0 112.272 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -73.46 -49.03 28.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.184 0.594 . . . . 0.0 110.554 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.51 92.17 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.891 -0.949 . . . . 0.0 114.608 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.61 -57.76 11.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.372 1.086 . . . . 0.0 110.655 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -61.18 -37.97 84.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.588 0.755 . . . . 0.0 112.253 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.93 -36.84 80.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.858 1.263 . . . . 0.0 112.146 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -87.28 -38.7 16.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.795 1.638 . . . . 0.0 113.521 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.6 p -93.03 -28.25 16.5 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t 74.15 3.74 4.43 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 126.751 2.02 . . . . 0.0 113.318 -171.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -62.03 133.47 94.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.84 1.256 . . . . 0.0 112.041 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.45 -46.83 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.54 2.16 . . . . 0.0 114.662 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -147.46 124.92 11.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.318 0.963 . . . . 0.0 112.224 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.44 153.79 89.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.844 1.258 . . . . 0.0 112.0 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.22 158.7 94.91 Favored 'Cis proline' 0 C--N 1.354 0.855 0 CA-C-N 119.872 0.99 . . . . 0.0 113.662 7.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.59 128.6 27.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.488 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.19 129.21 40.88 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 109.177 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 141.83 47.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.409 1.884 . . . . 0.0 111.802 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.74 129.05 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 67.24 -19.34 0.12 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 128.218 2.607 . . . . 0.0 115.868 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.72 1.66 0.71 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.254 1.883 . . . . 0.0 115.153 -174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.34 158.88 43.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.141 1.47 . . . . 0.0 111.311 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -77.34 144.5 37.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.779 -0.576 . . . . 0.0 111.823 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -92.6 -40.06 10.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.71 1.204 . . . . 0.0 111.428 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.57 25.43 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.852 1.215 . . . . 0.0 113.49 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.47 169.73 33.23 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.04 1.305 . . . . 0.0 112.773 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 85.6 m -69.87 -44.55 69.59 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.591 -0.947 . . . . 0.0 113.099 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.01 -42.67 98.91 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.15 -0.969 . . . . 0.0 111.325 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.48 -40.2 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.9 0.88 . . . . 0.0 110.431 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.4 m -65.47 -42.71 91.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.621 1.169 . . . . 0.0 111.752 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -59.69 -43.8 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.022 0.828 . . . . 0.0 110.961 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -67.68 -37.04 81.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.845 0.748 . . . . 0.0 112.481 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.69 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.185 0.994 . . . . 0.0 112.19 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -63.78 -43.59 95.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.162 0.985 . . . . 0.0 112.113 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.18 -31.09 71.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 112.451 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.6 m -83.54 -14.2 52.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.442 1.097 . . . . 0.0 113.356 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.79 81.42 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.309 1.433 . . . . 0.0 114.31 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -71.25 -46.51 60.85 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.94 1.296 . . . . 0.0 111.031 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.58 -40.51 97.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.912 -0.493 . . . . 0.0 111.024 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.85 -47.92 83.17 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.355 0.662 . . . . 0.0 110.02 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.96 -49.42 74.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.309 0.644 . . . . 0.0 111.482 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -67.81 -39.08 84.0 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.78 -42.12 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.478 1.035 . . . . 0.0 110.536 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -45.52 91.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.872 0.76 . . . . 0.0 111.326 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -60.95 -40.59 93.92 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 112.292 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.82 82.98 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.809 0.843 . . . . 0.0 112.731 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.9 mmm -75.71 -45.91 34.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.145 0.978 . . . . 0.0 113.104 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.14 -45.67 7.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.774 1.23 . . . . 0.0 113.017 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.689 1.996 . . . . 0.0 113.178 -178.561 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.78 -53.36 58.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.447 1.099 . . . . 0.0 111.056 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -59.36 -42.89 92.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.494 0.718 . . . . 0.0 111.619 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.2 m -60.21 -45.35 93.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.398 1.479 . . . . 0.0 111.609 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.2 m -63.59 -54.83 29.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.463 1.105 . . . . 0.0 110.904 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.42 -43.57 98.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.858 0.863 . . . . 0.0 111.768 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.96 -50.36 74.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.563 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.145 0.884 . . . . 0.0 111.564 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 t -55.97 -58.99 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.901 0.881 . . . . 0.0 110.944 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -74.01 -19.52 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.3 p -89.54 -32.18 17.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.477 1.111 . . . . 0.0 112.716 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.7 t -66.01 -35.85 81.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.112 0.869 . . . . 0.0 111.71 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -156.48 130.04 8.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.675 1.19 . . . . 0.0 112.12 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.8 160.67 17.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.97 0.908 . . . . 0.0 112.468 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t 65.56 83.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.327 1.851 . . . . 0.0 109.728 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.72 130.96 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.784 0.834 . . . . 0.0 110.205 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.3 120.47 42.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.439 1.096 . . . . 0.0 110.018 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.02 120.5 35.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.307 1.043 . . . . 0.0 109.058 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -152.78 -176.14 5.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.641 1.576 . . . . 0.0 110.816 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -78.7 36.1 0.26 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.387 -1.445 . . . . 0.0 113.326 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.59 -173.5 45.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.95 1.262 . . . . 0.0 113.763 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -131.91 -174.05 3.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.749 1.619 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -63.96 -11.69 30.9 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.39 -30.29 69.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.324 1.049 . . . . 0.0 112.318 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -154.43 88.23 3.41 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.37 1.468 . . . . 0.0 110.147 170.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.04 134.55 62.91 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.445 2.764 . . . . 0.0 111.235 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -85.24 130.81 34.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.074 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.4 m -55.73 152.39 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.763 2.025 . . . . 0.0 115.184 -169.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.28 -117.69 4.52 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.53 1.062 . . . . 0.0 112.007 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -48.47 -60.88 2.33 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.526 2.33 . . . . 0.0 112.185 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -43.33 92.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.02 -1.05 . . . . 0.0 112.434 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -57.09 -46.92 82.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -60.48 -46.07 91.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.497 1.119 . . . . 0.0 111.013 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.07 -48.43 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.62 -35.04 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.925 1.239 . . . . 0.0 111.904 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.58 -43.38 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.071 1.348 . . . . 0.0 111.491 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.15 -51.4 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.561 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.01 -53.54 56.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.264 0.938 . . . . 0.0 111.115 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.52 -62.26 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.019 1.328 . . . . 0.0 110.608 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.9 p -68.8 -27.95 66.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.766 1.627 . . . . 0.0 115.271 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -32.53 70.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.311 1.044 . . . . 0.0 110.326 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 116.21 60.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 130.462 3.505 . . . . 0.0 109.989 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.3 150.88 32.65 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.02 162.91 36.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.142 2.561 . . . . 0.0 110.675 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.55 159.65 41.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.938 1.295 . . . . 0.0 110.727 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -133.23 169.39 16.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.48 1.512 . . . . 0.0 108.547 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 p -152.13 155.45 37.88 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.66 -1.275 . . . . 0.0 114.021 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.63 133.17 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.056 1.343 . . . . 0.0 110.027 -170.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -80.46 106.41 12.45 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.902 0.881 . . . . 0.0 111.892 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.38 -27.61 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.593 1.157 . . . . 0.0 113.411 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.37 -2.95 54.51 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.655 1.182 . . . . 0.0 113.532 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -88.63 -10.98 46.7 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -157.4 124.7 5.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.512 1.125 . . . . 0.0 111.946 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.16 -41.24 90.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.399 1.079 . . . . 0.0 113.157 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.53 -37.81 85.82 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.21 0.604 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.54 -52.01 65.14 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.691 0.796 . . . . 0.0 109.908 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.39 -47.27 82.13 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.136 0.974 . . . . 0.0 113.07 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -73.86 -41.46 62.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 0.0 111.398 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -40.48 33.38 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.663 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.68 -31.7 70.94 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.978 1.389 . . . . 0.0 112.064 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.54 -38.55 91.39 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.795 0.838 . . . . 0.0 112.069 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.04 -46.13 53.62 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.224 1.01 . . . . 0.0 111.152 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.1 -46.49 88.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 112.646 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -90.87 -20.21 22.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.0 m 62.92 6.12 2.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.89 1.676 . . . . 0.0 113.544 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -69.13 134.81 89.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.215 1.406 . . . . 0.0 111.911 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.1 -43.68 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 113.686 -169.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p -147.9 113.06 5.53 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.232 1.013 . . . . 0.0 110.945 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.43 158.49 20.55 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.695 1.198 . . . . 0.0 111.538 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.76 173.12 42.09 Favored 'Cis proline' 0 C--N 1.355 0.889 0 CA-C-N 120.839 1.335 . . . . 0.0 115.509 5.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -161.87 152.16 17.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.259 1.024 . . . . 0.0 112.495 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 78' ' ' TYR . 1.6 tt -85.97 148.15 25.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.554 1.942 . . . . 0.0 109.343 171.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.527 ' H ' HD23 ' A' ' 77' ' ' LEU . 34.1 t80 -149.85 139.47 21.64 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.774 2.029 . . . . 0.0 111.217 -171.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.3 pt -149.35 141.76 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.604 1.562 . . . . 0.0 112.174 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.78 -21.5 0.09 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 127.625 2.37 . . . . 0.0 115.926 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.89 5.17 2.23 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.134 2.302 . . . . 0.0 114.343 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.15 161.72 35.38 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.573 1.549 . . . . 0.0 111.19 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -75.21 150.92 38.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.211 -0.931 . . . . 0.0 111.688 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -101.91 -41.44 6.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.138 1.375 . . . . 0.0 111.009 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.53 -162.37 20.7 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 124.653 1.12 . . . . 0.0 114.468 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.9 -176.9 50.12 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.906 1.241 . . . . 0.0 115.615 -169.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.62 -41.13 98.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.306 1.042 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -57.87 -49.55 76.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.215 1.006 . . . . 0.0 111.773 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.4 -43.33 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.063 0.945 . . . . 0.0 110.312 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.0 m -62.75 -44.87 95.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.87 1.268 . . . . 0.0 111.351 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.99 -45.78 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.56 1.144 . . . . 0.0 111.313 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -70.16 -38.18 75.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.893 0.77 . . . . 0.0 112.273 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.42 -30.34 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 113.022 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -65.65 -37.6 86.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.725 1.21 . . . . 0.0 112.174 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.2 -40.34 82.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 0.0 112.77 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.6 p -85.56 -16.54 39.05 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.0 81.3 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.853 1.216 . . . . 0.0 113.217 -173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.69 -27.13 66.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.343 1.057 . . . . 0.0 111.89 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.87 -46.72 83.68 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.818 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.09 -48.66 79.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.401 0.546 . . . . 0.0 110.609 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -57.48 -48.48 79.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.565 0.746 . . . . 0.0 111.611 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -70.0 -38.86 76.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.61 -43.42 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 111.107 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.78 -44.66 95.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.163 0.892 . . . . 0.0 111.371 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.68 -40.26 87.25 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.745 -0.597 . . . . 0.0 111.823 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.74 83.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 113.087 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.06 -38.65 86.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.379 -0.826 . . . . 0.0 111.964 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.7 m -73.77 -37.09 65.1 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.635 2.374 . . . . 0.0 112.357 -172.668 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.51 -58.0 5.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 110.366 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.37 -31.11 72.18 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.242 -0.912 . . . . 0.0 112.429 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -60.66 -39.39 88.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.878 2.071 . . . . 0.0 112.24 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -70.22 -43.57 70.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.61 1.164 . . . . 0.0 111.004 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.3 -52.6 64.91 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.58 0.752 . . . . 0.0 110.485 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.17 -40.93 74.67 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 112.015 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.57 -50.11 73.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.341 -0.849 . . . . 0.0 111.774 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.35 -34.11 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.168 1.349 . . . . 0.0 112.672 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.43 -45.69 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.965 0.906 . . . . 0.0 112.207 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -76.92 -41.33 43.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.64 0.654 . . . . 0.0 112.641 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 m -78.27 -32.44 49.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -127.21 -7.74 5.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 66.44 -56.88 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.434 2.294 . . . . 0.0 114.972 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.08 124.38 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 109.177 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.32 138.64 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.122 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.4 126.05 52.9 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.125 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.81 100.59 12.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -145.29 151.01 37.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.389 1.075 . . . . 0.0 111.514 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.37 -19.67 59.43 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 178.57 34.32 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.999 1.761 . . . . 0.0 112.919 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 p -103.03 172.4 6.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.52 1.528 . . . . 0.0 111.128 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -64.12 -35.82 82.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.93 -15.93 52.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.016 1.326 . . . . 0.0 114.014 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -150.95 88.25 4.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.85 1.26 . . . . 0.0 111.022 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.52 168.97 20.59 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.314 2.676 . . . . 0.0 111.741 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -78.58 -3.23 42.77 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.6 m 72.99 -1.23 3.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.495 2.318 . . . . 0.0 115.236 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.47 -150.5 24.35 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 125.553 1.549 . . . . 0.0 112.754 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -60.37 -25.82 66.16 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.057 0.943 . . . . 0.0 113.174 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -59.01 -48.6 81.02 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.806 1.242 . . . . 0.0 111.554 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.63 -42.69 88.88 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.093 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 m -59.53 -46.69 88.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.366 0.985 . . . . 0.0 112.0 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 t -58.95 -46.06 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.955 0.902 . . . . 0.0 111.557 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -59.55 -45.23 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.143 0.577 . . . . 0.0 111.073 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -65.54 -38.7 90.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.722 1.209 . . . . 0.0 112.257 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mt -58.91 -49.38 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.915 1.286 . . . . 0.0 110.523 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 mt -63.74 -50.12 70.34 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.998 0.919 . . . . 0.0 111.176 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -53.98 -57.68 10.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 110.916 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.7 p -68.66 -27.63 66.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.869 1.668 . . . . 0.0 114.849 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.92 -34.86 72.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.266 0.939 . . . . 0.0 109.828 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.9 t30 118.71 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.504 3.522 . . . . 0.0 110.095 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.99 148.44 20.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.22 170.12 21.04 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.56 2.84 . . . . 0.0 110.605 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -155.08 143.66 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -106.93 89.96 3.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.809 0.843 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.3 p -72.66 81.37 1.12 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.138 -0.976 . . . . 0.0 109.868 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.08 116.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 108.41 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.66 94.67 3.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.702 1.201 . . . . 0.0 111.821 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -74.72 173.74 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.243 1.017 . . . . 0.0 111.313 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.95 -46.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.905 2.082 . . . . 0.0 112.425 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.36 -39.84 94.67 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.329 1.052 . . . . 0.0 112.284 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -95.5 124.23 39.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.64 1.176 . . . . 0.0 110.156 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.68 -26.79 67.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.134 0.974 . . . . 0.0 113.073 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.84 -38.98 93.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.851 0.75 . . . . 0.0 112.289 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.87 -32.98 71.63 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.607 0.763 . . . . 0.0 112.076 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -55.01 -43.78 73.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.208 1.003 . . . . 0.0 112.516 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -91.18 -45.37 8.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.393 1.077 . . . . 0.0 111.333 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.06 90.35 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.774 -1.014 . . . . 0.0 114.706 -169.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.91 -42.14 63.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 111.815 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.63 -40.84 96.29 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.869 -0.519 . . . . 0.0 111.445 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.91 -52.33 50.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.987 0.915 . . . . 0.0 111.447 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.15 -38.67 82.4 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.14 -28.81 25.29 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m 75.99 -4.84 2.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.813 2.445 . . . . 0.0 112.684 -169.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CB ' HE22 ' A' ' 76' ' ' GLN . 24.2 m95 -76.79 137.3 66.46 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.975 -1.078 . . . . 0.0 111.437 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.71 -23.7 3.81 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.78 2.32 . . . . 0.0 111.532 169.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.6 m -96.19 131.17 42.94 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.564 1.546 . . . . 0.0 112.508 -169.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -138.8 151.74 69.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.859 2.063 . . . . 0.0 109.812 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.27 167.66 79.15 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 120.093 1.069 . . . . 0.0 113.317 5.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.422 HE22 ' CB ' ' A' ' 71' ' ' TRP . 8.4 pt20 -160.69 161.07 32.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 113.18 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.75 141.78 30.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.26 2.224 . . . . 0.0 109.801 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.55 131.94 25.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.878 2.071 . . . . 0.0 110.352 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.9 mt -138.74 118.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.878 -1.139 . . . . 0.0 111.476 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.69 32.32 11.78 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.333 1.453 . . . . 0.0 114.249 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.68 65.87 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.601 1.096 . . . . 0.0 115.023 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -103.5 120.73 41.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.841 1.32 . . . . 0.0 111.022 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.01 106.72 8.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.184 0.993 . . . . 0.0 109.669 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -82.66 -31.43 28.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.634 1.173 . . . . 0.0 111.971 -170.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.66 -155.18 16.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.687 1.137 . . . . 0.0 114.892 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.87 177.19 54.25 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.647 1.118 . . . . 0.0 114.922 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 21.9 p -63.94 -44.94 91.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.193 0.997 . . . . 0.0 113.509 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.88 -44.38 97.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.467 0.707 . . . . 0.0 111.38 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.48 -45.31 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.631 0.773 . . . . 0.0 109.722 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -62.41 -47.56 83.59 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.44 -42.88 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 111.35 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -72.47 -34.8 67.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.852 0.751 . . . . 0.0 112.416 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.94 85.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.17 -40.86 86.68 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.768 1.227 . . . . 0.0 112.355 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -64.02 -39.04 93.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.94 0.896 . . . . 0.0 111.964 170.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -77.15 -16.57 59.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.928 0.891 . . . . 0.0 113.361 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.54 80.89 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.095 1.331 . . . . 0.0 113.82 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.11 -47.26 65.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.022 1.329 . . . . 0.0 110.883 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.7 tp -62.27 -42.91 99.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.717 -0.614 . . . . 0.0 110.534 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -59.43 -46.5 88.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.627 0.771 . . . . 0.0 110.537 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -63.98 -49.28 73.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.166 0.586 . . . . 0.0 111.613 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -68.72 -37.27 79.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.462 1.028 . . . . 0.0 112.886 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.14 -45.09 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.203 0.91 . . . . 0.0 110.495 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.63 -46.34 86.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.775 0.716 . . . . 0.0 111.083 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -60.76 -40.17 91.5 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.776 1.23 . . . . 0.0 112.074 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.58 89.47 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.815 0.846 . . . . 0.0 112.1 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -66.88 -33.17 75.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.288 0.635 . . . . 0.0 112.656 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.2 m -71.72 -43.05 66.56 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.453 2.301 . . . . 0.0 112.582 -173.939 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 tt -55.81 -50.92 69.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.443 1.097 . . . . 0.0 110.331 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -60.39 -43.46 96.63 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 0.0 111.68 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -37.77 80.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.426 1.89 . . . . 0.0 112.321 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.4 m -67.6 -49.37 63.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.392 1.077 . . . . 0.0 110.507 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.91 -46.36 85.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 110.976 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.36 -45.67 90.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.177 0.991 . . . . 0.0 112.236 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.328 -0.857 . . . . 0.0 111.781 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.02 -47.5 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.021 0.828 . . . . 0.0 111.15 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.74 -36.55 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.996 1.318 . . . . 0.0 113.123 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 p -84.33 -35.55 23.19 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.173 0.897 . . . . 0.0 112.906 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.3 t -75.58 -42.33 52.35 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -101.82 -6.44 23.59 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 63.47 -59.54 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.792 2.437 . . . . 0.0 114.566 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.3 125.1 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.437 1.495 . . . . 0.0 109.928 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.19 130.56 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.923 0.489 . . . . 0.0 111.369 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 139.42 34.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.56 1.144 . . . . 0.0 110.344 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.09 123.21 43.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 109.497 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -159.49 179.5 8.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.929 1.692 . . . . 0.0 109.855 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -77.91 35.16 0.2 Allowed 'General case' 0 CA--C 1.556 1.191 0 O-C-N 120.068 -1.645 . . . . 0.0 114.037 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.96 161.52 34.83 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.894 1.711 . . . . 0.0 113.77 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.6 p -94.76 -176.01 3.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.887 1.675 . . . . 0.0 111.588 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -67.22 -28.99 68.53 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.361 0.664 . . . . 0.0 111.95 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.12 -29.02 48.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.868 1.267 . . . . 0.0 112.561 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.69 73.95 75.03 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.273 1.429 . . . . 0.0 111.739 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.22 154.83 37.95 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.353 2.702 . . . . 0.0 111.954 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.06 146.19 32.93 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.885 0.874 . . . . 0.0 111.355 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -68.01 161.65 26.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.04 1.336 . . . . 0.0 113.684 -173.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.84 -146.71 21.51 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.696 1.141 . . . . 0.0 112.035 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -57.62 -32.23 67.03 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 m -59.3 -47.43 85.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.609 1.095 . . . . 0.0 112.056 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.67 -46.31 87.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.291 1.037 . . . . 0.0 110.743 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -44.99 91.61 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.871 0.868 . . . . 0.0 110.639 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.59 -43.0 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.645 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.66 -34.06 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.898 1.681 . . . . 0.0 112.158 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.97 -44.34 89.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.602 0.637 . . . . 0.0 111.405 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -59.19 -52.35 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.619 1.168 . . . . 0.0 111.466 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.0 mt -65.13 -47.88 75.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.57 0.748 . . . . 0.0 111.281 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -50.48 -55.94 13.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.903 0.881 . . . . 0.0 110.891 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 m -68.25 -36.08 78.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.823 1.649 . . . . 0.0 114.176 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.59 -32.83 71.92 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.301 1.44 . . . . 0.0 111.076 173.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.6 t30 122.69 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 131.261 3.825 . . . . 0.0 109.815 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.7 137.65 11.54 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.58 61.2 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.47 3.447 . . . . 0.0 109.268 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -62.18 156.53 21.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.452 1.101 . . . . 0.0 112.94 -171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -121.44 170.31 9.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.466 1.107 . . . . 0.0 110.902 171.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 m -149.89 121.59 8.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.293 -1.505 . . . . 0.0 111.46 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -106.92 129.67 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.597 1.559 . . . . 0.0 109.677 -173.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -80.42 107.97 13.66 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.249 0.62 . . . . 0.0 111.42 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.7 pt -64.28 -27.37 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.101 -0.999 . . . . 0.0 112.928 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -0.16 51.63 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.286 1.434 . . . . 0.0 113.385 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.04 -29.46 67.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.776 0.83 . . . . 0.0 112.638 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -159.41 139.64 12.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.82 1.248 . . . . 0.0 110.919 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.05 -40.37 63.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.014 1.726 . . . . 0.0 114.087 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 tp -66.08 -31.32 72.13 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.338 1.055 . . . . 0.0 112.168 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.72 -45.77 41.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.856 0.863 . . . . 0.0 110.016 171.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.09 -44.99 75.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.995 1.318 . . . . 0.0 112.591 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -84.44 -28.77 26.63 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.94 -31.75 64.19 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 124.403 1.002 . . . . 0.0 113.422 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.22 -31.77 70.48 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 1.284 . . . . 0.0 112.511 176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.07 -38.55 91.46 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.154 -0.966 . . . . 0.0 111.873 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -71.51 -40.3 70.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.512 0.725 . . . . 0.0 111.298 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -63.68 -38.03 89.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.937 1.295 . . . . 0.0 113.455 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.1 m -118.01 -19.79 8.98 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p 68.62 -12.09 0.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.611 2.364 . . . . 0.0 114.194 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -61.78 136.79 94.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 125.739 1.616 . . . . 0.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.53 -42.89 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.754 2.303 . . . . 0.0 115.371 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -140.22 108.72 5.87 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.113 0.869 . . . . 0.0 111.681 -169.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.34 162.71 71.22 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.511 1.524 . . . . 0.0 112.173 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.15 163.97 36.33 Favored 'Cis proline' 0 C--N 1.356 0.931 0 N-CA-C 116.027 1.51 . . . . 0.0 116.027 2.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.36 158.31 37.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.363 1.065 . . . . 0.0 111.512 170.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -105.94 138.97 41.21 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.358 1.863 . . . . 0.0 109.295 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.34 141.04 52.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.672 1.989 . . . . 0.0 111.162 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mt -139.03 123.07 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.93 -26.75 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.954 3.302 . . . . 0.0 117.014 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.51 1.39 0.04 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.447 1.975 . . . . 0.0 115.237 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -140.2 157.0 46.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.441 1.62 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -76.48 148.58 37.1 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.695 -0.628 . . . . 0.0 110.954 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -98.66 -43.66 6.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.931 1.292 . . . . 0.0 111.807 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.66 -165.73 24.98 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.276 1.417 . . . . 0.0 113.176 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.84 49.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.488 1.042 . . . . 0.0 112.994 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.8 m -61.48 -32.96 72.99 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.6 -39.15 87.07 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 112.049 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.55 -42.37 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.188 0.595 . . . . 0.0 109.586 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -62.61 -42.68 99.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.263 1.025 . . . . 0.0 111.924 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.46 -41.97 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.754 0.706 . . . . 0.0 111.417 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -67.9 -39.16 83.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.971 0.805 . . . . 0.0 112.281 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.89 81.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 112.617 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.67 -41.78 87.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.016 0.926 . . . . 0.0 112.025 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -68.46 -35.05 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.621 1.168 . . . . 0.0 112.624 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 p -90.02 -12.83 37.44 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.02 -0.17 72.22 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 125.463 1.506 . . . . 0.0 114.652 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.27 -37.26 85.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 111.846 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -66.4 -41.55 89.15 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.078 0.551 . . . . 0.0 111.191 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.82 -47.37 82.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.198 0.599 . . . . 0.0 110.568 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.67 -46.11 91.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.884 0.473 . . . . 0.0 111.947 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -68.56 -40.51 80.58 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.128 0.876 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.57 -39.41 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 118.993 0.815 . . . . 0.0 110.42 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.09 -43.67 91.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.236 0.925 . . . . 0.0 111.027 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -63.54 -38.92 92.97 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.902 -1.124 . . . . 0.0 112.777 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.51 83.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.94 0.791 . . . . 0.0 112.939 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.16 -47.95 10.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.394 1.078 . . . . 0.0 112.97 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.3 m -109.93 -28.3 8.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.283 1.433 . . . . 0.0 114.526 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 127.009 2.124 . . . . 0.0 114.293 177.146 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.72 -53.25 58.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 110.663 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -60.08 -37.46 80.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.1 0.56 . . . . 0.0 112.492 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 m -66.86 -40.84 87.99 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.174 1.79 . . . . 0.0 111.967 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -65.69 -47.25 76.08 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.29 1.036 . . . . 0.0 110.699 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.3 -54.21 48.07 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.748 1.219 . . . . 0.0 110.635 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.24 -43.0 78.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 111.954 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.06 -45.69 91.03 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.28 -0.887 . . . . 0.0 111.894 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.24 -37.82 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.563 1.529 . . . . 0.0 111.875 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.73 -33.74 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.04 0.936 . . . . 0.0 112.993 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 p -90.63 -43.47 10.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.1 p -73.27 -32.01 64.42 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -134.54 70.04 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 109.402 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.73 139.81 38.02 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t 83.52 88.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.958 2.503 . . . . 0.0 107.777 -169.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -108.08 133.03 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.06 0.544 . . . . 0.0 110.099 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.69 123.49 45.77 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.653 0.781 . . . . 0.0 108.965 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -104.98 116.12 31.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.311 1.045 . . . . 0.0 109.683 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.76 -167.99 1.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.042 1.737 . . . . 0.0 110.748 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.56 -1.11 53.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.98 171.64 15.3 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.065 1.793 . . . . 0.0 113.64 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.4 p -103.54 178.01 4.68 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.972 1.709 . . . . 0.0 110.684 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.6 -32.03 73.1 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.341 -0.849 . . . . 0.0 111.937 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.77 -32.92 58.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.936 1.294 . . . . 0.0 112.663 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -137.0 82.2 31.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.138 1.375 . . . . 0.0 110.634 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.63 171.77 16.91 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.786 2.99 . . . . 0.0 111.555 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -86.49 150.4 24.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.916 0.886 . . . . 0.0 111.224 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -72.37 171.31 12.45 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.425 1.49 . . . . 0.0 113.518 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 -136.89 22.02 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.353 0.977 . . . . 0.0 112.239 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -52.14 -40.87 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.747 0.819 . . . . 0.0 112.184 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 m -59.11 -43.61 91.91 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.317 -0.864 . . . . 0.0 112.576 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -62.65 -47.02 85.53 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.415 -0.803 . . . . 0.0 110.522 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.9 m -58.89 -44.47 91.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.017 0.927 . . . . 0.0 110.736 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.97 -44.18 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.006 1.322 . . . . 0.0 112.204 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.9 -43.71 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.901 0.773 . . . . 0.0 110.955 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.01 -40.0 94.27 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 mt -59.69 -53.46 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 112.195 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.17 -47.93 75.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.932 1.242 . . . . 0.0 110.834 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -49.1 -57.06 7.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.949 0.5 . . . . 0.0 110.331 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -67.02 -31.57 72.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.861 1.665 . . . . 0.0 114.266 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.39 -23.09 64.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.89 1.276 . . . . 0.0 111.222 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.8 t30 114.48 32.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 130.961 3.704 . . . . 0.0 112.282 168.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.76 138.42 29.63 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 121.261 -0.899 . . . . 0.0 113.089 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -82.17 49.89 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.457 3.438 . . . . 0.0 109.056 169.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -66.14 169.16 7.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.447 1.899 . . . . 0.0 115.133 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -150.96 130.04 12.62 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.588 0.755 . . . . 0.0 111.043 169.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.1 m -90.39 124.15 34.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.606 -0.684 . . . . 0.0 109.177 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.64 125.48 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 109.251 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -75.09 101.43 4.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.394 0.678 . . . . 0.0 111.026 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -72.36 -24.52 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.28 -1.72 34.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.969 1.308 . . . . 0.0 113.184 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.4 -24.85 66.54 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.574 1.149 . . . . 0.0 112.843 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -154.69 134.58 12.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 111.487 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.79 -41.78 87.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -25.14 67.83 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.701 1.137 . . . . 0.0 113.24 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.32 -46.98 21.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.083 0.953 . . . . 0.0 110.329 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -56.64 -47.86 78.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.874 0.87 . . . . 0.0 112.229 174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.08 -40.56 30.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.192 0.997 . . . . 0.0 112.449 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.01 -28.92 48.42 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.608 -170.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.3 tp -57.59 -36.71 72.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.756 1.278 . . . . 0.0 112.588 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -50.08 -43.8 51.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.362 1.065 . . . . 0.0 112.478 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -83.17 -30.19 28.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.789 0.836 . . . . 0.0 112.592 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -64.68 -39.66 94.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.8 p -88.68 -67.89 0.8 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.227 0.611 . . . . 0.0 111.894 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.2 m 130.05 -12.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 1 C-N-CA 133.598 4.759 . . . . 0.0 111.209 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -66.74 134.28 94.18 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.05 -43.37 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.888 2.392 . . . . 0.0 115.48 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.0 p -142.22 117.69 10.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.152 0.887 . . . . 0.0 112.176 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -60.6 159.19 26.19 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.298 1.439 . . . . 0.0 113.352 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -59.79 161.43 35.68 Favored 'Cis proline' 0 C--N 1.358 1.034 0 N-CA-C 115.672 1.374 . . . . 0.0 115.672 -2.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -154.82 161.91 41.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.38 1.072 . . . . 0.0 111.356 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.89 123.09 40.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.198 1.399 . . . . 0.0 109.418 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -111.31 138.3 47.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.508 1.123 . . . . 0.0 111.291 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 pt -149.89 110.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.727 1.611 . . . . 0.0 112.857 -169.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.24 41.49 32.14 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.994 1.317 . . . . 0.0 114.23 169.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.01 -8.5 69.94 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.265 0.935 . . . . 0.0 114.121 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -104.76 177.61 4.8 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.083 1.753 . . . . 0.0 110.516 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -150.77 161.71 42.11 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.892 1.33 . . . . 0.0 112.624 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -136.12 177.51 7.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.931 2.092 . . . . 0.0 109.898 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.78 -168.01 30.77 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.732 1.634 . . . . 0.0 115.624 -169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.62 -179.73 32.22 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.969 1.271 . . . . 0.0 113.99 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.1 m -67.5 -48.42 67.16 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.61 -42.39 88.06 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 111.811 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.73 -41.67 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.133 0.973 . . . . 0.0 110.593 172.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.2 m -64.16 -41.58 97.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.656 1.182 . . . . 0.0 111.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.12 -44.02 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.829 0.741 . . . . 0.0 111.281 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.92 -36.8 80.8 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.89 0.768 . . . . 0.0 112.476 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.0 83.89 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 112.522 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -65.59 -41.08 93.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.225 1.01 . . . . 0.0 112.322 172.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -68.68 -29.59 68.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.661 0.785 . . . . 0.0 112.647 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -87.39 -13.53 43.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.48 1.112 . . . . 0.0 113.379 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.92 -0.61 84.45 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.49 1.519 . . . . 0.0 114.268 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.9 -39.13 64.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.825 1.25 . . . . 0.0 111.321 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.35 -45.07 92.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.775 0.43 . . . . 0.0 110.626 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.85 -47.9 76.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.084 0.953 . . . . 0.0 111.018 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.17 -47.93 83.89 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.124 0.57 . . . . 0.0 112.063 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -68.9 -42.59 76.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.587 -0.696 . . . . 0.0 112.585 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.99 -40.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.973 0.909 . . . . 0.0 111.153 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.26 -46.45 89.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.449 1.022 . . . . 0.0 110.696 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.52 -44.68 93.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.58 -0.7 . . . . 0.0 111.795 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.43 87.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.002 0.921 . . . . 0.0 113.151 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 85.0 mtp -70.19 -39.76 75.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.603 1.161 . . . . 0.0 112.579 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.22 -34.39 77.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.335 0.654 . . . . 0.0 111.973 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.211 2.605 . . . . 0.0 112.688 173.313 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.3 -52.07 39.69 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.494 1.517 . . . . 0.0 111.018 170.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.74 -42.39 98.91 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.345 -0.847 . . . . 0.0 112.345 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -60.12 -39.08 84.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.25 1.82 . . . . 0.0 111.866 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -68.0 -50.45 55.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.995 1.318 . . . . 0.0 110.379 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.29 -51.28 67.18 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.454 0.702 . . . . 0.0 111.334 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.75 -48.85 76.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.988 0.915 . . . . 0.0 112.112 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.32 -42.74 96.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.94 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.96 -43.75 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.325 -0.859 . . . . 0.0 111.074 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.73 -42.8 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.408 1.483 . . . . 0.0 112.934 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.9 p -76.4 -42.89 42.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.216 0.916 . . . . 0.0 112.329 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.7 p -76.35 -36.05 58.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -95.95 -13.76 23.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.41 -48.24 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.508 2.723 . . . . 0.0 115.032 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.26 120.74 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.493 1.917 . . . . 0.0 108.048 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.65 154.93 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.144 0.578 . . . . 0.0 111.154 -172.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.96 132.65 46.39 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.602 1.161 . . . . 0.0 110.452 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -108.24 114.94 29.2 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.3 ptm -160.73 174.23 14.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.777 1.231 . . . . 0.0 110.615 -169.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -85.3 29.78 0.65 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.014 -1.054 . . . . 0.0 113.274 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.83 172.43 42.59 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.517 1.532 . . . . 0.0 113.089 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.0 p -100.27 178.48 4.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.178 1.391 . . . . 0.0 110.742 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.56 -23.47 62.61 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -84.43 -30.2 25.51 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 112.394 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -132.14 76.0 73.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.614 1.566 . . . . 0.0 110.35 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.39 173.23 14.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.547 2.832 . . . . 0.0 111.001 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -112.27 136.23 51.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.8 0.84 . . . . 0.0 110.735 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.87 149.83 46.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 112.739 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.51 -113.19 3.94 Favored Glycine 0 N--CA 1.468 0.822 0 C-N-CA 124.1 0.857 . . . . 0.0 111.526 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -59.97 -57.12 14.23 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.646 1.178 . . . . 0.0 113.072 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.3 m -62.53 -46.36 88.76 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.387 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -52.23 -47.65 65.59 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.497 1.519 . . . . 0.0 111.341 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -61.57 -50.37 72.92 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.15 0.98 . . . . 0.0 110.54 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -59.13 -47.77 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.012 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.71 -35.44 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.479 1.036 . . . . 0.0 112.098 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -64.97 -38.48 91.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.003 0.819 . . . . 0.0 111.558 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mt -59.82 -51.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.823 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -59.3 -51.14 71.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.553 1.069 . . . . 0.0 111.723 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -51.38 -60.93 2.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.338 1.055 . . . . 0.0 110.654 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 94.1 p -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.046 1.738 . . . . 0.0 115.262 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -58.86 -32.65 69.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.31 1.044 . . . . 0.0 109.892 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 t30 114.63 56.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.717 3.607 . . . . 0.0 109.333 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.62 38.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.45 168.49 14.47 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.721 2.947 . . . . 0.0 112.281 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.46 141.1 15.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.427 1.491 . . . . 0.0 109.583 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -123.98 93.47 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.733 0.813 . . . . 0.0 109.746 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 m -78.93 115.81 18.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.732 -0.605 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.52 125.5 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.809 1.643 . . . . 0.0 108.518 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -78.15 107.46 10.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.714 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.67 -23.76 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.75 -11.38 60.15 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.928 -1.107 . . . . 0.0 112.848 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -70.0 -29.03 66.01 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.879 0.872 . . . . 0.0 113.05 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -154.4 135.44 13.86 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.883 0.765 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.98 -34.24 74.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.54 1.136 . . . . 0.0 111.668 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 -26.14 68.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.044 0.938 . . . . 0.0 112.738 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.65 -56.51 5.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.915 0.78 . . . . 0.0 109.47 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -55.24 -39.43 69.72 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -86.72 -36.87 18.42 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.81 -37.77 21.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.692 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -64.26 -39.43 93.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.533 1.167 . . . . 0.0 112.952 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -58.82 -37.35 76.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.004 0.522 . . . . 0.0 111.9 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.36 -40.63 50.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 111.781 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.56 -45.55 93.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.065 1.346 . . . . 0.0 113.503 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.5 p -95.81 -23.51 16.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 p 78.7 -12.05 1.13 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.944 2.898 . . . . 0.0 113.561 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -81.47 127.08 74.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 121.321 -0.862 . . . . 0.0 110.669 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -83.83 -12.34 8.6 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.419 2.746 . . . . 0.0 116.51 -169.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -123.34 171.13 9.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.98 1.264 . . . . 0.0 112.894 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.13 148.9 69.86 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.042 1.337 . . . . 0.0 110.526 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.42 156.9 69.3 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.894 0.998 . . . . 0.0 114.145 -3.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.37 139.04 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.408 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.59 149.1 21.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.526 1.53 . . . . 0.0 110.453 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -149.58 140.93 23.23 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -144.79 124.58 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.593 1.157 . . . . 0.0 112.405 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 61.7 -17.8 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.329 2.652 . . . . 0.0 117.504 169.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.04 6.17 1.11 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.379 1.942 . . . . 0.0 113.821 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -128.24 144.01 51.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.208 1.803 . . . . 0.0 110.433 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -91.63 163.49 14.09 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.974 1.369 . . . . 0.0 112.791 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -142.37 176.08 9.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.064 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.84 -169.99 39.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.369 -1.287 . . . . 0.0 114.523 -171.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.62 -163.65 35.37 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.878 1.228 . . . . 0.0 113.002 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.12 -50.51 72.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.654 0.782 . . . . 0.0 112.97 -172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -59.78 -43.98 94.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.916 0.78 . . . . 0.0 111.596 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.37 -43.05 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.33 0.652 . . . . 0.0 110.175 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -62.81 -44.2 96.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 111.066 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.68 -45.13 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.898 1.279 . . . . 0.0 111.235 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.31 -38.75 81.9 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.842 0.746 . . . . 0.0 112.237 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.26 80.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.096 0.958 . . . . 0.0 112.485 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -67.52 -38.94 85.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.859 1.264 . . . . 0.0 112.182 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -68.03 -36.52 80.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.061 0.944 . . . . 0.0 111.931 173.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 m -84.28 -16.33 43.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.45 -0.39 80.64 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.107 1.337 . . . . 0.0 114.26 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -68.01 -42.83 80.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.764 1.226 . . . . 0.0 110.926 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.61 -43.78 92.67 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.028 -0.42 . . . . 0.0 110.531 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -55.44 -48.58 74.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.929 0.891 . . . . 0.0 111.182 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.06 -48.64 77.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.281 0.492 . . . . 0.0 111.776 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.85 -39.57 79.86 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.552 -0.718 . . . . 0.0 112.821 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -38.68 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.931 0.893 . . . . 0.0 111.035 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.3 -45.97 92.22 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.38 0.991 . . . . 0.0 111.368 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.95 -39.99 87.44 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.532 -0.73 . . . . 0.0 111.903 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.79 91.97 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.061 0.846 . . . . 0.0 112.899 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.5 mtm -68.28 -35.0 77.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.836 0.855 . . . . 0.0 112.674 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.5 t -65.97 -43.9 86.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.99 0.916 . . . . 0.0 111.891 170.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.255 1.353 0 C-N-CA 129.215 3.006 . . . . 0.0 112.408 174.07 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.51 -57.35 8.44 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.798 1.239 . . . . 0.0 110.947 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -59.88 -41.03 90.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.984 0.514 . . . . 0.0 111.193 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -60.84 -41.66 96.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.262 2.225 . . . . 0.0 112.881 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.5 m -66.91 -50.17 63.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.83 0.852 . . . . 0.0 110.317 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.33 -36.54 84.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.81 -48.72 80.53 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.261 1.024 . . . . 0.0 112.002 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -59.89 -41.67 92.1 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.093 -1.004 . . . . 0.0 111.782 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.66 -53.1 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.328 -0.858 . . . . 0.0 111.739 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.31 -30.24 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.924 1.238 . . . . 0.0 113.233 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.8 p -75.28 -30.14 60.33 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.204 0.911 . . . . 0.0 112.629 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.4 m -78.1 -40.75 37.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -107.07 -9.67 16.12 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 64.61 -47.96 0.32 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.733 2.813 . . . . 0.0 115.299 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -116.12 122.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.258 1.823 . . . . 0.0 109.369 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.36 135.54 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.873 0.869 . . . . 0.0 110.033 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.02 128.79 56.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.616 1.566 . . . . 0.0 108.941 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -108.83 120.14 41.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 109.764 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -156.45 167.34 30.75 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.92 1.688 . . . . 0.0 110.505 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -78.56 31.71 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.93 163.7 31.93 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.356 1.931 . . . . 0.0 113.018 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.1 p -82.06 178.43 8.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 111.199 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -64.31 -26.9 68.69 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.63 0.772 . . . . 0.0 112.449 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.8 -25.76 26.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 113.229 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -119.01 65.02 6.98 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.8 1.64 . . . . 0.0 111.169 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.93 150.05 85.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.059 2.506 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -94.77 115.03 27.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.042 0.537 . . . . 0.0 110.55 -170.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.14 146.44 33.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.838 1.255 . . . . 0.0 112.805 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.76 -149.0 19.19 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -53.44 -41.03 65.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -64.63 -46.51 82.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 112.541 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -57.43 -44.57 84.8 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.403 -0.811 . . . . 0.0 110.452 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -59.08 -43.76 91.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.788 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.1 -42.25 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.422 1.01 . . . . 0.0 111.821 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.67 -47.93 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.689 0.677 . . . . 0.0 110.967 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.43 -37.5 87.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.504 0.722 . . . . 0.0 111.811 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.6 -50.68 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.071 1.748 . . . . 0.0 112.278 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.12 -49.7 73.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.328 0.967 . . . . 0.0 110.82 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -53.12 -54.95 28.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.342 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -30.69 69.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.011 2.124 . . . . 0.0 115.007 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.9 tp -57.16 -31.66 65.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.43 1.092 . . . . 0.0 109.882 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 t30 112.53 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.495 3.518 . . . . 0.0 109.199 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.26 150.28 28.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.54 163.7 35.47 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.364 2.709 . . . . 0.0 110.542 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -161.72 164.95 28.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.595 1.558 . . . . 0.0 110.119 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.2 148.57 48.18 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.055 -0.403 . . . . 0.0 111.21 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.9 m -113.71 117.5 31.69 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 111.32 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.3 t -92.93 122.53 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.119 0.968 . . . . 0.0 109.463 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -81.96 93.16 6.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.404 1.482 . . . . 0.0 111.546 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -77.6 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.574 1.15 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.43 -54.09 0.64 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.653 1.981 . . . . 0.0 112.862 169.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -67.32 -44.36 79.31 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 111.89 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -87.81 128.52 35.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.632 1.173 . . . . 0.0 111.167 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.25 -40.55 86.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 113.341 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -61.79 -41.67 98.03 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.814 0.846 . . . . 0.0 111.22 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.88 -48.16 69.61 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.507 0.723 . . . . 0.0 110.745 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.35 -40.81 62.43 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.221 1.008 . . . . 0.0 112.305 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.22 -36.97 24.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.608 1.163 . . . . 0.0 113.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.62 -23.0 37.74 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.24 174.68 6.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.493 1.146 . . . . 0.0 111.478 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 73.6 -53.07 0.7 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.581 2.352 . . . . 0.0 110.085 -169.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -70.07 -38.71 75.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.63 1.572 . . . . 0.0 112.327 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -63.48 -49.53 73.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -97.01 -15.82 20.88 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p 80.52 -9.47 1.36 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 129.477 3.111 . . . . 0.0 114.227 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -68.7 132.03 91.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.211 -0.93 . . . . 0.0 111.382 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.21 -36.0 2.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.11 2.54 . . . . 0.0 115.007 -169.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -140.57 90.93 2.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.801 0.728 . . . . 0.0 111.454 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -60.77 158.74 30.34 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.303 1.441 . . . . 0.0 110.814 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.46 162.25 37.53 Favored 'Cis proline' 0 C--N 1.358 1.035 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 1.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 152.65 7.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.128 1.371 . . . . 0.0 112.53 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -93.77 146.78 23.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.046 1.339 . . . . 0.0 111.196 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -138.58 138.73 38.2 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.013 2.125 . . . . 0.0 110.675 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -143.29 127.18 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.307 1.443 . . . . 0.0 111.632 -172.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 51.87 23.15 1.98 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.28 41.96 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.809 1.195 . . . . 0.0 115.32 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.32 150.21 45.13 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.209 1.504 . . . . 0.0 111.215 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.83 150.04 29.31 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.989 -1.069 . . . . 0.0 111.967 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -97.72 -47.55 5.56 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.215 1.006 . . . . 0.0 111.638 173.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 145.95 -172.55 26.57 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.287 1.422 . . . . 0.0 112.81 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.26 164.18 41.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.413 1.006 . . . . 0.0 113.544 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.0 m -66.89 -41.75 86.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.625 -0.927 . . . . 0.0 112.874 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.02 -43.91 94.95 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.403 -0.811 . . . . 0.0 111.306 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.92 -42.1 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 109.978 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.2 m -63.0 -43.02 99.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.041 1.336 . . . . 0.0 111.581 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.8 t -60.02 -45.46 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.467 0.707 . . . . 0.0 111.346 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -71.32 -32.78 69.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.912 0.778 . . . . 0.0 112.82 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.73 80.09 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.011 -1.056 . . . . 0.0 112.783 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -63.3 -43.31 98.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.811 0.845 . . . . 0.0 112.071 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.19 -32.86 74.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.991 0.516 . . . . 0.0 112.222 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -86.92 -11.76 49.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.408 1.083 . . . . 0.0 113.614 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.81 -0.16 87.81 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.525 1.536 . . . . 0.0 114.582 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.83 -36.1 59.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 111.251 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.5 tp -64.42 -43.64 93.74 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.675 -0.641 . . . . 0.0 110.708 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -55.69 -48.39 75.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.454 0.702 . . . . 0.0 110.552 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.52 -47.89 82.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.358 0.663 . . . . 0.0 111.899 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -73.47 -35.03 65.65 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.28 -42.34 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.473 1.033 . . . . 0.0 110.793 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.01 -45.97 89.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.277 0.944 . . . . 0.0 111.03 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.83 -43.75 94.42 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.605 -0.685 . . . . 0.0 111.993 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.41 92.79 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.173 0.989 . . . . 0.0 112.868 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.02 -35.47 74.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.242 1.017 . . . . 0.0 112.549 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.19 -38.09 87.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.302 0.641 . . . . 0.0 112.059 170.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.732 2.413 . . . . 0.0 112.578 170.909 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.86 -47.04 79.34 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.97 0.804 . . . . 0.0 110.354 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.76 -43.83 90.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.023 0.529 . . . . 0.0 111.633 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.9 m -65.48 -43.89 88.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.042 1.737 . . . . 0.0 111.566 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -61.8 -53.4 56.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.941 0.897 . . . . 0.0 110.425 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.81 -50.16 75.01 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.625 0.77 . . . . 0.0 111.36 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -56.53 -49.19 75.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 112.359 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.88 -46.31 85.49 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.563 -0.711 . . . . 0.0 111.966 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.48 -48.28 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.86 0.755 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.37 -20.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 p -93.41 -37.31 12.05 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.976 0.807 . . . . 0.0 112.932 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 t -74.04 -43.02 59.37 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.87 0.759 . . . . 0.0 112.317 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -97.43 -10.54 25.24 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mttm 63.09 -40.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.072 2.549 . . . . 0.0 116.139 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -120.79 128.11 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.066 1.746 . . . . 0.0 108.731 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.09 139.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.49 0.586 . . . . 0.0 112.422 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.17 129.45 56.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.171 1.388 . . . . 0.0 110.643 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -107.53 128.92 54.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.967 0.907 . . . . 0.0 111.04 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -162.58 -175.56 4.54 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.858 1.663 . . . . 0.0 110.851 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -76.6 51.48 0.74 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.25 -1.531 . . . . 0.0 112.412 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.96 168.02 30.42 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.695 1.14 . . . . 0.0 114.305 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.7 p -113.15 -175.73 2.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.258 1.823 . . . . 0.0 111.401 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.88 -32.76 74.61 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.543 -0.723 . . . . 0.0 112.119 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.46 -32.72 42.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.834 1.253 . . . . 0.0 112.667 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -122.81 77.68 48.98 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.217 1.407 . . . . 0.0 110.636 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 164.85 33.07 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -107.34 138.35 43.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.999 0.919 . . . . 0.0 111.755 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.4 m -66.48 157.93 30.85 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.068 1.347 . . . . 0.0 113.849 -172.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 -118.92 4.73 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.392 0.996 . . . . 0.0 112.271 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -59.1 -46.17 88.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.295 1.038 . . . . 0.0 112.883 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.7 m -69.79 -44.21 70.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.906 -1.121 . . . . 0.0 112.146 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.19 -46.66 69.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.755 1.222 . . . . 0.0 110.832 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -59.9 -50.37 74.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.416 1.086 . . . . 0.0 110.539 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 t -61.56 -44.56 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.246 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.82 -34.89 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.424 1.465 . . . . 0.0 111.545 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -68.03 -37.43 81.35 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.242 0.928 . . . . 0.0 112.524 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.68 -51.41 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.774 1.23 . . . . 0.0 110.777 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.55 -51.27 70.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.804 0.729 . . . . 0.0 111.266 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -47.24 -59.2 3.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.087 0.555 . . . . 0.0 109.991 174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m -62.97 -33.97 76.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.602 1.961 . . . . 0.0 114.103 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.81 -21.4 66.41 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.295 1.438 . . . . 0.0 111.951 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 109.02 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 131.51 3.924 . . . . 0.0 110.697 169.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 136.53 24.31 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -169.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -83.58 48.18 2.55 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.549 3.5 . . . . 0.0 109.665 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.44 164.53 18.56 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -169.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -130.89 170.05 14.95 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.722 1.609 . . . . 0.0 110.038 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -147.99 137.64 22.43 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.088 -1.632 . . . . 0.0 110.761 170.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.4 140.49 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.106 0.962 . . . . 0.0 110.529 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.49 142.99 35.33 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.0 pt -89.01 -174.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.432 1.093 . . . . 0.0 109.718 168.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt 71.16 174.91 0.3 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.553 2.341 . . . . 0.0 113.869 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 78.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.527 2.731 . . . . 0.0 110.854 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.95 141.5 54.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.636 0.774 . . . . 0.0 111.007 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.65 -37.91 74.17 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.034 -1.041 . . . . 0.0 113.429 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.21 -26.41 66.6 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.072 -1.018 . . . . 0.0 111.75 176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.82 -15.96 40.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.418 1.087 . . . . 0.0 113.237 170.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -80.57 -51.96 8.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.094 1.316 . . . . 0.0 111.677 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.39 -20.78 8.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -170.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.08 -30.72 69.62 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 120.975 -1.078 . . . . 0.0 113.388 -170.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.85 -41.27 91.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.765 1.283 . . . . 0.0 111.52 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.47 -45.38 91.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.72 -0.612 . . . . 0.0 110.834 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -68.72 -38.53 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.311 0.644 . . . . 0.0 112.736 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -70.04 -44.96 68.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.988 0.813 . . . . 0.0 112.531 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.99 -17.96 33.89 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m 69.81 -5.42 1.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.297 2.239 . . . . 0.0 113.756 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -74.93 127.56 86.67 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.764 1.226 . . . . 0.0 111.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.6 143.33 21.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.154 2.569 . . . . 0.0 110.27 172.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p 64.53 -161.35 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.782 2.033 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -146.19 163.56 29.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.79 2.036 . . . . 0.0 110.675 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.16 172.64 17.17 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 120.229 1.117 . . . . 0.0 114.875 -6.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.78 121.89 21.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.815 1.246 . . . . 0.0 108.435 170.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.14 123.38 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.181 0.992 . . . . 0.0 109.541 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -106.48 134.74 49.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.615 1.566 . . . . 0.0 110.911 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.3 pt -129.96 112.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 111.306 172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.43 17.57 4.94 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.556 1.942 . . . . 0.0 114.469 172.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.07 -3.53 41.04 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.155 1.836 . . . . 0.0 114.62 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -100.99 149.14 24.23 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 111.402 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -103.16 132.2 49.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.253 1.421 . . . . 0.0 111.046 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -99.28 -28.86 13.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.128 0.971 . . . . 0.0 113.45 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.78 -156.8 18.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.468 1.508 . . . . 0.0 111.743 -169.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.44 169.19 41.05 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.704 1.145 . . . . 0.0 114.141 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.9 m -57.65 -34.31 69.22 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.15 -40.92 95.65 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.38 -0.825 . . . . 0.0 111.802 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.23 -40.92 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.678 0.791 . . . . 0.0 109.937 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 m -61.39 -44.64 96.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.046 0.938 . . . . 0.0 111.665 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.69 -43.62 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.324 0.65 . . . . 0.0 111.485 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.99 -41.73 95.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.259 0.936 . . . . 0.0 111.987 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.62 -31.26 71.15 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.76 0.824 . . . . 0.0 113.17 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -67.91 -35.74 78.98 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.985 -1.072 . . . . 0.0 111.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.29 -32.35 66.52 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.9 p -88.15 -15.75 35.25 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.734 1.152 . . . . 0.0 113.76 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.57 1.01 78.38 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 125.306 1.431 . . . . 0.0 113.955 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.89 -30.37 68.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.288 . . . . 0.0 111.999 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.62 -47.65 69.02 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.556 -0.715 . . . . 0.0 110.165 172.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -56.41 -47.46 78.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 110.923 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.79 -50.67 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.51 0.724 . . . . 0.0 111.852 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -73.1 -36.74 66.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.279 -0.888 . . . . 0.0 113.183 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.28 -38.32 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.367 0.985 . . . . 0.0 111.087 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.05 -46.35 91.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.273 0.942 . . . . 0.0 110.866 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.57 -36.26 80.13 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.402 -0.811 . . . . 0.0 112.738 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.69 -36.61 84.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.158 0.983 . . . . 0.0 112.683 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 72.9 mtm -73.18 -41.28 64.03 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.555 0.742 . . . . 0.0 112.254 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.87 -39.37 69.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 129.718 3.207 . . . . 0.0 115.76 -176.829 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.64 -62.61 1.62 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.516 1.127 . . . . 0.0 110.998 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -66.57 -30.72 71.08 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.62 -0.675 . . . . 0.0 112.172 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -63.32 -46.29 87.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.807 1.643 . . . . 0.0 111.668 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -65.29 -48.68 72.31 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.776 0.83 . . . . 0.0 110.651 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.11 -55.04 35.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.153 0.981 . . . . 0.0 110.735 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.85 -46.59 74.67 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 111.713 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.7 -51.59 69.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.796 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.78 -36.49 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.4 1.454 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.89 -13.9 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.924 1.238 . . . . 0.0 113.763 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -102.41 -38.15 7.72 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.22 0.918 . . . . 0.0 113.107 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 t -80.13 -50.57 10.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.988 0.813 . . . . 0.0 111.853 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -88.79 -15.09 35.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.34 -0.85 . . . . 0.0 112.731 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.04 -52.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.913 2.885 . . . . 0.0 115.241 172.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 t -102.08 116.83 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.43 1.492 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -135.64 133.34 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.148 0.431 . . . . 0.0 110.893 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.02 138.2 44.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.004 1.722 . . . . 0.0 109.2 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -125.18 117.61 24.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.53 1.132 . . . . 0.0 110.186 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -167.25 -170.5 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.99 2.116 . . . . 0.0 109.589 -176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -81.04 -32.37 34.12 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.218 1.372 . . . . 0.0 112.517 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 154.54 47.47 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.193 1.378 . . . . 0.0 113.387 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -96.8 -179.59 4.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.734 1.614 . . . . 0.0 110.789 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.47 -18.76 60.58 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.106 -0.996 . . . . 0.0 113.554 172.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.9 -27.64 23.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 112.355 171.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.38 72.77 80.64 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.733 1.613 . . . . 0.0 111.058 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.56 157.09 59.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.006 2.471 . . . . 0.0 110.994 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.03 126.91 33.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.204 0.602 . . . . 0.0 111.133 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.1 t -59.22 143.68 48.35 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.781 1.232 . . . . 0.0 112.178 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.07 -146.11 18.06 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.919 1.247 . . . . 0.0 111.61 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -55.45 -36.69 66.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -169.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 m -64.55 -47.07 80.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.898 1.226 . . . . 0.0 112.404 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -57.73 -43.76 85.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.307 0.958 . . . . 0.0 110.648 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 m -58.83 -46.95 86.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.114 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.4 -42.23 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.173 0.989 . . . . 0.0 112.13 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -59.91 -45.72 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.433 0.693 . . . . 0.0 110.872 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.68 -41.41 96.07 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.594 0.757 . . . . 0.0 111.912 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.49 -52.01 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 111.608 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.14 -50.29 68.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.801 0.728 . . . . 0.0 110.438 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -50.4 -56.36 11.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.798 0.839 . . . . 0.0 110.691 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.53 -31.56 70.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.35 1.86 . . . . 0.0 114.638 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.01 -29.18 68.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 0.0 110.659 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 112.88 63.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 130.163 3.385 . . . . 0.0 109.71 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.32 154.74 34.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.39 173.95 13.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.232 2.621 . . . . 0.0 110.336 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -161.15 145.87 13.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 109.773 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -123.33 95.2 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.919 0.888 . . . . 0.0 109.833 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.4 m -76.07 97.35 4.04 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.934 -1.104 . . . . 0.0 110.667 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.77 129.47 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.513 1.925 . . . . 0.0 110.137 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -74.41 107.59 6.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.83 0.852 . . . . 0.0 110.953 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.49 -28.75 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -20.4 49.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.331 1.052 . . . . 0.0 112.87 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.69 -42.83 93.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.207 1.403 . . . . 0.0 113.687 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -119.55 129.9 54.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.926 0.891 . . . . 0.0 111.551 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.4 -30.2 71.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.6 -52.47 17.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.992 0.814 . . . . 0.0 110.702 173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.46 -33.17 70.96 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.455 1.502 . . . . 0.0 112.417 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.07 -22.06 62.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.378 1.871 . . . . 0.0 113.523 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.47 -56.15 1.62 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.656 1.182 . . . . 0.0 113.427 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -19.03 79.82 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.42 -34.36 72.39 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.489 1.145 . . . . 0.0 112.584 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -59.04 -37.39 76.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.245 1.018 . . . . 0.0 112.523 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.96 -30.92 27.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.514 1.126 . . . . 0.0 112.179 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -62.6 -41.47 99.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.77 0.828 . . . . 0.0 112.447 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.5 p -82.12 -68.21 0.72 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.381 0.673 . . . . 0.0 111.953 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.2 m 123.31 -13.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 133.293 4.637 . . . . 0.0 111.099 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -70.45 128.32 91.3 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.059 1.344 . . . . 0.0 112.003 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.18 140.11 13.75 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.37 2.713 . . . . 0.0 110.625 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.6 p 64.9 -174.55 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.563 2.345 . . . . 0.0 113.108 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -138.32 159.96 65.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.139 1.776 . . . . 0.0 110.476 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.89 165.51 35.68 Favored 'Cis proline' 0 C--N 1.355 0.877 0 N-CA-C 115.739 1.399 . . . . 0.0 115.739 1.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -141.89 132.78 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.253 1.421 . . . . 0.0 109.559 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.59 138.19 40.61 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.026 1.331 . . . . 0.0 108.75 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -134.95 137.2 42.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.917 1.687 . . . . 0.0 110.773 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.2 124.53 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.973 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.34 49.78 5.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.917 2.087 . . . . 0.0 114.845 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.25 3.06 73.02 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.362 -1.243 . . . . 0.0 115.435 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.09 143.48 50.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.347 1.573 . . . . 0.0 111.835 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -82.97 142.4 31.41 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.754 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -94.44 -33.62 13.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.221 1.008 . . . . 0.0 112.101 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.31 -153.93 16.81 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.62 1.581 . . . . 0.0 112.008 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.98 162.36 37.04 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.398 0.999 . . . . 0.0 113.114 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.9 m -58.26 -33.72 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.16 -44.98 84.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 0.0 111.817 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.0 -42.47 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.934 0.893 . . . . 0.0 109.606 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.7 m -62.7 -46.42 88.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.369 1.068 . . . . 0.0 111.911 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.88 -41.89 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.388 0.54 . . . . 0.0 111.342 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.58 -34.23 65.01 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.977 0.808 . . . . 0.0 112.868 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.43 80.62 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.022 -1.049 . . . . 0.0 112.178 173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.11 -39.56 82.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.804 0.841 . . . . 0.0 112.437 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.74 -34.38 77.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.347 0.659 . . . . 0.0 111.971 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.07 -12.11 53.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.215 1.006 . . . . 0.0 113.571 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.49 -6.2 82.79 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 125.855 1.693 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -68.79 -37.41 79.27 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.01 1.324 . . . . 0.0 111.55 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.02 -40.73 96.69 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.933 -0.48 . . . . 0.0 111.17 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -60.74 -48.12 83.23 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.376 0.535 . . . . 0.0 109.8 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.2 -44.48 97.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.348 0.659 . . . . 0.0 112.01 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.28 -35.44 76.04 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.382 -0.824 . . . . 0.0 113.057 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.08 -41.39 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.528 1.058 . . . . 0.0 110.672 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -59.59 -45.78 90.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.352 0.978 . . . . 0.0 110.913 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -57.8 -43.05 85.39 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.472 -0.767 . . . . 0.0 111.674 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.19 66.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.85 -36.82 14.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.631 0.772 . . . . 0.0 113.021 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.92 -25.39 26.15 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.255 1.395 0 C-N-CA 128.163 2.585 . . . . 0.0 113.275 174.484 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.87 -48.15 77.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.519 0.727 . . . . 0.0 110.421 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.39 -42.9 88.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.769 -0.582 . . . . 0.0 112.081 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -66.96 -38.94 87.02 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.243 1.817 . . . . 0.0 111.884 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -63.82 -49.89 71.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.175 0.99 . . . . 0.0 110.475 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.91 -43.7 95.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.07 0.948 . . . . 0.0 111.394 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.63 -45.13 92.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.075 0.852 . . . . 0.0 112.618 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.4 -42.57 96.22 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -0.934 . . . . 0.0 111.356 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -60.82 -48.63 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.277 -0.89 . . . . 0.0 111.583 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.02 -38.03 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.553 1.141 . . . . 0.0 113.44 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -81.34 -33.36 32.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.938 0.895 . . . . 0.0 112.824 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -77.59 -32.26 53.5 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.23 112.42 11.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.145 1.378 . . . . 0.0 110.437 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -59.86 -38.16 81.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.95 134.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.192 1.797 . . . . 0.0 109.171 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.24 130.52 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.464 1.106 . . . . 0.0 109.903 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.19 127.21 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.084 0.954 . . . . 0.0 110.272 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.99 124.47 52.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -164.91 -177.82 4.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.846 1.658 . . . . 0.0 110.433 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.61 38.1 0.61 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.46 -1.4 . . . . 0.0 113.114 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.83 160.62 31.64 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 125.339 1.447 . . . . 0.0 113.368 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 p -96.93 -179.42 4.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.372 1.469 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.25 -29.75 68.63 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.608 -0.683 . . . . 0.0 112.337 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.55 -34.18 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.039 1.336 . . . . 0.0 112.502 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.01 76.2 67.13 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.612 1.565 . . . . 0.0 110.365 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.84 170.98 19.17 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.433 2.756 . . . . 0.0 111.569 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -114.02 136.51 52.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.98 0.912 . . . . 0.0 110.397 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.0 t -71.16 156.29 39.75 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.493 1.117 . . . . 0.0 112.313 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.49 -149.42 19.24 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 125.36 1.457 . . . . 0.0 111.803 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.03 -30.17 65.92 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -56.74 -53.37 58.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.314 1.446 . . . . 0.0 111.653 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.29 -40.29 89.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.373 -0.829 . . . . 0.0 110.653 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -58.59 -50.11 75.01 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.724 0.809 . . . . 0.0 111.321 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.21 -35.58 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.648 1.113 . . . . 0.0 112.517 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.27 -47.31 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.208 0.913 . . . . 0.0 111.054 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -65.04 -39.64 93.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.862 0.865 . . . . 0.0 112.312 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt -56.66 -49.49 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.59 1.156 . . . . 0.0 111.996 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.66 -51.33 67.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.078 0.854 . . . . 0.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -49.02 -57.06 7.16 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.458 0.703 . . . . 0.0 110.128 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 t -65.68 -33.58 76.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.832 2.053 . . . . 0.0 114.605 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.59 -28.31 67.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.819 0.736 . . . . 0.0 111.123 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 t30 110.96 57.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.96 3.304 . . . . 0.0 109.621 169.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 142.77 22.28 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.88 162.44 26.59 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.137 3.225 . . . . 0.0 110.499 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -163.65 165.94 22.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.255 1.022 . . . . 0.0 112.285 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.25 162.19 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 108.257 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.8 m -144.52 128.43 17.42 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 119.979 -1.701 . . . . 0.0 111.483 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.9 131.19 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.813 1.245 . . . . 0.0 110.289 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -75.7 110.02 9.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.136 0.574 . . . . 0.0 110.849 174.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -61.0 -29.74 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -87.57 8.13 26.52 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.671 1.188 . . . . 0.0 113.208 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.87 -31.07 71.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.955 0.902 . . . . 0.0 113.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.33 154.5 30.69 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.193 0.997 . . . . 0.0 111.693 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.716 1.207 . . . . 0.0 113.91 -169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.27 -31.85 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.39 -54.95 15.98 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.743 0.817 . . . . 0.0 110.963 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -57.87 -29.85 65.35 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.6 -37.99 11.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.98 -32.19 27.03 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 118.904 0.775 . . . . 0.0 113.428 -172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.38 -36.94 74.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.881 0.872 . . . . 0.0 112.222 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.29 -53.34 45.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.151 1.38 . . . . 0.0 112.63 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -81.66 -23.88 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -67.08 -48.86 66.94 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.937 0.79 . . . . 0.0 112.471 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.0 p -77.84 -46.8 20.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.017 0.826 . . . . 0.0 112.081 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m 122.87 -26.11 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 1 C-N-CA 132.879 4.471 . . . . 0.0 112.693 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.08 142.14 68.3 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.514 -0.741 . . . . 0.0 112.034 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.12 -13.17 11.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.027 2.485 . . . . 0.0 116.162 -169.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -138.67 169.25 18.12 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.892 1.224 . . . . 0.0 112.521 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -137.06 155.85 75.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.737 1.615 . . . . 0.0 110.719 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.17 156.6 47.72 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.602 1.251 . . . . 0.0 115.281 -1.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.73 134.76 8.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.338 1.055 . . . . 0.0 110.968 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.48 140.99 38.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 111.197 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -131.97 132.6 43.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.252 1.821 . . . . 0.0 109.239 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.28 125.21 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.204 1.002 . . . . 0.0 109.348 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.3 22.83 5.09 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.34 48.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.308 0.956 . . . . 0.0 114.932 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.13 145.13 45.5 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.001 1.4 . . . . 0.0 110.993 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -76.87 143.9 39.36 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.265 -0.897 . . . . 0.0 111.97 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -103.76 -26.75 12.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.512 1.125 . . . . 0.0 112.055 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.36 -168.66 12.95 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 125.427 1.489 . . . . 0.0 113.55 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.36 172.67 55.12 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.789 1.185 . . . . 0.0 114.085 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 83.6 m -65.83 -41.99 91.11 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -63.45 -42.65 98.66 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.73 0.696 . . . . 0.0 111.376 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.63 -42.79 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 0.0 109.987 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -64.0 -42.78 97.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.935 1.294 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.39 -39.95 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.062 0.945 . . . . 0.0 111.519 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.22 -39.5 82.37 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.453 1.024 . . . . 0.0 112.435 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.68 91.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.72 0.808 . . . . 0.0 112.352 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -61.33 -45.2 95.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.243 1.417 . . . . 0.0 112.313 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -67.51 -29.17 68.52 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.966 0.906 . . . . 0.0 112.636 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -88.01 -12.85 43.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.459 1.104 . . . . 0.0 113.446 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.17 -1.44 87.62 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.65 1.595 . . . . 0.0 114.428 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.93 -35.29 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 111.822 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -49.06 76.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.423 0.689 . . . . 0.0 110.042 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -56.72 -49.03 76.4 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.122 0.969 . . . . 0.0 110.711 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.05 -46.91 88.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.405 0.682 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.94 -36.17 77.64 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.51 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.543 1.065 . . . . 0.0 110.751 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.58 -46.52 89.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.703 1.138 . . . . 0.0 111.36 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.11 -39.95 88.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.922 . . . . 0.0 112.555 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.05 78.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.572 -0.705 . . . . 0.0 111.966 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 mmt -67.27 -38.19 84.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.865 0.866 . . . . 0.0 112.805 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.5 -23.97 42.61 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.255 1.373 0 C-N-CA 127.265 2.226 . . . . 0.0 112.811 177.518 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.43 -54.43 43.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.819 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.26 -37.71 84.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -65.05 -40.99 95.54 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.883 1.673 . . . . 0.0 111.887 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.9 m -63.42 -48.18 78.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.861 0.864 . . . . 0.0 110.737 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.63 -49.32 77.95 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.247 0.619 . . . . 0.0 111.565 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.81 -45.16 86.53 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.668 0.787 . . . . 0.0 112.373 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -61.4 -44.66 96.76 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 111.787 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.9 -46.95 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.201 0.909 . . . . 0.0 111.484 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -60.19 -43.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 112.107 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -78.36 -29.05 47.26 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 m -79.96 -39.03 31.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.28 -10.97 12.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 60.97 -58.87 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.059 2.544 . . . . 0.0 114.813 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.46 125.77 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.414 1.486 . . . . 0.0 108.877 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.79 128.07 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.018 0.927 . . . . 0.0 110.761 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.42 142.13 34.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.038 1.335 . . . . 0.0 110.32 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.16 119.23 35.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.525 1.53 . . . . 0.0 109.624 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -174.19 -169.16 0.44 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.677 1.991 . . . . 0.0 110.038 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -91.59 -18.44 24.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.01 156.06 30.72 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.154 1.359 . . . . 0.0 113.143 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.7 p -86.85 177.31 7.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.073 1.349 . . . . 0.0 111.446 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.67 -28.78 69.84 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -87.68 -33.3 18.82 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.02 1.328 . . . . 0.0 112.475 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -120.56 84.7 36.85 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.13 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 139.35 52.03 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.523 2.149 . . . . 0.0 108.868 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -0.31 56.25 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.0 t -160.24 163.44 33.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.146 1.379 . . . . 0.0 111.613 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.61 -32.59 84.68 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.029 0.823 . . . . 0.0 113.058 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -73.3 -46.26 50.63 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.332 1.066 . . . . 0.0 112.364 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -62.31 -45.67 92.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.562 -0.712 . . . . 0.0 110.914 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.76 -46.72 74.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.094 0.958 . . . . 0.0 111.279 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.6 m -59.34 -51.61 69.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.092 0.957 . . . . 0.0 110.762 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.81 -37.89 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.846 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.16 -34.14 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 120.656 1.571 . . . . 0.0 111.92 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.02 -44.34 89.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.637 0.653 . . . . 0.0 111.223 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.04 -51.69 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 111.034 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.0 -50.61 71.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.401 1.08 . . . . 0.0 110.591 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.79 -51.43 68.97 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.184 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -68.23 -32.7 73.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.433 1.493 . . . . 0.0 114.05 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.45 -32.67 70.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.908 1.283 . . . . 0.0 110.609 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 118.7 72.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 129.989 3.316 . . . . 0.0 110.711 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.45 140.9 13.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.96 158.39 34.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.141 2.561 . . . . 0.0 108.248 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.88 172.6 17.76 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.51 155.3 42.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.911 1.284 . . . . 0.0 110.367 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -118.26 129.87 55.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.44 -0.787 . . . . 0.0 110.821 172.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -97.06 121.89 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.661 1.184 . . . . 0.0 108.485 173.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -74.23 90.47 2.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.593 1.157 . . . . 0.0 110.191 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pt -69.81 -17.51 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 -1.92 55.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.717 1.207 . . . . 0.0 113.116 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -64.25 -28.77 69.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.141 0.882 . . . . 0.0 112.975 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -159.27 162.27 36.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.242 1.417 . . . . 0.0 112.111 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.85 -31.58 70.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.533 -0.729 . . . . 0.0 112.781 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.63 -39.83 95.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.83 0.741 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.52 -51.49 56.08 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.89 -0.506 . . . . 0.0 110.914 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -56.01 -44.99 79.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.216 1.006 . . . . 0.0 112.858 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -83.34 -24.82 31.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.646 0.778 . . . . 0.0 112.658 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.57 -40.02 6.51 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.296 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.17 -33.55 74.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.493 1.647 . . . . 0.0 113.401 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -60.82 -31.38 70.79 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -83.45 -34.85 25.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.185 0.994 . . . . 0.0 112.158 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.23 -42.32 94.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.217 1.007 . . . . 0.0 112.337 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.9 p -83.47 -67.54 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.829 0.852 . . . . 0.0 112.695 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.6 m 135.05 -23.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 133.341 4.657 . . . . 0.0 111.218 -173.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -83.81 132.17 49.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.23 1.012 . . . . 0.0 111.775 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.02 -25.83 2.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.826 2.351 . . . . 0.0 114.72 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -95.93 151.55 19.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.563 1.145 . . . . 0.0 111.521 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -127.83 151.12 75.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.652 1.581 . . . . 0.0 110.605 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.79 155.95 52.55 Favored 'Cis proline' 0 C--N 1.355 0.869 0 CA-C-N 120.694 1.283 . . . . 0.0 114.422 -2.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -150.49 143.08 24.5 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.987 0.915 . . . . 0.0 110.728 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 tp -110.32 146.81 35.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.317 1.447 . . . . 0.0 111.458 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -148.76 137.81 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.825 2.05 . . . . 0.0 109.392 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -142.62 122.54 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.183 -0.948 . . . . 0.0 111.611 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.83 33.64 6.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.563 1.945 . . . . 0.0 115.284 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.95 -0.78 51.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.813 1.197 . . . . 0.0 115.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.51 141.0 48.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.033 1.417 . . . . 0.0 110.763 173.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -84.1 144.25 29.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.448 -0.783 . . . . 0.0 110.669 170.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.93 -31.69 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.969 0.908 . . . . 0.0 112.285 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.48 -151.2 17.06 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.055 1.312 . . . . 0.0 112.134 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.58 162.69 49.38 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 124.157 0.884 . . . . 0.0 112.934 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -56.23 -35.89 67.86 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.3 -39.97 84.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.633 0.773 . . . . 0.0 112.036 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.39 -42.22 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.406 0.682 . . . . 0.0 109.848 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 m -62.07 -47.27 85.45 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.469 1.108 . . . . 0.0 111.051 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.11 -44.72 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 0.0 111.338 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.35 -37.26 77.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.897 0.771 . . . . 0.0 112.444 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -29.91 70.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 113.048 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -70.85 -33.6 70.81 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.339 -0.851 . . . . 0.0 112.267 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.55 -40.38 76.85 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.9 p -81.05 -17.53 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.201 -0.937 . . . . 0.0 113.208 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.79 69.83 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.336 1.446 . . . . 0.0 113.57 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -36.93 84.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.95 1.3 . . . . 0.0 111.889 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.61 -40.68 97.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.321 0.648 . . . . 0.0 111.189 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.97 -44.34 94.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.965 0.506 . . . . 0.0 110.039 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -61.92 -44.17 97.33 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.326 173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -69.22 -38.84 78.76 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.796 1.18 . . . . 0.0 112.439 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.86 -39.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 118.859 0.754 . . . . 0.0 110.626 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.85 -45.88 92.78 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.132 0.878 . . . . 0.0 111.37 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -59.15 -44.85 92.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.97 0.908 . . . . 0.0 111.772 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.04 96.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.755 1.222 . . . . 0.0 112.807 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.9 mmt -73.57 -33.98 64.92 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.333 -0.854 . . . . 0.0 112.092 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.67 -47.0 70.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.037 0.935 . . . . 0.0 112.628 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.258 1.508 0 C-N-CA 128.755 2.822 . . . . 0.0 114.702 -175.249 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.453 0.168 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.42 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.18 -60.16 3.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.98 1.312 . . . . 0.0 113.225 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 -43.19 4.22 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-O 115.829 -2.034 . . . . 0.0 114.761 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.66 -29.82 2.12 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 122.927 2.081 . . . . 0.0 114.119 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.83 -46.29 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.21 -49.73 26.37 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.159 0.89 . . . . 0.0 111.7 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.6 -34.15 76.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.472 -0.768 . . . . 0.0 112.04 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -61.52 -42.56 98.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.422 1.889 . . . . 0.0 111.934 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.756 1.223 . . . . 0.0 110.933 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.82 -45.6 85.92 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.712 0.805 . . . . 0.0 111.312 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.19 -43.73 95.64 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.239 0.927 . . . . 0.0 112.389 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -60.41 -42.93 97.0 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.352 -0.843 . . . . 0.0 111.892 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.12 -48.97 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 119.175 0.898 . . . . 0.0 111.148 173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.84 -38.25 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.051 1.34 . . . . 0.0 112.853 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -81.8 -28.83 32.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 0.0 112.834 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -78.1 -31.2 49.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -138.06 114.78 10.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.412 1.485 . . . . 0.0 109.737 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -66.56 -20.67 66.07 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.1 t -119.62 123.71 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.793 1.237 . . . . 0.0 109.119 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.64 139.09 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.344 1.058 . . . . 0.0 109.563 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.91 135.72 54.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.311 1.444 . . . . 0.0 110.02 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.57 116.64 29.11 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.353 1.061 . . . . 0.0 108.775 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ptm -162.16 176.05 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.492 1.517 . . . . 0.0 110.791 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.56 26.97 0.75 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.711 -1.243 . . . . 0.0 113.617 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.42 169.79 39.35 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.6 1.572 . . . . 0.0 113.266 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.2 p -97.75 176.37 5.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.072 1.349 . . . . 0.0 111.272 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -66.43 -26.32 67.17 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.804 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -86.29 -27.0 24.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.468 1.507 . . . . 0.0 112.401 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.93 78.51 59.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 0.0 110.678 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.11 178.99 1.64 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.322 3.348 . . . . 0.0 113.622 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -130.36 138.08 50.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.552 1.141 . . . . 0.0 109.688 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.18 160.99 28.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.651 1.18 . . . . 0.0 113.661 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.78 -126.56 8.22 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.633 1.111 . . . . 0.0 111.527 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -56.12 -49.55 73.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.933 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -52.2 66.11 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 111.323 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -57.83 -39.11 76.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.393 0.677 . . . . 0.0 111.337 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.5 m -63.27 -51.89 64.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.546 1.139 . . . . 0.0 110.935 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.24 -44.61 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.565 0.62 . . . . 0.0 111.088 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -61.28 -47.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.637 0.775 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -64.18 -40.5 96.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.224 1.01 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mt -59.71 -51.35 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.737 0.815 . . . . 0.0 111.291 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.17 -46.83 82.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.627 0.771 . . . . 0.0 111.286 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -52.6 -52.46 55.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.352 0.661 . . . . 0.0 110.727 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.5 m -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.527 1.931 . . . . 0.0 114.684 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.46 -39.46 76.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.711 0.804 . . . . 0.0 109.701 170.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 t30 123.74 68.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.979 3.712 . . . . 0.0 109.546 169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.93 152.56 28.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.28 178.49 7.56 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.675 2.916 . . . . 0.0 110.21 169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -163.48 141.2 7.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.856 1.263 . . . . 0.0 111.189 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.31 92.2 3.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.214 1.005 . . . . 0.0 109.663 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.9 m -75.37 111.57 10.78 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.98 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.6 t -92.73 126.77 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.604 1.962 . . . . 0.0 108.543 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -78.5 113.05 16.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.58 -25.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -4.28 58.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -173.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -74.45 -18.88 60.57 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -156.81 128.56 7.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.477 1.111 . . . . 0.0 110.657 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.8 -25.94 67.8 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.269 -0.894 . . . . 0.0 112.869 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.93 -30.7 69.22 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.202 -0.937 . . . . 0.0 112.393 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.51 -53.92 12.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.213 0.915 . . . . 0.0 108.993 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.86 66.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.71 -44.07 11.44 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.702 0.801 . . . . 0.0 112.41 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.16 -30.87 56.52 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-O 119.05 -0.861 . . . . 0.0 114.566 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.58 -20.63 66.05 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.141 1.471 . . . . 0.0 113.686 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -68.3 -38.65 81.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.12 0.968 . . . . 0.0 111.678 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.39 -29.31 30.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.399 1.08 . . . . 0.0 112.517 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.69 -34.33 72.73 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.98 1.312 . . . . 0.0 112.529 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -94.51 -58.58 2.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.663 1.585 . . . . 0.0 112.934 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t 107.8 -2.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 131.886 4.075 . . . . 0.0 110.406 -169.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -88.98 131.7 40.36 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.293 1.837 . . . . 0.0 111.602 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.19 142.64 12.24 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.636 2.891 . . . . 0.0 111.556 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 p 74.33 165.13 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 128.54 2.736 . . . . 0.0 114.09 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.61 159.21 59.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.03 1.732 . . . . 0.0 111.115 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.64 160.65 49.19 Favored 'Cis proline' 0 C--N 1.354 0.865 0 CA-C-N 120.159 1.093 . . . . 0.0 114.91 -2.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -140.19 130.36 25.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.935 1.294 . . . . 0.0 110.058 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.86 137.86 36.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.987 1.715 . . . . 0.0 109.641 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -140.53 136.8 33.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.158 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -144.82 128.62 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.159 1.384 . . . . 0.0 112.615 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 46.3 31.95 1.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.494 2.318 . . . . 0.0 115.883 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.54 10.58 37.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.227 -1.318 . . . . 0.0 115.686 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -147.06 149.07 32.34 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.694 1.747 . . . . 0.0 112.193 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -79.7 150.79 30.77 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.347 -0.845 . . . . 0.0 111.504 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -105.9 -33.73 7.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.929 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.0 -153.61 18.51 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.099 1.333 . . . . 0.0 113.382 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.66 -177.74 42.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.795 1.188 . . . . 0.0 114.135 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.7 t -63.15 -43.02 99.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 113.13 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.33 -46.38 88.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.978 0.808 . . . . 0.0 111.258 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.32 -45.46 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.834 0.853 . . . . 0.0 110.19 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.3 m -62.56 -47.62 83.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.056 1.342 . . . . 0.0 110.957 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.08 -46.15 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.857 1.263 . . . . 0.0 111.23 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.75 -38.55 80.2 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.898 0.772 . . . . 0.0 111.76 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.37 80.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.531 0.732 . . . . 0.0 112.666 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.9 -40.49 95.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.022 0.929 . . . . 0.0 112.268 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.533 1.133 . . . . 0.0 112.889 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.4 m -85.69 -11.91 52.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.043 0.937 . . . . 0.0 113.499 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.05 85.03 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.516 1.532 . . . . 0.0 114.059 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.43 -41.65 65.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 111.566 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.88 -42.01 97.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.506 -0.746 . . . . 0.0 110.033 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -59.7 -48.86 80.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.07 0.548 . . . . 0.0 109.691 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.16 -50.86 71.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.318 1.047 . . . . 0.0 111.918 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -72.14 -32.27 66.76 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.17 -39.6 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.393 0.997 . . . . 0.0 111.024 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.34 -43.21 99.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.842 1.201 . . . . 0.0 111.252 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.16 -39.6 86.96 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.382 -0.823 . . . . 0.0 112.366 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.33 -29.52 70.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.876 0.87 . . . . 0.0 113.186 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.3 mmt -76.8 -48.93 17.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.73 0.695 . . . . 0.0 112.138 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.3 p -80.05 -25.73 40.01 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 126.806 2.043 . . . . 0.0 112.344 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.635 0.255 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.47 175.7 12.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.754 2.022 . . . . 0.0 110.386 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.1 -15.34 61.49 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.48 1.112 . . . . 0.0 113.514 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p -60.03 -23.11 1.09 Allowed Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 118.372 2.73 . . . . 0.0 118.372 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -62.26 178.9 0.72 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.639 2.893 . . . . 0.0 114.825 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.46 -8.15 5.71 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.588 1.555 . . . . 0.0 114.932 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -54.8 -49.25 71.43 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 110.019 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -59.72 -41.21 90.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.653 1.115 . . . . 0.0 112.367 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -62.42 -41.62 98.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.146 1.778 . . . . 0.0 111.905 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -68.81 -46.85 67.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.033 1.333 . . . . 0.0 110.738 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.78 -53.55 53.73 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.194 1.797 . . . . 0.0 110.634 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.25 -47.53 78.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.222 1.009 . . . . 0.0 111.904 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -59.2 -42.25 90.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.237 0.615 . . . . 0.0 112.618 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.63 -43.56 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.52 -41.32 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.388 1.075 . . . . 0.0 112.63 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.3 p -78.93 -38.28 37.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.581 1.082 . . . . 0.0 112.587 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -73.91 -33.99 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -113.26 -7.35 13.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 61.05 -63.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 127.711 2.405 . . . . 0.0 114.47 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -91.57 121.1 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.008 1.323 . . . . 0.0 109.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.41 147.74 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.427 0.691 . . . . 0.0 110.847 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 125.63 47.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.707 1.603 . . . . 0.0 109.185 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -94.91 116.74 29.09 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptm -156.63 170.8 21.57 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 111.748 -169.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.47 -13.63 25.98 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.23 -163.89 25.59 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.753 1.644 . . . . 0.0 112.913 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.3 p -128.32 175.18 8.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.767 1.627 . . . . 0.0 111.439 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.66 -31.02 72.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.748 1.219 . . . . 0.0 111.958 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.3 -29.79 28.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.935 1.294 . . . . 0.0 112.915 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -138.06 84.29 21.2 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.4 1.48 . . . . 0.0 111.323 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.09 165.37 19.47 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.693 2.929 . . . . 0.0 112.396 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -80.06 124.86 29.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.4 m -58.04 138.52 55.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.762 0.825 . . . . 0.0 111.294 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.88 -119.53 5.79 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -52.47 -65.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.425 1.49 . . . . 0.0 114.16 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -64.4 -42.92 95.83 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.92 -45.72 82.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.24 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -61.48 -48.39 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.138 0.975 . . . . 0.0 110.431 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.72 -50.29 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.681 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.37 -31.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 119.24 0.927 . . . . 0.0 112.341 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.01 -45.71 84.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.694 0.679 . . . . 0.0 110.736 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.96 -50.58 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.853 0.861 . . . . 0.0 111.237 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.52 -50.3 74.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.813 0.733 . . . . 0.0 111.219 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -57.07 -52.91 63.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.029 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 t -66.34 -33.29 75.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 114.024 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -57.61 -34.22 69.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.446 1.098 . . . . 0.0 110.874 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 117.71 64.7 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.519 3.528 . . . . 0.0 109.887 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.81 154.61 31.54 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.93 172.44 16.18 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.549 2.833 . . . . 0.0 111.063 170.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.25 146.83 15.75 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.506 1.522 . . . . 0.0 110.459 170.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.3 118.29 35.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.205 0.602 . . . . 0.0 111.076 169.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -76.11 82.43 2.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.246 1.018 . . . . 0.0 110.413 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.22 104.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.02 119.93 20.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.017 0.527 . . . . 0.0 111.739 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -74.79 -34.81 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.79 -38.4 70.27 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.35 -21.63 59.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -99.02 -49.48 4.5 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.787 0.835 . . . . 0.0 113.115 -176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 69.0 -34.64 0.28 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.062 2.545 . . . . 0.0 115.772 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -42.86 99.35 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.919 -1.113 . . . . 0.0 109.693 170.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.09 -45.99 92.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.031 1.332 . . . . 0.0 111.652 169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -56.91 -39.76 75.04 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.431 1.092 . . . . 0.0 112.677 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -89.89 -33.91 16.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.1 -34.62 9.6 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 123.977 0.798 . . . . 0.0 114.727 -172.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -29.75 69.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.313 1.556 . . . . 0.0 110.984 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -63.5 -27.69 69.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.29 -1.506 . . . . 0.0 113.085 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -78.54 -37.55 42.59 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.007 0.821 . . . . 0.0 111.549 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -66.72 -35.22 79.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.426 1.09 . . . . 0.0 113.26 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.6 p -108.81 -14.1 14.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 114.937 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.1 m 66.53 6.17 4.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.527 1.931 . . . . 0.0 113.95 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -74.94 141.65 75.31 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.599 1.56 . . . . 0.0 113.155 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 -49.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.81 2.34 . . . . 0.0 114.105 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.4 p -149.74 125.86 10.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.138 0.975 . . . . 0.0 112.178 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.75 158.94 72.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.001 1.32 . . . . 0.0 112.396 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -64.43 163.26 59.28 Favored 'Cis proline' 0 C--N 1.357 0.982 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 2.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -149.16 134.47 18.37 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.999 0.92 . . . . 0.0 110.524 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.05 139.31 30.75 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.964 1.305 . . . . 0.0 109.475 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -143.35 137.75 28.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.414 1.086 . . . . 0.0 110.221 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 mt -139.25 121.84 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.588 -0.695 . . . . 0.0 110.785 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t70 64.44 -22.68 0.07 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.202 3.001 . . . . 0.0 116.893 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.03 10.72 0.06 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.845 1.688 . . . . 0.0 115.277 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.86 150.23 30.65 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.311 1.555 . . . . 0.0 111.074 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -73.53 141.75 46.72 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.889 -0.507 . . . . 0.0 111.026 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.94 -39.61 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.734 0.814 . . . . 0.0 111.836 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.53 -151.04 22.39 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.455 1.026 . . . . 0.0 113.942 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.25 -173.16 20.31 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.767 1.651 . . . . 0.0 113.387 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -60.98 -47.2 87.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.826 0.85 . . . . 0.0 112.842 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.05 -45.14 93.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.413 0.552 . . . . 0.0 111.587 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.45 -44.28 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.594 0.757 . . . . 0.0 109.998 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.1 m -62.89 -46.15 89.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.822 1.249 . . . . 0.0 111.198 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.97 -43.43 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.183 0.993 . . . . 0.0 111.252 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.97 -42.38 80.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.774 0.715 . . . . 0.0 111.973 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.36 79.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 112.771 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -66.39 -40.58 89.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.031 1.332 . . . . 0.0 112.304 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -70.98 -32.87 69.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.169 0.588 . . . . 0.0 112.436 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.69 -12.14 51.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.92 -0.1 87.62 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 125.404 1.478 . . . . 0.0 114.092 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.74 -36.58 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.468 1.107 . . . . 0.0 111.381 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.69 -46.44 85.5 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.884 -0.51 . . . . 0.0 110.176 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -56.75 -48.82 76.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.67 0.788 . . . . 0.0 110.986 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.07 -49.63 77.15 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.813 0.845 . . . . 0.0 111.668 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -71.43 -35.54 70.98 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.9 -42.08 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.679 1.127 . . . . 0.0 110.887 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.07 -43.05 99.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.048 0.84 . . . . 0.0 111.488 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -59.98 -42.48 94.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.343 -0.848 . . . . 0.0 111.866 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.05 72.79 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.235 0.925 . . . . 0.0 112.812 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.68 -54.36 7.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.743 0.817 . . . . 0.0 111.255 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.571 1.148 . . . . 0.0 113.058 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.916 2.486 . . . . 0.0 112.538 171.353 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.479 0.18 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.57 59.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.3 tp -141.6 152.36 43.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.667 1.587 . . . . 0.0 110.426 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.8 p -61.51 123.06 74.92 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.724 1.61 . . . . 0.0 111.663 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.59 -34.14 81.71 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.109 3.206 . . . . 0.0 115.425 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.21 93.81 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.072 0.851 . . . . 0.0 112.192 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.6 tp -67.33 -47.75 69.58 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.146 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -58.63 -37.26 75.53 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.303 0.956 . . . . 0.0 112.261 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.9 m -66.09 -41.65 90.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.508 1.923 . . . . 0.0 111.678 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.2 m -67.23 -45.89 75.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.625 1.17 . . . . 0.0 111.159 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 99.4 mt -56.92 -54.65 44.14 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.869 1.268 . . . . 0.0 110.343 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.71 -41.6 74.04 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.794 0.725 . . . . 0.0 112.153 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -61.7 -47.36 85.62 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.333 -0.855 . . . . 0.0 112.101 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.94 -36.76 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.414 1.461 . . . . 0.0 112.705 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.85 -40.77 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.712 1.205 . . . . 0.0 112.308 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -80.18 -45.39 18.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.571 0.748 . . . . 0.0 112.361 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 76.3 p -70.7 -38.86 73.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -100.77 -3.8 29.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.629 0.771 . . . . 0.0 112.921 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt 62.14 -59.53 0.12 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.344 2.658 . . . . 0.0 114.395 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.87 137.21 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.65 1.58 . . . . 0.0 108.977 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.04 142.25 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.453 0.701 . . . . 0.0 111.032 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.36 145.4 28.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.058 1.343 . . . . 0.0 110.768 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -123.8 116.18 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.928 1.691 . . . . 0.0 109.401 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -173.18 1.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.338 1.455 . . . . 0.0 112.311 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.19 -154.93 0.13 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.286 1.434 . . . . 0.0 113.31 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.79 -146.8 50.62 Favored Glycine 0 N--CA 1.481 1.689 0 O-C-N 120.574 -1.329 . . . . 0.0 113.605 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.5 p -128.62 175.61 8.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.537 1.535 . . . . 0.0 109.46 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.29 -14.56 63.08 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.718 -1.238 . . . . 0.0 112.903 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.34 -39.88 8.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.808 1.243 . . . . 0.0 113.53 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -90.04 119.37 69.32 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.961 0.904 . . . . 0.0 111.34 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 134.46 24.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.183 2.589 . . . . 0.0 112.334 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -80.35 -34.37 36.62 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.855 2.062 . . . . 0.0 112.982 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.55 153.58 2.35 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.331 2.252 . . . . 0.0 108.954 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.35 -35.77 89.3 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 123.731 0.682 . . . . 0.0 113.308 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.77 -51.66 61.11 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.25 1.025 . . . . 0.0 111.089 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -60.15 -43.17 95.97 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.368 -0.833 . . . . 0.0 111.939 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -59.95 -46.41 89.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.537 0.735 . . . . 0.0 110.792 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -59.85 -45.12 93.44 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.808 0.843 . . . . 0.0 110.729 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.07 -43.65 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.075 0.95 . . . . 0.0 112.413 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.81 -46.69 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 110.802 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -65.58 -38.49 89.69 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mt -59.09 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.645 1.578 . . . . 0.0 111.561 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.03 -48.28 79.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.338 0.972 . . . . 0.0 110.66 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -51.28 -56.53 12.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.19 70.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.432 2.293 . . . . 0.0 114.805 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.63 -29.89 66.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.926 1.291 . . . . 0.0 109.974 169.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.7 t30 109.58 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 130.309 3.444 . . . . 0.0 108.885 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.9 149.72 28.46 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 167.27 17.37 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.121 3.214 . . . . 0.0 110.101 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -169.16 158.67 8.52 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.619 1.568 . . . . 0.0 111.046 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 168.33 9.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.448 1.099 . . . . 0.0 110.327 175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -148.3 105.15 3.59 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 119.792 -1.817 . . . . 0.0 110.774 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -87.36 118.32 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.921 1.288 . . . . 0.0 108.378 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -86.01 101.27 12.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 109.126 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.47 -32.4 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.61 -24.89 66.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -168.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.15 -10.8 59.8 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -134.98 119.22 17.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.563 1.074 . . . . 0.0 113.354 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.1 -32.08 69.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.06 -41.56 81.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.902 0.881 . . . . 0.0 110.871 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.42 -49.16 74.82 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.204 0.602 . . . . 0.0 110.868 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -55.76 -43.68 76.92 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -82.34 -32.35 29.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.71 -38.33 12.14 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.373 0.987 . . . . 0.0 113.98 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.21 -26.42 65.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.552 1.176 . . . . 0.0 112.503 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.45 -37.63 81.59 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.658 0.783 . . . . 0.0 112.003 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.25 -44.3 38.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.89 0.876 . . . . 0.0 111.241 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -61.43 -41.56 97.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.208 1.003 . . . . 0.0 113.055 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.1 p -101.01 -18.87 16.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m 68.7 0.62 2.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.894 2.078 . . . . 0.0 114.561 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 74.2 t-105 -74.08 140.54 77.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 51.2 Cg_exo -63.58 -57.58 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.302 2.668 . . . . 0.0 115.259 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.8 p -149.01 122.49 9.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 112.386 -169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -64.52 157.59 71.89 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.015 1.326 . . . . 0.0 112.269 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.66 158.24 41.85 Favored 'Cis proline' 0 C--N 1.358 1.06 0 N-CA-C 116.07 1.527 . . . . 0.0 116.07 2.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.79 146.94 26.08 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.133 0.973 . . . . 0.0 111.299 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.0 141.5 47.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.627 1.571 . . . . 0.0 109.031 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -139.29 144.55 38.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 0.0 109.745 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.83 126.91 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.538 -0.726 . . . . 0.0 111.432 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.38 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 129.143 2.977 . . . . 0.0 117.86 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.44 4.91 0.12 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.657 1.598 . . . . 0.0 115.418 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -148.47 151.03 34.48 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.548 1.674 . . . . 0.0 111.596 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -73.09 147.56 44.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.353 0.596 . . . . 0.0 111.716 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -100.37 -40.14 7.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.402 1.081 . . . . 0.0 111.765 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.45 -155.63 22.64 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 125.571 1.558 . . . . 0.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.05 173.52 52.21 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.756 1.17 . . . . 0.0 113.752 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.44 -46.71 66.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.665 -0.903 . . . . 0.0 112.716 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.45 -40.27 90.58 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 111.641 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.6 -41.63 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.514 0.726 . . . . 0.0 110.242 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.2 m -63.85 -44.5 92.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.151 0.98 . . . . 0.0 111.956 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -57.85 -43.85 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.858 0.753 . . . . 0.0 111.108 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.11 -37.59 78.44 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.1 91.43 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 112.497 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -64.17 -42.04 96.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.259 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.13 -28.32 68.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.586 0.754 . . . . 0.0 112.497 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -87.48 -12.89 44.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.598 1.159 . . . . 0.0 113.581 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.66 0.34 84.13 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 125.616 1.579 . . . . 0.0 114.229 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.92 -37.66 64.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.79 1.236 . . . . 0.0 111.485 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.78 -45.48 89.55 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.624 -0.672 . . . . 0.0 110.812 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -56.72 -48.45 77.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 110.802 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.57 -48.53 81.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 0.0 111.797 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -70.21 -38.42 75.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.46 -40.59 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 119.564 1.074 . . . . 0.0 110.607 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.85 -46.11 90.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.534 0.607 . . . . 0.0 110.819 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -62.52 -35.95 81.05 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.092 -1.005 . . . . 0.0 112.661 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.3 -31.57 72.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.008 -1.058 . . . . 0.0 112.825 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.51 -46.8 9.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.319 1.047 . . . . 0.0 112.981 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.67 -18.92 21.62 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -172.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 130.568 3.547 . . . . 0.0 113.259 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 110.751 -0.092 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.55 63.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.57 0.748 . . . . 0.0 112.586 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.3 mt -96.55 167.74 10.96 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.637 1.575 . . . . 0.0 110.13 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p -72.89 142.48 83.14 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 121.749 -0.595 . . . . 0.0 109.97 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.84 -34.44 96.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 0.0 112.739 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.23 -37.87 84.62 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.436 1.094 . . . . 0.0 113.366 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.13 -56.51 20.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.999 0.919 . . . . 0.0 109.925 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -62.54 -38.5 90.26 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.4 m -64.7 -39.87 94.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 111.968 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.6 m -64.98 -51.52 61.28 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.572 0.749 . . . . 0.0 110.236 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.56 -42.79 93.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.942 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.89 -48.78 80.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.451 1.023 . . . . 0.0 112.395 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -62.24 -42.03 98.95 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.54 -0.725 . . . . 0.0 111.905 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.06 -56.33 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.093 0.957 . . . . 0.0 110.546 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -58.99 -45.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.622 1.169 . . . . 0.0 112.721 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -73.19 -41.72 63.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.565 0.746 . . . . 0.0 112.758 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -81.84 -32.31 31.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -15.7 30.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 59.56 -66.16 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.998 2.519 . . . . 0.0 114.057 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.32 122.31 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.388 1.875 . . . . 0.0 108.597 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.34 117.99 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.357 0.663 . . . . 0.0 110.391 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -96.42 128.01 42.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.065 0.946 . . . . 0.0 110.405 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.17 122.88 47.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.357 1.063 . . . . 0.0 109.991 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.58 -177.94 6.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.273 1.429 . . . . 0.0 111.434 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.72 37.97 0.31 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.593 -1.317 . . . . 0.0 112.76 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.59 -165.04 35.63 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 126.557 2.027 . . . . 0.0 112.016 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -156.93 -167.31 2.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.443 1.097 . . . . 0.0 110.892 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.42 -33.32 71.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.09 1.356 . . . . 0.0 113.012 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.82 -15.58 58.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.518 1.527 . . . . 0.0 113.778 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -148.3 70.8 10.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.642 1.577 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.76 146.31 48.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.032 2.488 . . . . 0.0 110.698 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -98.93 127.02 44.76 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.411 0.684 . . . . 0.0 110.218 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -65.94 155.07 37.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.565 1.146 . . . . 0.0 113.664 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.59 -118.38 4.79 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 124.237 0.922 . . . . 0.0 112.019 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -54.24 -58.6 6.76 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.748 1.219 . . . . 0.0 112.674 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -62.39 -46.51 88.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.606 -0.683 . . . . 0.0 111.746 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.38 -46.57 69.68 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.587 1.155 . . . . 0.0 111.092 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.0 m -65.59 -46.1 80.69 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.159 0.984 . . . . 0.0 110.843 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -44.16 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.201 0.91 . . . . 0.0 110.993 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.02 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.516 0.726 . . . . 0.0 111.032 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.62 -38.7 91.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.961 0.8 . . . . 0.0 112.453 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.49 -47.35 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.31 0.959 . . . . 0.0 110.889 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.36 -51.29 68.21 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.38 0.991 . . . . 0.0 111.218 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -49.14 -61.75 1.91 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.646 0.778 . . . . 0.0 110.522 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.9 p -68.5 -25.86 65.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.947 1.699 . . . . 0.0 115.049 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.92 -34.26 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.915 0.886 . . . . 0.0 109.318 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 115.58 55.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.218 3.407 . . . . 0.0 109.461 168.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.2 145.15 31.37 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.35 163.16 35.08 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.178 2.585 . . . . 0.0 110.742 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -160.84 162.39 32.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.541 1.536 . . . . 0.0 109.928 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.23 178.39 7.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.744 1.217 . . . . 0.0 108.739 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.0 m -150.92 159.6 44.45 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 119.727 -1.858 . . . . 0.0 112.963 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.89 133.94 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.305 1.042 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -79.12 118.02 20.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.382 0.673 . . . . 0.0 110.997 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.6 pt -69.35 -20.81 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.44 -3.99 49.1 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.07 -17.94 62.58 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.74 139.38 13.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.799 1.24 . . . . 0.0 111.211 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -64.65 -36.56 84.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.9 -43.81 97.78 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.644 -0.66 . . . . 0.0 111.022 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.35 -49.1 78.33 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.434 0.694 . . . . 0.0 111.036 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp85 -55.37 -38.85 69.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.108 0.963 . . . . 0.0 112.429 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -76.85 -50.22 13.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.664 1.186 . . . . 0.0 112.365 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.98 -26.8 54.93 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 115.591 0.997 . . . . 0.0 115.591 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.77 -33.87 74.86 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.634 1.217 . . . . 0.0 112.103 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.88 -43.69 98.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.841 0.856 . . . . 0.0 111.814 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.1 -44.63 75.75 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.636 0.774 . . . . 0.0 111.138 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.6 -41.18 89.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.75 0.82 . . . . 0.0 112.343 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.3 m -80.62 -21.89 41.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.4 p 69.24 -35.73 0.32 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.322 3.049 . . . . 0.0 113.716 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -70.66 137.23 85.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.754 1.622 . . . . 0.0 111.278 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.85 -27.57 0.69 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.875 2.383 . . . . 0.0 116.215 -169.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 m -102.54 130.26 49.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.496 1.043 . . . . 0.0 112.915 -168.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -115.28 152.47 46.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.929 1.292 . . . . 0.0 110.504 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.53 157.64 55.37 Favored 'Cis proline' 0 C--N 1.355 0.92 0 N-CA-C 114.996 1.114 . . . . 0.0 114.996 -3.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.36 151.47 8.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.14 1.376 . . . . 0.0 111.298 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.0 tp -90.21 159.41 16.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.942 1.297 . . . . 0.0 110.735 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -150.31 139.76 21.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.433 1.093 . . . . 0.0 110.198 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 mt -142.68 126.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.719 -0.613 . . . . 0.0 111.139 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 63.37 -25.74 0.07 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.985 2.914 . . . . 0.0 117.407 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.01 10.26 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.914 1.721 . . . . 0.0 115.114 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.11 151.25 32.87 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.289 1.544 . . . . 0.0 111.243 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -71.64 161.02 31.65 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.42 1.105 . . . . 0.0 112.536 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -136.08 143.31 44.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.275 1.43 . . . . 0.0 109.31 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.93 -178.75 10.27 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.325 1.441 . . . . 0.0 115.54 -170.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.88 -173.8 20.19 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.971 1.272 . . . . 0.0 114.55 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.42 -45.09 94.88 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.678 -0.895 . . . . 0.0 113.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.72 -44.3 97.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.719 -0.613 . . . . 0.0 111.458 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.59 -44.07 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.756 0.822 . . . . 0.0 110.348 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.7 m -62.78 -44.89 94.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.067 1.347 . . . . 0.0 111.131 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.22 -45.55 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.597 1.159 . . . . 0.0 111.489 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.53 -42.06 87.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.095 0.861 . . . . 0.0 112.224 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.58 81.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.117 0.967 . . . . 0.0 112.457 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.98 -47.45 86.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.678 1.191 . . . . 0.0 111.605 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.19 -32.61 70.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.008 0.923 . . . . 0.0 113.2 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -83.38 -13.59 54.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.94 -6.34 76.51 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.023 1.296 . . . . 0.0 113.922 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.94 -37.16 72.84 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.765 1.226 . . . . 0.0 111.906 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.13 -43.23 78.79 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.665 -0.647 . . . . 0.0 110.38 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.79 -49.11 78.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.887 0.875 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.69 1.196 . . . . 0.0 112.054 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.06 -39.25 79.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.949 0.795 . . . . 0.0 112.844 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.52 -45.67 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.401 1.001 . . . . 0.0 110.414 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -62.77 -46.94 85.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.239 0.927 . . . . 0.0 111.647 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.91 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.458 -0.777 . . . . 0.0 112.126 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.03 81.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.952 0.796 . . . . 0.0 112.835 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.09 -40.58 82.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.802 0.728 . . . . 0.0 111.841 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.34 -47.52 83.85 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.139 0.575 . . . . 0.0 111.97 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.488 1.431 1 C-N-CA 132.153 4.181 . . . . 0.0 111.491 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.93 86.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.571 1.078 . . . . 0.0 112.007 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.4 mt -91.61 154.23 19.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.097 1.359 . . . . 0.0 109.44 169.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.6 p -78.23 153.21 79.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.104 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.5 -28.56 81.31 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.99 2.46 . . . . 0.0 113.213 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.49 61.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.79 -65.6 0.65 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.983 1.265 . . . . 0.0 111.485 -171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -65.29 -29.0 69.72 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.448 -0.782 . . . . 0.0 112.136 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.1 m -63.56 -44.01 95.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.326 1.85 . . . . 0.0 112.117 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.9 m -64.65 -45.46 86.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.033 0.933 . . . . 0.0 110.375 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.2 mt -56.02 -50.22 71.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.059 0.544 . . . . 0.0 111.675 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.91 -48.48 78.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.478 0.711 . . . . 0.0 112.288 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.43 -38.65 87.91 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.506 -0.746 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.86 -47.58 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.178 -0.951 . . . . 0.0 110.727 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.22 -36.02 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.046 1.339 . . . . 0.0 113.008 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -84.28 -31.28 25.0 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.206 0.912 . . . . 0.0 113.054 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -70.77 -37.85 73.4 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.865 0.757 . . . . 0.0 112.757 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -137.39 114.17 10.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.249 1.42 . . . . 0.0 108.448 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.88 -33.81 76.53 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.12 137.25 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.53 1.059 . . . . 0.0 109.162 169.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.16 126.87 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.815 0.846 . . . . 0.0 109.454 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.08 125.71 47.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.511 1.125 . . . . 0.0 109.169 170.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -97.32 118.19 33.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.2 ptm -155.39 159.53 39.96 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -168.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.16 -20.53 48.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.217 1.007 . . . . 0.0 112.889 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.99 -170.38 43.1 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.186 1.375 . . . . 0.0 112.294 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 p -127.53 174.29 9.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 110.947 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -69.32 -21.43 63.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -83.31 -31.53 26.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.654 1.182 . . . . 0.0 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.37 100.24 3.59 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.321 1.448 . . . . 0.0 110.274 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.26 164.46 32.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.107 2.538 . . . . 0.0 111.458 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.6 139.36 30.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.289 0.636 . . . . 0.0 110.176 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.7 p -69.59 159.54 33.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.984 0.914 . . . . 0.0 113.196 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.11 -104.98 2.4 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 124.138 0.875 . . . . 0.0 111.283 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.76 -71.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.293 1.437 . . . . 0.0 112.728 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 m -60.98 -41.33 96.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.574 -0.704 . . . . 0.0 111.355 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -53.8 -46.43 71.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.3 1.44 . . . . 0.0 111.964 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.1 m -67.78 -51.38 49.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.554 1.142 . . . . 0.0 110.996 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.141 0.576 . . . . 0.0 111.742 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.98 -47.02 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.652 0.781 . . . . 0.0 111.031 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -64.73 -41.64 95.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.911 0.778 . . . . 0.0 112.126 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.91 -52.58 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.591 0.756 . . . . 0.0 111.187 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.33 -47.75 66.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.38 0.672 . . . . 0.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -50.2 -53.52 27.33 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.855 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -33.42 75.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.804 1.641 . . . . 0.0 114.277 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.41 -25.59 66.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.165 0.986 . . . . 0.0 111.61 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.5 t30 112.61 47.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.955 3.702 . . . . 0.0 110.862 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.44 132.89 21.3 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.32 122.4 6.09 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.424 2.749 . . . . 0.0 109.128 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -131.79 161.0 33.94 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -136.51 144.65 44.42 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.6 m -108.15 93.44 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 0.0 109.564 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.47 121.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.407 1.083 . . . . 0.0 109.341 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -74.32 122.92 23.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 111.278 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -119.15 -169.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.895 1.278 . . . . 0.0 111.27 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.9 -56.88 0.54 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.454 2.302 . . . . 0.0 112.208 169.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.39 -41.16 85.42 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.822 0.849 . . . . 0.0 110.532 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -73.77 109.4 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.993 0.917 . . . . 0.0 110.526 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -73.34 -27.63 61.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 113.488 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.99 -44.58 76.27 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.145 -0.972 . . . . 0.0 110.954 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.4 -40.5 89.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.711 0.804 . . . . 0.0 111.863 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -54.46 -37.99 65.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.025 0.93 . . . . 0.0 112.368 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -85.64 -46.06 11.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.44 1.096 . . . . 0.0 112.584 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.5 -30.91 57.61 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.54 -26.17 66.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.978 1.389 . . . . 0.0 113.033 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.22 -40.61 96.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.712 0.687 . . . . 0.0 111.682 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.64 -45.11 54.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.833 0.853 . . . . 0.0 111.468 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.43 -37.6 87.39 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.1 p -107.56 -20.85 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.0 m 69.41 -29.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.64 2.376 . . . . 0.0 114.702 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -75.27 128.48 84.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.579 1.552 . . . . 0.0 112.386 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.52 150.59 19.38 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.523 2.815 . . . . 0.0 111.422 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p 77.99 156.93 0.17 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.971 2.908 . . . . 0.0 113.419 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.54 157.8 64.69 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.165 1.786 . . . . 0.0 111.363 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.05 158.22 89.13 Favored 'Cis proline' 0 C--N 1.354 0.862 0 CA-C-N 119.999 1.035 . . . . 0.0 112.541 3.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.26 141.85 37.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.317 1.047 . . . . 0.0 110.36 -172.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.5 tp -95.08 144.91 25.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.955 1.302 . . . . 0.0 110.941 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -146.73 139.24 25.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 109.599 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mp -137.85 120.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.366 -0.834 . . . . 0.0 111.094 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 61.85 -24.92 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.968 3.307 . . . . 0.0 117.415 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.28 -1.89 0.04 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.09 1.805 . . . . 0.0 115.345 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.9 147.64 49.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.221 1.511 . . . . 0.0 111.708 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.31 158.76 30.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.423 1.106 . . . . 0.0 111.801 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -133.07 155.16 49.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.826 1.651 . . . . 0.0 108.968 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.79 -180.0 9.71 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.834 1.206 . . . . 0.0 114.568 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.2 -176.84 11.37 Favored Glycine 0 N--CA 1.474 1.223 0 C-N-CA 124.667 1.127 . . . . 0.0 113.996 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.25 -42.71 95.87 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.535 -0.979 . . . . 0.0 112.808 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.9 -47.16 86.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.432 0.56 . . . . 0.0 111.191 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.6 mt -60.67 -42.99 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.906 0.882 . . . . 0.0 110.304 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 m -62.81 -46.83 86.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.088 1.355 . . . . 0.0 111.327 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.51 -42.79 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.628 1.171 . . . . 0.0 111.656 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.95 -43.31 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.71 0.686 . . . . 0.0 111.564 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.74 95.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.888 . . . . 0.0 112.001 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.71 -37.77 88.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 112.782 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -69.37 -30.85 68.94 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.382 1.073 . . . . 0.0 112.254 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -87.99 -11.14 48.25 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.534 1.134 . . . . 0.0 113.949 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.36 84.07 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.176 1.37 . . . . 0.0 114.137 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.05 -34.43 50.46 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 112.104 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -64.45 -46.24 83.96 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.776 -0.578 . . . . 0.0 109.721 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -57.34 -48.39 79.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.547 1.139 . . . . 0.0 110.258 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.35 -52.96 62.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.839 0.856 . . . . 0.0 111.775 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -74.38 -33.61 63.1 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.578 -0.701 . . . . 0.0 112.869 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.56 -44.37 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.36 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -59.7 -43.27 94.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.199 1.363 . . . . 0.0 111.376 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -57.76 -47.82 81.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.374 0.67 . . . . 0.0 111.249 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.38 -31.28 71.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.132 0.973 . . . . 0.0 113.268 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.1 mmt -72.14 -36.5 69.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.301 -0.874 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.6 -40.42 76.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.681 0.792 . . . . 0.0 112.63 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.254 1.305 0 C-N-CA 129.643 3.177 . . . . 0.0 112.597 179.018 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 119.742 -0.171 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.6 173.42 16.89 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.016 1.326 . . . . 0.0 113.195 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.55 154.93 43.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.086 1.754 . . . . 0.0 111.063 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 p -93.89 161.43 30.02 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.855 1.262 . . . . 0.0 110.661 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.46 -30.13 62.16 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.136 1.891 . . . . 0.0 111.455 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.96 87.93 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.103 0.865 . . . . 0.0 112.485 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.78 -51.28 67.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 109.755 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -58.92 -42.74 90.38 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.646 0.778 . . . . 0.0 112.566 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -64.68 -39.01 92.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.777 1.631 . . . . 0.0 112.081 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -62.54 -49.42 75.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.239 0.927 . . . . 0.0 110.39 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -56.98 -53.26 60.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.652 0.781 . . . . 0.0 110.943 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.27 -44.96 76.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.755 0.822 . . . . 0.0 112.314 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -59.91 -49.2 78.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.799 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.8 -34.92 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.293 1.406 . . . . 0.0 112.802 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.35 -36.28 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.936 1.295 . . . . 0.0 112.489 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.9 p -84.56 -39.03 19.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.71 0.804 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -74.44 -25.13 59.24 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -130.05 130.92 45.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.771 1.228 . . . . 0.0 109.605 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -68.85 -44.38 73.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -114.23 132.02 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.563 1.145 . . . . 0.0 109.243 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.87 121.04 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.207 0.603 . . . . 0.0 110.88 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.52 149.6 21.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.741 0.817 . . . . 0.0 110.528 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.5 114.09 18.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.367 1.467 . . . . 0.0 109.136 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -163.09 -178.57 6.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.257 1.823 . . . . 0.0 110.653 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.13 -39.9 65.35 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.774 -1.204 . . . . 0.0 111.709 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.84 161.9 46.34 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.926 1.727 . . . . 0.0 114.419 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -87.65 172.02 10.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.157 1.783 . . . . 0.0 111.774 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -71.96 -23.74 61.49 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.42 -13.42 32.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.518 1.527 . . . . 0.0 113.642 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -131.57 65.68 76.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.71 1.604 . . . . 0.0 110.276 169.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -71.7 143.12 41.17 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.486 2.79 . . . . 0.0 110.843 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.0 127.62 33.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.689 0.796 . . . . 0.0 112.12 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -54.89 145.25 20.46 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.443 . . . . 0.0 113.174 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.16 -143.35 16.56 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -51.71 -45.11 63.44 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.3 m -63.82 -47.07 82.27 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.32 1.418 . . . . 0.0 112.346 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.12 -40.72 90.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.785 0.834 . . . . 0.0 111.741 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -60.97 -48.06 83.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.452 0.701 . . . . 0.0 110.919 170.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.43 -42.85 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.629 1.172 . . . . 0.0 112.898 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -66.45 -34.85 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.205 1.366 . . . . 0.0 111.999 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.22 -41.54 89.97 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.777 0.717 . . . . 0.0 111.924 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mt -57.36 -51.53 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.85 1.26 . . . . 0.0 111.388 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.0 -47.57 77.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.272 1.029 . . . . 0.0 111.032 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -51.88 -55.74 18.3 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.252 0.621 . . . . 0.0 110.76 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -68.33 -33.12 73.73 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.983 1.713 . . . . 0.0 113.837 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.2 -29.99 69.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.374 1.07 . . . . 0.0 110.997 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 115.27 70.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 130.234 3.414 . . . . 0.0 111.038 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.97 139.48 12.7 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.97 119.46 5.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.089 2.526 . . . . 0.0 109.38 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -106.14 152.4 23.49 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.112 0.965 . . . . 0.0 112.011 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.15 171.72 7.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.272 1.429 . . . . 0.0 110.139 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 m -147.99 104.73 3.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.176 -1.577 . . . . 0.0 109.88 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.92 127.74 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.597 1.159 . . . . 0.0 109.022 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -73.42 93.8 2.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 110.865 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.99 -178.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.39 0.676 . . . . 0.0 110.507 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.05 -37.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.907 2.083 . . . . 0.0 113.104 172.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.1 -20.18 64.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.731 1.612 . . . . 0.0 113.38 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -125.06 134.9 52.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.068 1.347 . . . . 0.0 111.364 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.44 -28.66 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.38 1.072 . . . . 0.0 113.752 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.66 -44.05 71.33 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.308 -0.87 . . . . 0.0 111.739 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.19 -23.27 65.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.75 -26.08 68.48 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.86 0.755 . . . . 0.0 112.726 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -109.98 -53.02 2.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.74 1.216 . . . . 0.0 112.252 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.04 -34.09 53.26 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.355 -169.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -47.9 77.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.657 1.729 . . . . 0.0 111.939 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.08 -26.1 67.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -80.44 -34.78 35.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.054 0.942 . . . . 0.0 112.201 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -65.05 -37.96 89.27 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.916 1.286 . . . . 0.0 112.273 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -78.81 -68.31 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.99 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m 124.06 -17.2 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 1 C-N-CA 133.163 4.585 . . . . 0.0 110.966 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -67.59 121.69 80.2 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.445 1.498 . . . . 0.0 111.545 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.27 145.45 19.03 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.993 2.462 . . . . 0.0 110.411 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 80.3 165.49 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.025 2.13 . . . . 0.0 112.561 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.62 150.12 51.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.531 1.533 . . . . 0.0 110.53 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.78 -177.49 21.18 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 120.125 1.08 . . . . 0.0 113.157 4.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.1 140.78 23.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.749 1.22 . . . . 0.0 111.182 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 tp -103.32 141.22 36.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.627 1.571 . . . . 0.0 110.075 169.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -140.46 142.98 35.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.053 1.741 . . . . 0.0 110.157 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.2 mt -140.18 116.4 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.65 0.78 . . . . 0.0 110.852 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.63 -24.8 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 130.114 3.366 . . . . 0.0 118.069 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -16.2 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.631 1.586 . . . . 0.0 114.69 -170.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.11 153.29 48.65 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.921 1.36 . . . . 0.0 112.87 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -81.09 149.23 29.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.906 -0.496 . . . . 0.0 111.515 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.07 -35.41 9.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.984 0.914 . . . . 0.0 112.311 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.26 -146.64 17.82 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 125.437 1.494 . . . . 0.0 111.937 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.02 165.72 47.66 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.293 0.949 . . . . 0.0 114.206 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.2 m -68.47 -41.56 80.01 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.736 -0.861 . . . . 0.0 112.244 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.13 -42.42 94.77 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.23 -0.919 . . . . 0.0 111.637 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.17 -40.34 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.247 0.619 . . . . 0.0 110.326 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.5 m -63.97 -43.21 96.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.085 0.954 . . . . 0.0 111.739 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.33 -46.13 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.914 0.779 . . . . 0.0 110.963 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -66.37 -37.17 84.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.743 0.701 . . . . 0.0 112.527 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.24 95.52 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.1 0.96 . . . . 0.0 111.971 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -67.54 -38.86 84.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.512 0.725 . . . . 0.0 112.771 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.1 -32.88 74.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 112.642 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 p -92.9 -10.03 38.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.52 -3.19 68.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.045 1.307 . . . . 0.0 114.485 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -72.37 -33.25 67.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.41 1.484 . . . . 0.0 112.493 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -47.2 70.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.716 0.689 . . . . 0.0 110.249 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -56.52 -48.79 76.49 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.684 1.194 . . . . 0.0 110.469 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.648 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.75 -33.13 72.02 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -39.93 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.3 0.954 . . . . 0.0 111.151 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.34 -44.73 96.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.12 0.873 . . . . 0.0 111.077 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.36 -36.36 79.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.409 -0.807 . . . . 0.0 112.701 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.88 74.52 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.038 1.29 . . . . 0.0 112.627 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.9 mtt -74.41 -41.99 59.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.836 0.854 . . . . 0.0 112.357 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 p -92.6 1.75 57.08 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 126.963 2.105 . . . . 0.0 114.272 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.62 -155.66 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.49 1.516 . . . . 0.0 111.346 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.86 36.87 0.14 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.33 1.852 . . . . 0.0 112.793 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -91.31 -27.46 0.3 Allowed Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 115.675 -2.107 . . . . 0.0 116.484 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -84.84 -168.8 0.56 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 CA-C-N 123.314 2.219 . . . . 0.0 112.036 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.27 -7.83 3.21 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.66 1.584 . . . . 0.0 115.065 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.65 -55.71 15.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.673 1.589 . . . . 0.0 109.798 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -61.37 -42.12 98.19 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.553 -0.717 . . . . 0.0 112.231 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -60.23 -39.45 86.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.335 1.854 . . . . 0.0 111.98 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 m -64.84 -49.16 71.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 110.141 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.09 -50.35 71.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.077 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.18 -48.65 75.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.527 1.131 . . . . 0.0 112.459 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.4 -42.72 99.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.558 -0.714 . . . . 0.0 111.821 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.9 -49.88 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.772 0.829 . . . . 0.0 111.787 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.14 -33.99 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.545 1.066 . . . . 0.0 112.772 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.2 p -74.93 -35.42 62.18 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.919 0.782 . . . . 0.0 112.781 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 m -79.37 -41.73 27.16 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.97 0.805 . . . . 0.0 112.976 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.03 -3.71 37.57 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 58.55 -74.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.536 2.334 . . . . 0.0 112.277 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.3 129.94 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.005 0.922 . . . . 0.0 109.642 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -137.79 131.27 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.423 0.689 . . . . 0.0 110.324 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.4 140.53 32.53 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.549 1.14 . . . . 0.0 111.314 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.18 108.41 16.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.714 1.606 . . . . 0.0 107.887 172.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.2 mtm -144.59 -176.72 5.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.273 1.429 . . . . 0.0 110.595 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -79.1 21.48 0.44 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.325 -1.485 . . . . 0.0 113.999 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.97 177.4 44.72 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.795 1.188 . . . . 0.0 114.733 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.4 p -97.46 -178.61 4.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.734 2.014 . . . . 0.0 111.244 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.06 -20.62 59.45 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.345 -0.847 . . . . 0.0 112.901 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.38 -31.82 37.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 111.853 172.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -134.17 74.61 67.32 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.892 1.277 . . . . 0.0 110.753 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 172.05 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.984 3.123 . . . . 0.0 111.281 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -99.3 152.43 19.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.053 0.941 . . . . 0.0 110.983 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.51 167.25 21.02 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.782 1.233 . . . . 0.0 113.507 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.73 -125.52 7.1 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.412 1.006 . . . . 0.0 112.362 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -60.31 -42.35 95.37 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.757 0.823 . . . . 0.0 112.591 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -59.2 -52.15 66.92 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.025 -1.047 . . . . 0.0 112.327 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -56.94 -44.56 82.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.783 1.233 . . . . 0.0 110.481 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.2 m -60.14 -47.69 84.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.461 1.104 . . . . 0.0 110.855 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.7 -42.57 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.249 1.02 . . . . 0.0 112.39 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.25 -34.66 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.476 1.489 . . . . 0.0 112.11 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.018 0.827 . . . . 0.0 111.69 170.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.84 -47.28 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.204 1.402 . . . . 0.0 111.258 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.92 -49.51 72.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.373 0.988 . . . . 0.0 111.409 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -49.42 -59.41 3.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.268 0.627 . . . . 0.0 109.845 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -67.97 -28.82 67.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.196 1.798 . . . . 0.0 114.91 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.78 -30.61 69.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 110.187 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.1 t30 111.15 55.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 130.721 3.608 . . . . 0.0 108.492 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.57 150.91 38.25 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.53 169.68 18.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.189 3.259 . . . . 0.0 110.696 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.8 164.8 26.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.254 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.24 167.06 19.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.37 1.468 . . . . 0.0 108.901 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -151.1 126.09 9.8 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 119.776 -1.827 . . . . 0.0 111.669 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.62 133.17 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.838 1.255 . . . . 0.0 109.591 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -74.17 125.59 28.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.94 0.496 . . . . 0.0 111.699 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 pt -72.93 -30.05 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.836 1.254 . . . . 0.0 113.038 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.66 167.6 13.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.194 0.998 . . . . 0.0 111.935 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 79.61 -107.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.919 2.488 . . . . 0.0 109.852 -170.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -55.71 124.22 16.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.722 1.209 . . . . 0.0 113.881 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.06 -39.64 90.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 113.653 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.83 -33.1 74.12 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.537 -0.727 . . . . 0.0 111.558 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.0 tp -72.45 -43.49 63.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.641 0.776 . . . . 0.0 111.157 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -56.09 -45.64 79.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.144 1.377 . . . . 0.0 112.345 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.18 -40.58 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.386 1.074 . . . . 0.0 111.575 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.92 -36.79 87.15 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 118.675 -1.07 . . . . 0.0 113.872 -172.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.91 -44.58 95.71 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.416 1.608 . . . . 0.0 111.566 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.8 -48.23 75.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.47 -32.99 73.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.435 0.694 . . . . 0.0 112.823 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -69.26 -37.97 78.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 0.0 112.572 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 m -87.55 -24.37 24.05 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m 74.53 -41.53 0.48 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.321 2.648 . . . . 0.0 113.756 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -68.45 129.11 92.91 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.921 1.288 . . . . 0.0 110.73 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.53 158.81 16.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.784 2.989 . . . . 0.0 112.07 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p 75.13 162.62 0.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.558 2.743 . . . . 0.0 113.665 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -143.28 159.72 54.43 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.461 1.904 . . . . 0.0 110.68 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.28 149.81 53.97 Favored 'Cis proline' 0 C--N 1.354 0.832 0 CA-C-N 120.313 1.147 . . . . 0.0 114.007 -2.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.14 148.88 32.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 0.0 110.344 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -114.09 140.31 48.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.362 1.465 . . . . 0.0 110.609 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -132.71 145.52 51.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.99 2.116 . . . . 0.0 109.997 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mt -137.23 119.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.383 -0.823 . . . . 0.0 112.465 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 t70 63.67 -43.09 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.95 3.3 . . . . 0.0 117.179 168.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.96 9.34 0.03 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.562 2.506 . . . . 0.0 114.151 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.01 145.15 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.47 1.508 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.53 152.35 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.527 -0.733 . . . . 0.0 109.97 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -110.47 -36.65 5.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.119 0.968 . . . . 0.0 112.615 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.37 -159.15 23.28 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.109 1.338 . . . . 0.0 113.293 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.05 169.28 54.68 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.147 0.879 . . . . 0.0 114.028 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.0 p -68.7 -49.55 58.06 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.444 -1.033 . . . . 0.0 112.922 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.47 -39.11 86.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.891 -1.131 . . . . 0.0 111.657 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.3 -41.87 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.591 0.756 . . . . 0.0 110.381 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.8 m -62.76 -40.92 98.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 0.0 111.668 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.14 -46.91 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.132 0.878 . . . . 0.0 111.484 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -31.7 63.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.267 0.94 . . . . 0.0 113.504 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.23 83.11 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.072 -1.018 . . . . 0.0 112.594 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.68 -44.8 92.65 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.646 1.178 . . . . 0.0 112.035 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.68 -27.99 68.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.6 m -86.84 -14.69 41.37 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 113.666 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.81 75.71 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 125.354 1.455 . . . . 0.0 114.19 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.39 -34.64 63.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.552 1.141 . . . . 0.0 111.312 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.46 -45.56 86.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.524 -0.735 . . . . 0.0 110.719 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.03 -47.39 77.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.71 0.804 . . . . 0.0 111.002 175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.42 -50.33 73.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.867 0.867 . . . . 0.0 112.074 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -76.44 -32.97 58.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.17 -40.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.964 0.802 . . . . 0.0 110.618 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.39 -43.99 95.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.347 0.976 . . . . 0.0 111.591 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -55.87 -45.12 78.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.911 0.778 . . . . 0.0 111.051 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.68 94.89 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 113.071 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 57.8 mtt -64.79 -35.27 80.56 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.731 0.813 . . . . 0.0 112.343 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.3 -36.01 76.59 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.762 0.825 . . . . 0.0 112.768 170.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.892 2.477 . . . . 0.0 112.241 -179.435 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.81 65.05 3.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.684 1.194 . . . . 0.0 110.999 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.33 49.14 1.5 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.549 1.54 . . . . 0.0 112.804 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.5 p -77.34 -22.12 0.39 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 115.605 -2.14 . . . . 0.0 115.658 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -60.11 168.61 5.84 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.126 2.551 . . . . 0.0 114.372 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.29 -6.67 7.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.98 -56.93 8.72 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.592 1.557 . . . . 0.0 110.622 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -59.67 -43.21 94.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.4 0.68 . . . . 0.0 111.784 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.11 -41.05 95.98 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.046 2.138 . . . . 0.0 112.163 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -67.78 -46.48 71.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.607 1.163 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -56.92 -53.82 53.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.404 0.681 . . . . 0.0 110.804 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.17 -43.85 78.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.259 0.623 . . . . 0.0 112.004 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.1 -51.08 71.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.771 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.92 -37.36 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.403 1.456 . . . . 0.0 112.214 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -63.64 -37.35 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.069 0.947 . . . . 0.0 112.648 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 p -86.37 -36.97 18.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.726 0.81 . . . . 0.0 113.169 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -75.92 -37.91 58.24 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.526 0.731 . . . . 0.0 112.804 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -110.11 114.66 28.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.01 0.924 . . . . 0.0 110.61 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -77.11 67.66 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.549 -1.344 . . . . 0.0 111.464 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.2 t 132.31 122.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 1 C-N-CA 133.913 4.885 . . . . 0.0 107.652 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.76 132.93 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.337 1.055 . . . . 0.0 109.337 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.59 137.9 38.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.49 1.516 . . . . 0.0 109.261 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -112.76 115.22 28.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.172 1.389 . . . . 0.0 107.732 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ptp -153.67 164.3 38.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.894 1.278 . . . . 0.0 112.933 -169.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -80.1 45.02 0.7 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.663 1.585 . . . . 0.0 111.261 174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.99 -161.93 27.02 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.151 1.358 . . . . 0.0 114.41 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.5 p -135.56 178.94 6.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.33 1.852 . . . . 0.0 111.18 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -66.36 -25.94 67.04 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.09 -26.44 19.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.853 1.261 . . . . 0.0 112.436 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -124.91 71.37 61.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.995 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.48 164.78 33.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.231 2.62 . . . . 0.0 110.902 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.48 129.62 34.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.925 0.49 . . . . 0.0 109.802 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.94 147.1 52.8 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.949 0.9 . . . . 0.0 112.673 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -116.06 4.71 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.057 0.837 . . . . 0.0 111.558 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -60.68 -54.98 38.75 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.874 0.87 . . . . 0.0 113.035 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -66.77 -39.44 87.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.642 -1.286 . . . . 0.0 112.22 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.57 -46.97 77.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.197 1.399 . . . . 0.0 111.151 170.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 m -61.24 -45.99 92.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.77 0.828 . . . . 0.0 110.247 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.81 -44.87 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.573 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.15 -34.97 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 120.78 1.627 . . . . 0.0 111.929 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -65.72 -35.43 80.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.791 0.723 . . . . 0.0 111.885 169.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.35 -51.21 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.897 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 121.137 1.789 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -49.46 -55.86 11.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.047 0.539 . . . . 0.0 109.815 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -66.51 -29.19 69.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.323 2.249 . . . . 0.0 115.059 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tt -59.54 -30.75 68.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.944 1.698 . . . . 0.0 109.481 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 108.08 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 131.443 3.897 . . . . 0.0 107.347 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.2 152.98 32.15 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.53 179.19 5.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.31 3.34 . . . . 0.0 110.853 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.61 171.86 13.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.436 1.894 . . . . 0.0 110.38 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.91 147.95 50.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.847 0.859 . . . . 0.0 109.597 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 m -122.61 111.83 17.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.909 0.884 . . . . 0.0 110.576 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.09 124.43 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.354 1.062 . . . . 0.0 109.452 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -72.95 105.76 4.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 110.45 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.9 pt -89.2 -173.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.35 1.06 . . . . 0.0 112.039 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt 68.75 -14.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.462 2.305 . . . . 0.0 115.085 169.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -65.16 -19.73 66.12 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.052 1.741 . . . . 0.0 114.475 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -158.22 169.05 25.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.639 1.576 . . . . 0.0 112.01 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -64.88 -31.87 73.3 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.14 -36.25 83.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.104 0.866 . . . . 0.0 111.337 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.43 -23.11 56.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.396 1.078 . . . . 0.0 113.088 172.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -82.78 -51.51 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.609 1.095 . . . . 0.0 112.685 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -95.48 -43.87 7.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.826 1.25 . . . . 0.0 112.039 -169.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.51 61.06 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.684 0.659 . . . . 0.0 112.019 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 tp -59.64 -41.99 91.73 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.419 0.688 . . . . 0.0 111.882 172.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -63.74 -40.16 96.06 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.919 -0.488 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -72.04 -33.73 68.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.551 0.614 . . . . 0.0 112.416 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -65.3 -47.41 76.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.146 0.978 . . . . 0.0 112.95 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -92.01 -25.93 18.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 74.64 -8.02 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.917 2.087 . . . . 0.0 113.464 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -65.56 133.77 95.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.027 1.331 . . . . 0.0 111.436 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 -41.91 0.62 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.066 2.51 . . . . 0.0 115.199 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -143.9 107.44 4.61 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.175 0.898 . . . . 0.0 111.815 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.25 162.78 16.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.007 1.323 . . . . 0.0 112.465 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -64.53 169.1 37.5 Favored 'Cis proline' 0 C--N 1.355 0.911 0 CA-C-N 120.772 1.311 . . . . 0.0 115.275 0.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.12 166.66 31.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.72 150.23 27.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.48 1.912 . . . . 0.0 108.834 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.35 143.65 32.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.107 2.163 . . . . 0.0 109.81 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.42 172.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.687 1.595 . . . . 0.0 111.532 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.69 103.17 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.392 1.077 . . . . 0.0 112.676 -171.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.64 89.13 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 117.601 -1.666 . . . . 0.0 116.072 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.22 134.97 10.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.652 2.226 . . . . 0.0 113.054 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.09 148.4 36.1 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.918 -1.114 . . . . 0.0 110.651 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -99.41 -45.76 5.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.69 -161.83 13.55 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.928 1.251 . . . . 0.0 112.911 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.26 165.1 46.84 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 124.18 0.895 . . . . 0.0 115.126 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -66.81 -38.9 87.38 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.982 -0.716 . . . . 0.0 112.273 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.9 -45.89 91.08 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.608 -0.683 . . . . 0.0 111.434 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.24 -40.38 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.195 0.598 . . . . 0.0 110.346 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 80.1 m -62.92 -44.13 96.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.693 1.197 . . . . 0.0 111.641 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.71 -46.36 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.905 0.775 . . . . 0.0 111.141 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.84 -36.96 81.27 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.62 0.645 . . . . 0.0 112.26 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.89 91.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.277 1.031 . . . . 0.0 112.202 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.01 -38.88 92.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.63 0.772 . . . . 0.0 112.519 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.46 -31.37 72.41 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.976 0.911 . . . . 0.0 111.791 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.9 m -88.26 -12.33 43.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.81 -2.57 76.65 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.081 1.324 . . . . 0.0 114.239 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.84 -36.19 42.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.981 1.312 . . . . 0.0 111.693 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.68 -42.21 95.51 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.701 -0.625 . . . . 0.0 110.453 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -56.26 -49.17 74.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.307 1.043 . . . . 0.0 110.169 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.38 -46.72 87.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.335 0.654 . . . . 0.0 112.067 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -71.42 -36.67 71.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.01 -37.77 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.581 1.082 . . . . 0.0 110.861 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.08 -44.89 94.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 110.434 169.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.78 -39.75 85.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.372 -0.83 . . . . 0.0 112.21 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.87 -44.73 96.22 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.828 1.195 . . . . 0.0 112.045 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmt -63.25 -38.07 89.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.259 1.023 . . . . 0.0 112.357 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.7 m -67.36 -36.88 82.27 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.005 0.922 . . . . 0.0 112.709 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.8 m . . . . . 0 C--O 1.255 1.379 0 C-N-CA 128.048 2.539 . . . . 0.0 112.036 -177.716 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.002 -0.047 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.22 62.54 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.3 93.46 0.64 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.236 1.414 . . . . 0.0 110.36 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.331 24.5 p 132.99 -50.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.648 1 C-N-CA 134.322 5.049 . . . . 0.0 112.765 172.128 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.87 -34.6 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 CA-C-N 122.305 1.859 . . . . 0.0 113.822 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.27 -46.63 2.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -67.68 -51.33 50.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.091 0.86 . . . . 0.0 111.792 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -64.61 -33.59 76.28 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.465 -0.772 . . . . 0.0 111.624 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -61.69 -43.19 99.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.433 2.293 . . . . 0.0 111.929 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -68.82 -43.41 75.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.868 1.267 . . . . 0.0 111.151 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.64 -41.12 89.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.868 0.867 . . . . 0.0 111.54 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.07 -42.96 99.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.525 1.057 . . . . 0.0 112.582 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.11 -40.9 98.99 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.275 -0.89 . . . . 0.0 111.816 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.04 -52.19 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.296 1.039 . . . . 0.0 110.853 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.09 -49.92 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.345 1.458 . . . . 0.0 112.101 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -74.85 -30.77 61.45 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.3 p -90.69 -36.56 14.27 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -38.81 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.223 -0.923 . . . . 0.0 112.21 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.77 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.088 2.955 . . . . 0.0 117.661 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.06 110.51 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.422 1.889 . . . . 0.0 107.66 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.26 158.29 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.85 117.17 15.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.177 1.391 . . . . 0.0 109.31 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -87.69 124.86 34.0 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.089 1.356 . . . . 0.0 109.924 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -163.45 172.97 13.74 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -69.81 -19.78 63.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.521 1.528 . . . . 0.0 114.083 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.1 -159.65 31.47 Favored Glycine 0 N--CA 1.477 1.417 0 C-N-CA 125.158 1.361 . . . . 0.0 113.547 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -136.47 -174.33 3.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.398 1.879 . . . . 0.0 110.348 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -80.38 -29.13 37.82 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.221 -0.924 . . . . 0.0 112.334 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.38 -34.36 65.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.638 1.175 . . . . 0.0 111.958 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -133.75 91.71 24.69 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.913 1.285 . . . . 0.0 110.413 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.64 157.52 48.34 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.739 2.293 . . . . 0.0 110.537 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -77.75 125.23 29.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.038 0.447 . . . . 0.0 110.275 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -59.49 143.54 49.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.297 1.439 . . . . 0.0 113.13 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.82 -100.4 2.08 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.085 0.85 . . . . 0.0 111.097 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -58.87 -64.3 0.99 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.454 1.501 . . . . 0.0 113.347 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -67.12 -37.41 83.83 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.706 -1.246 . . . . 0.0 111.447 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -54.42 -46.75 73.25 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.9 m -61.61 -48.0 82.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.263 1.025 . . . . 0.0 110.839 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.76 -49.03 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.918 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.93 -32.92 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.417 1.008 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -63.81 -41.55 97.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.911 0.885 . . . . 0.0 111.242 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 mt -59.6 -50.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 111.15 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.08 -52.22 65.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.424 0.69 . . . . 0.0 111.045 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -51.3 -55.59 17.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.983 0.513 . . . . 0.0 110.615 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -68.1 -31.02 70.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.094 1.758 . . . . 0.0 114.36 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.31 -33.9 71.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.7 t30 117.75 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.728 3.611 . . . . 0.0 109.645 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.13 137.79 23.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.83 89.81 1.27 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.723 2.948 . . . . 0.0 109.868 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -70.2 152.97 43.65 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.887 0.475 . . . . 0.0 110.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -129.23 121.33 27.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.399 0.619 . . . . 0.0 110.534 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -73.36 120.7 19.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.246 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.37 118.58 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.523 1.129 . . . . 0.0 108.092 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -75.07 120.03 20.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.033 0.933 . . . . 0.0 111.09 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -127.14 179.23 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.253 1.421 . . . . 0.0 112.082 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 77.71 -52.2 0.52 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 127.739 2.416 . . . . 0.0 112.406 169.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.25 -25.07 65.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.86 0.864 . . . . 0.0 112.983 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -104.13 113.94 27.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.717 2.407 . . . . 0.0 110.596 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.49 -28.63 69.33 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.36 -50.65 66.9 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 110.944 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.72 -39.91 91.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.39 0.676 . . . . 0.0 110.791 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -54.21 -44.53 71.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 0.0 112.082 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.093 0.957 . . . . 0.0 112.26 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.59 -42.68 46.82 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 113.776 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.81 -25.99 64.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.648 1.224 . . . . 0.0 113.341 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.07 -44.11 94.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.26 0.936 . . . . 0.0 111.376 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.41 -46.11 56.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.668 0.787 . . . . 0.0 111.19 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.94 -39.61 94.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 0.0 112.832 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.2 p -88.89 -35.68 16.38 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p 64.27 -23.24 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.222 2.609 . . . . 0.0 114.367 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -67.11 130.39 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.781 1.632 . . . . 0.0 111.27 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.25 136.97 13.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.83 2.354 . . . . 0.0 111.599 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.1 p 77.24 165.36 0.24 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 128.679 2.791 . . . . 0.0 114.65 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.65 161.89 49.62 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 127.208 2.203 . . . . 0.0 110.723 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -58.2 157.01 34.79 Favored 'Cis proline' 0 C--N 1.356 0.965 0 CA-C-N 120.777 1.313 . . . . 0.0 114.655 -2.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -152.7 132.43 13.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.021 0.528 . . . . 0.0 110.863 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 tt -93.9 142.35 27.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.027 1.331 . . . . 0.0 110.85 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -133.08 143.05 49.08 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.716 1.206 . . . . 0.0 111.519 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.52 138.64 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.07 1.348 . . . . 0.0 110.318 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -15.21 89.09 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.921 2.888 . . . . 0.0 115.809 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.3 55.65 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.167 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.8 130.49 21.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.189 1.994 . . . . 0.0 114.233 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -81.24 121.81 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.153 1.381 . . . . 0.0 108.841 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -92.59 -32.82 14.66 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.7 -154.1 16.6 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.819 1.2 . . . . 0.0 113.712 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.87 47.1 Favored Glycine 0 N--CA 1.473 1.1 0 C-N-CA 124.718 1.151 . . . . 0.0 115.498 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.5 t -58.58 -51.25 70.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.993 1.317 . . . . 0.0 112.782 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -60.64 -43.57 97.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.948 0.499 . . . . 0.0 111.77 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.13 -45.42 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.469 0.708 . . . . 0.0 110.24 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.1 -46.58 88.45 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.668 1.187 . . . . 0.0 110.882 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.23 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.87 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.17 -39.38 86.46 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.276 0.943 . . . . 0.0 111.916 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.44 79.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.649 -0.657 . . . . 0.0 112.226 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.86 -43.76 91.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.985 0.914 . . . . 0.0 112.047 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.24 -30.76 69.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.016 0.926 . . . . 0.0 112.79 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -84.79 -13.37 51.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.121 0.969 . . . . 0.0 113.374 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.26 83.89 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.418 1.485 . . . . 0.0 114.144 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -73.47 -38.82 65.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 111.571 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.15 -42.95 88.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.659 -0.65 . . . . 0.0 110.066 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -58.55 -48.08 82.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.583 0.753 . . . . 0.0 110.44 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.33 -50.17 72.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.861 0.865 . . . . 0.0 111.517 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -72.36 -35.37 68.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.252 -0.905 . . . . 0.0 113.435 -173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.43 -39.46 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.35 0.977 . . . . 0.0 110.722 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.95 -46.23 88.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.107 0.867 . . . . 0.0 111.296 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.73 -37.07 77.93 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.315 -0.865 . . . . 0.0 112.466 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.21 65.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 77.3 mtm -76.28 -38.24 56.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.606 0.639 . . . . 0.0 111.675 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.5 -41.34 69.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 127.668 2.387 . . . . 0.0 112.464 -172.9 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.2 173.57 11.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.321 1.049 . . . . 0.0 112.512 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -12.08 60.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -54.86 -46.94 99.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-O 115.555 -2.164 . . . . 0.0 116.28 -169.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.59 -40.49 5.52 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 123.47 2.275 . . . . 0.0 112.381 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.572 0.749 . . . . 0.0 111.504 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -54.36 47.45 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.03 1.332 . . . . 0.0 110.43 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.23 -35.2 76.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.856 -0.593 . . . . 0.0 112.218 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -62.94 -46.02 89.7 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.148 1.379 . . . . 0.0 111.439 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -62.27 -50.81 70.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.634 0.774 . . . . 0.0 111.137 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.04 -42.95 99.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.988 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.93 -48.99 77.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.639 1.109 . . . . 0.0 111.654 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.44 -41.7 90.21 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.355 0.662 . . . . 0.0 111.788 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.54 -53.34 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.916 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.2 -21.83 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.274 1.397 . . . . 0.0 113.681 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.3 p -80.14 -31.62 39.02 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.417 170.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.2 m -77.5 -38.5 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.662 0.665 . . . . 0.0 112.761 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.05 102.37 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.283 1.833 . . . . 0.0 108.999 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -60.84 -38.72 86.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.107 -0.995 . . . . 0.0 113.384 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -99.13 136.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.868 1.267 . . . . 0.0 109.096 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.15 136.82 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.05 142.24 30.78 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.28 1.032 . . . . 0.0 111.289 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -119.63 116.07 25.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.075 1.35 . . . . 0.0 108.623 169.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 48.2 mtm -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.819 1.247 . . . . 0.0 110.538 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -76.02 20.93 0.18 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.637 1.175 . . . . 0.0 113.78 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.19 168.12 41.15 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 126.797 2.141 . . . . 0.0 112.768 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -96.49 -175.48 3.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.961 1.304 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -11.1 33.97 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 170.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.17 -28.23 59.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 112.262 170.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -146.2 79.06 10.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.797 1.639 . . . . 0.0 111.075 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.47 135.99 64.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.027 2.485 . . . . 0.0 110.359 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -83.29 98.8 9.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.504 0.722 . . . . 0.0 112.413 -169.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.2 t 89.51 160.67 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.455 2.702 . . . . 0.0 112.325 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.08 -31.04 75.23 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 124.893 1.235 . . . . 0.0 113.408 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -62.0 -53.38 56.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.119 0.96 . . . . 0.0 110.671 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -61.73 -42.93 99.61 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.135 -0.978 . . . . 0.0 111.747 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.34 -44.26 92.67 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.038 0.935 . . . . 0.0 110.968 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.2 m -63.36 -45.13 92.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.862 0.865 . . . . 0.0 110.638 173.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.798 1.239 . . . . 0.0 112.514 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.02 -34.78 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 120.426 1.467 . . . . 0.0 111.8 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.91 -43.85 82.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 112.199 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.88 -51.49 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.559 1.544 . . . . 0.0 111.225 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.83 -49.09 69.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.309 1.043 . . . . 0.0 111.276 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -52.38 -49.89 63.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -68.24 -36.05 78.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.211 1.805 . . . . 0.0 114.176 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.87 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 120.78 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 131.051 3.74 . . . . 0.0 109.198 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.96 133.47 8.98 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -82.84 63.22 7.92 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.396 3.397 . . . . 0.0 108.422 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -70.01 168.68 14.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 113.891 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -134.38 172.54 12.75 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.377 1.084 . . . . 0.0 111.621 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -153.28 115.35 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.559 -1.338 . . . . 0.0 110.269 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.73 137.26 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.65 1.18 . . . . 0.0 110.324 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -81.05 123.24 28.21 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 112.106 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -27.95 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.839 1.256 . . . . 0.0 113.006 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.45 148.65 37.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.525 1.13 . . . . 0.0 109.731 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 66.0 6.56 4.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.468 1.907 . . . . 0.0 112.735 -169.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -135.3 57.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.673 1.989 . . . . 0.0 110.076 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -51.82 -37.27 51.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.239 1.416 . . . . 0.0 114.399 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.25 -42.63 91.59 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.343 1.057 . . . . 0.0 111.841 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.88 -41.98 64.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.356 1.062 . . . . 0.0 110.977 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -55.44 -47.12 76.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.909 1.284 . . . . 0.0 112.272 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -73.46 -49.03 28.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.184 0.594 . . . . 0.0 110.554 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.51 92.17 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.891 -0.949 . . . . 0.0 114.608 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.61 -57.76 11.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.372 1.086 . . . . 0.0 110.655 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -61.18 -37.97 84.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.588 0.755 . . . . 0.0 112.253 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.93 -36.84 80.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.858 1.263 . . . . 0.0 112.146 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -87.28 -38.7 16.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.795 1.638 . . . . 0.0 113.521 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.6 p -93.03 -28.25 16.5 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t 74.15 3.74 4.43 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 126.751 2.02 . . . . 0.0 113.318 -171.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -62.03 133.47 94.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.84 1.256 . . . . 0.0 112.041 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.45 -46.83 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.54 2.16 . . . . 0.0 114.662 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -147.46 124.92 11.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.318 0.963 . . . . 0.0 112.224 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.44 153.79 89.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.844 1.258 . . . . 0.0 112.0 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.22 158.7 94.91 Favored 'Cis proline' 0 C--N 1.354 0.855 0 CA-C-N 119.872 0.99 . . . . 0.0 113.662 7.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.59 128.6 27.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.488 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.19 129.21 40.88 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 109.177 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 141.83 47.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.409 1.884 . . . . 0.0 111.802 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.74 129.05 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 67.24 -19.34 0.12 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 128.218 2.607 . . . . 0.0 115.868 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.72 1.66 0.71 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.254 1.883 . . . . 0.0 115.153 -174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.34 158.88 43.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.141 1.47 . . . . 0.0 111.311 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -77.34 144.5 37.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.779 -0.576 . . . . 0.0 111.823 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -92.6 -40.06 10.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.71 1.204 . . . . 0.0 111.428 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.57 25.43 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.852 1.215 . . . . 0.0 113.49 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.47 169.73 33.23 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.04 1.305 . . . . 0.0 112.773 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 85.6 m -69.87 -44.55 69.59 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.591 -0.947 . . . . 0.0 113.099 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.01 -42.67 98.91 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.15 -0.969 . . . . 0.0 111.325 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.48 -40.2 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.9 0.88 . . . . 0.0 110.431 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.4 m -65.47 -42.71 91.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.621 1.169 . . . . 0.0 111.752 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -59.69 -43.8 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.022 0.828 . . . . 0.0 110.961 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -67.68 -37.04 81.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.845 0.748 . . . . 0.0 112.481 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.69 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.185 0.994 . . . . 0.0 112.19 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -63.78 -43.59 95.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.162 0.985 . . . . 0.0 112.113 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.18 -31.09 71.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 112.451 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.6 m -83.54 -14.2 52.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.442 1.097 . . . . 0.0 113.356 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.79 81.42 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.309 1.433 . . . . 0.0 114.31 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -71.25 -46.51 60.85 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.94 1.296 . . . . 0.0 111.031 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.58 -40.51 97.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.912 -0.493 . . . . 0.0 111.024 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.85 -47.92 83.17 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.355 0.662 . . . . 0.0 110.02 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.96 -49.42 74.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.309 0.644 . . . . 0.0 111.482 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -67.81 -39.08 84.0 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.78 -42.12 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.478 1.035 . . . . 0.0 110.536 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -45.52 91.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.872 0.76 . . . . 0.0 111.326 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -60.95 -40.59 93.92 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 112.292 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.82 82.98 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.809 0.843 . . . . 0.0 112.731 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.9 mmm -75.71 -45.91 34.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.145 0.978 . . . . 0.0 113.104 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.14 -45.67 7.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.774 1.23 . . . . 0.0 113.017 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.689 1.996 . . . . 0.0 113.178 -178.561 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.897 -0.038 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.75 172.24 13.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 111.363 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.01 -12.9 61.45 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -175.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.275 7.7 t -58.44 -37.68 57.33 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 116.243 -1.837 . . . . 0.0 115.753 -169.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -66.0 -44.27 7.79 Favored 'Trans proline' 0 C--N 1.355 0.916 0 CA-C-N 122.936 2.084 . . . . 0.0 112.191 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.26 -40.08 82.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.096 0.958 . . . . 0.0 111.843 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.78 -53.36 58.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.447 1.099 . . . . 0.0 111.056 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -59.36 -42.89 92.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.494 0.718 . . . . 0.0 111.619 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.2 m -60.21 -45.35 93.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.398 1.479 . . . . 0.0 111.609 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.2 m -63.59 -54.83 29.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.463 1.105 . . . . 0.0 110.904 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.42 -43.57 98.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.858 0.863 . . . . 0.0 111.768 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.96 -50.36 74.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.563 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.145 0.884 . . . . 0.0 111.564 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 t -55.97 -58.99 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.901 0.881 . . . . 0.0 110.944 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -74.01 -19.52 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.3 p -89.54 -32.18 17.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.477 1.111 . . . . 0.0 112.716 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.7 t -66.01 -35.85 81.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.112 0.869 . . . . 0.0 111.71 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -156.48 130.04 8.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.675 1.19 . . . . 0.0 112.12 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.8 160.67 17.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.97 0.908 . . . . 0.0 112.468 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t 65.56 83.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.327 1.851 . . . . 0.0 109.728 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.72 130.96 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.784 0.834 . . . . 0.0 110.205 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.3 120.47 42.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.439 1.096 . . . . 0.0 110.018 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.02 120.5 35.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.307 1.043 . . . . 0.0 109.058 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -152.78 -176.14 5.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.641 1.576 . . . . 0.0 110.816 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -78.7 36.1 0.26 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.387 -1.445 . . . . 0.0 113.326 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.59 -173.5 45.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.95 1.262 . . . . 0.0 113.763 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -131.91 -174.05 3.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.749 1.619 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -63.96 -11.69 30.9 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.39 -30.29 69.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.324 1.049 . . . . 0.0 112.318 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -154.43 88.23 3.41 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.37 1.468 . . . . 0.0 110.147 170.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.04 134.55 62.91 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.445 2.764 . . . . 0.0 111.235 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -85.24 130.81 34.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.074 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.4 m -55.73 152.39 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.763 2.025 . . . . 0.0 115.184 -169.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.28 -117.69 4.52 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.53 1.062 . . . . 0.0 112.007 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -48.47 -60.88 2.33 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.526 2.33 . . . . 0.0 112.185 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -43.33 92.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.02 -1.05 . . . . 0.0 112.434 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -57.09 -46.92 82.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -60.48 -46.07 91.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.497 1.119 . . . . 0.0 111.013 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.07 -48.43 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.62 -35.04 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.925 1.239 . . . . 0.0 111.904 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.58 -43.38 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.071 1.348 . . . . 0.0 111.491 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.15 -51.4 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.561 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.01 -53.54 56.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.264 0.938 . . . . 0.0 111.115 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.52 -62.26 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.019 1.328 . . . . 0.0 110.608 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.9 p -68.8 -27.95 66.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.766 1.627 . . . . 0.0 115.271 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -32.53 70.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.311 1.044 . . . . 0.0 110.326 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 116.21 60.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 130.462 3.505 . . . . 0.0 109.989 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.3 150.88 32.65 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.02 162.91 36.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.142 2.561 . . . . 0.0 110.675 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.55 159.65 41.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.938 1.295 . . . . 0.0 110.727 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -133.23 169.39 16.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.48 1.512 . . . . 0.0 108.547 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 p -152.13 155.45 37.88 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.66 -1.275 . . . . 0.0 114.021 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.63 133.17 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.056 1.343 . . . . 0.0 110.027 -170.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -80.46 106.41 12.45 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.902 0.881 . . . . 0.0 111.892 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.38 -27.61 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.593 1.157 . . . . 0.0 113.411 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.37 -2.95 54.51 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.655 1.182 . . . . 0.0 113.532 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -88.63 -10.98 46.7 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -157.4 124.7 5.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.512 1.125 . . . . 0.0 111.946 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.16 -41.24 90.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.399 1.079 . . . . 0.0 113.157 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.53 -37.81 85.82 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.21 0.604 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.54 -52.01 65.14 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.691 0.796 . . . . 0.0 109.908 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.39 -47.27 82.13 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.136 0.974 . . . . 0.0 113.07 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -73.86 -41.46 62.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 0.0 111.398 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -40.48 33.38 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.663 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.68 -31.7 70.94 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.978 1.389 . . . . 0.0 112.064 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.54 -38.55 91.39 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.795 0.838 . . . . 0.0 112.069 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.04 -46.13 53.62 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.224 1.01 . . . . 0.0 111.152 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.1 -46.49 88.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 112.646 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -90.87 -20.21 22.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.0 m 62.92 6.12 2.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.89 1.676 . . . . 0.0 113.544 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -69.13 134.81 89.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.215 1.406 . . . . 0.0 111.911 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.1 -43.68 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 113.686 -169.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p -147.9 113.06 5.53 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.232 1.013 . . . . 0.0 110.945 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.43 158.49 20.55 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.695 1.198 . . . . 0.0 111.538 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.76 173.12 42.09 Favored 'Cis proline' 0 C--N 1.355 0.889 0 CA-C-N 120.839 1.335 . . . . 0.0 115.509 5.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -161.87 152.16 17.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.259 1.024 . . . . 0.0 112.495 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 78' ' ' TYR . 1.6 tt -85.97 148.15 25.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.554 1.942 . . . . 0.0 109.343 171.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.527 ' H ' HD23 ' A' ' 77' ' ' LEU . 34.1 t80 -149.85 139.47 21.64 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.774 2.029 . . . . 0.0 111.217 -171.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.3 pt -149.35 141.76 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.604 1.562 . . . . 0.0 112.174 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.78 -21.5 0.09 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 127.625 2.37 . . . . 0.0 115.926 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.89 5.17 2.23 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.134 2.302 . . . . 0.0 114.343 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.15 161.72 35.38 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.573 1.549 . . . . 0.0 111.19 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -75.21 150.92 38.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.211 -0.931 . . . . 0.0 111.688 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -101.91 -41.44 6.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.138 1.375 . . . . 0.0 111.009 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.53 -162.37 20.7 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 124.653 1.12 . . . . 0.0 114.468 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.9 -176.9 50.12 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.906 1.241 . . . . 0.0 115.615 -169.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.62 -41.13 98.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.306 1.042 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -57.87 -49.55 76.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.215 1.006 . . . . 0.0 111.773 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.4 -43.33 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.063 0.945 . . . . 0.0 110.312 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.0 m -62.75 -44.87 95.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.87 1.268 . . . . 0.0 111.351 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.99 -45.78 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.56 1.144 . . . . 0.0 111.313 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -70.16 -38.18 75.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.893 0.77 . . . . 0.0 112.273 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.42 -30.34 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 113.022 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -65.65 -37.6 86.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.725 1.21 . . . . 0.0 112.174 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.2 -40.34 82.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 0.0 112.77 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.6 p -85.56 -16.54 39.05 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.0 81.3 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.853 1.216 . . . . 0.0 113.217 -173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.69 -27.13 66.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.343 1.057 . . . . 0.0 111.89 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.87 -46.72 83.68 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.818 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.09 -48.66 79.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.401 0.546 . . . . 0.0 110.609 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -57.48 -48.48 79.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.565 0.746 . . . . 0.0 111.611 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -70.0 -38.86 76.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.61 -43.42 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 111.107 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.78 -44.66 95.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.163 0.892 . . . . 0.0 111.371 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.68 -40.26 87.25 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.745 -0.597 . . . . 0.0 111.823 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.74 83.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 113.087 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.06 -38.65 86.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.379 -0.826 . . . . 0.0 111.964 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.7 m -73.77 -37.09 65.1 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.635 2.374 . . . . 0.0 112.357 -172.668 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.42 33.17 3.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.563 1.545 . . . . 0.0 113.294 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.78 -65.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.244 1.418 . . . . 0.0 113.208 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 p -74.5 -33.99 1.75 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 115.792 -2.051 . . . . 0.0 114.46 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -74.97 -40.44 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 122.84 2.05 . . . . 0.0 114.614 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.38 -46.93 2.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.51 -58.0 5.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 110.366 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.37 -31.11 72.18 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.242 -0.912 . . . . 0.0 112.429 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -60.66 -39.39 88.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.878 2.071 . . . . 0.0 112.24 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -70.22 -43.57 70.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.61 1.164 . . . . 0.0 111.004 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.3 -52.6 64.91 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.58 0.752 . . . . 0.0 110.485 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.17 -40.93 74.67 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 112.015 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.57 -50.11 73.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.341 -0.849 . . . . 0.0 111.774 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.35 -34.11 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.168 1.349 . . . . 0.0 112.672 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.43 -45.69 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.965 0.906 . . . . 0.0 112.207 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -76.92 -41.33 43.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.64 0.654 . . . . 0.0 112.641 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 m -78.27 -32.44 49.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -127.21 -7.74 5.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 66.44 -56.88 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.434 2.294 . . . . 0.0 114.972 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.08 124.38 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 109.177 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.32 138.64 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.122 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.4 126.05 52.9 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.125 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.81 100.59 12.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -145.29 151.01 37.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.389 1.075 . . . . 0.0 111.514 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.37 -19.67 59.43 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 178.57 34.32 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.999 1.761 . . . . 0.0 112.919 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 p -103.03 172.4 6.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.52 1.528 . . . . 0.0 111.128 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -64.12 -35.82 82.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.93 -15.93 52.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.016 1.326 . . . . 0.0 114.014 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -150.95 88.25 4.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.85 1.26 . . . . 0.0 111.022 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.52 168.97 20.59 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.314 2.676 . . . . 0.0 111.741 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -78.58 -3.23 42.77 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.6 m 72.99 -1.23 3.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.495 2.318 . . . . 0.0 115.236 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.47 -150.5 24.35 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 125.553 1.549 . . . . 0.0 112.754 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -60.37 -25.82 66.16 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.057 0.943 . . . . 0.0 113.174 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -59.01 -48.6 81.02 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.806 1.242 . . . . 0.0 111.554 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.63 -42.69 88.88 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.093 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 m -59.53 -46.69 88.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.366 0.985 . . . . 0.0 112.0 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 t -58.95 -46.06 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.955 0.902 . . . . 0.0 111.557 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -59.55 -45.23 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.143 0.577 . . . . 0.0 111.073 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -65.54 -38.7 90.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.722 1.209 . . . . 0.0 112.257 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mt -58.91 -49.38 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.915 1.286 . . . . 0.0 110.523 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 mt -63.74 -50.12 70.34 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.998 0.919 . . . . 0.0 111.176 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -53.98 -57.68 10.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 110.916 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.7 p -68.66 -27.63 66.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.869 1.668 . . . . 0.0 114.849 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.92 -34.86 72.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.266 0.939 . . . . 0.0 109.828 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.9 t30 118.71 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.504 3.522 . . . . 0.0 110.095 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.99 148.44 20.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.22 170.12 21.04 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.56 2.84 . . . . 0.0 110.605 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -155.08 143.66 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -106.93 89.96 3.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.809 0.843 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.3 p -72.66 81.37 1.12 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.138 -0.976 . . . . 0.0 109.868 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.08 116.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 108.41 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.66 94.67 3.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.702 1.201 . . . . 0.0 111.821 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -74.72 173.74 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.243 1.017 . . . . 0.0 111.313 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.95 -46.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.905 2.082 . . . . 0.0 112.425 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.36 -39.84 94.67 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.329 1.052 . . . . 0.0 112.284 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -95.5 124.23 39.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.64 1.176 . . . . 0.0 110.156 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.68 -26.79 67.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.134 0.974 . . . . 0.0 113.073 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.84 -38.98 93.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.851 0.75 . . . . 0.0 112.289 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.87 -32.98 71.63 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.607 0.763 . . . . 0.0 112.076 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -55.01 -43.78 73.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.208 1.003 . . . . 0.0 112.516 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -91.18 -45.37 8.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.393 1.077 . . . . 0.0 111.333 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.06 90.35 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.774 -1.014 . . . . 0.0 114.706 -169.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.91 -42.14 63.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 111.815 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.63 -40.84 96.29 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.869 -0.519 . . . . 0.0 111.445 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.91 -52.33 50.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.987 0.915 . . . . 0.0 111.447 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.15 -38.67 82.4 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.14 -28.81 25.29 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m 75.99 -4.84 2.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.813 2.445 . . . . 0.0 112.684 -169.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CB ' HE22 ' A' ' 76' ' ' GLN . 24.2 m95 -76.79 137.3 66.46 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.975 -1.078 . . . . 0.0 111.437 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.71 -23.7 3.81 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.78 2.32 . . . . 0.0 111.532 169.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.6 m -96.19 131.17 42.94 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.564 1.546 . . . . 0.0 112.508 -169.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -138.8 151.74 69.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.859 2.063 . . . . 0.0 109.812 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.27 167.66 79.15 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 120.093 1.069 . . . . 0.0 113.317 5.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.422 HE22 ' CB ' ' A' ' 71' ' ' TRP . 8.4 pt20 -160.69 161.07 32.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 113.18 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.75 141.78 30.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.26 2.224 . . . . 0.0 109.801 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.55 131.94 25.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.878 2.071 . . . . 0.0 110.352 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.9 mt -138.74 118.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.878 -1.139 . . . . 0.0 111.476 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.69 32.32 11.78 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.333 1.453 . . . . 0.0 114.249 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.68 65.87 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.601 1.096 . . . . 0.0 115.023 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -103.5 120.73 41.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.841 1.32 . . . . 0.0 111.022 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.01 106.72 8.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.184 0.993 . . . . 0.0 109.669 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -82.66 -31.43 28.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.634 1.173 . . . . 0.0 111.971 -170.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.66 -155.18 16.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.687 1.137 . . . . 0.0 114.892 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.87 177.19 54.25 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.647 1.118 . . . . 0.0 114.922 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 21.9 p -63.94 -44.94 91.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.193 0.997 . . . . 0.0 113.509 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.88 -44.38 97.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.467 0.707 . . . . 0.0 111.38 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.48 -45.31 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.631 0.773 . . . . 0.0 109.722 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -62.41 -47.56 83.59 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.44 -42.88 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 111.35 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -72.47 -34.8 67.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.852 0.751 . . . . 0.0 112.416 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.94 85.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.17 -40.86 86.68 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.768 1.227 . . . . 0.0 112.355 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -64.02 -39.04 93.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.94 0.896 . . . . 0.0 111.964 170.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -77.15 -16.57 59.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.928 0.891 . . . . 0.0 113.361 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.54 80.89 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.095 1.331 . . . . 0.0 113.82 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.11 -47.26 65.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.022 1.329 . . . . 0.0 110.883 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.7 tp -62.27 -42.91 99.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.717 -0.614 . . . . 0.0 110.534 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -59.43 -46.5 88.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.627 0.771 . . . . 0.0 110.537 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -63.98 -49.28 73.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.166 0.586 . . . . 0.0 111.613 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -68.72 -37.27 79.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.462 1.028 . . . . 0.0 112.886 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.14 -45.09 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.203 0.91 . . . . 0.0 110.495 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.63 -46.34 86.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.775 0.716 . . . . 0.0 111.083 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -60.76 -40.17 91.5 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.776 1.23 . . . . 0.0 112.074 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.58 89.47 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.815 0.846 . . . . 0.0 112.1 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -66.88 -33.17 75.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.288 0.635 . . . . 0.0 112.656 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.2 m -71.72 -43.05 66.56 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.453 2.301 . . . . 0.0 112.582 -173.939 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 173.68 15.27 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.068 1.347 . . . . 0.0 112.042 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.91 165.55 23.07 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.831 0.853 . . . . 0.0 113.155 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 t 179.55 -32.53 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 128.067 2.547 . . . . 0.0 114.615 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -68.93 -169.25 0.28 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 123.007 2.472 . . . . 0.0 113.069 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.43 -4.1 1.18 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 tt -55.81 -50.92 69.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.443 1.097 . . . . 0.0 110.331 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -60.39 -43.46 96.63 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 0.0 111.68 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -37.77 80.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.426 1.89 . . . . 0.0 112.321 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.4 m -67.6 -49.37 63.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.392 1.077 . . . . 0.0 110.507 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.91 -46.36 85.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 110.976 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.36 -45.67 90.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.177 0.991 . . . . 0.0 112.236 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.328 -0.857 . . . . 0.0 111.781 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.02 -47.5 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.021 0.828 . . . . 0.0 111.15 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.74 -36.55 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.996 1.318 . . . . 0.0 113.123 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 p -84.33 -35.55 23.19 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.173 0.897 . . . . 0.0 112.906 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.3 t -75.58 -42.33 52.35 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -101.82 -6.44 23.59 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 63.47 -59.54 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.792 2.437 . . . . 0.0 114.566 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.3 125.1 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.437 1.495 . . . . 0.0 109.928 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.19 130.56 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.923 0.489 . . . . 0.0 111.369 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 139.42 34.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.56 1.144 . . . . 0.0 110.344 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.09 123.21 43.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 109.497 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -159.49 179.5 8.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.929 1.692 . . . . 0.0 109.855 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -77.91 35.16 0.2 Allowed 'General case' 0 CA--C 1.556 1.191 0 O-C-N 120.068 -1.645 . . . . 0.0 114.037 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.96 161.52 34.83 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.894 1.711 . . . . 0.0 113.77 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.6 p -94.76 -176.01 3.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.887 1.675 . . . . 0.0 111.588 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -67.22 -28.99 68.53 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.361 0.664 . . . . 0.0 111.95 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.12 -29.02 48.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.868 1.267 . . . . 0.0 112.561 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.69 73.95 75.03 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.273 1.429 . . . . 0.0 111.739 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.22 154.83 37.95 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.353 2.702 . . . . 0.0 111.954 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.06 146.19 32.93 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.885 0.874 . . . . 0.0 111.355 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -68.01 161.65 26.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.04 1.336 . . . . 0.0 113.684 -173.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.84 -146.71 21.51 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.696 1.141 . . . . 0.0 112.035 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -57.62 -32.23 67.03 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 m -59.3 -47.43 85.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.609 1.095 . . . . 0.0 112.056 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.67 -46.31 87.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.291 1.037 . . . . 0.0 110.743 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -44.99 91.61 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.871 0.868 . . . . 0.0 110.639 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.59 -43.0 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.645 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.66 -34.06 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.898 1.681 . . . . 0.0 112.158 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.97 -44.34 89.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.602 0.637 . . . . 0.0 111.405 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -59.19 -52.35 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.619 1.168 . . . . 0.0 111.466 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.0 mt -65.13 -47.88 75.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.57 0.748 . . . . 0.0 111.281 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -50.48 -55.94 13.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.903 0.881 . . . . 0.0 110.891 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 m -68.25 -36.08 78.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.823 1.649 . . . . 0.0 114.176 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.59 -32.83 71.92 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.301 1.44 . . . . 0.0 111.076 173.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.6 t30 122.69 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 131.261 3.825 . . . . 0.0 109.815 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.7 137.65 11.54 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.58 61.2 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.47 3.447 . . . . 0.0 109.268 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -62.18 156.53 21.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.452 1.101 . . . . 0.0 112.94 -171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -121.44 170.31 9.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.466 1.107 . . . . 0.0 110.902 171.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 m -149.89 121.59 8.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.293 -1.505 . . . . 0.0 111.46 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -106.92 129.67 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.597 1.559 . . . . 0.0 109.677 -173.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -80.42 107.97 13.66 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.249 0.62 . . . . 0.0 111.42 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.7 pt -64.28 -27.37 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.101 -0.999 . . . . 0.0 112.928 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -0.16 51.63 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.286 1.434 . . . . 0.0 113.385 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.04 -29.46 67.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.776 0.83 . . . . 0.0 112.638 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -159.41 139.64 12.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.82 1.248 . . . . 0.0 110.919 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.05 -40.37 63.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.014 1.726 . . . . 0.0 114.087 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 tp -66.08 -31.32 72.13 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.338 1.055 . . . . 0.0 112.168 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.72 -45.77 41.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.856 0.863 . . . . 0.0 110.016 171.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.09 -44.99 75.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.995 1.318 . . . . 0.0 112.591 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -84.44 -28.77 26.63 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.94 -31.75 64.19 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 124.403 1.002 . . . . 0.0 113.422 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.22 -31.77 70.48 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 1.284 . . . . 0.0 112.511 176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.07 -38.55 91.46 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.154 -0.966 . . . . 0.0 111.873 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -71.51 -40.3 70.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.512 0.725 . . . . 0.0 111.298 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -63.68 -38.03 89.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.937 1.295 . . . . 0.0 113.455 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.1 m -118.01 -19.79 8.98 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p 68.62 -12.09 0.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.611 2.364 . . . . 0.0 114.194 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -61.78 136.79 94.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 125.739 1.616 . . . . 0.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.53 -42.89 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.754 2.303 . . . . 0.0 115.371 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -140.22 108.72 5.87 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.113 0.869 . . . . 0.0 111.681 -169.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.34 162.71 71.22 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.511 1.524 . . . . 0.0 112.173 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.15 163.97 36.33 Favored 'Cis proline' 0 C--N 1.356 0.931 0 N-CA-C 116.027 1.51 . . . . 0.0 116.027 2.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.36 158.31 37.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.363 1.065 . . . . 0.0 111.512 170.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -105.94 138.97 41.21 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.358 1.863 . . . . 0.0 109.295 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.34 141.04 52.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.672 1.989 . . . . 0.0 111.162 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mt -139.03 123.07 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.93 -26.75 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.954 3.302 . . . . 0.0 117.014 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.51 1.39 0.04 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.447 1.975 . . . . 0.0 115.237 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -140.2 157.0 46.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.441 1.62 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -76.48 148.58 37.1 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.695 -0.628 . . . . 0.0 110.954 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -98.66 -43.66 6.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.931 1.292 . . . . 0.0 111.807 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.66 -165.73 24.98 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.276 1.417 . . . . 0.0 113.176 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.84 49.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.488 1.042 . . . . 0.0 112.994 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.8 m -61.48 -32.96 72.99 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.6 -39.15 87.07 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 112.049 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.55 -42.37 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.188 0.595 . . . . 0.0 109.586 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -62.61 -42.68 99.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.263 1.025 . . . . 0.0 111.924 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.46 -41.97 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.754 0.706 . . . . 0.0 111.417 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -67.9 -39.16 83.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.971 0.805 . . . . 0.0 112.281 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.89 81.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 112.617 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.67 -41.78 87.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.016 0.926 . . . . 0.0 112.025 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -68.46 -35.05 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.621 1.168 . . . . 0.0 112.624 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 p -90.02 -12.83 37.44 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.02 -0.17 72.22 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 125.463 1.506 . . . . 0.0 114.652 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.27 -37.26 85.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 111.846 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -66.4 -41.55 89.15 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.078 0.551 . . . . 0.0 111.191 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.82 -47.37 82.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.198 0.599 . . . . 0.0 110.568 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.67 -46.11 91.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.884 0.473 . . . . 0.0 111.947 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -68.56 -40.51 80.58 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.128 0.876 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.57 -39.41 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 118.993 0.815 . . . . 0.0 110.42 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.09 -43.67 91.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.236 0.925 . . . . 0.0 111.027 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -63.54 -38.92 92.97 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.902 -1.124 . . . . 0.0 112.777 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.51 83.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.94 0.791 . . . . 0.0 112.939 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.16 -47.95 10.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.394 1.078 . . . . 0.0 112.97 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.3 m -109.93 -28.3 8.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.283 1.433 . . . . 0.0 114.526 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 127.009 2.124 . . . . 0.0 114.293 177.146 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.24 172.07 13.47 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.456 1.102 . . . . 0.0 113.201 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.65 134.26 53.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.677 1.191 . . . . 0.0 110.332 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 p -83.4 156.26 65.89 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.794 0.838 . . . . 0.0 110.356 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.54 -33.12 57.64 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.136 1.89 . . . . 0.0 111.38 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.44 98.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.801 0.84 . . . . 0.0 112.732 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.72 -53.25 58.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 110.663 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -60.08 -37.46 80.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.1 0.56 . . . . 0.0 112.492 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 m -66.86 -40.84 87.99 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.174 1.79 . . . . 0.0 111.967 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -65.69 -47.25 76.08 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.29 1.036 . . . . 0.0 110.699 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.3 -54.21 48.07 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.748 1.219 . . . . 0.0 110.635 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.24 -43.0 78.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 111.954 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.06 -45.69 91.03 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.28 -0.887 . . . . 0.0 111.894 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.24 -37.82 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.563 1.529 . . . . 0.0 111.875 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.73 -33.74 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.04 0.936 . . . . 0.0 112.993 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 p -90.63 -43.47 10.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.1 p -73.27 -32.01 64.42 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -134.54 70.04 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 109.402 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.73 139.81 38.02 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t 83.52 88.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.958 2.503 . . . . 0.0 107.777 -169.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -108.08 133.03 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.06 0.544 . . . . 0.0 110.099 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.69 123.49 45.77 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.653 0.781 . . . . 0.0 108.965 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -104.98 116.12 31.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.311 1.045 . . . . 0.0 109.683 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.76 -167.99 1.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.042 1.737 . . . . 0.0 110.748 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.56 -1.11 53.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.98 171.64 15.3 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.065 1.793 . . . . 0.0 113.64 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.4 p -103.54 178.01 4.68 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.972 1.709 . . . . 0.0 110.684 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.6 -32.03 73.1 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.341 -0.849 . . . . 0.0 111.937 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.77 -32.92 58.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.936 1.294 . . . . 0.0 112.663 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -137.0 82.2 31.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.138 1.375 . . . . 0.0 110.634 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.63 171.77 16.91 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.786 2.99 . . . . 0.0 111.555 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -86.49 150.4 24.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.916 0.886 . . . . 0.0 111.224 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -72.37 171.31 12.45 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.425 1.49 . . . . 0.0 113.518 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 -136.89 22.02 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.353 0.977 . . . . 0.0 112.239 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -52.14 -40.87 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.747 0.819 . . . . 0.0 112.184 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 m -59.11 -43.61 91.91 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.317 -0.864 . . . . 0.0 112.576 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -62.65 -47.02 85.53 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.415 -0.803 . . . . 0.0 110.522 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.9 m -58.89 -44.47 91.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.017 0.927 . . . . 0.0 110.736 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.97 -44.18 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.006 1.322 . . . . 0.0 112.204 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.9 -43.71 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.901 0.773 . . . . 0.0 110.955 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.01 -40.0 94.27 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 mt -59.69 -53.46 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 112.195 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.17 -47.93 75.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.932 1.242 . . . . 0.0 110.834 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -49.1 -57.06 7.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.949 0.5 . . . . 0.0 110.331 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -67.02 -31.57 72.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.861 1.665 . . . . 0.0 114.266 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.39 -23.09 64.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.89 1.276 . . . . 0.0 111.222 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.8 t30 114.48 32.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 130.961 3.704 . . . . 0.0 112.282 168.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.76 138.42 29.63 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 121.261 -0.899 . . . . 0.0 113.089 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -82.17 49.89 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.457 3.438 . . . . 0.0 109.056 169.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -66.14 169.16 7.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.447 1.899 . . . . 0.0 115.133 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -150.96 130.04 12.62 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.588 0.755 . . . . 0.0 111.043 169.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.1 m -90.39 124.15 34.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.606 -0.684 . . . . 0.0 109.177 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.64 125.48 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 109.251 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -75.09 101.43 4.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.394 0.678 . . . . 0.0 111.026 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -72.36 -24.52 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.28 -1.72 34.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.969 1.308 . . . . 0.0 113.184 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.4 -24.85 66.54 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.574 1.149 . . . . 0.0 112.843 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -154.69 134.58 12.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 111.487 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.79 -41.78 87.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -25.14 67.83 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.701 1.137 . . . . 0.0 113.24 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.32 -46.98 21.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.083 0.953 . . . . 0.0 110.329 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -56.64 -47.86 78.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.874 0.87 . . . . 0.0 112.229 174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.08 -40.56 30.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.192 0.997 . . . . 0.0 112.449 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.01 -28.92 48.42 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.608 -170.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.3 tp -57.59 -36.71 72.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.756 1.278 . . . . 0.0 112.588 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -50.08 -43.8 51.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.362 1.065 . . . . 0.0 112.478 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -83.17 -30.19 28.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.789 0.836 . . . . 0.0 112.592 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -64.68 -39.66 94.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.8 p -88.68 -67.89 0.8 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.227 0.611 . . . . 0.0 111.894 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.2 m 130.05 -12.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 1 C-N-CA 133.598 4.759 . . . . 0.0 111.209 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -66.74 134.28 94.18 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.05 -43.37 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.888 2.392 . . . . 0.0 115.48 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.0 p -142.22 117.69 10.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.152 0.887 . . . . 0.0 112.176 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -60.6 159.19 26.19 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.298 1.439 . . . . 0.0 113.352 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -59.79 161.43 35.68 Favored 'Cis proline' 0 C--N 1.358 1.034 0 N-CA-C 115.672 1.374 . . . . 0.0 115.672 -2.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -154.82 161.91 41.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.38 1.072 . . . . 0.0 111.356 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.89 123.09 40.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.198 1.399 . . . . 0.0 109.418 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -111.31 138.3 47.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.508 1.123 . . . . 0.0 111.291 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 pt -149.89 110.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.727 1.611 . . . . 0.0 112.857 -169.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.24 41.49 32.14 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.994 1.317 . . . . 0.0 114.23 169.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.01 -8.5 69.94 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.265 0.935 . . . . 0.0 114.121 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -104.76 177.61 4.8 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.083 1.753 . . . . 0.0 110.516 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -150.77 161.71 42.11 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.892 1.33 . . . . 0.0 112.624 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -136.12 177.51 7.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.931 2.092 . . . . 0.0 109.898 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.78 -168.01 30.77 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.732 1.634 . . . . 0.0 115.624 -169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.62 -179.73 32.22 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.969 1.271 . . . . 0.0 113.99 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.1 m -67.5 -48.42 67.16 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.61 -42.39 88.06 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 111.811 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.73 -41.67 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.133 0.973 . . . . 0.0 110.593 172.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.2 m -64.16 -41.58 97.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.656 1.182 . . . . 0.0 111.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.12 -44.02 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.829 0.741 . . . . 0.0 111.281 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.92 -36.8 80.8 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.89 0.768 . . . . 0.0 112.476 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.0 83.89 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 112.522 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -65.59 -41.08 93.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.225 1.01 . . . . 0.0 112.322 172.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -68.68 -29.59 68.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.661 0.785 . . . . 0.0 112.647 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -87.39 -13.53 43.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.48 1.112 . . . . 0.0 113.379 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.92 -0.61 84.45 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.49 1.519 . . . . 0.0 114.268 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.9 -39.13 64.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.825 1.25 . . . . 0.0 111.321 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.35 -45.07 92.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.775 0.43 . . . . 0.0 110.626 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.85 -47.9 76.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.084 0.953 . . . . 0.0 111.018 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.17 -47.93 83.89 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.124 0.57 . . . . 0.0 112.063 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -68.9 -42.59 76.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.587 -0.696 . . . . 0.0 112.585 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.99 -40.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.973 0.909 . . . . 0.0 111.153 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.26 -46.45 89.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.449 1.022 . . . . 0.0 110.696 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.52 -44.68 93.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.58 -0.7 . . . . 0.0 111.795 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.43 87.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.002 0.921 . . . . 0.0 113.151 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 85.0 mtp -70.19 -39.76 75.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.603 1.161 . . . . 0.0 112.579 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.22 -34.39 77.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.335 0.654 . . . . 0.0 111.973 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.211 2.605 . . . . 0.0 112.688 173.313 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.36 164.48 35.71 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.581 1.552 . . . . 0.0 111.548 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.9 tp 70.65 -22.34 0.18 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.98 2.512 . . . . 0.0 114.43 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 p -63.37 -32.14 7.87 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-O 115.682 -2.104 . . . . 0.0 116.302 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.86 -167.13 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 CA-C-N 123.379 2.243 . . . . 0.0 111.615 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.07 -2.68 1.36 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.3 -52.07 39.69 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.494 1.517 . . . . 0.0 111.018 170.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.74 -42.39 98.91 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.345 -0.847 . . . . 0.0 112.345 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -60.12 -39.08 84.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.25 1.82 . . . . 0.0 111.866 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -68.0 -50.45 55.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.995 1.318 . . . . 0.0 110.379 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.29 -51.28 67.18 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.454 0.702 . . . . 0.0 111.334 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.75 -48.85 76.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.988 0.915 . . . . 0.0 112.112 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.32 -42.74 96.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.94 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.96 -43.75 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.325 -0.859 . . . . 0.0 111.074 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.73 -42.8 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.408 1.483 . . . . 0.0 112.934 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.9 p -76.4 -42.89 42.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.216 0.916 . . . . 0.0 112.329 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.7 p -76.35 -36.05 58.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -95.95 -13.76 23.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.41 -48.24 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.508 2.723 . . . . 0.0 115.032 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.26 120.74 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.493 1.917 . . . . 0.0 108.048 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.65 154.93 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.144 0.578 . . . . 0.0 111.154 -172.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.96 132.65 46.39 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.602 1.161 . . . . 0.0 110.452 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -108.24 114.94 29.2 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.3 ptm -160.73 174.23 14.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.777 1.231 . . . . 0.0 110.615 -169.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -85.3 29.78 0.65 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.014 -1.054 . . . . 0.0 113.274 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.83 172.43 42.59 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.517 1.532 . . . . 0.0 113.089 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.0 p -100.27 178.48 4.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.178 1.391 . . . . 0.0 110.742 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.56 -23.47 62.61 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -84.43 -30.2 25.51 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 112.394 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -132.14 76.0 73.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.614 1.566 . . . . 0.0 110.35 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.39 173.23 14.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.547 2.832 . . . . 0.0 111.001 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -112.27 136.23 51.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.8 0.84 . . . . 0.0 110.735 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.87 149.83 46.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 112.739 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.51 -113.19 3.94 Favored Glycine 0 N--CA 1.468 0.822 0 C-N-CA 124.1 0.857 . . . . 0.0 111.526 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -59.97 -57.12 14.23 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.646 1.178 . . . . 0.0 113.072 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.3 m -62.53 -46.36 88.76 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.387 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -52.23 -47.65 65.59 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.497 1.519 . . . . 0.0 111.341 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -61.57 -50.37 72.92 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.15 0.98 . . . . 0.0 110.54 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -59.13 -47.77 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.012 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.71 -35.44 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.479 1.036 . . . . 0.0 112.098 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -64.97 -38.48 91.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.003 0.819 . . . . 0.0 111.558 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mt -59.82 -51.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.823 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -59.3 -51.14 71.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.553 1.069 . . . . 0.0 111.723 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -51.38 -60.93 2.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.338 1.055 . . . . 0.0 110.654 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 94.1 p -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.046 1.738 . . . . 0.0 115.262 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -58.86 -32.65 69.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.31 1.044 . . . . 0.0 109.892 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 t30 114.63 56.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.717 3.607 . . . . 0.0 109.333 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.62 38.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.45 168.49 14.47 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.721 2.947 . . . . 0.0 112.281 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.46 141.1 15.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.427 1.491 . . . . 0.0 109.583 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -123.98 93.47 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.733 0.813 . . . . 0.0 109.746 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 m -78.93 115.81 18.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.732 -0.605 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.52 125.5 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.809 1.643 . . . . 0.0 108.518 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -78.15 107.46 10.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.714 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.67 -23.76 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.75 -11.38 60.15 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.928 -1.107 . . . . 0.0 112.848 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -70.0 -29.03 66.01 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.879 0.872 . . . . 0.0 113.05 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -154.4 135.44 13.86 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.883 0.765 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.98 -34.24 74.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.54 1.136 . . . . 0.0 111.668 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 -26.14 68.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.044 0.938 . . . . 0.0 112.738 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.65 -56.51 5.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.915 0.78 . . . . 0.0 109.47 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -55.24 -39.43 69.72 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -86.72 -36.87 18.42 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.81 -37.77 21.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.692 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -64.26 -39.43 93.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.533 1.167 . . . . 0.0 112.952 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -58.82 -37.35 76.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.004 0.522 . . . . 0.0 111.9 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.36 -40.63 50.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 111.781 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.56 -45.55 93.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.065 1.346 . . . . 0.0 113.503 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.5 p -95.81 -23.51 16.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 p 78.7 -12.05 1.13 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.944 2.898 . . . . 0.0 113.561 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -81.47 127.08 74.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 121.321 -0.862 . . . . 0.0 110.669 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -83.83 -12.34 8.6 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.419 2.746 . . . . 0.0 116.51 -169.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -123.34 171.13 9.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.98 1.264 . . . . 0.0 112.894 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.13 148.9 69.86 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.042 1.337 . . . . 0.0 110.526 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.42 156.9 69.3 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.894 0.998 . . . . 0.0 114.145 -3.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.37 139.04 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.408 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.59 149.1 21.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.526 1.53 . . . . 0.0 110.453 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -149.58 140.93 23.23 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -144.79 124.58 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.593 1.157 . . . . 0.0 112.405 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 61.7 -17.8 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.329 2.652 . . . . 0.0 117.504 169.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.04 6.17 1.11 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.379 1.942 . . . . 0.0 113.821 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -128.24 144.01 51.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.208 1.803 . . . . 0.0 110.433 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -91.63 163.49 14.09 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.974 1.369 . . . . 0.0 112.791 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -142.37 176.08 9.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.064 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.84 -169.99 39.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.369 -1.287 . . . . 0.0 114.523 -171.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.62 -163.65 35.37 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.878 1.228 . . . . 0.0 113.002 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.12 -50.51 72.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.654 0.782 . . . . 0.0 112.97 -172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -59.78 -43.98 94.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.916 0.78 . . . . 0.0 111.596 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.37 -43.05 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.33 0.652 . . . . 0.0 110.175 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -62.81 -44.2 96.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 111.066 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.68 -45.13 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.898 1.279 . . . . 0.0 111.235 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.31 -38.75 81.9 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.842 0.746 . . . . 0.0 112.237 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.26 80.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.096 0.958 . . . . 0.0 112.485 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -67.52 -38.94 85.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.859 1.264 . . . . 0.0 112.182 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -68.03 -36.52 80.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.061 0.944 . . . . 0.0 111.931 173.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 m -84.28 -16.33 43.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.45 -0.39 80.64 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.107 1.337 . . . . 0.0 114.26 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -68.01 -42.83 80.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.764 1.226 . . . . 0.0 110.926 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.61 -43.78 92.67 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.028 -0.42 . . . . 0.0 110.531 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -55.44 -48.58 74.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.929 0.891 . . . . 0.0 111.182 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.06 -48.64 77.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.281 0.492 . . . . 0.0 111.776 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.85 -39.57 79.86 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.552 -0.718 . . . . 0.0 112.821 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -38.68 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.931 0.893 . . . . 0.0 111.035 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.3 -45.97 92.22 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.38 0.991 . . . . 0.0 111.368 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.95 -39.99 87.44 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.532 -0.73 . . . . 0.0 111.903 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.79 91.97 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.061 0.846 . . . . 0.0 112.899 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.5 mtm -68.28 -35.0 77.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.836 0.855 . . . . 0.0 112.674 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.5 t -65.97 -43.9 86.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.99 0.916 . . . . 0.0 111.891 170.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.255 1.353 0 C-N-CA 129.215 3.006 . . . . 0.0 112.408 174.07 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 119.806 -0.14 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.79 165.36 12.15 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.663 1.185 . . . . 0.0 112.813 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -25.59 51.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.301 1.041 . . . . 0.0 113.726 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.3 p -56.61 -39.58 78.8 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 115.861 -2.019 . . . . 0.0 116.333 -169.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.97 -12.21 16.26 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.961 2.093 . . . . 0.0 113.723 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.21 -58.15 2.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.246 1.018 . . . . 0.0 112.822 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.51 -57.35 8.44 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.798 1.239 . . . . 0.0 110.947 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -59.88 -41.03 90.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.984 0.514 . . . . 0.0 111.193 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -60.84 -41.66 96.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.262 2.225 . . . . 0.0 112.881 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.5 m -66.91 -50.17 63.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.83 0.852 . . . . 0.0 110.317 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.33 -36.54 84.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.81 -48.72 80.53 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.261 1.024 . . . . 0.0 112.002 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -59.89 -41.67 92.1 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.093 -1.004 . . . . 0.0 111.782 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.66 -53.1 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.328 -0.858 . . . . 0.0 111.739 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.31 -30.24 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.924 1.238 . . . . 0.0 113.233 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.8 p -75.28 -30.14 60.33 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.204 0.911 . . . . 0.0 112.629 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.4 m -78.1 -40.75 37.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -107.07 -9.67 16.12 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 64.61 -47.96 0.32 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.733 2.813 . . . . 0.0 115.299 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -116.12 122.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.258 1.823 . . . . 0.0 109.369 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.36 135.54 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.873 0.869 . . . . 0.0 110.033 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.02 128.79 56.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.616 1.566 . . . . 0.0 108.941 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -108.83 120.14 41.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 109.764 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -156.45 167.34 30.75 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.92 1.688 . . . . 0.0 110.505 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -78.56 31.71 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.93 163.7 31.93 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.356 1.931 . . . . 0.0 113.018 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.1 p -82.06 178.43 8.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 111.199 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -64.31 -26.9 68.69 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.63 0.772 . . . . 0.0 112.449 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.8 -25.76 26.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 113.229 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -119.01 65.02 6.98 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.8 1.64 . . . . 0.0 111.169 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.93 150.05 85.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.059 2.506 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -94.77 115.03 27.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.042 0.537 . . . . 0.0 110.55 -170.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.14 146.44 33.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.838 1.255 . . . . 0.0 112.805 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.76 -149.0 19.19 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -53.44 -41.03 65.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -64.63 -46.51 82.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 112.541 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -57.43 -44.57 84.8 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.403 -0.811 . . . . 0.0 110.452 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -59.08 -43.76 91.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.788 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.1 -42.25 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.422 1.01 . . . . 0.0 111.821 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.67 -47.93 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.689 0.677 . . . . 0.0 110.967 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.43 -37.5 87.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.504 0.722 . . . . 0.0 111.811 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.6 -50.68 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.071 1.748 . . . . 0.0 112.278 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.12 -49.7 73.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.328 0.967 . . . . 0.0 110.82 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -53.12 -54.95 28.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.342 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -30.69 69.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.011 2.124 . . . . 0.0 115.007 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.9 tp -57.16 -31.66 65.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.43 1.092 . . . . 0.0 109.882 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 t30 112.53 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.495 3.518 . . . . 0.0 109.199 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.26 150.28 28.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.54 163.7 35.47 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.364 2.709 . . . . 0.0 110.542 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -161.72 164.95 28.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.595 1.558 . . . . 0.0 110.119 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.2 148.57 48.18 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.055 -0.403 . . . . 0.0 111.21 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.9 m -113.71 117.5 31.69 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 111.32 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.3 t -92.93 122.53 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.119 0.968 . . . . 0.0 109.463 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -81.96 93.16 6.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.404 1.482 . . . . 0.0 111.546 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -77.6 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.574 1.15 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.43 -54.09 0.64 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.653 1.981 . . . . 0.0 112.862 169.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -67.32 -44.36 79.31 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 111.89 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -87.81 128.52 35.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.632 1.173 . . . . 0.0 111.167 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.25 -40.55 86.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 113.341 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -61.79 -41.67 98.03 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.814 0.846 . . . . 0.0 111.22 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.88 -48.16 69.61 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.507 0.723 . . . . 0.0 110.745 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.35 -40.81 62.43 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.221 1.008 . . . . 0.0 112.305 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.22 -36.97 24.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.608 1.163 . . . . 0.0 113.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.62 -23.0 37.74 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.24 174.68 6.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.493 1.146 . . . . 0.0 111.478 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 73.6 -53.07 0.7 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.581 2.352 . . . . 0.0 110.085 -169.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -70.07 -38.71 75.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.63 1.572 . . . . 0.0 112.327 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -63.48 -49.53 73.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -97.01 -15.82 20.88 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p 80.52 -9.47 1.36 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 129.477 3.111 . . . . 0.0 114.227 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -68.7 132.03 91.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.211 -0.93 . . . . 0.0 111.382 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.21 -36.0 2.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.11 2.54 . . . . 0.0 115.007 -169.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -140.57 90.93 2.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.801 0.728 . . . . 0.0 111.454 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -60.77 158.74 30.34 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.303 1.441 . . . . 0.0 110.814 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.46 162.25 37.53 Favored 'Cis proline' 0 C--N 1.358 1.035 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 1.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 152.65 7.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.128 1.371 . . . . 0.0 112.53 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -93.77 146.78 23.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.046 1.339 . . . . 0.0 111.196 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -138.58 138.73 38.2 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.013 2.125 . . . . 0.0 110.675 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -143.29 127.18 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.307 1.443 . . . . 0.0 111.632 -172.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 51.87 23.15 1.98 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.28 41.96 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.809 1.195 . . . . 0.0 115.32 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.32 150.21 45.13 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.209 1.504 . . . . 0.0 111.215 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.83 150.04 29.31 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.989 -1.069 . . . . 0.0 111.967 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -97.72 -47.55 5.56 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.215 1.006 . . . . 0.0 111.638 173.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 145.95 -172.55 26.57 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.287 1.422 . . . . 0.0 112.81 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.26 164.18 41.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.413 1.006 . . . . 0.0 113.544 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.0 m -66.89 -41.75 86.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.625 -0.927 . . . . 0.0 112.874 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.02 -43.91 94.95 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.403 -0.811 . . . . 0.0 111.306 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.92 -42.1 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 109.978 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.2 m -63.0 -43.02 99.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.041 1.336 . . . . 0.0 111.581 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.8 t -60.02 -45.46 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.467 0.707 . . . . 0.0 111.346 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -71.32 -32.78 69.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.912 0.778 . . . . 0.0 112.82 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.73 80.09 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.011 -1.056 . . . . 0.0 112.783 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -63.3 -43.31 98.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.811 0.845 . . . . 0.0 112.071 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.19 -32.86 74.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.991 0.516 . . . . 0.0 112.222 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -86.92 -11.76 49.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.408 1.083 . . . . 0.0 113.614 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.81 -0.16 87.81 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.525 1.536 . . . . 0.0 114.582 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.83 -36.1 59.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 111.251 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.5 tp -64.42 -43.64 93.74 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.675 -0.641 . . . . 0.0 110.708 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -55.69 -48.39 75.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.454 0.702 . . . . 0.0 110.552 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.52 -47.89 82.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.358 0.663 . . . . 0.0 111.899 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -73.47 -35.03 65.65 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.28 -42.34 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.473 1.033 . . . . 0.0 110.793 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.01 -45.97 89.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.277 0.944 . . . . 0.0 111.03 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.83 -43.75 94.42 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.605 -0.685 . . . . 0.0 111.993 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.41 92.79 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.173 0.989 . . . . 0.0 112.868 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.02 -35.47 74.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.242 1.017 . . . . 0.0 112.549 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.19 -38.09 87.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.302 0.641 . . . . 0.0 112.059 170.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.732 2.413 . . . . 0.0 112.578 170.909 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.6 -101.38 0.11 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.54 1.136 . . . . 0.0 109.1 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.88 157.06 36.99 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.55 0.74 . . . . 0.0 109.724 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -69.12 145.27 96.18 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.95 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.41 -34.86 73.22 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.993 2.462 . . . . 0.0 112.43 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.03 -47.7 85.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.35 1.06 . . . . 0.0 113.065 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.86 -47.04 79.34 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.97 0.804 . . . . 0.0 110.354 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.76 -43.83 90.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.023 0.529 . . . . 0.0 111.633 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.9 m -65.48 -43.89 88.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.042 1.737 . . . . 0.0 111.566 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -61.8 -53.4 56.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.941 0.897 . . . . 0.0 110.425 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.81 -50.16 75.01 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.625 0.77 . . . . 0.0 111.36 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -56.53 -49.19 75.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 112.359 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.88 -46.31 85.49 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.563 -0.711 . . . . 0.0 111.966 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.48 -48.28 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.86 0.755 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.37 -20.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 p -93.41 -37.31 12.05 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.976 0.807 . . . . 0.0 112.932 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 t -74.04 -43.02 59.37 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.87 0.759 . . . . 0.0 112.317 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -97.43 -10.54 25.24 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mttm 63.09 -40.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.072 2.549 . . . . 0.0 116.139 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -120.79 128.11 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.066 1.746 . . . . 0.0 108.731 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.09 139.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.49 0.586 . . . . 0.0 112.422 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.17 129.45 56.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.171 1.388 . . . . 0.0 110.643 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -107.53 128.92 54.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.967 0.907 . . . . 0.0 111.04 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -162.58 -175.56 4.54 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.858 1.663 . . . . 0.0 110.851 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -76.6 51.48 0.74 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.25 -1.531 . . . . 0.0 112.412 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.96 168.02 30.42 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.695 1.14 . . . . 0.0 114.305 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.7 p -113.15 -175.73 2.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.258 1.823 . . . . 0.0 111.401 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.88 -32.76 74.61 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.543 -0.723 . . . . 0.0 112.119 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.46 -32.72 42.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.834 1.253 . . . . 0.0 112.667 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -122.81 77.68 48.98 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.217 1.407 . . . . 0.0 110.636 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 164.85 33.07 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -107.34 138.35 43.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.999 0.919 . . . . 0.0 111.755 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.4 m -66.48 157.93 30.85 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.068 1.347 . . . . 0.0 113.849 -172.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 -118.92 4.73 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.392 0.996 . . . . 0.0 112.271 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -59.1 -46.17 88.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.295 1.038 . . . . 0.0 112.883 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.7 m -69.79 -44.21 70.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.906 -1.121 . . . . 0.0 112.146 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.19 -46.66 69.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.755 1.222 . . . . 0.0 110.832 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -59.9 -50.37 74.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.416 1.086 . . . . 0.0 110.539 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 t -61.56 -44.56 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.246 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.82 -34.89 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.424 1.465 . . . . 0.0 111.545 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -68.03 -37.43 81.35 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.242 0.928 . . . . 0.0 112.524 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.68 -51.41 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.774 1.23 . . . . 0.0 110.777 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.55 -51.27 70.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.804 0.729 . . . . 0.0 111.266 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -47.24 -59.2 3.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.087 0.555 . . . . 0.0 109.991 174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m -62.97 -33.97 76.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.602 1.961 . . . . 0.0 114.103 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.81 -21.4 66.41 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.295 1.438 . . . . 0.0 111.951 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 109.02 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 131.51 3.924 . . . . 0.0 110.697 169.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 136.53 24.31 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -169.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -83.58 48.18 2.55 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.549 3.5 . . . . 0.0 109.665 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.44 164.53 18.56 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -169.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -130.89 170.05 14.95 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.722 1.609 . . . . 0.0 110.038 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -147.99 137.64 22.43 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.088 -1.632 . . . . 0.0 110.761 170.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.4 140.49 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.106 0.962 . . . . 0.0 110.529 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.49 142.99 35.33 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.0 pt -89.01 -174.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.432 1.093 . . . . 0.0 109.718 168.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt 71.16 174.91 0.3 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.553 2.341 . . . . 0.0 113.869 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 78.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.527 2.731 . . . . 0.0 110.854 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.95 141.5 54.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.636 0.774 . . . . 0.0 111.007 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.65 -37.91 74.17 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.034 -1.041 . . . . 0.0 113.429 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.21 -26.41 66.6 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.072 -1.018 . . . . 0.0 111.75 176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.82 -15.96 40.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.418 1.087 . . . . 0.0 113.237 170.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -80.57 -51.96 8.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.094 1.316 . . . . 0.0 111.677 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.39 -20.78 8.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -170.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.08 -30.72 69.62 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 120.975 -1.078 . . . . 0.0 113.388 -170.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.85 -41.27 91.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.765 1.283 . . . . 0.0 111.52 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.47 -45.38 91.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.72 -0.612 . . . . 0.0 110.834 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -68.72 -38.53 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.311 0.644 . . . . 0.0 112.736 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -70.04 -44.96 68.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.988 0.813 . . . . 0.0 112.531 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.99 -17.96 33.89 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m 69.81 -5.42 1.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.297 2.239 . . . . 0.0 113.756 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -74.93 127.56 86.67 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.764 1.226 . . . . 0.0 111.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.6 143.33 21.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.154 2.569 . . . . 0.0 110.27 172.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p 64.53 -161.35 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.782 2.033 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -146.19 163.56 29.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.79 2.036 . . . . 0.0 110.675 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.16 172.64 17.17 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 120.229 1.117 . . . . 0.0 114.875 -6.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.78 121.89 21.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.815 1.246 . . . . 0.0 108.435 170.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.14 123.38 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.181 0.992 . . . . 0.0 109.541 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -106.48 134.74 49.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.615 1.566 . . . . 0.0 110.911 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.3 pt -129.96 112.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 111.306 172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.43 17.57 4.94 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.556 1.942 . . . . 0.0 114.469 172.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.07 -3.53 41.04 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.155 1.836 . . . . 0.0 114.62 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -100.99 149.14 24.23 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 111.402 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -103.16 132.2 49.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.253 1.421 . . . . 0.0 111.046 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -99.28 -28.86 13.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.128 0.971 . . . . 0.0 113.45 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.78 -156.8 18.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.468 1.508 . . . . 0.0 111.743 -169.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.44 169.19 41.05 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.704 1.145 . . . . 0.0 114.141 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.9 m -57.65 -34.31 69.22 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.15 -40.92 95.65 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.38 -0.825 . . . . 0.0 111.802 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.23 -40.92 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.678 0.791 . . . . 0.0 109.937 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 m -61.39 -44.64 96.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.046 0.938 . . . . 0.0 111.665 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.69 -43.62 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.324 0.65 . . . . 0.0 111.485 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.99 -41.73 95.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.259 0.936 . . . . 0.0 111.987 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.62 -31.26 71.15 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.76 0.824 . . . . 0.0 113.17 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -67.91 -35.74 78.98 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.985 -1.072 . . . . 0.0 111.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.29 -32.35 66.52 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.9 p -88.15 -15.75 35.25 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.734 1.152 . . . . 0.0 113.76 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.57 1.01 78.38 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 125.306 1.431 . . . . 0.0 113.955 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.89 -30.37 68.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.288 . . . . 0.0 111.999 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.62 -47.65 69.02 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.556 -0.715 . . . . 0.0 110.165 172.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -56.41 -47.46 78.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 110.923 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.79 -50.67 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.51 0.724 . . . . 0.0 111.852 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -73.1 -36.74 66.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.279 -0.888 . . . . 0.0 113.183 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.28 -38.32 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.367 0.985 . . . . 0.0 111.087 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.05 -46.35 91.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.273 0.942 . . . . 0.0 110.866 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.57 -36.26 80.13 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.402 -0.811 . . . . 0.0 112.738 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.69 -36.61 84.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.158 0.983 . . . . 0.0 112.683 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 72.9 mtm -73.18 -41.28 64.03 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.555 0.742 . . . . 0.0 112.254 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.87 -39.37 69.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 129.718 3.207 . . . . 0.0 115.76 -176.829 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 120.176 0.036 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.64 152.47 39.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.068 0.947 . . . . 0.0 112.58 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 mt 73.37 -51.33 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.579 2.751 . . . . 0.0 113.843 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.9 m -45.14 -53.99 15.27 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.682 2.393 . . . . 0.0 114.845 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.3 -12.47 19.02 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.372 2.048 . . . . 0.0 114.332 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.12 -72.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.375 0.988 . . . . 0.0 111.616 -174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.64 -62.61 1.62 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.516 1.127 . . . . 0.0 110.998 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -66.57 -30.72 71.08 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.62 -0.675 . . . . 0.0 112.172 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -63.32 -46.29 87.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.807 1.643 . . . . 0.0 111.668 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -65.29 -48.68 72.31 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.776 0.83 . . . . 0.0 110.651 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.11 -55.04 35.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.153 0.981 . . . . 0.0 110.735 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.85 -46.59 74.67 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 111.713 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.7 -51.59 69.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.796 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.78 -36.49 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.4 1.454 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.89 -13.9 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.924 1.238 . . . . 0.0 113.763 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -102.41 -38.15 7.72 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.22 0.918 . . . . 0.0 113.107 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 t -80.13 -50.57 10.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.988 0.813 . . . . 0.0 111.853 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -88.79 -15.09 35.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.34 -0.85 . . . . 0.0 112.731 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.04 -52.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.913 2.885 . . . . 0.0 115.241 172.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 t -102.08 116.83 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.43 1.492 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -135.64 133.34 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.148 0.431 . . . . 0.0 110.893 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.02 138.2 44.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.004 1.722 . . . . 0.0 109.2 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -125.18 117.61 24.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.53 1.132 . . . . 0.0 110.186 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -167.25 -170.5 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.99 2.116 . . . . 0.0 109.589 -176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -81.04 -32.37 34.12 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.218 1.372 . . . . 0.0 112.517 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 154.54 47.47 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.193 1.378 . . . . 0.0 113.387 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -96.8 -179.59 4.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.734 1.614 . . . . 0.0 110.789 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.47 -18.76 60.58 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.106 -0.996 . . . . 0.0 113.554 172.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.9 -27.64 23.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 112.355 171.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.38 72.77 80.64 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.733 1.613 . . . . 0.0 111.058 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.56 157.09 59.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.006 2.471 . . . . 0.0 110.994 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.03 126.91 33.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.204 0.602 . . . . 0.0 111.133 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.1 t -59.22 143.68 48.35 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.781 1.232 . . . . 0.0 112.178 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.07 -146.11 18.06 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.919 1.247 . . . . 0.0 111.61 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -55.45 -36.69 66.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -169.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 m -64.55 -47.07 80.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.898 1.226 . . . . 0.0 112.404 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -57.73 -43.76 85.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.307 0.958 . . . . 0.0 110.648 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 m -58.83 -46.95 86.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.114 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.4 -42.23 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.173 0.989 . . . . 0.0 112.13 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -59.91 -45.72 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.433 0.693 . . . . 0.0 110.872 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.68 -41.41 96.07 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.594 0.757 . . . . 0.0 111.912 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.49 -52.01 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 111.608 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.14 -50.29 68.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.801 0.728 . . . . 0.0 110.438 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -50.4 -56.36 11.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.798 0.839 . . . . 0.0 110.691 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.53 -31.56 70.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.35 1.86 . . . . 0.0 114.638 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.01 -29.18 68.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 0.0 110.659 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 112.88 63.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 130.163 3.385 . . . . 0.0 109.71 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.32 154.74 34.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.39 173.95 13.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.232 2.621 . . . . 0.0 110.336 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -161.15 145.87 13.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 109.773 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -123.33 95.2 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.919 0.888 . . . . 0.0 109.833 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.4 m -76.07 97.35 4.04 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.934 -1.104 . . . . 0.0 110.667 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.77 129.47 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.513 1.925 . . . . 0.0 110.137 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -74.41 107.59 6.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.83 0.852 . . . . 0.0 110.953 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.49 -28.75 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -20.4 49.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.331 1.052 . . . . 0.0 112.87 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.69 -42.83 93.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.207 1.403 . . . . 0.0 113.687 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -119.55 129.9 54.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.926 0.891 . . . . 0.0 111.551 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.4 -30.2 71.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.6 -52.47 17.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.992 0.814 . . . . 0.0 110.702 173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.46 -33.17 70.96 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.455 1.502 . . . . 0.0 112.417 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.07 -22.06 62.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.378 1.871 . . . . 0.0 113.523 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.47 -56.15 1.62 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.656 1.182 . . . . 0.0 113.427 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -19.03 79.82 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.42 -34.36 72.39 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.489 1.145 . . . . 0.0 112.584 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -59.04 -37.39 76.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.245 1.018 . . . . 0.0 112.523 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.96 -30.92 27.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.514 1.126 . . . . 0.0 112.179 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -62.6 -41.47 99.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.77 0.828 . . . . 0.0 112.447 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.5 p -82.12 -68.21 0.72 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.381 0.673 . . . . 0.0 111.953 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.2 m 123.31 -13.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 133.293 4.637 . . . . 0.0 111.099 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -70.45 128.32 91.3 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.059 1.344 . . . . 0.0 112.003 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.18 140.11 13.75 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.37 2.713 . . . . 0.0 110.625 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.6 p 64.9 -174.55 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.563 2.345 . . . . 0.0 113.108 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -138.32 159.96 65.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.139 1.776 . . . . 0.0 110.476 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.89 165.51 35.68 Favored 'Cis proline' 0 C--N 1.355 0.877 0 N-CA-C 115.739 1.399 . . . . 0.0 115.739 1.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -141.89 132.78 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.253 1.421 . . . . 0.0 109.559 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.59 138.19 40.61 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.026 1.331 . . . . 0.0 108.75 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -134.95 137.2 42.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.917 1.687 . . . . 0.0 110.773 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.2 124.53 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.973 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.34 49.78 5.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.917 2.087 . . . . 0.0 114.845 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.25 3.06 73.02 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.362 -1.243 . . . . 0.0 115.435 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.09 143.48 50.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.347 1.573 . . . . 0.0 111.835 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -82.97 142.4 31.41 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.754 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -94.44 -33.62 13.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.221 1.008 . . . . 0.0 112.101 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.31 -153.93 16.81 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.62 1.581 . . . . 0.0 112.008 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.98 162.36 37.04 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.398 0.999 . . . . 0.0 113.114 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.9 m -58.26 -33.72 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.16 -44.98 84.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 0.0 111.817 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.0 -42.47 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.934 0.893 . . . . 0.0 109.606 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.7 m -62.7 -46.42 88.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.369 1.068 . . . . 0.0 111.911 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.88 -41.89 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.388 0.54 . . . . 0.0 111.342 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.58 -34.23 65.01 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.977 0.808 . . . . 0.0 112.868 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.43 80.62 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.022 -1.049 . . . . 0.0 112.178 173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.11 -39.56 82.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.804 0.841 . . . . 0.0 112.437 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.74 -34.38 77.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.347 0.659 . . . . 0.0 111.971 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.07 -12.11 53.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.215 1.006 . . . . 0.0 113.571 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.49 -6.2 82.79 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 125.855 1.693 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -68.79 -37.41 79.27 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.01 1.324 . . . . 0.0 111.55 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.02 -40.73 96.69 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.933 -0.48 . . . . 0.0 111.17 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -60.74 -48.12 83.23 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.376 0.535 . . . . 0.0 109.8 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.2 -44.48 97.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.348 0.659 . . . . 0.0 112.01 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.28 -35.44 76.04 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.382 -0.824 . . . . 0.0 113.057 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.08 -41.39 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.528 1.058 . . . . 0.0 110.672 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -59.59 -45.78 90.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.352 0.978 . . . . 0.0 110.913 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -57.8 -43.05 85.39 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.472 -0.767 . . . . 0.0 111.674 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.19 66.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.85 -36.82 14.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.631 0.772 . . . . 0.0 113.021 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.92 -25.39 26.15 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.255 1.395 0 C-N-CA 128.163 2.585 . . . . 0.0 113.275 174.484 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 119.893 -0.098 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.99 48.03 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.7 tp -159.25 101.38 1.56 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.604 1.561 . . . . 0.0 108.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.5 p -92.62 159.96 35.44 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.751 1.22 . . . . 0.0 112.023 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.73 -36.37 94.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 112.705 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.65 91.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.87 -48.15 77.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.519 0.727 . . . . 0.0 110.421 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.39 -42.9 88.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.769 -0.582 . . . . 0.0 112.081 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -66.96 -38.94 87.02 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.243 1.817 . . . . 0.0 111.884 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -63.82 -49.89 71.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.175 0.99 . . . . 0.0 110.475 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.91 -43.7 95.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.07 0.948 . . . . 0.0 111.394 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.63 -45.13 92.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.075 0.852 . . . . 0.0 112.618 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.4 -42.57 96.22 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -0.934 . . . . 0.0 111.356 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -60.82 -48.63 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.277 -0.89 . . . . 0.0 111.583 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.02 -38.03 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.553 1.141 . . . . 0.0 113.44 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -81.34 -33.36 32.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.938 0.895 . . . . 0.0 112.824 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -77.59 -32.26 53.5 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.23 112.42 11.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.145 1.378 . . . . 0.0 110.437 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -59.86 -38.16 81.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.95 134.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.192 1.797 . . . . 0.0 109.171 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.24 130.52 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.464 1.106 . . . . 0.0 109.903 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.19 127.21 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.084 0.954 . . . . 0.0 110.272 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.99 124.47 52.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -164.91 -177.82 4.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.846 1.658 . . . . 0.0 110.433 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.61 38.1 0.61 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.46 -1.4 . . . . 0.0 113.114 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.83 160.62 31.64 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 125.339 1.447 . . . . 0.0 113.368 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 p -96.93 -179.42 4.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.372 1.469 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.25 -29.75 68.63 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.608 -0.683 . . . . 0.0 112.337 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.55 -34.18 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.039 1.336 . . . . 0.0 112.502 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.01 76.2 67.13 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.612 1.565 . . . . 0.0 110.365 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.84 170.98 19.17 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.433 2.756 . . . . 0.0 111.569 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -114.02 136.51 52.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.98 0.912 . . . . 0.0 110.397 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.0 t -71.16 156.29 39.75 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.493 1.117 . . . . 0.0 112.313 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.49 -149.42 19.24 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 125.36 1.457 . . . . 0.0 111.803 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.03 -30.17 65.92 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -56.74 -53.37 58.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.314 1.446 . . . . 0.0 111.653 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.29 -40.29 89.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.373 -0.829 . . . . 0.0 110.653 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -58.59 -50.11 75.01 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.724 0.809 . . . . 0.0 111.321 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.21 -35.58 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.648 1.113 . . . . 0.0 112.517 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.27 -47.31 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.208 0.913 . . . . 0.0 111.054 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -65.04 -39.64 93.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.862 0.865 . . . . 0.0 112.312 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt -56.66 -49.49 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.59 1.156 . . . . 0.0 111.996 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.66 -51.33 67.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.078 0.854 . . . . 0.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -49.02 -57.06 7.16 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.458 0.703 . . . . 0.0 110.128 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 t -65.68 -33.58 76.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.832 2.053 . . . . 0.0 114.605 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.59 -28.31 67.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.819 0.736 . . . . 0.0 111.123 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 t30 110.96 57.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.96 3.304 . . . . 0.0 109.621 169.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 142.77 22.28 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.88 162.44 26.59 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.137 3.225 . . . . 0.0 110.499 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -163.65 165.94 22.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.255 1.022 . . . . 0.0 112.285 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.25 162.19 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 108.257 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.8 m -144.52 128.43 17.42 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 119.979 -1.701 . . . . 0.0 111.483 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.9 131.19 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.813 1.245 . . . . 0.0 110.289 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -75.7 110.02 9.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.136 0.574 . . . . 0.0 110.849 174.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -61.0 -29.74 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -87.57 8.13 26.52 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.671 1.188 . . . . 0.0 113.208 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.87 -31.07 71.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.955 0.902 . . . . 0.0 113.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.33 154.5 30.69 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.193 0.997 . . . . 0.0 111.693 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.716 1.207 . . . . 0.0 113.91 -169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.27 -31.85 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.39 -54.95 15.98 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.743 0.817 . . . . 0.0 110.963 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -57.87 -29.85 65.35 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.6 -37.99 11.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.98 -32.19 27.03 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 118.904 0.775 . . . . 0.0 113.428 -172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.38 -36.94 74.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.881 0.872 . . . . 0.0 112.222 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.29 -53.34 45.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.151 1.38 . . . . 0.0 112.63 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -81.66 -23.88 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -67.08 -48.86 66.94 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.937 0.79 . . . . 0.0 112.471 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.0 p -77.84 -46.8 20.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.017 0.826 . . . . 0.0 112.081 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m 122.87 -26.11 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 1 C-N-CA 132.879 4.471 . . . . 0.0 112.693 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.08 142.14 68.3 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.514 -0.741 . . . . 0.0 112.034 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.12 -13.17 11.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.027 2.485 . . . . 0.0 116.162 -169.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -138.67 169.25 18.12 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.892 1.224 . . . . 0.0 112.521 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -137.06 155.85 75.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.737 1.615 . . . . 0.0 110.719 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.17 156.6 47.72 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.602 1.251 . . . . 0.0 115.281 -1.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.73 134.76 8.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.338 1.055 . . . . 0.0 110.968 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.48 140.99 38.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 111.197 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -131.97 132.6 43.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.252 1.821 . . . . 0.0 109.239 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.28 125.21 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.204 1.002 . . . . 0.0 109.348 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.3 22.83 5.09 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.34 48.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.308 0.956 . . . . 0.0 114.932 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.13 145.13 45.5 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.001 1.4 . . . . 0.0 110.993 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -76.87 143.9 39.36 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.265 -0.897 . . . . 0.0 111.97 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -103.76 -26.75 12.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.512 1.125 . . . . 0.0 112.055 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.36 -168.66 12.95 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 125.427 1.489 . . . . 0.0 113.55 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.36 172.67 55.12 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.789 1.185 . . . . 0.0 114.085 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 83.6 m -65.83 -41.99 91.11 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -63.45 -42.65 98.66 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.73 0.696 . . . . 0.0 111.376 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.63 -42.79 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 0.0 109.987 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -64.0 -42.78 97.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.935 1.294 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.39 -39.95 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.062 0.945 . . . . 0.0 111.519 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.22 -39.5 82.37 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.453 1.024 . . . . 0.0 112.435 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.68 91.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.72 0.808 . . . . 0.0 112.352 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -61.33 -45.2 95.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.243 1.417 . . . . 0.0 112.313 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -67.51 -29.17 68.52 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.966 0.906 . . . . 0.0 112.636 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -88.01 -12.85 43.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.459 1.104 . . . . 0.0 113.446 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.17 -1.44 87.62 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.65 1.595 . . . . 0.0 114.428 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.93 -35.29 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 111.822 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -49.06 76.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.423 0.689 . . . . 0.0 110.042 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -56.72 -49.03 76.4 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.122 0.969 . . . . 0.0 110.711 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.05 -46.91 88.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.405 0.682 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.94 -36.17 77.64 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.51 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.543 1.065 . . . . 0.0 110.751 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.58 -46.52 89.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.703 1.138 . . . . 0.0 111.36 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.11 -39.95 88.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.922 . . . . 0.0 112.555 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.05 78.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.572 -0.705 . . . . 0.0 111.966 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 mmt -67.27 -38.19 84.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.865 0.866 . . . . 0.0 112.805 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.5 -23.97 42.61 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.255 1.373 0 C-N-CA 127.265 2.226 . . . . 0.0 112.811 177.518 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.751 -0.643 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.91 79.95 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.17 156.7 16.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.138 1.375 . . . . 0.0 109.858 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -81.53 154.78 71.43 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.655 0.782 . . . . 0.0 111.243 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.31 -37.43 95.2 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.122 2.548 . . . . 0.0 112.151 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.29 96.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.442 1.097 . . . . 0.0 112.902 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.43 -54.43 43.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.819 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.26 -37.71 84.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -65.05 -40.99 95.54 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.883 1.673 . . . . 0.0 111.887 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.9 m -63.42 -48.18 78.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.861 0.864 . . . . 0.0 110.737 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.63 -49.32 77.95 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.247 0.619 . . . . 0.0 111.565 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.81 -45.16 86.53 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.668 0.787 . . . . 0.0 112.373 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -61.4 -44.66 96.76 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 111.787 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.9 -46.95 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.201 0.909 . . . . 0.0 111.484 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -60.19 -43.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 112.107 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -78.36 -29.05 47.26 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 m -79.96 -39.03 31.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.28 -10.97 12.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 60.97 -58.87 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.059 2.544 . . . . 0.0 114.813 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.46 125.77 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.414 1.486 . . . . 0.0 108.877 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.79 128.07 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.018 0.927 . . . . 0.0 110.761 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.42 142.13 34.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.038 1.335 . . . . 0.0 110.32 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.16 119.23 35.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.525 1.53 . . . . 0.0 109.624 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -174.19 -169.16 0.44 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.677 1.991 . . . . 0.0 110.038 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -91.59 -18.44 24.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.01 156.06 30.72 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.154 1.359 . . . . 0.0 113.143 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.7 p -86.85 177.31 7.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.073 1.349 . . . . 0.0 111.446 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.67 -28.78 69.84 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -87.68 -33.3 18.82 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.02 1.328 . . . . 0.0 112.475 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -120.56 84.7 36.85 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.13 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 139.35 52.03 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.523 2.149 . . . . 0.0 108.868 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -0.31 56.25 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.0 t -160.24 163.44 33.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.146 1.379 . . . . 0.0 111.613 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.61 -32.59 84.68 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.029 0.823 . . . . 0.0 113.058 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -73.3 -46.26 50.63 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.332 1.066 . . . . 0.0 112.364 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -62.31 -45.67 92.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.562 -0.712 . . . . 0.0 110.914 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.76 -46.72 74.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.094 0.958 . . . . 0.0 111.279 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.6 m -59.34 -51.61 69.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.092 0.957 . . . . 0.0 110.762 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.81 -37.89 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.846 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.16 -34.14 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 120.656 1.571 . . . . 0.0 111.92 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.02 -44.34 89.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.637 0.653 . . . . 0.0 111.223 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.04 -51.69 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 111.034 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.0 -50.61 71.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.401 1.08 . . . . 0.0 110.591 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.79 -51.43 68.97 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.184 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -68.23 -32.7 73.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.433 1.493 . . . . 0.0 114.05 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.45 -32.67 70.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.908 1.283 . . . . 0.0 110.609 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 118.7 72.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 129.989 3.316 . . . . 0.0 110.711 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.45 140.9 13.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.96 158.39 34.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.141 2.561 . . . . 0.0 108.248 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.88 172.6 17.76 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.51 155.3 42.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.911 1.284 . . . . 0.0 110.367 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -118.26 129.87 55.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.44 -0.787 . . . . 0.0 110.821 172.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -97.06 121.89 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.661 1.184 . . . . 0.0 108.485 173.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -74.23 90.47 2.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.593 1.157 . . . . 0.0 110.191 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pt -69.81 -17.51 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 -1.92 55.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.717 1.207 . . . . 0.0 113.116 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -64.25 -28.77 69.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.141 0.882 . . . . 0.0 112.975 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -159.27 162.27 36.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.242 1.417 . . . . 0.0 112.111 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.85 -31.58 70.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.533 -0.729 . . . . 0.0 112.781 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.63 -39.83 95.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.83 0.741 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.52 -51.49 56.08 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.89 -0.506 . . . . 0.0 110.914 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -56.01 -44.99 79.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.216 1.006 . . . . 0.0 112.858 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -83.34 -24.82 31.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.646 0.778 . . . . 0.0 112.658 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.57 -40.02 6.51 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.296 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.17 -33.55 74.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.493 1.647 . . . . 0.0 113.401 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -60.82 -31.38 70.79 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -83.45 -34.85 25.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.185 0.994 . . . . 0.0 112.158 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.23 -42.32 94.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.217 1.007 . . . . 0.0 112.337 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.9 p -83.47 -67.54 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.829 0.852 . . . . 0.0 112.695 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.6 m 135.05 -23.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 133.341 4.657 . . . . 0.0 111.218 -173.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -83.81 132.17 49.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.23 1.012 . . . . 0.0 111.775 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.02 -25.83 2.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.826 2.351 . . . . 0.0 114.72 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -95.93 151.55 19.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.563 1.145 . . . . 0.0 111.521 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -127.83 151.12 75.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.652 1.581 . . . . 0.0 110.605 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.79 155.95 52.55 Favored 'Cis proline' 0 C--N 1.355 0.869 0 CA-C-N 120.694 1.283 . . . . 0.0 114.422 -2.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -150.49 143.08 24.5 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.987 0.915 . . . . 0.0 110.728 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 tp -110.32 146.81 35.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.317 1.447 . . . . 0.0 111.458 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -148.76 137.81 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.825 2.05 . . . . 0.0 109.392 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -142.62 122.54 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.183 -0.948 . . . . 0.0 111.611 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.83 33.64 6.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.563 1.945 . . . . 0.0 115.284 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.95 -0.78 51.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.813 1.197 . . . . 0.0 115.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.51 141.0 48.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.033 1.417 . . . . 0.0 110.763 173.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -84.1 144.25 29.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.448 -0.783 . . . . 0.0 110.669 170.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.93 -31.69 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.969 0.908 . . . . 0.0 112.285 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.48 -151.2 17.06 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.055 1.312 . . . . 0.0 112.134 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.58 162.69 49.38 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 124.157 0.884 . . . . 0.0 112.934 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -56.23 -35.89 67.86 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.3 -39.97 84.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.633 0.773 . . . . 0.0 112.036 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.39 -42.22 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.406 0.682 . . . . 0.0 109.848 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 m -62.07 -47.27 85.45 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.469 1.108 . . . . 0.0 111.051 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.11 -44.72 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 0.0 111.338 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.35 -37.26 77.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.897 0.771 . . . . 0.0 112.444 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -29.91 70.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 113.048 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -70.85 -33.6 70.81 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.339 -0.851 . . . . 0.0 112.267 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.55 -40.38 76.85 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.9 p -81.05 -17.53 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.201 -0.937 . . . . 0.0 113.208 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.79 69.83 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.336 1.446 . . . . 0.0 113.57 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -36.93 84.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.95 1.3 . . . . 0.0 111.889 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.61 -40.68 97.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.321 0.648 . . . . 0.0 111.189 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.97 -44.34 94.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.965 0.506 . . . . 0.0 110.039 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -61.92 -44.17 97.33 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.326 173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -69.22 -38.84 78.76 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.796 1.18 . . . . 0.0 112.439 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.86 -39.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 118.859 0.754 . . . . 0.0 110.626 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.85 -45.88 92.78 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.132 0.878 . . . . 0.0 111.37 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -59.15 -44.85 92.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.97 0.908 . . . . 0.0 111.772 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.04 96.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.755 1.222 . . . . 0.0 112.807 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.9 mmt -73.57 -33.98 64.92 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.333 -0.854 . . . . 0.0 112.092 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.67 -47.0 70.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.037 0.935 . . . . 0.0 112.628 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.258 1.508 0 C-N-CA 128.755 2.822 . . . . 0.0 114.702 -175.249 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.21 -49.73 26.37 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.159 0.89 . . . . 0.0 111.7 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.6 -34.15 76.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.472 -0.768 . . . . 0.0 112.04 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -61.52 -42.56 98.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.422 1.889 . . . . 0.0 111.934 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.756 1.223 . . . . 0.0 110.933 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.82 -45.6 85.92 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.712 0.805 . . . . 0.0 111.312 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.19 -43.73 95.64 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.239 0.927 . . . . 0.0 112.389 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -60.41 -42.93 97.0 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.352 -0.843 . . . . 0.0 111.892 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.12 -48.97 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 119.175 0.898 . . . . 0.0 111.148 173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.84 -38.25 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.051 1.34 . . . . 0.0 112.853 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -81.8 -28.83 32.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 0.0 112.834 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -78.1 -31.2 49.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -138.06 114.78 10.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.412 1.485 . . . . 0.0 109.737 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -66.56 -20.67 66.07 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.1 t -119.62 123.71 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.793 1.237 . . . . 0.0 109.119 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.64 139.09 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.344 1.058 . . . . 0.0 109.563 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.91 135.72 54.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.311 1.444 . . . . 0.0 110.02 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.57 116.64 29.11 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.353 1.061 . . . . 0.0 108.775 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ptm -162.16 176.05 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.492 1.517 . . . . 0.0 110.791 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.56 26.97 0.75 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.711 -1.243 . . . . 0.0 113.617 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.42 169.79 39.35 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.6 1.572 . . . . 0.0 113.266 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.2 p -97.75 176.37 5.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.072 1.349 . . . . 0.0 111.272 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -66.43 -26.32 67.17 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.804 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -86.29 -27.0 24.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.468 1.507 . . . . 0.0 112.401 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.93 78.51 59.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 0.0 110.678 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.11 178.99 1.64 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.322 3.348 . . . . 0.0 113.622 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -130.36 138.08 50.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.552 1.141 . . . . 0.0 109.688 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.18 160.99 28.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.651 1.18 . . . . 0.0 113.661 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.78 -126.56 8.22 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.633 1.111 . . . . 0.0 111.527 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -56.12 -49.55 73.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.933 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -52.2 66.11 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 111.323 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -57.83 -39.11 76.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.393 0.677 . . . . 0.0 111.337 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.5 m -63.27 -51.89 64.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.546 1.139 . . . . 0.0 110.935 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.24 -44.61 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.565 0.62 . . . . 0.0 111.088 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -61.28 -47.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.637 0.775 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -64.18 -40.5 96.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.224 1.01 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mt -59.71 -51.35 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.737 0.815 . . . . 0.0 111.291 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.17 -46.83 82.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.627 0.771 . . . . 0.0 111.286 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -52.6 -52.46 55.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.352 0.661 . . . . 0.0 110.727 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.5 m -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.527 1.931 . . . . 0.0 114.684 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.46 -39.46 76.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.711 0.804 . . . . 0.0 109.701 170.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 t30 123.74 68.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.979 3.712 . . . . 0.0 109.546 169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.93 152.56 28.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.28 178.49 7.56 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.675 2.916 . . . . 0.0 110.21 169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -163.48 141.2 7.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.856 1.263 . . . . 0.0 111.189 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.31 92.2 3.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.214 1.005 . . . . 0.0 109.663 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.9 m -75.37 111.57 10.78 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.98 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.6 t -92.73 126.77 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.604 1.962 . . . . 0.0 108.543 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -78.5 113.05 16.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.58 -25.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -4.28 58.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -173.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -74.45 -18.88 60.57 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -156.81 128.56 7.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.477 1.111 . . . . 0.0 110.657 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.8 -25.94 67.8 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.269 -0.894 . . . . 0.0 112.869 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.93 -30.7 69.22 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.202 -0.937 . . . . 0.0 112.393 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.51 -53.92 12.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.213 0.915 . . . . 0.0 108.993 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.86 66.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.71 -44.07 11.44 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.702 0.801 . . . . 0.0 112.41 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.16 -30.87 56.52 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-O 119.05 -0.861 . . . . 0.0 114.566 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.58 -20.63 66.05 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.141 1.471 . . . . 0.0 113.686 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -68.3 -38.65 81.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.12 0.968 . . . . 0.0 111.678 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.39 -29.31 30.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.399 1.08 . . . . 0.0 112.517 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.69 -34.33 72.73 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.98 1.312 . . . . 0.0 112.529 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -94.51 -58.58 2.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.663 1.585 . . . . 0.0 112.934 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t 107.8 -2.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 131.886 4.075 . . . . 0.0 110.406 -169.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -88.98 131.7 40.36 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.293 1.837 . . . . 0.0 111.602 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.19 142.64 12.24 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.636 2.891 . . . . 0.0 111.556 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 p 74.33 165.13 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 128.54 2.736 . . . . 0.0 114.09 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.61 159.21 59.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.03 1.732 . . . . 0.0 111.115 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.64 160.65 49.19 Favored 'Cis proline' 0 C--N 1.354 0.865 0 CA-C-N 120.159 1.093 . . . . 0.0 114.91 -2.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -140.19 130.36 25.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.935 1.294 . . . . 0.0 110.058 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.86 137.86 36.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.987 1.715 . . . . 0.0 109.641 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -140.53 136.8 33.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.158 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -144.82 128.62 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.159 1.384 . . . . 0.0 112.615 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 46.3 31.95 1.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.494 2.318 . . . . 0.0 115.883 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.54 10.58 37.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.227 -1.318 . . . . 0.0 115.686 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -147.06 149.07 32.34 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.694 1.747 . . . . 0.0 112.193 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -79.7 150.79 30.77 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.347 -0.845 . . . . 0.0 111.504 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -105.9 -33.73 7.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.929 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.0 -153.61 18.51 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.099 1.333 . . . . 0.0 113.382 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.66 -177.74 42.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.795 1.188 . . . . 0.0 114.135 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.7 t -63.15 -43.02 99.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 113.13 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.33 -46.38 88.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.978 0.808 . . . . 0.0 111.258 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.32 -45.46 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.834 0.853 . . . . 0.0 110.19 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.3 m -62.56 -47.62 83.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.056 1.342 . . . . 0.0 110.957 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.08 -46.15 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.857 1.263 . . . . 0.0 111.23 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.75 -38.55 80.2 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.898 0.772 . . . . 0.0 111.76 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.37 80.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.531 0.732 . . . . 0.0 112.666 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.9 -40.49 95.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.022 0.929 . . . . 0.0 112.268 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.533 1.133 . . . . 0.0 112.889 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.4 m -85.69 -11.91 52.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.043 0.937 . . . . 0.0 113.499 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.05 85.03 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.516 1.532 . . . . 0.0 114.059 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.43 -41.65 65.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 111.566 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.88 -42.01 97.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.506 -0.746 . . . . 0.0 110.033 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -59.7 -48.86 80.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.07 0.548 . . . . 0.0 109.691 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.16 -50.86 71.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.318 1.047 . . . . 0.0 111.918 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -72.14 -32.27 66.76 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.17 -39.6 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.393 0.997 . . . . 0.0 111.024 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.34 -43.21 99.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.842 1.201 . . . . 0.0 111.252 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.16 -39.6 86.96 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.382 -0.823 . . . . 0.0 112.366 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.33 -29.52 70.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.876 0.87 . . . . 0.0 113.186 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.3 mmt -76.8 -48.93 17.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.73 0.695 . . . . 0.0 112.138 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.3 p -80.05 -25.73 40.01 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 126.806 2.043 . . . . 0.0 112.344 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -54.8 -49.25 71.43 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 110.019 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -59.72 -41.21 90.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.653 1.115 . . . . 0.0 112.367 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -62.42 -41.62 98.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.146 1.778 . . . . 0.0 111.905 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -68.81 -46.85 67.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.033 1.333 . . . . 0.0 110.738 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.78 -53.55 53.73 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.194 1.797 . . . . 0.0 110.634 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.25 -47.53 78.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.222 1.009 . . . . 0.0 111.904 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -59.2 -42.25 90.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.237 0.615 . . . . 0.0 112.618 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.63 -43.56 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.52 -41.32 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.388 1.075 . . . . 0.0 112.63 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.3 p -78.93 -38.28 37.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.581 1.082 . . . . 0.0 112.587 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -73.91 -33.99 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -113.26 -7.35 13.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 61.05 -63.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 127.711 2.405 . . . . 0.0 114.47 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -91.57 121.1 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.008 1.323 . . . . 0.0 109.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.41 147.74 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.427 0.691 . . . . 0.0 110.847 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 125.63 47.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.707 1.603 . . . . 0.0 109.185 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -94.91 116.74 29.09 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptm -156.63 170.8 21.57 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 111.748 -169.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.47 -13.63 25.98 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.23 -163.89 25.59 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.753 1.644 . . . . 0.0 112.913 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.3 p -128.32 175.18 8.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.767 1.627 . . . . 0.0 111.439 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.66 -31.02 72.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.748 1.219 . . . . 0.0 111.958 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.3 -29.79 28.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.935 1.294 . . . . 0.0 112.915 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -138.06 84.29 21.2 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.4 1.48 . . . . 0.0 111.323 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.09 165.37 19.47 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.693 2.929 . . . . 0.0 112.396 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -80.06 124.86 29.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.4 m -58.04 138.52 55.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.762 0.825 . . . . 0.0 111.294 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.88 -119.53 5.79 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -52.47 -65.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.425 1.49 . . . . 0.0 114.16 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -64.4 -42.92 95.83 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.92 -45.72 82.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.24 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -61.48 -48.39 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.138 0.975 . . . . 0.0 110.431 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.72 -50.29 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.681 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.37 -31.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 119.24 0.927 . . . . 0.0 112.341 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.01 -45.71 84.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.694 0.679 . . . . 0.0 110.736 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.96 -50.58 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.853 0.861 . . . . 0.0 111.237 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.52 -50.3 74.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.813 0.733 . . . . 0.0 111.219 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -57.07 -52.91 63.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.029 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 t -66.34 -33.29 75.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 114.024 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -57.61 -34.22 69.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.446 1.098 . . . . 0.0 110.874 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 117.71 64.7 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.519 3.528 . . . . 0.0 109.887 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.81 154.61 31.54 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.93 172.44 16.18 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.549 2.833 . . . . 0.0 111.063 170.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.25 146.83 15.75 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.506 1.522 . . . . 0.0 110.459 170.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.3 118.29 35.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.205 0.602 . . . . 0.0 111.076 169.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -76.11 82.43 2.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.246 1.018 . . . . 0.0 110.413 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.22 104.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.02 119.93 20.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.017 0.527 . . . . 0.0 111.739 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -74.79 -34.81 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.79 -38.4 70.27 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.35 -21.63 59.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -99.02 -49.48 4.5 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.787 0.835 . . . . 0.0 113.115 -176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 69.0 -34.64 0.28 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.062 2.545 . . . . 0.0 115.772 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -42.86 99.35 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.919 -1.113 . . . . 0.0 109.693 170.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.09 -45.99 92.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.031 1.332 . . . . 0.0 111.652 169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -56.91 -39.76 75.04 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.431 1.092 . . . . 0.0 112.677 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -89.89 -33.91 16.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.1 -34.62 9.6 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 123.977 0.798 . . . . 0.0 114.727 -172.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -29.75 69.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.313 1.556 . . . . 0.0 110.984 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -63.5 -27.69 69.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.29 -1.506 . . . . 0.0 113.085 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -78.54 -37.55 42.59 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.007 0.821 . . . . 0.0 111.549 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -66.72 -35.22 79.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.426 1.09 . . . . 0.0 113.26 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.6 p -108.81 -14.1 14.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 114.937 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.1 m 66.53 6.17 4.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.527 1.931 . . . . 0.0 113.95 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -74.94 141.65 75.31 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.599 1.56 . . . . 0.0 113.155 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 -49.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.81 2.34 . . . . 0.0 114.105 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.4 p -149.74 125.86 10.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.138 0.975 . . . . 0.0 112.178 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.75 158.94 72.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.001 1.32 . . . . 0.0 112.396 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -64.43 163.26 59.28 Favored 'Cis proline' 0 C--N 1.357 0.982 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 2.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -149.16 134.47 18.37 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.999 0.92 . . . . 0.0 110.524 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.05 139.31 30.75 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.964 1.305 . . . . 0.0 109.475 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -143.35 137.75 28.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.414 1.086 . . . . 0.0 110.221 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 mt -139.25 121.84 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.588 -0.695 . . . . 0.0 110.785 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t70 64.44 -22.68 0.07 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.202 3.001 . . . . 0.0 116.893 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.03 10.72 0.06 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.845 1.688 . . . . 0.0 115.277 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.86 150.23 30.65 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.311 1.555 . . . . 0.0 111.074 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -73.53 141.75 46.72 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.889 -0.507 . . . . 0.0 111.026 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.94 -39.61 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.734 0.814 . . . . 0.0 111.836 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.53 -151.04 22.39 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.455 1.026 . . . . 0.0 113.942 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.25 -173.16 20.31 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.767 1.651 . . . . 0.0 113.387 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -60.98 -47.2 87.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.826 0.85 . . . . 0.0 112.842 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.05 -45.14 93.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.413 0.552 . . . . 0.0 111.587 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.45 -44.28 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.594 0.757 . . . . 0.0 109.998 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.1 m -62.89 -46.15 89.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.822 1.249 . . . . 0.0 111.198 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.97 -43.43 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.183 0.993 . . . . 0.0 111.252 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.97 -42.38 80.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.774 0.715 . . . . 0.0 111.973 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.36 79.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 112.771 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -66.39 -40.58 89.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.031 1.332 . . . . 0.0 112.304 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -70.98 -32.87 69.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.169 0.588 . . . . 0.0 112.436 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.69 -12.14 51.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.92 -0.1 87.62 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 125.404 1.478 . . . . 0.0 114.092 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.74 -36.58 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.468 1.107 . . . . 0.0 111.381 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.69 -46.44 85.5 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.884 -0.51 . . . . 0.0 110.176 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -56.75 -48.82 76.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.67 0.788 . . . . 0.0 110.986 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.07 -49.63 77.15 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.813 0.845 . . . . 0.0 111.668 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -71.43 -35.54 70.98 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.9 -42.08 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.679 1.127 . . . . 0.0 110.887 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.07 -43.05 99.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.048 0.84 . . . . 0.0 111.488 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -59.98 -42.48 94.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.343 -0.848 . . . . 0.0 111.866 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.05 72.79 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.235 0.925 . . . . 0.0 112.812 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.68 -54.36 7.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.743 0.817 . . . . 0.0 111.255 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.571 1.148 . . . . 0.0 113.058 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.916 2.486 . . . . 0.0 112.538 171.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.6 tp -67.33 -47.75 69.58 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.146 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -58.63 -37.26 75.53 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.303 0.956 . . . . 0.0 112.261 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.9 m -66.09 -41.65 90.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.508 1.923 . . . . 0.0 111.678 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.2 m -67.23 -45.89 75.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.625 1.17 . . . . 0.0 111.159 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 99.4 mt -56.92 -54.65 44.14 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.869 1.268 . . . . 0.0 110.343 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.71 -41.6 74.04 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.794 0.725 . . . . 0.0 112.153 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -61.7 -47.36 85.62 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.333 -0.855 . . . . 0.0 112.101 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.94 -36.76 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.414 1.461 . . . . 0.0 112.705 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.85 -40.77 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.712 1.205 . . . . 0.0 112.308 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -80.18 -45.39 18.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.571 0.748 . . . . 0.0 112.361 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 76.3 p -70.7 -38.86 73.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -100.77 -3.8 29.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.629 0.771 . . . . 0.0 112.921 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt 62.14 -59.53 0.12 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.344 2.658 . . . . 0.0 114.395 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.87 137.21 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.65 1.58 . . . . 0.0 108.977 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.04 142.25 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.453 0.701 . . . . 0.0 111.032 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.36 145.4 28.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.058 1.343 . . . . 0.0 110.768 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -123.8 116.18 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.928 1.691 . . . . 0.0 109.401 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -173.18 1.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.338 1.455 . . . . 0.0 112.311 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.19 -154.93 0.13 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.286 1.434 . . . . 0.0 113.31 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.79 -146.8 50.62 Favored Glycine 0 N--CA 1.481 1.689 0 O-C-N 120.574 -1.329 . . . . 0.0 113.605 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.5 p -128.62 175.61 8.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.537 1.535 . . . . 0.0 109.46 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.29 -14.56 63.08 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.718 -1.238 . . . . 0.0 112.903 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.34 -39.88 8.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.808 1.243 . . . . 0.0 113.53 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -90.04 119.37 69.32 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.961 0.904 . . . . 0.0 111.34 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 134.46 24.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.183 2.589 . . . . 0.0 112.334 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -80.35 -34.37 36.62 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.855 2.062 . . . . 0.0 112.982 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.55 153.58 2.35 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.331 2.252 . . . . 0.0 108.954 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.35 -35.77 89.3 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 123.731 0.682 . . . . 0.0 113.308 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.77 -51.66 61.11 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.25 1.025 . . . . 0.0 111.089 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -60.15 -43.17 95.97 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.368 -0.833 . . . . 0.0 111.939 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -59.95 -46.41 89.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.537 0.735 . . . . 0.0 110.792 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -59.85 -45.12 93.44 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.808 0.843 . . . . 0.0 110.729 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.07 -43.65 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.075 0.95 . . . . 0.0 112.413 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.81 -46.69 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 110.802 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -65.58 -38.49 89.69 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mt -59.09 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.645 1.578 . . . . 0.0 111.561 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.03 -48.28 79.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.338 0.972 . . . . 0.0 110.66 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -51.28 -56.53 12.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.19 70.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.432 2.293 . . . . 0.0 114.805 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.63 -29.89 66.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.926 1.291 . . . . 0.0 109.974 169.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.7 t30 109.58 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 130.309 3.444 . . . . 0.0 108.885 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.9 149.72 28.46 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 167.27 17.37 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.121 3.214 . . . . 0.0 110.101 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -169.16 158.67 8.52 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.619 1.568 . . . . 0.0 111.046 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 168.33 9.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.448 1.099 . . . . 0.0 110.327 175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -148.3 105.15 3.59 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 119.792 -1.817 . . . . 0.0 110.774 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -87.36 118.32 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.921 1.288 . . . . 0.0 108.378 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -86.01 101.27 12.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 109.126 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.47 -32.4 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.61 -24.89 66.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -168.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.15 -10.8 59.8 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -134.98 119.22 17.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.563 1.074 . . . . 0.0 113.354 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.1 -32.08 69.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.06 -41.56 81.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.902 0.881 . . . . 0.0 110.871 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.42 -49.16 74.82 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.204 0.602 . . . . 0.0 110.868 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -55.76 -43.68 76.92 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -82.34 -32.35 29.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.71 -38.33 12.14 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.373 0.987 . . . . 0.0 113.98 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.21 -26.42 65.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.552 1.176 . . . . 0.0 112.503 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.45 -37.63 81.59 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.658 0.783 . . . . 0.0 112.003 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.25 -44.3 38.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.89 0.876 . . . . 0.0 111.241 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -61.43 -41.56 97.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.208 1.003 . . . . 0.0 113.055 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.1 p -101.01 -18.87 16.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m 68.7 0.62 2.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.894 2.078 . . . . 0.0 114.561 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 74.2 t-105 -74.08 140.54 77.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 51.2 Cg_exo -63.58 -57.58 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.302 2.668 . . . . 0.0 115.259 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.8 p -149.01 122.49 9.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 112.386 -169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -64.52 157.59 71.89 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.015 1.326 . . . . 0.0 112.269 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.66 158.24 41.85 Favored 'Cis proline' 0 C--N 1.358 1.06 0 N-CA-C 116.07 1.527 . . . . 0.0 116.07 2.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.79 146.94 26.08 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.133 0.973 . . . . 0.0 111.299 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.0 141.5 47.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.627 1.571 . . . . 0.0 109.031 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -139.29 144.55 38.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 0.0 109.745 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.83 126.91 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.538 -0.726 . . . . 0.0 111.432 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.38 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 129.143 2.977 . . . . 0.0 117.86 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.44 4.91 0.12 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.657 1.598 . . . . 0.0 115.418 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -148.47 151.03 34.48 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.548 1.674 . . . . 0.0 111.596 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -73.09 147.56 44.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.353 0.596 . . . . 0.0 111.716 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -100.37 -40.14 7.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.402 1.081 . . . . 0.0 111.765 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.45 -155.63 22.64 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 125.571 1.558 . . . . 0.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.05 173.52 52.21 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.756 1.17 . . . . 0.0 113.752 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.44 -46.71 66.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.665 -0.903 . . . . 0.0 112.716 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.45 -40.27 90.58 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 111.641 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.6 -41.63 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.514 0.726 . . . . 0.0 110.242 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.2 m -63.85 -44.5 92.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.151 0.98 . . . . 0.0 111.956 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -57.85 -43.85 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.858 0.753 . . . . 0.0 111.108 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.11 -37.59 78.44 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.1 91.43 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 112.497 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -64.17 -42.04 96.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.259 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.13 -28.32 68.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.586 0.754 . . . . 0.0 112.497 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -87.48 -12.89 44.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.598 1.159 . . . . 0.0 113.581 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.66 0.34 84.13 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 125.616 1.579 . . . . 0.0 114.229 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.92 -37.66 64.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.79 1.236 . . . . 0.0 111.485 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.78 -45.48 89.55 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.624 -0.672 . . . . 0.0 110.812 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -56.72 -48.45 77.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 110.802 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.57 -48.53 81.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 0.0 111.797 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -70.21 -38.42 75.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.46 -40.59 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 119.564 1.074 . . . . 0.0 110.607 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.85 -46.11 90.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.534 0.607 . . . . 0.0 110.819 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -62.52 -35.95 81.05 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.092 -1.005 . . . . 0.0 112.661 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.3 -31.57 72.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.008 -1.058 . . . . 0.0 112.825 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.51 -46.8 9.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.319 1.047 . . . . 0.0 112.981 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.67 -18.92 21.62 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -172.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 130.568 3.547 . . . . 0.0 113.259 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.13 -56.51 20.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.999 0.919 . . . . 0.0 109.925 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -62.54 -38.5 90.26 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.4 m -64.7 -39.87 94.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 111.968 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.6 m -64.98 -51.52 61.28 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.572 0.749 . . . . 0.0 110.236 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.56 -42.79 93.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.942 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.89 -48.78 80.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.451 1.023 . . . . 0.0 112.395 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -62.24 -42.03 98.95 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.54 -0.725 . . . . 0.0 111.905 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.06 -56.33 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.093 0.957 . . . . 0.0 110.546 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -58.99 -45.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.622 1.169 . . . . 0.0 112.721 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -73.19 -41.72 63.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.565 0.746 . . . . 0.0 112.758 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -81.84 -32.31 31.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -15.7 30.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 59.56 -66.16 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.998 2.519 . . . . 0.0 114.057 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.32 122.31 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.388 1.875 . . . . 0.0 108.597 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.34 117.99 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.357 0.663 . . . . 0.0 110.391 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -96.42 128.01 42.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.065 0.946 . . . . 0.0 110.405 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.17 122.88 47.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.357 1.063 . . . . 0.0 109.991 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.58 -177.94 6.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.273 1.429 . . . . 0.0 111.434 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.72 37.97 0.31 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.593 -1.317 . . . . 0.0 112.76 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.59 -165.04 35.63 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 126.557 2.027 . . . . 0.0 112.016 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -156.93 -167.31 2.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.443 1.097 . . . . 0.0 110.892 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.42 -33.32 71.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.09 1.356 . . . . 0.0 113.012 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.82 -15.58 58.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.518 1.527 . . . . 0.0 113.778 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -148.3 70.8 10.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.642 1.577 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.76 146.31 48.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.032 2.488 . . . . 0.0 110.698 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -98.93 127.02 44.76 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.411 0.684 . . . . 0.0 110.218 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -65.94 155.07 37.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.565 1.146 . . . . 0.0 113.664 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.59 -118.38 4.79 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 124.237 0.922 . . . . 0.0 112.019 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -54.24 -58.6 6.76 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.748 1.219 . . . . 0.0 112.674 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -62.39 -46.51 88.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.606 -0.683 . . . . 0.0 111.746 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.38 -46.57 69.68 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.587 1.155 . . . . 0.0 111.092 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.0 m -65.59 -46.1 80.69 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.159 0.984 . . . . 0.0 110.843 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -44.16 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.201 0.91 . . . . 0.0 110.993 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.02 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.516 0.726 . . . . 0.0 111.032 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.62 -38.7 91.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.961 0.8 . . . . 0.0 112.453 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.49 -47.35 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.31 0.959 . . . . 0.0 110.889 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.36 -51.29 68.21 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.38 0.991 . . . . 0.0 111.218 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -49.14 -61.75 1.91 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.646 0.778 . . . . 0.0 110.522 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.9 p -68.5 -25.86 65.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.947 1.699 . . . . 0.0 115.049 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.92 -34.26 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.915 0.886 . . . . 0.0 109.318 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 115.58 55.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.218 3.407 . . . . 0.0 109.461 168.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.2 145.15 31.37 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.35 163.16 35.08 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.178 2.585 . . . . 0.0 110.742 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -160.84 162.39 32.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.541 1.536 . . . . 0.0 109.928 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.23 178.39 7.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.744 1.217 . . . . 0.0 108.739 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.0 m -150.92 159.6 44.45 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 119.727 -1.858 . . . . 0.0 112.963 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.89 133.94 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.305 1.042 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -79.12 118.02 20.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.382 0.673 . . . . 0.0 110.997 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.6 pt -69.35 -20.81 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.44 -3.99 49.1 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.07 -17.94 62.58 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.74 139.38 13.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.799 1.24 . . . . 0.0 111.211 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -64.65 -36.56 84.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.9 -43.81 97.78 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.644 -0.66 . . . . 0.0 111.022 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.35 -49.1 78.33 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.434 0.694 . . . . 0.0 111.036 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp85 -55.37 -38.85 69.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.108 0.963 . . . . 0.0 112.429 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -76.85 -50.22 13.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.664 1.186 . . . . 0.0 112.365 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.98 -26.8 54.93 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 115.591 0.997 . . . . 0.0 115.591 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.77 -33.87 74.86 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.634 1.217 . . . . 0.0 112.103 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.88 -43.69 98.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.841 0.856 . . . . 0.0 111.814 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.1 -44.63 75.75 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.636 0.774 . . . . 0.0 111.138 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.6 -41.18 89.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.75 0.82 . . . . 0.0 112.343 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.3 m -80.62 -21.89 41.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.4 p 69.24 -35.73 0.32 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.322 3.049 . . . . 0.0 113.716 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -70.66 137.23 85.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.754 1.622 . . . . 0.0 111.278 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.85 -27.57 0.69 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.875 2.383 . . . . 0.0 116.215 -169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 m -102.54 130.26 49.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.496 1.043 . . . . 0.0 112.915 -168.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -115.28 152.47 46.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.929 1.292 . . . . 0.0 110.504 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.53 157.64 55.37 Favored 'Cis proline' 0 C--N 1.355 0.92 0 N-CA-C 114.996 1.114 . . . . 0.0 114.996 -3.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.36 151.47 8.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.14 1.376 . . . . 0.0 111.298 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.0 tp -90.21 159.41 16.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.942 1.297 . . . . 0.0 110.735 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -150.31 139.76 21.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.433 1.093 . . . . 0.0 110.198 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 mt -142.68 126.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.719 -0.613 . . . . 0.0 111.139 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 63.37 -25.74 0.07 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.985 2.914 . . . . 0.0 117.407 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.01 10.26 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.914 1.721 . . . . 0.0 115.114 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.11 151.25 32.87 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.289 1.544 . . . . 0.0 111.243 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -71.64 161.02 31.65 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.42 1.105 . . . . 0.0 112.536 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -136.08 143.31 44.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.275 1.43 . . . . 0.0 109.31 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.93 -178.75 10.27 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.325 1.441 . . . . 0.0 115.54 -170.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.88 -173.8 20.19 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.971 1.272 . . . . 0.0 114.55 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.42 -45.09 94.88 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.678 -0.895 . . . . 0.0 113.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.72 -44.3 97.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.719 -0.613 . . . . 0.0 111.458 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.59 -44.07 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.756 0.822 . . . . 0.0 110.348 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.7 m -62.78 -44.89 94.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.067 1.347 . . . . 0.0 111.131 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.22 -45.55 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.597 1.159 . . . . 0.0 111.489 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.53 -42.06 87.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.095 0.861 . . . . 0.0 112.224 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.58 81.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.117 0.967 . . . . 0.0 112.457 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.98 -47.45 86.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.678 1.191 . . . . 0.0 111.605 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.19 -32.61 70.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.008 0.923 . . . . 0.0 113.2 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -83.38 -13.59 54.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.94 -6.34 76.51 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.023 1.296 . . . . 0.0 113.922 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.94 -37.16 72.84 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.765 1.226 . . . . 0.0 111.906 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.13 -43.23 78.79 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.665 -0.647 . . . . 0.0 110.38 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.79 -49.11 78.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.887 0.875 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.69 1.196 . . . . 0.0 112.054 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.06 -39.25 79.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.949 0.795 . . . . 0.0 112.844 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.52 -45.67 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.401 1.001 . . . . 0.0 110.414 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -62.77 -46.94 85.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.239 0.927 . . . . 0.0 111.647 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.91 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.458 -0.777 . . . . 0.0 112.126 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.03 81.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.952 0.796 . . . . 0.0 112.835 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.09 -40.58 82.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.802 0.728 . . . . 0.0 111.841 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.34 -47.52 83.85 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.139 0.575 . . . . 0.0 111.97 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.488 1.431 1 C-N-CA 132.153 4.181 . . . . 0.0 111.491 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.79 -65.6 0.65 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.983 1.265 . . . . 0.0 111.485 -171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -65.29 -29.0 69.72 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.448 -0.782 . . . . 0.0 112.136 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.1 m -63.56 -44.01 95.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.326 1.85 . . . . 0.0 112.117 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.9 m -64.65 -45.46 86.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.033 0.933 . . . . 0.0 110.375 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.2 mt -56.02 -50.22 71.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.059 0.544 . . . . 0.0 111.675 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.91 -48.48 78.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.478 0.711 . . . . 0.0 112.288 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.43 -38.65 87.91 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.506 -0.746 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.86 -47.58 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.178 -0.951 . . . . 0.0 110.727 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.22 -36.02 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.046 1.339 . . . . 0.0 113.008 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -84.28 -31.28 25.0 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.206 0.912 . . . . 0.0 113.054 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -70.77 -37.85 73.4 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.865 0.757 . . . . 0.0 112.757 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -137.39 114.17 10.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.249 1.42 . . . . 0.0 108.448 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.88 -33.81 76.53 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.12 137.25 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.53 1.059 . . . . 0.0 109.162 169.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.16 126.87 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.815 0.846 . . . . 0.0 109.454 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.08 125.71 47.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.511 1.125 . . . . 0.0 109.169 170.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -97.32 118.19 33.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.2 ptm -155.39 159.53 39.96 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -168.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.16 -20.53 48.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.217 1.007 . . . . 0.0 112.889 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.99 -170.38 43.1 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.186 1.375 . . . . 0.0 112.294 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 p -127.53 174.29 9.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 110.947 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -69.32 -21.43 63.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -83.31 -31.53 26.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.654 1.182 . . . . 0.0 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.37 100.24 3.59 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.321 1.448 . . . . 0.0 110.274 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.26 164.46 32.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.107 2.538 . . . . 0.0 111.458 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.6 139.36 30.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.289 0.636 . . . . 0.0 110.176 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.7 p -69.59 159.54 33.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.984 0.914 . . . . 0.0 113.196 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.11 -104.98 2.4 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 124.138 0.875 . . . . 0.0 111.283 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.76 -71.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.293 1.437 . . . . 0.0 112.728 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 m -60.98 -41.33 96.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.574 -0.704 . . . . 0.0 111.355 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -53.8 -46.43 71.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.3 1.44 . . . . 0.0 111.964 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.1 m -67.78 -51.38 49.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.554 1.142 . . . . 0.0 110.996 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.141 0.576 . . . . 0.0 111.742 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.98 -47.02 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.652 0.781 . . . . 0.0 111.031 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -64.73 -41.64 95.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.911 0.778 . . . . 0.0 112.126 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.91 -52.58 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.591 0.756 . . . . 0.0 111.187 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.33 -47.75 66.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.38 0.672 . . . . 0.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -50.2 -53.52 27.33 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.855 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -33.42 75.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.804 1.641 . . . . 0.0 114.277 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.41 -25.59 66.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.165 0.986 . . . . 0.0 111.61 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.5 t30 112.61 47.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.955 3.702 . . . . 0.0 110.862 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.44 132.89 21.3 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.32 122.4 6.09 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.424 2.749 . . . . 0.0 109.128 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -131.79 161.0 33.94 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -136.51 144.65 44.42 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.6 m -108.15 93.44 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 0.0 109.564 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.47 121.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.407 1.083 . . . . 0.0 109.341 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -74.32 122.92 23.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 111.278 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -119.15 -169.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.895 1.278 . . . . 0.0 111.27 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.9 -56.88 0.54 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.454 2.302 . . . . 0.0 112.208 169.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.39 -41.16 85.42 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.822 0.849 . . . . 0.0 110.532 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -73.77 109.4 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.993 0.917 . . . . 0.0 110.526 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -73.34 -27.63 61.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 113.488 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.99 -44.58 76.27 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.145 -0.972 . . . . 0.0 110.954 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.4 -40.5 89.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.711 0.804 . . . . 0.0 111.863 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -54.46 -37.99 65.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.025 0.93 . . . . 0.0 112.368 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -85.64 -46.06 11.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.44 1.096 . . . . 0.0 112.584 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.5 -30.91 57.61 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.54 -26.17 66.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.978 1.389 . . . . 0.0 113.033 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.22 -40.61 96.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.712 0.687 . . . . 0.0 111.682 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.64 -45.11 54.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.833 0.853 . . . . 0.0 111.468 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.43 -37.6 87.39 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.1 p -107.56 -20.85 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.0 m 69.41 -29.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.64 2.376 . . . . 0.0 114.702 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -75.27 128.48 84.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.579 1.552 . . . . 0.0 112.386 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.52 150.59 19.38 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.523 2.815 . . . . 0.0 111.422 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p 77.99 156.93 0.17 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.971 2.908 . . . . 0.0 113.419 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.54 157.8 64.69 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.165 1.786 . . . . 0.0 111.363 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.05 158.22 89.13 Favored 'Cis proline' 0 C--N 1.354 0.862 0 CA-C-N 119.999 1.035 . . . . 0.0 112.541 3.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.26 141.85 37.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.317 1.047 . . . . 0.0 110.36 -172.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.5 tp -95.08 144.91 25.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.955 1.302 . . . . 0.0 110.941 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -146.73 139.24 25.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 109.599 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mp -137.85 120.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.366 -0.834 . . . . 0.0 111.094 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 61.85 -24.92 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.968 3.307 . . . . 0.0 117.415 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.28 -1.89 0.04 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.09 1.805 . . . . 0.0 115.345 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.9 147.64 49.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.221 1.511 . . . . 0.0 111.708 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.31 158.76 30.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.423 1.106 . . . . 0.0 111.801 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -133.07 155.16 49.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.826 1.651 . . . . 0.0 108.968 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.79 -180.0 9.71 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.834 1.206 . . . . 0.0 114.568 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.2 -176.84 11.37 Favored Glycine 0 N--CA 1.474 1.223 0 C-N-CA 124.667 1.127 . . . . 0.0 113.996 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.25 -42.71 95.87 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.535 -0.979 . . . . 0.0 112.808 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.9 -47.16 86.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.432 0.56 . . . . 0.0 111.191 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.6 mt -60.67 -42.99 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.906 0.882 . . . . 0.0 110.304 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 m -62.81 -46.83 86.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.088 1.355 . . . . 0.0 111.327 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.51 -42.79 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.628 1.171 . . . . 0.0 111.656 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.95 -43.31 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.71 0.686 . . . . 0.0 111.564 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.74 95.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.888 . . . . 0.0 112.001 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.71 -37.77 88.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 112.782 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -69.37 -30.85 68.94 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.382 1.073 . . . . 0.0 112.254 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -87.99 -11.14 48.25 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.534 1.134 . . . . 0.0 113.949 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.36 84.07 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.176 1.37 . . . . 0.0 114.137 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.05 -34.43 50.46 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 112.104 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -64.45 -46.24 83.96 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.776 -0.578 . . . . 0.0 109.721 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -57.34 -48.39 79.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.547 1.139 . . . . 0.0 110.258 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.35 -52.96 62.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.839 0.856 . . . . 0.0 111.775 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -74.38 -33.61 63.1 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.578 -0.701 . . . . 0.0 112.869 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.56 -44.37 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.36 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -59.7 -43.27 94.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.199 1.363 . . . . 0.0 111.376 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -57.76 -47.82 81.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.374 0.67 . . . . 0.0 111.249 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.38 -31.28 71.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.132 0.973 . . . . 0.0 113.268 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.1 mmt -72.14 -36.5 69.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.301 -0.874 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.6 -40.42 76.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.681 0.792 . . . . 0.0 112.63 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.254 1.305 0 C-N-CA 129.643 3.177 . . . . 0.0 112.597 179.018 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.78 -51.28 67.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 109.755 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -58.92 -42.74 90.38 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.646 0.778 . . . . 0.0 112.566 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -64.68 -39.01 92.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.777 1.631 . . . . 0.0 112.081 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -62.54 -49.42 75.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.239 0.927 . . . . 0.0 110.39 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -56.98 -53.26 60.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.652 0.781 . . . . 0.0 110.943 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.27 -44.96 76.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.755 0.822 . . . . 0.0 112.314 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -59.91 -49.2 78.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.799 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.8 -34.92 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.293 1.406 . . . . 0.0 112.802 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.35 -36.28 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.936 1.295 . . . . 0.0 112.489 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.9 p -84.56 -39.03 19.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.71 0.804 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -74.44 -25.13 59.24 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -130.05 130.92 45.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.771 1.228 . . . . 0.0 109.605 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -68.85 -44.38 73.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -114.23 132.02 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.563 1.145 . . . . 0.0 109.243 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.87 121.04 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.207 0.603 . . . . 0.0 110.88 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.52 149.6 21.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.741 0.817 . . . . 0.0 110.528 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.5 114.09 18.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.367 1.467 . . . . 0.0 109.136 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -163.09 -178.57 6.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.257 1.823 . . . . 0.0 110.653 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.13 -39.9 65.35 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.774 -1.204 . . . . 0.0 111.709 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.84 161.9 46.34 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.926 1.727 . . . . 0.0 114.419 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -87.65 172.02 10.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.157 1.783 . . . . 0.0 111.774 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -71.96 -23.74 61.49 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.42 -13.42 32.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.518 1.527 . . . . 0.0 113.642 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -131.57 65.68 76.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.71 1.604 . . . . 0.0 110.276 169.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -71.7 143.12 41.17 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.486 2.79 . . . . 0.0 110.843 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.0 127.62 33.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.689 0.796 . . . . 0.0 112.12 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -54.89 145.25 20.46 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.443 . . . . 0.0 113.174 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.16 -143.35 16.56 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -51.71 -45.11 63.44 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.3 m -63.82 -47.07 82.27 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.32 1.418 . . . . 0.0 112.346 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.12 -40.72 90.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.785 0.834 . . . . 0.0 111.741 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -60.97 -48.06 83.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.452 0.701 . . . . 0.0 110.919 170.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.43 -42.85 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.629 1.172 . . . . 0.0 112.898 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -66.45 -34.85 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.205 1.366 . . . . 0.0 111.999 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.22 -41.54 89.97 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.777 0.717 . . . . 0.0 111.924 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mt -57.36 -51.53 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.85 1.26 . . . . 0.0 111.388 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.0 -47.57 77.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.272 1.029 . . . . 0.0 111.032 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -51.88 -55.74 18.3 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.252 0.621 . . . . 0.0 110.76 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -68.33 -33.12 73.73 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.983 1.713 . . . . 0.0 113.837 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.2 -29.99 69.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.374 1.07 . . . . 0.0 110.997 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 115.27 70.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 130.234 3.414 . . . . 0.0 111.038 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.97 139.48 12.7 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.97 119.46 5.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.089 2.526 . . . . 0.0 109.38 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -106.14 152.4 23.49 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.112 0.965 . . . . 0.0 112.011 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.15 171.72 7.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.272 1.429 . . . . 0.0 110.139 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 m -147.99 104.73 3.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.176 -1.577 . . . . 0.0 109.88 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.92 127.74 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.597 1.159 . . . . 0.0 109.022 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -73.42 93.8 2.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 110.865 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.99 -178.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.39 0.676 . . . . 0.0 110.507 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.05 -37.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.907 2.083 . . . . 0.0 113.104 172.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.1 -20.18 64.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.731 1.612 . . . . 0.0 113.38 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -125.06 134.9 52.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.068 1.347 . . . . 0.0 111.364 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.44 -28.66 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.38 1.072 . . . . 0.0 113.752 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.66 -44.05 71.33 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.308 -0.87 . . . . 0.0 111.739 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.19 -23.27 65.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.75 -26.08 68.48 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.86 0.755 . . . . 0.0 112.726 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -109.98 -53.02 2.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.74 1.216 . . . . 0.0 112.252 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.04 -34.09 53.26 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.355 -169.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -47.9 77.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.657 1.729 . . . . 0.0 111.939 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.08 -26.1 67.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -80.44 -34.78 35.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.054 0.942 . . . . 0.0 112.201 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -65.05 -37.96 89.27 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.916 1.286 . . . . 0.0 112.273 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -78.81 -68.31 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.99 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m 124.06 -17.2 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 1 C-N-CA 133.163 4.585 . . . . 0.0 110.966 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -67.59 121.69 80.2 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.445 1.498 . . . . 0.0 111.545 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.27 145.45 19.03 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.993 2.462 . . . . 0.0 110.411 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 80.3 165.49 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.025 2.13 . . . . 0.0 112.561 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.62 150.12 51.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.531 1.533 . . . . 0.0 110.53 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.78 -177.49 21.18 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 120.125 1.08 . . . . 0.0 113.157 4.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.1 140.78 23.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.749 1.22 . . . . 0.0 111.182 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 tp -103.32 141.22 36.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.627 1.571 . . . . 0.0 110.075 169.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -140.46 142.98 35.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.053 1.741 . . . . 0.0 110.157 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.2 mt -140.18 116.4 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.65 0.78 . . . . 0.0 110.852 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.63 -24.8 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 130.114 3.366 . . . . 0.0 118.069 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -16.2 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.631 1.586 . . . . 0.0 114.69 -170.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.11 153.29 48.65 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.921 1.36 . . . . 0.0 112.87 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -81.09 149.23 29.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.906 -0.496 . . . . 0.0 111.515 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.07 -35.41 9.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.984 0.914 . . . . 0.0 112.311 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.26 -146.64 17.82 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 125.437 1.494 . . . . 0.0 111.937 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.02 165.72 47.66 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.293 0.949 . . . . 0.0 114.206 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.2 m -68.47 -41.56 80.01 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.736 -0.861 . . . . 0.0 112.244 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.13 -42.42 94.77 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.23 -0.919 . . . . 0.0 111.637 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.17 -40.34 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.247 0.619 . . . . 0.0 110.326 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.5 m -63.97 -43.21 96.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.085 0.954 . . . . 0.0 111.739 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.33 -46.13 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.914 0.779 . . . . 0.0 110.963 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -66.37 -37.17 84.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.743 0.701 . . . . 0.0 112.527 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.24 95.52 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.1 0.96 . . . . 0.0 111.971 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -67.54 -38.86 84.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.512 0.725 . . . . 0.0 112.771 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.1 -32.88 74.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 112.642 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 p -92.9 -10.03 38.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.52 -3.19 68.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.045 1.307 . . . . 0.0 114.485 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -72.37 -33.25 67.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.41 1.484 . . . . 0.0 112.493 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -47.2 70.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.716 0.689 . . . . 0.0 110.249 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -56.52 -48.79 76.49 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.684 1.194 . . . . 0.0 110.469 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.648 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.75 -33.13 72.02 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -39.93 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.3 0.954 . . . . 0.0 111.151 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.34 -44.73 96.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.12 0.873 . . . . 0.0 111.077 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.36 -36.36 79.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.409 -0.807 . . . . 0.0 112.701 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.88 74.52 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.038 1.29 . . . . 0.0 112.627 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.9 mtt -74.41 -41.99 59.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.836 0.854 . . . . 0.0 112.357 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 p -92.6 1.75 57.08 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 126.963 2.105 . . . . 0.0 114.272 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.65 -55.71 15.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.673 1.589 . . . . 0.0 109.798 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -61.37 -42.12 98.19 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.553 -0.717 . . . . 0.0 112.231 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -60.23 -39.45 86.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.335 1.854 . . . . 0.0 111.98 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 m -64.84 -49.16 71.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 110.141 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.09 -50.35 71.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.077 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.18 -48.65 75.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.527 1.131 . . . . 0.0 112.459 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.4 -42.72 99.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.558 -0.714 . . . . 0.0 111.821 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.9 -49.88 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.772 0.829 . . . . 0.0 111.787 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.14 -33.99 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.545 1.066 . . . . 0.0 112.772 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.2 p -74.93 -35.42 62.18 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.919 0.782 . . . . 0.0 112.781 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 m -79.37 -41.73 27.16 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.97 0.805 . . . . 0.0 112.976 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.03 -3.71 37.57 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 58.55 -74.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.536 2.334 . . . . 0.0 112.277 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.3 129.94 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.005 0.922 . . . . 0.0 109.642 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -137.79 131.27 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.423 0.689 . . . . 0.0 110.324 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.4 140.53 32.53 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.549 1.14 . . . . 0.0 111.314 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.18 108.41 16.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.714 1.606 . . . . 0.0 107.887 172.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.2 mtm -144.59 -176.72 5.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.273 1.429 . . . . 0.0 110.595 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -79.1 21.48 0.44 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.325 -1.485 . . . . 0.0 113.999 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.97 177.4 44.72 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.795 1.188 . . . . 0.0 114.733 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.4 p -97.46 -178.61 4.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.734 2.014 . . . . 0.0 111.244 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.06 -20.62 59.45 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.345 -0.847 . . . . 0.0 112.901 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.38 -31.82 37.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 111.853 172.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -134.17 74.61 67.32 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.892 1.277 . . . . 0.0 110.753 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 172.05 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.984 3.123 . . . . 0.0 111.281 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -99.3 152.43 19.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.053 0.941 . . . . 0.0 110.983 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.51 167.25 21.02 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.782 1.233 . . . . 0.0 113.507 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.73 -125.52 7.1 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.412 1.006 . . . . 0.0 112.362 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -60.31 -42.35 95.37 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.757 0.823 . . . . 0.0 112.591 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -59.2 -52.15 66.92 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.025 -1.047 . . . . 0.0 112.327 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -56.94 -44.56 82.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.783 1.233 . . . . 0.0 110.481 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.2 m -60.14 -47.69 84.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.461 1.104 . . . . 0.0 110.855 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.7 -42.57 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.249 1.02 . . . . 0.0 112.39 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.25 -34.66 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.476 1.489 . . . . 0.0 112.11 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.018 0.827 . . . . 0.0 111.69 170.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.84 -47.28 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.204 1.402 . . . . 0.0 111.258 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.92 -49.51 72.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.373 0.988 . . . . 0.0 111.409 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -49.42 -59.41 3.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.268 0.627 . . . . 0.0 109.845 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -67.97 -28.82 67.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.196 1.798 . . . . 0.0 114.91 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.78 -30.61 69.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 110.187 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.1 t30 111.15 55.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 130.721 3.608 . . . . 0.0 108.492 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.57 150.91 38.25 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.53 169.68 18.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.189 3.259 . . . . 0.0 110.696 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.8 164.8 26.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.254 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.24 167.06 19.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.37 1.468 . . . . 0.0 108.901 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -151.1 126.09 9.8 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 119.776 -1.827 . . . . 0.0 111.669 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.62 133.17 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.838 1.255 . . . . 0.0 109.591 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -74.17 125.59 28.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.94 0.496 . . . . 0.0 111.699 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 pt -72.93 -30.05 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.836 1.254 . . . . 0.0 113.038 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.66 167.6 13.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.194 0.998 . . . . 0.0 111.935 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 79.61 -107.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.919 2.488 . . . . 0.0 109.852 -170.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -55.71 124.22 16.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.722 1.209 . . . . 0.0 113.881 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.06 -39.64 90.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 113.653 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.83 -33.1 74.12 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.537 -0.727 . . . . 0.0 111.558 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.0 tp -72.45 -43.49 63.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.641 0.776 . . . . 0.0 111.157 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -56.09 -45.64 79.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.144 1.377 . . . . 0.0 112.345 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.18 -40.58 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.386 1.074 . . . . 0.0 111.575 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.92 -36.79 87.15 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 118.675 -1.07 . . . . 0.0 113.872 -172.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.91 -44.58 95.71 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.416 1.608 . . . . 0.0 111.566 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.8 -48.23 75.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.47 -32.99 73.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.435 0.694 . . . . 0.0 112.823 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -69.26 -37.97 78.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 0.0 112.572 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 m -87.55 -24.37 24.05 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m 74.53 -41.53 0.48 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.321 2.648 . . . . 0.0 113.756 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -68.45 129.11 92.91 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.921 1.288 . . . . 0.0 110.73 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.53 158.81 16.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.784 2.989 . . . . 0.0 112.07 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p 75.13 162.62 0.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.558 2.743 . . . . 0.0 113.665 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -143.28 159.72 54.43 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.461 1.904 . . . . 0.0 110.68 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.28 149.81 53.97 Favored 'Cis proline' 0 C--N 1.354 0.832 0 CA-C-N 120.313 1.147 . . . . 0.0 114.007 -2.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.14 148.88 32.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 0.0 110.344 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -114.09 140.31 48.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.362 1.465 . . . . 0.0 110.609 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -132.71 145.52 51.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.99 2.116 . . . . 0.0 109.997 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mt -137.23 119.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.383 -0.823 . . . . 0.0 112.465 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 t70 63.67 -43.09 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.95 3.3 . . . . 0.0 117.179 168.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.96 9.34 0.03 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.562 2.506 . . . . 0.0 114.151 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.01 145.15 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.47 1.508 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.53 152.35 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.527 -0.733 . . . . 0.0 109.97 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -110.47 -36.65 5.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.119 0.968 . . . . 0.0 112.615 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.37 -159.15 23.28 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.109 1.338 . . . . 0.0 113.293 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.05 169.28 54.68 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.147 0.879 . . . . 0.0 114.028 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.0 p -68.7 -49.55 58.06 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.444 -1.033 . . . . 0.0 112.922 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.47 -39.11 86.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.891 -1.131 . . . . 0.0 111.657 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.3 -41.87 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.591 0.756 . . . . 0.0 110.381 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.8 m -62.76 -40.92 98.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 0.0 111.668 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.14 -46.91 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.132 0.878 . . . . 0.0 111.484 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -31.7 63.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.267 0.94 . . . . 0.0 113.504 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.23 83.11 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.072 -1.018 . . . . 0.0 112.594 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.68 -44.8 92.65 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.646 1.178 . . . . 0.0 112.035 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.68 -27.99 68.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.6 m -86.84 -14.69 41.37 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 113.666 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.81 75.71 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 125.354 1.455 . . . . 0.0 114.19 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.39 -34.64 63.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.552 1.141 . . . . 0.0 111.312 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.46 -45.56 86.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.524 -0.735 . . . . 0.0 110.719 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.03 -47.39 77.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.71 0.804 . . . . 0.0 111.002 175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.42 -50.33 73.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.867 0.867 . . . . 0.0 112.074 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -76.44 -32.97 58.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.17 -40.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.964 0.802 . . . . 0.0 110.618 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.39 -43.99 95.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.347 0.976 . . . . 0.0 111.591 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -55.87 -45.12 78.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.911 0.778 . . . . 0.0 111.051 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.68 94.89 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 113.071 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 57.8 mtt -64.79 -35.27 80.56 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.731 0.813 . . . . 0.0 112.343 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.3 -36.01 76.59 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.762 0.825 . . . . 0.0 112.768 170.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.892 2.477 . . . . 0.0 112.241 -179.435 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.98 -56.93 8.72 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.592 1.557 . . . . 0.0 110.622 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -59.67 -43.21 94.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.4 0.68 . . . . 0.0 111.784 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.11 -41.05 95.98 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.046 2.138 . . . . 0.0 112.163 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -67.78 -46.48 71.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.607 1.163 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -56.92 -53.82 53.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.404 0.681 . . . . 0.0 110.804 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.17 -43.85 78.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.259 0.623 . . . . 0.0 112.004 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.1 -51.08 71.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.771 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.92 -37.36 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.403 1.456 . . . . 0.0 112.214 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -63.64 -37.35 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.069 0.947 . . . . 0.0 112.648 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 p -86.37 -36.97 18.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.726 0.81 . . . . 0.0 113.169 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -75.92 -37.91 58.24 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.526 0.731 . . . . 0.0 112.804 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -110.11 114.66 28.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.01 0.924 . . . . 0.0 110.61 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -77.11 67.66 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.549 -1.344 . . . . 0.0 111.464 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.2 t 132.31 122.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 1 C-N-CA 133.913 4.885 . . . . 0.0 107.652 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.76 132.93 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.337 1.055 . . . . 0.0 109.337 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.59 137.9 38.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.49 1.516 . . . . 0.0 109.261 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -112.76 115.22 28.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.172 1.389 . . . . 0.0 107.732 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ptp -153.67 164.3 38.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.894 1.278 . . . . 0.0 112.933 -169.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -80.1 45.02 0.7 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.663 1.585 . . . . 0.0 111.261 174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.99 -161.93 27.02 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.151 1.358 . . . . 0.0 114.41 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.5 p -135.56 178.94 6.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.33 1.852 . . . . 0.0 111.18 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -66.36 -25.94 67.04 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.09 -26.44 19.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.853 1.261 . . . . 0.0 112.436 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -124.91 71.37 61.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.995 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.48 164.78 33.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.231 2.62 . . . . 0.0 110.902 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.48 129.62 34.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.925 0.49 . . . . 0.0 109.802 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.94 147.1 52.8 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.949 0.9 . . . . 0.0 112.673 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -116.06 4.71 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.057 0.837 . . . . 0.0 111.558 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -60.68 -54.98 38.75 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.874 0.87 . . . . 0.0 113.035 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -66.77 -39.44 87.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.642 -1.286 . . . . 0.0 112.22 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.57 -46.97 77.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.197 1.399 . . . . 0.0 111.151 170.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 m -61.24 -45.99 92.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.77 0.828 . . . . 0.0 110.247 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.81 -44.87 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.573 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.15 -34.97 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 120.78 1.627 . . . . 0.0 111.929 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -65.72 -35.43 80.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.791 0.723 . . . . 0.0 111.885 169.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.35 -51.21 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.897 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 121.137 1.789 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -49.46 -55.86 11.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.047 0.539 . . . . 0.0 109.815 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -66.51 -29.19 69.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.323 2.249 . . . . 0.0 115.059 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tt -59.54 -30.75 68.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.944 1.698 . . . . 0.0 109.481 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 108.08 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 131.443 3.897 . . . . 0.0 107.347 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.2 152.98 32.15 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.53 179.19 5.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.31 3.34 . . . . 0.0 110.853 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.61 171.86 13.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.436 1.894 . . . . 0.0 110.38 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.91 147.95 50.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.847 0.859 . . . . 0.0 109.597 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 m -122.61 111.83 17.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.909 0.884 . . . . 0.0 110.576 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.09 124.43 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.354 1.062 . . . . 0.0 109.452 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -72.95 105.76 4.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 110.45 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.9 pt -89.2 -173.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.35 1.06 . . . . 0.0 112.039 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt 68.75 -14.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.462 2.305 . . . . 0.0 115.085 169.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -65.16 -19.73 66.12 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.052 1.741 . . . . 0.0 114.475 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -158.22 169.05 25.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.639 1.576 . . . . 0.0 112.01 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -64.88 -31.87 73.3 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.14 -36.25 83.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.104 0.866 . . . . 0.0 111.337 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.43 -23.11 56.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.396 1.078 . . . . 0.0 113.088 172.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -82.78 -51.51 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.609 1.095 . . . . 0.0 112.685 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -95.48 -43.87 7.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.826 1.25 . . . . 0.0 112.039 -169.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.51 61.06 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.684 0.659 . . . . 0.0 112.019 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 tp -59.64 -41.99 91.73 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.419 0.688 . . . . 0.0 111.882 172.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -63.74 -40.16 96.06 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.919 -0.488 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -72.04 -33.73 68.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.551 0.614 . . . . 0.0 112.416 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -65.3 -47.41 76.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.146 0.978 . . . . 0.0 112.95 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -92.01 -25.93 18.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 74.64 -8.02 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.917 2.087 . . . . 0.0 113.464 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -65.56 133.77 95.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.027 1.331 . . . . 0.0 111.436 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 -41.91 0.62 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.066 2.51 . . . . 0.0 115.199 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -143.9 107.44 4.61 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.175 0.898 . . . . 0.0 111.815 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.25 162.78 16.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.007 1.323 . . . . 0.0 112.465 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -64.53 169.1 37.5 Favored 'Cis proline' 0 C--N 1.355 0.911 0 CA-C-N 120.772 1.311 . . . . 0.0 115.275 0.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.12 166.66 31.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.72 150.23 27.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.48 1.912 . . . . 0.0 108.834 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.35 143.65 32.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.107 2.163 . . . . 0.0 109.81 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.42 172.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.687 1.595 . . . . 0.0 111.532 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.69 103.17 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.392 1.077 . . . . 0.0 112.676 -171.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.64 89.13 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 117.601 -1.666 . . . . 0.0 116.072 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.22 134.97 10.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.652 2.226 . . . . 0.0 113.054 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.09 148.4 36.1 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.918 -1.114 . . . . 0.0 110.651 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -99.41 -45.76 5.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.69 -161.83 13.55 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.928 1.251 . . . . 0.0 112.911 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.26 165.1 46.84 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 124.18 0.895 . . . . 0.0 115.126 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -66.81 -38.9 87.38 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.982 -0.716 . . . . 0.0 112.273 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.9 -45.89 91.08 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.608 -0.683 . . . . 0.0 111.434 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.24 -40.38 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.195 0.598 . . . . 0.0 110.346 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 80.1 m -62.92 -44.13 96.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.693 1.197 . . . . 0.0 111.641 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.71 -46.36 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.905 0.775 . . . . 0.0 111.141 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.84 -36.96 81.27 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.62 0.645 . . . . 0.0 112.26 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.89 91.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.277 1.031 . . . . 0.0 112.202 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.01 -38.88 92.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.63 0.772 . . . . 0.0 112.519 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.46 -31.37 72.41 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.976 0.911 . . . . 0.0 111.791 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.9 m -88.26 -12.33 43.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.81 -2.57 76.65 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.081 1.324 . . . . 0.0 114.239 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.84 -36.19 42.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.981 1.312 . . . . 0.0 111.693 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.68 -42.21 95.51 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.701 -0.625 . . . . 0.0 110.453 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -56.26 -49.17 74.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.307 1.043 . . . . 0.0 110.169 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.38 -46.72 87.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.335 0.654 . . . . 0.0 112.067 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -71.42 -36.67 71.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.01 -37.77 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.581 1.082 . . . . 0.0 110.861 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.08 -44.89 94.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 110.434 169.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.78 -39.75 85.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.372 -0.83 . . . . 0.0 112.21 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.87 -44.73 96.22 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.828 1.195 . . . . 0.0 112.045 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmt -63.25 -38.07 89.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.259 1.023 . . . . 0.0 112.357 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.7 m -67.36 -36.88 82.27 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.005 0.922 . . . . 0.0 112.709 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.8 m . . . . . 0 C--O 1.255 1.379 0 C-N-CA 128.048 2.539 . . . . 0.0 112.036 -177.716 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -67.68 -51.33 50.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.091 0.86 . . . . 0.0 111.792 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -64.61 -33.59 76.28 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.465 -0.772 . . . . 0.0 111.624 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -61.69 -43.19 99.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.433 2.293 . . . . 0.0 111.929 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -68.82 -43.41 75.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.868 1.267 . . . . 0.0 111.151 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.64 -41.12 89.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.868 0.867 . . . . 0.0 111.54 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.07 -42.96 99.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.525 1.057 . . . . 0.0 112.582 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.11 -40.9 98.99 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.275 -0.89 . . . . 0.0 111.816 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.04 -52.19 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.296 1.039 . . . . 0.0 110.853 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.09 -49.92 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.345 1.458 . . . . 0.0 112.101 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -74.85 -30.77 61.45 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.3 p -90.69 -36.56 14.27 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -38.81 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.223 -0.923 . . . . 0.0 112.21 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.77 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.088 2.955 . . . . 0.0 117.661 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.06 110.51 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.422 1.889 . . . . 0.0 107.66 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.26 158.29 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.85 117.17 15.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.177 1.391 . . . . 0.0 109.31 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -87.69 124.86 34.0 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.089 1.356 . . . . 0.0 109.924 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -163.45 172.97 13.74 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -69.81 -19.78 63.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.521 1.528 . . . . 0.0 114.083 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.1 -159.65 31.47 Favored Glycine 0 N--CA 1.477 1.417 0 C-N-CA 125.158 1.361 . . . . 0.0 113.547 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -136.47 -174.33 3.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.398 1.879 . . . . 0.0 110.348 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -80.38 -29.13 37.82 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.221 -0.924 . . . . 0.0 112.334 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.38 -34.36 65.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.638 1.175 . . . . 0.0 111.958 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -133.75 91.71 24.69 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.913 1.285 . . . . 0.0 110.413 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.64 157.52 48.34 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.739 2.293 . . . . 0.0 110.537 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -77.75 125.23 29.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.038 0.447 . . . . 0.0 110.275 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -59.49 143.54 49.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.297 1.439 . . . . 0.0 113.13 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.82 -100.4 2.08 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.085 0.85 . . . . 0.0 111.097 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -58.87 -64.3 0.99 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.454 1.501 . . . . 0.0 113.347 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -67.12 -37.41 83.83 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.706 -1.246 . . . . 0.0 111.447 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -54.42 -46.75 73.25 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.9 m -61.61 -48.0 82.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.263 1.025 . . . . 0.0 110.839 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.76 -49.03 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.918 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.93 -32.92 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.417 1.008 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -63.81 -41.55 97.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.911 0.885 . . . . 0.0 111.242 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 mt -59.6 -50.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 111.15 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.08 -52.22 65.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.424 0.69 . . . . 0.0 111.045 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -51.3 -55.59 17.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.983 0.513 . . . . 0.0 110.615 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -68.1 -31.02 70.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.094 1.758 . . . . 0.0 114.36 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.31 -33.9 71.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.7 t30 117.75 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.728 3.611 . . . . 0.0 109.645 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.13 137.79 23.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.83 89.81 1.27 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.723 2.948 . . . . 0.0 109.868 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -70.2 152.97 43.65 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.887 0.475 . . . . 0.0 110.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -129.23 121.33 27.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.399 0.619 . . . . 0.0 110.534 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -73.36 120.7 19.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.246 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.37 118.58 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.523 1.129 . . . . 0.0 108.092 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -75.07 120.03 20.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.033 0.933 . . . . 0.0 111.09 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -127.14 179.23 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.253 1.421 . . . . 0.0 112.082 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 77.71 -52.2 0.52 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 127.739 2.416 . . . . 0.0 112.406 169.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.25 -25.07 65.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.86 0.864 . . . . 0.0 112.983 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -104.13 113.94 27.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.717 2.407 . . . . 0.0 110.596 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.49 -28.63 69.33 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.36 -50.65 66.9 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 110.944 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.72 -39.91 91.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.39 0.676 . . . . 0.0 110.791 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -54.21 -44.53 71.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 0.0 112.082 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.093 0.957 . . . . 0.0 112.26 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.59 -42.68 46.82 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 113.776 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.81 -25.99 64.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.648 1.224 . . . . 0.0 113.341 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.07 -44.11 94.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.26 0.936 . . . . 0.0 111.376 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.41 -46.11 56.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.668 0.787 . . . . 0.0 111.19 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.94 -39.61 94.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 0.0 112.832 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.2 p -88.89 -35.68 16.38 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p 64.27 -23.24 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.222 2.609 . . . . 0.0 114.367 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -67.11 130.39 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.781 1.632 . . . . 0.0 111.27 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.25 136.97 13.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.83 2.354 . . . . 0.0 111.599 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.1 p 77.24 165.36 0.24 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 128.679 2.791 . . . . 0.0 114.65 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.65 161.89 49.62 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 127.208 2.203 . . . . 0.0 110.723 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -58.2 157.01 34.79 Favored 'Cis proline' 0 C--N 1.356 0.965 0 CA-C-N 120.777 1.313 . . . . 0.0 114.655 -2.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -152.7 132.43 13.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.021 0.528 . . . . 0.0 110.863 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 tt -93.9 142.35 27.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.027 1.331 . . . . 0.0 110.85 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -133.08 143.05 49.08 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.716 1.206 . . . . 0.0 111.519 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.52 138.64 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.07 1.348 . . . . 0.0 110.318 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -15.21 89.09 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.921 2.888 . . . . 0.0 115.809 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.3 55.65 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.167 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.8 130.49 21.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.189 1.994 . . . . 0.0 114.233 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -81.24 121.81 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.153 1.381 . . . . 0.0 108.841 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -92.59 -32.82 14.66 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.7 -154.1 16.6 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.819 1.2 . . . . 0.0 113.712 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.87 47.1 Favored Glycine 0 N--CA 1.473 1.1 0 C-N-CA 124.718 1.151 . . . . 0.0 115.498 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.5 t -58.58 -51.25 70.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.993 1.317 . . . . 0.0 112.782 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -60.64 -43.57 97.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.948 0.499 . . . . 0.0 111.77 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.13 -45.42 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.469 0.708 . . . . 0.0 110.24 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.1 -46.58 88.45 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.668 1.187 . . . . 0.0 110.882 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.23 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.87 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.17 -39.38 86.46 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.276 0.943 . . . . 0.0 111.916 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.44 79.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.649 -0.657 . . . . 0.0 112.226 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.86 -43.76 91.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.985 0.914 . . . . 0.0 112.047 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.24 -30.76 69.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.016 0.926 . . . . 0.0 112.79 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -84.79 -13.37 51.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.121 0.969 . . . . 0.0 113.374 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.26 83.89 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.418 1.485 . . . . 0.0 114.144 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -73.47 -38.82 65.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 111.571 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.15 -42.95 88.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.659 -0.65 . . . . 0.0 110.066 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -58.55 -48.08 82.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.583 0.753 . . . . 0.0 110.44 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.33 -50.17 72.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.861 0.865 . . . . 0.0 111.517 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -72.36 -35.37 68.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.252 -0.905 . . . . 0.0 113.435 -173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.43 -39.46 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.35 0.977 . . . . 0.0 110.722 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.95 -46.23 88.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.107 0.867 . . . . 0.0 111.296 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.73 -37.07 77.93 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.315 -0.865 . . . . 0.0 112.466 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.21 65.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 77.3 mtm -76.28 -38.24 56.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.606 0.639 . . . . 0.0 111.675 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.5 -41.34 69.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 127.668 2.387 . . . . 0.0 112.464 -172.9 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -54.36 47.45 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.03 1.332 . . . . 0.0 110.43 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.23 -35.2 76.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.856 -0.593 . . . . 0.0 112.218 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -62.94 -46.02 89.7 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.148 1.379 . . . . 0.0 111.439 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -62.27 -50.81 70.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.634 0.774 . . . . 0.0 111.137 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.04 -42.95 99.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.988 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.93 -48.99 77.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.639 1.109 . . . . 0.0 111.654 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.44 -41.7 90.21 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.355 0.662 . . . . 0.0 111.788 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.54 -53.34 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.916 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.2 -21.83 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.274 1.397 . . . . 0.0 113.681 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.3 p -80.14 -31.62 39.02 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.417 170.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.2 m -77.5 -38.5 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.662 0.665 . . . . 0.0 112.761 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.05 102.37 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.283 1.833 . . . . 0.0 108.999 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -60.84 -38.72 86.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.107 -0.995 . . . . 0.0 113.384 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -99.13 136.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.868 1.267 . . . . 0.0 109.096 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.15 136.82 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.05 142.24 30.78 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.28 1.032 . . . . 0.0 111.289 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -119.63 116.07 25.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.075 1.35 . . . . 0.0 108.623 169.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 48.2 mtm -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.819 1.247 . . . . 0.0 110.538 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -76.02 20.93 0.18 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.637 1.175 . . . . 0.0 113.78 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.19 168.12 41.15 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 126.797 2.141 . . . . 0.0 112.768 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -96.49 -175.48 3.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.961 1.304 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -11.1 33.97 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 170.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.17 -28.23 59.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 112.262 170.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -146.2 79.06 10.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.797 1.639 . . . . 0.0 111.075 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.47 135.99 64.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.027 2.485 . . . . 0.0 110.359 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -83.29 98.8 9.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.504 0.722 . . . . 0.0 112.413 -169.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.2 t 89.51 160.67 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.455 2.702 . . . . 0.0 112.325 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.08 -31.04 75.23 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 124.893 1.235 . . . . 0.0 113.408 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -62.0 -53.38 56.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.119 0.96 . . . . 0.0 110.671 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -61.73 -42.93 99.61 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.135 -0.978 . . . . 0.0 111.747 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.34 -44.26 92.67 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.038 0.935 . . . . 0.0 110.968 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.2 m -63.36 -45.13 92.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.862 0.865 . . . . 0.0 110.638 173.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.798 1.239 . . . . 0.0 112.514 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.02 -34.78 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 120.426 1.467 . . . . 0.0 111.8 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.91 -43.85 82.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 112.199 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.88 -51.49 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.559 1.544 . . . . 0.0 111.225 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.83 -49.09 69.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.309 1.043 . . . . 0.0 111.276 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -52.38 -49.89 63.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -68.24 -36.05 78.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.211 1.805 . . . . 0.0 114.176 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.87 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 120.78 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 131.051 3.74 . . . . 0.0 109.198 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.96 133.47 8.98 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -82.84 63.22 7.92 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.396 3.397 . . . . 0.0 108.422 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -70.01 168.68 14.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 113.891 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -134.38 172.54 12.75 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.377 1.084 . . . . 0.0 111.621 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -153.28 115.35 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.559 -1.338 . . . . 0.0 110.269 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.73 137.26 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.65 1.18 . . . . 0.0 110.324 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -81.05 123.24 28.21 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 112.106 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -27.95 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.839 1.256 . . . . 0.0 113.006 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.45 148.65 37.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.525 1.13 . . . . 0.0 109.731 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 66.0 6.56 4.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.468 1.907 . . . . 0.0 112.735 -169.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -135.3 57.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.673 1.989 . . . . 0.0 110.076 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -51.82 -37.27 51.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.239 1.416 . . . . 0.0 114.399 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.25 -42.63 91.59 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.343 1.057 . . . . 0.0 111.841 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.88 -41.98 64.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.356 1.062 . . . . 0.0 110.977 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -55.44 -47.12 76.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.909 1.284 . . . . 0.0 112.272 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -73.46 -49.03 28.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.184 0.594 . . . . 0.0 110.554 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.51 92.17 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.891 -0.949 . . . . 0.0 114.608 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.61 -57.76 11.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.372 1.086 . . . . 0.0 110.655 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -61.18 -37.97 84.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.588 0.755 . . . . 0.0 112.253 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.93 -36.84 80.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.858 1.263 . . . . 0.0 112.146 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -87.28 -38.7 16.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.795 1.638 . . . . 0.0 113.521 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.6 p -93.03 -28.25 16.5 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t 74.15 3.74 4.43 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 126.751 2.02 . . . . 0.0 113.318 -171.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -62.03 133.47 94.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.84 1.256 . . . . 0.0 112.041 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.45 -46.83 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.54 2.16 . . . . 0.0 114.662 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -147.46 124.92 11.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.318 0.963 . . . . 0.0 112.224 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.44 153.79 89.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.844 1.258 . . . . 0.0 112.0 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.22 158.7 94.91 Favored 'Cis proline' 0 C--N 1.354 0.855 0 CA-C-N 119.872 0.99 . . . . 0.0 113.662 7.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.59 128.6 27.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.488 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.19 129.21 40.88 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 109.177 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 141.83 47.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.409 1.884 . . . . 0.0 111.802 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.74 129.05 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 67.24 -19.34 0.12 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 128.218 2.607 . . . . 0.0 115.868 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.72 1.66 0.71 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.254 1.883 . . . . 0.0 115.153 -174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.34 158.88 43.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.141 1.47 . . . . 0.0 111.311 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -77.34 144.5 37.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.779 -0.576 . . . . 0.0 111.823 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -92.6 -40.06 10.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.71 1.204 . . . . 0.0 111.428 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.57 25.43 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.852 1.215 . . . . 0.0 113.49 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.47 169.73 33.23 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.04 1.305 . . . . 0.0 112.773 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 85.6 m -69.87 -44.55 69.59 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.591 -0.947 . . . . 0.0 113.099 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.01 -42.67 98.91 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.15 -0.969 . . . . 0.0 111.325 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.48 -40.2 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.9 0.88 . . . . 0.0 110.431 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.4 m -65.47 -42.71 91.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.621 1.169 . . . . 0.0 111.752 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -59.69 -43.8 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.022 0.828 . . . . 0.0 110.961 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -67.68 -37.04 81.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.845 0.748 . . . . 0.0 112.481 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.69 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.185 0.994 . . . . 0.0 112.19 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -63.78 -43.59 95.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.162 0.985 . . . . 0.0 112.113 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.18 -31.09 71.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 112.451 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.6 m -83.54 -14.2 52.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.442 1.097 . . . . 0.0 113.356 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.79 81.42 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.309 1.433 . . . . 0.0 114.31 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -71.25 -46.51 60.85 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.94 1.296 . . . . 0.0 111.031 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.58 -40.51 97.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.912 -0.493 . . . . 0.0 111.024 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.85 -47.92 83.17 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.355 0.662 . . . . 0.0 110.02 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.96 -49.42 74.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.309 0.644 . . . . 0.0 111.482 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -67.81 -39.08 84.0 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.78 -42.12 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.478 1.035 . . . . 0.0 110.536 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -45.52 91.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.872 0.76 . . . . 0.0 111.326 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -60.95 -40.59 93.92 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 112.292 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.82 82.98 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.809 0.843 . . . . 0.0 112.731 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.9 mmm -75.71 -45.91 34.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.145 0.978 . . . . 0.0 113.104 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.14 -45.67 7.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.774 1.23 . . . . 0.0 113.017 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.689 1.996 . . . . 0.0 113.178 -178.561 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.78 -53.36 58.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.447 1.099 . . . . 0.0 111.056 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -59.36 -42.89 92.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.494 0.718 . . . . 0.0 111.619 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.2 m -60.21 -45.35 93.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.398 1.479 . . . . 0.0 111.609 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.2 m -63.59 -54.83 29.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.463 1.105 . . . . 0.0 110.904 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.42 -43.57 98.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.858 0.863 . . . . 0.0 111.768 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.96 -50.36 74.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.563 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.145 0.884 . . . . 0.0 111.564 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 t -55.97 -58.99 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.901 0.881 . . . . 0.0 110.944 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -74.01 -19.52 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.3 p -89.54 -32.18 17.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.477 1.111 . . . . 0.0 112.716 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.7 t -66.01 -35.85 81.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.112 0.869 . . . . 0.0 111.71 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -156.48 130.04 8.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.675 1.19 . . . . 0.0 112.12 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.8 160.67 17.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.97 0.908 . . . . 0.0 112.468 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t 65.56 83.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.327 1.851 . . . . 0.0 109.728 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.72 130.96 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.784 0.834 . . . . 0.0 110.205 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.3 120.47 42.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.439 1.096 . . . . 0.0 110.018 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.02 120.5 35.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.307 1.043 . . . . 0.0 109.058 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -152.78 -176.14 5.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.641 1.576 . . . . 0.0 110.816 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -78.7 36.1 0.26 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.387 -1.445 . . . . 0.0 113.326 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.59 -173.5 45.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.95 1.262 . . . . 0.0 113.763 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -131.91 -174.05 3.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.749 1.619 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -63.96 -11.69 30.9 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.39 -30.29 69.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.324 1.049 . . . . 0.0 112.318 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -154.43 88.23 3.41 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.37 1.468 . . . . 0.0 110.147 170.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.04 134.55 62.91 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.445 2.764 . . . . 0.0 111.235 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -85.24 130.81 34.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.074 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.4 m -55.73 152.39 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.763 2.025 . . . . 0.0 115.184 -169.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.28 -117.69 4.52 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.53 1.062 . . . . 0.0 112.007 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -48.47 -60.88 2.33 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.526 2.33 . . . . 0.0 112.185 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -43.33 92.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.02 -1.05 . . . . 0.0 112.434 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -57.09 -46.92 82.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -60.48 -46.07 91.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.497 1.119 . . . . 0.0 111.013 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.07 -48.43 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.62 -35.04 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.925 1.239 . . . . 0.0 111.904 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.58 -43.38 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.071 1.348 . . . . 0.0 111.491 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.15 -51.4 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.561 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.01 -53.54 56.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.264 0.938 . . . . 0.0 111.115 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.52 -62.26 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.019 1.328 . . . . 0.0 110.608 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.9 p -68.8 -27.95 66.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.766 1.627 . . . . 0.0 115.271 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -32.53 70.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.311 1.044 . . . . 0.0 110.326 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 116.21 60.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 130.462 3.505 . . . . 0.0 109.989 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.3 150.88 32.65 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.02 162.91 36.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.142 2.561 . . . . 0.0 110.675 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.55 159.65 41.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.938 1.295 . . . . 0.0 110.727 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -133.23 169.39 16.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.48 1.512 . . . . 0.0 108.547 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 p -152.13 155.45 37.88 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.66 -1.275 . . . . 0.0 114.021 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.63 133.17 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.056 1.343 . . . . 0.0 110.027 -170.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -80.46 106.41 12.45 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.902 0.881 . . . . 0.0 111.892 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.38 -27.61 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.593 1.157 . . . . 0.0 113.411 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.37 -2.95 54.51 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.655 1.182 . . . . 0.0 113.532 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -88.63 -10.98 46.7 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -157.4 124.7 5.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.512 1.125 . . . . 0.0 111.946 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.16 -41.24 90.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.399 1.079 . . . . 0.0 113.157 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.53 -37.81 85.82 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.21 0.604 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.54 -52.01 65.14 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.691 0.796 . . . . 0.0 109.908 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.39 -47.27 82.13 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.136 0.974 . . . . 0.0 113.07 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -73.86 -41.46 62.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 0.0 111.398 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -40.48 33.38 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.663 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.68 -31.7 70.94 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.978 1.389 . . . . 0.0 112.064 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.54 -38.55 91.39 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.795 0.838 . . . . 0.0 112.069 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.04 -46.13 53.62 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.224 1.01 . . . . 0.0 111.152 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.1 -46.49 88.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 112.646 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -90.87 -20.21 22.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.0 m 62.92 6.12 2.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.89 1.676 . . . . 0.0 113.544 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -69.13 134.81 89.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.215 1.406 . . . . 0.0 111.911 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.1 -43.68 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 113.686 -169.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p -147.9 113.06 5.53 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.232 1.013 . . . . 0.0 110.945 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.43 158.49 20.55 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.695 1.198 . . . . 0.0 111.538 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.76 173.12 42.09 Favored 'Cis proline' 0 C--N 1.355 0.889 0 CA-C-N 120.839 1.335 . . . . 0.0 115.509 5.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -161.87 152.16 17.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.259 1.024 . . . . 0.0 112.495 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 78' ' ' TYR . 1.6 tt -85.97 148.15 25.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.554 1.942 . . . . 0.0 109.343 171.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.527 ' H ' HD23 ' A' ' 77' ' ' LEU . 34.1 t80 -149.85 139.47 21.64 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.774 2.029 . . . . 0.0 111.217 -171.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.3 pt -149.35 141.76 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.604 1.562 . . . . 0.0 112.174 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.78 -21.5 0.09 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 127.625 2.37 . . . . 0.0 115.926 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.89 5.17 2.23 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.134 2.302 . . . . 0.0 114.343 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.15 161.72 35.38 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.573 1.549 . . . . 0.0 111.19 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -75.21 150.92 38.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.211 -0.931 . . . . 0.0 111.688 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -101.91 -41.44 6.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.138 1.375 . . . . 0.0 111.009 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.53 -162.37 20.7 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 124.653 1.12 . . . . 0.0 114.468 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.9 -176.9 50.12 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.906 1.241 . . . . 0.0 115.615 -169.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.62 -41.13 98.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.306 1.042 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -57.87 -49.55 76.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.215 1.006 . . . . 0.0 111.773 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.4 -43.33 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.063 0.945 . . . . 0.0 110.312 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.0 m -62.75 -44.87 95.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.87 1.268 . . . . 0.0 111.351 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.99 -45.78 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.56 1.144 . . . . 0.0 111.313 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -70.16 -38.18 75.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.893 0.77 . . . . 0.0 112.273 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.42 -30.34 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 113.022 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -65.65 -37.6 86.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.725 1.21 . . . . 0.0 112.174 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.2 -40.34 82.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 0.0 112.77 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.6 p -85.56 -16.54 39.05 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.0 81.3 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.853 1.216 . . . . 0.0 113.217 -173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.69 -27.13 66.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.343 1.057 . . . . 0.0 111.89 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.87 -46.72 83.68 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.818 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.09 -48.66 79.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.401 0.546 . . . . 0.0 110.609 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -57.48 -48.48 79.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.565 0.746 . . . . 0.0 111.611 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -70.0 -38.86 76.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.61 -43.42 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 111.107 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.78 -44.66 95.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.163 0.892 . . . . 0.0 111.371 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.68 -40.26 87.25 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.745 -0.597 . . . . 0.0 111.823 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.74 83.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 113.087 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.06 -38.65 86.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.379 -0.826 . . . . 0.0 111.964 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.7 m -73.77 -37.09 65.1 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.635 2.374 . . . . 0.0 112.357 -172.668 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.51 -58.0 5.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 110.366 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.37 -31.11 72.18 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.242 -0.912 . . . . 0.0 112.429 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -60.66 -39.39 88.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.878 2.071 . . . . 0.0 112.24 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -70.22 -43.57 70.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.61 1.164 . . . . 0.0 111.004 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.3 -52.6 64.91 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.58 0.752 . . . . 0.0 110.485 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.17 -40.93 74.67 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 112.015 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.57 -50.11 73.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.341 -0.849 . . . . 0.0 111.774 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.35 -34.11 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.168 1.349 . . . . 0.0 112.672 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.43 -45.69 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.965 0.906 . . . . 0.0 112.207 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -76.92 -41.33 43.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.64 0.654 . . . . 0.0 112.641 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 m -78.27 -32.44 49.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -127.21 -7.74 5.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 66.44 -56.88 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.434 2.294 . . . . 0.0 114.972 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.08 124.38 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 109.177 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.32 138.64 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.122 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.4 126.05 52.9 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.125 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.81 100.59 12.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -145.29 151.01 37.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.389 1.075 . . . . 0.0 111.514 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.37 -19.67 59.43 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 178.57 34.32 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.999 1.761 . . . . 0.0 112.919 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 p -103.03 172.4 6.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.52 1.528 . . . . 0.0 111.128 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -64.12 -35.82 82.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.93 -15.93 52.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.016 1.326 . . . . 0.0 114.014 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -150.95 88.25 4.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.85 1.26 . . . . 0.0 111.022 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.52 168.97 20.59 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.314 2.676 . . . . 0.0 111.741 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -78.58 -3.23 42.77 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.6 m 72.99 -1.23 3.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.495 2.318 . . . . 0.0 115.236 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.47 -150.5 24.35 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 125.553 1.549 . . . . 0.0 112.754 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -60.37 -25.82 66.16 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.057 0.943 . . . . 0.0 113.174 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -59.01 -48.6 81.02 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.806 1.242 . . . . 0.0 111.554 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.63 -42.69 88.88 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.093 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 m -59.53 -46.69 88.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.366 0.985 . . . . 0.0 112.0 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 t -58.95 -46.06 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.955 0.902 . . . . 0.0 111.557 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -59.55 -45.23 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.143 0.577 . . . . 0.0 111.073 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -65.54 -38.7 90.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.722 1.209 . . . . 0.0 112.257 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mt -58.91 -49.38 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.915 1.286 . . . . 0.0 110.523 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 mt -63.74 -50.12 70.34 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.998 0.919 . . . . 0.0 111.176 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -53.98 -57.68 10.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 110.916 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.7 p -68.66 -27.63 66.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.869 1.668 . . . . 0.0 114.849 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.92 -34.86 72.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.266 0.939 . . . . 0.0 109.828 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.9 t30 118.71 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.504 3.522 . . . . 0.0 110.095 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.99 148.44 20.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.22 170.12 21.04 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.56 2.84 . . . . 0.0 110.605 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -155.08 143.66 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -106.93 89.96 3.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.809 0.843 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.3 p -72.66 81.37 1.12 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.138 -0.976 . . . . 0.0 109.868 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.08 116.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 108.41 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.66 94.67 3.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.702 1.201 . . . . 0.0 111.821 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -74.72 173.74 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.243 1.017 . . . . 0.0 111.313 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.95 -46.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.905 2.082 . . . . 0.0 112.425 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.36 -39.84 94.67 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.329 1.052 . . . . 0.0 112.284 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -95.5 124.23 39.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.64 1.176 . . . . 0.0 110.156 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.68 -26.79 67.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.134 0.974 . . . . 0.0 113.073 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.84 -38.98 93.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.851 0.75 . . . . 0.0 112.289 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.87 -32.98 71.63 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.607 0.763 . . . . 0.0 112.076 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -55.01 -43.78 73.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.208 1.003 . . . . 0.0 112.516 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -91.18 -45.37 8.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.393 1.077 . . . . 0.0 111.333 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.06 90.35 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.774 -1.014 . . . . 0.0 114.706 -169.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.91 -42.14 63.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 111.815 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.63 -40.84 96.29 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.869 -0.519 . . . . 0.0 111.445 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.91 -52.33 50.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.987 0.915 . . . . 0.0 111.447 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.15 -38.67 82.4 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.14 -28.81 25.29 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m 75.99 -4.84 2.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.813 2.445 . . . . 0.0 112.684 -169.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CB ' HE22 ' A' ' 76' ' ' GLN . 24.2 m95 -76.79 137.3 66.46 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.975 -1.078 . . . . 0.0 111.437 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.71 -23.7 3.81 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.78 2.32 . . . . 0.0 111.532 169.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.6 m -96.19 131.17 42.94 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.564 1.546 . . . . 0.0 112.508 -169.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -138.8 151.74 69.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.859 2.063 . . . . 0.0 109.812 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.27 167.66 79.15 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 120.093 1.069 . . . . 0.0 113.317 5.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.422 HE22 ' CB ' ' A' ' 71' ' ' TRP . 8.4 pt20 -160.69 161.07 32.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 113.18 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.75 141.78 30.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.26 2.224 . . . . 0.0 109.801 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.55 131.94 25.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.878 2.071 . . . . 0.0 110.352 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.9 mt -138.74 118.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.878 -1.139 . . . . 0.0 111.476 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.69 32.32 11.78 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.333 1.453 . . . . 0.0 114.249 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.68 65.87 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.601 1.096 . . . . 0.0 115.023 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -103.5 120.73 41.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.841 1.32 . . . . 0.0 111.022 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.01 106.72 8.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.184 0.993 . . . . 0.0 109.669 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -82.66 -31.43 28.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.634 1.173 . . . . 0.0 111.971 -170.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.66 -155.18 16.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.687 1.137 . . . . 0.0 114.892 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.87 177.19 54.25 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.647 1.118 . . . . 0.0 114.922 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 21.9 p -63.94 -44.94 91.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.193 0.997 . . . . 0.0 113.509 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.88 -44.38 97.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.467 0.707 . . . . 0.0 111.38 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.48 -45.31 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.631 0.773 . . . . 0.0 109.722 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -62.41 -47.56 83.59 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.44 -42.88 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 111.35 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -72.47 -34.8 67.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.852 0.751 . . . . 0.0 112.416 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.94 85.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.17 -40.86 86.68 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.768 1.227 . . . . 0.0 112.355 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -64.02 -39.04 93.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.94 0.896 . . . . 0.0 111.964 170.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -77.15 -16.57 59.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.928 0.891 . . . . 0.0 113.361 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.54 80.89 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.095 1.331 . . . . 0.0 113.82 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.11 -47.26 65.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.022 1.329 . . . . 0.0 110.883 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.7 tp -62.27 -42.91 99.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.717 -0.614 . . . . 0.0 110.534 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -59.43 -46.5 88.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.627 0.771 . . . . 0.0 110.537 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -63.98 -49.28 73.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.166 0.586 . . . . 0.0 111.613 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -68.72 -37.27 79.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.462 1.028 . . . . 0.0 112.886 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.14 -45.09 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.203 0.91 . . . . 0.0 110.495 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.63 -46.34 86.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.775 0.716 . . . . 0.0 111.083 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -60.76 -40.17 91.5 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.776 1.23 . . . . 0.0 112.074 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.58 89.47 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.815 0.846 . . . . 0.0 112.1 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -66.88 -33.17 75.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.288 0.635 . . . . 0.0 112.656 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.2 m -71.72 -43.05 66.56 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.453 2.301 . . . . 0.0 112.582 -173.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 tt -55.81 -50.92 69.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.443 1.097 . . . . 0.0 110.331 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -60.39 -43.46 96.63 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 0.0 111.68 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -37.77 80.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.426 1.89 . . . . 0.0 112.321 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.4 m -67.6 -49.37 63.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.392 1.077 . . . . 0.0 110.507 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.91 -46.36 85.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 110.976 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.36 -45.67 90.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.177 0.991 . . . . 0.0 112.236 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.328 -0.857 . . . . 0.0 111.781 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.02 -47.5 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.021 0.828 . . . . 0.0 111.15 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.74 -36.55 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.996 1.318 . . . . 0.0 113.123 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 p -84.33 -35.55 23.19 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.173 0.897 . . . . 0.0 112.906 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.3 t -75.58 -42.33 52.35 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -101.82 -6.44 23.59 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 63.47 -59.54 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.792 2.437 . . . . 0.0 114.566 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.3 125.1 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.437 1.495 . . . . 0.0 109.928 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.19 130.56 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.923 0.489 . . . . 0.0 111.369 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 139.42 34.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.56 1.144 . . . . 0.0 110.344 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.09 123.21 43.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 109.497 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -159.49 179.5 8.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.929 1.692 . . . . 0.0 109.855 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -77.91 35.16 0.2 Allowed 'General case' 0 CA--C 1.556 1.191 0 O-C-N 120.068 -1.645 . . . . 0.0 114.037 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.96 161.52 34.83 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.894 1.711 . . . . 0.0 113.77 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.6 p -94.76 -176.01 3.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.887 1.675 . . . . 0.0 111.588 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -67.22 -28.99 68.53 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.361 0.664 . . . . 0.0 111.95 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.12 -29.02 48.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.868 1.267 . . . . 0.0 112.561 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.69 73.95 75.03 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.273 1.429 . . . . 0.0 111.739 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.22 154.83 37.95 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.353 2.702 . . . . 0.0 111.954 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.06 146.19 32.93 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.885 0.874 . . . . 0.0 111.355 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -68.01 161.65 26.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.04 1.336 . . . . 0.0 113.684 -173.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.84 -146.71 21.51 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.696 1.141 . . . . 0.0 112.035 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -57.62 -32.23 67.03 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 m -59.3 -47.43 85.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.609 1.095 . . . . 0.0 112.056 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.67 -46.31 87.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.291 1.037 . . . . 0.0 110.743 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -44.99 91.61 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.871 0.868 . . . . 0.0 110.639 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.59 -43.0 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.645 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.66 -34.06 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.898 1.681 . . . . 0.0 112.158 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.97 -44.34 89.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.602 0.637 . . . . 0.0 111.405 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -59.19 -52.35 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.619 1.168 . . . . 0.0 111.466 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.0 mt -65.13 -47.88 75.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.57 0.748 . . . . 0.0 111.281 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -50.48 -55.94 13.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.903 0.881 . . . . 0.0 110.891 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 m -68.25 -36.08 78.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.823 1.649 . . . . 0.0 114.176 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.59 -32.83 71.92 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.301 1.44 . . . . 0.0 111.076 173.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.6 t30 122.69 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 131.261 3.825 . . . . 0.0 109.815 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.7 137.65 11.54 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.58 61.2 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.47 3.447 . . . . 0.0 109.268 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -62.18 156.53 21.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.452 1.101 . . . . 0.0 112.94 -171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -121.44 170.31 9.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.466 1.107 . . . . 0.0 110.902 171.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 m -149.89 121.59 8.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.293 -1.505 . . . . 0.0 111.46 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -106.92 129.67 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.597 1.559 . . . . 0.0 109.677 -173.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -80.42 107.97 13.66 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.249 0.62 . . . . 0.0 111.42 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.7 pt -64.28 -27.37 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.101 -0.999 . . . . 0.0 112.928 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -0.16 51.63 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.286 1.434 . . . . 0.0 113.385 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.04 -29.46 67.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.776 0.83 . . . . 0.0 112.638 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -159.41 139.64 12.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.82 1.248 . . . . 0.0 110.919 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.05 -40.37 63.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.014 1.726 . . . . 0.0 114.087 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 tp -66.08 -31.32 72.13 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.338 1.055 . . . . 0.0 112.168 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.72 -45.77 41.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.856 0.863 . . . . 0.0 110.016 171.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.09 -44.99 75.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.995 1.318 . . . . 0.0 112.591 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -84.44 -28.77 26.63 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.94 -31.75 64.19 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 124.403 1.002 . . . . 0.0 113.422 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.22 -31.77 70.48 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 1.284 . . . . 0.0 112.511 176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.07 -38.55 91.46 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.154 -0.966 . . . . 0.0 111.873 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -71.51 -40.3 70.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.512 0.725 . . . . 0.0 111.298 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -63.68 -38.03 89.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.937 1.295 . . . . 0.0 113.455 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.1 m -118.01 -19.79 8.98 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p 68.62 -12.09 0.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.611 2.364 . . . . 0.0 114.194 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -61.78 136.79 94.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 125.739 1.616 . . . . 0.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.53 -42.89 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.754 2.303 . . . . 0.0 115.371 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -140.22 108.72 5.87 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.113 0.869 . . . . 0.0 111.681 -169.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.34 162.71 71.22 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.511 1.524 . . . . 0.0 112.173 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.15 163.97 36.33 Favored 'Cis proline' 0 C--N 1.356 0.931 0 N-CA-C 116.027 1.51 . . . . 0.0 116.027 2.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.36 158.31 37.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.363 1.065 . . . . 0.0 111.512 170.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -105.94 138.97 41.21 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.358 1.863 . . . . 0.0 109.295 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.34 141.04 52.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.672 1.989 . . . . 0.0 111.162 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mt -139.03 123.07 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.93 -26.75 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.954 3.302 . . . . 0.0 117.014 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.51 1.39 0.04 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.447 1.975 . . . . 0.0 115.237 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -140.2 157.0 46.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.441 1.62 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -76.48 148.58 37.1 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.695 -0.628 . . . . 0.0 110.954 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -98.66 -43.66 6.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.931 1.292 . . . . 0.0 111.807 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.66 -165.73 24.98 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.276 1.417 . . . . 0.0 113.176 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.84 49.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.488 1.042 . . . . 0.0 112.994 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.8 m -61.48 -32.96 72.99 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.6 -39.15 87.07 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 112.049 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.55 -42.37 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.188 0.595 . . . . 0.0 109.586 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -62.61 -42.68 99.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.263 1.025 . . . . 0.0 111.924 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.46 -41.97 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.754 0.706 . . . . 0.0 111.417 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -67.9 -39.16 83.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.971 0.805 . . . . 0.0 112.281 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.89 81.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 112.617 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.67 -41.78 87.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.016 0.926 . . . . 0.0 112.025 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -68.46 -35.05 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.621 1.168 . . . . 0.0 112.624 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 p -90.02 -12.83 37.44 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.02 -0.17 72.22 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 125.463 1.506 . . . . 0.0 114.652 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.27 -37.26 85.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 111.846 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -66.4 -41.55 89.15 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.078 0.551 . . . . 0.0 111.191 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.82 -47.37 82.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.198 0.599 . . . . 0.0 110.568 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.67 -46.11 91.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.884 0.473 . . . . 0.0 111.947 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -68.56 -40.51 80.58 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.128 0.876 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.57 -39.41 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 118.993 0.815 . . . . 0.0 110.42 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.09 -43.67 91.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.236 0.925 . . . . 0.0 111.027 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -63.54 -38.92 92.97 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.902 -1.124 . . . . 0.0 112.777 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.51 83.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.94 0.791 . . . . 0.0 112.939 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.16 -47.95 10.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.394 1.078 . . . . 0.0 112.97 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.3 m -109.93 -28.3 8.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.283 1.433 . . . . 0.0 114.526 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 127.009 2.124 . . . . 0.0 114.293 177.146 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.72 -53.25 58.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 110.663 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -60.08 -37.46 80.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.1 0.56 . . . . 0.0 112.492 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 m -66.86 -40.84 87.99 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.174 1.79 . . . . 0.0 111.967 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -65.69 -47.25 76.08 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.29 1.036 . . . . 0.0 110.699 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.3 -54.21 48.07 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.748 1.219 . . . . 0.0 110.635 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.24 -43.0 78.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 111.954 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.06 -45.69 91.03 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.28 -0.887 . . . . 0.0 111.894 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.24 -37.82 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.563 1.529 . . . . 0.0 111.875 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.73 -33.74 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.04 0.936 . . . . 0.0 112.993 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 p -90.63 -43.47 10.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.1 p -73.27 -32.01 64.42 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -134.54 70.04 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 109.402 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.73 139.81 38.02 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t 83.52 88.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.958 2.503 . . . . 0.0 107.777 -169.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -108.08 133.03 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.06 0.544 . . . . 0.0 110.099 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.69 123.49 45.77 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.653 0.781 . . . . 0.0 108.965 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -104.98 116.12 31.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.311 1.045 . . . . 0.0 109.683 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.76 -167.99 1.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.042 1.737 . . . . 0.0 110.748 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.56 -1.11 53.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.98 171.64 15.3 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.065 1.793 . . . . 0.0 113.64 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.4 p -103.54 178.01 4.68 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.972 1.709 . . . . 0.0 110.684 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.6 -32.03 73.1 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.341 -0.849 . . . . 0.0 111.937 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.77 -32.92 58.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.936 1.294 . . . . 0.0 112.663 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -137.0 82.2 31.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.138 1.375 . . . . 0.0 110.634 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.63 171.77 16.91 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.786 2.99 . . . . 0.0 111.555 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -86.49 150.4 24.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.916 0.886 . . . . 0.0 111.224 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -72.37 171.31 12.45 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.425 1.49 . . . . 0.0 113.518 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 -136.89 22.02 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.353 0.977 . . . . 0.0 112.239 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -52.14 -40.87 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.747 0.819 . . . . 0.0 112.184 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 m -59.11 -43.61 91.91 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.317 -0.864 . . . . 0.0 112.576 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -62.65 -47.02 85.53 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.415 -0.803 . . . . 0.0 110.522 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.9 m -58.89 -44.47 91.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.017 0.927 . . . . 0.0 110.736 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.97 -44.18 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.006 1.322 . . . . 0.0 112.204 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.9 -43.71 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.901 0.773 . . . . 0.0 110.955 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.01 -40.0 94.27 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 mt -59.69 -53.46 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 112.195 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.17 -47.93 75.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.932 1.242 . . . . 0.0 110.834 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -49.1 -57.06 7.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.949 0.5 . . . . 0.0 110.331 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -67.02 -31.57 72.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.861 1.665 . . . . 0.0 114.266 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.39 -23.09 64.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.89 1.276 . . . . 0.0 111.222 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.8 t30 114.48 32.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 130.961 3.704 . . . . 0.0 112.282 168.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.76 138.42 29.63 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 121.261 -0.899 . . . . 0.0 113.089 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -82.17 49.89 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.457 3.438 . . . . 0.0 109.056 169.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -66.14 169.16 7.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.447 1.899 . . . . 0.0 115.133 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -150.96 130.04 12.62 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.588 0.755 . . . . 0.0 111.043 169.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.1 m -90.39 124.15 34.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.606 -0.684 . . . . 0.0 109.177 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.64 125.48 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 109.251 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -75.09 101.43 4.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.394 0.678 . . . . 0.0 111.026 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -72.36 -24.52 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.28 -1.72 34.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.969 1.308 . . . . 0.0 113.184 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.4 -24.85 66.54 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.574 1.149 . . . . 0.0 112.843 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -154.69 134.58 12.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 111.487 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.79 -41.78 87.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -25.14 67.83 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.701 1.137 . . . . 0.0 113.24 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.32 -46.98 21.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.083 0.953 . . . . 0.0 110.329 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -56.64 -47.86 78.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.874 0.87 . . . . 0.0 112.229 174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.08 -40.56 30.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.192 0.997 . . . . 0.0 112.449 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.01 -28.92 48.42 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.608 -170.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.3 tp -57.59 -36.71 72.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.756 1.278 . . . . 0.0 112.588 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -50.08 -43.8 51.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.362 1.065 . . . . 0.0 112.478 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -83.17 -30.19 28.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.789 0.836 . . . . 0.0 112.592 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -64.68 -39.66 94.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.8 p -88.68 -67.89 0.8 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.227 0.611 . . . . 0.0 111.894 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.2 m 130.05 -12.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 1 C-N-CA 133.598 4.759 . . . . 0.0 111.209 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -66.74 134.28 94.18 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.05 -43.37 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.888 2.392 . . . . 0.0 115.48 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.0 p -142.22 117.69 10.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.152 0.887 . . . . 0.0 112.176 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -60.6 159.19 26.19 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.298 1.439 . . . . 0.0 113.352 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -59.79 161.43 35.68 Favored 'Cis proline' 0 C--N 1.358 1.034 0 N-CA-C 115.672 1.374 . . . . 0.0 115.672 -2.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -154.82 161.91 41.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.38 1.072 . . . . 0.0 111.356 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.89 123.09 40.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.198 1.399 . . . . 0.0 109.418 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -111.31 138.3 47.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.508 1.123 . . . . 0.0 111.291 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 pt -149.89 110.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.727 1.611 . . . . 0.0 112.857 -169.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.24 41.49 32.14 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.994 1.317 . . . . 0.0 114.23 169.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.01 -8.5 69.94 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.265 0.935 . . . . 0.0 114.121 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -104.76 177.61 4.8 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.083 1.753 . . . . 0.0 110.516 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -150.77 161.71 42.11 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.892 1.33 . . . . 0.0 112.624 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -136.12 177.51 7.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.931 2.092 . . . . 0.0 109.898 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.78 -168.01 30.77 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.732 1.634 . . . . 0.0 115.624 -169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.62 -179.73 32.22 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.969 1.271 . . . . 0.0 113.99 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.1 m -67.5 -48.42 67.16 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.61 -42.39 88.06 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 111.811 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.73 -41.67 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.133 0.973 . . . . 0.0 110.593 172.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.2 m -64.16 -41.58 97.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.656 1.182 . . . . 0.0 111.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.12 -44.02 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.829 0.741 . . . . 0.0 111.281 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.92 -36.8 80.8 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.89 0.768 . . . . 0.0 112.476 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.0 83.89 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 112.522 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -65.59 -41.08 93.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.225 1.01 . . . . 0.0 112.322 172.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -68.68 -29.59 68.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.661 0.785 . . . . 0.0 112.647 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -87.39 -13.53 43.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.48 1.112 . . . . 0.0 113.379 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.92 -0.61 84.45 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.49 1.519 . . . . 0.0 114.268 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.9 -39.13 64.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.825 1.25 . . . . 0.0 111.321 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.35 -45.07 92.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.775 0.43 . . . . 0.0 110.626 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.85 -47.9 76.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.084 0.953 . . . . 0.0 111.018 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.17 -47.93 83.89 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.124 0.57 . . . . 0.0 112.063 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -68.9 -42.59 76.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.587 -0.696 . . . . 0.0 112.585 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.99 -40.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.973 0.909 . . . . 0.0 111.153 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.26 -46.45 89.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.449 1.022 . . . . 0.0 110.696 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.52 -44.68 93.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.58 -0.7 . . . . 0.0 111.795 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.43 87.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.002 0.921 . . . . 0.0 113.151 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 85.0 mtp -70.19 -39.76 75.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.603 1.161 . . . . 0.0 112.579 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.22 -34.39 77.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.335 0.654 . . . . 0.0 111.973 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.211 2.605 . . . . 0.0 112.688 173.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.3 -52.07 39.69 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.494 1.517 . . . . 0.0 111.018 170.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.74 -42.39 98.91 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.345 -0.847 . . . . 0.0 112.345 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -60.12 -39.08 84.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.25 1.82 . . . . 0.0 111.866 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -68.0 -50.45 55.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.995 1.318 . . . . 0.0 110.379 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.29 -51.28 67.18 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.454 0.702 . . . . 0.0 111.334 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.75 -48.85 76.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.988 0.915 . . . . 0.0 112.112 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.32 -42.74 96.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.94 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.96 -43.75 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.325 -0.859 . . . . 0.0 111.074 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.73 -42.8 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.408 1.483 . . . . 0.0 112.934 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.9 p -76.4 -42.89 42.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.216 0.916 . . . . 0.0 112.329 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.7 p -76.35 -36.05 58.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -95.95 -13.76 23.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.41 -48.24 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.508 2.723 . . . . 0.0 115.032 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.26 120.74 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.493 1.917 . . . . 0.0 108.048 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.65 154.93 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.144 0.578 . . . . 0.0 111.154 -172.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.96 132.65 46.39 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.602 1.161 . . . . 0.0 110.452 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -108.24 114.94 29.2 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.3 ptm -160.73 174.23 14.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.777 1.231 . . . . 0.0 110.615 -169.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -85.3 29.78 0.65 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.014 -1.054 . . . . 0.0 113.274 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.83 172.43 42.59 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.517 1.532 . . . . 0.0 113.089 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.0 p -100.27 178.48 4.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.178 1.391 . . . . 0.0 110.742 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.56 -23.47 62.61 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -84.43 -30.2 25.51 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 112.394 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -132.14 76.0 73.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.614 1.566 . . . . 0.0 110.35 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.39 173.23 14.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.547 2.832 . . . . 0.0 111.001 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -112.27 136.23 51.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.8 0.84 . . . . 0.0 110.735 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.87 149.83 46.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 112.739 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.51 -113.19 3.94 Favored Glycine 0 N--CA 1.468 0.822 0 C-N-CA 124.1 0.857 . . . . 0.0 111.526 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -59.97 -57.12 14.23 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.646 1.178 . . . . 0.0 113.072 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.3 m -62.53 -46.36 88.76 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.387 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -52.23 -47.65 65.59 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.497 1.519 . . . . 0.0 111.341 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -61.57 -50.37 72.92 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.15 0.98 . . . . 0.0 110.54 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -59.13 -47.77 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.012 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.71 -35.44 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.479 1.036 . . . . 0.0 112.098 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -64.97 -38.48 91.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.003 0.819 . . . . 0.0 111.558 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mt -59.82 -51.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.823 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -59.3 -51.14 71.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.553 1.069 . . . . 0.0 111.723 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -51.38 -60.93 2.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.338 1.055 . . . . 0.0 110.654 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 94.1 p -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.046 1.738 . . . . 0.0 115.262 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -58.86 -32.65 69.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.31 1.044 . . . . 0.0 109.892 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 t30 114.63 56.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.717 3.607 . . . . 0.0 109.333 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.62 38.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.45 168.49 14.47 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.721 2.947 . . . . 0.0 112.281 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.46 141.1 15.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.427 1.491 . . . . 0.0 109.583 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -123.98 93.47 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.733 0.813 . . . . 0.0 109.746 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 m -78.93 115.81 18.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.732 -0.605 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.52 125.5 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.809 1.643 . . . . 0.0 108.518 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -78.15 107.46 10.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.714 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.67 -23.76 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.75 -11.38 60.15 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.928 -1.107 . . . . 0.0 112.848 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -70.0 -29.03 66.01 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.879 0.872 . . . . 0.0 113.05 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -154.4 135.44 13.86 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.883 0.765 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.98 -34.24 74.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.54 1.136 . . . . 0.0 111.668 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 -26.14 68.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.044 0.938 . . . . 0.0 112.738 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.65 -56.51 5.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.915 0.78 . . . . 0.0 109.47 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -55.24 -39.43 69.72 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -86.72 -36.87 18.42 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.81 -37.77 21.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.692 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -64.26 -39.43 93.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.533 1.167 . . . . 0.0 112.952 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -58.82 -37.35 76.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.004 0.522 . . . . 0.0 111.9 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.36 -40.63 50.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 111.781 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.56 -45.55 93.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.065 1.346 . . . . 0.0 113.503 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.5 p -95.81 -23.51 16.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 p 78.7 -12.05 1.13 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.944 2.898 . . . . 0.0 113.561 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -81.47 127.08 74.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 121.321 -0.862 . . . . 0.0 110.669 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -83.83 -12.34 8.6 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.419 2.746 . . . . 0.0 116.51 -169.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -123.34 171.13 9.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.98 1.264 . . . . 0.0 112.894 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.13 148.9 69.86 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.042 1.337 . . . . 0.0 110.526 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.42 156.9 69.3 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.894 0.998 . . . . 0.0 114.145 -3.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.37 139.04 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.408 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.59 149.1 21.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.526 1.53 . . . . 0.0 110.453 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -149.58 140.93 23.23 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -144.79 124.58 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.593 1.157 . . . . 0.0 112.405 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 61.7 -17.8 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.329 2.652 . . . . 0.0 117.504 169.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.04 6.17 1.11 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.379 1.942 . . . . 0.0 113.821 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -128.24 144.01 51.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.208 1.803 . . . . 0.0 110.433 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -91.63 163.49 14.09 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.974 1.369 . . . . 0.0 112.791 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -142.37 176.08 9.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.064 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.84 -169.99 39.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.369 -1.287 . . . . 0.0 114.523 -171.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.62 -163.65 35.37 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.878 1.228 . . . . 0.0 113.002 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.12 -50.51 72.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.654 0.782 . . . . 0.0 112.97 -172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -59.78 -43.98 94.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.916 0.78 . . . . 0.0 111.596 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.37 -43.05 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.33 0.652 . . . . 0.0 110.175 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -62.81 -44.2 96.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 111.066 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.68 -45.13 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.898 1.279 . . . . 0.0 111.235 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.31 -38.75 81.9 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.842 0.746 . . . . 0.0 112.237 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.26 80.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.096 0.958 . . . . 0.0 112.485 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -67.52 -38.94 85.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.859 1.264 . . . . 0.0 112.182 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -68.03 -36.52 80.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.061 0.944 . . . . 0.0 111.931 173.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 m -84.28 -16.33 43.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.45 -0.39 80.64 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.107 1.337 . . . . 0.0 114.26 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -68.01 -42.83 80.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.764 1.226 . . . . 0.0 110.926 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.61 -43.78 92.67 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.028 -0.42 . . . . 0.0 110.531 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -55.44 -48.58 74.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.929 0.891 . . . . 0.0 111.182 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.06 -48.64 77.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.281 0.492 . . . . 0.0 111.776 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.85 -39.57 79.86 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.552 -0.718 . . . . 0.0 112.821 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -38.68 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.931 0.893 . . . . 0.0 111.035 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.3 -45.97 92.22 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.38 0.991 . . . . 0.0 111.368 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.95 -39.99 87.44 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.532 -0.73 . . . . 0.0 111.903 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.79 91.97 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.061 0.846 . . . . 0.0 112.899 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.5 mtm -68.28 -35.0 77.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.836 0.855 . . . . 0.0 112.674 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.5 t -65.97 -43.9 86.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.99 0.916 . . . . 0.0 111.891 170.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.255 1.353 0 C-N-CA 129.215 3.006 . . . . 0.0 112.408 174.07 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.51 -57.35 8.44 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.798 1.239 . . . . 0.0 110.947 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -59.88 -41.03 90.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.984 0.514 . . . . 0.0 111.193 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -60.84 -41.66 96.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.262 2.225 . . . . 0.0 112.881 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.5 m -66.91 -50.17 63.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.83 0.852 . . . . 0.0 110.317 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.33 -36.54 84.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.81 -48.72 80.53 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.261 1.024 . . . . 0.0 112.002 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -59.89 -41.67 92.1 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.093 -1.004 . . . . 0.0 111.782 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.66 -53.1 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.328 -0.858 . . . . 0.0 111.739 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.31 -30.24 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.924 1.238 . . . . 0.0 113.233 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.8 p -75.28 -30.14 60.33 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.204 0.911 . . . . 0.0 112.629 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.4 m -78.1 -40.75 37.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -107.07 -9.67 16.12 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 64.61 -47.96 0.32 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.733 2.813 . . . . 0.0 115.299 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -116.12 122.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.258 1.823 . . . . 0.0 109.369 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.36 135.54 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.873 0.869 . . . . 0.0 110.033 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.02 128.79 56.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.616 1.566 . . . . 0.0 108.941 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -108.83 120.14 41.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 109.764 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -156.45 167.34 30.75 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.92 1.688 . . . . 0.0 110.505 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -78.56 31.71 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.93 163.7 31.93 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.356 1.931 . . . . 0.0 113.018 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.1 p -82.06 178.43 8.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 111.199 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -64.31 -26.9 68.69 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.63 0.772 . . . . 0.0 112.449 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.8 -25.76 26.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 113.229 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -119.01 65.02 6.98 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.8 1.64 . . . . 0.0 111.169 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.93 150.05 85.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.059 2.506 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -94.77 115.03 27.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.042 0.537 . . . . 0.0 110.55 -170.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.14 146.44 33.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.838 1.255 . . . . 0.0 112.805 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.76 -149.0 19.19 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -53.44 -41.03 65.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -64.63 -46.51 82.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 112.541 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -57.43 -44.57 84.8 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.403 -0.811 . . . . 0.0 110.452 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -59.08 -43.76 91.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.788 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.1 -42.25 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.422 1.01 . . . . 0.0 111.821 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.67 -47.93 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.689 0.677 . . . . 0.0 110.967 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.43 -37.5 87.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.504 0.722 . . . . 0.0 111.811 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.6 -50.68 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.071 1.748 . . . . 0.0 112.278 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.12 -49.7 73.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.328 0.967 . . . . 0.0 110.82 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -53.12 -54.95 28.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.342 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -30.69 69.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.011 2.124 . . . . 0.0 115.007 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.9 tp -57.16 -31.66 65.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.43 1.092 . . . . 0.0 109.882 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 t30 112.53 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.495 3.518 . . . . 0.0 109.199 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.26 150.28 28.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.54 163.7 35.47 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.364 2.709 . . . . 0.0 110.542 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -161.72 164.95 28.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.595 1.558 . . . . 0.0 110.119 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.2 148.57 48.18 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.055 -0.403 . . . . 0.0 111.21 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.9 m -113.71 117.5 31.69 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 111.32 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.3 t -92.93 122.53 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.119 0.968 . . . . 0.0 109.463 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -81.96 93.16 6.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.404 1.482 . . . . 0.0 111.546 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -77.6 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.574 1.15 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.43 -54.09 0.64 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.653 1.981 . . . . 0.0 112.862 169.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -67.32 -44.36 79.31 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 111.89 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -87.81 128.52 35.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.632 1.173 . . . . 0.0 111.167 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.25 -40.55 86.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 113.341 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -61.79 -41.67 98.03 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.814 0.846 . . . . 0.0 111.22 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.88 -48.16 69.61 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.507 0.723 . . . . 0.0 110.745 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.35 -40.81 62.43 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.221 1.008 . . . . 0.0 112.305 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.22 -36.97 24.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.608 1.163 . . . . 0.0 113.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.62 -23.0 37.74 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.24 174.68 6.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.493 1.146 . . . . 0.0 111.478 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 73.6 -53.07 0.7 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.581 2.352 . . . . 0.0 110.085 -169.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -70.07 -38.71 75.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.63 1.572 . . . . 0.0 112.327 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -63.48 -49.53 73.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -97.01 -15.82 20.88 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p 80.52 -9.47 1.36 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 129.477 3.111 . . . . 0.0 114.227 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -68.7 132.03 91.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.211 -0.93 . . . . 0.0 111.382 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.21 -36.0 2.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.11 2.54 . . . . 0.0 115.007 -169.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -140.57 90.93 2.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.801 0.728 . . . . 0.0 111.454 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -60.77 158.74 30.34 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.303 1.441 . . . . 0.0 110.814 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.46 162.25 37.53 Favored 'Cis proline' 0 C--N 1.358 1.035 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 1.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 152.65 7.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.128 1.371 . . . . 0.0 112.53 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -93.77 146.78 23.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.046 1.339 . . . . 0.0 111.196 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -138.58 138.73 38.2 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.013 2.125 . . . . 0.0 110.675 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -143.29 127.18 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.307 1.443 . . . . 0.0 111.632 -172.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 51.87 23.15 1.98 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.28 41.96 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.809 1.195 . . . . 0.0 115.32 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.32 150.21 45.13 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.209 1.504 . . . . 0.0 111.215 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.83 150.04 29.31 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.989 -1.069 . . . . 0.0 111.967 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -97.72 -47.55 5.56 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.215 1.006 . . . . 0.0 111.638 173.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 145.95 -172.55 26.57 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.287 1.422 . . . . 0.0 112.81 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.26 164.18 41.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.413 1.006 . . . . 0.0 113.544 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.0 m -66.89 -41.75 86.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.625 -0.927 . . . . 0.0 112.874 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.02 -43.91 94.95 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.403 -0.811 . . . . 0.0 111.306 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.92 -42.1 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 109.978 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.2 m -63.0 -43.02 99.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.041 1.336 . . . . 0.0 111.581 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.8 t -60.02 -45.46 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.467 0.707 . . . . 0.0 111.346 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -71.32 -32.78 69.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.912 0.778 . . . . 0.0 112.82 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.73 80.09 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.011 -1.056 . . . . 0.0 112.783 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -63.3 -43.31 98.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.811 0.845 . . . . 0.0 112.071 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.19 -32.86 74.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.991 0.516 . . . . 0.0 112.222 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -86.92 -11.76 49.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.408 1.083 . . . . 0.0 113.614 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.81 -0.16 87.81 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.525 1.536 . . . . 0.0 114.582 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.83 -36.1 59.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 111.251 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.5 tp -64.42 -43.64 93.74 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.675 -0.641 . . . . 0.0 110.708 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -55.69 -48.39 75.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.454 0.702 . . . . 0.0 110.552 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.52 -47.89 82.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.358 0.663 . . . . 0.0 111.899 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -73.47 -35.03 65.65 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.28 -42.34 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.473 1.033 . . . . 0.0 110.793 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.01 -45.97 89.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.277 0.944 . . . . 0.0 111.03 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.83 -43.75 94.42 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.605 -0.685 . . . . 0.0 111.993 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.41 92.79 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.173 0.989 . . . . 0.0 112.868 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.02 -35.47 74.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.242 1.017 . . . . 0.0 112.549 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.19 -38.09 87.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.302 0.641 . . . . 0.0 112.059 170.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.732 2.413 . . . . 0.0 112.578 170.909 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.86 -47.04 79.34 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.97 0.804 . . . . 0.0 110.354 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.76 -43.83 90.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.023 0.529 . . . . 0.0 111.633 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.9 m -65.48 -43.89 88.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.042 1.737 . . . . 0.0 111.566 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -61.8 -53.4 56.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.941 0.897 . . . . 0.0 110.425 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.81 -50.16 75.01 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.625 0.77 . . . . 0.0 111.36 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -56.53 -49.19 75.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 112.359 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.88 -46.31 85.49 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.563 -0.711 . . . . 0.0 111.966 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.48 -48.28 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.86 0.755 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.37 -20.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 p -93.41 -37.31 12.05 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.976 0.807 . . . . 0.0 112.932 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 t -74.04 -43.02 59.37 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.87 0.759 . . . . 0.0 112.317 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -97.43 -10.54 25.24 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mttm 63.09 -40.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.072 2.549 . . . . 0.0 116.139 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -120.79 128.11 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.066 1.746 . . . . 0.0 108.731 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.09 139.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.49 0.586 . . . . 0.0 112.422 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.17 129.45 56.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.171 1.388 . . . . 0.0 110.643 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -107.53 128.92 54.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.967 0.907 . . . . 0.0 111.04 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -162.58 -175.56 4.54 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.858 1.663 . . . . 0.0 110.851 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -76.6 51.48 0.74 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.25 -1.531 . . . . 0.0 112.412 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.96 168.02 30.42 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.695 1.14 . . . . 0.0 114.305 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.7 p -113.15 -175.73 2.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.258 1.823 . . . . 0.0 111.401 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.88 -32.76 74.61 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.543 -0.723 . . . . 0.0 112.119 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.46 -32.72 42.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.834 1.253 . . . . 0.0 112.667 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -122.81 77.68 48.98 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.217 1.407 . . . . 0.0 110.636 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 164.85 33.07 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -107.34 138.35 43.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.999 0.919 . . . . 0.0 111.755 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.4 m -66.48 157.93 30.85 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.068 1.347 . . . . 0.0 113.849 -172.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 -118.92 4.73 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.392 0.996 . . . . 0.0 112.271 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -59.1 -46.17 88.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.295 1.038 . . . . 0.0 112.883 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.7 m -69.79 -44.21 70.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.906 -1.121 . . . . 0.0 112.146 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.19 -46.66 69.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.755 1.222 . . . . 0.0 110.832 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -59.9 -50.37 74.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.416 1.086 . . . . 0.0 110.539 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 t -61.56 -44.56 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.246 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.82 -34.89 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.424 1.465 . . . . 0.0 111.545 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -68.03 -37.43 81.35 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.242 0.928 . . . . 0.0 112.524 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.68 -51.41 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.774 1.23 . . . . 0.0 110.777 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.55 -51.27 70.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.804 0.729 . . . . 0.0 111.266 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -47.24 -59.2 3.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.087 0.555 . . . . 0.0 109.991 174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m -62.97 -33.97 76.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.602 1.961 . . . . 0.0 114.103 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.81 -21.4 66.41 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.295 1.438 . . . . 0.0 111.951 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 109.02 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 131.51 3.924 . . . . 0.0 110.697 169.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 136.53 24.31 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -169.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -83.58 48.18 2.55 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.549 3.5 . . . . 0.0 109.665 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.44 164.53 18.56 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -169.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -130.89 170.05 14.95 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.722 1.609 . . . . 0.0 110.038 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -147.99 137.64 22.43 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.088 -1.632 . . . . 0.0 110.761 170.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.4 140.49 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.106 0.962 . . . . 0.0 110.529 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.49 142.99 35.33 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.0 pt -89.01 -174.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.432 1.093 . . . . 0.0 109.718 168.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt 71.16 174.91 0.3 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.553 2.341 . . . . 0.0 113.869 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 78.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.527 2.731 . . . . 0.0 110.854 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.95 141.5 54.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.636 0.774 . . . . 0.0 111.007 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.65 -37.91 74.17 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.034 -1.041 . . . . 0.0 113.429 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.21 -26.41 66.6 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.072 -1.018 . . . . 0.0 111.75 176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.82 -15.96 40.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.418 1.087 . . . . 0.0 113.237 170.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -80.57 -51.96 8.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.094 1.316 . . . . 0.0 111.677 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.39 -20.78 8.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -170.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.08 -30.72 69.62 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 120.975 -1.078 . . . . 0.0 113.388 -170.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.85 -41.27 91.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.765 1.283 . . . . 0.0 111.52 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.47 -45.38 91.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.72 -0.612 . . . . 0.0 110.834 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -68.72 -38.53 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.311 0.644 . . . . 0.0 112.736 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -70.04 -44.96 68.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.988 0.813 . . . . 0.0 112.531 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.99 -17.96 33.89 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m 69.81 -5.42 1.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.297 2.239 . . . . 0.0 113.756 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -74.93 127.56 86.67 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.764 1.226 . . . . 0.0 111.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.6 143.33 21.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.154 2.569 . . . . 0.0 110.27 172.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p 64.53 -161.35 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.782 2.033 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -146.19 163.56 29.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.79 2.036 . . . . 0.0 110.675 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.16 172.64 17.17 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 120.229 1.117 . . . . 0.0 114.875 -6.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.78 121.89 21.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.815 1.246 . . . . 0.0 108.435 170.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.14 123.38 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.181 0.992 . . . . 0.0 109.541 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -106.48 134.74 49.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.615 1.566 . . . . 0.0 110.911 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.3 pt -129.96 112.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 111.306 172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.43 17.57 4.94 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.556 1.942 . . . . 0.0 114.469 172.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.07 -3.53 41.04 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.155 1.836 . . . . 0.0 114.62 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -100.99 149.14 24.23 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 111.402 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -103.16 132.2 49.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.253 1.421 . . . . 0.0 111.046 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -99.28 -28.86 13.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.128 0.971 . . . . 0.0 113.45 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.78 -156.8 18.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.468 1.508 . . . . 0.0 111.743 -169.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.44 169.19 41.05 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.704 1.145 . . . . 0.0 114.141 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.9 m -57.65 -34.31 69.22 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.15 -40.92 95.65 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.38 -0.825 . . . . 0.0 111.802 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.23 -40.92 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.678 0.791 . . . . 0.0 109.937 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 m -61.39 -44.64 96.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.046 0.938 . . . . 0.0 111.665 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.69 -43.62 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.324 0.65 . . . . 0.0 111.485 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.99 -41.73 95.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.259 0.936 . . . . 0.0 111.987 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.62 -31.26 71.15 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.76 0.824 . . . . 0.0 113.17 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -67.91 -35.74 78.98 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.985 -1.072 . . . . 0.0 111.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.29 -32.35 66.52 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.9 p -88.15 -15.75 35.25 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.734 1.152 . . . . 0.0 113.76 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.57 1.01 78.38 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 125.306 1.431 . . . . 0.0 113.955 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.89 -30.37 68.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.288 . . . . 0.0 111.999 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.62 -47.65 69.02 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.556 -0.715 . . . . 0.0 110.165 172.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -56.41 -47.46 78.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 110.923 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.79 -50.67 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.51 0.724 . . . . 0.0 111.852 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -73.1 -36.74 66.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.279 -0.888 . . . . 0.0 113.183 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.28 -38.32 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.367 0.985 . . . . 0.0 111.087 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.05 -46.35 91.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.273 0.942 . . . . 0.0 110.866 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.57 -36.26 80.13 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.402 -0.811 . . . . 0.0 112.738 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.69 -36.61 84.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.158 0.983 . . . . 0.0 112.683 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 72.9 mtm -73.18 -41.28 64.03 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.555 0.742 . . . . 0.0 112.254 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.87 -39.37 69.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 129.718 3.207 . . . . 0.0 115.76 -176.829 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.64 -62.61 1.62 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.516 1.127 . . . . 0.0 110.998 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -66.57 -30.72 71.08 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.62 -0.675 . . . . 0.0 112.172 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -63.32 -46.29 87.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.807 1.643 . . . . 0.0 111.668 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -65.29 -48.68 72.31 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.776 0.83 . . . . 0.0 110.651 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.11 -55.04 35.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.153 0.981 . . . . 0.0 110.735 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.85 -46.59 74.67 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 111.713 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.7 -51.59 69.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.796 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.78 -36.49 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.4 1.454 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.89 -13.9 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.924 1.238 . . . . 0.0 113.763 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -102.41 -38.15 7.72 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.22 0.918 . . . . 0.0 113.107 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 t -80.13 -50.57 10.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.988 0.813 . . . . 0.0 111.853 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -88.79 -15.09 35.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.34 -0.85 . . . . 0.0 112.731 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.04 -52.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.913 2.885 . . . . 0.0 115.241 172.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 t -102.08 116.83 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.43 1.492 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -135.64 133.34 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.148 0.431 . . . . 0.0 110.893 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.02 138.2 44.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.004 1.722 . . . . 0.0 109.2 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -125.18 117.61 24.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.53 1.132 . . . . 0.0 110.186 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -167.25 -170.5 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.99 2.116 . . . . 0.0 109.589 -176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -81.04 -32.37 34.12 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.218 1.372 . . . . 0.0 112.517 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 154.54 47.47 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.193 1.378 . . . . 0.0 113.387 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -96.8 -179.59 4.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.734 1.614 . . . . 0.0 110.789 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.47 -18.76 60.58 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.106 -0.996 . . . . 0.0 113.554 172.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.9 -27.64 23.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 112.355 171.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.38 72.77 80.64 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.733 1.613 . . . . 0.0 111.058 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.56 157.09 59.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.006 2.471 . . . . 0.0 110.994 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.03 126.91 33.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.204 0.602 . . . . 0.0 111.133 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.1 t -59.22 143.68 48.35 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.781 1.232 . . . . 0.0 112.178 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.07 -146.11 18.06 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.919 1.247 . . . . 0.0 111.61 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -55.45 -36.69 66.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -169.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 m -64.55 -47.07 80.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.898 1.226 . . . . 0.0 112.404 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -57.73 -43.76 85.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.307 0.958 . . . . 0.0 110.648 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 m -58.83 -46.95 86.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.114 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.4 -42.23 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.173 0.989 . . . . 0.0 112.13 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -59.91 -45.72 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.433 0.693 . . . . 0.0 110.872 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.68 -41.41 96.07 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.594 0.757 . . . . 0.0 111.912 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.49 -52.01 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 111.608 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.14 -50.29 68.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.801 0.728 . . . . 0.0 110.438 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -50.4 -56.36 11.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.798 0.839 . . . . 0.0 110.691 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.53 -31.56 70.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.35 1.86 . . . . 0.0 114.638 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.01 -29.18 68.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 0.0 110.659 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 112.88 63.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 130.163 3.385 . . . . 0.0 109.71 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.32 154.74 34.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.39 173.95 13.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.232 2.621 . . . . 0.0 110.336 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -161.15 145.87 13.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 109.773 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -123.33 95.2 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.919 0.888 . . . . 0.0 109.833 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.4 m -76.07 97.35 4.04 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.934 -1.104 . . . . 0.0 110.667 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.77 129.47 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.513 1.925 . . . . 0.0 110.137 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -74.41 107.59 6.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.83 0.852 . . . . 0.0 110.953 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.49 -28.75 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -20.4 49.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.331 1.052 . . . . 0.0 112.87 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.69 -42.83 93.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.207 1.403 . . . . 0.0 113.687 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -119.55 129.9 54.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.926 0.891 . . . . 0.0 111.551 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.4 -30.2 71.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.6 -52.47 17.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.992 0.814 . . . . 0.0 110.702 173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.46 -33.17 70.96 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.455 1.502 . . . . 0.0 112.417 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.07 -22.06 62.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.378 1.871 . . . . 0.0 113.523 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.47 -56.15 1.62 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.656 1.182 . . . . 0.0 113.427 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -19.03 79.82 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.42 -34.36 72.39 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.489 1.145 . . . . 0.0 112.584 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -59.04 -37.39 76.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.245 1.018 . . . . 0.0 112.523 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.96 -30.92 27.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.514 1.126 . . . . 0.0 112.179 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -62.6 -41.47 99.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.77 0.828 . . . . 0.0 112.447 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.5 p -82.12 -68.21 0.72 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.381 0.673 . . . . 0.0 111.953 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.2 m 123.31 -13.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 133.293 4.637 . . . . 0.0 111.099 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -70.45 128.32 91.3 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.059 1.344 . . . . 0.0 112.003 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.18 140.11 13.75 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.37 2.713 . . . . 0.0 110.625 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.6 p 64.9 -174.55 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.563 2.345 . . . . 0.0 113.108 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -138.32 159.96 65.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.139 1.776 . . . . 0.0 110.476 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.89 165.51 35.68 Favored 'Cis proline' 0 C--N 1.355 0.877 0 N-CA-C 115.739 1.399 . . . . 0.0 115.739 1.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -141.89 132.78 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.253 1.421 . . . . 0.0 109.559 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.59 138.19 40.61 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.026 1.331 . . . . 0.0 108.75 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -134.95 137.2 42.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.917 1.687 . . . . 0.0 110.773 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.2 124.53 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.973 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.34 49.78 5.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.917 2.087 . . . . 0.0 114.845 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.25 3.06 73.02 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.362 -1.243 . . . . 0.0 115.435 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.09 143.48 50.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.347 1.573 . . . . 0.0 111.835 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -82.97 142.4 31.41 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.754 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -94.44 -33.62 13.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.221 1.008 . . . . 0.0 112.101 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.31 -153.93 16.81 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.62 1.581 . . . . 0.0 112.008 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.98 162.36 37.04 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.398 0.999 . . . . 0.0 113.114 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.9 m -58.26 -33.72 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.16 -44.98 84.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 0.0 111.817 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.0 -42.47 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.934 0.893 . . . . 0.0 109.606 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.7 m -62.7 -46.42 88.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.369 1.068 . . . . 0.0 111.911 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.88 -41.89 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.388 0.54 . . . . 0.0 111.342 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.58 -34.23 65.01 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.977 0.808 . . . . 0.0 112.868 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.43 80.62 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.022 -1.049 . . . . 0.0 112.178 173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.11 -39.56 82.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.804 0.841 . . . . 0.0 112.437 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.74 -34.38 77.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.347 0.659 . . . . 0.0 111.971 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.07 -12.11 53.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.215 1.006 . . . . 0.0 113.571 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.49 -6.2 82.79 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 125.855 1.693 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -68.79 -37.41 79.27 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.01 1.324 . . . . 0.0 111.55 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.02 -40.73 96.69 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.933 -0.48 . . . . 0.0 111.17 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -60.74 -48.12 83.23 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.376 0.535 . . . . 0.0 109.8 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.2 -44.48 97.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.348 0.659 . . . . 0.0 112.01 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.28 -35.44 76.04 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.382 -0.824 . . . . 0.0 113.057 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.08 -41.39 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.528 1.058 . . . . 0.0 110.672 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -59.59 -45.78 90.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.352 0.978 . . . . 0.0 110.913 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -57.8 -43.05 85.39 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.472 -0.767 . . . . 0.0 111.674 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.19 66.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.85 -36.82 14.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.631 0.772 . . . . 0.0 113.021 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.92 -25.39 26.15 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.255 1.395 0 C-N-CA 128.163 2.585 . . . . 0.0 113.275 174.484 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.87 -48.15 77.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.519 0.727 . . . . 0.0 110.421 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.39 -42.9 88.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.769 -0.582 . . . . 0.0 112.081 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -66.96 -38.94 87.02 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.243 1.817 . . . . 0.0 111.884 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -63.82 -49.89 71.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.175 0.99 . . . . 0.0 110.475 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.91 -43.7 95.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.07 0.948 . . . . 0.0 111.394 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.63 -45.13 92.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.075 0.852 . . . . 0.0 112.618 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.4 -42.57 96.22 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -0.934 . . . . 0.0 111.356 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -60.82 -48.63 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.277 -0.89 . . . . 0.0 111.583 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.02 -38.03 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.553 1.141 . . . . 0.0 113.44 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -81.34 -33.36 32.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.938 0.895 . . . . 0.0 112.824 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -77.59 -32.26 53.5 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.23 112.42 11.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.145 1.378 . . . . 0.0 110.437 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -59.86 -38.16 81.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.95 134.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.192 1.797 . . . . 0.0 109.171 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.24 130.52 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.464 1.106 . . . . 0.0 109.903 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.19 127.21 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.084 0.954 . . . . 0.0 110.272 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.99 124.47 52.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -164.91 -177.82 4.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.846 1.658 . . . . 0.0 110.433 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.61 38.1 0.61 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.46 -1.4 . . . . 0.0 113.114 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.83 160.62 31.64 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 125.339 1.447 . . . . 0.0 113.368 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 p -96.93 -179.42 4.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.372 1.469 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.25 -29.75 68.63 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.608 -0.683 . . . . 0.0 112.337 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.55 -34.18 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.039 1.336 . . . . 0.0 112.502 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.01 76.2 67.13 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.612 1.565 . . . . 0.0 110.365 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.84 170.98 19.17 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.433 2.756 . . . . 0.0 111.569 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -114.02 136.51 52.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.98 0.912 . . . . 0.0 110.397 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.0 t -71.16 156.29 39.75 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.493 1.117 . . . . 0.0 112.313 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.49 -149.42 19.24 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 125.36 1.457 . . . . 0.0 111.803 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.03 -30.17 65.92 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -56.74 -53.37 58.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.314 1.446 . . . . 0.0 111.653 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.29 -40.29 89.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.373 -0.829 . . . . 0.0 110.653 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -58.59 -50.11 75.01 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.724 0.809 . . . . 0.0 111.321 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.21 -35.58 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.648 1.113 . . . . 0.0 112.517 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.27 -47.31 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.208 0.913 . . . . 0.0 111.054 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -65.04 -39.64 93.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.862 0.865 . . . . 0.0 112.312 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt -56.66 -49.49 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.59 1.156 . . . . 0.0 111.996 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.66 -51.33 67.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.078 0.854 . . . . 0.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -49.02 -57.06 7.16 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.458 0.703 . . . . 0.0 110.128 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 t -65.68 -33.58 76.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.832 2.053 . . . . 0.0 114.605 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.59 -28.31 67.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.819 0.736 . . . . 0.0 111.123 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 t30 110.96 57.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.96 3.304 . . . . 0.0 109.621 169.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 142.77 22.28 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.88 162.44 26.59 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.137 3.225 . . . . 0.0 110.499 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -163.65 165.94 22.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.255 1.022 . . . . 0.0 112.285 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.25 162.19 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 108.257 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.8 m -144.52 128.43 17.42 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 119.979 -1.701 . . . . 0.0 111.483 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.9 131.19 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.813 1.245 . . . . 0.0 110.289 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -75.7 110.02 9.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.136 0.574 . . . . 0.0 110.849 174.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -61.0 -29.74 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -87.57 8.13 26.52 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.671 1.188 . . . . 0.0 113.208 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.87 -31.07 71.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.955 0.902 . . . . 0.0 113.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.33 154.5 30.69 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.193 0.997 . . . . 0.0 111.693 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.716 1.207 . . . . 0.0 113.91 -169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.27 -31.85 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.39 -54.95 15.98 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.743 0.817 . . . . 0.0 110.963 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -57.87 -29.85 65.35 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.6 -37.99 11.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.98 -32.19 27.03 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 118.904 0.775 . . . . 0.0 113.428 -172.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.38 -36.94 74.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.881 0.872 . . . . 0.0 112.222 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.29 -53.34 45.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.151 1.38 . . . . 0.0 112.63 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -81.66 -23.88 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -67.08 -48.86 66.94 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.937 0.79 . . . . 0.0 112.471 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.0 p -77.84 -46.8 20.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.017 0.826 . . . . 0.0 112.081 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m 122.87 -26.11 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 1 C-N-CA 132.879 4.471 . . . . 0.0 112.693 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.08 142.14 68.3 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.514 -0.741 . . . . 0.0 112.034 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.12 -13.17 11.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.027 2.485 . . . . 0.0 116.162 -169.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -138.67 169.25 18.12 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.892 1.224 . . . . 0.0 112.521 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -137.06 155.85 75.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.737 1.615 . . . . 0.0 110.719 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.17 156.6 47.72 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.602 1.251 . . . . 0.0 115.281 -1.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.73 134.76 8.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.338 1.055 . . . . 0.0 110.968 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.48 140.99 38.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 111.197 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -131.97 132.6 43.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.252 1.821 . . . . 0.0 109.239 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.28 125.21 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.204 1.002 . . . . 0.0 109.348 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.3 22.83 5.09 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.34 48.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.308 0.956 . . . . 0.0 114.932 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.13 145.13 45.5 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.001 1.4 . . . . 0.0 110.993 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -76.87 143.9 39.36 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.265 -0.897 . . . . 0.0 111.97 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -103.76 -26.75 12.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.512 1.125 . . . . 0.0 112.055 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.36 -168.66 12.95 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 125.427 1.489 . . . . 0.0 113.55 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.36 172.67 55.12 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.789 1.185 . . . . 0.0 114.085 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 83.6 m -65.83 -41.99 91.11 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -63.45 -42.65 98.66 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.73 0.696 . . . . 0.0 111.376 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.63 -42.79 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 0.0 109.987 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -64.0 -42.78 97.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.935 1.294 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.39 -39.95 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.062 0.945 . . . . 0.0 111.519 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.22 -39.5 82.37 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.453 1.024 . . . . 0.0 112.435 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.68 91.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.72 0.808 . . . . 0.0 112.352 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -61.33 -45.2 95.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.243 1.417 . . . . 0.0 112.313 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -67.51 -29.17 68.52 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.966 0.906 . . . . 0.0 112.636 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -88.01 -12.85 43.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.459 1.104 . . . . 0.0 113.446 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.17 -1.44 87.62 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.65 1.595 . . . . 0.0 114.428 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.93 -35.29 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 111.822 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -49.06 76.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.423 0.689 . . . . 0.0 110.042 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -56.72 -49.03 76.4 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.122 0.969 . . . . 0.0 110.711 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.05 -46.91 88.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.405 0.682 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.94 -36.17 77.64 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.51 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.543 1.065 . . . . 0.0 110.751 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.58 -46.52 89.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.703 1.138 . . . . 0.0 111.36 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.11 -39.95 88.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.922 . . . . 0.0 112.555 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.05 78.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.572 -0.705 . . . . 0.0 111.966 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 mmt -67.27 -38.19 84.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.865 0.866 . . . . 0.0 112.805 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.5 -23.97 42.61 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.255 1.373 0 C-N-CA 127.265 2.226 . . . . 0.0 112.811 177.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.43 -54.43 43.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.819 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.26 -37.71 84.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -65.05 -40.99 95.54 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.883 1.673 . . . . 0.0 111.887 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.9 m -63.42 -48.18 78.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.861 0.864 . . . . 0.0 110.737 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.63 -49.32 77.95 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.247 0.619 . . . . 0.0 111.565 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.81 -45.16 86.53 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.668 0.787 . . . . 0.0 112.373 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -61.4 -44.66 96.76 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 111.787 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.9 -46.95 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.201 0.909 . . . . 0.0 111.484 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -60.19 -43.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 112.107 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -78.36 -29.05 47.26 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 m -79.96 -39.03 31.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.28 -10.97 12.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 60.97 -58.87 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.059 2.544 . . . . 0.0 114.813 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.46 125.77 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.414 1.486 . . . . 0.0 108.877 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.79 128.07 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.018 0.927 . . . . 0.0 110.761 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.42 142.13 34.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.038 1.335 . . . . 0.0 110.32 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.16 119.23 35.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.525 1.53 . . . . 0.0 109.624 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -174.19 -169.16 0.44 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.677 1.991 . . . . 0.0 110.038 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -91.59 -18.44 24.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.01 156.06 30.72 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.154 1.359 . . . . 0.0 113.143 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.7 p -86.85 177.31 7.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.073 1.349 . . . . 0.0 111.446 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.67 -28.78 69.84 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -87.68 -33.3 18.82 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.02 1.328 . . . . 0.0 112.475 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -120.56 84.7 36.85 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.13 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 139.35 52.03 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.523 2.149 . . . . 0.0 108.868 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -0.31 56.25 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.0 t -160.24 163.44 33.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.146 1.379 . . . . 0.0 111.613 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.61 -32.59 84.68 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.029 0.823 . . . . 0.0 113.058 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -73.3 -46.26 50.63 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.332 1.066 . . . . 0.0 112.364 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -62.31 -45.67 92.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.562 -0.712 . . . . 0.0 110.914 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.76 -46.72 74.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.094 0.958 . . . . 0.0 111.279 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.6 m -59.34 -51.61 69.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.092 0.957 . . . . 0.0 110.762 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.81 -37.89 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.846 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.16 -34.14 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 120.656 1.571 . . . . 0.0 111.92 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.02 -44.34 89.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.637 0.653 . . . . 0.0 111.223 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.04 -51.69 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 111.034 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.0 -50.61 71.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.401 1.08 . . . . 0.0 110.591 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.79 -51.43 68.97 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.184 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -68.23 -32.7 73.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.433 1.493 . . . . 0.0 114.05 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.45 -32.67 70.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.908 1.283 . . . . 0.0 110.609 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 118.7 72.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 129.989 3.316 . . . . 0.0 110.711 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.45 140.9 13.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.96 158.39 34.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.141 2.561 . . . . 0.0 108.248 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.88 172.6 17.76 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.51 155.3 42.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.911 1.284 . . . . 0.0 110.367 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -118.26 129.87 55.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.44 -0.787 . . . . 0.0 110.821 172.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -97.06 121.89 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.661 1.184 . . . . 0.0 108.485 173.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -74.23 90.47 2.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.593 1.157 . . . . 0.0 110.191 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pt -69.81 -17.51 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 -1.92 55.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.717 1.207 . . . . 0.0 113.116 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -64.25 -28.77 69.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.141 0.882 . . . . 0.0 112.975 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -159.27 162.27 36.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.242 1.417 . . . . 0.0 112.111 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.85 -31.58 70.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.533 -0.729 . . . . 0.0 112.781 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.63 -39.83 95.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.83 0.741 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.52 -51.49 56.08 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.89 -0.506 . . . . 0.0 110.914 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -56.01 -44.99 79.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.216 1.006 . . . . 0.0 112.858 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -83.34 -24.82 31.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.646 0.778 . . . . 0.0 112.658 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.57 -40.02 6.51 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.296 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.17 -33.55 74.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.493 1.647 . . . . 0.0 113.401 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -60.82 -31.38 70.79 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -83.45 -34.85 25.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.185 0.994 . . . . 0.0 112.158 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.23 -42.32 94.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.217 1.007 . . . . 0.0 112.337 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.9 p -83.47 -67.54 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.829 0.852 . . . . 0.0 112.695 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.6 m 135.05 -23.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 133.341 4.657 . . . . 0.0 111.218 -173.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -83.81 132.17 49.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.23 1.012 . . . . 0.0 111.775 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.02 -25.83 2.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.826 2.351 . . . . 0.0 114.72 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -95.93 151.55 19.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.563 1.145 . . . . 0.0 111.521 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -127.83 151.12 75.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.652 1.581 . . . . 0.0 110.605 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.79 155.95 52.55 Favored 'Cis proline' 0 C--N 1.355 0.869 0 CA-C-N 120.694 1.283 . . . . 0.0 114.422 -2.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -150.49 143.08 24.5 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.987 0.915 . . . . 0.0 110.728 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 tp -110.32 146.81 35.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.317 1.447 . . . . 0.0 111.458 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -148.76 137.81 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.825 2.05 . . . . 0.0 109.392 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -142.62 122.54 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.183 -0.948 . . . . 0.0 111.611 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.83 33.64 6.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.563 1.945 . . . . 0.0 115.284 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.95 -0.78 51.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.813 1.197 . . . . 0.0 115.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.51 141.0 48.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.033 1.417 . . . . 0.0 110.763 173.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -84.1 144.25 29.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.448 -0.783 . . . . 0.0 110.669 170.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.93 -31.69 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.969 0.908 . . . . 0.0 112.285 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.48 -151.2 17.06 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.055 1.312 . . . . 0.0 112.134 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.58 162.69 49.38 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 124.157 0.884 . . . . 0.0 112.934 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -56.23 -35.89 67.86 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.3 -39.97 84.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.633 0.773 . . . . 0.0 112.036 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.39 -42.22 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.406 0.682 . . . . 0.0 109.848 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 m -62.07 -47.27 85.45 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.469 1.108 . . . . 0.0 111.051 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.11 -44.72 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 0.0 111.338 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.35 -37.26 77.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.897 0.771 . . . . 0.0 112.444 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -29.91 70.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 113.048 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -70.85 -33.6 70.81 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.339 -0.851 . . . . 0.0 112.267 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.55 -40.38 76.85 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.9 p -81.05 -17.53 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.201 -0.937 . . . . 0.0 113.208 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.79 69.83 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.336 1.446 . . . . 0.0 113.57 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -36.93 84.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.95 1.3 . . . . 0.0 111.889 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.61 -40.68 97.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.321 0.648 . . . . 0.0 111.189 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.97 -44.34 94.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.965 0.506 . . . . 0.0 110.039 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -61.92 -44.17 97.33 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.326 173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -69.22 -38.84 78.76 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.796 1.18 . . . . 0.0 112.439 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.86 -39.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 118.859 0.754 . . . . 0.0 110.626 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.85 -45.88 92.78 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.132 0.878 . . . . 0.0 111.37 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -59.15 -44.85 92.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.97 0.908 . . . . 0.0 111.772 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.04 96.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.755 1.222 . . . . 0.0 112.807 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.9 mmt -73.57 -33.98 64.92 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.333 -0.854 . . . . 0.0 112.092 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.67 -47.0 70.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.037 0.935 . . . . 0.0 112.628 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.258 1.508 0 C-N-CA 128.755 2.822 . . . . 0.0 114.702 -175.249 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.453 0.168 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.42 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.18 -60.16 3.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.98 1.312 . . . . 0.0 113.225 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p -75.43 -43.19 4.22 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-O 115.829 -2.034 . . . . 0.0 114.761 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.66 -29.82 2.12 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 122.927 2.081 . . . . 0.0 114.119 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.83 -46.29 1.99 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.2 tp -73.21 -49.73 26.37 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.159 0.89 . . . . 0.0 111.7 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.6 -34.15 76.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.472 -0.768 . . . . 0.0 112.04 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m -61.52 -42.56 98.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.422 1.889 . . . . 0.0 111.934 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.756 1.223 . . . . 0.0 110.933 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.82 -45.6 85.92 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.712 0.805 . . . . 0.0 111.312 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.19 -43.73 95.64 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.239 0.927 . . . . 0.0 112.389 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -60.41 -42.93 97.0 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.352 -0.843 . . . . 0.0 111.892 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.12 -48.97 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 119.175 0.898 . . . . 0.0 111.148 173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.84 -38.25 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.051 1.34 . . . . 0.0 112.853 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -81.8 -28.83 32.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 0.0 112.834 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -78.1 -31.2 49.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -138.06 114.78 10.6 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.412 1.485 . . . . 0.0 109.737 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -66.56 -20.67 66.07 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.1 t -119.62 123.71 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.793 1.237 . . . . 0.0 109.119 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.64 139.09 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.344 1.058 . . . . 0.0 109.563 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.91 135.72 54.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.311 1.444 . . . . 0.0 110.02 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.57 116.64 29.11 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.353 1.061 . . . . 0.0 108.775 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ptm -162.16 176.05 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.492 1.517 . . . . 0.0 110.791 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.56 26.97 0.75 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.711 -1.243 . . . . 0.0 113.617 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.42 169.79 39.35 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.6 1.572 . . . . 0.0 113.266 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.2 p -97.75 176.37 5.84 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.072 1.349 . . . . 0.0 111.272 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -66.43 -26.32 67.17 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.804 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -86.29 -27.0 24.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.468 1.507 . . . . 0.0 112.401 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.93 78.51 59.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 0.0 110.678 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.11 178.99 1.64 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.322 3.348 . . . . 0.0 113.622 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -130.36 138.08 50.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.552 1.141 . . . . 0.0 109.688 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.6 m -68.18 160.99 28.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.651 1.18 . . . . 0.0 113.661 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.78 -126.56 8.22 Favored Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.633 1.111 . . . . 0.0 111.527 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -56.12 -49.55 73.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.072 1.349 . . . . 0.0 112.933 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -52.2 66.11 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 111.323 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -57.83 -39.11 76.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.393 0.677 . . . . 0.0 111.337 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 95.5 m -63.27 -51.89 64.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.546 1.139 . . . . 0.0 110.935 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.24 -44.61 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.565 0.62 . . . . 0.0 111.088 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.6 t -61.28 -47.63 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.637 0.775 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -64.18 -40.5 96.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.224 1.01 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mt -59.71 -51.35 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.737 0.815 . . . . 0.0 111.291 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.17 -46.83 82.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.627 0.771 . . . . 0.0 111.286 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -52.6 -52.46 55.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.352 0.661 . . . . 0.0 110.727 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.5 m -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.527 1.931 . . . . 0.0 114.684 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.46 -39.46 76.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.711 0.804 . . . . 0.0 109.701 170.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.1 t30 123.74 68.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.979 3.712 . . . . 0.0 109.546 169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.93 152.56 28.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.28 178.49 7.56 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.675 2.916 . . . . 0.0 110.21 169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -163.48 141.2 7.58 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.856 1.263 . . . . 0.0 111.189 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.31 92.2 3.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.214 1.005 . . . . 0.0 109.663 173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.9 m -75.37 111.57 10.78 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.98 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.6 t -92.73 126.77 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.604 1.962 . . . . 0.0 108.543 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -78.5 113.05 16.18 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.58 -25.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -4.28 58.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -173.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -74.45 -18.88 60.57 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -156.81 128.56 7.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.477 1.111 . . . . 0.0 110.657 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.8 -25.94 67.8 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.269 -0.894 . . . . 0.0 112.869 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -68.93 -30.7 69.22 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.202 -0.937 . . . . 0.0 112.393 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.51 -53.92 12.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.213 0.915 . . . . 0.0 108.993 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.86 66.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.512 1.125 . . . . 0.0 113.081 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.71 -44.07 11.44 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.702 0.801 . . . . 0.0 112.41 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.16 -30.87 56.52 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-O 119.05 -0.861 . . . . 0.0 114.566 -169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.58 -20.63 66.05 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.141 1.471 . . . . 0.0 113.686 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -68.3 -38.65 81.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.12 0.968 . . . . 0.0 111.678 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.39 -29.31 30.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.399 1.08 . . . . 0.0 112.517 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.69 -34.33 72.73 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.98 1.312 . . . . 0.0 112.529 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -94.51 -58.58 2.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.663 1.585 . . . . 0.0 112.934 172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t 107.8 -2.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 131.886 4.075 . . . . 0.0 110.406 -169.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -88.98 131.7 40.36 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.293 1.837 . . . . 0.0 111.602 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.19 142.64 12.24 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.636 2.891 . . . . 0.0 111.556 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 p 74.33 165.13 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 128.54 2.736 . . . . 0.0 114.09 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.61 159.21 59.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.03 1.732 . . . . 0.0 111.115 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -61.64 160.65 49.19 Favored 'Cis proline' 0 C--N 1.354 0.865 0 CA-C-N 120.159 1.093 . . . . 0.0 114.91 -2.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -140.19 130.36 25.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.935 1.294 . . . . 0.0 110.058 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.86 137.86 36.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.987 1.715 . . . . 0.0 109.641 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -140.53 136.8 33.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.158 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -144.82 128.62 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.159 1.384 . . . . 0.0 112.615 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 46.3 31.95 1.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.494 2.318 . . . . 0.0 115.883 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.54 10.58 37.93 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.227 -1.318 . . . . 0.0 115.686 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -147.06 149.07 32.34 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.694 1.747 . . . . 0.0 112.193 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -79.7 150.79 30.77 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.347 -0.845 . . . . 0.0 111.504 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -105.9 -33.73 7.86 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.929 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.0 -153.61 18.51 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.099 1.333 . . . . 0.0 113.382 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.66 -177.74 42.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.795 1.188 . . . . 0.0 114.135 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.7 t -63.15 -43.02 99.5 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 113.13 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -59.33 -46.38 88.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.978 0.808 . . . . 0.0 111.258 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.32 -45.46 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.834 0.853 . . . . 0.0 110.19 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.3 m -62.56 -47.62 83.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.056 1.342 . . . . 0.0 110.957 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.08 -46.15 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.857 1.263 . . . . 0.0 111.23 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.75 -38.55 80.2 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.898 0.772 . . . . 0.0 111.76 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.37 80.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.531 0.732 . . . . 0.0 112.666 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.9 -40.49 95.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.022 0.929 . . . . 0.0 112.268 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.533 1.133 . . . . 0.0 112.889 173.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.4 m -85.69 -11.91 52.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.043 0.937 . . . . 0.0 113.499 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.05 85.03 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.516 1.532 . . . . 0.0 114.059 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.43 -41.65 65.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.895 1.278 . . . . 0.0 111.566 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 tp -63.88 -42.01 97.59 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.506 -0.746 . . . . 0.0 110.033 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -59.7 -48.86 80.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.07 0.548 . . . . 0.0 109.691 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.16 -50.86 71.49 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.318 1.047 . . . . 0.0 111.918 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -72.14 -32.27 66.76 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.17 -39.6 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.393 0.997 . . . . 0.0 111.024 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.34 -43.21 99.25 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.842 1.201 . . . . 0.0 111.252 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -60.16 -39.6 86.96 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.382 -0.823 . . . . 0.0 112.366 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.33 -29.52 70.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.876 0.87 . . . . 0.0 113.186 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.3 mmt -76.8 -48.93 17.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.73 0.695 . . . . 0.0 112.138 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.3 p -80.05 -25.73 40.01 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 126.806 2.043 . . . . 0.0 112.344 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.635 0.255 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.47 175.7 12.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.754 2.022 . . . . 0.0 110.386 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.1 -15.34 61.49 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.48 1.112 . . . . 0.0 113.514 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p -60.03 -23.11 1.09 Allowed Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 118.372 2.73 . . . . 0.0 118.372 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -62.26 178.9 0.72 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.639 2.893 . . . . 0.0 114.825 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.46 -8.15 5.71 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.588 1.555 . . . . 0.0 114.932 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -54.8 -49.25 71.43 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.048 0.939 . . . . 0.0 110.019 169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -59.72 -41.21 90.34 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.653 1.115 . . . . 0.0 112.367 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -62.42 -41.62 98.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.146 1.778 . . . . 0.0 111.905 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -68.81 -46.85 67.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.033 1.333 . . . . 0.0 110.738 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.78 -53.55 53.73 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.194 1.797 . . . . 0.0 110.634 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.25 -47.53 78.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.222 1.009 . . . . 0.0 111.904 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -59.2 -42.25 90.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.237 0.615 . . . . 0.0 112.618 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.63 -43.56 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.52 -41.32 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.388 1.075 . . . . 0.0 112.63 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.3 p -78.93 -38.28 37.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.581 1.082 . . . . 0.0 112.587 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.8 m -73.91 -33.99 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -113.26 -7.35 13.55 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 61.05 -63.27 0.07 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 127.711 2.405 . . . . 0.0 114.47 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -91.57 121.1 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.008 1.323 . . . . 0.0 109.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.41 147.74 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.427 0.691 . . . . 0.0 110.847 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 125.63 47.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.707 1.603 . . . . 0.0 109.185 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -94.91 116.74 29.09 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptm -156.63 170.8 21.57 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.46 1.104 . . . . 0.0 111.748 -169.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.47 -13.63 25.98 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.23 -163.89 25.59 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.753 1.644 . . . . 0.0 112.913 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.3 p -128.32 175.18 8.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.767 1.627 . . . . 0.0 111.439 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.66 -31.02 72.05 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.748 1.219 . . . . 0.0 111.958 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.3 -29.79 28.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.935 1.294 . . . . 0.0 112.915 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -138.06 84.29 21.2 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.4 1.48 . . . . 0.0 111.323 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.09 165.37 19.47 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.693 2.929 . . . . 0.0 112.396 171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -80.06 124.86 29.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.4 m -58.04 138.52 55.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.762 0.825 . . . . 0.0 111.294 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.88 -119.53 5.79 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -52.47 -65.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.425 1.49 . . . . 0.0 114.16 -169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -64.4 -42.92 95.83 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.92 -45.72 82.5 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.24 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -61.48 -48.39 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.138 0.975 . . . . 0.0 110.431 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.72 -50.29 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.681 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.37 -31.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 119.24 0.927 . . . . 0.0 112.341 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.01 -45.71 84.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.694 0.679 . . . . 0.0 110.736 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.96 -50.58 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.853 0.861 . . . . 0.0 111.237 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.52 -50.3 74.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.813 0.733 . . . . 0.0 111.219 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -57.07 -52.91 63.39 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.029 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 t -66.34 -33.29 75.39 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.094 1.758 . . . . 0.0 114.024 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -57.61 -34.22 69.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.446 1.098 . . . . 0.0 110.874 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 117.71 64.7 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 130.519 3.528 . . . . 0.0 109.887 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.81 154.61 31.54 Favored Pre-proline 0 N--CA 1.475 0.801 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.93 172.44 16.18 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.549 2.833 . . . . 0.0 111.063 170.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.25 146.83 15.75 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.506 1.522 . . . . 0.0 110.459 170.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -110.3 118.29 35.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.205 0.602 . . . . 0.0 111.076 169.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 79.6 p -76.11 82.43 2.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.246 1.018 . . . . 0.0 110.413 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.22 104.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.02 119.93 20.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.017 0.527 . . . . 0.0 111.739 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -74.79 -34.81 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.79 -38.4 70.27 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.35 -21.63 59.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -99.02 -49.48 4.5 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.787 0.835 . . . . 0.0 113.115 -176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 69.0 -34.64 0.28 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 128.062 2.545 . . . . 0.0 115.772 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -42.86 99.35 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.919 -1.113 . . . . 0.0 109.693 170.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.09 -45.99 92.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.031 1.332 . . . . 0.0 111.652 169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -56.91 -39.76 75.04 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.431 1.092 . . . . 0.0 112.677 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -89.89 -33.91 16.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.1 -34.62 9.6 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 123.977 0.798 . . . . 0.0 114.727 -172.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -29.75 69.83 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.313 1.556 . . . . 0.0 110.984 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -63.5 -27.69 69.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.29 -1.506 . . . . 0.0 113.085 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -78.54 -37.55 42.59 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.007 0.821 . . . . 0.0 111.549 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -66.72 -35.22 79.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.426 1.09 . . . . 0.0 113.26 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.6 p -108.81 -14.1 14.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 114.937 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.1 m 66.53 6.17 4.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.527 1.931 . . . . 0.0 113.95 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -74.94 141.65 75.31 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.599 1.56 . . . . 0.0 113.155 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 -49.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.81 2.34 . . . . 0.0 114.105 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.4 p -149.74 125.86 10.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.138 0.975 . . . . 0.0 112.178 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.75 158.94 72.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.001 1.32 . . . . 0.0 112.396 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -64.43 163.26 59.28 Favored 'Cis proline' 0 C--N 1.357 0.982 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 2.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -149.16 134.47 18.37 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.999 0.92 . . . . 0.0 110.524 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.05 139.31 30.75 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.964 1.305 . . . . 0.0 109.475 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -143.35 137.75 28.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.414 1.086 . . . . 0.0 110.221 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.2 mt -139.25 121.84 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.588 -0.695 . . . . 0.0 110.785 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 t70 64.44 -22.68 0.07 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.202 3.001 . . . . 0.0 116.893 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.03 10.72 0.06 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.845 1.688 . . . . 0.0 115.277 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.86 150.23 30.65 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.311 1.555 . . . . 0.0 111.074 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -73.53 141.75 46.72 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.889 -0.507 . . . . 0.0 111.026 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -95.94 -39.61 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.734 0.814 . . . . 0.0 111.836 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.53 -151.04 22.39 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.455 1.026 . . . . 0.0 113.942 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.25 -173.16 20.31 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.767 1.651 . . . . 0.0 113.387 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -60.98 -47.2 87.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.826 0.85 . . . . 0.0 112.842 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.05 -45.14 93.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.413 0.552 . . . . 0.0 111.587 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.45 -44.28 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.594 0.757 . . . . 0.0 109.998 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.1 m -62.89 -46.15 89.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.822 1.249 . . . . 0.0 111.198 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.97 -43.43 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.183 0.993 . . . . 0.0 111.252 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.97 -42.38 80.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.774 0.715 . . . . 0.0 111.973 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.36 79.72 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 112.771 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -66.39 -40.58 89.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.031 1.332 . . . . 0.0 112.304 174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -70.98 -32.87 69.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.169 0.588 . . . . 0.0 112.436 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.69 -12.14 51.97 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.92 -0.1 87.62 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 125.404 1.478 . . . . 0.0 114.092 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -72.74 -36.58 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.468 1.107 . . . . 0.0 111.381 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.69 -46.44 85.5 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.884 -0.51 . . . . 0.0 110.176 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -56.75 -48.82 76.97 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.67 0.788 . . . . 0.0 110.986 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.07 -49.63 77.15 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.813 0.845 . . . . 0.0 111.668 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -71.43 -35.54 70.98 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.9 -42.08 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.679 1.127 . . . . 0.0 110.887 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -63.07 -43.05 99.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.048 0.84 . . . . 0.0 111.488 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -59.98 -42.48 94.26 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.343 -0.848 . . . . 0.0 111.866 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.05 72.79 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.235 0.925 . . . . 0.0 112.812 177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.68 -54.36 7.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.743 0.817 . . . . 0.0 111.255 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.571 1.148 . . . . 0.0 113.058 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.255 1.371 0 C-N-CA 127.916 2.486 . . . . 0.0 112.538 171.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.479 0.18 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.01 -21.57 59.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.3 tp -141.6 152.36 43.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.667 1.587 . . . . 0.0 110.426 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.8 p -61.51 123.06 74.92 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.724 1.61 . . . . 0.0 111.663 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.59 -34.14 81.71 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.109 3.206 . . . . 0.0 115.425 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.21 93.81 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.072 0.851 . . . . 0.0 112.192 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.6 tp -67.33 -47.75 69.58 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.146 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -58.63 -37.26 75.53 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.303 0.956 . . . . 0.0 112.261 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.9 m -66.09 -41.65 90.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.508 1.923 . . . . 0.0 111.678 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.2 m -67.23 -45.89 75.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.625 1.17 . . . . 0.0 111.159 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 99.4 mt -56.92 -54.65 44.14 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.869 1.268 . . . . 0.0 110.343 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.71 -41.6 74.04 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.794 0.725 . . . . 0.0 112.153 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -61.7 -47.36 85.62 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.333 -0.855 . . . . 0.0 112.101 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.94 -36.76 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.414 1.461 . . . . 0.0 112.705 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.85 -40.77 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.712 1.205 . . . . 0.0 112.308 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.8 p -80.18 -45.39 18.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.571 0.748 . . . . 0.0 112.361 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 76.3 p -70.7 -38.86 73.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -100.77 -3.8 29.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.629 0.771 . . . . 0.0 112.921 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt 62.14 -59.53 0.12 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.344 2.658 . . . . 0.0 114.395 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.87 137.21 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.65 1.58 . . . . 0.0 108.977 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.04 142.25 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.453 0.701 . . . . 0.0 111.032 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.36 145.4 28.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.058 1.343 . . . . 0.0 110.768 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -123.8 116.18 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.928 1.691 . . . . 0.0 109.401 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.59 -173.18 1.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.338 1.455 . . . . 0.0 112.311 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -82.19 -154.93 0.13 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.286 1.434 . . . . 0.0 113.31 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.79 -146.8 50.62 Favored Glycine 0 N--CA 1.481 1.689 0 O-C-N 120.574 -1.329 . . . . 0.0 113.605 169.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.5 p -128.62 175.61 8.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.537 1.535 . . . . 0.0 109.46 169.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.29 -14.56 63.08 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.718 -1.238 . . . . 0.0 112.903 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.34 -39.88 8.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.808 1.243 . . . . 0.0 113.53 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -90.04 119.37 69.32 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.961 0.904 . . . . 0.0 111.34 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.32 134.46 24.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.183 2.589 . . . . 0.0 112.334 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -80.35 -34.37 36.62 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.855 2.062 . . . . 0.0 112.982 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.55 153.58 2.35 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.331 2.252 . . . . 0.0 108.954 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.35 -35.77 89.3 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 123.731 0.682 . . . . 0.0 113.308 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.77 -51.66 61.11 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.25 1.025 . . . . 0.0 111.089 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -60.15 -43.17 95.97 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.368 -0.833 . . . . 0.0 111.939 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -59.95 -46.41 89.52 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.537 0.735 . . . . 0.0 110.792 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -59.85 -45.12 93.44 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.808 0.843 . . . . 0.0 110.729 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -61.07 -43.65 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.075 0.95 . . . . 0.0 112.413 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 t -58.81 -46.69 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 110.802 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -65.58 -38.49 89.69 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mt -59.09 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.645 1.578 . . . . 0.0 111.561 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.03 -48.28 79.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.338 0.972 . . . . 0.0 110.66 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -51.28 -56.53 12.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.19 70.56 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.432 2.293 . . . . 0.0 114.805 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.63 -29.89 66.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.926 1.291 . . . . 0.0 109.974 169.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.7 t30 109.58 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 130.309 3.444 . . . . 0.0 108.885 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.9 149.72 28.46 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.45 167.27 17.37 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.121 3.214 . . . . 0.0 110.101 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -169.16 158.67 8.52 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.619 1.568 . . . . 0.0 111.046 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 168.33 9.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.448 1.099 . . . . 0.0 110.327 175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -148.3 105.15 3.59 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 119.792 -1.817 . . . . 0.0 110.774 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.3 t -87.36 118.32 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.921 1.288 . . . . 0.0 108.378 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -86.01 101.27 12.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 109.126 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.47 -32.4 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.61 -24.89 66.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -168.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.15 -10.8 59.8 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -134.98 119.22 17.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.563 1.074 . . . . 0.0 113.354 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.1 -32.08 69.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.06 -41.56 81.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.902 0.881 . . . . 0.0 110.871 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.42 -49.16 74.82 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.204 0.602 . . . . 0.0 110.868 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -55.76 -43.68 76.92 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -82.34 -32.35 29.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.71 -38.33 12.14 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.373 0.987 . . . . 0.0 113.98 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.21 -26.42 65.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.552 1.176 . . . . 0.0 112.503 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.45 -37.63 81.59 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.658 0.783 . . . . 0.0 112.003 169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -76.25 -44.3 38.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.89 0.876 . . . . 0.0 111.241 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -61.43 -41.56 97.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.208 1.003 . . . . 0.0 113.055 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.1 p -101.01 -18.87 16.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m 68.7 0.62 2.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.894 2.078 . . . . 0.0 114.561 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 74.2 t-105 -74.08 140.54 77.03 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 51.2 Cg_exo -63.58 -57.58 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.302 2.668 . . . . 0.0 115.259 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.8 p -149.01 122.49 9.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.089 0.956 . . . . 0.0 112.386 -169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -64.52 157.59 71.89 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.015 1.326 . . . . 0.0 112.269 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.66 158.24 41.85 Favored 'Cis proline' 0 C--N 1.358 1.06 0 N-CA-C 116.07 1.527 . . . . 0.0 116.07 2.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.79 146.94 26.08 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.133 0.973 . . . . 0.0 111.299 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.0 141.5 47.34 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.627 1.571 . . . . 0.0 109.031 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -139.29 144.55 38.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.456 1.902 . . . . 0.0 109.745 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.83 126.91 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.538 -0.726 . . . . 0.0 111.432 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.0 t70 59.38 -17.9 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 129.143 2.977 . . . . 0.0 117.86 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.44 4.91 0.12 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.657 1.598 . . . . 0.0 115.418 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -148.47 151.03 34.48 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.548 1.674 . . . . 0.0 111.596 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -73.09 147.56 44.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.353 0.596 . . . . 0.0 111.716 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -100.37 -40.14 7.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.402 1.081 . . . . 0.0 111.765 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.45 -155.63 22.64 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 125.571 1.558 . . . . 0.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.05 173.52 52.21 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.756 1.17 . . . . 0.0 113.752 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.44 -46.71 66.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.665 -0.903 . . . . 0.0 112.716 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.45 -40.27 90.58 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 111.641 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.6 -41.63 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.514 0.726 . . . . 0.0 110.242 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.2 m -63.85 -44.5 92.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.151 0.98 . . . . 0.0 111.956 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -57.85 -43.85 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.858 0.753 . . . . 0.0 111.108 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.11 -37.59 78.44 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.1 91.43 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.245 1.018 . . . . 0.0 112.497 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -64.17 -42.04 96.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.259 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.13 -28.32 68.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.586 0.754 . . . . 0.0 112.497 173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -87.48 -12.89 44.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.598 1.159 . . . . 0.0 113.581 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.66 0.34 84.13 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 125.616 1.579 . . . . 0.0 114.229 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.92 -37.66 64.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.79 1.236 . . . . 0.0 111.485 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.78 -45.48 89.55 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.624 -0.672 . . . . 0.0 110.812 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -56.72 -48.45 77.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 110.802 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.57 -48.53 81.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 0.0 111.797 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -70.21 -38.42 75.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.46 -40.59 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 119.564 1.074 . . . . 0.0 110.607 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.85 -46.11 90.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.534 0.607 . . . . 0.0 110.819 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -62.52 -35.95 81.05 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.092 -1.005 . . . . 0.0 112.661 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.3 -31.57 72.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.008 -1.058 . . . . 0.0 112.825 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.51 -46.8 9.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.319 1.047 . . . . 0.0 112.981 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.67 -18.92 21.62 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -172.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 130.568 3.547 . . . . 0.0 113.259 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 110.751 -0.092 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.55 63.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.57 0.748 . . . . 0.0 112.586 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.3 mt -96.55 167.74 10.96 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.637 1.575 . . . . 0.0 110.13 169.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p -72.89 142.48 83.14 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 121.749 -0.595 . . . . 0.0 109.97 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.84 -34.44 96.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 0.0 112.739 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.23 -37.87 84.62 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.436 1.094 . . . . 0.0 113.366 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -61.13 -56.51 20.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.999 0.919 . . . . 0.0 109.925 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -62.54 -38.5 90.26 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.4 m -64.7 -39.87 94.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 111.968 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.6 m -64.98 -51.52 61.28 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.572 0.749 . . . . 0.0 110.236 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.56 -42.79 93.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.942 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.89 -48.78 80.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.451 1.023 . . . . 0.0 112.395 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -62.24 -42.03 98.95 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.54 -0.725 . . . . 0.0 111.905 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.06 -56.33 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.093 0.957 . . . . 0.0 110.546 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -58.99 -45.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.622 1.169 . . . . 0.0 112.721 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -73.19 -41.72 63.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.565 0.746 . . . . 0.0 112.758 -175.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -81.84 -32.31 31.24 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -15.7 30.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 59.56 -66.16 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.998 2.519 . . . . 0.0 114.057 -172.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.32 122.31 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.388 1.875 . . . . 0.0 108.597 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.34 117.99 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.357 0.663 . . . . 0.0 110.391 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -96.42 128.01 42.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.065 0.946 . . . . 0.0 110.405 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.17 122.88 47.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.357 1.063 . . . . 0.0 109.991 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -154.58 -177.94 6.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.273 1.429 . . . . 0.0 111.434 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.72 37.97 0.31 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.593 -1.317 . . . . 0.0 112.76 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.59 -165.04 35.63 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 126.557 2.027 . . . . 0.0 112.016 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -156.93 -167.31 2.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.443 1.097 . . . . 0.0 110.892 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.42 -33.32 71.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.09 1.356 . . . . 0.0 113.012 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.82 -15.58 58.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.518 1.527 . . . . 0.0 113.778 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -148.3 70.8 10.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.642 1.577 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.76 146.31 48.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.032 2.488 . . . . 0.0 110.698 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -98.93 127.02 44.76 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.411 0.684 . . . . 0.0 110.218 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -65.94 155.07 37.6 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.565 1.146 . . . . 0.0 113.664 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.59 -118.38 4.79 Favored Glycine 0 N--CA 1.469 0.84 0 C-N-CA 124.237 0.922 . . . . 0.0 112.019 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -54.24 -58.6 6.76 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.748 1.219 . . . . 0.0 112.674 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -62.39 -46.51 88.27 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.606 -0.683 . . . . 0.0 111.746 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.38 -46.57 69.68 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.587 1.155 . . . . 0.0 111.092 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.0 m -65.59 -46.1 80.69 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.159 0.984 . . . . 0.0 110.843 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.3 -44.16 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.201 0.91 . . . . 0.0 110.993 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.02 -45.81 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.516 0.726 . . . . 0.0 111.032 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.62 -38.7 91.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.961 0.8 . . . . 0.0 112.453 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.49 -47.35 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 119.31 0.959 . . . . 0.0 110.889 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.36 -51.29 68.21 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.38 0.991 . . . . 0.0 111.218 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -49.14 -61.75 1.91 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.646 0.778 . . . . 0.0 110.522 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.9 p -68.5 -25.86 65.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.947 1.699 . . . . 0.0 115.049 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.92 -34.26 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.915 0.886 . . . . 0.0 109.318 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 115.58 55.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.218 3.407 . . . . 0.0 109.461 168.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.2 145.15 31.37 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.35 163.16 35.08 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.178 2.585 . . . . 0.0 110.742 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -160.84 162.39 32.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.541 1.536 . . . . 0.0 109.928 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -134.23 178.39 7.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.744 1.217 . . . . 0.0 108.739 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.0 m -150.92 159.6 44.45 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 119.727 -1.858 . . . . 0.0 112.963 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.89 133.94 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.305 1.042 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -79.12 118.02 20.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.382 0.673 . . . . 0.0 110.997 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.6 pt -69.35 -20.81 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.44 -3.99 49.1 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.07 -17.94 62.58 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -157.74 139.38 13.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.799 1.24 . . . . 0.0 111.211 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -64.65 -36.56 84.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.9 -43.81 97.78 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.644 -0.66 . . . . 0.0 111.022 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.9 tp -61.35 -49.1 78.33 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.434 0.694 . . . . 0.0 111.036 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp85 -55.37 -38.85 69.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.108 0.963 . . . . 0.0 112.429 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -76.85 -50.22 13.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.664 1.186 . . . . 0.0 112.365 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.98 -26.8 54.93 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 115.591 0.997 . . . . 0.0 115.591 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.77 -33.87 74.86 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.634 1.217 . . . . 0.0 112.103 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.88 -43.69 98.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.841 0.856 . . . . 0.0 111.814 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.1 -44.63 75.75 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.636 0.774 . . . . 0.0 111.138 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.6 -41.18 89.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.75 0.82 . . . . 0.0 112.343 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.3 m -80.62 -21.89 41.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.4 p 69.24 -35.73 0.32 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.322 3.049 . . . . 0.0 113.716 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -70.66 137.23 85.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.754 1.622 . . . . 0.0 111.278 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -86.85 -27.57 0.69 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.875 2.383 . . . . 0.0 116.215 -169.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 m -102.54 130.26 49.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.496 1.043 . . . . 0.0 112.915 -168.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -115.28 152.47 46.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.929 1.292 . . . . 0.0 110.504 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.53 157.64 55.37 Favored 'Cis proline' 0 C--N 1.355 0.92 0 N-CA-C 114.996 1.114 . . . . 0.0 114.996 -3.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.36 151.47 8.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.14 1.376 . . . . 0.0 111.298 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.0 tp -90.21 159.41 16.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.942 1.297 . . . . 0.0 110.735 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -150.31 139.76 21.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.433 1.093 . . . . 0.0 110.198 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 mt -142.68 126.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.719 -0.613 . . . . 0.0 111.139 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 63.37 -25.74 0.07 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.985 2.914 . . . . 0.0 117.407 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.01 10.26 0.05 OUTLIER Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.914 1.721 . . . . 0.0 115.114 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -150.11 151.25 32.87 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.289 1.544 . . . . 0.0 111.243 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -71.64 161.02 31.65 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.42 1.105 . . . . 0.0 112.536 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -136.08 143.31 44.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.275 1.43 . . . . 0.0 109.31 170.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.93 -178.75 10.27 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.325 1.441 . . . . 0.0 115.54 -170.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.88 -173.8 20.19 Favored Glycine 0 N--CA 1.473 1.105 0 C-N-CA 124.971 1.272 . . . . 0.0 114.55 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.42 -45.09 94.88 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.678 -0.895 . . . . 0.0 113.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.72 -44.3 97.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.719 -0.613 . . . . 0.0 111.458 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.59 -44.07 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.756 0.822 . . . . 0.0 110.348 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.7 m -62.78 -44.89 94.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.067 1.347 . . . . 0.0 111.131 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.22 -45.55 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.597 1.159 . . . . 0.0 111.489 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -66.53 -42.06 87.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.095 0.861 . . . . 0.0 112.224 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.58 81.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.117 0.967 . . . . 0.0 112.457 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.98 -47.45 86.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.678 1.191 . . . . 0.0 111.605 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.19 -32.61 70.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.008 0.923 . . . . 0.0 113.2 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -83.38 -13.59 54.61 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.94 -6.34 76.51 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.023 1.296 . . . . 0.0 113.922 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.94 -37.16 72.84 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.765 1.226 . . . . 0.0 111.906 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.13 -43.23 78.79 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.665 -0.647 . . . . 0.0 110.38 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.79 -49.11 78.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.887 0.875 . . . . 0.0 110.224 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.69 1.196 . . . . 0.0 112.054 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.06 -39.25 79.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.949 0.795 . . . . 0.0 112.844 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.52 -45.67 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.401 1.001 . . . . 0.0 110.414 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -62.77 -46.94 85.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.239 0.927 . . . . 0.0 111.647 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.91 -37.87 89.01 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.458 -0.777 . . . . 0.0 112.126 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.03 81.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.952 0.796 . . . . 0.0 112.835 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.09 -40.58 82.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.802 0.728 . . . . 0.0 111.841 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.34 -47.52 83.85 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.139 0.575 . . . . 0.0 111.97 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.488 1.431 1 C-N-CA 132.153 4.181 . . . . 0.0 111.491 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.93 86.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.571 1.078 . . . . 0.0 112.007 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.4 mt -91.61 154.23 19.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.097 1.359 . . . . 0.0 109.44 169.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.6 p -78.23 153.21 79.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.104 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.5 -28.56 81.31 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.99 2.46 . . . . 0.0 113.213 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.49 61.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.79 -65.6 0.65 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.983 1.265 . . . . 0.0 111.485 -171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -65.29 -29.0 69.72 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.448 -0.782 . . . . 0.0 112.136 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.1 m -63.56 -44.01 95.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.326 1.85 . . . . 0.0 112.117 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.9 m -64.65 -45.46 86.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.033 0.933 . . . . 0.0 110.375 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.2 mt -56.02 -50.22 71.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.059 0.544 . . . . 0.0 111.675 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.91 -48.48 78.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.478 0.711 . . . . 0.0 112.288 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.43 -38.65 87.91 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.506 -0.746 . . . . 0.0 112.572 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.86 -47.58 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.178 -0.951 . . . . 0.0 110.727 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.22 -36.02 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.046 1.339 . . . . 0.0 113.008 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -84.28 -31.28 25.0 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.206 0.912 . . . . 0.0 113.054 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -70.77 -37.85 73.4 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.865 0.757 . . . . 0.0 112.757 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -137.39 114.17 10.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.249 1.42 . . . . 0.0 108.448 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.88 -33.81 76.53 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.12 137.25 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.53 1.059 . . . . 0.0 109.162 169.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -134.16 126.87 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.815 0.846 . . . . 0.0 109.454 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.08 125.71 47.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.511 1.125 . . . . 0.0 109.169 170.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -97.32 118.19 33.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.2 ptm -155.39 159.53 39.96 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -168.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.16 -20.53 48.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.217 1.007 . . . . 0.0 112.889 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.99 -170.38 43.1 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.186 1.375 . . . . 0.0 112.294 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.8 p -127.53 174.29 9.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.341 1.456 . . . . 0.0 110.947 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -69.32 -21.43 63.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -83.31 -31.53 26.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.654 1.182 . . . . 0.0 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.37 100.24 3.59 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.321 1.448 . . . . 0.0 110.274 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.26 164.46 32.83 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.107 2.538 . . . . 0.0 111.458 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.6 139.36 30.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.289 0.636 . . . . 0.0 110.176 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.7 p -69.59 159.54 33.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.984 0.914 . . . . 0.0 113.196 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.11 -104.98 2.4 Favored Glycine 0 N--CA 1.468 0.79 0 C-N-CA 124.138 0.875 . . . . 0.0 111.283 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.76 -71.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.293 1.437 . . . . 0.0 112.728 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.7 m -60.98 -41.33 96.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.574 -0.704 . . . . 0.0 111.355 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -53.8 -46.43 71.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.3 1.44 . . . . 0.0 111.964 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.1 m -67.78 -51.38 49.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.554 1.142 . . . . 0.0 110.996 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.93 -42.33 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.141 0.576 . . . . 0.0 111.742 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.98 -47.02 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.652 0.781 . . . . 0.0 111.031 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -64.73 -41.64 95.81 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.911 0.778 . . . . 0.0 112.126 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.91 -52.58 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.591 0.756 . . . . 0.0 111.187 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.33 -47.75 66.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.38 0.672 . . . . 0.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -50.2 -53.52 27.33 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.855 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -66.04 -33.42 75.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.804 1.641 . . . . 0.0 114.277 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.41 -25.59 66.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.165 0.986 . . . . 0.0 111.61 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 55.5 t30 112.61 47.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 130.955 3.702 . . . . 0.0 110.862 169.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.44 132.89 21.3 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.32 122.4 6.09 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.424 2.749 . . . . 0.0 109.128 169.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -131.79 161.0 33.94 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -136.51 144.65 44.42 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.786 1.234 . . . . 0.0 110.318 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.6 m -108.15 93.44 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 0.0 109.564 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.47 121.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.407 1.083 . . . . 0.0 109.341 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -74.32 122.92 23.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 111.278 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 pt -119.15 -169.49 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.895 1.278 . . . . 0.0 111.27 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.9 -56.88 0.54 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.454 2.302 . . . . 0.0 112.208 169.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.39 -41.16 85.42 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.822 0.849 . . . . 0.0 110.532 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -73.77 109.4 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.993 0.917 . . . . 0.0 110.526 171.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -73.34 -27.63 61.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 113.488 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.99 -44.58 76.27 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.145 -0.972 . . . . 0.0 110.954 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.4 -40.5 89.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.711 0.804 . . . . 0.0 111.863 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -54.46 -37.99 65.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.025 0.93 . . . . 0.0 112.368 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -85.64 -46.06 11.12 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.44 1.096 . . . . 0.0 112.584 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.5 -30.91 57.61 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -169.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.54 -26.17 66.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.978 1.389 . . . . 0.0 113.033 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.22 -40.61 96.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.712 0.687 . . . . 0.0 111.682 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.64 -45.11 54.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.833 0.853 . . . . 0.0 111.468 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -65.43 -37.6 87.39 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.1 p -107.56 -20.85 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.0 m 69.41 -29.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.64 2.376 . . . . 0.0 114.702 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -75.27 128.48 84.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.579 1.552 . . . . 0.0 112.386 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.52 150.59 19.38 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.523 2.815 . . . . 0.0 111.422 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p 77.99 156.93 0.17 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.971 2.908 . . . . 0.0 113.419 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.54 157.8 64.69 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.165 1.786 . . . . 0.0 111.363 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.05 158.22 89.13 Favored 'Cis proline' 0 C--N 1.354 0.862 0 CA-C-N 119.999 1.035 . . . . 0.0 112.541 3.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.26 141.85 37.8 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.317 1.047 . . . . 0.0 110.36 -172.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.5 tp -95.08 144.91 25.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.955 1.302 . . . . 0.0 110.941 171.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -146.73 139.24 25.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 109.599 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mp -137.85 120.45 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.366 -0.834 . . . . 0.0 111.094 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 61.85 -24.92 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.968 3.307 . . . . 0.0 117.415 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.28 -1.89 0.04 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.09 1.805 . . . . 0.0 115.345 -172.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.9 147.64 49.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.221 1.511 . . . . 0.0 111.708 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.31 158.76 30.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.423 1.106 . . . . 0.0 111.801 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -133.07 155.16 49.74 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.826 1.651 . . . . 0.0 108.968 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.79 -180.0 9.71 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.834 1.206 . . . . 0.0 114.568 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.2 -176.84 11.37 Favored Glycine 0 N--CA 1.474 1.223 0 C-N-CA 124.667 1.127 . . . . 0.0 113.996 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.25 -42.71 95.87 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.535 -0.979 . . . . 0.0 112.808 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.9 -47.16 86.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.432 0.56 . . . . 0.0 111.191 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.6 mt -60.67 -42.99 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.906 0.882 . . . . 0.0 110.304 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 m -62.81 -46.83 86.15 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.088 1.355 . . . . 0.0 111.327 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.51 -42.79 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.628 1.171 . . . . 0.0 111.656 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -63.95 -43.31 96.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.71 0.686 . . . . 0.0 111.564 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.74 95.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.888 . . . . 0.0 112.001 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.71 -37.77 88.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 112.782 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -69.37 -30.85 68.94 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.382 1.073 . . . . 0.0 112.254 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -87.99 -11.14 48.25 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.534 1.134 . . . . 0.0 113.949 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.36 84.07 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.176 1.37 . . . . 0.0 114.137 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.05 -34.43 50.46 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.031 1.332 . . . . 0.0 112.104 -172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -64.45 -46.24 83.96 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.776 -0.578 . . . . 0.0 109.721 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -57.34 -48.39 79.1 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.547 1.139 . . . . 0.0 110.258 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.35 -52.96 62.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.839 0.856 . . . . 0.0 111.775 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -74.38 -33.61 63.1 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.578 -0.701 . . . . 0.0 112.869 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.56 -44.37 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.36 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -59.7 -43.27 94.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.199 1.363 . . . . 0.0 111.376 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -57.76 -47.82 81.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.374 0.67 . . . . 0.0 111.249 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.38 -31.28 71.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.132 0.973 . . . . 0.0 113.268 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.1 mmt -72.14 -36.5 69.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.301 -0.874 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.6 m -69.6 -40.42 76.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.681 0.792 . . . . 0.0 112.63 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.254 1.305 0 C-N-CA 129.643 3.177 . . . . 0.0 112.597 179.018 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 119.742 -0.171 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.6 173.42 16.89 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.016 1.326 . . . . 0.0 113.195 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.55 154.93 43.38 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.086 1.754 . . . . 0.0 111.063 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 p -93.89 161.43 30.02 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.855 1.262 . . . . 0.0 110.661 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.46 -30.13 62.16 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.136 1.891 . . . . 0.0 111.455 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.96 87.93 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.103 0.865 . . . . 0.0 112.485 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.78 -51.28 67.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 109.755 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -58.92 -42.74 90.38 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.646 0.778 . . . . 0.0 112.566 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.5 m -64.68 -39.01 92.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.777 1.631 . . . . 0.0 112.081 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -62.54 -49.42 75.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.239 0.927 . . . . 0.0 110.39 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.6 mt -56.98 -53.26 60.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.652 0.781 . . . . 0.0 110.943 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.27 -44.96 76.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.755 0.822 . . . . 0.0 112.314 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -59.91 -49.2 78.61 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.799 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.8 -34.92 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.293 1.406 . . . . 0.0 112.802 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.35 -36.28 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.936 1.295 . . . . 0.0 112.489 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.9 p -84.56 -39.03 19.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.71 0.804 . . . . 0.0 112.477 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.0 m -74.44 -25.13 59.24 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -130.05 130.92 45.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.771 1.228 . . . . 0.0 109.605 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -68.85 -44.38 73.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -114.23 132.02 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.563 1.145 . . . . 0.0 109.243 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.87 121.04 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.207 0.603 . . . . 0.0 110.88 -172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.52 149.6 21.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.741 0.817 . . . . 0.0 110.528 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.5 114.09 18.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.367 1.467 . . . . 0.0 109.136 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -163.09 -178.57 6.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.257 1.823 . . . . 0.0 110.653 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.13 -39.9 65.35 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.774 -1.204 . . . . 0.0 111.709 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.84 161.9 46.34 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.926 1.727 . . . . 0.0 114.419 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -87.65 172.02 10.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.157 1.783 . . . . 0.0 111.774 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -71.96 -23.74 61.49 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.42 -13.42 32.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.518 1.527 . . . . 0.0 113.642 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -131.57 65.68 76.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.71 1.604 . . . . 0.0 110.276 169.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -71.7 143.12 41.17 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.486 2.79 . . . . 0.0 110.843 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.0 127.62 33.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.689 0.796 . . . . 0.0 112.12 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.8 p -54.89 145.25 20.46 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.443 . . . . 0.0 113.174 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.16 -143.35 16.56 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -51.71 -45.11 63.44 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.3 m -63.82 -47.07 82.27 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.32 1.418 . . . . 0.0 112.346 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -60.12 -40.72 90.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.785 0.834 . . . . 0.0 111.741 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -60.97 -48.06 83.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.452 0.701 . . . . 0.0 110.919 170.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.43 -42.85 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.629 1.172 . . . . 0.0 112.898 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -66.45 -34.85 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.205 1.366 . . . . 0.0 111.999 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -66.22 -41.54 89.97 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.777 0.717 . . . . 0.0 111.924 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.9 mt -57.36 -51.53 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.85 1.26 . . . . 0.0 111.388 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.0 -47.57 77.05 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.272 1.029 . . . . 0.0 111.032 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -51.88 -55.74 18.3 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.252 0.621 . . . . 0.0 110.76 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -68.33 -33.12 73.73 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.983 1.713 . . . . 0.0 113.837 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.2 -29.99 69.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.374 1.07 . . . . 0.0 110.997 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 115.27 70.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 130.234 3.414 . . . . 0.0 111.038 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.97 139.48 12.7 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.97 119.46 5.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.089 2.526 . . . . 0.0 109.38 170.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -106.14 152.4 23.49 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.112 0.965 . . . . 0.0 112.011 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.15 171.72 7.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.272 1.429 . . . . 0.0 110.139 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 m -147.99 104.73 3.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.176 -1.577 . . . . 0.0 109.88 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.92 127.74 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.597 1.159 . . . . 0.0 109.022 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -73.42 93.8 2.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 110.865 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.99 -178.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.39 0.676 . . . . 0.0 110.507 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.05 -37.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.907 2.083 . . . . 0.0 113.104 172.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.1 -20.18 64.91 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.731 1.612 . . . . 0.0 113.38 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -125.06 134.9 52.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.068 1.347 . . . . 0.0 111.364 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.44 -28.66 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.38 1.072 . . . . 0.0 113.752 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.66 -44.05 71.33 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.308 -0.87 . . . . 0.0 111.739 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.19 -23.27 65.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.75 -26.08 68.48 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.86 0.755 . . . . 0.0 112.726 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -109.98 -53.02 2.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.74 1.216 . . . . 0.0 112.252 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.04 -34.09 53.26 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.355 -169.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -47.9 77.9 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.657 1.729 . . . . 0.0 111.939 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.08 -26.1 67.33 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -80.44 -34.78 35.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.054 0.942 . . . . 0.0 112.201 174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -65.05 -37.96 89.27 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.916 1.286 . . . . 0.0 112.273 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -78.81 -68.31 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.99 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m 124.06 -17.2 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 1 C-N-CA 133.163 4.585 . . . . 0.0 110.966 -169.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -67.59 121.69 80.2 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.445 1.498 . . . . 0.0 111.545 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.27 145.45 19.03 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.993 2.462 . . . . 0.0 110.411 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 80.3 165.49 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.025 2.13 . . . . 0.0 112.561 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.62 150.12 51.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.531 1.533 . . . . 0.0 110.53 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.78 -177.49 21.18 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 CA-C-N 120.125 1.08 . . . . 0.0 113.157 4.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -149.1 140.78 23.52 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.749 1.22 . . . . 0.0 111.182 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 tp -103.32 141.22 36.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.627 1.571 . . . . 0.0 110.075 169.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -140.46 142.98 35.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.053 1.741 . . . . 0.0 110.157 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.2 mt -140.18 116.4 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.65 0.78 . . . . 0.0 110.852 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.63 -24.8 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 130.114 3.366 . . . . 0.0 118.069 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -16.2 0.05 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.631 1.586 . . . . 0.0 114.69 -170.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.11 153.29 48.65 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.921 1.36 . . . . 0.0 112.87 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -81.09 149.23 29.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.906 -0.496 . . . . 0.0 111.515 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -100.07 -35.41 9.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.984 0.914 . . . . 0.0 112.311 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.26 -146.64 17.82 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 125.437 1.494 . . . . 0.0 111.937 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.02 165.72 47.66 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.293 0.949 . . . . 0.0 114.206 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.2 m -68.47 -41.56 80.01 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.736 -0.861 . . . . 0.0 112.244 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.13 -42.42 94.77 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.23 -0.919 . . . . 0.0 111.637 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.17 -40.34 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.247 0.619 . . . . 0.0 110.326 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.5 m -63.97 -43.21 96.44 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.085 0.954 . . . . 0.0 111.739 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.0 t -59.33 -46.13 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 118.914 0.779 . . . . 0.0 110.963 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -66.37 -37.17 84.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.743 0.701 . . . . 0.0 112.527 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.24 95.52 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.1 0.96 . . . . 0.0 111.971 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -67.54 -38.86 84.83 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.512 0.725 . . . . 0.0 112.771 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.1 -32.88 74.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.977 0.911 . . . . 0.0 112.642 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 p -92.9 -10.03 38.04 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.52 -3.19 68.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.045 1.307 . . . . 0.0 114.485 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -72.37 -33.25 67.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.41 1.484 . . . . 0.0 112.493 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.56 -47.2 70.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.716 0.689 . . . . 0.0 110.249 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -56.52 -48.79 76.49 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.684 1.194 . . . . 0.0 110.469 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.48 -48.41 81.88 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.648 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.75 -33.13 72.02 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.07 -39.93 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.3 0.954 . . . . 0.0 111.151 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.34 -44.73 96.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.12 0.873 . . . . 0.0 111.077 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.36 -36.36 79.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.409 -0.807 . . . . 0.0 112.701 174.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.88 74.52 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.038 1.29 . . . . 0.0 112.627 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.9 mtt -74.41 -41.99 59.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.836 0.854 . . . . 0.0 112.357 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 p -92.6 1.75 57.08 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 126.963 2.105 . . . . 0.0 114.272 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.62 -155.66 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.49 1.516 . . . . 0.0 111.346 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.86 36.87 0.14 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.33 1.852 . . . . 0.0 112.793 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -91.31 -27.46 0.3 Allowed Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 115.675 -2.107 . . . . 0.0 116.484 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -84.84 -168.8 0.56 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 CA-C-N 123.314 2.219 . . . . 0.0 112.036 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.27 -7.83 3.21 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.66 1.584 . . . . 0.0 115.065 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.65 -55.71 15.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.673 1.589 . . . . 0.0 109.798 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -61.37 -42.12 98.19 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.553 -0.717 . . . . 0.0 112.231 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -60.23 -39.45 86.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.335 1.854 . . . . 0.0 111.98 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 m -64.84 -49.16 71.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 110.141 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.09 -50.35 71.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.077 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -56.18 -48.65 75.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.527 1.131 . . . . 0.0 112.459 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.4 -42.72 99.18 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.558 -0.714 . . . . 0.0 111.821 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.3 t -63.9 -49.88 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.772 0.829 . . . . 0.0 111.787 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.14 -33.99 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.545 1.066 . . . . 0.0 112.772 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.2 p -74.93 -35.42 62.18 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.919 0.782 . . . . 0.0 112.781 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 m -79.37 -41.73 27.16 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.97 0.805 . . . . 0.0 112.976 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.03 -3.71 37.57 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? 58.55 -74.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.536 2.334 . . . . 0.0 112.277 -173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.3 129.94 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.005 0.922 . . . . 0.0 109.642 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -137.79 131.27 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.423 0.689 . . . . 0.0 110.324 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.4 140.53 32.53 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.549 1.14 . . . . 0.0 111.314 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.18 108.41 16.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.714 1.606 . . . . 0.0 107.887 172.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.2 mtm -144.59 -176.72 5.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.273 1.429 . . . . 0.0 110.595 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -79.1 21.48 0.44 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.325 -1.485 . . . . 0.0 113.999 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.97 177.4 44.72 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.795 1.188 . . . . 0.0 114.733 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.4 p -97.46 -178.61 4.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.734 2.014 . . . . 0.0 111.244 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -75.06 -20.62 59.45 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.345 -0.847 . . . . 0.0 112.901 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.38 -31.82 37.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 111.853 172.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -134.17 74.61 67.32 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.892 1.277 . . . . 0.0 110.753 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 172.05 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.984 3.123 . . . . 0.0 111.281 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -99.3 152.43 19.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.053 0.941 . . . . 0.0 110.983 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.51 167.25 21.02 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.782 1.233 . . . . 0.0 113.507 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.73 -125.52 7.1 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.412 1.006 . . . . 0.0 112.362 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -60.31 -42.35 95.37 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.757 0.823 . . . . 0.0 112.591 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -59.2 -52.15 66.92 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.025 -1.047 . . . . 0.0 112.327 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -56.94 -44.56 82.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.783 1.233 . . . . 0.0 110.481 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.2 m -60.14 -47.69 84.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.461 1.104 . . . . 0.0 110.855 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.7 -42.57 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.249 1.02 . . . . 0.0 112.39 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.25 -34.66 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.476 1.489 . . . . 0.0 112.11 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.018 0.827 . . . . 0.0 111.69 170.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 mt -59.84 -47.28 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.204 1.402 . . . . 0.0 111.258 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.92 -49.51 72.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.373 0.988 . . . . 0.0 111.409 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -49.42 -59.41 3.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.268 0.627 . . . . 0.0 109.845 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -67.97 -28.82 67.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.196 1.798 . . . . 0.0 114.91 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.78 -30.61 69.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.82 1.248 . . . . 0.0 110.187 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.1 t30 111.15 55.99 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 130.721 3.608 . . . . 0.0 108.492 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.57 150.91 38.25 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.53 169.68 18.2 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.189 3.259 . . . . 0.0 110.696 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.8 164.8 26.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.254 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -131.24 167.06 19.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.37 1.468 . . . . 0.0 108.901 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -151.1 126.09 9.8 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 119.776 -1.827 . . . . 0.0 111.669 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.62 133.17 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.838 1.255 . . . . 0.0 109.591 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -74.17 125.59 28.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.94 0.496 . . . . 0.0 111.699 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 pt -72.93 -30.05 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.836 1.254 . . . . 0.0 113.038 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.66 167.6 13.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.194 0.998 . . . . 0.0 111.935 -171.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 79.61 -107.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.919 2.488 . . . . 0.0 109.852 -170.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -55.71 124.22 16.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.722 1.209 . . . . 0.0 113.881 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.06 -39.64 90.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.867 1.267 . . . . 0.0 113.653 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.83 -33.1 74.12 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.537 -0.727 . . . . 0.0 111.558 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.0 tp -72.45 -43.49 63.71 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.641 0.776 . . . . 0.0 111.157 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -56.09 -45.64 79.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.144 1.377 . . . . 0.0 112.345 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.18 -40.58 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.386 1.074 . . . . 0.0 111.575 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.92 -36.79 87.15 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 118.675 -1.07 . . . . 0.0 113.872 -172.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.91 -44.58 95.71 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.416 1.608 . . . . 0.0 111.566 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.8 -48.23 75.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.47 -32.99 73.38 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.435 0.694 . . . . 0.0 112.823 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -69.26 -37.97 78.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 0.0 112.572 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 m -87.55 -24.37 24.05 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m 74.53 -41.53 0.48 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.321 2.648 . . . . 0.0 113.756 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -68.45 129.11 92.91 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.921 1.288 . . . . 0.0 110.73 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -82.53 158.81 16.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.784 2.989 . . . . 0.0 112.07 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p 75.13 162.62 0.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 128.558 2.743 . . . . 0.0 113.665 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -143.28 159.72 54.43 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.461 1.904 . . . . 0.0 110.68 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.28 149.81 53.97 Favored 'Cis proline' 0 C--N 1.354 0.832 0 CA-C-N 120.313 1.147 . . . . 0.0 114.007 -2.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.14 148.88 32.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 0.0 110.344 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -114.09 140.31 48.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.362 1.465 . . . . 0.0 110.609 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -132.71 145.52 51.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.99 2.116 . . . . 0.0 109.997 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mt -137.23 119.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.383 -0.823 . . . . 0.0 112.465 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 t70 63.67 -43.09 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 129.95 3.3 . . . . 0.0 117.179 168.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.96 9.34 0.03 OUTLIER Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.562 2.506 . . . . 0.0 114.151 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.01 145.15 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.47 1.508 . . . . 0.0 110.441 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.53 152.35 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.527 -0.733 . . . . 0.0 109.97 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -110.47 -36.65 5.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.119 0.968 . . . . 0.0 112.615 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.37 -159.15 23.28 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.109 1.338 . . . . 0.0 113.293 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.05 169.28 54.68 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.147 0.879 . . . . 0.0 114.028 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 11.0 p -68.7 -49.55 58.06 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.444 -1.033 . . . . 0.0 112.922 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.47 -39.11 86.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.891 -1.131 . . . . 0.0 111.657 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.3 -41.87 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.591 0.756 . . . . 0.0 110.381 170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.8 m -62.76 -40.92 98.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 0.0 111.668 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.14 -46.91 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.132 0.878 . . . . 0.0 111.484 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.69 -31.7 63.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.267 0.94 . . . . 0.0 113.504 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.23 83.11 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.072 -1.018 . . . . 0.0 112.594 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.68 -44.8 92.65 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.646 1.178 . . . . 0.0 112.035 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.68 -27.99 68.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.6 m -86.84 -14.69 41.37 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.896 1.278 . . . . 0.0 113.666 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.81 75.71 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 125.354 1.455 . . . . 0.0 114.19 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.39 -34.64 63.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.552 1.141 . . . . 0.0 111.312 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.46 -45.56 86.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.524 -0.735 . . . . 0.0 110.719 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.03 -47.39 77.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.71 0.804 . . . . 0.0 111.002 175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.42 -50.33 73.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.867 0.867 . . . . 0.0 112.074 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -76.44 -32.97 58.75 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.17 -40.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 118.964 0.802 . . . . 0.0 110.618 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.39 -43.99 95.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.347 0.976 . . . . 0.0 111.591 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -55.87 -45.12 78.62 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.911 0.778 . . . . 0.0 111.051 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.68 94.89 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 113.071 177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 57.8 mtt -64.79 -35.27 80.56 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.731 0.813 . . . . 0.0 112.343 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.3 -36.01 76.59 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.762 0.825 . . . . 0.0 112.768 170.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.892 2.477 . . . . 0.0 112.241 -179.435 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.81 65.05 3.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.684 1.194 . . . . 0.0 110.999 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.8 tp -83.33 49.14 1.5 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.549 1.54 . . . . 0.0 112.804 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.5 p -77.34 -22.12 0.39 Allowed Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 115.605 -2.14 . . . . 0.0 115.658 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -60.11 168.61 5.84 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.126 2.551 . . . . 0.0 114.372 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.29 -6.67 7.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.98 -56.93 8.72 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.592 1.557 . . . . 0.0 110.622 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -59.67 -43.21 94.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.4 0.68 . . . . 0.0 111.784 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -61.11 -41.05 95.98 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.046 2.138 . . . . 0.0 112.163 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -67.78 -46.48 71.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.607 1.163 . . . . 0.0 110.938 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.5 mt -56.92 -53.82 53.59 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.404 0.681 . . . . 0.0 110.804 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.17 -43.85 78.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.259 0.623 . . . . 0.0 112.004 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.1 -51.08 71.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.771 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.92 -37.36 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.403 1.456 . . . . 0.0 112.214 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -63.64 -37.35 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.069 0.947 . . . . 0.0 112.648 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.8 p -86.37 -36.97 18.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.726 0.81 . . . . 0.0 113.169 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -75.92 -37.91 58.24 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.526 0.731 . . . . 0.0 112.804 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -110.11 114.66 28.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.01 0.924 . . . . 0.0 110.61 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -77.11 67.66 3.12 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.549 -1.344 . . . . 0.0 111.464 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.2 t 132.31 122.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 1 C-N-CA 133.913 4.885 . . . . 0.0 107.652 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.76 132.93 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.337 1.055 . . . . 0.0 109.337 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.59 137.9 38.37 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.49 1.516 . . . . 0.0 109.261 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -112.76 115.22 28.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.172 1.389 . . . . 0.0 107.732 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.3 ptp -153.67 164.3 38.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.894 1.278 . . . . 0.0 112.933 -169.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -80.1 45.02 0.7 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.663 1.585 . . . . 0.0 111.261 174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.99 -161.93 27.02 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.151 1.358 . . . . 0.0 114.41 -169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.5 p -135.56 178.94 6.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.33 1.852 . . . . 0.0 111.18 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -66.36 -25.94 67.04 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.09 -26.44 19.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.853 1.261 . . . . 0.0 112.436 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -124.91 71.37 61.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.995 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.48 164.78 33.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.231 2.62 . . . . 0.0 110.902 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -81.48 129.62 34.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.925 0.49 . . . . 0.0 109.802 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.4 m -63.94 147.1 52.8 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.949 0.9 . . . . 0.0 112.673 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 -116.06 4.71 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.057 0.837 . . . . 0.0 111.558 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -60.68 -54.98 38.75 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.874 0.87 . . . . 0.0 113.035 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -66.77 -39.44 87.86 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.642 -1.286 . . . . 0.0 112.22 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -55.57 -46.97 77.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.197 1.399 . . . . 0.0 111.151 170.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 m -61.24 -45.99 92.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.77 0.828 . . . . 0.0 110.247 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.81 -44.87 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.573 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.15 -34.97 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 120.78 1.627 . . . . 0.0 111.929 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -65.72 -35.43 80.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.791 0.723 . . . . 0.0 111.885 169.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 mt -60.35 -51.21 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.897 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 121.137 1.789 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -49.46 -55.86 11.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.047 0.539 . . . . 0.0 109.815 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -66.51 -29.19 69.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.323 2.249 . . . . 0.0 115.059 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tt -59.54 -30.75 68.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.944 1.698 . . . . 0.0 109.481 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 108.08 52.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 131.443 3.897 . . . . 0.0 107.347 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.2 152.98 32.15 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.53 179.19 5.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.31 3.34 . . . . 0.0 110.853 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.61 171.86 13.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.436 1.894 . . . . 0.0 110.38 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.91 147.95 50.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.847 0.859 . . . . 0.0 109.597 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 m -122.61 111.83 17.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.909 0.884 . . . . 0.0 110.576 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -86.09 124.43 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.354 1.062 . . . . 0.0 109.452 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -72.95 105.76 4.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.525 0.73 . . . . 0.0 110.45 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.9 pt -89.2 -173.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.35 1.06 . . . . 0.0 112.039 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.4 mt 68.75 -14.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.462 2.305 . . . . 0.0 115.085 169.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -65.16 -19.73 66.12 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.052 1.741 . . . . 0.0 114.475 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -158.22 169.05 25.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.639 1.576 . . . . 0.0 112.01 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -64.88 -31.87 73.3 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.14 -36.25 83.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.104 0.866 . . . . 0.0 111.337 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.43 -23.11 56.91 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.396 1.078 . . . . 0.0 113.088 172.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -82.78 -51.51 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.609 1.095 . . . . 0.0 112.685 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -95.48 -43.87 7.78 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.826 1.25 . . . . 0.0 112.039 -169.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.51 61.06 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.684 0.659 . . . . 0.0 112.019 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 tp -59.64 -41.99 91.73 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.419 0.688 . . . . 0.0 111.882 172.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -63.74 -40.16 96.06 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.919 -0.488 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -72.04 -33.73 68.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.551 0.614 . . . . 0.0 112.416 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -65.3 -47.41 76.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.146 0.978 . . . . 0.0 112.95 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.2 p -92.01 -25.93 18.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 74.64 -8.02 1.59 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.917 2.087 . . . . 0.0 113.464 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -65.56 133.77 95.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.027 1.331 . . . . 0.0 111.436 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.87 -41.91 0.62 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.066 2.51 . . . . 0.0 115.199 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -143.9 107.44 4.61 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.175 0.898 . . . . 0.0 111.815 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.25 162.78 16.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.007 1.323 . . . . 0.0 112.465 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -64.53 169.1 37.5 Favored 'Cis proline' 0 C--N 1.355 0.911 0 CA-C-N 120.772 1.311 . . . . 0.0 115.275 0.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.12 166.66 31.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.72 150.23 27.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.48 1.912 . . . . 0.0 108.834 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.35 143.65 32.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.107 2.163 . . . . 0.0 109.81 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.42 172.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.687 1.595 . . . . 0.0 111.532 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.69 103.17 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.392 1.077 . . . . 0.0 112.676 -171.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.64 89.13 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 117.601 -1.666 . . . . 0.0 116.072 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.22 134.97 10.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.652 2.226 . . . . 0.0 113.054 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.09 148.4 36.1 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.918 -1.114 . . . . 0.0 110.651 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -99.41 -45.76 5.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.69 -161.83 13.55 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.928 1.251 . . . . 0.0 112.911 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -68.26 165.1 46.84 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 124.18 0.895 . . . . 0.0 115.126 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.9 m -66.81 -38.9 87.38 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.982 -0.716 . . . . 0.0 112.273 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.9 -45.89 91.08 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.608 -0.683 . . . . 0.0 111.434 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.9 mt -59.24 -40.38 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.195 0.598 . . . . 0.0 110.346 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 80.1 m -62.92 -44.13 96.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.693 1.197 . . . . 0.0 111.641 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.71 -46.36 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.905 0.775 . . . . 0.0 111.141 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -67.84 -36.96 81.27 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.62 0.645 . . . . 0.0 112.26 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.89 91.57 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.277 1.031 . . . . 0.0 112.202 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.01 -38.88 92.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.63 0.772 . . . . 0.0 112.519 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.46 -31.37 72.41 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.976 0.911 . . . . 0.0 111.791 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.9 m -88.26 -12.33 43.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.81 -2.57 76.65 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.081 1.324 . . . . 0.0 114.239 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.84 -36.19 42.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.981 1.312 . . . . 0.0 111.693 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -64.68 -42.21 95.51 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.701 -0.625 . . . . 0.0 110.453 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -56.26 -49.17 74.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.307 1.043 . . . . 0.0 110.169 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.38 -46.72 87.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.335 0.654 . . . . 0.0 112.067 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -71.42 -36.67 71.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.01 -37.77 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.581 1.082 . . . . 0.0 110.861 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.08 -44.89 94.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.22 0.918 . . . . 0.0 110.434 169.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.78 -39.75 85.96 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.372 -0.83 . . . . 0.0 112.21 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.87 -44.73 96.22 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.828 1.195 . . . . 0.0 112.045 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmt -63.25 -38.07 89.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.259 1.023 . . . . 0.0 112.357 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.7 m -67.36 -36.88 82.27 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.005 0.922 . . . . 0.0 112.709 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.8 m . . . . . 0 C--O 1.255 1.379 0 C-N-CA 128.048 2.539 . . . . 0.0 112.036 -177.716 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.002 -0.047 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.22 62.54 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.3 93.46 0.64 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.236 1.414 . . . . 0.0 110.36 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.331 24.5 p 132.99 -50.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.648 1 C-N-CA 134.322 5.049 . . . . 0.0 112.765 172.128 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.87 -34.6 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 CA-C-N 122.305 1.859 . . . . 0.0 113.822 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.27 -46.63 2.04 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -67.68 -51.33 50.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.091 0.86 . . . . 0.0 111.792 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -64.61 -33.59 76.28 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.465 -0.772 . . . . 0.0 111.624 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -61.69 -43.19 99.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.433 2.293 . . . . 0.0 111.929 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -68.82 -43.41 75.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.868 1.267 . . . . 0.0 111.151 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.64 -41.12 89.8 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.868 0.867 . . . . 0.0 111.54 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.07 -42.96 99.74 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.525 1.057 . . . . 0.0 112.582 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.11 -40.9 98.99 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.275 -0.89 . . . . 0.0 111.816 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.04 -52.19 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.296 1.039 . . . . 0.0 110.853 172.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.09 -49.92 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.345 1.458 . . . . 0.0 112.101 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -74.85 -30.77 61.45 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.3 p -90.69 -36.56 14.27 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -38.81 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.223 -0.923 . . . . 0.0 112.21 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 60.77 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.088 2.955 . . . . 0.0 117.661 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.06 110.51 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.422 1.889 . . . . 0.0 107.66 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.26 158.29 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -134.85 117.17 15.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.177 1.391 . . . . 0.0 109.31 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -87.69 124.86 34.0 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.089 1.356 . . . . 0.0 109.924 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -163.45 172.97 13.74 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -69.81 -19.78 63.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.521 1.528 . . . . 0.0 114.083 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.1 -159.65 31.47 Favored Glycine 0 N--CA 1.477 1.417 0 C-N-CA 125.158 1.361 . . . . 0.0 113.547 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -136.47 -174.33 3.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.398 1.879 . . . . 0.0 110.348 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -80.38 -29.13 37.82 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.221 -0.924 . . . . 0.0 112.334 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.38 -34.36 65.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.638 1.175 . . . . 0.0 111.958 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -133.75 91.71 24.69 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.913 1.285 . . . . 0.0 110.413 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.64 157.52 48.34 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.739 2.293 . . . . 0.0 110.537 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -77.75 125.23 29.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.038 0.447 . . . . 0.0 110.275 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -59.49 143.54 49.72 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.297 1.439 . . . . 0.0 113.13 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.82 -100.4 2.08 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 124.085 0.85 . . . . 0.0 111.097 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -58.87 -64.3 0.99 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.454 1.501 . . . . 0.0 113.347 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -67.12 -37.41 83.83 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.706 -1.246 . . . . 0.0 111.447 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -54.42 -46.75 73.25 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.9 m -61.61 -48.0 82.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.263 1.025 . . . . 0.0 110.839 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.76 -49.03 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.918 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.93 -32.92 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.417 1.008 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -63.81 -41.55 97.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.911 0.885 . . . . 0.0 111.242 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 mt -59.6 -50.91 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 111.15 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.08 -52.22 65.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.424 0.69 . . . . 0.0 111.045 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -51.3 -55.59 17.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.983 0.513 . . . . 0.0 110.615 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -68.1 -31.02 70.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.094 1.758 . . . . 0.0 114.36 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.31 -33.9 71.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 54.7 t30 117.75 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 130.728 3.611 . . . . 0.0 109.645 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.13 137.79 23.72 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.83 89.81 1.27 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.723 2.948 . . . . 0.0 109.868 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -70.2 152.97 43.65 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.887 0.475 . . . . 0.0 110.836 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -129.23 121.33 27.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.399 0.619 . . . . 0.0 110.534 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 m -73.36 120.7 19.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.246 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.37 118.58 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.523 1.129 . . . . 0.0 108.092 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -75.07 120.03 20.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.033 0.933 . . . . 0.0 111.09 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -127.14 179.23 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.253 1.421 . . . . 0.0 112.082 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 77.71 -52.2 0.52 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 127.739 2.416 . . . . 0.0 112.406 169.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.25 -25.07 65.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.86 0.864 . . . . 0.0 112.983 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -104.13 113.94 27.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.717 2.407 . . . . 0.0 110.596 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.49 -28.63 69.33 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.36 -50.65 66.9 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 110.944 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.72 -39.91 91.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.39 0.676 . . . . 0.0 110.791 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -54.21 -44.53 71.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.44 1.096 . . . . 0.0 112.082 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.88 -41.92 20.29 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.093 0.957 . . . . 0.0 112.26 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.59 -42.68 46.82 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 113.776 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.81 -25.99 64.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.648 1.224 . . . . 0.0 113.341 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.07 -44.11 94.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.26 0.936 . . . . 0.0 111.376 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.41 -46.11 56.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.668 0.787 . . . . 0.0 111.19 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.94 -39.61 94.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.581 0.752 . . . . 0.0 112.832 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.2 p -88.89 -35.68 16.38 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p 64.27 -23.24 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 128.222 2.609 . . . . 0.0 114.367 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -67.11 130.39 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.781 1.632 . . . . 0.0 111.27 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.25 136.97 13.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.83 2.354 . . . . 0.0 111.599 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.1 p 77.24 165.36 0.24 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 128.679 2.791 . . . . 0.0 114.65 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.65 161.89 49.62 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 127.208 2.203 . . . . 0.0 110.723 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -58.2 157.01 34.79 Favored 'Cis proline' 0 C--N 1.356 0.965 0 CA-C-N 120.777 1.313 . . . . 0.0 114.655 -2.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -152.7 132.43 13.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.021 0.528 . . . . 0.0 110.863 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 tt -93.9 142.35 27.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.027 1.331 . . . . 0.0 110.85 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -133.08 143.05 49.08 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.716 1.206 . . . . 0.0 111.519 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.52 138.64 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.07 1.348 . . . . 0.0 110.318 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -15.21 89.09 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.921 2.888 . . . . 0.0 115.809 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.3 55.65 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.167 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.8 130.49 21.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.189 1.994 . . . . 0.0 114.233 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -81.24 121.81 26.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.153 1.381 . . . . 0.0 108.841 170.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -92.59 -32.82 14.66 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.7 -154.1 16.6 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.819 1.2 . . . . 0.0 113.712 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.87 47.1 Favored Glycine 0 N--CA 1.473 1.1 0 C-N-CA 124.718 1.151 . . . . 0.0 115.498 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.5 t -58.58 -51.25 70.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.993 1.317 . . . . 0.0 112.782 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -60.64 -43.57 97.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.948 0.499 . . . . 0.0 111.77 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.13 -45.42 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.469 0.708 . . . . 0.0 110.24 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -62.1 -46.58 88.45 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.668 1.187 . . . . 0.0 110.882 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.23 -44.14 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.87 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.17 -39.38 86.46 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.276 0.943 . . . . 0.0 111.916 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.18 -35.44 79.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.649 -0.657 . . . . 0.0 112.226 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.86 -43.76 91.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.985 0.914 . . . . 0.0 112.047 173.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.24 -30.76 69.89 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.016 0.926 . . . . 0.0 112.79 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -84.79 -13.37 51.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.121 0.969 . . . . 0.0 113.374 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.26 83.89 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.418 1.485 . . . . 0.0 114.144 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -73.47 -38.82 65.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 111.571 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.15 -42.95 88.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.659 -0.65 . . . . 0.0 110.066 171.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -58.55 -48.08 82.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.583 0.753 . . . . 0.0 110.44 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.33 -50.17 72.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.861 0.865 . . . . 0.0 111.517 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -72.36 -35.37 68.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.252 -0.905 . . . . 0.0 113.435 -173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.43 -39.46 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.35 0.977 . . . . 0.0 110.722 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.95 -46.23 88.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.107 0.867 . . . . 0.0 111.296 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.73 -37.07 77.93 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.315 -0.865 . . . . 0.0 112.466 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.21 65.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 77.3 mtm -76.28 -38.24 56.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.606 0.639 . . . . 0.0 111.675 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.5 -41.34 69.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.256 1.434 0 C-N-CA 127.668 2.387 . . . . 0.0 112.464 -172.9 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.2 173.57 11.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.321 1.049 . . . . 0.0 112.512 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -72.59 -12.08 60.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -54.86 -46.94 99.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-O 115.555 -2.164 . . . . 0.0 116.28 -169.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.59 -40.49 5.52 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 123.47 2.275 . . . . 0.0 112.381 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.572 0.749 . . . . 0.0 111.504 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -54.36 47.45 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.03 1.332 . . . . 0.0 110.43 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.23 -35.2 76.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.856 -0.593 . . . . 0.0 112.218 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 m -62.94 -46.02 89.7 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.148 1.379 . . . . 0.0 111.439 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -62.27 -50.81 70.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.634 0.774 . . . . 0.0 111.137 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.04 -42.95 99.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.988 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.93 -48.99 77.0 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.639 1.109 . . . . 0.0 111.654 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.44 -41.7 90.21 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.355 0.662 . . . . 0.0 111.788 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.54 -53.34 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.916 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -72.2 -21.83 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.274 1.397 . . . . 0.0 113.681 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.3 p -80.14 -31.62 39.02 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.417 170.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.2 m -77.5 -38.5 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.662 0.665 . . . . 0.0 112.761 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.05 102.37 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.283 1.833 . . . . 0.0 108.999 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -60.84 -38.72 86.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.107 -0.995 . . . . 0.0 113.384 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -99.13 136.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.868 1.267 . . . . 0.0 109.096 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.15 136.82 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.05 142.24 30.78 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.28 1.032 . . . . 0.0 111.289 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -119.63 116.07 25.26 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.075 1.35 . . . . 0.0 108.623 169.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 48.2 mtm -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.819 1.247 . . . . 0.0 110.538 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -76.02 20.93 0.18 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.637 1.175 . . . . 0.0 113.78 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.19 168.12 41.15 Favored Glycine 0 N--CA 1.474 1.215 0 C-N-CA 126.797 2.141 . . . . 0.0 112.768 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -96.49 -175.48 3.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.961 1.304 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -11.1 33.97 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 170.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.17 -28.23 59.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 112.262 170.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -146.2 79.06 10.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 125.797 1.639 . . . . 0.0 111.075 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.47 135.99 64.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.027 2.485 . . . . 0.0 110.359 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -83.29 98.8 9.62 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.504 0.722 . . . . 0.0 112.413 -169.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.2 t 89.51 160.67 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.455 2.702 . . . . 0.0 112.325 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.08 -31.04 75.23 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 124.893 1.235 . . . . 0.0 113.408 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -62.0 -53.38 56.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.119 0.96 . . . . 0.0 110.671 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -61.73 -42.93 99.61 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.135 -0.978 . . . . 0.0 111.747 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.34 -44.26 92.67 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.038 0.935 . . . . 0.0 110.968 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.2 m -63.36 -45.13 92.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.862 0.865 . . . . 0.0 110.638 173.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.41 -45.59 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.798 1.239 . . . . 0.0 112.514 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.02 -34.78 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 120.426 1.467 . . . . 0.0 111.8 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.91 -43.85 82.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 112.199 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.88 -51.49 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.559 1.544 . . . . 0.0 111.225 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.83 -49.09 69.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.309 1.043 . . . . 0.0 111.276 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -52.38 -49.89 63.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -68.24 -36.05 78.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.211 1.805 . . . . 0.0 114.176 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.87 170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 120.78 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 131.051 3.74 . . . . 0.0 109.198 169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.96 133.47 8.98 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -82.84 63.22 7.92 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.396 3.397 . . . . 0.0 108.422 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -70.01 168.68 14.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 113.891 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -134.38 172.54 12.75 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.377 1.084 . . . . 0.0 111.621 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -153.28 115.35 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.559 -1.338 . . . . 0.0 110.269 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.73 137.26 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.65 1.18 . . . . 0.0 110.324 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -81.05 123.24 28.21 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 112.106 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 pt -79.64 -27.95 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.839 1.256 . . . . 0.0 113.006 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.45 148.65 37.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.525 1.13 . . . . 0.0 109.731 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 66.0 6.56 4.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.468 1.907 . . . . 0.0 112.735 -169.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -135.3 57.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.673 1.989 . . . . 0.0 110.076 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -51.82 -37.27 51.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.239 1.416 . . . . 0.0 114.399 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.25 -42.63 91.59 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.343 1.057 . . . . 0.0 111.841 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.88 -41.98 64.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.356 1.062 . . . . 0.0 110.977 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -55.44 -47.12 76.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.909 1.284 . . . . 0.0 112.272 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -73.46 -49.03 28.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.184 0.594 . . . . 0.0 110.554 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.51 92.17 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.891 -0.949 . . . . 0.0 114.608 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.61 -57.76 11.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.372 1.086 . . . . 0.0 110.655 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -61.18 -37.97 84.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.588 0.755 . . . . 0.0 112.253 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.93 -36.84 80.37 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.858 1.263 . . . . 0.0 112.146 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -87.28 -38.7 16.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.795 1.638 . . . . 0.0 113.521 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.6 p -93.03 -28.25 16.5 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t 74.15 3.74 4.43 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 126.751 2.02 . . . . 0.0 113.318 -171.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -62.03 133.47 94.03 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.84 1.256 . . . . 0.0 112.041 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.45 -46.83 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.54 2.16 . . . . 0.0 114.662 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -147.46 124.92 11.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.318 0.963 . . . . 0.0 112.224 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.44 153.79 89.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.844 1.258 . . . . 0.0 112.0 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.22 158.7 94.91 Favored 'Cis proline' 0 C--N 1.354 0.855 0 CA-C-N 119.872 0.99 . . . . 0.0 113.662 7.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.59 128.6 27.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.488 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -94.19 129.21 40.88 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 109.177 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 141.83 47.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.409 1.884 . . . . 0.0 111.802 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.74 129.05 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 67.24 -19.34 0.12 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 128.218 2.607 . . . . 0.0 115.868 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.72 1.66 0.71 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.254 1.883 . . . . 0.0 115.153 -174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.34 158.88 43.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.141 1.47 . . . . 0.0 111.311 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -77.34 144.5 37.97 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.779 -0.576 . . . . 0.0 111.823 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -92.6 -40.06 10.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.71 1.204 . . . . 0.0 111.428 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.57 25.43 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.852 1.215 . . . . 0.0 113.49 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -91.47 169.73 33.23 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.04 1.305 . . . . 0.0 112.773 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 85.6 m -69.87 -44.55 69.59 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.591 -0.947 . . . . 0.0 113.099 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.01 -42.67 98.91 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.15 -0.969 . . . . 0.0 111.325 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.48 -40.2 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.9 0.88 . . . . 0.0 110.431 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.4 m -65.47 -42.71 91.97 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.621 1.169 . . . . 0.0 111.752 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.8 t -59.69 -43.8 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.022 0.828 . . . . 0.0 110.961 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -67.68 -37.04 81.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.845 0.748 . . . . 0.0 112.481 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.69 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.185 0.994 . . . . 0.0 112.19 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -63.78 -43.59 95.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.162 0.985 . . . . 0.0 112.113 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.18 -31.09 71.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 112.451 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.6 m -83.54 -14.2 52.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.442 1.097 . . . . 0.0 113.356 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.79 81.42 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.309 1.433 . . . . 0.0 114.31 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -71.25 -46.51 60.85 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.94 1.296 . . . . 0.0 111.031 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.58 -40.51 97.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.912 -0.493 . . . . 0.0 111.024 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -58.85 -47.92 83.17 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.355 0.662 . . . . 0.0 110.02 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.96 -49.42 74.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.309 0.644 . . . . 0.0 111.482 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -67.81 -39.08 84.0 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.78 -42.12 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.478 1.035 . . . . 0.0 110.536 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -45.52 91.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.872 0.76 . . . . 0.0 111.326 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -60.95 -40.59 93.92 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 112.292 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.82 82.98 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.809 0.843 . . . . 0.0 112.731 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 90.9 mmm -75.71 -45.91 34.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.145 0.978 . . . . 0.0 113.104 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.14 -45.67 7.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.774 1.23 . . . . 0.0 113.017 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.689 1.996 . . . . 0.0 113.178 -178.561 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.897 -0.038 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.75 172.24 13.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 111.363 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.01 -12.9 61.45 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -175.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.275 7.7 t -58.44 -37.68 57.33 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 116.243 -1.837 . . . . 0.0 115.753 -169.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -66.0 -44.27 7.79 Favored 'Trans proline' 0 C--N 1.355 0.916 0 CA-C-N 122.936 2.084 . . . . 0.0 112.191 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.26 -40.08 82.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.096 0.958 . . . . 0.0 111.843 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.78 -53.36 58.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.447 1.099 . . . . 0.0 111.056 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -59.36 -42.89 92.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.494 0.718 . . . . 0.0 111.619 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 97.2 m -60.21 -45.35 93.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.398 1.479 . . . . 0.0 111.609 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.2 m -63.59 -54.83 29.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.463 1.105 . . . . 0.0 110.904 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.42 -43.57 98.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.858 0.863 . . . . 0.0 111.768 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.96 -50.36 74.06 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.563 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.145 0.884 . . . . 0.0 111.564 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.6 t -55.97 -58.99 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.901 0.881 . . . . 0.0 110.944 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -74.01 -19.52 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.3 p -89.54 -32.18 17.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.477 1.111 . . . . 0.0 112.716 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.7 t -66.01 -35.85 81.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.112 0.869 . . . . 0.0 111.71 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -156.48 130.04 8.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.675 1.19 . . . . 0.0 112.12 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.8 160.67 17.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.97 0.908 . . . . 0.0 112.468 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 t 65.56 83.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.327 1.851 . . . . 0.0 109.728 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.72 130.96 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.784 0.834 . . . . 0.0 110.205 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -109.3 120.47 42.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.439 1.096 . . . . 0.0 110.018 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.02 120.5 35.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.307 1.043 . . . . 0.0 109.058 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -152.78 -176.14 5.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.641 1.576 . . . . 0.0 110.816 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -78.7 36.1 0.26 Allowed 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.387 -1.445 . . . . 0.0 113.326 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.59 -173.5 45.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.95 1.262 . . . . 0.0 113.763 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -131.91 -174.05 3.31 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.749 1.619 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -63.96 -11.69 30.9 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -68.39 -30.29 69.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.324 1.049 . . . . 0.0 112.318 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -154.43 88.23 3.41 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.37 1.468 . . . . 0.0 110.147 170.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.04 134.55 62.91 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.445 2.764 . . . . 0.0 111.235 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -85.24 130.81 34.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.045 0.45 . . . . 0.0 111.074 -173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.4 m -55.73 152.39 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.763 2.025 . . . . 0.0 115.184 -169.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.28 -117.69 4.52 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.53 1.062 . . . . 0.0 112.007 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -48.47 -60.88 2.33 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.526 2.33 . . . . 0.0 112.185 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -43.33 92.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.02 -1.05 . . . . 0.0 112.434 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -57.09 -46.92 82.18 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -60.48 -46.07 91.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.497 1.119 . . . . 0.0 111.013 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.07 -48.43 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.62 -35.04 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.925 1.239 . . . . 0.0 111.904 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.58 -43.38 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.071 1.348 . . . . 0.0 111.491 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.15 -51.4 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.561 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 mt -57.01 -53.54 56.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.264 0.938 . . . . 0.0 111.115 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.52 -62.26 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.019 1.328 . . . . 0.0 110.608 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.9 p -68.8 -27.95 66.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.766 1.627 . . . . 0.0 115.271 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -32.53 70.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.311 1.044 . . . . 0.0 110.326 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 116.21 60.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 130.462 3.505 . . . . 0.0 109.989 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.3 150.88 32.65 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.02 162.91 36.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.142 2.561 . . . . 0.0 110.675 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.55 159.65 41.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.938 1.295 . . . . 0.0 110.727 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -133.23 169.39 16.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.48 1.512 . . . . 0.0 108.547 169.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 p -152.13 155.45 37.88 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.66 -1.275 . . . . 0.0 114.021 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.63 133.17 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.056 1.343 . . . . 0.0 110.027 -170.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -80.46 106.41 12.45 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.902 0.881 . . . . 0.0 111.892 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.9 pt -62.38 -27.61 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.593 1.157 . . . . 0.0 113.411 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.37 -2.95 54.51 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.655 1.182 . . . . 0.0 113.532 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -88.63 -10.98 46.7 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -157.4 124.7 5.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.512 1.125 . . . . 0.0 111.946 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.16 -41.24 90.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.399 1.079 . . . . 0.0 113.157 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.53 -37.81 85.82 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.21 0.604 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.54 -52.01 65.14 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.691 0.796 . . . . 0.0 109.908 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.39 -47.27 82.13 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.136 0.974 . . . . 0.0 113.07 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -73.86 -41.46 62.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 0.0 111.398 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -40.48 33.38 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.663 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.68 -31.7 70.94 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.978 1.389 . . . . 0.0 112.064 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.54 -38.55 91.39 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.795 0.838 . . . . 0.0 112.069 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.04 -46.13 53.62 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.224 1.01 . . . . 0.0 111.152 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -59.1 -46.49 88.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 112.646 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -90.87 -20.21 22.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.0 m 62.92 6.12 2.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.89 1.676 . . . . 0.0 113.544 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -69.13 134.81 89.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.215 1.406 . . . . 0.0 111.911 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.1 -43.68 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 113.686 -169.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p -147.9 113.06 5.53 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.232 1.013 . . . . 0.0 110.945 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.43 158.49 20.55 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.695 1.198 . . . . 0.0 111.538 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.76 173.12 42.09 Favored 'Cis proline' 0 C--N 1.355 0.889 0 CA-C-N 120.839 1.335 . . . . 0.0 115.509 5.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -161.87 152.16 17.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.259 1.024 . . . . 0.0 112.495 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 78' ' ' TYR . 1.6 tt -85.97 148.15 25.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.554 1.942 . . . . 0.0 109.343 171.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.527 ' H ' HD23 ' A' ' 77' ' ' LEU . 34.1 t80 -149.85 139.47 21.64 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.774 2.029 . . . . 0.0 111.217 -171.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.3 pt -149.35 141.76 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.604 1.562 . . . . 0.0 112.174 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 65.78 -21.5 0.09 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 127.625 2.37 . . . . 0.0 115.926 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.89 5.17 2.23 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 127.134 2.302 . . . . 0.0 114.343 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.15 161.72 35.38 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.573 1.549 . . . . 0.0 111.19 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -75.21 150.92 38.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.211 -0.931 . . . . 0.0 111.688 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -101.91 -41.44 6.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.138 1.375 . . . . 0.0 111.009 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.53 -162.37 20.7 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 124.653 1.12 . . . . 0.0 114.468 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.9 -176.9 50.12 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.906 1.241 . . . . 0.0 115.615 -169.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.62 -41.13 98.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.306 1.042 . . . . 0.0 112.185 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -57.87 -49.55 76.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.215 1.006 . . . . 0.0 111.773 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.4 -43.33 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.063 0.945 . . . . 0.0 110.312 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.0 m -62.75 -44.87 95.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.87 1.268 . . . . 0.0 111.351 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.99 -45.78 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.56 1.144 . . . . 0.0 111.313 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -70.16 -38.18 75.37 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.893 0.77 . . . . 0.0 112.273 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.42 -30.34 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 113.022 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -65.65 -37.6 86.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.725 1.21 . . . . 0.0 112.174 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.2 -40.34 82.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.474 0.71 . . . . 0.0 112.77 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.6 p -85.56 -16.54 39.05 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.32 4.0 81.3 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.853 1.216 . . . . 0.0 113.217 -173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.69 -27.13 66.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.343 1.057 . . . . 0.0 111.89 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.87 -46.72 83.68 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.818 173.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -58.09 -48.66 79.5 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.401 0.546 . . . . 0.0 110.609 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -57.48 -48.48 79.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.565 0.746 . . . . 0.0 111.611 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -70.0 -38.86 76.09 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.61 -43.42 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 111.107 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.78 -44.66 95.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.163 0.892 . . . . 0.0 111.371 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.68 -40.26 87.25 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.745 -0.597 . . . . 0.0 111.823 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.74 83.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.887 0.875 . . . . 0.0 113.087 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.06 -38.65 86.18 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.379 -0.826 . . . . 0.0 111.964 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.7 m -73.77 -37.09 65.1 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.635 2.374 . . . . 0.0 112.357 -172.668 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.42 33.17 3.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.563 1.545 . . . . 0.0 113.294 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.78 -65.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.244 1.418 . . . . 0.0 113.208 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 p -74.5 -33.99 1.75 Allowed Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 115.792 -2.051 . . . . 0.0 114.46 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -74.97 -40.44 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 122.84 2.05 . . . . 0.0 114.614 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.38 -46.93 2.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.51 -58.0 5.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 110.366 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.37 -31.11 72.18 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.242 -0.912 . . . . 0.0 112.429 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -60.66 -39.39 88.2 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.878 2.071 . . . . 0.0 112.24 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -70.22 -43.57 70.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.61 1.164 . . . . 0.0 111.004 175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.9 mt -58.3 -52.6 64.91 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.58 0.752 . . . . 0.0 110.485 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.17 -40.93 74.67 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 112.015 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.57 -50.11 73.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.341 -0.849 . . . . 0.0 111.774 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.35 -34.11 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.168 1.349 . . . . 0.0 112.672 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.43 -45.69 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.965 0.906 . . . . 0.0 112.207 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -76.92 -41.33 43.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.64 0.654 . . . . 0.0 112.641 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 m -78.27 -32.44 49.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -127.21 -7.74 5.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -171.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 66.44 -56.88 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.434 2.294 . . . . 0.0 114.972 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.08 124.38 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 109.177 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 t -132.32 138.64 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.122 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -116.4 126.05 52.9 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.177 1.391 . . . . 0.0 109.125 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.81 100.59 12.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -145.29 151.01 37.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.389 1.075 . . . . 0.0 111.514 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.37 -19.67 59.43 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.34 178.57 34.32 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.999 1.761 . . . . 0.0 112.919 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 p -103.03 172.4 6.84 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.52 1.528 . . . . 0.0 111.128 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -64.12 -35.82 82.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.93 -15.93 52.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.016 1.326 . . . . 0.0 114.014 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -150.95 88.25 4.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.85 1.26 . . . . 0.0 111.022 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.52 168.97 20.59 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.314 2.676 . . . . 0.0 111.741 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -78.58 -3.23 42.77 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.6 m 72.99 -1.23 3.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.495 2.318 . . . . 0.0 115.236 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.47 -150.5 24.35 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 125.553 1.549 . . . . 0.0 112.754 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -60.37 -25.82 66.16 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.057 0.943 . . . . 0.0 113.174 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -59.01 -48.6 81.02 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.806 1.242 . . . . 0.0 111.554 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.63 -42.69 88.88 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.093 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 m -59.53 -46.69 88.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.366 0.985 . . . . 0.0 112.0 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 t -58.95 -46.06 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.955 0.902 . . . . 0.0 111.557 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.5 t -59.55 -45.23 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.143 0.577 . . . . 0.0 111.073 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -65.54 -38.7 90.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.722 1.209 . . . . 0.0 112.257 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.6 mt -58.91 -49.38 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.915 1.286 . . . . 0.0 110.523 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 mt -63.74 -50.12 70.34 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.998 0.919 . . . . 0.0 111.176 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -53.98 -57.68 10.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 110.916 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.7 p -68.66 -27.63 66.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.869 1.668 . . . . 0.0 114.849 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.92 -34.86 72.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.266 0.939 . . . . 0.0 109.828 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.9 t30 118.71 65.27 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.504 3.522 . . . . 0.0 110.095 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.99 148.44 20.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.22 170.12 21.04 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.56 2.84 . . . . 0.0 110.605 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -155.08 143.66 20.54 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -106.93 89.96 3.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.809 0.843 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.3 p -72.66 81.37 1.12 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.138 -0.976 . . . . 0.0 109.868 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.08 116.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 108.41 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.66 94.67 3.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.702 1.201 . . . . 0.0 111.821 -173.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -74.72 173.74 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.243 1.017 . . . . 0.0 111.313 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.95 -46.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.905 2.082 . . . . 0.0 112.425 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.36 -39.84 94.67 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.329 1.052 . . . . 0.0 112.284 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -95.5 124.23 39.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.64 1.176 . . . . 0.0 110.156 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.68 -26.79 67.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.134 0.974 . . . . 0.0 113.073 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.84 -38.98 93.1 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.851 0.75 . . . . 0.0 112.289 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.87 -32.98 71.63 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.607 0.763 . . . . 0.0 112.076 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -55.01 -43.78 73.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.208 1.003 . . . . 0.0 112.516 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -91.18 -45.37 8.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.393 1.077 . . . . 0.0 111.333 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.06 90.35 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.774 -1.014 . . . . 0.0 114.706 -169.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.91 -42.14 63.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 111.815 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.63 -40.84 96.29 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.869 -0.519 . . . . 0.0 111.445 175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.91 -52.33 50.92 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.987 0.915 . . . . 0.0 111.447 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.15 -38.67 82.4 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.14 -28.81 25.29 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m 75.99 -4.84 2.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.813 2.445 . . . . 0.0 112.684 -169.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CB ' HE22 ' A' ' 76' ' ' GLN . 24.2 m95 -76.79 137.3 66.46 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.975 -1.078 . . . . 0.0 111.437 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.71 -23.7 3.81 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.78 2.32 . . . . 0.0 111.532 169.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.6 m -96.19 131.17 42.94 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.564 1.546 . . . . 0.0 112.508 -169.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -138.8 151.74 69.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.859 2.063 . . . . 0.0 109.812 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.27 167.66 79.15 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 120.093 1.069 . . . . 0.0 113.317 5.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.422 HE22 ' CB ' ' A' ' 71' ' ' TRP . 8.4 pt20 -160.69 161.07 32.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 113.18 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.75 141.78 30.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.26 2.224 . . . . 0.0 109.801 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.55 131.94 25.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.878 2.071 . . . . 0.0 110.352 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.9 mt -138.74 118.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 120.878 -1.139 . . . . 0.0 111.476 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.69 32.32 11.78 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.333 1.453 . . . . 0.0 114.249 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.68 65.87 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.601 1.096 . . . . 0.0 115.023 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -103.5 120.73 41.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.841 1.32 . . . . 0.0 111.022 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -77.01 106.72 8.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.184 0.993 . . . . 0.0 109.669 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -82.66 -31.43 28.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.634 1.173 . . . . 0.0 111.971 -170.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.66 -155.18 16.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.687 1.137 . . . . 0.0 114.892 170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.87 177.19 54.25 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.647 1.118 . . . . 0.0 114.922 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 21.9 p -63.94 -44.94 91.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.193 0.997 . . . . 0.0 113.509 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.88 -44.38 97.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.467 0.707 . . . . 0.0 111.38 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.48 -45.31 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.631 0.773 . . . . 0.0 109.722 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 85.5 m -62.41 -47.56 83.59 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.495 1.118 . . . . 0.0 111.386 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.44 -42.88 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 111.35 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -72.47 -34.8 67.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.852 0.751 . . . . 0.0 112.416 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.94 85.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.17 -40.86 86.68 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.768 1.227 . . . . 0.0 112.355 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -64.02 -39.04 93.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.94 0.896 . . . . 0.0 111.964 170.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -77.15 -16.57 59.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.928 0.891 . . . . 0.0 113.361 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.54 80.89 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.095 1.331 . . . . 0.0 113.82 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -69.11 -47.26 65.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.022 1.329 . . . . 0.0 110.883 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.7 tp -62.27 -42.91 99.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.717 -0.614 . . . . 0.0 110.534 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -59.43 -46.5 88.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.627 0.771 . . . . 0.0 110.537 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -63.98 -49.28 73.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.166 0.586 . . . . 0.0 111.613 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -68.72 -37.27 79.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.462 1.028 . . . . 0.0 112.886 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.14 -45.09 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.203 0.91 . . . . 0.0 110.495 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -63.63 -46.34 86.16 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.775 0.716 . . . . 0.0 111.083 176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -60.76 -40.17 91.5 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.776 1.23 . . . . 0.0 112.074 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.58 89.47 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.815 0.846 . . . . 0.0 112.1 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -66.88 -33.17 75.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.288 0.635 . . . . 0.0 112.656 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 72.2 m -71.72 -43.05 66.56 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.453 2.301 . . . . 0.0 112.582 -173.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 173.68 15.27 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.068 1.347 . . . . 0.0 112.042 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.91 165.55 23.07 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.831 0.853 . . . . 0.0 113.155 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 t 179.55 -32.53 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 128.067 2.547 . . . . 0.0 114.615 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -68.93 -169.25 0.28 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 123.007 2.472 . . . . 0.0 113.069 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.43 -4.1 1.18 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 tt -55.81 -50.92 69.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.443 1.097 . . . . 0.0 110.331 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -60.39 -43.46 96.63 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 0.0 111.68 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -37.77 80.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.426 1.89 . . . . 0.0 112.321 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.4 m -67.6 -49.37 63.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.392 1.077 . . . . 0.0 110.507 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.91 -46.36 85.08 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 110.976 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.36 -45.67 90.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.177 0.991 . . . . 0.0 112.236 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.328 -0.857 . . . . 0.0 111.781 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.02 -47.5 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.021 0.828 . . . . 0.0 111.15 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.74 -36.55 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.996 1.318 . . . . 0.0 113.123 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 p -84.33 -35.55 23.19 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.173 0.897 . . . . 0.0 112.906 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.3 t -75.58 -42.33 52.35 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -101.82 -6.44 23.59 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 63.47 -59.54 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.792 2.437 . . . . 0.0 114.566 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.3 125.1 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.437 1.495 . . . . 0.0 109.928 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.19 130.56 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.923 0.489 . . . . 0.0 111.369 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 139.42 34.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.56 1.144 . . . . 0.0 110.344 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.09 123.21 43.89 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 109.497 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -159.49 179.5 8.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.929 1.692 . . . . 0.0 109.855 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -77.91 35.16 0.2 Allowed 'General case' 0 CA--C 1.556 1.191 0 O-C-N 120.068 -1.645 . . . . 0.0 114.037 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.96 161.52 34.83 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.894 1.711 . . . . 0.0 113.77 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.6 p -94.76 -176.01 3.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.887 1.675 . . . . 0.0 111.588 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -67.22 -28.99 68.53 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.361 0.664 . . . . 0.0 111.95 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.12 -29.02 48.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.868 1.267 . . . . 0.0 112.561 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.69 73.95 75.03 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.273 1.429 . . . . 0.0 111.739 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.22 154.83 37.95 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.353 2.702 . . . . 0.0 111.954 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.06 146.19 32.93 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.885 0.874 . . . . 0.0 111.355 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -68.01 161.65 26.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.04 1.336 . . . . 0.0 113.684 -173.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.84 -146.71 21.51 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.696 1.141 . . . . 0.0 112.035 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -57.62 -32.23 67.03 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 m -59.3 -47.43 85.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.609 1.095 . . . . 0.0 112.056 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.67 -46.31 87.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.291 1.037 . . . . 0.0 110.743 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -44.99 91.61 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.871 0.868 . . . . 0.0 110.639 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.59 -43.0 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 117.687 -1.149 . . . . 0.0 112.645 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.66 -34.06 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.898 1.681 . . . . 0.0 112.158 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.97 -44.34 89.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.602 0.637 . . . . 0.0 111.405 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -59.19 -52.35 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.619 1.168 . . . . 0.0 111.466 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 65.0 mt -65.13 -47.88 75.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.57 0.748 . . . . 0.0 111.281 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -50.48 -55.94 13.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.903 0.881 . . . . 0.0 110.891 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 m -68.25 -36.08 78.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.823 1.649 . . . . 0.0 114.176 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.59 -32.83 71.92 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.301 1.44 . . . . 0.0 111.076 173.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.6 t30 122.69 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 131.261 3.825 . . . . 0.0 109.815 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.7 137.65 11.54 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.58 61.2 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.47 3.447 . . . . 0.0 109.268 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -62.18 156.53 21.58 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.452 1.101 . . . . 0.0 112.94 -171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -121.44 170.31 9.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.466 1.107 . . . . 0.0 110.902 171.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.1 m -149.89 121.59 8.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.293 -1.505 . . . . 0.0 111.46 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -106.92 129.67 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.597 1.559 . . . . 0.0 109.677 -173.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -80.42 107.97 13.66 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.249 0.62 . . . . 0.0 111.42 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.7 pt -64.28 -27.37 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.101 -0.999 . . . . 0.0 112.928 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -0.16 51.63 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.286 1.434 . . . . 0.0 113.385 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.04 -29.46 67.61 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.776 0.83 . . . . 0.0 112.638 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -159.41 139.64 12.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.82 1.248 . . . . 0.0 110.919 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -53.05 -40.37 63.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.014 1.726 . . . . 0.0 114.087 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 tp -66.08 -31.32 72.13 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.338 1.055 . . . . 0.0 112.168 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.72 -45.77 41.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.856 0.863 . . . . 0.0 110.016 171.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.09 -44.99 75.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.995 1.318 . . . . 0.0 112.591 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -84.44 -28.77 26.63 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.94 -31.75 64.19 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 124.403 1.002 . . . . 0.0 113.422 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.22 -31.77 70.48 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.767 1.284 . . . . 0.0 112.511 176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.07 -38.55 91.46 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.154 -0.966 . . . . 0.0 111.873 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -71.51 -40.3 70.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.512 0.725 . . . . 0.0 111.298 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -63.68 -38.03 89.57 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.937 1.295 . . . . 0.0 113.455 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.1 m -118.01 -19.79 8.98 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.6 p 68.62 -12.09 0.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.611 2.364 . . . . 0.0 114.194 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -61.78 136.79 94.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 125.739 1.616 . . . . 0.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.53 -42.89 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.754 2.303 . . . . 0.0 115.371 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.3 p -140.22 108.72 5.87 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.113 0.869 . . . . 0.0 111.681 -169.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.34 162.71 71.22 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.511 1.524 . . . . 0.0 112.173 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.15 163.97 36.33 Favored 'Cis proline' 0 C--N 1.356 0.931 0 N-CA-C 116.027 1.51 . . . . 0.0 116.027 2.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.36 158.31 37.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.363 1.065 . . . . 0.0 111.512 170.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -105.94 138.97 41.21 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.358 1.863 . . . . 0.0 109.295 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.34 141.04 52.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.672 1.989 . . . . 0.0 111.162 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 mt -139.03 123.07 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.514 -0.741 . . . . 0.0 112.009 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 t70 62.93 -26.75 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.954 3.302 . . . . 0.0 117.014 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.51 1.39 0.04 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.447 1.975 . . . . 0.0 115.237 -175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -140.2 157.0 46.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.441 1.62 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -76.48 148.58 37.1 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.695 -0.628 . . . . 0.0 110.954 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -98.66 -43.66 6.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.931 1.292 . . . . 0.0 111.807 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.66 -165.73 24.98 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.276 1.417 . . . . 0.0 113.176 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.84 49.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.488 1.042 . . . . 0.0 112.994 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.8 m -61.48 -32.96 72.99 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.6 -39.15 87.07 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 112.049 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.55 -42.37 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.188 0.595 . . . . 0.0 109.586 173.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -62.61 -42.68 99.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.263 1.025 . . . . 0.0 111.924 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.46 -41.97 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.754 0.706 . . . . 0.0 111.417 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -67.9 -39.16 83.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.971 0.805 . . . . 0.0 112.281 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.63 -36.89 81.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.801 1.24 . . . . 0.0 112.617 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.67 -41.78 87.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.016 0.926 . . . . 0.0 112.025 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -68.46 -35.05 77.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.621 1.168 . . . . 0.0 112.624 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 p -90.02 -12.83 37.44 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.02 -0.17 72.22 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 125.463 1.506 . . . . 0.0 114.652 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.27 -37.26 85.04 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.19 1.396 . . . . 0.0 111.846 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.5 tp -66.4 -41.55 89.15 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.078 0.551 . . . . 0.0 111.191 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -57.82 -47.37 82.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.198 0.599 . . . . 0.0 110.568 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.67 -46.11 91.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.884 0.473 . . . . 0.0 111.947 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -68.56 -40.51 80.58 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.128 0.876 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.57 -39.41 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 118.993 0.815 . . . . 0.0 110.42 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.09 -43.67 91.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.236 0.925 . . . . 0.0 111.027 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -63.54 -38.92 92.97 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.902 -1.124 . . . . 0.0 112.777 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.51 83.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.94 0.791 . . . . 0.0 112.939 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.16 -47.95 10.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.394 1.078 . . . . 0.0 112.97 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 76.3 m -109.93 -28.3 8.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.283 1.433 . . . . 0.0 114.526 -169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 m . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 127.009 2.124 . . . . 0.0 114.293 177.146 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.24 172.07 13.47 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.456 1.102 . . . . 0.0 113.201 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.65 134.26 53.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.677 1.191 . . . . 0.0 110.332 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 p -83.4 156.26 65.89 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.794 0.838 . . . . 0.0 110.356 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.54 -33.12 57.64 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.136 1.89 . . . . 0.0 111.38 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.44 98.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.801 0.84 . . . . 0.0 112.732 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.72 -53.25 58.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 110.663 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -60.08 -37.46 80.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.1 0.56 . . . . 0.0 112.492 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 m -66.86 -40.84 87.99 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.174 1.79 . . . . 0.0 111.967 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -65.69 -47.25 76.08 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.29 1.036 . . . . 0.0 110.699 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.3 -54.21 48.07 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.748 1.219 . . . . 0.0 110.635 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.24 -43.0 78.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 111.954 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.06 -45.69 91.03 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.28 -0.887 . . . . 0.0 111.894 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.24 -37.82 78.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.563 1.529 . . . . 0.0 111.875 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -64.73 -33.74 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.04 0.936 . . . . 0.0 112.993 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 p -90.63 -43.47 10.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.1 p -73.27 -32.01 64.42 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -134.54 70.04 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 109.402 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.73 139.81 38.02 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t 83.52 88.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 127.958 2.503 . . . . 0.0 107.777 -169.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -108.08 133.03 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.06 0.544 . . . . 0.0 110.099 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.69 123.49 45.77 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.653 0.781 . . . . 0.0 108.965 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -104.98 116.12 31.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.311 1.045 . . . . 0.0 109.683 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.76 -167.99 1.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.042 1.737 . . . . 0.0 110.748 -175.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.56 -1.11 53.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.98 171.64 15.3 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.065 1.793 . . . . 0.0 113.64 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.4 p -103.54 178.01 4.68 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.972 1.709 . . . . 0.0 110.684 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.6 -32.03 73.1 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.341 -0.849 . . . . 0.0 111.937 172.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.77 -32.92 58.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.936 1.294 . . . . 0.0 112.663 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -137.0 82.2 31.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.138 1.375 . . . . 0.0 110.634 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.63 171.77 16.91 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.786 2.99 . . . . 0.0 111.555 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -86.49 150.4 24.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.916 0.886 . . . . 0.0 111.224 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -72.37 171.31 12.45 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.425 1.49 . . . . 0.0 113.518 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 -136.89 22.02 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.353 0.977 . . . . 0.0 112.239 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -52.14 -40.87 61.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.747 0.819 . . . . 0.0 112.184 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 m -59.11 -43.61 91.91 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.317 -0.864 . . . . 0.0 112.576 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -62.65 -47.02 85.53 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.415 -0.803 . . . . 0.0 110.522 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.9 m -58.89 -44.47 91.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.017 0.927 . . . . 0.0 110.736 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.97 -44.18 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.006 1.322 . . . . 0.0 112.204 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.9 -43.71 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.901 0.773 . . . . 0.0 110.955 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.01 -40.0 94.27 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 mt -59.69 -53.46 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 112.195 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.17 -47.93 75.25 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.932 1.242 . . . . 0.0 110.834 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -49.1 -57.06 7.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.949 0.5 . . . . 0.0 110.331 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -67.02 -31.57 72.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.861 1.665 . . . . 0.0 114.266 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.39 -23.09 64.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.89 1.276 . . . . 0.0 111.222 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.8 t30 114.48 32.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 130.961 3.704 . . . . 0.0 112.282 168.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.76 138.42 29.63 Favored Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 121.261 -0.899 . . . . 0.0 113.089 -169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -82.17 49.89 3.27 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 124.457 3.438 . . . . 0.0 109.056 169.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -66.14 169.16 7.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.447 1.899 . . . . 0.0 115.133 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -150.96 130.04 12.62 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.588 0.755 . . . . 0.0 111.043 169.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.1 m -90.39 124.15 34.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.606 -0.684 . . . . 0.0 109.177 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.0 t -113.64 125.48 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 109.251 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -75.09 101.43 4.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.394 0.678 . . . . 0.0 111.026 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 pt -72.36 -24.52 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.28 -1.72 34.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.969 1.308 . . . . 0.0 113.184 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.4 -24.85 66.54 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.574 1.149 . . . . 0.0 112.843 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -154.69 134.58 12.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 111.487 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.79 -41.78 87.51 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -25.14 67.83 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.701 1.137 . . . . 0.0 113.24 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.32 -46.98 21.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.083 0.953 . . . . 0.0 110.329 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -56.64 -47.86 78.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.874 0.87 . . . . 0.0 112.229 174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.08 -40.56 30.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.192 0.997 . . . . 0.0 112.449 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.01 -28.92 48.42 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.608 -170.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.3 tp -57.59 -36.71 72.09 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.756 1.278 . . . . 0.0 112.588 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -50.08 -43.8 51.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.362 1.065 . . . . 0.0 112.478 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -83.17 -30.19 28.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.789 0.836 . . . . 0.0 112.592 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -64.68 -39.66 94.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.8 p -88.68 -67.89 0.8 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.227 0.611 . . . . 0.0 111.894 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.2 m 130.05 -12.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 1 C-N-CA 133.598 4.759 . . . . 0.0 111.209 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -66.74 134.28 94.18 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.203 1.001 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.05 -43.37 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.888 2.392 . . . . 0.0 115.48 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.0 p -142.22 117.69 10.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.152 0.887 . . . . 0.0 112.176 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -60.6 159.19 26.19 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.298 1.439 . . . . 0.0 113.352 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -59.79 161.43 35.68 Favored 'Cis proline' 0 C--N 1.358 1.034 0 N-CA-C 115.672 1.374 . . . . 0.0 115.672 -2.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -154.82 161.91 41.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.38 1.072 . . . . 0.0 111.356 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.89 123.09 40.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.198 1.399 . . . . 0.0 109.418 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -111.31 138.3 47.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.508 1.123 . . . . 0.0 111.291 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 pt -149.89 110.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.727 1.611 . . . . 0.0 112.857 -169.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.24 41.49 32.14 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.994 1.317 . . . . 0.0 114.23 169.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.01 -8.5 69.94 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.265 0.935 . . . . 0.0 114.121 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -104.76 177.61 4.8 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.083 1.753 . . . . 0.0 110.516 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -150.77 161.71 42.11 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.892 1.33 . . . . 0.0 112.624 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -136.12 177.51 7.78 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.931 2.092 . . . . 0.0 109.898 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.78 -168.01 30.77 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.732 1.634 . . . . 0.0 115.624 -169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.62 -179.73 32.22 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.969 1.271 . . . . 0.0 113.99 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.1 m -67.5 -48.42 67.16 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.61 -42.39 88.06 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.408 -0.807 . . . . 0.0 111.811 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.73 -41.67 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.133 0.973 . . . . 0.0 110.593 172.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.2 m -64.16 -41.58 97.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.656 1.182 . . . . 0.0 111.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.12 -44.02 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.829 0.741 . . . . 0.0 111.281 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.92 -36.8 80.8 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.89 0.768 . . . . 0.0 112.476 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.0 83.89 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 112.522 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -65.59 -41.08 93.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.225 1.01 . . . . 0.0 112.322 172.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -68.68 -29.59 68.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.661 0.785 . . . . 0.0 112.647 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -87.39 -13.53 43.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.48 1.112 . . . . 0.0 113.379 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.92 -0.61 84.45 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.49 1.519 . . . . 0.0 114.268 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.9 -39.13 64.1 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.825 1.25 . . . . 0.0 111.321 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.35 -45.07 92.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.775 0.43 . . . . 0.0 110.626 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -55.85 -47.9 76.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.084 0.953 . . . . 0.0 111.018 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.17 -47.93 83.89 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.124 0.57 . . . . 0.0 112.063 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -68.9 -42.59 76.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.587 -0.696 . . . . 0.0 112.585 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.99 -40.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.973 0.909 . . . . 0.0 111.153 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.26 -46.45 89.76 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.449 1.022 . . . . 0.0 110.696 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.52 -44.68 93.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.58 -0.7 . . . . 0.0 111.795 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.43 87.43 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.002 0.921 . . . . 0.0 113.151 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 85.0 mtp -70.19 -39.76 75.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.603 1.161 . . . . 0.0 112.579 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.22 -34.39 77.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.335 0.654 . . . . 0.0 111.973 169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.211 2.605 . . . . 0.0 112.688 173.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.36 164.48 35.71 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.581 1.552 . . . . 0.0 111.548 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 17.9 tp 70.65 -22.34 0.18 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.98 2.512 . . . . 0.0 114.43 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 p -63.37 -32.14 7.87 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-O 115.682 -2.104 . . . . 0.0 116.302 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.86 -167.13 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 CA-C-N 123.379 2.243 . . . . 0.0 111.615 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.07 -2.68 1.36 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.3 -52.07 39.69 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.494 1.517 . . . . 0.0 111.018 170.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.74 -42.39 98.91 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.345 -0.847 . . . . 0.0 112.345 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -60.12 -39.08 84.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.25 1.82 . . . . 0.0 111.866 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.8 m -68.0 -50.45 55.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.995 1.318 . . . . 0.0 110.379 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.29 -51.28 67.18 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.454 0.702 . . . . 0.0 111.334 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.75 -48.85 76.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.988 0.915 . . . . 0.0 112.112 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.32 -42.74 96.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.642 0.777 . . . . 0.0 111.94 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.96 -43.75 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.325 -0.859 . . . . 0.0 111.074 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.73 -42.8 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.408 1.483 . . . . 0.0 112.934 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.9 p -76.4 -42.89 42.8 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.216 0.916 . . . . 0.0 112.329 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.7 p -76.35 -36.05 58.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -95.95 -13.76 23.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.41 -48.24 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.508 2.723 . . . . 0.0 115.032 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.26 120.74 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.493 1.917 . . . . 0.0 108.048 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.65 154.93 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.144 0.578 . . . . 0.0 111.154 -172.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.96 132.65 46.39 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.602 1.161 . . . . 0.0 110.452 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -108.24 114.94 29.2 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 8.3 ptm -160.73 174.23 14.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.777 1.231 . . . . 0.0 110.615 -169.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -85.3 29.78 0.65 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.014 -1.054 . . . . 0.0 113.274 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.83 172.43 42.59 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.517 1.532 . . . . 0.0 113.089 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.0 p -100.27 178.48 4.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.178 1.391 . . . . 0.0 110.742 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.56 -23.47 62.61 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -84.43 -30.2 25.51 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.97 1.308 . . . . 0.0 112.394 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -132.14 76.0 73.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.614 1.566 . . . . 0.0 110.35 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.39 173.23 14.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.547 2.832 . . . . 0.0 111.001 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -112.27 136.23 51.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.8 0.84 . . . . 0.0 110.735 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.87 149.83 46.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.395 1.078 . . . . 0.0 112.739 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.51 -113.19 3.94 Favored Glycine 0 N--CA 1.468 0.822 0 C-N-CA 124.1 0.857 . . . . 0.0 111.526 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -59.97 -57.12 14.23 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.646 1.178 . . . . 0.0 113.072 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.3 m -62.53 -46.36 88.76 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.383 -0.823 . . . . 0.0 111.387 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -52.23 -47.65 65.59 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.497 1.519 . . . . 0.0 111.341 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -61.57 -50.37 72.92 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.15 0.98 . . . . 0.0 110.54 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 64.9 t -59.13 -47.77 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.012 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.71 -35.44 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.479 1.036 . . . . 0.0 112.098 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -64.97 -38.48 91.1 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.003 0.819 . . . . 0.0 111.558 174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mt -59.82 -51.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.823 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.4 mt -59.3 -51.14 71.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.553 1.069 . . . . 0.0 111.723 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -51.38 -60.93 2.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.338 1.055 . . . . 0.0 110.654 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 94.1 p -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.046 1.738 . . . . 0.0 115.262 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -58.86 -32.65 69.64 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.31 1.044 . . . . 0.0 109.892 169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 t30 114.63 56.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.717 3.607 . . . . 0.0 109.333 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.62 38.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.45 168.49 14.47 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.721 2.947 . . . . 0.0 112.281 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.46 141.1 15.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.427 1.491 . . . . 0.0 109.583 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -123.98 93.47 3.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.733 0.813 . . . . 0.0 109.746 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 m -78.93 115.81 18.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.732 -0.605 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.52 125.5 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.809 1.643 . . . . 0.0 108.518 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -78.15 107.46 10.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.714 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.67 -23.76 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.75 -11.38 60.15 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.928 -1.107 . . . . 0.0 112.848 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -70.0 -29.03 66.01 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.879 0.872 . . . . 0.0 113.05 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -154.4 135.44 13.86 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.883 0.765 . . . . 0.0 112.396 -173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.98 -34.24 74.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.54 1.136 . . . . 0.0 111.668 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 -26.14 68.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.044 0.938 . . . . 0.0 112.738 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.65 -56.51 5.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.915 0.78 . . . . 0.0 109.47 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -55.24 -39.43 69.72 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -86.72 -36.87 18.42 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.81 -37.77 21.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.692 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 mt -64.26 -39.43 93.92 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.533 1.167 . . . . 0.0 112.952 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -58.82 -37.35 76.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.004 0.522 . . . . 0.0 111.9 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.36 -40.63 50.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 111.781 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.56 -45.55 93.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.065 1.346 . . . . 0.0 113.503 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.5 p -95.81 -23.51 16.9 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 p 78.7 -12.05 1.13 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.944 2.898 . . . . 0.0 113.561 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -81.47 127.08 74.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 121.321 -0.862 . . . . 0.0 110.669 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -83.83 -12.34 8.6 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.419 2.746 . . . . 0.0 116.51 -169.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -123.34 171.13 9.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.98 1.264 . . . . 0.0 112.894 -171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.13 148.9 69.86 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.042 1.337 . . . . 0.0 110.526 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.42 156.9 69.3 Favored 'Cis proline' 0 C--N 1.351 0.674 0 CA-C-N 119.894 0.998 . . . . 0.0 114.145 -3.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.37 139.04 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.408 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.59 149.1 21.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.526 1.53 . . . . 0.0 110.453 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -149.58 140.93 23.23 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.33 -0.856 . . . . 0.0 111.343 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -144.79 124.58 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.593 1.157 . . . . 0.0 112.405 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 61.7 -17.8 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.329 2.652 . . . . 0.0 117.504 169.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.04 6.17 1.11 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.379 1.942 . . . . 0.0 113.821 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -128.24 144.01 51.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.208 1.803 . . . . 0.0 110.433 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -91.63 163.49 14.09 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.974 1.369 . . . . 0.0 112.791 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -142.37 176.08 9.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.064 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.84 -169.99 39.81 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.369 -1.287 . . . . 0.0 114.523 -171.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.62 -163.65 35.37 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.878 1.228 . . . . 0.0 113.002 174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.12 -50.51 72.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.654 0.782 . . . . 0.0 112.97 -172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -59.78 -43.98 94.12 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.916 0.78 . . . . 0.0 111.596 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.37 -43.05 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.33 0.652 . . . . 0.0 110.175 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.9 m -62.81 -44.2 96.79 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 111.066 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.68 -45.13 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.898 1.279 . . . . 0.0 111.235 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.31 -38.75 81.9 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.842 0.746 . . . . 0.0 112.237 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.26 80.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.096 0.958 . . . . 0.0 112.485 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -67.52 -38.94 85.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.859 1.264 . . . . 0.0 112.182 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -68.03 -36.52 80.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.061 0.944 . . . . 0.0 111.931 173.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 m -84.28 -16.33 43.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.45 -0.39 80.64 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.107 1.337 . . . . 0.0 114.26 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -68.01 -42.83 80.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.764 1.226 . . . . 0.0 110.926 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 tp -64.61 -43.78 92.67 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.028 -0.42 . . . . 0.0 110.531 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -55.44 -48.58 74.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.929 0.891 . . . . 0.0 111.182 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.06 -48.64 77.79 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.281 0.492 . . . . 0.0 111.776 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.85 -39.57 79.86 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.552 -0.718 . . . . 0.0 112.821 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -38.68 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.931 0.893 . . . . 0.0 111.035 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.3 -45.97 92.22 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.38 0.991 . . . . 0.0 111.368 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -59.95 -39.99 87.44 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.532 -0.73 . . . . 0.0 111.903 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.79 91.97 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.061 0.846 . . . . 0.0 112.899 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.5 mtm -68.28 -35.0 77.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.836 0.855 . . . . 0.0 112.674 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.5 t -65.97 -43.9 86.53 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.99 0.916 . . . . 0.0 111.891 170.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.255 1.353 0 C-N-CA 129.215 3.006 . . . . 0.0 112.408 174.07 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 119.806 -0.14 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.79 165.36 12.15 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.663 1.185 . . . . 0.0 112.813 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -25.59 51.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.301 1.041 . . . . 0.0 113.726 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.3 p -56.61 -39.58 78.8 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-O 115.861 -2.019 . . . . 0.0 116.333 -169.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.97 -12.21 16.26 Favored 'Trans proline' 0 C--N 1.356 0.922 0 CA-C-N 122.961 2.093 . . . . 0.0 113.723 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.21 -58.15 2.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.246 1.018 . . . . 0.0 112.822 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.51 -57.35 8.44 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.798 1.239 . . . . 0.0 110.947 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -59.88 -41.03 90.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.984 0.514 . . . . 0.0 111.193 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -60.84 -41.66 96.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.262 2.225 . . . . 0.0 112.881 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.5 m -66.91 -50.17 63.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.83 0.852 . . . . 0.0 110.317 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.33 -36.54 84.46 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.81 -48.72 80.53 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.261 1.024 . . . . 0.0 112.002 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -59.89 -41.67 92.1 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.093 -1.004 . . . . 0.0 111.782 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.66 -53.1 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.328 -0.858 . . . . 0.0 111.739 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.31 -30.24 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.924 1.238 . . . . 0.0 113.233 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.8 p -75.28 -30.14 60.33 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.204 0.911 . . . . 0.0 112.629 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.4 m -78.1 -40.75 37.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -107.07 -9.67 16.12 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 64.61 -47.96 0.32 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 128.733 2.813 . . . . 0.0 115.299 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -116.12 122.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.258 1.823 . . . . 0.0 109.369 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 t -132.36 135.54 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.873 0.869 . . . . 0.0 110.033 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.02 128.79 56.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.616 1.566 . . . . 0.0 108.941 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -108.83 120.14 41.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 109.764 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -156.45 167.34 30.75 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.92 1.688 . . . . 0.0 110.505 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -78.56 31.71 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.93 163.7 31.93 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.356 1.931 . . . . 0.0 113.018 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.1 p -82.06 178.43 8.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 111.199 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -64.31 -26.9 68.69 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.63 0.772 . . . . 0.0 112.449 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.8 -25.76 26.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 113.229 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -119.01 65.02 6.98 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.8 1.64 . . . . 0.0 111.169 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.93 150.05 85.91 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.059 2.506 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -94.77 115.03 27.01 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.042 0.537 . . . . 0.0 110.55 -170.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.2 m -58.14 146.44 33.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.838 1.255 . . . . 0.0 112.805 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.76 -149.0 19.19 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -169.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -53.44 -41.03 65.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -64.63 -46.51 82.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 112.541 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -57.43 -44.57 84.8 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.403 -0.811 . . . . 0.0 110.452 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.8 m -59.08 -43.76 91.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.788 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.1 -42.25 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.422 1.01 . . . . 0.0 111.821 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -58.67 -47.93 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.689 0.677 . . . . 0.0 110.967 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.43 -37.5 87.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.504 0.722 . . . . 0.0 111.811 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.6 -50.68 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.071 1.748 . . . . 0.0 112.278 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.12 -49.7 73.36 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.328 0.967 . . . . 0.0 110.82 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -53.12 -54.95 28.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.342 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -30.69 69.47 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.011 2.124 . . . . 0.0 115.007 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.9 tp -57.16 -31.66 65.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.43 1.092 . . . . 0.0 109.882 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 t30 112.53 58.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.495 3.518 . . . . 0.0 109.199 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.26 150.28 28.94 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.54 163.7 35.47 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.364 2.709 . . . . 0.0 110.542 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -161.72 164.95 28.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.595 1.558 . . . . 0.0 110.119 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -136.2 148.57 48.18 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.055 -0.403 . . . . 0.0 111.21 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.9 m -113.71 117.5 31.69 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 111.32 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.3 t -92.93 122.53 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.119 0.968 . . . . 0.0 109.463 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -81.96 93.16 6.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.404 1.482 . . . . 0.0 111.546 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 pt -77.6 177.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.574 1.15 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 75.43 -54.09 0.64 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.653 1.981 . . . . 0.0 112.862 169.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -67.32 -44.36 79.31 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.027 1.331 . . . . 0.0 111.89 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -87.81 128.52 35.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.632 1.173 . . . . 0.0 111.167 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.25 -40.55 86.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.704 1.202 . . . . 0.0 113.341 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -61.79 -41.67 98.03 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.814 0.846 . . . . 0.0 111.22 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.88 -48.16 69.61 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.507 0.723 . . . . 0.0 110.745 172.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -52.35 -40.81 62.43 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.221 1.008 . . . . 0.0 112.305 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.22 -36.97 24.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.608 1.163 . . . . 0.0 113.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.62 -23.0 37.74 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 115.443 0.937 . . . . 0.0 115.443 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.24 174.68 6.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.493 1.146 . . . . 0.0 111.478 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 73.6 -53.07 0.7 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.581 2.352 . . . . 0.0 110.085 -169.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -70.07 -38.71 75.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.63 1.572 . . . . 0.0 112.327 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -63.48 -49.53 73.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -97.01 -15.82 20.88 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p 80.52 -9.47 1.36 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 129.477 3.111 . . . . 0.0 114.227 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -68.7 132.03 91.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.211 -0.93 . . . . 0.0 111.382 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -75.21 -36.0 2.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.11 2.54 . . . . 0.0 115.007 -169.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.9 p -140.57 90.93 2.39 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.801 0.728 . . . . 0.0 111.454 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -60.77 158.74 30.34 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 125.303 1.441 . . . . 0.0 110.814 174.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.46 162.25 37.53 Favored 'Cis proline' 0 C--N 1.358 1.035 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 1.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 152.65 7.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.128 1.371 . . . . 0.0 112.53 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tt -93.77 146.78 23.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.046 1.339 . . . . 0.0 111.196 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -138.58 138.73 38.2 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.013 2.125 . . . . 0.0 110.675 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -143.29 127.18 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.307 1.443 . . . . 0.0 111.632 -172.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 51.87 23.15 1.98 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.28 41.96 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.809 1.195 . . . . 0.0 115.32 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -139.32 150.21 45.13 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.209 1.504 . . . . 0.0 111.215 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.83 150.04 29.31 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.989 -1.069 . . . . 0.0 111.967 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -97.72 -47.55 5.56 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.215 1.006 . . . . 0.0 111.638 173.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 145.95 -172.55 26.57 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.287 1.422 . . . . 0.0 112.81 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -66.26 164.18 41.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.413 1.006 . . . . 0.0 113.544 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.0 m -66.89 -41.75 86.66 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.625 -0.927 . . . . 0.0 112.874 -174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.02 -43.91 94.95 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.403 -0.811 . . . . 0.0 111.306 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.92 -42.1 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 109.978 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.2 m -63.0 -43.02 99.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.041 1.336 . . . . 0.0 111.581 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.8 t -60.02 -45.46 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.467 0.707 . . . . 0.0 111.346 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -71.32 -32.78 69.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.912 0.778 . . . . 0.0 112.82 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.73 80.09 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.011 -1.056 . . . . 0.0 112.783 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -63.3 -43.31 98.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.811 0.845 . . . . 0.0 112.071 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.19 -32.86 74.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.991 0.516 . . . . 0.0 112.222 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -86.92 -11.76 49.67 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.408 1.083 . . . . 0.0 113.614 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.81 -0.16 87.81 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.525 1.536 . . . . 0.0 114.582 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.83 -36.1 59.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 111.251 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.5 tp -64.42 -43.64 93.74 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.675 -0.641 . . . . 0.0 110.708 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -55.69 -48.39 75.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.454 0.702 . . . . 0.0 110.552 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.52 -47.89 82.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.358 0.663 . . . . 0.0 111.899 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -73.47 -35.03 65.65 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.6 t -66.28 -42.34 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.473 1.033 . . . . 0.0 110.793 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -59.01 -45.97 89.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.277 0.944 . . . . 0.0 111.03 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.83 -43.75 94.42 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.605 -0.685 . . . . 0.0 111.993 175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.41 92.79 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.173 0.989 . . . . 0.0 112.868 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.02 -35.47 74.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.242 1.017 . . . . 0.0 112.549 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.19 -38.09 87.18 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.302 0.641 . . . . 0.0 112.059 170.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.732 2.413 . . . . 0.0 112.578 170.909 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.863 -0.113 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.6 -101.38 0.11 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.54 1.136 . . . . 0.0 109.1 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.88 157.06 36.99 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.55 0.74 . . . . 0.0 109.724 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -69.12 145.27 96.18 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.95 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.41 -34.86 73.22 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.993 2.462 . . . . 0.0 112.43 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.03 -47.7 85.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.35 1.06 . . . . 0.0 113.065 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.86 -47.04 79.34 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.97 0.804 . . . . 0.0 110.354 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.76 -43.83 90.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.023 0.529 . . . . 0.0 111.633 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.9 m -65.48 -43.89 88.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.042 1.737 . . . . 0.0 111.566 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -61.8 -53.4 56.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.941 0.897 . . . . 0.0 110.425 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.81 -50.16 75.01 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.625 0.77 . . . . 0.0 111.36 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -56.53 -49.19 75.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 112.359 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.88 -46.31 85.49 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.563 -0.711 . . . . 0.0 111.966 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.48 -48.28 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.86 0.755 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.37 -20.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.1 p -93.41 -37.31 12.05 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.976 0.807 . . . . 0.0 112.932 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 t -74.04 -43.02 59.37 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.87 0.759 . . . . 0.0 112.317 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -97.43 -10.54 25.24 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mttm 63.09 -40.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.072 2.549 . . . . 0.0 116.139 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -120.79 128.11 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.066 1.746 . . . . 0.0 108.731 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.09 139.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.49 0.586 . . . . 0.0 112.422 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.17 129.45 56.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.171 1.388 . . . . 0.0 110.643 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -107.53 128.92 54.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.967 0.907 . . . . 0.0 111.04 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -162.58 -175.56 4.54 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.858 1.663 . . . . 0.0 110.851 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -76.6 51.48 0.74 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.25 -1.531 . . . . 0.0 112.412 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.96 168.02 30.42 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.695 1.14 . . . . 0.0 114.305 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.7 p -113.15 -175.73 2.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.258 1.823 . . . . 0.0 111.401 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.88 -32.76 74.61 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.543 -0.723 . . . . 0.0 112.119 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.46 -32.72 42.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.834 1.253 . . . . 0.0 112.667 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -122.81 77.68 48.98 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.217 1.407 . . . . 0.0 110.636 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.44 164.85 33.07 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -107.34 138.35 43.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.999 0.919 . . . . 0.0 111.755 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.4 m -66.48 157.93 30.85 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.068 1.347 . . . . 0.0 113.849 -172.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 -118.92 4.73 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.392 0.996 . . . . 0.0 112.271 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -59.1 -46.17 88.99 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.295 1.038 . . . . 0.0 112.883 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.7 m -69.79 -44.21 70.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.906 -1.121 . . . . 0.0 112.146 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -53.19 -46.66 69.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.755 1.222 . . . . 0.0 110.832 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -59.9 -50.37 74.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.416 1.086 . . . . 0.0 110.539 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 t -61.56 -44.56 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.246 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.82 -34.89 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 120.424 1.465 . . . . 0.0 111.545 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -68.03 -37.43 81.35 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.242 0.928 . . . . 0.0 112.524 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.68 -51.41 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.774 1.23 . . . . 0.0 110.777 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.55 -51.27 70.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.804 0.729 . . . . 0.0 111.266 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -47.24 -59.2 3.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.087 0.555 . . . . 0.0 109.991 174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m -62.97 -33.97 76.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.602 1.961 . . . . 0.0 114.103 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.81 -21.4 66.41 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.295 1.438 . . . . 0.0 111.951 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 109.02 39.62 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 131.51 3.924 . . . . 0.0 110.697 169.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.26 136.53 24.31 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -169.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -83.58 48.18 2.55 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.549 3.5 . . . . 0.0 109.665 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.44 164.53 18.56 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -169.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -130.89 170.05 14.95 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.722 1.609 . . . . 0.0 110.038 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.2 m -147.99 137.64 22.43 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.088 -1.632 . . . . 0.0 110.761 170.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.4 140.49 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.106 0.962 . . . . 0.0 110.529 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.49 142.99 35.33 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.0 pt -89.01 -174.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.432 1.093 . . . . 0.0 109.718 168.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.4 mt 71.16 174.91 0.3 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.553 2.341 . . . . 0.0 113.869 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 78.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.527 2.731 . . . . 0.0 110.854 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.95 141.5 54.95 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.636 0.774 . . . . 0.0 111.007 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.65 -37.91 74.17 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.034 -1.041 . . . . 0.0 113.429 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.21 -26.41 66.6 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.072 -1.018 . . . . 0.0 111.75 176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.82 -15.96 40.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.418 1.087 . . . . 0.0 113.237 170.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -80.57 -51.96 8.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.094 1.316 . . . . 0.0 111.677 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.39 -20.78 8.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -170.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.08 -30.72 69.62 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 120.975 -1.078 . . . . 0.0 113.388 -170.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.85 -41.27 91.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.765 1.283 . . . . 0.0 111.52 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.47 -45.38 91.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.72 -0.612 . . . . 0.0 110.834 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -68.72 -38.53 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.311 0.644 . . . . 0.0 112.736 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -70.04 -44.96 68.16 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.988 0.813 . . . . 0.0 112.531 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -85.99 -17.96 33.89 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m 69.81 -5.42 1.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.297 2.239 . . . . 0.0 113.756 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -74.93 127.56 86.67 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.764 1.226 . . . . 0.0 111.485 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.6 143.33 21.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.154 2.569 . . . . 0.0 110.27 172.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p 64.53 -161.35 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.782 2.033 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -146.19 163.56 29.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.79 2.036 . . . . 0.0 110.675 -176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.16 172.64 17.17 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 120.229 1.117 . . . . 0.0 114.875 -6.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.78 121.89 21.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.815 1.246 . . . . 0.0 108.435 170.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.14 123.38 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.181 0.992 . . . . 0.0 109.541 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -106.48 134.74 49.15 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.615 1.566 . . . . 0.0 110.911 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.3 pt -129.96 112.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 111.306 172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.43 17.57 4.94 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.556 1.942 . . . . 0.0 114.469 172.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.07 -3.53 41.04 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.155 1.836 . . . . 0.0 114.62 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -100.99 149.14 24.23 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 111.402 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -103.16 132.2 49.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.253 1.421 . . . . 0.0 111.046 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -99.28 -28.86 13.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.128 0.971 . . . . 0.0 113.45 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.78 -156.8 18.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.468 1.508 . . . . 0.0 111.743 -169.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.44 169.19 41.05 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.704 1.145 . . . . 0.0 114.141 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.9 m -57.65 -34.31 69.22 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.15 -40.92 95.65 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.38 -0.825 . . . . 0.0 111.802 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.23 -40.92 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.678 0.791 . . . . 0.0 109.937 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 m -61.39 -44.64 96.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.046 0.938 . . . . 0.0 111.665 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.69 -43.62 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.324 0.65 . . . . 0.0 111.485 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.99 -41.73 95.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.259 0.936 . . . . 0.0 111.987 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.62 -31.26 71.15 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.76 0.824 . . . . 0.0 113.17 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -67.91 -35.74 78.98 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.985 -1.072 . . . . 0.0 111.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.29 -32.35 66.52 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.9 p -88.15 -15.75 35.25 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.734 1.152 . . . . 0.0 113.76 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.57 1.01 78.38 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 125.306 1.431 . . . . 0.0 113.955 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -68.89 -30.37 68.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.288 . . . . 0.0 111.999 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.62 -47.65 69.02 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.556 -0.715 . . . . 0.0 110.165 172.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -56.41 -47.46 78.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 110.923 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.79 -50.67 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.51 0.724 . . . . 0.0 111.852 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -73.1 -36.74 66.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.279 -0.888 . . . . 0.0 113.183 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.28 -38.32 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.367 0.985 . . . . 0.0 111.087 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.05 -46.35 91.06 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.273 0.942 . . . . 0.0 110.866 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -61.57 -36.26 80.13 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.402 -0.811 . . . . 0.0 112.738 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.69 -36.61 84.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.158 0.983 . . . . 0.0 112.683 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 72.9 mtm -73.18 -41.28 64.03 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.555 0.742 . . . . 0.0 112.254 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.3 m -71.87 -39.37 69.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 129.718 3.207 . . . . 0.0 115.76 -176.829 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 120.176 0.036 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.64 152.47 39.19 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.068 0.947 . . . . 0.0 112.58 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 mt 73.37 -51.33 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.579 2.751 . . . . 0.0 113.843 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.9 m -45.14 -53.99 15.27 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.682 2.393 . . . . 0.0 114.845 -174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.3 -12.47 19.02 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.372 2.048 . . . . 0.0 114.332 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.12 -72.9 0.66 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.375 0.988 . . . . 0.0 111.616 -174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.64 -62.61 1.62 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.516 1.127 . . . . 0.0 110.998 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -66.57 -30.72 71.08 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.62 -0.675 . . . . 0.0 112.172 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -63.32 -46.29 87.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.807 1.643 . . . . 0.0 111.668 171.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -65.29 -48.68 72.31 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.776 0.83 . . . . 0.0 110.651 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.11 -55.04 35.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.153 0.981 . . . . 0.0 110.735 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.85 -46.59 74.67 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.05 0.94 . . . . 0.0 111.713 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.7 -51.59 69.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.796 174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.78 -36.49 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.4 1.454 . . . . 0.0 113.153 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.89 -13.9 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 119.924 1.238 . . . . 0.0 113.763 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -102.41 -38.15 7.72 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.22 0.918 . . . . 0.0 113.107 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 t -80.13 -50.57 10.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.988 0.813 . . . . 0.0 111.853 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -88.79 -15.09 35.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.34 -0.85 . . . . 0.0 112.731 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.04 -52.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.913 2.885 . . . . 0.0 115.241 172.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 t -102.08 116.83 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.43 1.492 . . . . 0.0 109.06 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -135.64 133.34 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.148 0.431 . . . . 0.0 110.893 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.02 138.2 44.68 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.004 1.722 . . . . 0.0 109.2 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -125.18 117.61 24.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.53 1.132 . . . . 0.0 110.186 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -167.25 -170.5 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.99 2.116 . . . . 0.0 109.589 -176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -81.04 -32.37 34.12 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.218 1.372 . . . . 0.0 112.517 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 154.54 47.47 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.193 1.378 . . . . 0.0 113.387 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -96.8 -179.59 4.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.734 1.614 . . . . 0.0 110.789 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.47 -18.76 60.58 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.106 -0.996 . . . . 0.0 113.554 172.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.9 -27.64 23.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 112.355 171.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -131.38 72.77 80.64 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.733 1.613 . . . . 0.0 111.058 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.56 157.09 59.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.006 2.471 . . . . 0.0 110.994 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -85.03 126.91 33.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.204 0.602 . . . . 0.0 111.133 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.1 t -59.22 143.68 48.35 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.781 1.232 . . . . 0.0 112.178 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.07 -146.11 18.06 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.919 1.247 . . . . 0.0 111.61 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -55.45 -36.69 66.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 -169.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.2 m -64.55 -47.07 80.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.898 1.226 . . . . 0.0 112.404 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -57.73 -43.76 85.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.307 0.958 . . . . 0.0 110.648 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 m -58.83 -46.95 86.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.705 0.802 . . . . 0.0 111.114 175.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.4 -42.23 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.173 0.989 . . . . 0.0 112.13 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.6 t -59.91 -45.72 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.433 0.693 . . . . 0.0 110.872 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.68 -41.41 96.07 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.594 0.757 . . . . 0.0 111.912 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.49 -52.01 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.37 1.468 . . . . 0.0 111.608 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.14 -50.29 68.78 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.801 0.728 . . . . 0.0 110.438 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -50.4 -56.36 11.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.798 0.839 . . . . 0.0 110.691 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -68.53 -31.56 70.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.35 1.86 . . . . 0.0 114.638 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.01 -29.18 68.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 0.0 110.659 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 112.88 63.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 130.163 3.385 . . . . 0.0 109.71 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.32 154.74 34.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -74.39 173.95 13.38 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.232 2.621 . . . . 0.0 110.336 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -161.15 145.87 13.72 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 109.773 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -123.33 95.2 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.919 0.888 . . . . 0.0 109.833 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.4 m -76.07 97.35 4.04 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.934 -1.104 . . . . 0.0 110.667 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.77 129.47 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.513 1.925 . . . . 0.0 110.137 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -74.41 107.59 6.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.83 0.852 . . . . 0.0 110.953 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.49 -28.75 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -20.4 49.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.331 1.052 . . . . 0.0 112.87 -171.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.69 -42.83 93.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.207 1.403 . . . . 0.0 113.687 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -119.55 129.9 54.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.926 0.891 . . . . 0.0 111.551 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.4 -30.2 71.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.6 -52.47 17.92 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.992 0.814 . . . . 0.0 110.702 173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.1 tp -59.46 -33.17 70.96 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.455 1.502 . . . . 0.0 112.417 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.07 -22.06 62.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.378 1.871 . . . . 0.0 113.523 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.47 -56.15 1.62 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.656 1.182 . . . . 0.0 113.427 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.33 -19.03 79.82 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.42 -34.36 72.39 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.489 1.145 . . . . 0.0 112.584 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -59.04 -37.39 76.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.245 1.018 . . . . 0.0 112.523 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.96 -30.92 27.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.514 1.126 . . . . 0.0 112.179 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -62.6 -41.47 99.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.77 0.828 . . . . 0.0 112.447 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.5 p -82.12 -68.21 0.72 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.381 0.673 . . . . 0.0 111.953 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.2 m 123.31 -13.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 133.293 4.637 . . . . 0.0 111.099 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -70.45 128.32 91.3 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.059 1.344 . . . . 0.0 112.003 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.18 140.11 13.75 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.37 2.713 . . . . 0.0 110.625 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.6 p 64.9 -174.55 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.563 2.345 . . . . 0.0 113.108 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -138.32 159.96 65.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.139 1.776 . . . . 0.0 110.476 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.89 165.51 35.68 Favored 'Cis proline' 0 C--N 1.355 0.877 0 N-CA-C 115.739 1.399 . . . . 0.0 115.739 1.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -141.89 132.78 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.253 1.421 . . . . 0.0 109.559 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -103.59 138.19 40.61 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.026 1.331 . . . . 0.0 108.75 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -134.95 137.2 42.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.917 1.687 . . . . 0.0 110.773 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.2 124.53 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.973 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.34 49.78 5.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.917 2.087 . . . . 0.0 114.845 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.25 3.06 73.02 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.362 -1.243 . . . . 0.0 115.435 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.09 143.48 50.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.347 1.573 . . . . 0.0 111.835 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -82.97 142.4 31.41 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.754 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -94.44 -33.62 13.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.221 1.008 . . . . 0.0 112.101 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.31 -153.93 16.81 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.62 1.581 . . . . 0.0 112.008 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.98 162.36 37.04 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.398 0.999 . . . . 0.0 113.114 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.9 m -58.26 -33.72 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.16 -44.98 84.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 0.0 111.817 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.0 -42.47 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.934 0.893 . . . . 0.0 109.606 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.7 m -62.7 -46.42 88.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.369 1.068 . . . . 0.0 111.911 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.88 -41.89 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.388 0.54 . . . . 0.0 111.342 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.58 -34.23 65.01 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.977 0.808 . . . . 0.0 112.868 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.43 80.62 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.022 -1.049 . . . . 0.0 112.178 173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.11 -39.56 82.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.804 0.841 . . . . 0.0 112.437 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.74 -34.38 77.75 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.347 0.659 . . . . 0.0 111.971 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -85.07 -12.11 53.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.215 1.006 . . . . 0.0 113.571 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.49 -6.2 82.79 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 125.855 1.693 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -68.79 -37.41 79.27 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.01 1.324 . . . . 0.0 111.55 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.02 -40.73 96.69 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.933 -0.48 . . . . 0.0 111.17 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -60.74 -48.12 83.23 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.376 0.535 . . . . 0.0 109.8 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -61.2 -44.48 97.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.348 0.659 . . . . 0.0 112.01 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.28 -35.44 76.04 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.382 -0.824 . . . . 0.0 113.057 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.08 -41.39 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.528 1.058 . . . . 0.0 110.672 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -59.59 -45.78 90.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.352 0.978 . . . . 0.0 110.913 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -57.8 -43.05 85.39 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.472 -0.767 . . . . 0.0 111.674 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.19 66.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.85 -36.82 14.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.631 0.772 . . . . 0.0 113.021 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.92 -25.39 26.15 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.255 1.395 0 C-N-CA 128.163 2.585 . . . . 0.0 113.275 174.484 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 119.893 -0.098 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 133.99 48.03 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.7 tp -159.25 101.38 1.56 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.604 1.561 . . . . 0.0 108.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.5 p -92.62 159.96 35.44 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.751 1.22 . . . . 0.0 112.023 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.73 -36.37 94.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 112.705 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.65 91.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.87 -48.15 77.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.519 0.727 . . . . 0.0 110.421 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.39 -42.9 88.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.769 -0.582 . . . . 0.0 112.081 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -66.96 -38.94 87.02 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.243 1.817 . . . . 0.0 111.884 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.6 m -63.82 -49.89 71.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.175 0.99 . . . . 0.0 110.475 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.91 -43.7 95.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.07 0.948 . . . . 0.0 111.394 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.63 -45.13 92.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.075 0.852 . . . . 0.0 112.618 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.4 -42.57 96.22 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -0.934 . . . . 0.0 111.356 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -60.82 -48.63 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.277 -0.89 . . . . 0.0 111.583 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.02 -38.03 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.553 1.141 . . . . 0.0 113.44 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -81.34 -33.36 32.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.938 0.895 . . . . 0.0 112.824 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -77.59 -32.26 53.5 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -134.23 112.42 11.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.145 1.378 . . . . 0.0 110.437 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -59.86 -38.16 81.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.95 134.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.192 1.797 . . . . 0.0 109.171 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 t -133.24 130.52 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.464 1.106 . . . . 0.0 109.903 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.19 127.21 41.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.084 0.954 . . . . 0.0 110.272 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.99 124.47 52.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -164.91 -177.82 4.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.846 1.658 . . . . 0.0 110.433 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.61 38.1 0.61 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.46 -1.4 . . . . 0.0 113.114 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.83 160.62 31.64 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 125.339 1.447 . . . . 0.0 113.368 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 p -96.93 -179.42 4.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.372 1.469 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -68.25 -29.75 68.63 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.608 -0.683 . . . . 0.0 112.337 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -80.55 -34.18 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.039 1.336 . . . . 0.0 112.502 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.01 76.2 67.13 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.612 1.565 . . . . 0.0 110.365 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.84 170.98 19.17 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.433 2.756 . . . . 0.0 111.569 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -114.02 136.51 52.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.98 0.912 . . . . 0.0 110.397 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.0 t -71.16 156.29 39.75 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.493 1.117 . . . . 0.0 112.313 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.49 -149.42 19.24 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 125.36 1.457 . . . . 0.0 111.803 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.03 -30.17 65.92 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -56.74 -53.37 58.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.314 1.446 . . . . 0.0 111.653 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.29 -40.29 89.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.373 -0.829 . . . . 0.0 110.653 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -58.59 -50.11 75.01 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.724 0.809 . . . . 0.0 111.321 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.21 -35.58 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.648 1.113 . . . . 0.0 112.517 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.27 -47.31 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.208 0.913 . . . . 0.0 111.054 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -65.04 -39.64 93.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.862 0.865 . . . . 0.0 112.312 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt -56.66 -49.49 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.59 1.156 . . . . 0.0 111.996 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.66 -51.33 67.66 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.078 0.854 . . . . 0.0 111.055 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -49.02 -57.06 7.16 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.458 0.703 . . . . 0.0 110.128 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 t -65.68 -33.58 76.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.832 2.053 . . . . 0.0 114.605 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.59 -28.31 67.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.819 0.736 . . . . 0.0 111.123 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 t30 110.96 57.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.96 3.304 . . . . 0.0 109.621 169.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.23 142.77 22.28 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.88 162.44 26.59 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.137 3.225 . . . . 0.0 110.499 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -163.65 165.94 22.84 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.255 1.022 . . . . 0.0 112.285 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.25 162.19 23.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 108.257 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.8 m -144.52 128.43 17.42 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 119.979 -1.701 . . . . 0.0 111.483 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.9 131.19 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.813 1.245 . . . . 0.0 110.289 -169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -75.7 110.02 9.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.136 0.574 . . . . 0.0 110.849 174.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -61.0 -29.74 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -87.57 8.13 26.52 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.671 1.188 . . . . 0.0 113.208 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.87 -31.07 71.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.955 0.902 . . . . 0.0 113.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.33 154.5 30.69 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.193 0.997 . . . . 0.0 111.693 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.716 1.207 . . . . 0.0 113.91 -169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.27 -31.85 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.39 -54.95 15.98 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.743 0.817 . . . . 0.0 110.963 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -57.87 -29.85 65.35 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.6 -37.99 11.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.98 -32.19 27.03 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 118.904 0.775 . . . . 0.0 113.428 -172.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.38 -36.94 74.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.881 0.872 . . . . 0.0 112.222 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.29 -53.34 45.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.151 1.38 . . . . 0.0 112.63 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -81.66 -23.88 36.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -67.08 -48.86 66.94 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.937 0.79 . . . . 0.0 112.471 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.0 p -77.84 -46.8 20.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.017 0.826 . . . . 0.0 112.081 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m 122.87 -26.11 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 1 C-N-CA 132.879 4.471 . . . . 0.0 112.693 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.08 142.14 68.3 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.514 -0.741 . . . . 0.0 112.034 -174.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.12 -13.17 11.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.027 2.485 . . . . 0.0 116.162 -169.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -138.67 169.25 18.12 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.892 1.224 . . . . 0.0 112.521 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -137.06 155.85 75.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.737 1.615 . . . . 0.0 110.719 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.17 156.6 47.72 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.602 1.251 . . . . 0.0 115.281 -1.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.73 134.76 8.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.338 1.055 . . . . 0.0 110.968 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.48 140.99 38.55 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.36 1.064 . . . . 0.0 111.197 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -131.97 132.6 43.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.252 1.821 . . . . 0.0 109.239 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.28 125.21 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.204 1.002 . . . . 0.0 109.348 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.3 22.83 5.09 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.34 48.87 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.308 0.956 . . . . 0.0 114.932 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.13 145.13 45.5 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.001 1.4 . . . . 0.0 110.993 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -76.87 143.9 39.36 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.265 -0.897 . . . . 0.0 111.97 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -103.76 -26.75 12.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.512 1.125 . . . . 0.0 112.055 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.36 -168.66 12.95 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 125.427 1.489 . . . . 0.0 113.55 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.36 172.67 55.12 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.789 1.185 . . . . 0.0 114.085 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 83.6 m -65.83 -41.99 91.11 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -63.45 -42.65 98.66 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.73 0.696 . . . . 0.0 111.376 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.63 -42.79 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 0.0 109.987 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -64.0 -42.78 97.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.935 1.294 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.39 -39.95 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.062 0.945 . . . . 0.0 111.519 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.22 -39.5 82.37 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.453 1.024 . . . . 0.0 112.435 173.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.68 91.68 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.72 0.808 . . . . 0.0 112.352 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -61.33 -45.2 95.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.243 1.417 . . . . 0.0 112.313 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -67.51 -29.17 68.52 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.966 0.906 . . . . 0.0 112.636 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -88.01 -12.85 43.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.459 1.104 . . . . 0.0 113.446 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.17 -1.44 87.62 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.65 1.595 . . . . 0.0 114.428 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.93 -35.29 69.58 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 111.822 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -49.06 76.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.423 0.689 . . . . 0.0 110.042 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -56.72 -49.03 76.4 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.122 0.969 . . . . 0.0 110.711 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.05 -46.91 88.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.405 0.682 . . . . 0.0 111.786 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.94 -36.17 77.64 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.51 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.543 1.065 . . . . 0.0 110.751 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.58 -46.52 89.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.703 1.138 . . . . 0.0 111.36 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.11 -39.95 88.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.004 0.922 . . . . 0.0 112.555 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.05 78.36 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.572 -0.705 . . . . 0.0 111.966 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 mmt -67.27 -38.19 84.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.865 0.866 . . . . 0.0 112.805 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.2 p -79.5 -23.97 42.61 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.255 1.373 0 C-N-CA 127.265 2.226 . . . . 0.0 112.811 177.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.751 -0.643 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.91 79.95 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.17 156.7 16.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.138 1.375 . . . . 0.0 109.858 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -81.53 154.78 71.43 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.655 0.782 . . . . 0.0 111.243 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.31 -37.43 95.2 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.122 2.548 . . . . 0.0 112.151 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.29 96.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.442 1.097 . . . . 0.0 112.902 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.43 -54.43 43.65 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.819 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.26 -37.71 84.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.6 m -65.05 -40.99 95.54 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.883 1.673 . . . . 0.0 111.887 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.9 m -63.42 -48.18 78.86 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.861 0.864 . . . . 0.0 110.737 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.63 -49.32 77.95 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.247 0.619 . . . . 0.0 111.565 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.81 -45.16 86.53 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.668 0.787 . . . . 0.0 112.373 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -61.4 -44.66 96.76 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 111.787 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.9 -46.95 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.201 0.909 . . . . 0.0 111.484 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 t -60.19 -43.75 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 112.107 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -78.36 -29.05 47.26 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 m -79.96 -39.03 31.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -114.28 -10.97 12.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 60.97 -58.87 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.059 2.544 . . . . 0.0 114.813 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.46 125.77 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.414 1.486 . . . . 0.0 108.877 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.79 128.07 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.018 0.927 . . . . 0.0 110.761 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.42 142.13 34.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.038 1.335 . . . . 0.0 110.32 173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -116.16 119.23 35.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.525 1.53 . . . . 0.0 109.624 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -174.19 -169.16 0.44 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.677 1.991 . . . . 0.0 110.038 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -91.59 -18.44 24.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 171.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.01 156.06 30.72 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.154 1.359 . . . . 0.0 113.143 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.7 p -86.85 177.31 7.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.073 1.349 . . . . 0.0 111.446 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.67 -28.78 69.84 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -87.68 -33.3 18.82 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.02 1.328 . . . . 0.0 112.475 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -120.56 84.7 36.85 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.13 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 139.35 52.03 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.523 2.149 . . . . 0.0 108.868 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -0.31 56.25 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.0 t -160.24 163.44 33.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.146 1.379 . . . . 0.0 111.613 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.61 -32.59 84.68 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.029 0.823 . . . . 0.0 113.058 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -73.3 -46.26 50.63 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.332 1.066 . . . . 0.0 112.364 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.6 p -62.31 -45.67 92.2 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.562 -0.712 . . . . 0.0 110.914 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -54.76 -46.72 74.38 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.094 0.958 . . . . 0.0 111.279 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.6 m -59.34 -51.61 69.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.092 0.957 . . . . 0.0 110.762 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.81 -37.89 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.846 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.16 -34.14 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 120.656 1.571 . . . . 0.0 111.92 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.02 -44.34 89.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.637 0.653 . . . . 0.0 111.223 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.2 mt -59.04 -51.69 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 111.034 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.0 -50.61 71.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.401 1.08 . . . . 0.0 110.591 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.79 -51.43 68.97 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.184 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -68.23 -32.7 73.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.433 1.493 . . . . 0.0 114.05 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.45 -32.67 70.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.908 1.283 . . . . 0.0 110.609 170.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 118.7 72.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 129.989 3.316 . . . . 0.0 110.711 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.45 140.9 13.4 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.96 158.39 34.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.141 2.561 . . . . 0.0 108.248 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.88 172.6 17.76 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -146.51 155.3 42.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.911 1.284 . . . . 0.0 110.367 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 t -118.26 129.87 55.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.44 -0.787 . . . . 0.0 110.821 172.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -97.06 121.89 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.661 1.184 . . . . 0.0 108.485 173.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -74.23 90.47 2.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.593 1.157 . . . . 0.0 110.191 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pt -69.81 -17.51 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 -1.92 55.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.717 1.207 . . . . 0.0 113.116 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -64.25 -28.77 69.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.141 0.882 . . . . 0.0 112.975 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -159.27 162.27 36.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.242 1.417 . . . . 0.0 112.111 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.85 -31.58 70.64 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.533 -0.729 . . . . 0.0 112.781 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.63 -39.83 95.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.83 0.741 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.52 -51.49 56.08 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.89 -0.506 . . . . 0.0 110.914 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -56.01 -44.99 79.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.216 1.006 . . . . 0.0 112.858 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -83.34 -24.82 31.93 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.646 0.778 . . . . 0.0 112.658 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.57 -40.02 6.51 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.296 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.17 -33.55 74.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.493 1.647 . . . . 0.0 113.401 -170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -60.82 -31.38 70.79 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -83.45 -34.85 25.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.185 0.994 . . . . 0.0 112.158 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.23 -42.32 94.96 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.217 1.007 . . . . 0.0 112.337 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.9 p -83.47 -67.54 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.829 0.852 . . . . 0.0 112.695 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.6 m 135.05 -23.71 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 1 C-N-CA 133.341 4.657 . . . . 0.0 111.218 -173.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -83.81 132.17 49.61 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.23 1.012 . . . . 0.0 111.775 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.02 -25.83 2.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.826 2.351 . . . . 0.0 114.72 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -95.93 151.55 19.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.563 1.145 . . . . 0.0 111.521 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -127.83 151.12 75.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.652 1.581 . . . . 0.0 110.605 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.79 155.95 52.55 Favored 'Cis proline' 0 C--N 1.355 0.869 0 CA-C-N 120.694 1.283 . . . . 0.0 114.422 -2.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -150.49 143.08 24.5 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.987 0.915 . . . . 0.0 110.728 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 tp -110.32 146.81 35.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.317 1.447 . . . . 0.0 111.458 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -148.76 137.81 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.825 2.05 . . . . 0.0 109.392 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -142.62 122.54 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.183 -0.948 . . . . 0.0 111.611 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.83 33.64 6.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.563 1.945 . . . . 0.0 115.284 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.95 -0.78 51.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.813 1.197 . . . . 0.0 115.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.51 141.0 48.87 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.033 1.417 . . . . 0.0 110.763 173.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -84.1 144.25 29.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.448 -0.783 . . . . 0.0 110.669 170.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.93 -31.69 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.969 0.908 . . . . 0.0 112.285 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.48 -151.2 17.06 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.055 1.312 . . . . 0.0 112.134 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.58 162.69 49.38 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 124.157 0.884 . . . . 0.0 112.934 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -56.23 -35.89 67.86 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.3 -39.97 84.73 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.633 0.773 . . . . 0.0 112.036 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.39 -42.22 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.406 0.682 . . . . 0.0 109.848 175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 m -62.07 -47.27 85.45 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.469 1.108 . . . . 0.0 111.051 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.11 -44.72 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 0.0 111.338 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.35 -37.26 77.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.897 0.771 . . . . 0.0 112.444 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -29.91 70.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 113.048 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -70.85 -33.6 70.81 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.339 -0.851 . . . . 0.0 112.267 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.55 -40.38 76.85 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.9 p -81.05 -17.53 49.83 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.201 -0.937 . . . . 0.0 113.208 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.97 -0.79 69.83 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.336 1.446 . . . . 0.0 113.57 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.21 -36.93 84.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.95 1.3 . . . . 0.0 111.889 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.61 -40.68 97.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.321 0.648 . . . . 0.0 111.189 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.97 -44.34 94.51 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.965 0.506 . . . . 0.0 110.039 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -61.92 -44.17 97.33 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.326 173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -69.22 -38.84 78.76 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.796 1.18 . . . . 0.0 112.439 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.86 -39.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 118.859 0.754 . . . . 0.0 110.626 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.85 -45.88 92.78 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.132 0.878 . . . . 0.0 111.37 170.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -59.15 -44.85 92.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.97 0.908 . . . . 0.0 111.772 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.04 96.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.755 1.222 . . . . 0.0 112.807 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.9 mmt -73.57 -33.98 64.92 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.333 -0.854 . . . . 0.0 112.092 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.67 -47.0 70.74 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.037 0.935 . . . . 0.0 112.628 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.258 1.508 0 C-N-CA 128.755 2.822 . . . . 0.0 114.702 -175.249 . . . . . . . . 0 0 . 1 stop_ save_